<SEC-DOCUMENT>0001140361-24-046512.txt : 20241113
<SEC-HEADER>0001140361-24-046512.hdr.sgml : 20241113
<ACCEPTANCE-DATETIME>20241113171607
ACCESSION NUMBER:		0001140361-24-046512
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		31
CONFORMED PERIOD OF REPORT:	20241106
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Completion of Acquisition or Disposition of Assets
ITEM INFORMATION:		Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Material Modifications to Rights of Security Holders
ITEM INFORMATION:		Changes in Control of Registrant
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
ITEM INFORMATION:		Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20241113
DATE AS OF CHANGE:		20241113

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			DevvStream Corp.
		CENTRAL INDEX KEY:			0001854480
		STANDARD INDUSTRIAL CLASSIFICATION:	INVESTORS, NEC [6799]
		ORGANIZATION NAME:           	05 Real Estate & Construction
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40977
		FILM NUMBER:		241455665

	BUSINESS ADDRESS:	
		STREET 1:		2133 - 1177 W. HASTINGS STREET
		CITY:			VANCOUVER
		STATE:			A1
		ZIP:			V6E 2K3
		BUSINESS PHONE:		647-689-6041

	MAIL ADDRESS:	
		STREET 1:		2133 - 1177 W. HASTINGS STREET
		CITY:			VANCOUVER
		STATE:			A1
		ZIP:			V6E 2K3

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Focus Impact Acquisition Corp.
		DATE OF NAME CHANGE:	20210331
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ef20038430_8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:srt="http://fasb.org/srt/2024" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:currency="http://xbrl.sec.gov/currency/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:naics="http://xbrl.sec.gov/naics/2024" xmlns:sic="http://xbrl.sec.gov/sic/2024" xmlns:stpr="http://xbrl.sec.gov/stpr/2024" xmlns:exch="http://xbrl.sec.gov/exch/2024" xmlns:cef="http://xbrl.sec.gov/cef/2024" xmlns:cyd="http://xbrl.sec.gov/cyd/2024" xmlns:fiac="http://auldbrasspartners.com/20241106" xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 24.9.1.5252
         Copyright 1995 - 2024 Broadridge -->
    <meta http-equiv="Content-Type" content="text/html"/>
</head>

<body style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; background-color: #ffffff;">
<div id="DSPFiXBRLHidden" style="display: none;"><ix:header><ix:hidden><ix:nonNumeric name="dei:AmendmentFlag" id="Fact_6aef2da6017649ca8eaf9ef1cbb46fa5" contextRef="c20241106to20241106" format="ixt:fixed-false">false</ix:nonNumeric><ix:nonNumeric name="dei:CurrentFiscalYearEndDate" id="Fact_01468f25e490424da8667e9f9557717c" contextRef="c20241106to20241106" format="ixt:date-month-day">12-31</ix:nonNumeric><ix:nonNumeric name="dei:EntityCentralIndexKey" id="Fact_3bcebf742a8848dd80751ab414941c8a" contextRef="c20241106to20241106">0001854480</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="fiac-20241106.xsd" xlink:type="simple"/></ix:references><ix:resources><xbrli:context id="c20241106to20241106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001854480</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-11-06</xbrli:startDate><xbrli:endDate>2024-11-06</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>
<div style="line-height: initial;">
  <div><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span></div>

  <div>
    <hr style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"/>
    <div>
      <div>
        <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 14pt; font-weight: bold;">UNITED STATES</div>

        <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 14pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>

        <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;">Washington, D.C. 20549</div>

        <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>

      </div>

      <div>
        <div style="font-family: 'Times New Roman'; font-size: 10pt;">
          <hr style="height: 2px; width: 20%; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;"/></div>

        <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>

      </div>

      <div style="font-family: 'Times New Roman'; font-size: 18pt;">
        <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">FORM <ix:nonNumeric name="dei:DocumentType" id="Fact_9dc2d34fc96a46a4b6df842da5fb07e7" contextRef="c20241106to20241106">8-K</ix:nonNumeric></div>

      </div>

      <div>
        <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span><span style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
          </span></div>

        <div style="font-family: 'Times New Roman'; font-size: 10pt;">
          <hr style="height: 2px; width: 20%; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;"/></div>

        <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>

      </div>

      <div>
        <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">CURRENT REPORT</div>

        <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Pursuant to Section 13 or Section 15(d)</div>

        <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">of the Securities Exchange Act of 1934</div>

      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
        <div>
          <div style="text-align: center;">
<div>Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" id="Fact_61baca87c3ba484e99fce19ab406f016" contextRef="c20241106to20241106" format="ixt:date-monthname-day-year-en">November 6, 2024</ix:nonNumeric></div>

            <div><br/>
            </div>

          </div>

          <div style="font-family: 'Times New Roman'; font-size: 10pt;">
            <hr style="height: 2px; width: 20%; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;"/></div>

        </div>

      </div>

      <div>
        <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>

        <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 24pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityRegistrantName" id="Fact_79488c88d7ec43f89c11163737988078" contextRef="c20241106to20241106">DEVVSTREAM CORP.</ix:nonNumeric><br/>
        </div>

        <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(Exact name of registrant as specified in its charter)</div>

        <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>

      </div>

      <div>
        <div style="font-family: 'Times New Roman'; font-size: 10pt;">
          <hr style="height: 2px; width: 20%; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;"/></div>

        <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>

      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 33%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" id="Fact_d9b828f9166c455ab41606de79c398df" contextRef="c20241106to20241106" format="ixt-sec:edgarprovcountryen">Alberta</ix:nonNumeric>, Canada</div>
            </td>

    <td style="width: 34%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"><ix:nonNumeric name="dei:EntityFileNumber" id="Fact_06077e7ca8674217baa379bf6e6676af" contextRef="c20241106to20241106">001-40977</ix:nonNumeric><br/>
              </div>
            </td>

    <td style="width: 33%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" id="Fact_0280d14b08724b04b8c86ba6bc7258d2" contextRef="c20241106to20241106">86-2433757</ix:nonNumeric><br/>
              </div>
            </td>

  </tr>

  <tr>

    <td style="width: 33%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;">
              <div style="text-align: center; color: rgb(0, 0, 0);">(State or other jurisdiction of incorporation or organization)</div>
            </td>

    <td style="width: 34%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0);">(Commission File Number)</div>
            </td>

    <td style="width: 33%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0);">(I.R.S. Employer Identification No.)</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
        <div><br/>
        </div>

      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 49%; vertical-align: bottom;">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">
                <div style="text-align: center; color: rgb(74, 74, 74); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:EntityAddressAddressLine1" id="Fact_f55bbaa99b6a41938500ced7c8730859" contextRef="c20241106to20241106">2108 N St., Suite 4254</ix:nonNumeric><br/>
                </div>
              </div>
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">
                <div style="text-align: center; color: rgb(74, 74, 74); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:EntityAddressCityOrTown" id="Fact_944d8a61959545d39e5896d2c36bddfa" contextRef="c20241106to20241106">Sacramento</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" id="Fact_70adaa552b73496e948b78e8d93e9e4b" contextRef="c20241106to20241106" format="ixt-sec:stateprovnameen">California</ix:nonNumeric></div>
              </div>
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(Address of principal executive offices)</div>
            </td>

    <td style="width: 2%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 49%; vertical-align: bottom;">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">
                <div style="text-align: center; color: rgb(71, 71, 71); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" id="Fact_83b6a4ede69b49399c64f4676fb99fb5" contextRef="c20241106to20241106">95816</ix:nonNumeric><br/>
                </div>
                (Zip Code)</div>
            </td>

  </tr>


</table>
      <div>
        <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(<ix:nonNumeric name="dei:CityAreaCode" id="Fact_0f666df4c42e4a55b6fe7cd95a898cf1" contextRef="c20241106to20241106">647</ix:nonNumeric>) <ix:nonNumeric name="dei:LocalPhoneNumber" id="Fact_fe616e4f45604ea3b5e2612032acbfdb" contextRef="c20241106to20241106">689-6041</ix:nonNumeric></div>

        <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(Registrant&#8217;s telephone number, including area code)</div>

      </div>

      <div>
        <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span><span style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
          </span></div>

      </div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Focus Impact Acquisition Corp.</div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">345 Avenue of the Americas, 33rd Floor</div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">New York, NY 10105</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
        <div style="text-align: center; color: rgb(0, 0, 0); font-size: 10pt;">(Former name or former address, if changed since last report)</div>

        <div style="text-align: center; color: rgb(0, 0, 0);"> <span style="font-size: 10pt;"><br/>
          </span></div>

      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
        <div>
          <hr style="height: 2px; width: 20%; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;"/>
          <div> <span style="font-size: 10pt;"><br/>
            </span></div>

        </div>

      </div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the
        following provisions:</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

      <div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;">


  <tr style="vertical-align: top;">

    <td style="text-align: right; vertical-align: top; width: 18pt;">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:WrittenCommunications" id="Fact_9db15126f62e45abb375a183157c2075" contextRef="c20241106to20241106" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric><br/>
                </div>
              </td>

    <td style="text-align: left; vertical-align: top; width: auto;">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</div>
              </td>

  </tr>


</table>
      </div>

      <div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;">


  <tr style="vertical-align: top;">

    <td style="text-align: left; vertical-align: top; width: 18pt;"><ix:nonNumeric name="dei:SolicitingMaterial" id="Fact_d1702915bad04d20b1a72cc949abdd81" contextRef="c20241106to20241106" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric><br/>
              </td>

    <td style="text-align: left; vertical-align: top; width: auto;">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</div>
              </td>

  </tr>


</table>
      </div>

      <div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;">


  <tr style="vertical-align: top;">

    <td style="text-align: right; vertical-align: top; width: 18pt;">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:PreCommencementTenderOffer" id="Fact_9818771142f948a0a5de7dd552aa305b" contextRef="c20241106to20241106" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric><br/>
                </div>
              </td>

    <td style="text-align: left; vertical-align: top; width: auto;">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</div>
              </td>

  </tr>


</table>
      </div>

      <div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;">


  <tr style="vertical-align: top;">

    <td style="text-align: right; vertical-align: top; width: 18pt;">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" id="Fact_38a2b1734d5845bf9dfc63ed3d1a6c51" contextRef="c20241106to20241106" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric><br/>
                </div>
              </td>

    <td style="text-align: left; vertical-align: top; width: auto;">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</div>
              </td>

  </tr>


</table>
      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
        <div style="text-align: left; color: rgb(0, 0, 0);">Securities registered pursuant to Section 12(b) of the Act:</div>

        <div style="text-align: left; color: rgb(0, 0, 0);"> <br/>
        </div>

      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 33%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Title of each class</div>
            </td>

    <td style="width: 34%; vertical-align: bottom;">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Trading</div>
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Symbol(s)</div>
            </td>

    <td style="width: 32.65%; vertical-align: bottom;">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Name of each exchange on</div>
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">which registered</div>
            </td>

  </tr>

  <tr>

    <td style="width: 33%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; text-align: center;"><ix:nonNumeric name="dei:Security12bTitle" id="Fact_09eb785f23054fb080d0e8e0bbe96205" contextRef="c20241106to20241106">Common shares</ix:nonNumeric><br/>
            </td>

    <td style="width: 34%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; text-align: center;"><ix:nonNumeric name="dei:TradingSymbol" id="Fact_7426a65284b843448961634b4fd52d7a" contextRef="c20241106to20241106">DEVS</ix:nonNumeric><br/>
            </td>

    <td style="width: 32.65%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0);"><ix:nonNumeric name="dei:SecurityExchangeName" id="Fact_f171f6715996479f95c531fceaa43512" contextRef="c20241106to20241106" format="ixt-sec:exchnameen">The Nasdaq Stock Market LLC</ix:nonNumeric><br/>
              </div>
            </td>

  </tr>


</table>
      <div>
        <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
        </div>

        <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the
          Securities Exchange Act of 1934.</div>

        <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Emerging growth company <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" id="Fact_7dc736359f6248ddaeb02acbac86ce2e" contextRef="c20241106to20241106" format="ixt-sec:boolballotbox">&#9746;</ix:nonNumeric></div>

        <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new
          or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <ix:nonNumeric name="dei:EntityExTransitionPeriod" id="Fact_40362fdaad5d496ba5cc5d4958a35da4" contextRef="c20241106to20241106" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></div>

      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
        <hr style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"/></div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

      </div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Introductory Note</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">On November 6, 2024 (the &#8220;Closing Date&#8221;), Focus Impact Acquisition Corp. and our predecessor company (&#8220;FIAC&#8221;) consummated the previously announced
        business combination with DevvStream Holdings Inc., a company existing under the Laws of the Province of British Columbia (&#8220;DevvStream&#8221;) pursuant to the Business Combination Agreement, <span style="color: rgb(0, 0, 0);">dated as of September 12,
          2023 (as amended by Amendment No. 1 to the Business Combination Agreement dated May 1, 2024, as further amended by Amendment No. 2 to the Business Combination Agreement dated August 10, 2024, and as further amended by Amendment No. 3 to the
          Business Combination Agreement dated October 29, 2024, the &#8220;Business Combination Agreement&#8221;), by and among FIAC,</span>&#160;<span style="color: rgb(0, 0, 0);">Focus Impact Amalco Sub Ltd. (&#8220;Amalco Sub&#8221;) and DevvStream.</span></div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Pursuant to the Business Combination Agreement, on the Closing Date, (a) FIAC changed its jurisdiction from the State of Delaware under
        the Delaware General Corporation Law to the Province of Alberta, Canada, and thereby become a company existing under the Business Corporations Act (Alberta) and changed its name to DevvStream Corp. (&#8220;New PubCo&#8221; or the &#8220;Company&#8221;), and (b) DevvStream
        and Amalco Sub amalgamated to form one corporate entity (such entity, &#8220;Amalco&#8221; and such transaction, the &#8220;Amalgamation&#8221;).</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">On November 6, 2024, New PubCo also issued (i) 194,809 common shares of New PubCo (the &#8220;New PubCo Common Shares&#8221;) to certain investors
        pursuant to subscription agreements, dated October 29, 2024, including a subscription agreement with Helena Global Investment Opportunities I Ltd. (such agreements together, the &#8220;PIPE Agreements&#8221;) for $2,250,000 in the aggregate, and (ii) 3,249,877
        New PubCo Common Shares to certain investors, including Karbon-X Corp, pursuant to certain carbon credit subscription agreements dated October 29, 2024 (such agreements together, the &#8220;Carbon Subscription Agreements&#8221;) (items (i) and (ii) in the
        foregoing together, the &#8220;PIPE Financing&#8221;). The Carbon Subscription Agreements were executed in connection with certain Carbon Credit Purchase Agreements with DevvStream (the &#8220;Carbon Credit Purchase Agreements&#8221;), pursuant to which DevvStream is
        purchasing carbon credits from certain sellers (&#8220;Carbon Credit Sellers&#8221;). The New PubCo Common Shares that are being issued to such Carbon Credit Sellers pursuant to the Carbon Subscription Agreements are being issued to the Carbon Credit Sellers
        in satisfaction of the purchase price owed to them under the Carbon Credit Purchase Agreements.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">As previously reported prior to the consummation of the Business Combination (as defined below), on October 29, 2024, FIAC entered into
        an amendment (the &#8220;Amendment to the Sponsor Side Letter Agreement&#8221;) to the side letter agreement, dated September 12, 2023, which was subsequently amended on May 1, 2024, by and among FIAC and the Sponsor (as amended, the &#8220;Letter Agreement&#8221;).
        Pursuant to the Amendment to the Sponsor Side Letter Agreement, FIAC amended the transfer restrictions included therein to enable the Sponsor to transfer on October 29, 2024 up to 5,750,000 shares of common stock of the Company (such shares of
        common stock that are being transferred, the &#8220;Sponsor Shares&#8221;) to (i) certain advisor parties in full or partial satisfaction of such advisor parties&#8217; fees and expenses incurred in connection with the the Business Combination with DevvStream
        (approximately $15.1 million of fees and expenses are being satisfied through the transfer of Sponsor Shares to advisor parties) (the &#8220;Equitization&#8221;), (ii) certain investors subscribing to PIPE Agreements (as defined below), and (iii) Helena Global
        Investment Opportunities I Ltd. as consideration for the execution of an equity line of credit purchase agreement, dated October 29, 2024 with FIAC and the Sponsor (the &#8220;ELOC Agreement&#8221;). On October 29, 2024, FIAC had also determined that it is
        advisable and in the best interest of FIAC and its stockholders to waive the transfer restrictions to which the Sponsor Shares were subject and that were included in the certain letter agreement, dated November 1, 2021, by and between FIAC and the
        Sponsor. Pursuant to the Amendment to the Sponsor Side Letter Agreement, FIAC agreed that in connection with the Closing (as defined below), the Sponsor will be issued New PubCo Common Shares in an amount that is equal to the number of Sponsor
        Shares that the Sponsor agreed to transfer prior to the Closing, as described in the foregoing items (i) to (iii).</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

      </div>

      <div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Further, as previously reported prior to the Closing, FIAC entered into a contribution and exchange agreement (the &#8220;Monroe Agreement&#8221;)
        on October 29, 2024, pursuant to which, among other things, Crestmont Investments LLC, a Delaware limited liability company, will, immediately following the Closing, contribute 2,000,000 units representing 50% of the limited liability company
        interests in Monroe Sequestration Partners LLC, a Delaware limited liability company, in exchange for 2,000,000 New PubCo Common Shares, subject to the terms and conditions described in the Monroe Agreement.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Unless the context otherwise requires, &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; and the &#8220;Company&#8221; refer to New PubCo. All references herein to the &#8220;Board&#8221; refer to the board
        of directors of New PubCo. All references herein to the &#8220;Closing&#8221; refer to the closing of the transactions contemplated by the Business Combination Agreement, including the PIPE Financing (the &#8220;Transactions&#8221; or the &#8220;Business Combination&#8221;). Defined
        terms included in this Current Report on Form 8-K (this &#8220;Current Report&#8221;) shall have the same meaning as the defined terms used in the definitive proxy statement/prospectus included in FIAC&#8217;s Registration Statement on Form S-4 (File No. 333-275871)
        that was initially filed with the U.S. Securities and Exchange Commission on December 4, 2024 (as amended, the &#8220;Proxy Statement/Prospectus&#8221;).</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 54pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 1.01.</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Entry into a Material Definitive Agreement.</div>
            </td>

  </tr>


</table>
      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br/>
      </div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> Registration Rights Agreement<br/>
      </div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br/>
      </div>

      <div style="text-align: left; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> On November 6, 2023, New PubCo, Focus Impact Sponsor, LLC, a Delaware limited liability company (the "Sponsor"), and certain
        historical holders of Devvstream securities (the &#8220;Legacy Devvstream Holders&#8221;) will enter into an Amended and Restated Registration Rights Agreement (the &#8220;Registration Rights Agreement&#8221;), pursuant to which, among other things, the Legacy Devvstream
        Holders and Sponsor will be granted customary registration rights with respect to the securities of New PubCo that they hold.<br/>
      </div>

      <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 27pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;&#160; <br/>
        </span></div>

      <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 27pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The foregoing description of the Registration Rights Agreements does not purport to be complete and is qualified in its entirety by the terms and conditions
          thereof, a copy of which is filed as Exhibit 10.13 of this Current Report and is incorporated herein by reference.</span><br/>
      </div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br/>
      </div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Indemnification Agreements</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: left; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">On November 6, 2024, in connection with the consummation of the Business Combination, New PubCo entered into indemnification
        agreements (the &#8220;Indemnification Agreements&#8221;) with each of its directors and executive officers. Each Indemnification Agreement provides for indemnification and advancements by New PubCo of certain expenses, including attorneys&#8217; fees, judgments,
        fines and settlement amounts incurred by a director or executive officer in any action or proceeding arising out of their services as one of New PubCo&#8217;s directors or executive officers or as a director or executive officer of any other company or
        enterprise to which the person provides services at New PubCo&#8217;s request.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The foregoing description of the Indemnification Agreements does not purport to be complete and is qualified in its entirety by the
        terms and conditions thereof, a form of which is filed as Exhibit 10.5 of this Current Report and is incorporated herein by reference.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Strategic Consulting Agreement</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">
        <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;">On November 13, 2024, New PubCo also entered into a strategic consulting agreement with Focus Impact Partners, LLC (the
          &#8220;Consultant&#8221;), pursuant to which the Consultant will provide New PubCo with certain consulting services (the &#8220;Strategic Consulting Agreement&#8221;) and New PubCo will pay the Consultant an annual consulting fee of $500,000, which will be payable in
          quarterly installments of $125,000 starting with an initial payment for the period beginnin December 31, 2023 (pro-rated based on the number of days from December 31, 2023 through and including November 13, 2024). Notwithstanding the foregoing,
          any fees due under the Strategic Consulting Agreement shall accrue and not be payable until (a) New PubCo has successfully raised $5.0 million in outside debt and/or equity capital, cumulatively since the period beginning December 31, 2023 or (b)
          New PubCo has 2 or more consecutive quarters of positive cash flow from operations. New PubCo agrees to pay the Consultant additional consulting fees as to be mutually agreed consistent with market practice in connection with any acquisition,
          merger, consolidation, business combination, sale, divestiture, financing, refinancing, restructuring or other similar transaction for which the Consultant provides consulting services to New PubCo. Further, New PubCo has agreed to issue the
          Sponsor 557,290 New PubCo Common Shares in a private placement pursuant to the Strategic Consulting Agreement in connection with the execution of the Strategic Consulting Agreement. The Strategic Consulting Agreement has a term of three (3) years
          unless terminated early with at least 120 days advance notice and will be automatically extended for successive one (1)-year periods at the end of each year unless New PubCo or the Consultant provide a written notice of its desire not to
          automatically extend at least 120 days prior to the end of each year during the term of the Strategic Consulting Agreement. Pursuant to the Strategic Consulting Agreement, New PubCo has also agreed to customary indemnification of the Consultant
          in connection with the performance of its services.</div>

        <div style="font-weight: normal; text-align: left;">&#160;</div>

        <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;">The foregoing description of the Strategic Consulting Agreement does not purport to be complete and is qualified in its entirety
          by the terms and conditions thereof, a form of which is filed herewith as Exhibit 10.20 of this Current Report and is incorporated herein by reference.</div>

        <div>&#160;</div>

      </div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">New Convertible Notes</div>

      <div><br/>
      </div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">On January 12, 2024, DevvStream issued an unsecured convertible grid note (the &#8220;Focus Partners Convertible Note&#8221;) to the Consultant and as of the date
        hereof, the Consultant had advanced a total of $637,150 to DevvStream under the Focus Convertible Note. Further, New PubCo was indebted to New PubCo for $3,000,000 pursuant to a convertible promissory note dated December 1, 2023 and a convertible
        promissory note, dated May 9, 2023 (together, the &#8220;Focus Sponsor Convertible Notes&#8221;). The terms and conditions of the Focus Partners Convertible Note provided that, following the consummation of the Business Combination, the Consultant would have
        the right to convert its convertible notes or to have its convertible notes repaid at its option. As of the Closing, New PubCo is also indebted to the Consultant in the amount of $345,000 of accrued and unpaid of fees under the administrative
        services agreement, dated October 27, 2021, by and between FIAC and the Sponsor (the &#8220;Unpaid Fees&#8221;). On November 13, 2024, New PubCo issued (i) $3,000,000 of new 5.3% convertible notes to the Sponsor, and (ii) a new $982,150 of new 5.3% convertible
        notes to the Consultant (together, the &#8220;New Convertible Notes&#8221;), in each case in exchange for the cancellation and conversion of the Focus Partners Convertible Note, the Focus Sponsor Convertible Notes and the Unpaid Fees. The New Convertible
        Bridge Notes have a maturity date that is twenty-four months from the Closing. The principal loan amount and any accrued and unpaid interest under the New Convertible Notes are convertible into New PubCo Common Shares at a 25% discount to the
        issuer's 20-day volume weighted average price, subject to a floor of $0.867 per share.</div>

      <div><br/>
      </div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The foregoing description of the New Convertible Notes does not purport to be complete and is qualified in its entirety by the terms and conditions
        thereof, a form of which is filed as Exhibit 10.21 of this Current Report and is incorporated herein by reference.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
        <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Extension of Devvio and Envviron Convertible Notes</div>

        <div><br/>
        </div>

        <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">DevvStream previously issued (i) an unsecured convertible note (the &#8220;Devvio Convertible Note&#8221;) to Devvio Inc. (&#8220;Devvio&#8221;) with a principal amount of
          $100,000, and (ii) an unsecured convertible note (the &#8220;Envviron Convertible Note&#8221;) to Envviron SAS (&#8220;Envviron&#8221;) with a principal amount of $250,000. The terms and conditions of the Devvio Convertible Note and Envviron Convertible Note each
          provided that, following the consummation of the Business Combination, Devvio and Envviron would have the right to convert their convertible notes or to have their convertible notes repaid. As a result of the consummation of the Business
          Combination, the maturity date of the Devvio Convertible Note and the Envviron Convertible Note was accelerated to the date that is 10 business days from the Closing, or November 21, 2024 (the &#8220;Maturity Date&#8221;). On November 6, 2024, New PubCo,
          Devvio and Envviron agreed to amend the terms of the Devvio Convertible Note and Envviron Convertible Note, respectively, in order to extend the Maturity Date by six (6) months.</div>

      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
        <div style="text-align: left; font-family: Helvetica; font-size: 12pt;">
          <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">Employment Agreements</div>

          <div style="font-family: 'Times New Roman';"><br/>
          </div>

          <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The information relating to the employment agreements with Bryan Went, Chris Merkel, and Sunny Trinh in Item 2.01 under "Executive Compensation&#8212;Employment
            Agreements") is incorporated herein by reference.</div>

        </div>

      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
      </div>

      <div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;">


  <tr style="vertical-align: top;">

    <td style="text-align: right; vertical-align: top; width: 54pt;">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 2.01.</div>
              </td>

    <td style="text-align: left; vertical-align: top; width: auto;">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Completion of Acquisition or Disposition of Assets.</div>
              </td>

  </tr>


</table>
      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The disclosure set forth in the &#8220;Introductory Note&#8221; above is incorporated into this Item 2.01 by reference. As previously reported, on September 13,
        2024, FIAC held a special meeting (the &#8220;Extraordinary Special&#8221;) at which the FIAC stockholders considered and adopted, among other matters, the Business Combination Agreement. On November 6, 2024, the parties to the Business Combination Agreement
        consummated the Transactions.</div>

      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

      </div>

      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">In connection with the shareholder meeting to approve the Business Combination (the &#8220;Business Combination Approval Meeting&#8221;) and the subsequent vote on
        October 31, 2024 to approve the extension of the time period during which FIAC may consummate a business combination, the holders of 1,569,414 shares of Class A Common Stock exercised their right to redeem their shares for cash, as provided for,
        prior to the Closing, in FIAC&#8217;s amended and restate certificate of incorporation.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">In connection with the Closing, (i) 3,444,686 New PubCo Common Shares were issued in the PIPE Financing, (ii) 5,148,164 shares of Class A Common Stock
        held by pre-Business Combination holders of FIAC were converted into 4,989,600 New PubCo Common Shares, (iii) the Sponsor <span style="color: rgb(0, 0, 0);">forfeited 575,000 shares of Class B Common Stock</span> of FIAC and was issued 5,000,531
        New PubCo Common Shares pursuant to the Letter Agreement <span style="color: rgb(0, 0, 0);">and upon conversion of 15,558 shares Class B Common Stock held by the Sponsor at the time of the Closing</span>, (iv) each redeemable warrant that was
        issued in connection with FIAC&#8217;s initial public offering that closed November 1, 2021 (the &#8220;FIAC IPO&#8221;) and that was exercisable for one share of Class A Common Stock at an exercise price of $11.50 (collectively, the &#8220;FIAC Warrants&#8221;) and each
        private placement warrant which was issued to the Sponsor in connection with the FIAC IPO and which entitles the holder thereof to purchase one whole share of Class A Common Stock at $11.50 per share (the &#8220;Private Placement Warrants&#8221; and together
        with the FIAC Warrants, the &#8220;Warrants&#8221;), were assumed by New PubCo and converted into a warrant to purchase a number of New PubCo Common Shares equal to the Reverse Split Factor at an exercise price equal to the Adjusted Exercise Price, on
        substantially similar terms as the Private Placement Warrants (the &#8220;Converted Private Placement Warrants&#8221; and together with the Converted Public Warrants, the &#8220;New PubCo Warrants&#8221;), (v) each of DevvStream&#8217;s multiple voting shares (the &#8220;Multiple
        Voting Company Shares&#8221;) and DevvStream&#8217;s subordinate voting shares (the &#8220;Subordinated Voting Company Shares&#8221; and together with the Multiple Voting Company Shares, the &#8220;Company Shares&#8221;) issued and outstanding immediately prior to the effective time
        of the Amalgamation (the &#8220;Effective Time&#8221;) were automatically exchanged for that certain number of New PubCo Common Shares equal to the applicable Per Common Share Amalgamation Consideration (as defined below), (vi) each option (whether vested or
        unvested) to purchase Company Shares (each, a &#8220;Company Option&#8221;) granted under DevvStream&#8217;s 2022 Equity Incentive Plan, as amended and restated from time to time, and DevvStream&#8217;s 2022 Non-Qualified Stock Option Plan (together, the &#8220;Company Equity
        Incentive Plans&#8221;) and each restricted stock unit representing the right to receive payment in Company Shares, granted under a restricted stock unit award agreement (each, a &#8220;Company RSU&#8221;) issued and outstanding immediately prior to the Effective
        Time was cancelled and converted into an option to purchase a number of New PubCo Common Shares (&#8220;Converted Options&#8221;) and New PubCo restricted stock units (&#8220;Converted RSUs&#8221;), respectively, in an amount equal to the Company Shares underlying such
        Company Option or Company RSU, respectively, multiplied by the Common Conversion Ratio, as defined below (and, for Company Options, at an adjusted exercise price equal to the exercise price for such Company Option immediately prior to the Effective
        Time divided by the Common Conversion Ratio), (vii) each warrant of DevvStream (each, a &#8220;Company Warrant&#8221;) issued and outstanding immediately prior to the Effective Time became exercisable for New PubCo Common Shares in an amount equal to the
        Company Shares underlying such Company Warrant multiplied by the Common Conversion Ratio (&#8220;Converted Warrants&#8221;) (and at an adjusted exercise price equal to the exercise price for such Company Warrant prior to the Effective Time divided by the
        Common Conversion Ratio), (viii) the holder of convertible notes to be issued by DevvStream, if any, issued and outstanding immediately prior to the Effective Time (the &#8220;Company Convertible Notes&#8221;) received New PubCo Common Shares in accordance
        with the terms of such Company Convertible Notes, and (ix) each common share of Amalco Sub issued and outstanding immediately prior to the Effective Time was automatically exchanged for one common share of Amalco.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

      </div>

      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The &#8220;Per Common Share Amalgamation Consideration&#8221; means (i) with respect to each Multiple Voting Company Share, an amount of New PubCo Common Shares
        equal to (a) ten (10), multiplied by (b) the Common Conversion Ratio, and (ii) with respect to each Subordinated Voting Company Share, an amount of New PubCo Common Shares equal to the Common Conversion Ratio. The &#8220;Common Conversion Ratio&#8221; means,
        in respect of a Company Share, 0.152934, which is equal to the Common Amalgamation Consideration divided by the Fully Diluted Common Shares Outstanding. The &#8220;Common Amalgamation Consideration&#8221; means (a)(i) the Reverse Split Factor multiplied by
        (ii)(x) $145 million plus the aggregate exercise price of all in-the-money Company Options and Company Warrants outstanding immediately prior to the Effective Time (or exercised in cash prior to the Effective Time) divided by (y) $10.20, plus (b)
        solely to the extent any Company Shares are required to be issued to Approved Financing Sources pursuant to Approved Financings in connection with the Closing, (i) each such Company Share multiplied by (ii) the Per Common Share Amalgamation
        Consideration in respect of such Company Share. The &#8220;Fully Diluted Common Shares Outstanding&#8221; means, without duplication, at any measurement time (a)(i) ten (10), multiplied by (ii) the aggregate number of Multiple Voting Company Shares that are
        issued and outstanding, plus (b) the aggregate number of Subordinated Voting Company Shares that are issued and outstanding, plus (c) the aggregate number of Subordinated Voting Company Shares to be issued pursuant to the exercise and conversion of
        the Company Options in accordance therewith, plus (d) the aggregate number of Subordinated Voting Company Shares to be issued pursuant to the exercise and conversion of the Company Warrants in accordance therewith, plus (e) the aggregate number of
        Subordinated Voting Company Shares to be issued pursuant to the vesting of the Company RSUs in accordance therewith; provided, that &#8220;Fully Diluted Common Shares Outstanding&#8221; shall not include any Subordinary Voting Company Shares to be issued
        (including pursuant to the exercise and conversion of Company Warrants) to any Approved Financing Source pursuant to an Approved Financing. The &#8220;Reverse Split Factor&#8221; means 0.9692, which is equal to the lesser of (a) the quotient obtained by
        dividing the Final Company Share Price by $0.6316 and (b) one. The &#8220;Final Company Share Price&#8221; means the closing price of the Subordinated Voting Company Shares on the Cboe Canada stock exchange (the &#8220;Cboe Canada&#8221;), as of the end of last trading
        day on the Cboe Canada prior to the Closing (and if there is no such closing price on the last trading day prior to the Closing, the closing price of the Subordinated Voting Company Shares on the last trading day prior to the Closing on which there
        is such a closing price), converted into United States dollars based on the Bank of Canada daily exchange rate on the last business day prior to the Closing. <br/>
      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
        <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">Each New PubCo Warrants is exercisable for 0.9692 New PubCo Common Shares for $11.86 (the "Adjusted Exercise Price"). The Converted Private Placement
          Warrants are also exerciseable cashless pursuant to the terms of the Converted Private Placement Warrants. Pursuant to the terms of the New PubCo Warrants, the exercise price of the New PubCo Warrants will be further adjusted pursuant to a
          provision in the New PubCo Warrants that was triggered in connection with the financing transactions that closed in connection with consummation of the Business Combination and will be adjusted to an exercise price that is equal to 115% of the
          higher of the Market Value and the New Issued Price. &#8220;Market Value&#8221; as used in the foregoing shall mean the volume-weighted average trading price of the New PubCo Common Shares during the twenty (20) trading day period starting on the trading day
          prior to the day on which New PubCo consummated the Business Combination. &#8220;Newly Issued Price&#8221; as used in the foregoing shall mean the issue price or effective issue price (as determined in good faith by the Board), at which New PubCo (or its
          predecessor) issued additional shares or securities convertible into or exercisable or exchangeable for shares for capital raising purposes in connection with the consummation of the Business Combination.</div>

        <div>&#160;</div>

      </div>

      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Immediately after giving effect to the Transactions, there were 27,413,444 New PubCo Common Shares (excluding 557,290 New PubCo Common Shares that are
        issued pursuant to the Strategic Consulting Agreement after the Closing), 11,495,295 Converted Public Warrants (which are exerciseable for cash for up to 11,141,239 New PubCo Common Shares), 11,200,000 Converted Private Placement Warrants (which
        are exerciseable cashless or for cash, and if exercised for cash maybe be exercised for up to 10,855,040 New PubCo Common Shares), 186,065 Converted Warrants, 523,799 Converted Options and 1,168,124 Converted RSUs issued and outstanding. On
        November 7, 2024, the New PubCo Common Shares began trading on the Nasdaq Stock Market LLC (&#8220;Nasdaq&#8221;).</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The material terms and conditions of the Business Combination Agreement are described in the Proxy Statement/Prospectus, in the subsection entitled
        &#8220;The Business Combination Agreement&#8221; of the section titled &#8220;Business Combination Proposal&#8221; beginning on page 119 of the Proxy Statement/Prospectus, which is incorporated herein by reference.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">FORM 10 INFORMATION</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: left; text-indent: 36pt; color: #212529; font-family: 'Times New Roman'; font-size: 10pt;">Item 2.01(f) of Form 8-K states that if the predecessor registrant was a shell company, as FIAC was immediately before the Business
        Combination, then the registrant must disclose the information that would be required if the registrant were filing a general form for registration of securities on Form 10. Accordingly, New PubCo is providing the information below that would be
        included in a Form 10 if New PubCo were to file a Form 10. Please note that the information provided below relates to New PubCo following the consummation of the Business Combination, unless otherwise specifically indicated or the context otherwise
        requires.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

      </div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Forward-Looking Statements</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div>
        <div style="text-align: left; text-indent: 20pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Some of the statements contained in this Current Report constitute forward-looking statements within the meaning of the federal
          securities laws. Forward-looking statements relate to expectations, beliefs, projections, future plans and strategies, anticipated events or trends and similar expressions concerning matters that are not historical facts. Forward-looking
          statements reflect the current views of New PubCo with respect to, among other things, the plans, strategies and prospects, both business and financial, of New PubCo. These statements are based on the beliefs and assumptions of the management of
          New PubCo. Likewise, the financial statements included herein and all of the statements regarding market conditions and results of operations are forward-looking statements. In some cases, you can identify these forward-looking statements by the
          use of terminology such as &#8220;outlook,&#8221; &#8220;believes,&#8221; &#8220;expects,&#8221; &#8220;potential,&#8221; &#8220;continues,&#8221; &#8220;may,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;could,&#8221; &#8220;seeks,&#8221; &#8220;approximately,&#8221; &#8220;predicts,&#8221; &#8220;intends,&#8221; &#8220;plans,&#8221; &#8220;estimates,&#8221; &#8220;projects,&#8221; &#8220;anticipates&#8221; or the negative version of
          these words or other comparable words or phrases.</div>

        <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>

        <div style="text-align: left; text-indent: 20pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The forward-looking statements contained in this Current Report reflect New PubCo&#8217;s current views about future events and are subject
          to numerous known and unknown risks, uncertainties, assumptions and changes in circumstances that may cause its actual results to differ significantly from those expressed in any forward-looking statement. Neither New PubCo can guarantee that the
          transactions and events described will happen as described (or that they will happen at all). The following factors, among others, could cause actual results and future events to differ materially from those set forth or contemplated in the
          forward-looking statements:</div>

      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;">&#160;</td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0);">the ability of New PubCo, following the consummation of the Business Combination, to realize the benefits from the Business Combination;</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; font-family: 'Times New Roman'; font-size: 10pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0);">changes in the market price of New PubCo Common Shares after the Business Combination, which may be affected by factors different from those that affected the price of shares of Class A Common Stock prior to
                the Business Combination;</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; font-family: 'Times New Roman'; font-size: 10pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0);">the ability of New PubCo, to maintain the listing of the New PubCo Common Shares on Nasdaq following the consummation of the Business Combination;</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; font-family: 'Times New Roman'; font-size: 10pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0);">future financial performance following the Business Combination;</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; font-family: 'Times New Roman'; font-size: 10pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0);">the impact from the outcome of any known and unknown litigation;</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; font-family: 'Times New Roman'; font-size: 10pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0);">the ability of New PubCo to forecast and maintain an adequate rate of revenue growth and appropriately plan its expenses;</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; font-family: 'Times New Roman'; font-size: 10pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0);">expectations regarding future expenditures of New PubCo following the Business Combination;</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; font-family: 'Times New Roman'; font-size: 10pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0);">the future mix of revenue and effect on gross margins of New PubCo following the Closing;</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; font-family: 'Times New Roman'; font-size: 10pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0);">changes in interest rates, rates of inflation, carbon credit prices and trends in the markets in which we operate;</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; font-family: 'Times New Roman'; font-size: 10pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0);">the attraction and retention of qualified directors, officers, employees and key personnel of New PubCo following the Closing;</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; font-family: 'Times New Roman'; font-size: 10pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0);">the ability of New PubCo to compete effectively in a competitive industry;</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; font-family: 'Times New Roman'; font-size: 10pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0);">the ability to protect and enhance New PubCo&#8217;s corporate reputation and brand;</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"/></div>

      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; font-family: 'Times New Roman'; font-size: 10pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0);">expectations concerning the relationships and actions of New PubCo and its affiliates with third parties;</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; font-family: 'Times New Roman'; font-size: 10pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0);">the impact from future regulatory, judicial and legislative changes in New PubCo&#8217;s industry;</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; font-family: 'Times New Roman'; font-size: 10pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0);">the ability to locate and acquire complementary products or product candidates and integrate those into New PubCo&#8217;s business;</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; font-family: 'Times New Roman'; font-size: 10pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0);">future arrangements with, or investments in, other entities or associations;</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; font-family: 'Times New Roman'; font-size: 10pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0);">intense competition and competitive pressures from other companies in the industries in which New PubCo will operate;</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; font-family: 'Times New Roman'; font-size: 10pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0);">the volatility of the market price and liquidity or trading of the securities of New PubCo; and</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; font-family: 'Times New Roman'; font-size: 10pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0);">other factors detailed under the section titled &#8220;<span style="font-style: italic;">Risk Factors</span>&#8221; beginning on page 66 of the Proxy Statement/Prospectus, which is incorporated herein by reference.</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

      <div>
        <div style="text-align: left; text-indent: 20pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">While forward-looking statements reflect New PubCo&#8217;s good faith beliefs, they are not guarantees of future performance. New PubCo
          disclaim any obligation to publicly update or revise any forward-looking statement to reflect changes in underlying assumptions or factors, new information, data or methods, future events or other changes after the date of this proxy statement,
          except as required by applicable law. You should not place undue reliance on any forward-looking statements, which are based only on information currently available to New PubCo.</div>

        <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>

      </div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Business</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">We are a capex-light carbon credit generation company focused on high quality and high return technology-based projects. We offer investors exposure to
        carbon credits, a key instrument used to offset emissions of carbon dioxide from industrial activities to reduce the effects of global warming.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">By utilizing blockchain technology to drive trust and transparency across the credit cycle and through leveraging partnerships with market leaders, we
        provide a turnkey solution to help companies generate, manage, and monetize environmental assets through carbon credits. The blockchain technology will be used in conjunction with DevvStream&#8217;s platform to track, manage and store data only. It will
        do so to keep an immutable record of the data. The blockchain technology will not be used to track any assets. The blockchain technology will not create a record of carbon credits. Carbon credits are tracked by third parties in traditional
        registries and those registries show ownership of the carbon credits. We will not use the blockchain technology to create or track any type of crypto asset, and our use of the blockchain does not involve or require the integration of any token or
        other crypto asset to support its functionality.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">As explained in the section titled &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations of DevvStream&#8212;Liquidity and
        Capital Resources&#8221; in the Proxy Statement/Prospectus, New PubCo&#8217;s management does not believe its current cash and cash equivalents are sufficient to fund operations for at least the next 12 months from the issuance date of the financial
        statements, which management believes raises substantial doubt about its ability to continue as a going concern. For more information also see &#8220;<span style="font-style: italic;">Risk Factors &#8212; Risks Related to DevvStream&#8217;s Business and Industry &#8212;
          We have incurred significant losses and expect to incur additional expenses and continuing losses for the foreseeable future, and we may not achieve or maintain profitability,</span>&#8221; which can be found beginning on page 66 of the Proxy
        Statement/Prospectus, which is incorporated herein by reference.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The mailing address of our principal executive offices is 2108 N St., Suite 4254 Sacramento, CA 95816 and our telephone number at such address is (647)
        689-6041.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

      </div>

      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">New PubCo owns no material assets other than the 100% issued and outstanding shares Amalco and does not operate any business.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Our business is further described in the Proxy Statement/Prospectus in the section titled &#8220;Information about DevvStream&#8221; beginning on page 223 of the
        Proxy Statement/Prospectus and that information is incorporated herein by reference.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Risk Factors</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The risk factors related to New PubCo, our business and operations and the Transactions are set forth in the Proxy Statement/Prospectus in the section
        titled &#8220;Risk Factors&#8221; beginning on page 66 of the Proxy Statement/Prospectus and that information is incorporated herein by reference.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Financial Information</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">New PubCo is currently experiencing delays (ii) in preparing the DevvStream audited financial statements for the year ended July 31,
        2024 and (ii) in filing FIAC&#8217;s quarterly report on Form 10-Q for the quarter ended September 30, 2024. New PubCo is working diligently to finalize New PubCo&#8217;s audited financials for July 31, 2024, FIAC&#8217;s quarterly report on Form 10-Q for the
        quarter ended September 30, 2024, an updated DevvStream &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; disclosure for the year ended July 31, 2024 and the acquired business pro forma financial information
        required to be filed with this Current Report under Item 9.01. New PubCo expects to file an amendment to this Current 8-K to add the required financial information as soon as practicable.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Properties</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Our corporate headquarters are located in Vancouver, British Columbia, Canada. We consider our current office space adequate for our current
        operations.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Security Ownership of Certain Beneficial Owners and Management</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The following table sets forth information regarding the beneficial ownership of New PubCo Common Shares immediately following
        consummation of the Transactions by:</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 38.7pt; font-family: 'Times New Roman'; font-size: 10pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>each person known by New PubCo to be the beneficial owner of more than 5% of New PubCo&#8217;s issued and outstanding common shares immediately following the consummation of the Transactions;</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 38.7pt; font-family: 'Times New Roman'; font-size: 10pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>each of New PubCo&#8217;s executive officers and directors; and</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 38.7pt; font-family: 'Times New Roman'; font-size: 10pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>all of New PubCo&#8217;s executive officers and directors as a group after the consummation of the Transactions.</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Beneficial ownership is determined according to the rules of the SEC, which generally provide that a person has beneficial ownership
        of a security if he, she or it possesses sole or shared voting or investment power over that security. Under those rules, beneficial ownership includes securities that the individual or entity has the right to acquire, such as through the exercise
        of stock options and warrants, within 60 days of the Closing Date. Shares subject to options or warrants that are currently exercisable or exercisable within 60 days of the Closing Date are considered outstanding and beneficially owned by the
        person holding such options for the purpose of computing the percentage ownership of that person but are not treated as outstanding for the purpose of computing the percentage ownership of any other person. Except as noted by footnote, and subject
        to community property laws where applicable, based on the information provided to New PubCo, New PubCo believes that the persons and entities named in the table below have sole voting and investment power with respect to all shares shown as
        beneficially owned by them. Unless otherwise noted, the business address of each of the directors and executive officers of New PubCo is 2108 N St., Suite 4254 Sacramento, CA 95816. The percentage of beneficial ownership of New PubCo is calculated
        based on 27,413,444 New PubCo Common Shares issued and outstanding immediately after giving effect to the Transactions.</div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 60.08%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Name and Address of Beneficial Owners</div>
            </td>

    <td style="width: 0.63%; vertical-align: middle; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>

    <td style="width: 18.98%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Number of Common Shares</div>
            </td>

    <td style="width: 0.63%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>

    <td style="width: 0.79%; vertical-align: middle; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>

    <td style="width: 18.82%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="3">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">% of Total Voting Power</div>
            </td>

  </tr>

  <tr>

    <td style="width: 60.08%; vertical-align: bottom;">
              <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Thomas G. Anderson<sup>(1)(2)</sup></div>
            </td>

    <td style="width: 0.63%; vertical-align: middle;">&#160;</td>

    <td style="width: 18.98%; vertical-align: bottom;">
              <div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">7,187,895</div>
            </td>

    <td style="width: 0.63%; vertical-align: bottom;">&#160;</td>

    <td style="width: 0.79%; vertical-align: middle;">&#160;</td>

    <td style="width: 18.82%; vertical-align: bottom;" colspan="3">
              <div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">26.1%</div>
            </td>

  </tr>

  <tr>

    <td style="width: 60.08%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Wray Thorn</div>
            </td>

    <td style="width: 0.63%; vertical-align: middle; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 18.98%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="background-color: #FFFFFF;"><span style="background-color: rgb(204, 238, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#8212;(11)</span></span></div>
            </td>

    <td style="width: 0.63%; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 0.79%; vertical-align: middle; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 18.82%; vertical-align: bottom; background-color: rgb(204, 238, 255);" colspan="3">
              <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;">&#8212;(11)</div>
            </td>

  </tr>

  <tr>

    <td style="background-color: rgb(255, 255, 255); vertical-align: bottom; width: 60.08%;">
              <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Carl Stanton</div>
            </td>

    <td style="background-color: rgb(255, 255, 255); vertical-align: middle; width: 0.63%;">&#160;</td>

    <td style="background-color: rgb(255, 255, 255); vertical-align: bottom; width: 18.98%;">
              <div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><span style="background-color: #FFFFFF;">&#8212;(11)</span></div>
            </td>

    <td style="background-color: rgb(255, 255, 255); vertical-align: bottom; width: 0.63%;">&#160;</td>

    <td style="background-color: rgb(255, 255, 255); vertical-align: middle; width: 0.79%;">&#160;</td>

    <td style="background-color: rgb(255, 255, 255); vertical-align: bottom; width: 18.82%;" colspan="3">
              <div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><span style="background-color: #FFFFFF;">&#8212;(11)</span></div>
            </td>

  </tr>

  <tr>

    <td style="width: 60.08%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Sunny Trinh<sup>(3)</sup></div>
            </td>

    <td style="width: 0.63%; vertical-align: middle; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 18.98%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><span style="background-color: #CCEEFF;">926,336</span></div>
            </td>

    <td style="width: 0.63%; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 0.79%; vertical-align: middle; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 18.82%; vertical-align: bottom; background-color: rgb(204, 238, 255);" colspan="3">
              <div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">3.3%</div>
            </td>

  </tr>

  <tr>

    <td style="width: 60.08%; vertical-align: bottom;">
              <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Stephen Kukucha<sup>(4)</sup></div>
            </td>

    <td style="width: 0.63%; vertical-align: middle;">&#160;</td>

    <td style="width: 18.98%; vertical-align: bottom;">
              <div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">76,467</div>
            </td>

    <td style="width: 0.63%; vertical-align: bottom;">&#160;</td>

    <td style="width: 0.79%; vertical-align: middle;">&#160;</td>

    <td style="width: 18.82%; vertical-align: bottom;" colspan="3">
              <div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">*</div>
            </td>

  </tr>

  <tr>

    <td style="width: 60.08%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Ray Quintana<sup>(5)</sup></div>
            </td>

    <td style="width: 0.63%; vertical-align: middle; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 18.98%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">76,467</div>
            </td>

    <td style="width: 0.63%; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 0.79%; vertical-align: middle; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 18.82%; vertical-align: bottom; background-color: rgb(204, 238, 255);" colspan="3">
              <div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">*</div>
            </td>

  </tr>

  <tr>

    <td style="width: 60.08%; vertical-align: bottom;">
              <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Bryan Went<sup>(6)</sup></div>
            </td>

    <td style="width: 0.63%; vertical-align: middle;">&#160;</td>

    <td style="width: 18.98%; vertical-align: bottom;">
              <div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">71,987</div>
            </td>

    <td style="width: 0.63%; vertical-align: bottom;">&#160;</td>

    <td style="width: 0.79%; vertical-align: middle;">&#160;</td>

    <td rowspan="1" style="width: 18.82%; vertical-align: bottom;" colspan="3">
              <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">*</div>
            </td>

  </tr>

  <tr>

    <td style="width: 60.08%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Chris Merkel<sup>(7)</sup></div>
            </td>

    <td style="width: 0.63%; vertical-align: middle; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 18.98%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">69,086</div>
            </td>

    <td style="width: 0.63%; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 0.79%; vertical-align: middle; background-color: rgb(204, 238, 255);">&#160;</td>

    <td colspan="3" rowspan="1" style="width: 18.82%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">*</div>
            </td>

  </tr>

  <tr>

    <td style="width: 60.08%; vertical-align: bottom;">
              <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">David Goertz<sup>(8)</sup></div>
            </td>

    <td style="width: 0.63%; vertical-align: middle;">&#160;</td>

    <td style="width: 18.98%; vertical-align: bottom;">
              <div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">58,356</div>
            </td>

    <td style="width: 0.63%; vertical-align: bottom;">&#160;</td>

    <td style="width: 0.79%; vertical-align: middle;">&#160;</td>

    <td style="width: 18.82%; vertical-align: bottom;" colspan="3">
              <div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">*</div>
            </td>

  </tr>

  <tr>

    <td style="width: 60.08%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><span style="background-color: #CCEEFF; font-size: 10pt; font-family: 'Times New Roman';">Michael Max Buhler</span><sup>(9)</sup></div>
            </td>

    <td style="width: 0.63%; vertical-align: middle; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 18.98%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><span style="background-color: #CCEEFF;">45,880</span></div>
            </td>

    <td style="width: 0.63%; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 0.79%; vertical-align: middle; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 18.82%; vertical-align: bottom; background-color: rgb(204, 238, 255);" colspan="3">
              <div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">*</div>
            </td>

  </tr>

  <tr>

    <td style="width: 60.08%; vertical-align: top;">
              <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Jamila Piracci<sup>(10)</sup></div>
            </td>

    <td style="width: 0.63%; vertical-align: middle;">&#160;</td>

    <td style="width: 18.98%; vertical-align: bottom;">
              <div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">45,880</div>
            </td>

    <td style="width: 0.63%; vertical-align: bottom;">&#160;</td>

    <td style="width: 0.79%; vertical-align: middle;">&#160;</td>

    <td colspan="3" rowspan="1" style="width: 18.82%; vertical-align: bottom;">
              <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">*</div>
            </td>

  </tr>

  <tr>

    <td style="width: 60.08%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">All directors and officers as a group (eleven individuals)</div>
            </td>

    <td style="width: 0.63%; vertical-align: middle; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 18.98%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">8,558,354</div>
            </td>

    <td style="width: 0.63%; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 0.79%; vertical-align: middle; background-color: rgb(204, 238, 255);">&#160;</td>

    <td colspan="3" rowspan="1" style="width: 18.82%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">29.7%</div>
            </td>

  </tr>

  <tr>

    <td style="width: 60.08%; vertical-align: top;">
              <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Five Percent Holders:</div>
            </td>

    <td style="width: 0.63%; vertical-align: middle;">&#160;</td>

    <td style="width: 18.98%; vertical-align: middle;">&#160;</td>

    <td style="width: 0.63%; vertical-align: middle;">&#160;</td>

    <td style="width: 16.93%; vertical-align: middle;" colspan="2">&#160;</td>

    <td style="width: 2.13%; vertical-align: top;">&#160;</td>

    <td style="width: 0.55%; vertical-align: top;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 60.08%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Focus Impact Sponsor, LLC<sup>(11)</sup></div>
            </td>

    <td style="width: 0.63%; vertical-align: middle; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 18.98%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">15,870,650<sup>(12)</sup></div>
            </td>

    <td style="width: 0.63%; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 0.79%; vertical-align: middle; background-color: rgb(204, 238, 255);">&#160;</td>

    <td colspan="3" rowspan="1" style="width: 18.82%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">41.1%</div>
            </td>

  </tr>

  <tr>

    <td style="width: 60.08%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Crestmont Investments LLC</div>
            </td>

    <td style="width: 0.63%; vertical-align: middle;">&#160;</td>

    <td style="width: 18.98%; vertical-align: bottom;">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">2,000,000</div>
            </td>

    <td style="width: 0.63%; vertical-align: bottom;">&#160;</td>

    <td rowspan="1" style="width: 16.93%; vertical-align: middle;" colspan="4">
              <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">7.3%</div>
            </td>

  </tr>

  <tr>

    <td style="width: 60.08%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Helena Global Investment Opportunities</div>
            </td>

    <td style="width: 0.63%; vertical-align: middle; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 18.98%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">1,441,560</div>
            </td>

    <td style="width: 0.63%; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 0.79%; vertical-align: middle; background-color: rgb(204, 238, 255);">&#160;</td>

    <td colspan="3" rowspan="1" style="width: 16.14%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">5.3%</div>
            </td>

  </tr>

  <tr>

    <td style="width: 60.08%; vertical-align: top;">&#160;</td>

    <td style="width: 0.63%; vertical-align: middle;">&#160;</td>

    <td style="width: 18.98%; vertical-align: bottom;">&#160;</td>

    <td style="width: 0.63%; vertical-align: bottom;">&#160;</td>

    <td style="width: 0.79%; vertical-align: middle;">&#160;</td>

    <td style="width: 16.14%; vertical-align: bottom;">&#160;</td>

    <td style="width: 2.13%; vertical-align: bottom;">&#160;</td>

    <td style="width: 0.55%; vertical-align: top;">&#160;</td>

  </tr>


</table>
      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">*&#160;&#160;&#160;&#160;Less than 1%</div>

      <div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt; vertical-align: top; text-align: right;">
                <div style="text-align: left; margin-left: 18pt; color: #0D0D0D; font-family: 'Times New Roman'; font-size: 10pt;">(1)</div>
              </td>

    <td style="width: auto; vertical-align: top;">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Consists of (i) 7,111,428 common shares issued to Devvio, Inc. ("Devvio") in exchange for multiple voting company shares of DevvStream in connection with the
                  closing of the Business C<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #0D0D0D;">ombination. Mr. Anderson is the founder and chief executive officer of Devvio and as a result, may be deemed to indirectly
                    beneficially own the common shares that are directly beneficially owned by Devvio. Mr. Anderson disclaims beneficial ownership other than to the extent of any pecuniary interest he may have therein. The business address of Devvio is
                    6300 Riverside Plaza Ln NW, Suite 100, Albuquerque, NM 87120 and (ii) 76,467 options to purchase subordinate voting shares of DevvStream was converted into an option to purchase common shares of the Issuer based on an exchange ratio
                    calculated at Closing of the Business Combination, as described in Item 2.01 of this Current Report.</span></div>
              </td>

  </tr>


</table>
      </div>

      <div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt; vertical-align: top; text-align: right;">
                <div style="text-align: left; margin-left: 18pt; color: #0D0D0D; font-family: 'Times New Roman'; font-size: 10pt;">(2)</div>
              </td>

    <td style="width: auto; vertical-align: top;">
                <div style="text-align: left; color: #0D0D0D; font-family: 'Times New Roman'; font-size: 10pt;">Consists of 76,467 stock options <span style="font-size: 10pt; font-family: 'Times New Roman';">granted on January 17, 2022. 10% of the options
                    vested on January 17, 2023 and 15% of the options vest every six months thereafter</span>. In connection with the closing of the Business Combination, each outstanding option to purchase subordinate voting shares of DevvStream was
                  converted into an option to purchase New PubCo Common Shares based on an exchange ratio calculated at Closing, as described in Item 2.01 of this Current Report. Thomas G. Anderson resigned from the Board on November 7, 2024. For more
                  information, also see Item 5.02 of this Current Report.</div>
              </td>

  </tr>


</table>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"/></div>

        </div>

      </div>

      <div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt; vertical-align: top; text-align: right;">
                <div style="text-align: left; margin-left: 18pt; color: #0D0D0D; font-family: 'Times New Roman'; font-size: 10pt;">(3)</div>
              </td>

    <td style="width: auto; vertical-align: top;">
                <div style="text-align: left; color: #0D0D0D; font-family: 'Times New Roman'; font-size: 10pt;">Consists of 887,017 restricted stock units granted on January 17, 2022 and March 14, 2022. 25% of the restricted stock units vested on January
                  17, 2023, July 17, 2023, January 17, 2024 and July 17, 2024, respectively. Also consists of 39,319 of restricted stock units granted on June 6, 2024. 10% of the restricted stock units vest on the six-month anniversary of the grant date
                  and 15% of the restricted stock units vest every six months thereafter for a period of 36 months. In connection with the closing of the Business Combination, each outstanding restricted stock unit of DevvStream was converted into
                  restricted stock units of the New PubCo Common Shares based on an exchange ratio calculated at Closing, as described in Item 2.01 of this Current Report. Each restricted stock unit represents the right to receive, at settlement, one New
                  PubCo Common Shares.</div>
              </td>

  </tr>


</table>
      </div>

      <div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt; vertical-align: top; text-align: right;">
                <div style="text-align: left; margin-left: 18pt; color: #0D0D0D; font-family: 'Times New Roman'; font-size: 10pt;">(4)</div>
              </td>

    <td style="width: auto; vertical-align: top;">
                <div style="text-align: left; color: #0D0D0D; font-family: 'Times New Roman'; font-size: 10pt;">Consists of 45,880 stock options granted on March 1, 2022. 10% of the options vested on January 17, 2023 and 15% of the options vest every six
                  months thereafter. Also consists of 30,587 o<span style="font-size: 10pt; font-family: 'Times New Roman';">ptions granted on October 14, 2022. 10% of the options vested on January 17, 2023 and 15% of the options vest every six months
                    thereafter.</span> In connection with the closing of the Business Combination, each outstanding option to purchase subordinate voting shares of DevvStream was converted into an option to purchase New PubCo Common Shares based on an
                  exchange ratio calculated at Closing, as described in Item 2.01 of this Current Report.</div>
              </td>

  </tr>


</table>
      </div>

      <div>
        <a id="z_Hlk182328609"></a>
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt; vertical-align: top; text-align: right;">
                <div style="text-align: left; margin-left: 18pt; color: #0D0D0D; font-family: 'Times New Roman'; font-size: 10pt;">(5)</div>
              </td>

    <td style="width: auto; vertical-align: top;">
                <div style="text-align: left; color: #0D0D0D; font-family: 'Times New Roman'; font-size: 10pt;">Consists of 76,467 stock options <span style="font-size: 10pt; font-family: 'Times New Roman';">granted on January
                    17, 2022. 10% of the options vested on January 17, 2023 and 15% of the options vest every six months thereafter.</span> In connection with the closing of the Business Combination, each outstanding option to purchase subordinate voting
                  shares of DevvStream was converted into an option to purchase New PubCo Common Shares based on an exchange ratio calculated at Closing, as described in Item 2.01 of this Current Report. Ray Quintana resigned from the Board on November 7,
                  2024. For more information, also see Item 5.02 of this Current Report.</div>
              </td>

  </tr>


</table>
      </div>

      <div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt; vertical-align: top; text-align: right;">
                <div style="text-align: left; margin-left: 18pt; color: #0D0D0D; font-family: 'Times New Roman'; font-size: 10pt;">(6)</div>
              </td>

    <td style="width: auto; vertical-align: top;">
                <div style="text-align: left; color: #0D0D0D; font-family: 'Times New Roman'; font-size: 10pt;">Consists of 45,880 restricted stock units granted on March 14, 2022. 10% of the restricted stock units vested on January 17, 2023 and 15% of the
                  restricted stock units vest every six months thereafter. Also consists of 26,106 restricted stock units granted on June 6, 2024. 10% of the restricted stock units vest on the six month anniversary of the grant date and 15% of the
                  restricted stock units vest every six months thereafter for a period of 36 months. In connection with the closing of the Business Combination, each outstanding restricted stock unit of DevvStream was converted into restricted stock units
                  of new PubCo. based on an exchange ratio calculated at Closing, as described in Item 2.01 of this Current Report. Each restricted stock unit represents the right to receive, at settlement, one New PubCo Common Shares.</div>
              </td>

  </tr>


</table>
      </div>

      <div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt; vertical-align: top; text-align: right;">
                <div style="text-align: left; margin-left: 18pt; color: #0D0D0D; font-family: 'Times New Roman'; font-size: 10pt;">(7)</div>
              </td>

    <td style="width: auto; vertical-align: top;">
                <div style="text-align: left; color: #0D0D0D; font-family: 'Times New Roman'; font-size: 10pt;">Consists of 45,880 restricted stock units granted on January 17, 2022. 10% of the restricted stock units vested on January 17, 2023 and 15% of
                  the restricted stock units vest every six months thereafter. Also consists of 23,206 restricted stock units granted on June 6, 2024. 10% of the restricted stock units vest on the six month anniversary of the grant date and 15% of the
                  restricted stock units vest every six months thereafter for a period of 36 months. In connection with the closing of the Business Combination, each outstanding restricted stock unit of DevvStream was converted into restricted stock units
                  of the New PubCo based on an exchange ratio calculated at Closing, as described in Item 2.01 of this Current Report. Each restricted stock unit represents the right to receive, at settlement, one New PubCo Common Shares.</div>
              </td>

  </tr>


</table>
      </div>

      <div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt; vertical-align: top; text-align: right;">
                <div style="text-align: left; margin-left: 18pt; color: #0D0D0D; font-family: 'Times New Roman'; font-size: 10pt;">(8)</div>
              </td>

    <td style="width: auto; vertical-align: top;">
                <div style="text-align: left; color: #0D0D0D; font-family: 'Times New Roman'; font-size: 10pt;">Consists of 30,587 restricted stock units granted on January 17, 2022. 10% of the restricted stock units vested on January 17, 2023 and 15% of
                  the restricted stock units vest every six months thereafter. Also consists of 27,769 restricted stock units granted on June 6, 2024. 10% of the restricted stock units vest on the six month anniversary of the grant date and 15% of the
                  restricted stock units vest every six months thereafter for a period of 36 months. These restricted stock units were granted to DJG Enterprises Inc. ("DJG") Mr. Goertz is the sole director of DJG and as a result, may be deemed to
                  indirectly beneficially own the common shares issuable upon exercise of the restricted stock units that are directly beneficially owned by DJG. Mr. Goertz disclaims beneficial ownership other than to the extent of any pecuniary interest
                  he may have therein. The business address of DJG is 1500 - 1140 West Pender Street, BC V6E 4G1.</div>
              </td>

  </tr>


</table>
      </div>

      <div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt; vertical-align: top; text-align: right;">
                <div style="text-align: left; margin-left: 18pt; color: #0D0D0D; font-family: 'Times New Roman'; font-size: 10pt;">(9)</div>
              </td>

    <td style="width: auto; vertical-align: top;">
                <div style="text-align: left; color: #0D0D0D; font-family: 'Times New Roman'; font-size: 10pt;">Consists of 45,880 stock options <span style="font-size: 10pt; font-family: 'Times New Roman';">granted on May 15, 2023. 10% of the options
                    vested on January 17, 2023 and 15% of the options vest every six months thereafter</span>. In connection with the closing of the Business Combination, each outstanding option to purchase subordinate voting shares of DevvStream was
                  converted into an option to purchase New PubCo Common Shares based on an exchange ratio calculated at Closing, as described in Item 2.01 of this Current Report.</div>
              </td>

  </tr>


</table>
      </div>

      <div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt; vertical-align: top; text-align: right;">
                <div style="text-align: left; margin-left: 18pt; color: #0D0D0D; font-family: 'Times New Roman'; font-size: 10pt;">(10)</div>
              </td>

    <td style="width: auto; vertical-align: top;">
                <div style="text-align: left; color: rgb(13, 13, 13); font-family: 'Times New Roman'; font-size: 10pt;">Consists of 45,880 stock options g<span style="font-size: 10pt; font-family: 'Times New Roman';">ranted on October 14, 2022. 10% of the
                    options vested on January 17, 2023 and 15% of the options vest every six months thereafter</span>. In connection with the closing of the Business Combination, each outstanding option to purchase subordinate voting shares of DevvStream
                  was converted into an option to purchase New PubCo Common Shares based on an exchange ratio calculated at Closing, as described in Item 2.01 of this Current Report.</div>
              </td>

  </tr>


</table>
      </div>

      <div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt; vertical-align: top; text-align: right;">
                <div style="text-align: left; margin-left: 18pt; font-family: 'Times New Roman'; font-size: 10pt;">(11)</div>
              </td>

    <td style="width: auto; vertical-align: top;">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(13, 13, 13);">In connection with the consummation of the Business Combination on
                    November 6, 2024, (i) the reporting person forfeited 575,000 Class B ordinary shares, par value $0.0001 per share, of the issuer ("Class B Shares"), (ii) 15,558 Class B Shares were converted into 15,079 New PubCo Common Shares"), and
                    (iii) 5,000,531 New PubCo Common Shares were issued to the reporting person in exchange for the Class A ordinary shares, par value $0.0001 per share, of the issuer and the Class B Shares that the reportin</span>g person transferred on
                  October 29, 2024. Does not include any New PubCo Common Shares upon exercise of any of the Converted Private Placement Warrant held by the reporting person. The reporting person is controlled by a four-member board of managers composed of
                  Carl Stanton, Ernest Lyles, Howard Sanders and Wray Thorn. Each manager has one vote, and the approval of a majority of the managers is required to approve an action of the reporting person. Under the so-called "rule of three," if voting
                  and dispositive decisions regarding an entity's securities are made by three or more individuals, and a voting or dispositive decision requires the approval of a majority of those individuals, then none of the individuals is deemed a
                  beneficial owner of the entity's securities. This is the situation with regard to the reporting person. Based upon the foregoing analysis, no individual manager of the reporting person exercises voting or dispositive control over any of
                  the securities held by the reporting, even those in which such manager holds a pecuniary interest. Accordingly, none of them will be deemed to have or share beneficial ownership of such securities. 11,200,000 private placement warrants of
                  the issuer held by the reporting person at the time of the closing of the Business Combination will be assumed by New PubCo and converted into 11,200,000 Converted Private Placement Warrants of New PubCo, with each Converted Private
                  Placement Warrant being exercisable for 0.9692 New PubCo Common Shares on a cashless basis or for cash at $11.86 (subject to additional adjustments pursuant to the terms of the Converted Private Placement Warrant). The issuance of
                  10,855,040 New PubCo Common Shares with respect to the Converted Private Placement Warrants held by the Sponsor assumes that each of the Converted Private Placement Warrant is exercised for cash. Pursuant to the terms of the Converted
                  Private Placement Warrants, the exercise price of the Converted Private Placement Warrants is adjustable if certain capital raising transactions meet certain requirements in connection with a business combination and shall be adjusted to
                  an exercise price that is equal to 115% of the higher of the Market Value and the New Issued Price. "Market Value" as used in the foregoing shall mean the volume-weighted average trading price of the New PubCo Common Shares during the
                  twenty (20) trading day period starting on the trading day prior to the day on which the issuer consummated the Business Combination. "Newly Issued Price" as used in the foregoing shall mean the issue price or effective issue price (as
                  determined in good faith by the board of directors of the issuer), at which the issuer issued additional shares or securities convertible into or exercisable or exchangeable for shares for capital raising purposes in connection with the
                  closing of the Business Combination. Does not reflect the additional New PubCo Common Shares issuable to the Sponsor pursuant to the terms of the Strategic Consulting Agreement or the New PubCo Common Shares issuable upon conversion of
                  the New Convertible Notes, which each were executed after the Closing.</div>
              </td>

  </tr>


</table>
      </div>

      <div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt; vertical-align: top; text-align: right;">
                <div style="text-align: left; margin-left: 18pt; font-family: 'Times New Roman'; font-size: 10pt;">(12)</div>
              </td>

    <td style="width: auto; vertical-align: top;">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Consists of 5,015,610 New PubCo Common Shares and 10,855,040 New PubCo Common Share issuable upon exercise of 11,200,000 Converted Private Placement Warrants
                  held by the Sponsor (assumes the exercise of the Converted Private Placement Warrants for cash). None of the Converted Private Placement Warrants have been exercised on the date this Current Report is filed.</div>
              </td>

  </tr>


</table>
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

      </div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
        <div style="font-family: 'Times New Roman'; font-size: 10pt;">
          <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Directors and Executive Officers</div>

        </div>

      </div>

      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
      </div>

      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The following sets forth certain information concerning the directors and executive officers of New PubCo immediately following consummation of the
        Transactions:</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <table cellspacing="0" cellpadding="0" border="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-weight: bold;">Name</div>
            </td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; border-bottom: #000000 solid 2px;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Age</div>
            </td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Position(s)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom;">
              <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">Executive Officers</span><span style="font-family: 'Times New Roman'; font-size: 10pt;">:</span></div>
            </td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;">&#160;&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; width: 44%; background-color: #CCEEFF;">
              <div style="text-align: left; color: rgb(0, 0, 0);">Sunny Trinh</div>
            </td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0); text-align: center;">53</div>
            </td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; width: 44%; background-color: #CCEEFF;">
              <div style="text-align: left; color: rgb(0, 0, 0);">Chief Executive Officer</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; width: 44%;">
              <div style="text-align: left; color: rgb(0, 0, 0);">David Goertz</div>
            </td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0); text-align: center;">44</div>
            </td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; width: 44%;">
              <div style="text-align: left; color: rgb(0, 0, 0);">Chief Financial Officer</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; width: 44%; background-color: #CCEEFF;">
              <div style="text-align: left; color: rgb(0, 0, 0);">Chris Merkel</div>
            </td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0); text-align: center;">57</div>
            </td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; width: 44%; background-color: #CCEEFF;">
              <div style="text-align: left; color: rgb(0, 0, 0);">Chief Operating Officer</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; width: 44%;">
              <div style="text-align: left; color: rgb(0, 0, 0);">Bryan Went</div>
            </td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0); text-align: center;">45</div>
            </td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; width: 44%;">
              <div style="text-align: left; color: rgb(0, 0, 0);">Chief Revenue Officer</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; width: 44%; background-color: #CCEEFF;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-style: italic; font-weight: bold;">Directors<sup>(1)</sup>:</div>
            </td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; vertical-align: bottom; text-align: center; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; width: 44%; background-color: #CCEEFF;">&#160;&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; width: 44%;">
              <div style="text-align: left; color: rgb(0, 0, 0);">Wray Thorn</div>
            </td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0); text-align: center;">52</div>
            </td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; width: 44%;">
              <div style="text-align: left; color: rgb(0, 0, 0);">Director</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; width: 44%; background-color: #CCEEFF;">
              <div style="text-align: left; color: rgb(0, 0, 0);">Carl Stanton</div>
            </td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0); text-align: center;">56</div>
            </td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; width: 44%; background-color: #CCEEFF;">
              <div style="text-align: left; color: rgb(0, 0, 0);">Director</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; width: 44%;">
              <div style="text-align: left; color: rgb(0, 0, 0);">Michael Max B&#252;hler</div>
            </td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0); text-align: center;">50</div>
            </td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; width: 44%;">
              <div style="text-align: left; color: rgb(0, 0, 0);">Director</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; width: 44%; background-color: #CCEEFF;">
              <div style="text-align: left; color: rgb(0, 0, 0);">Stephen Kukucha</div>
            </td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0); text-align: center;">56</div>
            </td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; width: 44%; background-color: #CCEEFF;">
              <div style="text-align: left; color: rgb(0, 0, 0);">Director</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; width: 44%;">
              <div style="text-align: left; color: rgb(0, 0, 0);">Jamila Piracci</div>
            </td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0); text-align: center;">51</div>
            </td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; width: 44%;">
              <div style="text-align: left; color: rgb(0, 0, 0);">Director</div>
            </td>

  </tr>


</table>
      <div>
        <div style="font-family: 'Times New Roman'; font-size: 10pt;">
          <div>
            <hr style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto 0px 0px; height: 2px; width: 12%; color: #000000; text-align: left; margin-left: 0px; margin-right: auto;"/> </div>

          <div> <br/>
          </div>

          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 8pt;">(1)</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
                  <div style="font-size: 8pt;">
                    <div style="text-align: left; font-family: 'Times New Roman';">Thomas G. Anderson and Ray Quintana were appointed to the Board in connection with the consummation of the Transactions and resigned from the Board on November 7, 2024. For
                      more information, also see Item 5.02 of this Current Report.</div>
                  </div>
                </td>

  </tr>


</table>
        </div>

        <div style="font-family: 'Times New Roman'; font-size: 10pt;">
          <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
          </div>

        </div>

        <div style="text-align: left; text-indent: 20pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Information regarding the executive officers, key employees, and directors following the Business Combination is set forth below:</div>

        <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>

      </div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Executive Officers</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Mr. Sunny Trinh serves as Chief Executive Officer of New PubCo following completion of the Business Combination. Mr. Trinh has served as Chief
        Executive Officer of DevvStream for the past two years and brings over 25 years of experience in the technology sector and directly in developing new verticals in ESG and carbon markets. Mr. Trinh also served as the Chief Digital Alchemist for
        Devvio, where he utilized their blockchain technology to develop solutions and new business models in the ESG and carbon markets. Mr. Trinh continues to advise Devvio in an informal capacity, and also advises Envviron SAS in an informal capacity
        regarding ESG matters. Prior to DevvStream, Mr. Trinh led innovation as the vice president of Strategic Partnerships and Ecosystem at Avnet Inc. (AVT: NASDAQ). He was also the chief operating officer for Jooster and vice president of sales for
        Arrow Electronics (ARW: NYSE) where he led the design team for a Corvette driven by a quadriplegic. Mr. Trinh also co-founded and served as Chief Executive Officer for 9:Fish Surfboards and was an adjunct professor for California Lutheran
        University&#8217;s master&#8217;s in business administration program, where he started the school&#8217;s technology tract. He also holds a patent on electronic accessories for cell phones. Mr. Trinh received his bachelor&#8217;s degree and master&#8217;s degree in engineering
        from Harvey Mudd College and his master&#8217;s in business administration from California Lutheran University.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Mr. David Goertz serves as the Chief Financial Officer of New PubCo following the completion of the Business Combination. Mr. Goertz has served as the
        Chief Financial Officer of DevvStream since November 2022. Mr. Goertz is a partner with Dale Matheson Carr-Hilton Labonte, LLP Chartered Professional Accountants, where he has worked since 2005 and became a partner in 2011. Mr. Goertz provides
        accounting, assurance, taxation and business advisory services to private and public companies, not-for-profit organizations and incorporate professionals. Mr. Goertz has an extensive background in public company operations, restructurings,
        acquisitions and initial public offerings. Mr. Goertz also has a specialized knowledge of the manufacturing, mining, real estate and technology industries. Mr. Goertz received his bachelor&#8217;s degree from the University of Victoria and has been a
        Chartered Professional Accountant since 2004.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

      </div>

      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Mr. Chris Merkel serves as the Chief Operating Officer of New PubCo following the completion of the Business Combination. Mr. Merkel has served as the
        Chief Operating Officer of DevvStream since December 2021. Prior to joining DevvStream, Mr. Merkel spent 24 years managing strategic customers, growing technical services verticals and held sales leadership roles at Avnet (AVT: NASDAQ) and Arrow
        Electronics (ARW:NYSE). He has engaged with companies at every stage, from pre-funded startups to global enterprises in markets such as the internet-of-things, consumer, industrial and medical. Mr. Merkel spent five years with Sierra Pacific
        Industries in a general sales and operations management role. Mr. Merkel has over 30 years of sales, operations and general management experience successfully managing diverse teams and projects.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Mr. Bryan Went serves as the Chief Revenue Officer of New PubCo following the completion of the Business Combination. Mr. Went has served as the Chief
        Revenue Officer of DevvStream since February 2022, and oversees corporate partnerships and the global project pipeline expansion. Mr. Went is the co-founder and co-chief executive officer of Matter Labs, a corporate innovation lab that focuses on
        solving problems in the technology industry at a local level. He also serves on the board of directors at FATHOMWERX, a public-private consortium and technical innovation lab located in Ventura County, California. Mr. Went has approximately 15
        years of experience as a founder, executive and investor in sustainability and blockchain technologies.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Non-Employee Directors</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Mr. Wray Thorn serves as a director of New PubCo following the completion of the Business Combination. Mr. Thorn is a Partner and Co-Founder of Focus
        Impact Partners, LLC and currently serves as the Chief Investment Officer of Focus Impact Acquisition Corp. He also serves as the Chief Investment Officer and a director of Focus Impact BH3 Acquisition Company, a special purpose acquisition
        corporation (Nasdaq: BHAC). Mr. Thorn is also the Founder and Chief Executive of Clear Heights Capital and a Board Member of Skipper Pets, Inc. Previously, Mr. Thorn was Managing Director and Chief Investment Officer - Private Investments at Two
        Sigma Investments, where he architected and led the firm&#8217;s private equity (Sightway Capital), venture capital (Two Sigma Ventures) and impact (Two Sigma Impact) investment businesses and was a leader in the creation of Hamilton Insurance Group and
        the incubation of Two Sigma&#8217;s insurance technology activities. With approximately three decades of experience as a chief investment officer, investment leader and lead director, Mr. Thorn has firsthand knowledge of investment firm leadership,
        private investing company value creation, asset allocation strategy and practice and risk management frameworks. Mr. Thorn has built and led businesses to source, structure, finance and make private investments, to allocate and risk manage capital
        across private investment strategies and to help companies, organizations and executives realize their growth and development objectives. Mr. Thorn has also been at the forefront of proactive impact investing and applying data and technology to
        innovate private investing. Mr. Thorn also serves as Co-Chair of the Board of Youth, INC, as Vice Chair of the Board and Chair of the Investment Committee for Futures and Options, as a grant monitor and event committee chair for Hour Children, and
        as an Associate of the Harvard College Fund.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

      </div>

      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Mr. Carl Stanton serves as a director of New PubCo following the completion of the Business Combination. Mr. Stanton is a Partner and Co-Founder of
        Focus Impact Partners, LLC and currently serves as the Chief Executive Officer. He also serves as the Chief Executive Officer and a director of Focus Impact BH3 Acquisition Company, a special purpose acquisition corporation (Nasdaq: BHAC). Mr.
        Stanton brings nearly three decades of experience in leading companies across transformative Private Equity/Alternative Asset management with a proven track record in creating shareholder value. Mr. Stanton has unique knowledge and skills across
        all facets of Asset Management. He is a team builder and has managed and co-led two Alternative Asset Management firms totaling over $4.5 billion AUM, and has delivered best-in-class investment performance results along with colleagues over
        multiple funds. He has advised CEOs, CFOs, and boards of directors of multiple companies and spread managerial, financial, and strategic best practices with demonstrated expertise in value creation strategies including revenue growth strategies,
        industry transformation, cost control, supply chain management, and technology best practices. Mr. Stanton has also served as Board Member to more than 15 portfolio companies across Industrial Products &amp; Services, Transportation &amp; Logistics
        and Consumer industries; including his current role as a Board Member of Skipper Pets, Inc.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Mr. Michael Max B&#252;hler serves as a director of New PubCo following the completion of the Business Combination. Mr. B&#252;hler is a member of various
        international committees, including the T20/G20 Task Force on Infrastructure Investment and the OECD Blue Dot Network. Mr. B&#252;hler is actively involved in the formation of a data cooperative for the construction industry and sits on the board of the
        International Resilience and Sustainability (inRES) Partnership, supporting Botswana&#8217;s digital transformation. Currently, Mr. B&#252;hler is a Professor of Construction Business Management at the University of Applied Sciences in Constance, Germany,
        with research interests in infrastructure planning and global challenges. Previously, he led initiatives at the World Economic Forum and worked with Deloitte in Vancouver. He also held roles at Bilfinger Berger in North America. He has over 25
        years of experience in construction and real estate. Mr. B&#252;hler has a PhD in civil engineering and an MBA with finance and accounting specialization.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Mr. Stephen Kukucha serves as a director of New PubCo following the completion of the Business Combination. Mr. Kukucha is a partner at PacBridge
        Partners with over twenty years of experience in clean technology, renewable power, investing and their intersection with public policy. At PacBridge Capital Partners, he specializes in providing early stage and growth capital to companies seeking
        to take disruptive technologies and build scalable businesses. PacBridge is based in Hong Kong and Vancouver and invests in opportunities globally, with a particular focus in Asia and North America. As well, Stephen also serves as a Senior Advisor
        to Fort Capital Partners, focusing on origination of M&amp;A, capital raising and advisory transactions. Prior to his current roles, Mr. Kukucha practiced law and was in a leadership position at Ballard Power Systems - leading their global External
        Affairs group (including emerging market business development in Asia). Following Ballard, Mr. Kukucha founded both a renewable power company and a strategic advisory firm. Mr. Kukucha also served as Chief Executive Officer and a director of CERO
        Technologies from April 2023 to June 2024, and as a director of Sustainable Development Technology Canada (SDTC) from March 2021 to May 2024. Mr. Kukucha has a Bachelor of Arts from the University of British Columbia and a Bachelor of Laws from the
        University of New Brunswick and graduated from the ICD-Rotman, Directors Education Program and became a member of the Institute of Corporate Directors, ICD.D.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Ms. Jamila Piracci serves as a director of New PubCo following the completion of the Business Combination. Ms. Piracci is the Founder of Roos
        Innovations, a financial services and commodities consultancy firm. She also serves on the boards of the Futures Industry Association and Fi&#249;tur Information Exchange Inc., and is a member of the advisory board of Itegriti Corporation. Prior to
        becoming a consultant, Ms. Piracci led the National Futures Association&#8217;s regulatory program from 2011 to 2019, overseeing swap dealers under the Dodd-Frank Act, including creating NFA&#8217;s program. Ms. Piracci previously worked at the Federal Reserve
        Bank of New York, where she was an attorney with a primary focus on orderly liquidation authority and resolution planning under the Dodd-Frank Act, as well as on market and other developments pertaining to OTC derivatives. Ms. Piracci also spent
        nearly a decade advising a range of OTC derivatives market participants, including dealer banks, investment managers, and energy firms. In addition, she was an Assistant General Counsel at the International Swaps and Derivatives Association, where
        she chaired working groups developing market documentation and best practices primarily in the credit derivatives area. Ms. Piracci received her J.D. from Cornell Law School and MBA from the S.C. Johnson Graduate School of Management at Cornell
        University. Ms. Piracci earned her B.A. from Harvard-Radcliffe College at Harvard University.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

      </div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Independence of Board of Directors</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Nasdaq listing standards require that a majority of our Board be independent. An &#8220;independent director&#8221; is defined generally as a person that, in the
        opinion of the FIAC Board, has no material relationship with the listed company (either directly or as a partner, stockholder or officer of an organization that has a relationship with FIAC). Our Board has determined that Michael Max B&#252;hler,
        Stephen Kukucha and Jamila Piracci are &#8220;independent directors&#8221; as defined in the Nasdaq listing standards and applicable SEC rules. Our independent directors will have regularly scheduled meetings at which only independent directors are present.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Committees of the Board of Directors</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
        <div style="text-align: left; text-indent: 36pt; color: rgb(0, 0, 0);">The Board will have the authority to appoint committees to perform certain management and administration functions. Upon the Closing, the Board is expected to have a standing
          audit committee, compensation committee, and nominating and corporate governance committee. The composition and responsibilities of each committee are described below. Members will serve on these committees until their resignation or until
          otherwise determined by the Board. The charters for each of these committees re available on New PubCo&#8217;s website.</div>

      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
        <div><br/>
        </div>

      </div>

      <div>
        <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Audit Committee</div>

        <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>

      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
        <div style="text-align: left; text-indent: 36pt; color: rgb(0, 0, 0);">The audit committee of the Board consists of Michael Max B&#252;hler, Stephen Kukucha and Jamila Piracci. The Board has determined that each proposed member is independent under the
          Nasdaq listing standards and Rule 10A-3(b)(1) under the Securities Exchange Act of 1934, as amended (&#8220;Exchange Act&#8221;). The chairperson of the audit committee is Michael Max B&#252;hler. Michael Max B&#252;hler qualifies as an &#8220;audit committee financial
          expert&#8221; as such term is defined in Item 407(d)(5) of Regulation S-K and each member of the audit committee possess financial sophistication, as defined under the rules of Nasdaq.</div>

      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
        <div><br/>
        </div>

      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
        <div style="text-align: left; text-indent: 36pt; color: rgb(0, 0, 0);">The primary purpose of the audit committee is to discharge the responsibilities of the Board with respect to our accounting, financial, and other reporting and internal control
          practices and to oversee our independent registered accounting firm. Specific responsibilities of our audit committee include:</div>

      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; font-family: 'Times New Roman'; font-size: 10pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0);">selecting a qualified firm to serve as the independent registered public accounting firm to audit New PubCo&#8217;s financial statements;</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; font-family: 'Times New Roman'; font-size: 10pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0);">helping to ensure the independence and performance of the independent registered public accounting firm;</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; font-family: 'Times New Roman'; font-size: 10pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0);">discussing the scope and results of the audit with the independent registered public accounting firm, and reviewing, with management and the independent accountants, our interim and year-end operating
                results;</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; font-family: 'Times New Roman'; font-size: 10pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0);">developing procedures for employees to submit concerns anonymously about questionable accounting or audit matters;</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; font-family: 'Times New Roman'; font-size: 10pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0);">reviewing policies on risk assessment and risk management;</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; font-family: 'Times New Roman'; font-size: 10pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0);">reviewing related party transactions;</div>
            </td>

  </tr>


</table>
      <div> <br/>
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; font-family: 'Times New Roman'; font-size: 10pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0);">obtaining and reviewing a report by the independent registered public accounting firm at least annually, that describes New PubCo&#8217;s internal quality-control procedures, any material issues with such
                procedures, and any steps taken to deal with such issues when required by applicable law; and</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; font-family: 'Times New Roman'; font-size: 10pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0);">approving (or, as permitted, pre-approving) all audit and all permissible non-audit service to be performed by the independent registered public accounting firm.</div>
            </td>

  </tr>


</table>
      <div>
        <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>

        <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Compensation Committee</div>

      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
        <div><br/>
        </div>

      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
        <div style="text-align: left; text-indent: 36pt; color: rgb(0, 0, 0);">The compensation committee of the Board consist of Jamila Piracci, Stephen Kukucha and Michael Max B&#252;hler. The Board has determined each proposed member is a &#8220;non-employee
          director&#8221; as defined in Rule 16b-3 promulgated under the Exchange Act. The chairperson of the compensation committee is expected to be Jamila Piracci. The primary purpose of the compensation committee is to discharge the responsibilities of the
          board of directors to oversee its compensation policies, plans and programs and to review and determine the compensation to be paid to its executive officers, directors and other senior management, as appropriate.</div>

      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
        <div><br/>
        </div>

      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
        <div style="text-align: left; text-indent: 21.3pt; color: rgb(0, 0, 0);">Specific responsibilities of the compensation committee include:</div>

      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; font-family: 'Times New Roman'; font-size: 10pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0);">reviewing and approving on an annual basis the corporate goals and objectives relevant to New PubCo&#8217;s Chief Executive Officer&#8217;s compensation, evaluating New PubCo&#8217;s Chief Executive Officer&#8217;s performance in
                light of such goals and objectives and determining and approving the remuneration (if any) of New PubCo&#8217;s Chief Executive Officer based on such evaluation;</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; font-family: 'Times New Roman'; font-size: 10pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0);">reviewing and approving the compensation of New PubCo&#8217;s other executive officers;</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; font-family: 'Times New Roman'; font-size: 10pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0);">reviewing and recommending to the Board the compensation of New PubCo&#8217;s directors;</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; font-family: 'Times New Roman'; font-size: 10pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0);">reviewing New PubCo&#8217;s executive compensation policies and plans;</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; font-family: 'Times New Roman'; font-size: 10pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0);">reviewing and approving, or recommending that the Board approve, incentive compensation and equity plans, severance agreements, change-of-control protections and any other compensatory arrangements for New
                PubCo&#8217;s executive officers and other senior management, as appropriate;</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; font-family: 'Times New Roman'; font-size: 10pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0);">administering New PubCo&#8217;s incentive compensation equity-based incentive plans;</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; font-family: 'Times New Roman'; font-size: 10pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0);">selecting independent compensation consultants and assessing whether there are any conflicts of interest with any of the committee&#8217;s compensation advisors;</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; font-family: 'Times New Roman'; font-size: 10pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0);">assisting management in complying with New PubCo&#8217;s proxy statement and annual report disclosure requirements;</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; font-family: 'Times New Roman'; font-size: 10pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0);">if required, producing a report on executive compensation to be included in New PubCo&#8217;s annual proxy statement;</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; font-family: 'Times New Roman'; font-size: 10pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0);">reviewing and establishing general policies relating to compensation and benefits of New PubCo&#8217;s employees; and</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; font-family: 'Times New Roman'; font-size: 10pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0);">reviewing New PubCo&#8217;s overall compensation philosophy.</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div>
        <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Nominating and Corporate Governance Committee</div>

        <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>

      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
        <div style="text-align: left; text-indent: 20pt; color: rgb(0, 0, 0);">The nominating and corporate governance committee of the Board consists of Stephen Kukucha, Jamila Piracci and Michael Max B&#252;hler. The Board has determined each proposed member
          is independent under Nasdaq listing standards. The chairperson of the nominating and corporate governance committee is expected to be Stephen Kukucha.</div>

        <div style="text-align: left; text-indent: 20pt; color: rgb(0, 0, 0);"> <br/>
        </div>

      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

      </div>

      <div>
        <div style="text-align: left; text-indent: 20pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Specific responsibilities of the nominating and corporate governance committee include:</div>

      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; font-family: 'Times New Roman'; font-size: 10pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0);">identifying, evaluating and selecting, or recommending that the Board approves, nominees for election to the Board;</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; font-family: 'Times New Roman'; font-size: 10pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0);">evaluating the performance of the Board and of individual directors;</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; font-family: 'Times New Roman'; font-size: 10pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0);">reviewing developments in corporate governance practices;</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; font-family: 'Times New Roman'; font-size: 10pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0);">evaluating the adequacy of New PubCo&#8217;s corporate governance practices and reporting;</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; font-family: 'Times New Roman'; font-size: 10pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0);">reviewing management succession plans; and</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; font-family: 'Times New Roman'; font-size: 10pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0);">developing and making recommendations to the Board regarding corporate governance guidelines and matters.</div>
            </td>

  </tr>


</table>
      <div>
        <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>

        <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Code of Business Conduct and Ethics</div>

      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
        <div><br/>
        </div>

      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
        <div style="text-align: left; text-indent: 36pt; color: rgb(0, 0, 0);">New PubCo will adopt a Code of Business Conduct and Ethics that applies to all of its employees, officers and directors, including those officers responsible for financial
          reporting. Following the Closing, the Code of Business Conduct and Ethics will be available on New PubCo&#8217;s website at<span style="font-style: italic;"> https://www.devvstream.com</span>. Information contained on or accessible through such website
          is not a part of this proxy statement/prospectus, and the inclusion of the website address in this proxy statement/prospectus is an inactive textual reference only. New PubCo intends to disclose any amendments to the Code of Business Conduct and
          Ethics, or any waivers of its requirements, on its website to the extent required by the applicable rules and exchange requirements.</div>

      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
        <div><br/>
        </div>

      </div>

      <div>
        <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Compensation Committee Interlocks and Insider Participation</div>

        <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>

      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
        <div style="text-align: left; text-indent: 36pt; color: rgb(0, 0, 0);">None of New PubCo&#8217;s expected executive officers serve, or have served during the last year, as a member of the board of directors, compensation committee, or other board
          committee performing equivalent functions of any other entity that has one or more executive officers serving as one of our directors or on either company&#8217;s compensation committee.</div>

      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
        <div><br/>
        </div>

      </div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Executive Compensation</div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br/>
      </div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><span style="font-weight: normal; font-style: italic;">Pre-Closing Compensation of Executive Officers</span><br/>
      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">A description of the compensation of the named executive officers of DevvStream and the compensation of the executive officers of FIAC before the
        consummation of the Transactions is set forth in the Proxy Statement/Prospectus in the sections titled &#8220;Executive and Director Compensation of DevvStream&#8221; beginning on page 276 of the Proxy Statement/Prospectus and the subsection titled &#8220;Officer
        and Director Compensation&#8221; in the section titled &#8220;FIAC&#8217;s Management,&#8221; beginning on page 203 of the Proxy Statement/Prospectus, respectively, and that information is incorporated herein by reference.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-weight: normal; font-style: italic;">Pre-Closing Compensation of Executive Officers</span> </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
      </div>

      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">At the Business Combination Approval Meeting, the FIAC stockholders approved the DevvStream Corp. 2024 Equity Incentive Plan as may be amended,
        restated or modified from time to time, (the &#8220;Equity Incentive Plan&#8221;). The summary of the Equity Incentive Plan set forth in the Proxy Statement/Prospectus in the section titled &#8220;The Incentive Plan Proposal&#8221; beginning on page 192 of the Proxy
        Statement/Prospectus is incorporated herein by reference. A copy of the full text of the Equity Incentive Plan is attached hereto as Exhibit 10.4 and is incorporated herein by reference. New PubCo intends to develop an executive compensation
        program that is designed to align compensation with New PubCo&#8217;s business objectives and the creation of shareholder value, while enabling New PubCo to attract, motivate and retain individuals who contribute to the long-term success of New PubCo.
        Decisions on the executive compensation program will be made by the compensation committee of the Board.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
        <div><br/>
        </div>

        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"/></div>

        </div>

        <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;"><a id="z_cp_change_81"></a><span style="font-size: 10pt; font-family: 'Times New Roman';">Employment Agreements</span></div>

        <div><br/>
        </div>

        <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><a id="z_cp_change_80"></a><a id="z_cp_change_83"></a><span style="font-size: 10pt; font-family: 'Times New Roman';">On November 6, 2024, in
            connection with the consummation of the Business Combination, New PubCo entered into employment agreements with Bryan Went, Chris Merkel, and Sunny Trinh (collectively, the &#8220;Executives&#8221;), We refer to the employment agreements herein
            collectively as the &#8220;Employment Agreements.&#8221;</span><a id="z_cp_change_82"></a></div>

        <div>&#160;</div>

        <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><a id="z_cp_change_85"></a><span style="font-size: 10pt; font-family: 'Times New Roman';">The Employment Agreements provide for a three-year
            initial term with automatic renewals for additional one-year periods unless either the applicable Executive or New PubCo gives written notice of non-renewal at least 90 days prior to the expiration of the then-current initial term or renewal
            term.</span><a id="z_cp_change_84"></a></div>

        <div>&#160;</div>

        <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><a id="z_cp_change_87"></a><span style="font-size: 10pt; font-family: 'Times New Roman';">The Employment Agreements provide for initial annualized
            base salary of $250,000 for Mr. Trinh and $180,000 for each of Messrs. Went and Merkel, which will be reviewed by the Board annually, based on personal and corporate achievements and the overall financial performance of New PubCo. While
            employed under the Employment Agreements, the Executives are eligible for certain additional benefits, including reimbursement of reasonable travel and other business-related expenses and participation in the Company&#8217;s benefit plans or
            programs.</span><a id="z_cp_change_86"></a></div>

        <div>&#160;</div>

        <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><a id="z_cp_change_89"></a><span style="font-size: 10pt; font-family: 'Times New Roman';">The Employment Agreements provide that upon a resignation
            by the applicable Executive for Good Reason or upon a termination by New PubCo without Cause (each as defined in the Employment Agreement), the Executive shall be entitled to receive 12 months of continued base salary payments (the &#8220;Severance
            Amount&#8221;), subject to the Executives execution and non-revocation of a release of claims.</span></div>

        <div><br/>
        </div>

        <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><a id="z_cp_change_88"></a><a id="z_cp_change_91"></a><span style="font-size: 10pt; font-family: 'Times New Roman';">Further, the Employment
            Agreements provide that upon a resignation by the applicable Executive for Good Reason (as defined in the Employment Agreement) or upon a termination by New PubCo without Cause, in either case, within 12 months following a Corporate Transaction
            (as defined in the Equity Incentive Plan), the Executive shall be entitled to receive the following payments or benefits: (i) the Severance Amount (as defined in the Employment Agreement), (ii) immediate vesting of any of New PubCo equity
            awards that vest solely based on continued service that are held by the Executive and (iii) immediate vesting of any New PubCo equity awards that were subject to performance-based vesting and held by the Executive based on the greater of (x)
            target level of performance and (y) New PubCo&#8217;s actual performance, measured as of the date of termination as determined by the Committee (as defined in the Equity Incentive Plan), subject to the Executives execution and non-revocation of a
            release of claims.&#160; </span><a id="z_cp_change_90"></a></div>

        <div>&#160;</div>

        <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><a id="z_cp_change_93"></a><span style="font-size: 10pt; font-family: 'Times New Roman';">The Employment Agreements also contain certain
            restrictive covenants, including provisions that require the Executive to assign their rights to intellectual property to New PubCo and create restrictions, with certain limitations, on the Executives competing with New PubCo, soliciting any
            employees or individual service providers of, or soliciting or inducing any customers, clients, suppliers or licensees of New PubCo. These restrictions are generally intended to apply during the term and any renewal term and, subject to
            applicable state laws, for the twelve-month period following the Executive&#8217;s termination of employment.&#160;&#160;</span><a id="z_cp_change_92"></a></div>

        <div>&#160;</div>

        <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><a id="z_cp_change_95"></a><span style="font-size: 10pt; font-family: 'Times New Roman';">The description of the Employment Agreements herein is
            qualified in its entirety by reference to the full text of the Employment Agreements, which are attached hereto as Exhibits 10.17, 10.18, and 10.19 incorporated by reference herein.</span><a id="z_cp_change_94"></a></div>

        <div>&#160;</div>

      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

      </div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Director Compensation</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The Board, or a committee thereof, will determine the annual compensation to be paid to the members of the Board. A description of the compensation of
        the named executive officers of DevvStream and the compensation of the executive officers of FIAC before the consummation of the Transactions is set forth in the Proxy Statement/Prospectus in the sections titled &#8220;Executive and Director Compensation
        of DevvStream&#8221; beginning on page 276 of the Proxy Statement/Prospectus and the subsection titled &#8220;Officer and Director Compensation&#8221; in the section titled &#8220;FIAC&#8217;s Management,&#8221; beginning on page 203 of the Proxy Statement/Prospectus, respectively,
        and that information is incorporated herein by reference.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Certain Relationships and Related Person Transactions</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">
<div>Certain relationships and related person transactions are described in the Proxy Statement/Prospectus in the section titled &#8220;Certain
        Relationships and Related Person Transactions,&#8221; beginning on page 278 of the Proxy Statement/Prospectus and that information is incorporated herein by reference. Reference is made to the disclosure regarding director independence under
        &#8220;Independence of our Board of Directors&#8221; above in this Item 2.01 of this Current Report. The information related to the Registration Rights Agreement, the Strategic Consulting Agreement and the New Convertible Notes in Item 1.01 of this Current
        Report is also incorporated herein by reference.
        </div>
<div>&#160;</div>

      </div>

      <div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">New PubCo adopted a formal written policy effective upon the consummation of the Business Combination providing that persons meeting
        the definition of &#8220;Related Person&#8221; under Item 404(a) of Regulation S-K such as New PubCo&#8217;s executive officers, directors, nominees for election as directors, beneficial owners of more than 5% of any class of New PubCo&#8217;s capital stock and any member
        of the immediate family of any of the foregoing persons are not permitted to enter into a related party transaction with New PubCo without the approval of New PubCo&#8217;s audit committee, subject to the exceptions described below.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">A related party transaction is a transaction, arrangement or relationship, or any series of similar transactions, arrangements or
        relationships in which New PubCo was or is to be a participant in which the amount involves exceeds $120,000 in the aggregate, and in which a related party had or will have a direct or indirect material interest. Transactions involving compensation
        for services provided to New PubCo as an employee or director and certain other transactions are not covered by this policy.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Under the policy, the audit committee will review information that it deems reasonably necessary to enable New PubCo to identify any
        existing or potential related person transactions and to effectuate the terms of the policy. In addition, under the Code of Conduct, employees and directors have an affirmative responsibility to disclose any transaction or relationship that
        reasonably could be expected to give rise to a conflict of interest.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Legal Proceedings</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Reference is made to the disclosure regarding legal proceedings in the subsections of the Proxy Statement/Prospectus titled &#8220;Legal
        Proceedings&#8221; in the sections titled &#8220;Information about FIAC&#8221; and &#8220;Information about DevvStream,&#8221; on page 202 and page 223 of the Proxy Statement/Prospectus, respectively, and that information is incorporated herein by reference.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Market Price of and Dividends on Common Equity and Related Stockholder Matters</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
        <div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The New PubCo Common Shares began trading on the Nasdaq under the symbol &#8220;DEVS&#8221; on November 7, 2024. As of immediately after the
          Closing Date, there were approximately 28 registered holders of New PubCo Common Shares.</div>

      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">New PubCo has not paid any cash dividends on its capital stock. Any decision of New PubCo to declare and pay dividends in the future
        will be made at the sole discretion of the Board and will depend on, among other things, applicable law, New PubCo&#8217;s results of operations, cash requirements, financial condition, contractual restrictions and other factors that the Board may deem
        relevant.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Recent Sales of Unregistered Securities.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Reference is made to the disclosure set forth below under Item 3.02 of this Current Report concerning the issuance and sale of certain
        unregistered securities, which is incorporated herein by reference.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Description of New PubCo&#8217;s Securities</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The description of New PubCo&#8217;s securities is contained in the Proxy Statement/Prospectus in the section titled &#8220;Description of
        Securities of new PubCo&#8221; beginning on page 251 of the Proxy Statement/Prospectus and that information is incorporated herein by reference.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Indemnification of Officers and Directors</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">New PubCo has entered into indemnification agreements with each of its directors and executive officers, in each case effective as of
        the Closing Date. Each indemnification agreement provides for indemnification and advancements by New PubCo of certain expenses and costs relating to claims, suits or proceedings arising from his or her service to New PubCo or, at our request,
        service to other entities, as officers or directors to the maximum extent permitted by applicable law. Information about indemnification of the Company&#8217;s directors and officers is also set forth in the Proxy Statement/Prospectus in the section
        titled &#8220;Information about FIAC&#8212;Limitation on Liability and Indemnification of Officers and Directors&#8221; beginning on page 203 thereof, the subsection &#8220;Survival and Indemnification&#8221; and &#8220;Comparison of DGCL and ABCA&#8221; in the Proxy Statement/Prospectus
        in the section titled &#8220;The Business Combination Proposal&#8221; beginning on page 119 thereof, and the subsection &#8220;Comparison of DGCL and ABCA&#8221; in the Proxy Statement/Prospectus in the section titled &#8220;The SPAC Continuance Proposal&#8221; beginning on page 168
        thereof, each of which are incorporated herein by reference. The disclosure set forth in Item 1.01 of this Current Report under the section titled &#8220;Indemnification Agreements&#8221; is also incorporated by reference into this Item 2.01.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The foregoing description of the indemnification agreements does not purport to be complete and is qualified in its entirety by the
        terms and conditions of the indemnification agreements, a form of which is filed as Exhibit 10.5 to this Current Report on Form 8-K and is incorporated herein by reference.</div>
<div>
      &#160;
      </div>
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Financial Statements and Exhibits</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The information set forth above under the section entitled &#8220;Financial Information&#8221; in this Item 2.01 of this Current Report and the information under Item 9.01 of this
        Current Report is incorporated herein by reference. </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

      </div>

    </div>

    <div>
      <div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;">


  <tr style="vertical-align: top;">

    <td style="text-align: right; vertical-align: top; width: 54pt;">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 2.03</div>
              </td>

    <td style="text-align: left; vertical-align: top; width: auto;">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement or a Registrant.</div>
              </td>

  </tr>


</table>
      </div>

      <div><br/>
      </div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The information in Item 1.01 of this Current Report regarding the New Convertible Note and the extension of the maturity of the Devvio and Envviron
        Convertible Notes is incorporated herein by reference.</div>

    </div>

    <div>
<div> &#160;&#160; <br/></div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 54pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 3.02.</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Unregistered Sales of Equity Securities</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The information described in the Introductory Note, Item 1.01 and Item 2.01 of this Current Report regarding the issuance of the New
        Convertible Notes and the issuance of New Pubco Common Shares pursuant to the PIPE Agreements, the Monroe Agreement and to the Sponsor pursuant to the Letter Agreement and the Strategic Consulting Agreement is incorporated herein by reference. The
        issuances of New Pubco Common Shares or shares of Class A common stock of FIAC pursuant to the PIPE Agreements, the New Convertible Notes, the Monroe Agreement and to the Sponsor pursuant to the Letter Agreement, as applicable, have not been
        registered under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;) and have been issued or are expected to be issued, as applicable, in reliance upon the exemption provided in Section 4(a)(2) of the Securities Act and/or Rule 506 of
        Regulation D under the Securities Act.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 54pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 3.03.</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Material Modifications to Rights of Security Holders.</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The disclosure set forth under Item 5.03 of this Current Report is incorporated herein by reference.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 54pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 5.01.</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Changes in Control of Registrant.</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The disclosure set forth under the Introductory Note and in the section titled &#8220;Security Ownership of Certain Beneficial Owners and
        Management&#8221; in Item 2.01 of this Current Report is incorporated herein by reference. Reference is also made to the disclosure in the Proxy Statement/Prospectus in the subsection titled &#8220;The Business Combination Agreement&#8221; in the section titled &#8220;The
        Business Combination Proposal,&#8221; beginning on page 119 of the Proxy Statement/Prospectus, which is incorporated herein by reference. Further reference is made to the information contained in the Introductory Note and Item 2.01 to this Current Report
        on Form 8-K, which is incorporated herein by reference.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 54pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 5.02.</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Upon the consummation of the Transactions, and in accordance with the terms of the Business Combination Agreement, each director of
        FIAC, other than Wray Thorn and Carl Stanton, and each officer of FIAC ceased serving in such capacities and five new directors were appointed to the Board, including Michael Max B&#252;hler, Stephen Kukucha, Jamila Piracci, Ray Quintana and Thomas G.
        Anderson.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">On November 7, 2024, Mr. Quintana and Mr. Anderson resigned from the Board as chairman and director and as director, respectively, and
        Wray Thorn was appointed chairman of the Board. Mr. Quintana&#8217;s and Mr. Anderson&#8217;s resignations were not the result of any disagreement with New PubCo on any matter relating to New PubCo&#8217;s operations, policies or practices.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The information on the composition of the Board and the new officers of New PubCo, director independence, committees of the Board,
        compensation of directors and officers, compensation committee interlocks and insider participation, indemnification of directors and certain related party transaction in the sections entitled &#8220;Directors and Executive Officers,&#8221; &#8220;Independence of
        Board of Director,&#8221; &#8220;Committees of the Board of Directors,&#8221; &#8220;Compensation Committee Interlocks and Insider Participation,&#8221; &#8220;Director Compensation,&#8221; &#8220;Executive Compensation,&#8221; &#8220;Indemnification of Officers and Directors&#8221; and &#8220;Certain Relationships and
        Related Person Transactions&#8221; in Item 2.01 of this Current Report are incorporated herein by reference.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 54pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 5.03.</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Pursuant to the Business Combination Agreement, on the Closing Date, (a) FIAC changed its jurisdiction from the State of Delaware under
        the Delaware General Corporation Law to the Province of Alberta, Canada, and thereby become a company existing under the Business Corporations Act (Alberta) and changed its name to DevvStream Corp., and (b) DevvStream and Amalco Sub amalgamated to
        form one corporate entity.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

      </div>

      <div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The material terms of each of the Articles of Continuance and New PubCo Bylaws and the general effect upon the rights of holders of New
        PubCo&#8217;s capital stock are discussed in the Proxy Statement/Prospectus in the sections titled &#8220;The SPAC Continuance Proposal (Proposal 2) &#8212; Comparison of DGCL and ABCA&#8221; and &#8220;Description of Securities of New PubCo&#8221; beginning on pages 168 and 251
        thereof, respectively, which are incorporated herein by reference.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Copies of the Articles of Continuance and New PubCo Bylaws are included as Exhibit 3.1 and Exhibit 3.2 to this Current Report,
        respectively, and are incorporated herein by reference.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Further, in connection with the consummation of the Business Combination, New PubCo changed its fiscal year end to July 31<sup>st</sup>.
        New PubCo expects to file an amendment to this Current Report to include the audited financial statements of the accounting acquirer, or DevvStream, for the year ended July 31, 2024 pursuant to Section 12240.4 of the SEC&#8217;s Division of Corporate
        Finance Financial Reporting Manual, which covers situations involving reverse acquisitions in which the registrant elects to adopt the fiscal year of the accounting acquirer that is a private operating company. As described in Item 2.01 of this
        Current Report under the section entitled &#8220;Financial Information,&#8221; New PubCo is currently experiencing delays (ii) in preparing the DevvStream audited financial statements for the year ended July 31, 2024 and (ii) in filing FIAC&#8217;s quarterly report
        on Form 10-Q for the quarter ended September 30, 2024. New PubCo is working diligently to finalize New PubCo&#8217;s audited financials for July 31, 2024, FIAC&#8217;s quarterly report on Form 10-Q for the quarter ended September 30, 2024, an updated
        DevvStream &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; disclosure for the year ended July 31, 2024 and the acquired business pro forma financial information required to be filed with this Current Report
        under Item 9.01. New PubCo expects to file an amendment to this Current 8-K to add the required financial information as soon as practicable.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;">


  <tr style="vertical-align: top;">

    <td style="text-align: right; vertical-align: top; width: 54pt;">
                <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000;">Item 5.05.</span></div>
              </td>

    <td style="text-align: left; vertical-align: top; width: auto;">
                <div style="text-align: left;"><span style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-weight: bold; color: rgb(0, 0, 0);">Amendments to the Registrant&#8217;s Code of Ethics, or Waiver of a Provision of the Code of
                      Ethics.</span></span></div>
              </td>

  </tr>


</table>
      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">In connection with the Transactions, on November 6, 2024, the Board approved and adopted a new Code of Business Conduct applicable to
        all employees, officers and directors of New PubCo. A copy of the Code of Business Conduct can be found on New PubCo&#8217;s website at https://www.devvstream.com. New PubCo intends to disclose future amendments to such code, or any waivers of its
        requirements, applicable to any principal executive officer, principal financial officer, principal accounting officer or controller or persons performing similar functions or its directors on its website identified above or in a current report on
        Form 8-K. Information contained on the website is not incorporated by reference herein and should not be considered to be part of this Current Report. The inclusion of New PubCo&#8217;s website address in this Current Report is an inactive textual
        reference only.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;">


  <tr style="vertical-align: top;">

    <td style="text-align: right; vertical-align: top; width: 54pt;">
                <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000;">Item 7.01.</span></div>
              </td>

    <td style="text-align: left; vertical-align: top; width: auto;">
                <div style="text-align: left;"><span style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-weight: bold; color: rgb(0, 0, 0);">Regulation FD Disclosure.</span></span></div>
              </td>

  </tr>


</table>
      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">On November 6, 2024, New PubCo issued a press release announcing the consummation of the Business Combination. A copy of such press
        release is furnished as Exhibit 99.1 of this Current Report and incorporated herein by reference.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

      </div>

      <div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;">


  <tr style="vertical-align: top;">

    <td style="text-align: right; vertical-align: top; width: 54pt;">
                <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000;">Item 8.01.</span></div>
              </td>

    <td style="text-align: left; vertical-align: top; width: auto;">
                <div style="text-align: left;"><span style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-weight: bold; color: rgb(0, 0, 0);">Other Events.</span></span></div>
              </td>

  </tr>


</table>
      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">In order to illustrate the pro forma impact of certain transactions that were entered into on October 29, 2024, including the PIPE
        Agreements, the Monroe Agreement and Equitization, FIAC filed with the SEC on October 29, 2024 an unaudited pro forma condensed combined balance sheet as of June 30, 2024 and an unaudited pro forma combined income statement for the first six fiscal
        months of 2024 of DevvStream and FIAC (the &#8220;Illustrative Pro Forma Income Statement). In connection with the closing of the Business Combination, New PubCo is furnishing as Exhibit 99.2 of this Current Report an amended version of the Illustrative
        Pro Forma Income Statement that corrects the pro forma number of New PubCo Common Shares and the resulting loss per Share (the &#8220;Amended Pro Formas&#8221;).<br/>
      </div>

      <div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160; <br/>
      </div>

      <div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Amended Pro Formas are presented for illustrative purposes only and are based on certain assumptions and New PubCo&#8217;s management&#8217;s
        current best estimates. Therefore, the Amended Pro Formas included in this Current Report are not necessarily indicative of the financial position or results that have been achieved by New PubCo upon closing of the Business Combination. The
        financial position and results of New PubCo after the consummation of the Business Combination may differ significantly from those indicated in the Amended Pro Formas furnished with this Current Report. You should not rely on the Amended Pro Formas
        as being indicative of (i) the historical financial position or results that have been achieved in connection with the consummation of the Business Combination, (ii) the financial position or results that would have been achieved had the Business
        Combination closed as of June 30, 2024, or (iii) the future financial position or results that New PubCo will achieve. FIAC&#8217;s or New PubCo&#8217;s auditors have not audited, reviewed, compiled or performed any procedures with respect to any of the data
        included in the Amended Pro Formas furnished with this Current Report and FIAC&#8217;s or New PubCo&#8217;s auditors do not express an opinion or any form of assurance with respect to the Amended Pro Formas furnished with this Current Report.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;">


  <tr style="vertical-align: top;">

    <td style="text-align: right; vertical-align: top; width: 54pt;">
                <div style="text-align: justify;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000;">Item 9.01.</span></div>
              </td>

    <td style="text-align: left; vertical-align: top; width: auto;">
                <div style="text-align: justify;"><span style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-weight: bold; color: rgb(0, 0, 0);">Financial Statements and Exhibits.</span></span></div>
              </td>

  </tr>


</table>
      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

      <div style="text-align: justify; text-indent: -18pt; margin-left: 28.35pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(a) Financial statements of businesses acquired.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">
<div>The information set forth in Item 2.01 of this Current Report under the section entitled &#8220;Financial Information&#8221; is incorporated
        herein by reference and New PubCo will be filing an amendment to this Current Report to supplement this Item 9.01 (a) of this Current Report as soon as practicable.
        </div>
<div>&#160;</div>

      </div>

      <div style="text-align: justify; text-indent: -18pt; margin-left: 28.35pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(b) Pro forma financial information.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

      <div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">
<div>The information set forth in Item 2.01 of this Current Report under the section entitled &#8220;Financial Information&#8221; is incorporated herein
        by reference and New PubCo will be filing an amendment to this Current Report to supplement this Item 9.01 (b) of this Current Report as soon as practicable.
        </div>
<div>&#160;</div>

      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

      </div>

      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 10.35pt; font-family: 'Times New Roman'; font-size: 10pt;"><br/>
              </td>

    <td style="width: 18pt; vertical-align: top; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(d)</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
                <div style="color: rgb(0, 0, 0); font-weight: bold;">Exhibits</div>
              </td>

  </tr>


</table>
      </div>

      <div> <br/>
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 7.76%; vertical-align: bottom; white-space: nowrap;">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Exhibit</div>
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Number</div>
            </td>

    <td style="width: 92.12%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Description</div>
            </td>

  </tr>

  <tr>

    <td style="width: 7.76%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 92.12%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 7.76%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><a href="https://www.sec.gov/Archives/edgar/data/1854480/000114036123043753/ef20010610_ex2-1.htm"><span style="font-size: 10pt; font-family: 'Times New Roman';">2.1&#8224;</span></a></div>
            </td>

    <td style="width: 92.12%; vertical-align: top; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0);">Business Combination Agreement, dated as of September 12, 2023, by and among FIAC, Focus Impact Amalco Sub Ltd., and DevvStream Holdings Inc. (incorporated by reference to Exhibit 2.1 to the
                Current Report on Form 8-K, filed by FIAC on September 13, 2023).</div>
            </td>

  </tr>

  <tr>

    <td style="width: 7.76%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1854480/000114036124024056/ny20010621x9_ex2-1.htm">2.2</a></div>
            </td>

    <td style="width: 92.12%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0);">First Amendment to the Business Combination Agreement, dated as of May 1, 2024, by and among FIAC, Focus Impact Amalco Sub Ltd., and DevvStream Holdings Inc. (incorporated by reference to
                Exhibit 2.1 to the Current Report on Form 8-K, filed by FIAC on May 2, 2024).</div>
            </td>

  </tr>

  <tr>

    <td style="width: 7.76%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1854480/000114036124036833/ny20010621x16_ex2-1.htm">2.3</a></div>
            </td>

    <td style="width: 92.12%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; color: rgb(0, 0, 0);">Amendment No. 2 to Business Combination Agreement, dated as of August 10, 2024, by and among FIAC, Amalco Sub and DevvStream (incorporated by reference to Exhibit 2.1 to the Current Report
                on Form 8-K, filed by FIAC on August 12, 2024).</div>
            </td>

  </tr>

  <tr>

    <td style="width: 7.76%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1854480/000114036124044562/ny20037189x8_ex10-7.htm">2.4</a></div>
            </td>

    <td style="width: 92.12%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0);">Waiver to Certain Business Combination Conditions Precedent, dated October 29, 2024, by and between FIAC, Amalco Sub and DevvStream (incorporated by reference to Exhibit 10.7 to the Current
                Report on Form 8-K, filed by FIAC on October 29, 2024).</div>
            </td>

  </tr>

  <tr>

    <td style="width: 7.76%; vertical-align: top; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left;"><a href="ef20038430_ex3-1.htm">3.1</a></div>
            </td>

    <td style="width: 92.12%; vertical-align: top; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0);">Certificate of Continuance of the Company.</div>
            </td>

  </tr>

  <tr>

    <td style="width: 7.76%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left;"><a href="ef20038430_ex3-2.htm">3.2</a></div>
            </td>

    <td style="width: 92.12%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0);">By-Laws of the Company.</div>
            </td>

  </tr>

  <tr>

    <td style="width: 7.76%; vertical-align: top; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1854480/000114036121019769/nt10022907x2_ex4-3.htm">4.1</a></div>
            </td>

    <td style="width: 92.12%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">Specimen Warrant Certificate (incorporated by reference to Exhibit 4.3 to the
                  Registration Statement on Form S-1, filed by FIAC on June 3, 2021).</span></div>
            </td>

  </tr>

  <tr>

    <td style="width: 7.76%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1854480/000114036121036170/nt10022907x12_ex4-1.htm">4.2</a></div>
            </td>

    <td style="width: 92.12%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0);">Warrant Agreement, dated November 1, 2021, by and between FIAC and Continental Stock Transfer &amp; Trust Company, as warrant agent (incorporated by reference to Exhibit 4.1 to the Current
                Report on Form 8-K, filed by FIAC on November 1, 2021).</div>
            </td>

  </tr>

  <tr>

    <td style="width: 7.76%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left;"><a href="ef20038430_ex4-3.htm">4.3</a></div>
            </td>

    <td style="width: 92.12%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; color: rgb(0, 0, 0);">Specimen Common Stock Certificate of DevvStream Corp.</div>
            </td>

  </tr>

  <tr>

    <td style="width: 7.76%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1854480/000114036123055895/ny20010621x1_ex10-6.htm">10.1</a></div>
            </td>

    <td style="width: 92.12%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0);">Strategic Partnership Agreement, dated November 28, 2021, between Devvio, Inc. and DevvESG Streaming, Inc. (incorporated by reference to Exhibit 10.6 to the Registration Statement on Form
                S-4, filed by FIAC on December 4, 2023).</div>
            </td>

  </tr>

  <tr>

    <td style="width: 7.76%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1854480/000114036123055895/ny20010621x1_ex10-7.htm">10.2</a></div>
            </td>

    <td style="width: 92.12%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; color: rgb(0, 0, 0);">Amendment No. 1 to the Strategic Partnership Agreement, dated November 30, 2021, between Devvio, Inc. and DevvESG Streaming, Inc. (incorporated by reference to Exhibit 10.7 to the
                Registration Statement on Form S-4, filed by FIAC on December 4, 2023).</div>
            </td>

  </tr>

  <tr>

    <td style="width: 7.76%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1854480/000114036123055895/ny20010621x1_ex10-8.htm">10.3</a></div>
            </td>

    <td style="width: 92.12%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0);">Amendment No. 2 to the Strategic Partnership Agreement, dated September 12, 2023, between Devvio, Inc. and DevvStream, Inc. (f/k/a DevvESG Streaming, Inc.) (incorporated by reference to
                Exhibit 10.8 to the Registration Statement on Form S-4, filed by FIAC on December 4, 2023).</div>
            </td>

  </tr>

  <tr>

    <td style="width: 7.76%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1854480/000114036124036478/ny20010621x15_424b3.htm#tANNF">10.4+</a></div>
            </td>

    <td style="width: 92.12%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; color: rgb(0, 0, 0);">DevvStream Corp. 2024 Equity Incentive Plan (incorporated by reference to Annex F to the Proxy Statement/Prospectus on Form 424B3, filed by FIAC on August 9, 2024).<br/>
              </div>
            </td>

  </tr>

  <tr>

    <td style="width: 7.76%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1854480/000114036124012487/ny20010621x4_ex10-15.htm">10.5</a></div>
            </td>

    <td style="width: 92.12%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0);">Form of DevvStream Corp. Indemnification Agreement (incorporated by reference to Exhibit 10.15 to the Registration Statement on Form S-4, filed by FIAC on July 10, 2024).</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 8%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><a href="https://www.sec.gov/Archives/edgar/data/1854480/000114036124032870/ny20010621x13_ex10-17.htm"><span style="font-size: 10pt; font-family: 'Times New Roman';">10.6</span></a></div>
            </td>

    <td style="width: 92%; vertical-align: top; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0);">Amendment No. 3 to the Strategic Partnership Agreement, dated July 8, 2024, between Devvio, Inc. and DevvStream, Inc. (f/k/a DevvESG Streaming, Inc.) (incorporated by reference to Exhibit
                10.17 to the Registration Statement on Form S-4, filed by FIAC on July 10, 2024).</div>
            </td>

  </tr>

  <tr>

    <td style="width: 8%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><a href="https://www.sec.gov/Archives/edgar/data/1854480/000114036123043753/ef20010610_ex10-1.htm"><span style="font-size: 10pt; font-family: 'Times New Roman';">10.7</span></a></div>
            </td>

    <td style="width: 92%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0);">Sponsor Side Letter, dated as of September 12, 2023, by and among FIAC and Focus Impact Sponsor, LLC (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K, filed by
                FIAC on September 13, 2023).</div>
            </td>

  </tr>

  <tr>

    <td style="width: 8%; vertical-align: top; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1854480/000114036124024056/ny20010621x9_ex10-1.htm">10.8</a></div>
            </td>

    <td style="width: 92%; vertical-align: top; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0);">Amendment No. 1 to the Sponsor Side Letter, dated as of May 1, 2024, by and among FIAC and Focus Impact Sponsor, LLC (incorporated by reference to Exhibit 10.1 to the Current Report on Form
                8-K, filed by FIAC on May 2, 2024)</div>
            </td>

  </tr>

  <tr>

    <td style="width: 8%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><a href="https://www.sec.gov/Archives/edgar/data/1854480/000114036124044562/ny20037189x8_ex10-1.htm"><span style="font-size: 10pt; font-family: 'Times New Roman';">10.9</span></a></div>
            </td>

    <td style="width: 92%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0);">Amendment No. 2 to Sponsor Letter Agreement, dated October 29, 2024, by and between FIAC and the Sponsor (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K, filed
                by FIAC on October 29, 2024).</div>
            </td>

  </tr>

  <tr>

    <td style="width: 8%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><a href="https://www.sec.gov/Archives/edgar/data/1854480/000114036124044562/ny20037189x8_ex10-2.htm"><span style="font-size: 10pt; font-family: 'Times New Roman';">10.10</span></a></div>
            </td>

    <td style="width: 92%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; color: rgb(0, 0, 0);">Contribution and Exchange Agreement, dated October 29, 2024, by and among FIAC, DevvStream and Crestmont (incorporated by reference to Exhibit 10.2 to the Current Report on Form 8-K, filed
                by FIAC on October 29, 2024).</div>
            </td>

  </tr>

  <tr>

    <td style="width: 8%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><a href="https://www.sec.gov/Archives/edgar/data/1854480/000114036124044562/ny20037189x8_ex10-3.htm"><span style="font-size: 10pt; font-family: 'Times New Roman';">10.11</span></a></div>
            </td>

    <td style="width: 92%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0);">Form of PIPE Agreement (incorporated by reference to Exhibit 10.3 to the Current Report on Form 8-K, filed by FIAC on October 29, 2024).</div>
            </td>

  </tr>

  <tr>

    <td style="width: 8%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><a href="https://www.sec.gov/Archives/edgar/data/1854480/000114036124044562/ny20037189x8_ex10-4.htm"><span style="font-size: 10pt; font-family: 'Times New Roman';">10.12</span></a></div>
            </td>

    <td style="width: 92%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; color: rgb(0, 0, 0);">Form of Carbon Subscription Agreement (incorporated by reference to Exhibit 10.4 to the Current Report on Form 8-K, filed by FIAC on October 29, 2024).</div>
            </td>

  </tr>

  <tr>

    <td style="width: 8%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left;"><a href="ef20038430_ex10-13.htm">10.13</a></div>
            </td>

    <td style="width: 92%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0);">Amended and Restated Registration Rights Agreement, dated November 6, 2024, by and among FIAC, the Sponsor and certain other legacy DevvStream holders.</div>
            </td>

  </tr>

  <tr>

    <td style="width: 8%; vertical-align: top; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1854480/000114036124044562/ny20037189x8_ex10-5.htm">10.14</a></div>
            </td>

    <td style="width: 92%; vertical-align: top; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0);">Registration Rights Agreement, dated October 29, 2024, by and between FIAC and Karbon-X Corp (incorporated by reference to Exhibit 10.5 to the Current Report on Form 8-K, filed by FIAC on
                October 29, 2024).</div>
            </td>

  </tr>

  <tr>

    <td style="width: 8%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1854480/000114036123043753/ef20010610_ex10-2.htm">10.15</a></div>
            </td>

    <td style="width: 92%; vertical-align: top;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
                <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Form of Company Support &amp; Lock-Up Agreement, by and between FIAC, the Sponsor and certain other legacy DevvStream holders (incorporated by
                  reference to Exhibit 10.2 to the Current Report on Form 8-K, filed by FIAC on September 13, 2023).</div>
              </div>
            </td>

  </tr>

  <tr>

    <td style="width: 8%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><a href="https://www.sec.gov/Archives/edgar/data/1854480/000114036124044562/ny20037189x8_ex10-6.htm"><span style="font-size: 10pt; font-family: 'Times New Roman';">10.16</span></a></div>
            </td>

    <td style="width: 92%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; color: rgb(0, 0, 0);">Purchase Agreement, dated October 29, 2024, by and between FIAC, Helena Global Investment Opportunities I Ltd. and the Sponsor (incorporated by reference to Exhibit 10.6 to the Current
                Report on Form 8-K, filed by FIAC on October 29, 2024).</div>
            </td>

  </tr>

  <tr>

    <td style="width: 8%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left;"><a href="ef20038430_ex10-17.htm">10.17+</a></div>
            </td>

    <td style="width: 92%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left;">Employment Agreement, dated November 6, 2024, between DevvStream Corp. and Sunny Trinh.</div>
            </td>

  </tr>

  <tr>

    <td style="width: 8%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left;"><a href="ef20038430_ex10-18.htm">10.18+</a></div>
            </td>

    <td style="width: 92%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left;">Employment Agreement, dated November 6, 2024, between DevvStream Corp. and Chris Merkel.</div>
            </td>

  </tr>

  <tr>

    <td style="width: 8%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left;"><a href="ef20038430_ex10-19.htm">10.19+</a></div>
            </td>

    <td style="width: 92%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left;">Employment Agreement, dated November 6, 2024, between DevvStream Corp. and Bryan Went.</div>
            </td>

  </tr>

  <tr>

    <td style="width: 8%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);" rowspan="1"><a href="ef20038430_ex10-20.htm">10.20<br/>
              </a></td>

    <td style="width: 92%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);" rowspan="1">
              <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Strategic Consulting Agreement, dated November 13, 2024, by and between DevvStream Corp. and Focus Impact Partners, LLC.</div>
            </td>

  </tr>

  <tr>

    <td style="width: 8%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;" rowspan="1"><a href="ef20038430_ex10-21.htm">10.21<br/>
              </a> </td>

    <td style="width: 92%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;" rowspan="1">Form of New Convertible Note.<br/>
            </td>

  </tr>

  <tr>

    <td style="width: 8%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left;"><a href="ef20038430_ex14-1.htm">14.1</a></div>
            </td>

    <td style="width: 92%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; color: rgb(0, 0, 0);">Company&#8217;s Code of Business Conduct and Ethics.</div>
            </td>

  </tr>

  <tr>

    <td style="width: 8%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left;"><a href="ef20038430_ex21-1.htm">21.1</a></div>
            </td>

    <td style="width: 92%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0);">List of Subsidiaries of the Company.</div>
            </td>

  </tr>

  <tr>

    <td style="width: 8%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left;"><a href="ef20038430_ex99-1.htm">99.1</a></div>
            </td>

    <td style="width: 92%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; color: rgb(0, 0, 0);">Press release, dated November 6, 2024, announcing the closing of the Business Combination.</div>
            </td>

  </tr>

  <tr>

    <td style="width: 8%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left;"><a href="ef20038430_ex99-2.htm">99.2</a></div>
            </td>

    <td style="width: 92%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0);">Amended unaudited pro forma income statement of DevvStream Holdings Inc.</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">+ Indicates management contract or compensatory plan.</div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#8224; Schedules and exhibits to this Exhibit omitted pursuant to Regulation S-K Item 601(b)(2). The Registrant agrees to furnish supplementally a copy of any
        omitted schedule or exhibit to the SEC upon request.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

      </div>

      <div>
        <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">SIGNATURE</div>

        <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>

      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
        <div style="text-align: left; text-indent: 24.5pt; color: rgb(0, 0, 0);">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly
          authorized.</div>

      </div>

      <div>
        <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>

      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 50%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0);">Dated: November 13, 2024</div>
            </td>

    <td colspan="2" style="vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td colspan="2" style="vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-weight: bold;">DEVVSTREAM CORP.</div>
            </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td colspan="2" style="vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0);">By:</div>
            </td>

    <td style="width: 45%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0);"><span style="text-decoration: underline;">/s/ David Goertz</span></div>
            </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 5%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0);">Name:</div>
            </td>

    <td style="width: 45%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0);">David Goertz</div>
            </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 5%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0);">Title:</div>
            </td>

    <td style="width: 45%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0);">Chief Financial Officer</div>
            </td>

  </tr>


</table>
      <div>
        <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>

      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
<div>&#160;
        </div>
<hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;"/></div>

    </div>

  </div>

  <div><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span></div>

</div>
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>2
<FILENAME>ef20038430_ex3-1.htm
<DESCRIPTION>EXHIBIT 3.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 24.9.1.5252
         Copyright 1995 - 2024 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
  <div>
    <div style="text-align: right;"><font style="font-weight: bold; font-size: 10pt;">Exhibit 3.1</font><font style="font-size: 10pt;"><br>
      </font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">CORPORATE ACCESS NUMBER: 2026610804</div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="text-align: center; font-size: 10pt;"><img width="138" height="45" src="image01.jpg"></div>
    <div style="font-size: 10pt; text-align: center;">&#160; <br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">BUSINESS CORPORATIONS ACT</div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">CERTIFICATE</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> OF</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">CONTINUANCE</div>
    <div style="font-size: 10pt; text-align: center;">&#160;</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">DEVVSTREAM CORP. (FORMERLY: FOCUS IMPACT ACQUISITION CORP.)</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">CONTINUED FROM DELAWARE TO ALBERTA ON 2024/11/06.</div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="text-align: right; font-size: 10pt;"><img width="247" height="247" src="image02.jpg"></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Articles of Continuance</div>
    <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#160;Business Corporations Act</div>
    <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">Section 188</div>
    <div style="font-size: 10pt;">&#160;</div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

        <tr>
          <td style="width: 5%; vertical-align: top; padding-bottom: 2px; font-weight: bold; font-size: 10pt;" rowspan="1">1.<br>
          </td>
          <td style="width: 1%; vertical-align: top; font-weight: bold; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" rowspan="1" colspan="2">
            <div style="text-align: left; font-family: 'Times New Roman'; font-weight: bold;">Name of Corporation</div>
          </td>
          <td style="width: 1%; vertical-align: top; font-weight: bold; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" rowspan="1">&#160;</td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top; padding-bottom: 2px; font-size: 10pt;">&#160;</td>
          <td style="width: 1%; vertical-align: top; font-weight: bold; border-left: 2px solid rgb(0, 0, 0); padding-bottom: 2px; font-size: 10pt;" rowspan="1"><br>
          </td>
          <td style="width: 93%; vertical-align: top; font-weight: bold; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" rowspan="1">DevvStream Corp.</td>
          <td style="width: 1%; vertical-align: top; font-weight: bold; border-right: 2px solid rgb(0, 0, 0); padding-bottom: 2px; font-size: 10pt;" rowspan="1">&#160;</td>
        </tr>

    </table>
    <div style="font-size: 10pt;"><br>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="e622c2032b294323b52a009d60ba3e77">

        <tr>
          <td style="width: 5%; vertical-align: top; padding-bottom: 2px; font-weight: bold; font-size: 10pt;" rowspan="1">2.</td>
          <td style="width: 1%; vertical-align: top; font-weight: bold; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" rowspan="1" colspan="2">The classes of shares, and any maximum number of shares that the
            corporation is authorized to issue:</td>
          <td style="width: 1%; vertical-align: top; font-weight: bold; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" rowspan="1">&#160;</td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top; padding-bottom: 2px; font-size: 10pt;">&#160;</td>
          <td style="width: 1%; vertical-align: top; font-weight: bold; border-left: 2px solid rgb(0, 0, 0); padding-bottom: 2px; font-size: 10pt;" rowspan="1">&#160;</td>
          <td style="width: 93%; vertical-align: top; font-weight: bold; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" rowspan="1">Refer to &#8220;Share Structure&#8221; attachment.</td>
          <td style="width: 1%; vertical-align: top; font-weight: bold; border-right: 2px solid rgb(0, 0, 0); padding-bottom: 2px; font-size: 10pt;" rowspan="1">&#160;</td>
        </tr>

    </table>
    <div><br>
      <div>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="a5b27b09bfea45a18dc84c44b8b2b15d">

            <tr>
              <td style="width: 5%; vertical-align: top; padding-bottom: 2px; font-weight: bold; font-size: 10pt;" rowspan="1">3.</td>
              <td style="width: 1%; vertical-align: top; font-weight: bold; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" rowspan="1" colspan="2">Restrictions on share transfers (if any):</td>
              <td style="width: 1%; vertical-align: top; font-weight: bold; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" rowspan="1">&#160;</td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; padding-bottom: 2px; font-size: 10pt;">&#160;</td>
              <td style="width: 1%; vertical-align: top; font-weight: bold; border-left: 2px solid rgb(0, 0, 0); padding-bottom: 2px; font-size: 10pt;" rowspan="1">&#160;</td>
              <td style="width: 93%; vertical-align: top; font-weight: bold; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" rowspan="1">There are no &#8220;Restrictions on Share Transfers&#8221;.</td>
              <td style="width: 1%; vertical-align: top; font-weight: bold; border-right: 2px solid rgb(0, 0, 0); padding-bottom: 2px; font-size: 10pt;" rowspan="1">&#160;</td>
            </tr>

        </table>
        <div style="font-size: 10pt;"><br>
        </div>
        </div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="3dcd1bca09c04e5eb3a4924635e96117">

          <tr>
            <td style="width: 5%; vertical-align: top; padding-bottom: 2px; font-weight: bold; font-size: 10pt;" rowspan="1">4.</td>
            <td style="width: 1%; vertical-align: top; font-weight: bold; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" rowspan="1" colspan="2">Number, or minimum and maximum number, of directors that the
              corporation may have:</td>
            <td style="width: 1%; vertical-align: top; font-weight: bold; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 5%; vertical-align: top; padding-bottom: 2px; font-size: 10pt;">&#160;</td>
            <td style="width: 1%; vertical-align: top; font-weight: bold; border-left: 2px solid rgb(0, 0, 0); padding-bottom: 2px; font-size: 10pt;" rowspan="1">&#160;</td>
            <td style="width: 93%; vertical-align: top; font-weight: bold; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" rowspan="1">The Corporation shall have a minimum of 3 and a maximum of 15 directors.</td>
            <td style="width: 1%; vertical-align: top; font-weight: bold; border-right: 2px solid rgb(0, 0, 0); padding-bottom: 2px; font-size: 10pt;" rowspan="1">&#160;</td>
          </tr>

      </table>
      <font style="font-size: 10pt;"><br>
      </font></div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="62156e1d38924dee86de61e7d90776e7">

        <tr>
          <td style="width: 5%; vertical-align: top; padding-bottom: 2px; font-weight: bold; font-size: 10pt;" rowspan="1">5.</td>
          <td style="width: 1%; vertical-align: top; font-weight: bold; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" rowspan="1" colspan="2">
            <div style="text-align: left; margin-left: 0.2pt; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">If the corporation is restricted FROM carrying on a certain business, or restricted TO carrying on a</div>
            <div style="text-align: left; margin-left: 0.2pt; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">certain business, specify the restriction(s):</div>
          </td>
          <td style="width: 1%; vertical-align: top; font-weight: bold; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" rowspan="1">&#160;</td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top; padding-bottom: 2px; font-size: 10pt;">&#160;</td>
          <td style="width: 1%; vertical-align: top; font-weight: bold; border-left: 2px solid rgb(0, 0, 0); padding-bottom: 2px; font-size: 10pt;" rowspan="1">&#160;</td>
          <td style="width: 93%; vertical-align: top; font-weight: bold; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" rowspan="1">There shall be no restrictions on the business that the Corporation may carry on.</td>
          <td style="width: 1%; vertical-align: top; font-weight: bold; border-right: 2px solid rgb(0, 0, 0); padding-bottom: 2px; font-size: 10pt;" rowspan="1">&#160;</td>
        </tr>

    </table>
    <div style="font-size: 10pt;">&#160;</div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="51da6581de9546b4818d5578cb208991">

        <tr>
          <td style="width: 5%; vertical-align: top; padding-bottom: 2px; font-weight: bold; font-size: 10pt;" rowspan="1">6.</td>
          <td style="width: 1%; vertical-align: top; font-weight: bold; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" rowspan="1" colspan="2">Other rules or provisions (if any):</td>
          <td style="width: 1%; vertical-align: top; font-weight: bold; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" rowspan="1">&#160;</td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top; padding-bottom: 2px; font-size: 10pt;">&#160;</td>
          <td style="width: 1%; vertical-align: top; font-weight: bold; border-left: 2px solid rgb(0, 0, 0); padding-bottom: 2px; font-size: 10pt;" rowspan="1">&#160;</td>
          <td style="width: 93%; vertical-align: top; font-weight: bold; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" rowspan="1">Refer to &#8220;Other Rules or Provisions&#8221; attachment.</td>
          <td style="width: 1%; vertical-align: top; font-weight: bold; border-right: 2px solid rgb(0, 0, 0); padding-bottom: 2px; font-size: 10pt;" rowspan="1">&#160;</td>
        </tr>

    </table>
    <div style="font-size: 10pt;"><br>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="4ad77f0582534aed8353d38b363e78af">

        <tr>
          <td style="width: 5%; vertical-align: top; padding-bottom: 2px; font-weight: bold; font-size: 10pt;" rowspan="1">7.</td>
          <td style="width: 1%; vertical-align: top; font-weight: bold; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" rowspan="1" colspan="2">
            <div style="text-align: left; margin-left: 0.2pt; font-family: 'Times New Roman'; font-weight: bold;">If a change of name is effected, indicate previous name:</div>
          </td>
          <td style="width: 1%; vertical-align: top; font-weight: bold; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" rowspan="1">&#160;</td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top; padding-bottom: 2px; font-size: 10pt;">&#160;</td>
          <td style="width: 1%; vertical-align: top; font-weight: bold; border-left: 2px solid rgb(0, 0, 0); padding-bottom: 2px; font-size: 10pt;" rowspan="1">&#160;</td>
          <td style="width: 93%; vertical-align: top; font-weight: bold; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" rowspan="1">Focus Impact Acquisition Corp.</td>
          <td style="width: 1%; vertical-align: top; font-weight: bold; border-right: 2px solid rgb(0, 0, 0); padding-bottom: 2px; font-size: 10pt;" rowspan="1">&#160;</td>
        </tr>

    </table>
    <div style="font-size: 10pt;"><br>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="10fb96636a4b49d8aff012f78b111a83">

        <tr>
          <td style="width: 5%; vertical-align: top; padding-bottom: 2px; font-weight: bold; font-size: 10pt;" rowspan="1">8.</td>
          <td style="vertical-align: top; font-weight: bold; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" rowspan="1" colspan="4">
            <div style="text-align: left; margin-left: 0.2pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Current Extra-Provincial Registration </font><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">(if applicable):</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; font-weight: bold;">Alberta Corporate Access
                  Number</font></font></div>
          </td>
          <td style="width: 1%; vertical-align: top; font-weight: bold; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" rowspan="1">&#160;</td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top; padding-bottom: 2px; font-size: 10pt;">&#160;</td>
          <td style="width: 1%; vertical-align: top; font-weight: bold; border-left: 2px solid rgb(0, 0, 0); padding-bottom: 2px; font-size: 10pt;" rowspan="1">&#160;</td>
          <td style="width: 46.5%; vertical-align: top; font-weight: bold; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt; border-right: 2px solid rgb(0, 0, 0);" rowspan="1">
            <div style="text-align: left; font-family: 'Times New Roman'; font-weight: bold;">N/A</div>
          </td>
          <td style="width: 1%; vertical-align: top; font-weight: bold; font-size: 10pt; padding-bottom: 2px;" rowspan="1"><br>
          </td>
          <td style="width: 46%; vertical-align: top; font-weight: bold; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" rowspan="1">N/A</td>
          <td style="width: 1%; vertical-align: top; font-weight: bold; border-right: 2px solid rgb(0, 0, 0); padding-bottom: 2px; font-size: 10pt;" rowspan="1">&#160;</td>
        </tr>

    </table>
    <div style="font-size: 10pt;"><br>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="f2e6026301f641c9954091c92b5ca587">

        <tr>
          <td style="width: 5%; vertical-align: top; padding-bottom: 2px; font-weight: bold; font-size: 10pt;" rowspan="1">9.</td>
          <td style="width: 1%; vertical-align: top; font-weight: bold; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" rowspan="1" colspan="2">Current Jurisdiction Information</td>
          <td style="width: 1%; vertical-align: top; font-weight: bold; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" rowspan="1">&#160;</td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top; padding-bottom: 2px; font-size: 10pt;">&#160;</td>
          <td style="width: 1%; vertical-align: top; font-weight: bold; border-left: 2px solid rgb(0, 0, 0); padding-bottom: 2px; font-size: 10pt;" rowspan="1">&#160;</td>
          <td style="width: 93%; vertical-align: top; font-weight: bold; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" rowspan="1">
            <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Name of Corporation: Focus Impact Acquisition Corp.<br>
            </div>
            <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Registration Number in Current Jurisdiction: 5219712 </div>
            <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Jurisdiction: Delaware</div>
            <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Date of Formation in Current Jurisdiction: February 23, 2021</div>
          </td>
          <td style="width: 1%; vertical-align: top; font-weight: bold; border-right: 2px solid rgb(0, 0, 0); padding-bottom: 2px; font-size: 10pt;" rowspan="1">&#160;</td>
        </tr>

    </table>
    <div style="font-size: 10pt;"><br>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="83f7a70993024cfb96a65f7f9a81dfd4">

        <tr>
          <td style="width: 5%; vertical-align: top; padding-bottom: 2px; font-weight: bold; font-size: 10pt;" rowspan="1">10.</td>
          <td style="width: 1%; vertical-align: top; font-weight: bold; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" rowspan="1" colspan="2">Business Number (If a business number is not provided, CRA will
            assign as new business number)</td>
          <td style="width: 1%; vertical-align: top; font-weight: bold; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" rowspan="1">&#160;</td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top; padding-bottom: 2px; font-size: 10pt;">&#160;</td>
          <td style="width: 1%; vertical-align: top; font-weight: bold; border-left: 2px solid rgb(0, 0, 0); padding-bottom: 2px; font-size: 10pt;" rowspan="1">&#160;</td>
          <td style="width: 93%; vertical-align: top; font-weight: bold; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" rowspan="1">N/A</td>
          <td style="width: 1%; vertical-align: top; font-weight: bold; border-right: 2px solid rgb(0, 0, 0); padding-bottom: 2px; font-size: 10pt;" rowspan="1">&#160;</td>
        </tr>

    </table>
    <div style="font-size: 10pt;"><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="z44eff8b7f4724cd8bf1e44c335d40091" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 4.82%; vertical-align: top; font-size: 10pt; font-weight: bold; padding-bottom: 2px;">11.</td>
          <td style="width: 20.62%; vertical-align: top; font-size: 10pt; padding-bottom: 2px;">
            <div style="text-align: left; margin-left: 3.4pt; font-family: 'Times New Roman'; font-weight: bold;">Date Authorized:</div>
          </td>
          <td style="width: 27.34%; vertical-align: top; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: left; margin-left: 45.3pt; font-family: 'Times New Roman'; font-weight: bold;">September 13, 2024</div>
          </td>
          <td style="width: 27.34%; vertical-align: top; font-size: 10pt; padding-bottom: 2px;">&#160;</td>
          <td style="width: 19.86%; vertical-align: top; font-size: 10pt; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 100%; vertical-align: top;" colspan="5">
            <div style="text-align: left; margin-left: 120.3pt; font-size: 10pt;"><img width="191" height="1" src="image03.jpg"></div>
            <div style="text-align: left; margin-left: 152.85pt; font-family: 'Times New Roman'; font-size: 10pt;">Month / Day / Year</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 4.82%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-weight: bold;">12.</div>
          </td>
          <td style="width: 1%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" colspan="6" rowspan="1">
            <div style="text-align: left; margin-left: 0.2pt; font-family: 'Times New Roman'; font-weight: bold;">Authorized Representative/Authorized Signing Authority for the Corporation</div>
          </td>
        </tr>
        <tr>
          <td style="width: 4.82%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); font-size: 10pt; padding-bottom: 2px;">&#160;</td>
          <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); font-size: 10pt; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td style="width: 43.35%; vertical-align: top; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: left; text-indent: -77.8pt; margin-right: 11.8pt; margin-left: 91.1pt; font-family: 'Times New Roman';">Name &amp; Title of Person Authorizing <font style="font-family: 'Times New Roman'; font-style: italic;">(please print)</font></div>
          </td>
          <td style="width: 1%; vertical-align: top; font-size: 10pt; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td style="width: 1%; vertical-align: top; font-size: 10pt; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td style="width: 31.97%; vertical-align: top; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: left; text-indent: -41.9pt; margin-right: 31.05pt; margin-left: 54.9pt; font-family: 'Times New Roman';">Address: <font style="font-family: 'Times New Roman'; font-style: italic;">(including postal
                code)</font></div>
          </td>
          <td style="width: 1%; vertical-align: top; font-size: 10pt; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td style="width: 1%; vertical-align: top; font-size: 10pt; border-top: 2px solid rgb(0, 0, 0); padding-bottom: 2px;" colspan="1">&#160;</td>
          <td style="width: 19.86%; vertical-align: top; font-size: 10pt; border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: left; text-indent: -3.4pt; margin-right: 24.45pt; margin-left: 26.7pt; font-family: 'Times New Roman';">Authorized Signature</div>
          </td>
          <td style="width: 1%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); font-size: 10pt; border-top: 2px solid rgb(0, 0, 0); padding-bottom: 2px;" colspan="1">&#160;</td>
        </tr>

    </table>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="font-size: 10pt; text-align: center;">&#160;<img src="image05.jpg">
      <div><br>
      </div>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="925a86ce444b461d8161d37a1e51708d">

        <tr>
          <td style="width: 5%; vertical-align: top; padding-bottom: 2px; font-weight: bold; font-size: 10pt;" rowspan="1"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">12.</font><font style="font-size: 10pt;">&#160; <br>
            </font></td>
          <td style="vertical-align: top; font-weight: bold; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" rowspan="1" colspan="4"><font style="font-size: 10pt;"><font style="font-family: 'Times New Roman'; font-weight: bold;">Authorized
                Representative/Authorized Signing Authority for the Corporation</font></font></td>
          <td style="width: 1%; vertical-align: top; font-weight: bold; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" rowspan="1" colspan="1">&#160;</td>
          <td style="width: 23.25%; vertical-align: top; font-weight: bold; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" rowspan="1">&#160;</td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top; font-size: 10pt;">&#160;</td>
          <td style="width: 1%; vertical-align: top; font-weight: bold; border-left: 2px solid rgb(0, 0, 0); font-size: 10pt;" rowspan="1">&#160;</td>
          <td style="width: 46.5%; vertical-align: top; font-weight: normal; font-size: 10pt; text-align: center;" rowspan="1">Name &amp; Title of Person Authorizing <font style="font-family: 'Times New Roman'; font-style: italic;">(please
              print)</font></td>
          <td style="width: 1%; vertical-align: top; font-weight: normal; font-size: 10pt; text-align: center;" rowspan="1" colspan="1">&#160;</td>
          <td style="width: 23.25%; vertical-align: top; font-weight: normal; font-size: 10pt; text-align: center;" rowspan="1">Address: <font style="font-family: 'Times New Roman'; font-style: italic;">(including postal code)</font></td>
          <td style="width: 1%; vertical-align: top; font-weight: normal; font-size: 10pt; text-align: center;" rowspan="1" colspan="1">&#160;</td>
          <td style="width: 23.25%; vertical-align: top; font-weight: normal; font-size: 10pt; text-align: center;" rowspan="1">Authorized Signature</td>
          <td style="width: 1%; vertical-align: top; font-weight: bold; border-right: 2px solid rgb(0, 0, 0); font-size: 10pt;" rowspan="1">&#160;</td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top; font-size: 10pt; padding-bottom: 2px;" rowspan="1"><br>
          </td>
          <td style="width: 1%; vertical-align: top; font-weight: bold; border-left: 2px solid rgb(0, 0, 0); font-size: 10pt; padding-bottom: 2px;" rowspan="1">&#160;</td>
          <td style="width: 46.5%; vertical-align: top; font-weight: normal; font-size: 10pt; text-align: center; border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1">&#160;
            <p style="margin: 0px; text-indent: 0px; text-align: center;">Carl Stanton</p>
          </td>
          <td style="width: 1%; vertical-align: top; font-weight: normal; font-size: 10pt; text-align: center; padding-bottom: 2px;" rowspan="1" colspan="1">&#160;</td>
          <td style="width: 23.25%; vertical-align: top; font-weight: normal; font-size: 10pt; text-align: center; border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1">
            <p style="margin-top: 0px; margin-bottom: 0px; text-align: left;">1345 Avenue of the Americas</p>
            <p style="margin-top: 0px; margin-bottom: 0px; line-height: 22px; text-align: left;">33rd Floor</p>
            <p style="margin-top: 0px; margin-bottom: 12px; line-height: 22px; text-align: left;">New York, NY 10105</p>
          </td>
          <td style="width: 1%; vertical-align: top; font-weight: normal; font-size: 10pt; text-align: center; padding-bottom: 2px;" rowspan="1" colspan="1">&#160;</td>
          <td style="width: 23.25%; vertical-align: top; font-weight: normal; font-size: 10pt; text-align: center; border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1">
            <p style=" margin-top:0px; margin-bottom:0px; margin-left:0px; margin-right:0px; -qt-block-indent:0; text-indent:0px;">DocuSigned by:<br>
              CARL STANTON<br>
              <u>8D15AFB895524FB</u></p>
          </td>
          <td style="width: 1%; vertical-align: top; font-weight: bold; border-right: 2px solid rgb(0, 0, 0); font-size: 10pt; padding-bottom: 2px;" rowspan="1">&#160;</td>
        </tr>

    </table>
    <div>
      <p style="margin: 0px; text-indent: 0px; font-style: italic;">This information is being collected for the purposes of corporate registry records in accordance with the Business Corporations Act. Questions about the collection of this information can
        be directed to the Freedom of Information and Protection of Privacy Coordinator for Alberta Registries. Research and Program Support, Box 314. Edmonton.AIberta T5.1 4L4. (780) 427-7013.</p>
    </div>
    <div><br>
    </div>
    <div>
      <p style="margin: 0px; text-indent: 0px; text-align: center;"><font style="font-weight: bold;">SHARE STRUCTURE</font></p>
      <p style="margin: 0px; text-indent: 0px;"></p>
      <p style="margin: 0px; text-indent: 0px;"></p>
      <p style="margin: 0px; text-indent: 0px; text-align: center;"></p>
      <p style="margin: 0px; text-indent: 0px; text-align: center;"></p>
      <p style="margin: 0px; text-indent: 0px; text-align: center;"><font style="font-weight: bold;">Attached to and Forming Part of </font></p>
      <p style="margin: 0px; text-indent: 0px; text-align: center;"><font style="font-weight: bold;">the Articles of DevvStream Corp.</font><br>
      </p>
      <p style="margin: 0px; text-indent: 0px; text-align: left;">The Corporation is authorized to issue an unlimited number of Common Shares and an unlimited number of Preferred Shares, issuable in series.<br>
      </p>
      <p style="margin: 0px; text-indent: 0px; text-align: left;"> <br>
      </p>
      <p style="margin: 0px; text-indent: 0px; text-align: left;"><font style="font-weight: bold;">1</font>.&#160;&#160;&#160; <font style="font-weight: bold;"><u>COMMON SHARES</u></font><br>
      </p>
      <p style="margin: 0px; text-indent: 0px; text-align: left;"></p>
      <p style="margin-top: 0px; margin-bottom: 0px; text-align: justify;">Subject to the rights, privileges, restrictions and conditions which attach to any other class of shares of the Corporation, the Common Shares, as a class, shall have attached
        thereto the following rights, privileges, restrictions and conditions:<br>
      </p>
      <p style="margin: 0px; text-indent: 0px; text-align: left;"> <br>
      </p>
      <p style="margin: 0px; text-indent: 0px; text-align: left;"></p>
      <p style="margin: 0px; text-indent: 18pt; text-align: left;"><font style="font-weight: bold;">1.1&#160;&#160;&#160; </font><u><font style="font-weight: bold;">Voting Rights</font></u><br>
      </p>
      <p style="margin: 0px; text-indent: 0px; text-align: left;"></p>
      <p style="margin: 0px; text-indent: 0px; text-align: left;"></p>
      <p style="margin-top: 0px; margin-bottom: 0px; text-align: justify;">Each holder of Common Shares shall be entitled to notice of and to attend (including, if applicable, virtually) any meeting of the shareholders of the Corporation. Holders of Common
        Shares shall be entitled to vote at any meeting of the shareholders of the Corporation, and at each such meeting, shall be entitled to one vote in respect of each Common Share held, except for a meeting of which only holders of another particular
        class or series of shares of the Corporation shall have the right to vote.<br>
      </p>
      <p style="margin: 0px; text-indent: 0px; text-align: left;"> <br>
      </p>
      <p style="margin: 0px; text-indent: 18pt; text-align: left;"><font style="font-weight: bold;">1.2</font>&#160;&#160;&#160; <u><font style="font-weight: bold;">Dividends and Distributions</font></u></p>
      <p style="margin: 0px; text-indent: 0px; text-align: justify;">Holders of Common Shares shall be entitled to receive, as and when declared by the Board, dividends or other distributions in cash or otherwise, subject to the rights, privileges,
        restrictions, and conditions attached to the Preferred Shares of any series or any other class or series of stock having a preference over the Common Shares with respect to the payment of dividends.<br>
      </p>
      <p style="margin: 0px; text-indent: 0px; text-align: left;"> <br>
      </p>
      <p style="margin: 0px; text-indent: 18pt; text-align: left;"><font style="font-weight: bold;">1.3</font>&#160;&#160;&#160; <u><font style="font-weight: bold;">Liquidation, Dissolution or Winding-Up</font><br>
          </u></p>
      <p style="margin: 0px; text-indent: 0px; text-align: justify;">In the event of the liquidation, dissolution or winding-up of the Corporation, whether voluntary or involuntary, or in the event of any other distribution of assets of the Corporation
        among its shareholders for the purpose of winding up its affairs, the holders of Common Shares shall, subject to the prior rights of the holders of any shares of the Corporation ranking in priority to the Common Shares, be entitled to participate
        ratably in the remaining property of the Corporation (on a per share basis).</p>
      <p style="margin-top: 12px; margin-bottom: 0px; line-height: 22px;"><font style="font-weight: bold;">2.</font>&#160;&#160;&#160; <u><font style="font-weight: bold;">PREFERRED SHARES</font></u></p>
      <p style="margin-top: 0px; margin-bottom: 12px; line-height: 22px;">The rights, privileges, restrictions and conditions attaching to the Preferred Shares, as a class, shall be as follows:</p>
      <p style=" margin-top:12px; margin-bottom:12px; margin-left:40px; margin-right:40px; -qt-block-indent:0; text-indent:0px; line-height:22px;">1. <u>Issuance in Series</u></p>
    </div>
    <div>
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;" id="za31f31d6284943c498cdb6eecfe24e0b" class="DSPFListTable">

            <tr style="vertical-align: top;">
              <td style="width: 36pt;">&#160;</td>
              <td style="text-align: right; vertical-align: top; width: 18pt;">
                <p style="margin: 0px; text-indent: 0px; text-align: left;">1.1.</p>
              </td>
              <td style="text-align: left; vertical-align: top;">
                <p style="margin-top: 0px; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; -qt-block-indent: 0; text-indent: 0px;">Subject to the filing of Articles of Amendment in accordance with the Business Corporations Act (Alberta) (the
                  "Act*"), the Board of Directors may at any time and from time to time issue the Preferred Shares in one or more series, each series to consist of such number of shares as may. before the issuance thereof. be determined by the Board of
                  Directors.</p>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <div><br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;" id="zb4c431b34d6b43819d754cc35de6036e" class="DSPFListTable">

          <tr style="vertical-align: top;">
            <td style="width: 36pt;">&#160;</td>
            <td style="text-align: right; vertical-align: top; width: 18pt;">
              <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">1.2.</div>
            </td>
            <td style="text-align: left; vertical-align: top;">
              <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Subject to the filing of Articles of Amendment in accordance with the Act, the Board of Directors may from time to time fix, before issuance, the designation,
                rights, privileges, restrictions and conditions attaching to each series of Preferred Shares including, without limiting the generality of the foregoing, the amount, if any, specified as being payable preferentially to such series on a
                Distribution; the extent, if any, of further participation on a Distribution; voting rights, if any; and dividend rights (including whether such dividends be preferential, or cumulative or non-cumulative), if any.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: center; margin-right: 36pt; margin-left: 0.05pt; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">OTHER RULES OR PROVISIONS</div>
    <div style="text-align: center; text-indent: 0.15pt; margin-right: 206.75pt; margin-left: 170.7pt; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Attached to and Forming Part of the Articles of DevvStream Corp.</div>
    <div style="font-size: 10pt;"><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="z11c5b1de6b3e49b3b5a705bd080ac3b3" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 21.15pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">1.</td>
          <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">The directors of the Corporation may appoint one or more directors of the Corporation but the total number of directors so appointed may not exceed one third of the number of directors
              elected at the previous annual meeting of shareholders of the Corporation. Any directors of the Corporation appointed pursuant to the previous sentence shall hold office for a term expiring not later than the close of the next annual meeting
              of shareholders</div>
          </td>
        </tr>

    </table>
    <div style="font-size: 10pt;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z7e4fa426a7044802bbc5f623a9d1ae9f" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 21.15pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">2.</td>
          <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">Shareholders meetings may be held anywhere inside or outside of Alberta, (i) entirely in person; or (ii) entirely by electronic means; or (iii) both in person and by electronic means, in
              all cases as the directors determine by resolution from time to time.</div>
          </td>
        </tr>

    </table>
    <div style="font-size: 10pt;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z255a4268d7a34a4ea31eb9cce46eba9b" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 21.15pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">3.</td>
          <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">Except as otherwise provided in these Articles or except as provided in the <font style="font-family: 'Times New Roman'; font-style: italic;">Business Corporations Act </font>(Alberta)
              or other applicable law, any shares entitled to vote on any matter shall vote together as if they were shares of a single class.</div>
          </td>
        </tr>

    </table>
    <div style="font-size: 10pt;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z4d993a2e6f8f479ba9f0449e844fd02d" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 21.15pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">4.</td>
          <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">To the extent required by applicable laws, the Corporation and/or its transfer agent may deduct and withhold any tax. To the extent any amounts are so withheld and are timely remitted to
              the applicable governmental authority, such amounts shall be treated for all purposes herein as having been paid to the person otherwise entitled thereto.</div>
          </td>
        </tr>

    </table>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="font-size: 10pt;"><br>
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.2
<SEQUENCE>3
<FILENAME>ef20038430_ex3-2.htm
<DESCRIPTION>EXHIBIT 3.2
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 24.9.1.5252
         Copyright 1995 - 2024 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Exhibit 3.2</div>
    <div>&#160;</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">DEVVSTREAM CORP.</div>
    <div>
      <div style="text-align: center; margin-right: 136.15pt; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">BY-LAW NO. 1</div>
      <div style="text-align: center;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ARTICLE 1</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">INTERPRETATION</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><br>
      </div>
      <div style="text-align: center; text-indent: 0.05pt; margin-right: 197.25pt; margin-left: 60.95pt; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br>
      </div>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Section 1.1</font>&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Definitions.</font></div>
    <div>&#160;</div>
    <div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">As used in this by-law, the following terms have the following meanings:</div>
      <div>&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Act</font>&#8221; means the <font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Business Corporations Act </font>(Alberta) and the regulations under the Act, all as amended, re-enacted or replaced from time to time.</div>
      <div>&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Authorized Signatory</font>&#8221; has the meaning specified in Section 2.2. </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Corporation</font>&#8221; means <font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">DevvStream Corp.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">person</font>&#8221; means a natural person, partnership, limited partnership, limited
        liability partnership, corporation, limited liability company, unlimited liability company, joint stock company, trust, unincorporated association, joint venture or other entity or governmental or regulatory entity, and pronouns have a similarly
        extended meaning.</div>
      <div>&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">recorded address</font>&#8221; means (i) in the case of a shareholder or other
        securityholder, the shareholder&#8217;s or securityholder&#8217;s latest address as shown in the records of the Corporation, (ii) in the case of joint shareholders or other joint securityholders, the address appearing in the records of the Corporation in
        respect of the joint holding or, if there is more than one address in respect of the joint holding, the first address that appears, and (iii) in the case of a director, officer or auditor, the person&#8217;s latest address as shown in the records of the
        Corporation or, if applicable, the last notice filed with the Director under the Act, whichever is the most recent.</div>
      <div>&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">show of hands</font>&#8221; means, in connection with a meeting, a show of hands by
        persons present at the meeting, the functional equivalent of a show of hands by telephonic or electronic means and any combination of such methods.</div>
      <div>&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Terms used in this by-law that are defined in the Act have the meanings given to such terms in the Act.</div>
      <div>&#160;</div>
      <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Section 1.2</font>&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Interpretation.</font></div>
      <div>&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The division of this by-law into Articles, Sections and other subdivisions and the insertion of headings are for convenient reference only and do not affect its
        interpretation. Words importing the singular number include the plural and vice versa. Any reference in this by-law to gender includes all genders. In this by-law the words &#8220;including&#8221;, &#8220;includes&#8221; and &#8220;include&#8221; means &#8220;including (or includes or
        include) without limitation&#8221;.</div>
      <div>&#160;</div>
      <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Section 1.3</font>&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Subject to Act and Articles.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">This by-law is subject to, and should be read in conjunction with, the Act and the articles. If there is any conflict or inconsistency between any provision of the Act
        or the articles and any provision of this by-law, the provision of the Act or the articles will govern.</div>
    </div>
    <div><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ARTICLE 2</div>
    <div>&#160;</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">BUSINESS OF THE CORPORATION</div>
    <div>
      <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Section 2.1</font>&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Financial Year.</font></div>
      <div style="text-align: left; margin-left: 60.95pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"> <br>
        </font></div>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The financial year of the Corporation ends on such date of each year as the directors determine from time to time.</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div>
      <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Section 2.2</font>&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Execution of Instruments and
          Voting Rights.</font></div>
      <div style="text-align: left; margin-left: 61pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"> <br>
        </font></div>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Contracts, documents and instruments may be signed on behalf of the Corporation, either manually or by facsimile or by electronic means, (i) by any one director or officer
      or (ii) by any other person authorized by the directors from time to time (each person referred to in (i) and (ii) is an &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Authorized Signatory</font>&#8221;). Voting rights
      for securities held by the Corporation may be exercised on behalf of the Corporation by any one Authorized Signatory. In addition, the directors may, from time to time, authorize any person or persons (i) to sign contracts, documents and instruments
      generally on behalf of the Corporation or to sign specific contracts, documents or instruments on behalf of the Corporation and (ii) to exercise voting rights for securities held by the Corporation generally or to exercise voting rights for specific
      securities held by the Corporation. Any Authorized Signatory, or other person authorized to sign any contract, document or instrument on behalf of the Corporation, may affix the corporate seal, if any, to any contract, document or instrument when
      required.</div>
    <div>&#160;</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">As used in this Section, the phrase &#8220;contracts, documents and instruments&#8221; means any and all kinds of contracts, documents and instruments in written or electronic form,
      including cheques, drafts, orders, guarantees, notes, acceptances and bills of exchange, deeds, mortgages, hypothecs, charges, conveyances, transfers, assignments, powers of attorney, agreements, proxies, releases, receipts, discharges and
      certificates and all other paper writings or electronic writings.</div>
    <div>&#160;</div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Section 2.3</font>&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Banking Arrangements.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The banking and borrowing business of the Corporation or any part of it may be transacted with such banks, trust companies or other firms or corporations as the directors
      determine from time to time. All such banking and borrowing business or any part of it may be transacted on the Corporation&#8217;s behalf under the agreements, instructions and delegations, and by the one or more officers and other persons, that the
      directors authorize from time to time. This paragraph does not limit in any way the authority granted under Section 2.2.</div>
    <div>&#160;</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ARTICLE 3</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">DIRECTORS</div>
    <div>&#160;</div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Section 3.1</font>&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Place of Meetings.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Any or all meetings of directors may be held at any place in or outside Canada.</div>
    <div>&#160;</div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Section 3.2</font>&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Calling of Meetings.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">A chair of the board, the chief executive officer, the president or any one or more directors may call a meeting of the directors at any time. Meetings of directors will be
      held at the time and place as the person(s) calling the meeting determine.</div>
    <div>&#160;</div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Section 3.3</font>&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Regular Meetings.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The directors may establish regular meetings of directors. Any resolution establishing such meetings will specify the dates, times and places of the regular meetings and
      will be sent to each director.</div>
    <div>&#160;</div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Section 3.4</font>&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Notice of Meeting.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Subject to this section, notice of the time and place of each meeting of directors will be given to each director not less than 24 hours before the time of the meeting. No
      notice of meeting is required for any regularly scheduled meeting except where the Act requires the notice to specify the purpose of, or the business to be transacted at, the meeting. Provided a quorum of directors is present, a meeting of directors
      may be held, without notice, immediately following the annual meeting of shareholders.</div>
    <div>&#160;</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The accidental omission to give notice of any meeting of directors to, or the non-receipt of any notice by, any person, or any error in any notice not affecting the
      substance of the notice, does not invalidate any resolution passed or any action taken at the meeting.</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div>
      <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Section 3.5</font>&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Waiver of Notice.</font></div>
    </div>
    <div>&#160;</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">A director may waive notice of a meeting of directors, any irregularity in a notice of meeting of directors or any irregularity in a meeting of directors. Such waiver may
      be given in any manner and may be given at any time either before or after the meeting to which the waiver relates. Waiver of any notice of a meeting of directors cures any irregularity in the notice, any default in the giving of the notice and any
      default in the timeliness of the notice.</div>
    <div>&#160;</div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Section 3.6</font>&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Quorum.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">A majority of the number of directors in office or such greater or lesser number as the directors may determine from time to time, constitutes a quorum at any meeting of
      the directors. Where the Corporation has fewer than</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">three directors, all directors must be present at any meeting of directors to constitute a quorum. Notwithstanding any vacancy among the directors, a quorum of directors
      may exercise all the powers of the directors.</div>
    <div>&#160;</div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Section 3.7</font>&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Meeting by Telephonic, Electronic
        or Other Communication Facility.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">If all the directors of the Corporation present at or participating in a meeting of directors consent, a director may participate in such meeting by means of a telephonic,
      electronic or other communication facility. A director participating in a meeting by such means is deemed to be present at the meeting. Any consent is effective whether given before or after the meeting to which it relates and may be given with
      respect to all meetings of the directors.</div>
    <div>&#160;</div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Section 3.8</font>&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Chair.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The chair of any meeting of directors is the first mentioned of the following officers that is a director and is present at the meeting:</div>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z6a97528006264af1a53c04dfc536dc7b">

        <tr>
          <td style="width: 18pt;">&#160;</td>
          <td style="width: 20.1pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(a)</td>
          <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">the co-chairs of the board or any one of them;</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zac2e8ea3d2ed46e8b7851bead7d3077d">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 20.1pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(b)</td>
          <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">the lead director, if any; or</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z970412318e4d4276b4ee7568e68f6792">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 20.1pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(c)</td>
          <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">the chief executive officer.</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">If no such person is present at the meeting, the directors present shall choose one of their number to chair the meeting.</div>
    <div>&#160;</div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Section 3.9</font>&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Secretary.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The corporate secretary, if any, will act as secretary at meetings of directors. If a corporate secretary has not been appointed or the corporate secretary is absent, the
      chair of the meeting will appoint a person, who need not be a director, to act as secretary of the meeting.</div>
    <div>&#160;</div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Section 3.10</font>&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Votes to Govern.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">At all meetings of directors, every question shall be decided by a majority of the votes cast. In case of an equality of votes, the chair of the meeting is not entitled to
      a second or casting vote.</div>
    <div>&#160;</div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Section 3.11</font>&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Remuneration and Expenses.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The directors may determine from time to time the remuneration, if any, to be paid to a director for his or her services as a director. The directors are also entitled to
      be reimbursed for travelling and other out-of-pocket expenses properly incurred by them in attending directors meetings, committee meetings and shareholders meetings and in the performance of other duties of directors of the Corporation. The
      directors may also award additional remuneration to any director undertaking special services on the Corporation&#8217;s behalf beyond the services ordinarily required of a director by the Corporation.</div>
    <div>&#160;</div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">A director may be employed by or provide services to the Corporation otherwise than as a director. Such a director may receive remuneration for such employment or
      services in addition to any remuneration paid to the director for his or her services as a director.</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: center; font-weight: bold;">ARTICLE 4</div>
    <div style="text-align: center;">&#160;</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">COMMITTEES</div>
    <div>&#160;</div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Section 4.1</font>&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Committees of Directors.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The directors may appoint from their number one or more committees and delegate to such committees any of the powers of the directors except those powers that, under the
      Act, a committee of directors has no authority to exercise.</div>
    <div>&#160;</div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Section 4.2</font>&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Proceedings.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Meetings of committees of directors may be held at any place in or outside Canada. At all meetings of committees, every question shall be decided by a majority of the votes
      cast on the question. Unless otherwise determined by the directors, each committee of directors may make, amend or repeal rules and procedures to regulate its meetings including: (i) fixing its quorum, provided that quorum may not be less than a
      majority of its members; (ii) procedures for calling meetings; (iii) requirements for providing notice of meetings; (iv) selecting a chair for a meeting; and (v) determining whether the chair will have a deciding vote in the event there is an
      equality of votes cast on a question.</div>
    <div>&#160;</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Subject to a committee of directors establishing rules and procedures to regulate its meetings, Section 3.1 to Section 3.11 inclusive apply to committees of directors, with
      such changes as are necessary.</div>
    <div>&#160;</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ARTICLE 5</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">OFFICERS</div>
    <div>&#160;</div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Section 5.1</font>&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Appointment of Officers.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The directors may appoint such officers of the Corporation as they deem appropriate from time to time. The officers may include any of a chair or co-chairs of the board,
        a chief executive officer, a president, one or more vice-presidents, a chief financial officer, a chief investment officer, a chief corporate officer, a general counsel, a corporate secretary and a treasurer and one or more assistants to any of the
        appointed officers. No person may be the chair or co-chair of the board unless that person is a director.</div>
      <div>&#160;</div>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Section 5.2</font>&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Powers and Duties.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Unless the directors determine otherwise, an officer has all powers and authority that are incident to his or her office. An officer will have such other powers,
      authority, functions and duties that are prescribed or delegated, from time to time, by the directors, or by other officers if authorized to do so by the directors. The directors or authorized officers may, from time to time, vary, add to or limit
      the powers and duties of any officer.</div>
    <div>&#160;</div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Section 5.3</font>&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Chair(s) of the Board.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">If appointed, the chair or co-chairs of the board will preside at directors meetings and shareholders meetings in accordance with Section 3.8 and Section 7.9, respectively.
      The chair or co-chairs of the board will have such other powers and duties as the directors determine.</div>
    <div>&#160;</div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Section 5.4</font>&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Chief Executive Officer.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">If appointed, the chief executive officer of the Corporation will have general powers and duties of supervision of the business and affairs of the Corporation. The chief
      executive officer will have such other powers and duties as the directors determine. Subject to Section 3.9 and Section 7.9, during the absence or disability of the corporate secretary or the treasurer, or if no corporate secretary or treasurer has
      been appointed, the chief executive officer will also have the powers and duties of the office of corporate secretary and treasurer, as the case may be.</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: left;">
      <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Section 5.5</font>&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">President.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">If appointed, the president of the Corporation will have general powers and duties of supervision of the business and affairs of the Corporation. The president will
        have such other powers and duties as the directors determine.</div>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"> <br>
      </font></div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Section 5.6</font>&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Corporate Secretary.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">If appointed, the corporate secretary will have the following powers and duties: (i) the corporate secretary will give or cause to be given, as and when instructed, notices
      required to be given to shareholders, directors, officers, auditors and members of committees of directors; (ii) the corporate secretary may attend at and be the secretary of meetings of directors, shareholders, and committees of directors and will
      have the minutes of all proceedings at such meetings entered in the books and records kept for that purpose; and (iii) the corporate secretary will be the custodian of any corporate seal of the Corporation and the books, papers, records, documents,
      and instruments belonging to the Corporation, except when another officer or agent has been appointed for that purpose. The corporate secretary will have such other powers and duties as the directors or the chief executive officer of the Corporation
      determine.</div>
    <div>&#160;</div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Section 5.7</font>&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Treasurer.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">If appointed, the treasurer of the Corporation will have the following powers and duties: (i) the treasurer will ensure that the Corporation prepares and maintains adequate
      accounting records in compliance with the Act; (ii) the treasurer will also be responsible for the deposit of money, the safekeeping of securities and the disbursement of the funds of the Corporation; and (iii) at the request of the directors, the
      treasurer will render an account of the Corporation&#8217;s financial transactions and of the financial position of the Corporation. The treasurer will have such other powers and duties as the directors or the chief executive officer of the Corporation
      determine.</div>
    <div>&#160;</div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Section 5.8</font>&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Removal of Officers.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The directors may remove an officer from office at any time, with or without cause. Such removal is without prejudice to the officer&#8217;s rights under any employment contract
      with the Corporation.</div>
    <div>&#160;</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ARTICLE 6</div>
    <div>&#160;</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">PROTECTION OF DIRECTORS, OFFICERS AND OTHERS</div>
    <div>&#160;</div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Section 6.1</font>&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Limitation of Liability.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Subject to the Act and other applicable law, no director or officer is liable for: (i) the acts, omissions, receipts, failures, neglects or defaults of any other director,
      officer or employee; (ii) joining in any receipt or other act for conformity; (iii) any loss, damage or expense happening to the Corporation through the insufficiency or deficiency of title to any property acquired for or on behalf of the
      Corporation; (iv) the insufficiency or deficiency of any security in or upon which any of the monies of the Corporation shall be invested; (v) any loss or damage arising from the bankruptcy, insolvency or tortious acts of any person with whom any of
      the monies, securities or effects of the Corporation shall be deposited; or (vi) any loss occasioned by any error of judgment or oversight on his part, or for any other loss, damage or misfortune whatever which shall happen in the execution of the
      duties of his office or in relation to his office.</div>
    <div>&#160;</div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Section 6.2</font>&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Indemnity.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The Corporation will indemnify to the fullest extent permitted by the Act (i) any director or officer of the Corporation, (ii) any former director or officer of the
      Corporation, (iii) any individual who acts or acted at the Corporation&#8217;s request as a director or officer, or in a similar capacity, of another entity, and (iv) their respective heirs and legal representatives. The Corporation is authorized to
      execute agreements in favour of any of the foregoing persons evidencing the terms of the indemnity. Nothing in this by-law limits the right of any person entitled to indemnity to claim indemnity apart from the provisions of this by-law.</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: center; font-weight: bold;">
      <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Section 6.3</font>&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Insurance.</font></div>
      <div>&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">The Corporation may purchase and maintain insurance for the benefit of any person referred to in Section 6.2 against such liabilities and in such
        amounts as the directors may determine and as are permitted by the Act.</div>
    </div>
    <div style="text-align: center; font-weight: bold;"> <br>
    </div>
    <div style="text-align: center; font-weight: bold;">&#160;ARTICLE 7</div>
    <div style="text-align: center; font-weight: bold;"> <br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">SHAREHOLDERS</div>
    <div>&#160;</div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Section 7.1</font>&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Calling Annual and Special
        Meetings.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The board of directors (by way of a resolution passed at a meeting where there is a quorum of directors or by way of written resolution signed by all directors) have the
      power to call annual meetings of shareholders and special meetings of shareholders. A chair of the board or the chief executive officer may also call meetings of shareholders provided that the business to be transacted at such meeting has been
      approved by the board. Annual meetings of shareholders and special meetings of shareholders will be held on the date and at the time and place in or outside Alberta as the person(s) calling the meeting determine.</div>
    <div>&#160;</div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Section 7.2</font>&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Electronic Meetings.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Meetings of shareholders may be held by telephonic or electronic means. A shareholder who, through those means, votes at the meeting or establishes a communications link to
      the meeting is deemed for the purposes of the Act to be present at the meeting. The directors may establish procedures regarding the holding of meetings of shareholders by such means.</div>
    <div>&#160;</div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Section 7.3</font>&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Notice of Meetings.</font></div>
    <div>&#160;</div>
    <div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The time period to provide notice of the time and place of a meeting of shareholders is not less than twenty-one&#160;(21)&#160;days and not more than fifty (50) days before the
        meeting.</div>
      <div>&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The accidental omission to give notice of any meeting of shareholders to, or the non-receipt of any notice by, any person, or any error in any notice not affecting the
        substance of the notice, does not invalidate any resolution passed or any action taken at the meeting.</div>
      <div>&#160;</div>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Section 7.4</font>&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Waiver of Notice.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">A shareholder, a proxyholder, a director or the auditor and any other person entitled to attend a meeting of shareholders may waive notice of a meeting of shareholders, any
      irregularity in a notice of meeting of shareholders or any irregularity in a meeting of shareholders. Such waiver may be waived in any manner and may be given at any time either before or after the meeting to which the waiver relates. Waiver of any
      notice of a meeting of shareholders cures any irregularity in the notice, any default in the giving of the notice and any default in the timeliness of the notice.</div>
    <div>&#160;</div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Section 7.5</font>&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Representatives.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">A representative of a shareholder that is a body corporate or an association will be recognized if (i) a certified copy of the resolution of the directors or governing body
      of the body corporate or association, or a certified copy of an extract from the by-laws of the body corporate or association, authorizing the representative to represent the body corporate or association is deposited with the Corporation, or (ii)
      the authorization of the representative is established in another manner that is satisfactory to the corporate secretary or the chair of the meeting.</div>
    <div>&#160;</div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Section 7.6</font>&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Persons Entitled to be Present.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The only persons entitled to be present at a meeting of shareholders are those persons entitled to vote at the meeting, the directors, the officers, the auditor of the
      Corporation and others who, although not entitled to vote, are entitled or required under any provision of the Act or the articles or by-laws to be present at the meeting. Any other person may be admitted with the consent of the chair of the meeting
      or the persons present who are entitled to vote at the meeting.</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: left;">
      <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Section 7.7</font>&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Quorum.</font></div>
      <div>&#160; <br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
        <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">A quorum of shareholders is present at a meeting of shareholders if the holders of not less than 33<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">1</sup>&#8725;3% of the votes entitled to be cast at the meeting are
          present in person or represented by proxy, irrespective of the number of persons actually present at the meeting.</div>
        <div>&#160;</div>
      </div>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Section 7.8</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Proxies.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">A proxy shall comply with the applicable requirements of the Act and other applicable law and will be in such form as the directors may approve from time to time or such
      other form as may be acceptable to the chair of the meeting at which the instrument of proxy is to be used. A proxy will be acted on only if it is deposited with the Corporation or its agent prior to the time specified in the notice calling the
      meeting at which the proxy is to be used or it is deposited with the corporate secretary, a scrutineer or the chair of the meeting or any adjournment of the meeting prior to the time of voting.</div>
    <div>&#160;</div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Section 7.9</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Chair, Secretary and
        Scrutineers.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The chair of any meeting of shareholders is the first mentioned of the following officers that is present at the meeting:</div>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z9cfea75789b04791b088e6255d8aad45">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 20.1pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(a)</td>
          <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">the co-chairs of the board or any one of them;</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zdf4d7c251b994880824be928838532f4">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 20.1pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(b)</td>
          <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">the chief executive officer; or</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf9333317b8954c3183db9d3e9f12d2dc">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 20.1pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(c)</td>
          <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">the lead director, if any.</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">If no such person is present at the meeting, the persons present who are entitled to vote shall choose a director who is present, or a shareholder who is present, to chair
      the meeting.</div>
    <div>&#160;</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The corporate secretary, if any, will act as secretary at meetings of shareholders. If a corporate secretary has not been appointed or the corporate secretary is absent,
      the chair of the meeting will appoint a person, who need not be a shareholder, to act as secretary of the meeting.</div>
    <div>&#160;</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">If desired, the chair of the meeting may appoint one or more persons, who need not be shareholders, to act as scrutineers at any meeting of shareholders. The scrutineers
      will assist in determining the number of shares held by persons entitled to vote who are present at the meeting and the existence of a quorum. The scrutineers will also receive, count and tabulate ballots and assist in determining the result of a
      vote by ballot, and do such acts as are necessary to conduct the vote in an equitable manner. The decision of a majority of the scrutineers shall be conclusive and binding upon the meeting and a declaration or certificate of the scrutineers shall be
      conclusive evidence of the facts declared or stated in it.</div>
    <div>&#160;</div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Section 7.10</font>&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Procedure.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The chair of a meeting of shareholders will conduct the meeting and determine the procedure to be followed at the meeting. The chair&#8217;s decision on all matters or things,
      including any questions regarding the validity or invalidity of a form of proxy or other instrument appointing a proxy, is conclusive and binding upon the meeting of shareholders.</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: left;">
      <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Section 7.11</font>&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Manner of Voting.</font></div>
      <div>&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Subject to the Act and other applicable law, any question at a meeting of shareholders shall be decided by a show of hands, unless a ballot on the question is required or
        demanded. Subject to the Act and other applicable law, the chair of the meeting may require a ballot or any person who is present and entitled to vote may demand a ballot on any question at a meeting of shareholders. The requirement or demand for a
        ballot may be made either before or after any vote on the question by a show of hands. A ballot will be taken in the manner the chair of the meeting directs. A requirement or demand for a ballot may be withdrawn at any time prior to the taking of
        the ballot. The result of such ballot shall be the decision of the shareholders upon the question.</div>
      <div>&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">In the case of a vote by a show of hands, each person present who is entitled to vote has one vote. If a ballot is taken, each person present who is entitled to vote is
        entitled to the number of votes that are attached to the shares which such person is entitled to vote at the meeting.</div>
    </div>
    <font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"> <br>
    </font>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Section 7.12</font>&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Votes to Govern.</font></div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Any question at a meeting of shareholders shall be decided by a majority of the votes cast on the question unless the articles, the by-laws, the Act or other applicable law
      requires otherwise. In case of an equality of votes either when the vote is by a show of hands or when the vote is by a ballot, the chair of the meeting is not entitled to a second or casting vote.</div>
    <div>&#160;</div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Section 7.13</font>&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Adjournment.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The chair of any meeting of shareholders may, with the consent of the persons present who are entitled to vote at the meeting, adjourn the meeting from time to time and
      place to place, subject to such conditions as such persons may decide. Any adjourned meeting is duly constituted if held in accordance with the terms of the adjournment and a quorum is present at the adjourned meeting. Any business may be considered
      and transacted at any adjourned meeting which might have been considered and transacted at the original meeting of shareholders.</div>
    <div>&#160;</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ARTICLE 8</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ADVANCE NOTICE</div>
    <div>&#160;</div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Section 8.1</font>&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Nomination of Directors.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Subject only to the Act, for so long as the Corporation is a distributing corporation, only persons who are nominated in accordance with the procedures set out in this
      Section 8.1 shall be eligible for election as directors to the board of the Corporation. Nominations of persons for election to the board may be made for any annual meeting of shareholders, or for any special meeting of shareholders if one of the
      purposes for which the special meeting was called was the election of directors:</div>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zae9cfdc810fb43ac88e048a6e9ed5e0d">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 20.1pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(a)</td>
          <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">by or at the direction of the board, including pursuant to a notice of meeting;</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0c79e9cd3fcd4d65abac03697949c039">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 20.1pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(b)</td>
          <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">by or at the direction or request of one or more shareholders pursuant to a requisition of shareholders made in accordance with the provisions of the Act; or</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z74439d9c7eed4fb4b8382df31e98efab">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 20.1pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(c)</td>
          <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">by any person (a &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Nominating Shareholder</font>&#8221;):</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z925de76a7f1540efa7a800fbcc8b447a">

        <tr>
          <td style="width: 45pt;">&#160;</td>
          <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(i)</td>
          <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">who, at the close of business on the date of the giving of the notice provided for in Section 8.3 below and on the record date for notice of such meeting, is entered in the
              Corporation&#8217;s securities register as a holder of one or more shares carrying the right to vote at such meeting or who beneficially owns shares that are entitled to be voted at such meeting; and</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7cf1e61036d74fabbef216735a4043f2">

        <tr>
          <td style="width: 45pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(ii)</td>
          <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">who complies with the notice procedures set forth in this Article 8.</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Section 8.2</font>&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Timely Notice.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">In addition to any other applicable requirements, for a nomination to be made by a Nominating Shareholder, such person must have given timely notice thereof (in
      accordance with Section 8.3 below) in proper written form to the board (in accordance with Section 8.4 below).</div>
    <div>&#160;</div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Section 8.3</font>&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Manner of Timely Notice.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">To be timely, a Nominating Shareholder&#8217;s notice to the board must be made:</div>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z79fbdec8ac5a41c38f55a997b662db9f">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 20.1pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(a)</td>
          <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">in the case of an annual meeting of shareholders, not less than 30 days prior to the date of the annual meeting of shareholders; provided, however, that in the event that the annual
              meeting of shareholders is to be held on a date that is less than 50 days after the date (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Notice Date</font>&#8221;) that is the earlier of the date that a
              notice of meeting is filed for such meeting and the date on which the first public announcement of the date of the annual meeting was made, notice by the Nominating Shareholder may be made not later than the close of business on the 10<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> day following the Notice Date; and</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zaaa290311a164255913ebc1ae425a1f2">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 20.1pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(b)</td>
          <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">in the case of a special meeting (which is not also an annual meeting) of shareholders called for the purpose of electing directors of the Corporation (whether or not called for such
              purposes), not later than the close of business on the 15<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> day following the day that is the earlier of the date that a notice of meeting is filed for such
              meeting and the date on which the first public announcement of the date of the special meeting of shareholders was made.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Section 8.4</font>&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Proper Form of Notice.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">To be in proper written form, a Nominating Shareholder&#8217;s notice to the board must set forth:</div>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zcc3de389207647c7bd6ce337afe90536">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 20.1pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(a)</td>
          <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">as to each person whom the Nominating Shareholder proposes to nominate for election as a director (a &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Proposed Nominee</font>&#8221;):</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z8f7a490db8f4488aa0bf73d26bb9fcf7">

        <tr>
          <td style="width: 45pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(i)</td>
          <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">the name, age, business address and residential address of the person;</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z66a2b8bed79047678cff27967cf1cf24">

        <tr>
          <td style="width: 45pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(ii)</td>
          <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">the principal occupation or employment of the person for the past five years;</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zac2bb3bd7c6f43609f77bf7a57519d67">

        <tr>
          <td style="width: 45pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(iii)</td>
          <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">the status of the person as a &#8220;resident Canadian&#8221; (as such term is defined in the Act);</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za4458c98cf584e1da9da29db8fa4cb45">

        <tr>
          <td style="width: 45pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(iv)</td>
          <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">the class or series and number of shares which are controlled or which are owned beneficially or of record by the person as of the record date for the meeting of shareholders (if
              such date shall then have been made publicly available and shall have occurred) and as of the date of such notice;</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z430b0bc2a2db494eae535cbcc05e8ca4">

        <tr>
          <td style="width: 45pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(v)</td>
          <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">full particulars regarding any contract, agreement, arrangement, understanding or relationship (collectively, &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Arrangements</font>&#8221;), including, without limitation, financial, compensation and indemnity related Arrangements, between the Proposed Nominee or any associate or affiliate of the Proposed Nominee and any Nominating
              Shareholder or any of its Representatives; and</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z8c7219771a4e4e94a95ffd00e07ec52d">

        <tr>
          <td style="width: 45pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(vi)</td>
          <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">any other information relating to the person that would be required to be disclosed in a dissident&#8217;s proxy circular in connection with solicitations of proxies for election of
              directors pursuant to the Act and Applicable Securities Laws; and</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z796dae7817434c04936e68e95cd03e7e">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 20.1pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(b)</td>
          <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">as to the Nominating Shareholder giving the notice:</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z99699aa4719a494aa439b61a838cf6f5">

        <tr>
          <td style="width: 45pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(i)</td>
          <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">the name, age, business address and, if applicable, residential address of such Nominating Shareholder;</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zdee4e6f45aef4af1879aa4f51cce953f">

        <tr>
          <td style="width: 45pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(ii)</td>
          <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">full particulars of any proxy, contract, relationship, arrangement, agreement or understanding pursuant to which such Nominating Shareholder has a right to vote any shares; and</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze8fe679ac09f4fee99c6c425fc82818a">

        <tr>
          <td style="width: 45pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(iii)</td>
          <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">any other information relating to such Nominating Shareholder that would be required to be made in a dissident&#8217;s proxy circular in connection with solicitations of proxies for
              election of directors pursuant to Applicable Securities Laws.</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The Corporation may require any Proposed Nominee to furnish such other information as may reasonably be required by the Corporation to determine the eligibility of such
      Proposed Nominee to serve as an independent director or that could be material to a reasonable shareholder&#8217;s understanding of the independence, or lack thereof, of such Proposed Nominee.</div>
    <div>&#160;</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">All information to be provided in a timely notice pursuant to Section 8.3 above shall be provided as of the record date for determining shareholders entitled to vote at the
      meeting (if such date shall then have been publicly announced) and as of the date of such notice. The Nominating Shareholder shall update such information forthwith if there are any material changes in the information previously disclosed.</div>
    <div>&#160;</div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Section 8.5</font>&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Determination of Eligibility.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Subject to Section 8.6, no person shall be eligible for election as a director of the Corporation unless such person has been nominated in accordance with the provisions of
      this Article 8; provided, however, that nothing in this Article 8 shall be deemed to preclude discussion by a shareholder (as distinct from the nomination of directors) at a meeting of shareholders of any matter in respect of which such shareholder
      would have been entitled to submit a proposal pursuant to the Act. The chairperson of the meeting shall have the power and duty to determine whether a nomination was made in accordance with the procedures set forth in the foregoing provisions and, if
      any proposed nomination is not in compliance with such foregoing provisions, to declare that such defective nomination shall be disregarded.
      <div>&#160;</div>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Section 8.6</font>&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Waiver.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Notwithstanding the foregoing, the board may, in its sole discretion, waive any requirement in this Article 8.</div>
    <div>&#160;</div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Section 8.7</font>&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Terms.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">For the purposes of this Section:</div>
    <div>&#160;</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Applicable Securities Laws</font>&#8221; means the applicable securities legislation of each
      relevant province and territory of Canada, as amended from time to time, the rules, regulations and forms made or promulgated under any such statute and the published national instruments, multilateral instruments, policies, bulletins and notices of
      the securities commission and similar regulatory authority of each province and territory of Canada;</div>
    <div>&#160;</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">public announcement</font>&#8221; means disclosure in a press release reported by a national
      news service in Canada, or in a document publicly filed by the Corporation under its profile on the System of Electronic Document Analysis and Retrieval at www.sedar.com; and</div>
    <div>&#160;</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Representatives</font>&#8221; of a person means the affiliates and associates of such person,
      all persons acting jointly or in concert with any of the foregoing, and the affiliates and associates of any of such persons acting jointly or in concert, and &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Representative</font>&#8221;
      means anyone of them.</div>
    <div>&#160;</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ARTICLE 9</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">SECURITIES</div>
    <div>&#160;</div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Section 9.1</font>&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Form of Security Certificates.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Subject to the Act, security certificates, if required, will be in the form that the directors approve from time to time or that the Corporation adopts.</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Section 9.2</font>&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Transfer of Shares.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">No transfer of a security issued by the Corporation will be registered except upon (i) presentation of the security certificate representing the security with an
      endorsement which complies with the Act, together with such reasonable assurance that the endorsement is genuine and effective as the directors may require, (ii) payment of all applicable taxes and fees and (iii) compliance with the articles of the
      Corporation. If no security certificate has been issued by the Corporation in respect of a security issued by the Corporation, clause (i) above may be satisfied by presentation of a duly executed security transfer power, together with such reasonable
      assurance that the security transfer power is genuine and effective as the directors may require.</div>
    <div>&#160;</div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Section 9.3</font>&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Transfer Agents and Registrars.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The Corporation may from time to time appoint one or more agents to maintain, for each class or series of securities issued by it in registered or other form, a central
      securities register and one or more branch securities registers. Such an agent may be designated as transfer agent or registrar according to their functions and one person may be designated both registrar and transfer agent. The Corporation may at
      any time terminate such appointment.</div>
    <div>&#160;</div>
    <div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ARTICLE 10</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">PAYMENTS</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br>
      </div>
      <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Section 10.1</font>&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Payments of Dividends and Other
          Distributions.</font></div>
    </div>
    <div>&#160;</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Any dividend or other distribution payable in cash to shareholders will be paid by cheque or by electronic means or by such other method as the directors may determine. The
      payment will be made to or to the order of each registered holder of shares in respect of which the payment is to be made. Cheques will be sent to the registered holder&#8217;s recorded address, unless the holder otherwise directs. In the case of joint
      holders, the payment will be made to the order of all such joint holders and, if applicable, sent to them at their recorded address, unless such joint holders otherwise direct. The sending of the cheque or the sending of the payment by electronic
      means or the sending of the payment by a method determined by the directors in an amount equal to the dividend or other distribution to be paid less any tax that the Corporation is required to withhold will satisfy and discharge the liability for the
      payment, unless payment is not made upon presentation, if applicable.</div>
    <div>&#160;</div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Section 10.2</font>&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Non-Receipt of Payment.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">In the event of non-receipt of any payment made as contemplated by Section 10.1 by the person to whom it is sent, the Corporation may issue re-payment to such person for a
      like amount. The directors may determine, whether generally or in any particular case, the terms on which any re-payment may be made, including terms as to indemnity, reimbursement of expenses, and evidence of non-receipt and of title.</div>
    <div>&#160;</div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Section 10.3</font>&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Unclaimed Dividends.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">To the extent permitted by law, any dividend or other distribution that remains unclaimed after a period of two years from the date on which the dividend has been declared
      to be payable is forfeited and will revert to the Corporation.</div>
    <div>&#160;</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ARTICLE 11</div>
    <div>&#160;</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">FORUM SELECTION AND CORPORATE OPPORTUNITIES</div>
    <div>&#160;</div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Section 11.1</font>&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Forum of Adjudication of Certain
        Disputes.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Unless the Corporation consents in writing to the selection of an alternative forum, the Courts of the Province of Alberta, Canada and the appellate Courts therefrom,
      shall, to the fullest extent permitted by law, be the sole and exclusive forum for: (i) any derivative action or proceeding brought on behalf of the Corporation; (ii) any action or proceeding asserting breach of fiduciary duty owed by any director,
      officer or other employee of the Corporation to the Corporation; (iii) any action or proceeding asserting a claim arising pursuant to any provision of the Act, or the Corporation&#8217;s articles or by-laws (as the same may be amended from time to time);
      or (iv) any action or proceeding asserting a claim otherwise related to the Corporation&#8217;s &#8220;affairs&#8221; (as such term is defined in the Act). If any action or proceeding the subject matter of which is within the scope of the preceding sentence is filed
      in a Court other than a Court located within the Province of Alberta (a &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Foreign Action</font>&#8221;) in the name of any securityholder, such securityholder shall be deemed
      to have consented to: (i) the personal jurisdiction of the provincial and federal Courts located within the Province of Alberta in connection with any action or proceeding brought in any such Court to enforce the preceding sentence; and (ii) having
      service of process made upon such securityholder in any such action or proceeding by service upon such securityholder&#8217;s counsel in the Foreign Action as agent for such securityholder.</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Section 11.2</font>&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Corporate Opportunities.</font></div>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z8b5fe1ddea2c4f4fafa587091f0e9620">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 20.1pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(1)</td>
          <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">The Corporation renounces, to the maximum extent permitted by law, any interest or expectancy of the Corporation in, or in being offered an opportunity to participate in, any
              Excluded Opportunity. An &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Excluded Opportunity</font>&#8221; is any matter, transaction or interest that is presented to, or acquired, created or developed by, or
              which otherwise comes into the possession of, any director or officer of the Corporation (or any of its subsidiaries) who is also a director or officer of another company or corporation (or of any subsidiaries thereof) (collectively, &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Covered Persons</font>&#8221;), unless such matter, transaction or interest is presented to, or acquired, created or developed by, or otherwise comes into the possession
              of, a Covered Person expressly and solely in such Covered Person&#8217;s capacity as a director or officer of the Corporation or a subsidiary thereof.</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd1c0475c4dec4509b57278c7bfa44463">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 20.1pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(2)</td>
          <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">The Corporation may enter into agreements with other parties regarding the allocation of corporate opportunities. To the maximum extent permissible under applicable law, no director
              or officer shall have any liability for complying or attempting to comply in good faith with the provisions thereof (which may involve, among other things, not bringing potential transactions to the attention of the Corporation).</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ARTICLE 12</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">MISCELLANEOUS</div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Section 12.1</font>&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Notices.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Any notice, communication or document required to be given, delivered or sent by the Corporation to any director, officer, shareholder or auditor is sufficiently given,
      delivered or sent if delivered personally, or if delivered to the person&#8217;s recorded address, or if mailed to the person at the person&#8217;s recorded address by prepaid mail, or if otherwise communicated by electronic means permitted by the Act. The
      directors may establish procedures to give, deliver or send a notice, communication or document to any director, officer, shareholder or auditor by any means of communication permitted by the Act or other applicable law. In addition, any notice,
      communication or document may be delivered by the Corporation in the form of an electronic document.</div>
    <div>&#160;</div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Section 12.2</font>&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Notice to Joint Holders.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">If two or more persons are registered as joint holders of any security, any notice may be addressed to all such joint holders but notice addressed to one of them
      constitutes sufficient notice to all of them.</div>
    <div>&#160;</div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Section 12.3</font>&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Computation of Time.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">In computing the date when notice must be given when a specified number of days&#8217; notice of any meeting or other event is required, the date of giving the notice is excluded
      and the date of the meeting or other event is included.</div>
    <div>&#160;</div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Section 12.4</font>&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Persons Entitled by Death or
        Operation of Law.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Every person who, by operation of law, transfer, death of a securityholder or any other means whatsoever, becomes entitled to any security, is bound by every notice in
      respect of such security which has been given to the securityholder from whom the person derives title to such security. Such notices may have been given before or after the happening of the event upon which they became entitled to the security.</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ARTICLE 13</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">EFFECTIVE DATE</div>
    <div>&#160;</div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Section 13.1</font>&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Effective Date.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">This by-law comes into force when made by the directors in accordance with the Act.</div>
    <div>&#160;</div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Section 13.2</font>&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Repeal.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">All previous by-laws of the Corporation are repealed as of the coming into force of this by-law. Such repeal shall not affect the previous operation of any by-law so
      repealed or affect the validity of any act done or right, privilege, obligation or liability acquired or incurred under any such by-law prior to its repeal.</div>
    <div>&#160;</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">This by-law was made by resolution of the directors in connection with the continuance of the Corporation into Alberta on <font style="font-size: 10pt; font-family: 'Times New Roman';">November 6, </font>2024.</div>
    <div>&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;" id="zef113d9a14c846c39b2ff3508ec336d1">

          <tr>
            <td style="width: 50%; padding-bottom: 2px;">
              <div>&#160;</div>
            </td>
            <td style="width: 50%; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>
                <div>/s/ Carl Stanton</div>
              </div>
            </td>
          </tr>
          <tr>
            <td style="width: 50.00%;">
              <div>&#160;</div>
            </td>
            <td style="width: 50.00%;">Authorized Signatory</td>
          </tr>

      </table>
    </div>
    <div> <br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">This by-law was confirmed by ordinary resolution of the shareholders in connection with the continuance of the Corporation into Alberta on <font style="font-size: 10pt; font-family: 'Times New Roman';">November 6, </font>2024.</div>
    <div>&#160;
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;" id="zdb84322aeb6c4ed7acb30b3d5ddc767d">

          <tr>
            <td style="width: 50%; padding-bottom: 2px;">
              <div>&#160;</div>
            </td>
            <td style="width: 50%; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>
                <div>/s/ Carl Stanton</div>
              </div>
            </td>
          </tr>
          <tr>
            <td style="width: 50.00%;">
              <div>&#160;</div>
            </td>
            <td style="width: 50.00%;">Authorized Signatory</td>
          </tr>

      </table>
    </div>
    <div>&#160;</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">[Signature Page to By-law No. 1-Devvstream Corp.]</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;"> <br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;"> <br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"> </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.3
<SEQUENCE>4
<FILENAME>ef20038430_ex4-3.htm
<DESCRIPTION>EXHIBIT 4.3
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 24.9.1.5252
         Copyright 1995 - 2024 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div>
      <div style="text-align: right;"><font style="font-weight: bold;"> Exhibit 4.3</font><br>
      </div>
      <div> <br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" id="zb16afc9a43a945a0ba5277ab16c46d9d" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 51.15%; vertical-align: top;">
              <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">NUMBER SHARES</div>
            </td>
            <td style="width: 48.73%; vertical-align: top;">
              <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">CERTIFICATE NUMBER</div>
            </td>
          </tr>
          <tr>
            <td style="width: 51.15%; vertical-align: top;">
              <div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><br>
              </div>
            </td>
            <td style="width: 48.73%; vertical-align: top;">
              <div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">SEE REVERSE FOR</div>
            </td>
          </tr>
          <tr>
            <td style="width: 51.15%; vertical-align: top;">
              <div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><br>
              </div>
            </td>
            <td style="width: 48.73%; vertical-align: top;">
              <div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">CERTAIN DEFINITIONS</div>
            </td>
          </tr>
          <tr>
            <td style="width: 51.15%; vertical-align: top;">
              <div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><br>
              </div>
            </td>
            <td style="width: 48.73%; vertical-align: top;">
              <div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">CUSIP [&#9679;]</div>
            </td>
          </tr>

      </table>
      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">SPECIMEN COMMON SHARE CERTIFICATE</div>
      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">DEVVSTREAM CORP.</div>
      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">INCORPORATED UNDER THE BUSINESS CORPORATIONS ACT (ALBERTA)</div>
      <div style="text-align: justify; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">This Certifies that ___________________________is the registered holder of _______________</div>
      <div style="text-align: justify; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">FULLY PAID AND NON-ASSESSABLE COMMON SHARES OF DEVVSTREAM CORP. (THE &#8220;COMPANY&#8221;) transferable on the books of the Company in person
        or by duly authorized attorney upon surrender of this certificate properly endorsed.</div>
      <div style="text-align: justify; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">This certificate is not valid unless countersigned by the Transfer Agent and registered by the Registrar.</div>
      <div style="text-align: justify; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">In witness whereof the Company has caused this certificate to be signed by the facsimile signatures of its duly authorized officers.</div>
      <table cellspacing="0" cellpadding="0" border="0" id="zab62492eeb0045bb89a3a28b1de4fcec" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 6%; vertical-align: top;">
              <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Dated:</div>
            </td>
            <td style="width: 13.99%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="vertical-align: top;" colspan="3">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align: top;" colspan="3" rowspan="1">&#160;</td>
            <td style="width: 33.78%; vertical-align: top;" rowspan="1">&#160;</td>
            <td style="width: 33.05%; vertical-align: top;" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);" colspan="3">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Chief Executive Officer</div>
            </td>
            <td style="width: 33.78%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
            <td style="width: 33.05%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Chief Financial Officer</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top;" colspan="3" rowspan="1">&#160;</td>
            <td style="width: 33.78%; vertical-align: top;" rowspan="1">&#160;</td>
            <td style="width: 33.05%; vertical-align: top;" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);" colspan="3">
              <div>
                <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Transfer Agent</div>
              </div>
            </td>
            <td style="width: 33.78%; vertical-align: top;">&#160;</td>
            <td style="width: 33.05%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align: top;" colspan="3" rowspan="1">&#160;</td>
            <td style="width: 33.78%; vertical-align: top;" rowspan="1">&#160;</td>
            <td style="width: 33.05%; vertical-align: top;" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align: top;" colspan="3" rowspan="1">&#160;</td>
            <td style="width: 33.78%; vertical-align: top;" rowspan="1">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Alberta</div>
            </td>
            <td style="width: 33.05%; vertical-align: top;" rowspan="1">&#160;</td>
          </tr>

      </table>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Devvstream Corp.</div>
      <div style="text-align: justify; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Class of shares represented by this certificate has rights, privileges, restrictions or conditions attached to it. The Company
        will furnish without charge to each shareholder who so requests a full copy of the text of the rights, privileges, restrictions and conditions attached to each class authorized to be issued and to each series insofar as they have been fixed by the
        directors, and the authority of the directors to fix the rights, privileges, restrictions and conditions of subsequent series.</div>
      <div style="text-align: justify; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The following abbreviations, when used in the inscription on the face of this certificate, shall be construed as though they were
        written out in full according to applicable laws or regulations:</div>
      <table cellspacing="0" cellpadding="0" border="0" id="z00a8f7e055ca48d08405a8a8cbf4e88a" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TEN COM</div>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div>
            </td>
            <td style="width: 45%; vertical-align: top;">
              <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">as tenants in common</div>
            </td>
            <td style="width: 16%; vertical-align: top;">
              <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">UNIF GIFT MIN ACT</div>
            </td>
            <td style="width: 22%; vertical-align: top;" colspan="3">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Custodian</div>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">&#160;</td>
            <td style="width: 5%; vertical-align: top;">&#160;</td>
            <td style="width: 45%; vertical-align: top;">&#160;</td>
            <td style="width: 16%; vertical-align: top;">&#160;</td>
            <td style="width: 10%; vertical-align: top; border-bottom: #000000 2px solid;">&#160;</td>
            <td style="width: 2%; vertical-align: top;">&#160;</td>
            <td style="width: 10%; vertical-align: top; border-bottom: #000000 2px solid;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">&#160;</td>
            <td style="width: 5%; vertical-align: top;">&#160;</td>
            <td style="width: 45%; vertical-align: top;">&#160;</td>
            <td style="width: 16%; vertical-align: top;">&#160;</td>
            <td style="width: 10%; vertical-align: top;">
              <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(Cust)</div>
            </td>
            <td style="width: 2%; vertical-align: top;">&#160;</td>
            <td style="width: 10%; vertical-align: top;">
              <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(Minor)</div>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TEN ENT</div>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div>
            </td>
            <td style="width: 45%; vertical-align: top;">
              <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">as tenants by the entireties</div>
            </td>
            <td style="width: 38%; vertical-align: top;" colspan="4">&#160;</td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">&#160;</td>
            <td style="width: 5%; vertical-align: top;">&#160;</td>
            <td style="width: 45%; vertical-align: top;">&#160;</td>
            <td style="width: 16%; vertical-align: top;">&#160;</td>
            <td style="width: 10%; vertical-align: top;">&#160;</td>
            <td style="width: 12%; vertical-align: top;" colspan="2">&#160;</td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">JT TEN</div>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div>
            </td>
            <td style="width: 45%; vertical-align: top;">
              <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">as joint tenants with right of survivorship and not as tenants in common</div>
            </td>
            <td style="width: 16%; vertical-align: top;">&#160;</td>
            <td style="width: 10%; vertical-align: top; border-bottom: #000000 2px solid;">&#160;</td>
            <td style="width: 12%; vertical-align: top; border-bottom: #000000 2px solid;" colspan="2">&#160;</td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">&#160;</td>
            <td style="width: 5%; vertical-align: top;">&#160;</td>
            <td style="width: 45%; vertical-align: top;">&#160;</td>
            <td style="width: 16%; vertical-align: top;">&#160;</td>
            <td style="width: 22%; vertical-align: top;" colspan="3">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(State)</div>
            </td>
          </tr>

      </table>
      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Additional abbreviations may also be used though not in the above list.</div>
      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">For value received, ________________________ hereby sells, assigns and transfers unto</div>
      <table cellspacing="0" cellpadding="0" border="0" id="zb484dc1d57514b9081cd4a9351613699" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 100%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(PLEASE INSERT SOCIAL SECURITY OR OTHER IDENTIFYING NUMBER(S) OF ASSIGNEE(S))</div>
            </td>
          </tr>
          <tr>
            <td style="width: 100%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(PLEASE PRINT OR TYPEWRITE NAME(S) AND ADDRESS(ES), INCLUDING POSTAL CODE, OF ASSIGNEE(S))</div>
            </td>
          </tr>

      </table>
      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Shares represented by the within Certificate, and does hereby irrevocably constitute and appoint</div>
      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">attorney to transfer the said shares on the books of the within named Company with full power of substitution in the premises.</div>
      <table cellspacing="0" cellpadding="0" border="0" id="zc433c253575147568604b7305302ce44" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 5%; vertical-align: top;">
              <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Dated</div>
            </td>
            <td style="width: 11%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"><br>
            </td>
            <td style="width: 9%; vertical-align: top;"><br>
            </td>
            <td style="width: 75%; vertical-align: top;"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 5%; vertical-align: top; padding-bottom: 2px;" rowspan="1"><br>
            </td>
            <td style="width: 11%; vertical-align: top; padding-bottom: 2px;" rowspan="1"><br>
            </td>
            <td style="width: 9%; vertical-align: top; padding-bottom: 2px;" rowspan="1"><br>
            </td>
            <td style="width: 75%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1"><br>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top;" colspan="3"><br>
            </td>
            <td style="width: 75%; vertical-align: top;">
              <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Shareholder</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">NOTICE: THE SIGNATURE(S) TO THIS ASSIGNMENT MUST CORRESPOND WITH THE NAME AS WRITTEN UPON THE FACE OF THE CERTIFICATE IN EVERY PARTICULAR, WITHOUT
        ALTERATION OR ENLARGEMENT OR ANY CHANGE WHATEVER.</div>
      <table cellspacing="0" cellpadding="0" border="0" id="z60d8320dc69440b4ba9797c83435f7ff" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 100%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Signature(s) Guaranteed: By</div>
            </td>
          </tr>

      </table>
      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">THE SIGNATURE(S) MUST BE GUARANTEED BY AN ELIGIBLE GUARANTOR INSTITUTION (BANKS, STOCKBROKERS, SAVINGS AND LOAN ASSOCIATIONS AND CREDIT UNIONS) WITH
        MEMBERSHIP IN AN APPROVED SIGNATURE GUARANTEE MEDALLION PROGRAM, PURSUANT TO S.E.C. RULE 17Ad-15 (OR ANY SUCCESSOR RULE).</div>
      <div><br>
      </div>
      <div><br>
      </div>
    </div>
    <div>
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.13
<SEQUENCE>5
<FILENAME>ef20038430_ex10-13.htm
<DESCRIPTION>EXHIBIT 10.13
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 24.9.1.5252
         Copyright 1995 - 2024 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <font style="font-family: 'Times New Roman';"> </font>
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div>
      <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Exhibit 10.13</div>
      <div style="font-family: 'Times New Roman';"><br>
      </div>
      <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">EXECUTION VERSION</div>
      <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman',Times,serif; font-size: 10pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">This AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT, dated as of
          November 6, 2024 (this &#8220;<u>Agreement</u>&#8221;), is made and entered into by and among DevvStream Corp. (formerly known as Focus Impact Acquisition Corp.), a company existing under the laws of the Province of Alberta (the &#8220;<u>Company</u>&#8221;), Focus
          Impact Sponsor, LLC, a Delaware limited liability company (the &#8220;<u>Sponsor</u>&#8221;), and the undersigned parties listed under Legacy Devvstream Holders on the signature page hereto (each a &#8220;<u>Legacy Devvstream Holder</u>&#8221; and, collectively, the &#8220;<u>Legacy

            Devvstream Holders</u>&#8221; and, together with Sponsor&#160;and any person or entity who hereafter becomes a party to this Agreement pursuant to <u>Section 6(e)</u> of this Agreement, each </font><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">a &#8220;<u>Holder</u>&#8221; and collectively the &#8220;<u>Holders</u>&#8221;</font><font style="font-size: 10pt; font-family: 'Times New Roman';">).</font></div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">RECITALS</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman',Times,serif; font-size: 10pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">WHEREAS</font><font style="font-family: 'Times New Roman';">, the Company, Focus Impact Amalco Sub Inc., a company existing under the Laws of the Province of British Columbia and a wholly-owned subsidiary of the Company (&#8220;<font style="font-size: 10pt;"><u>Amalco Sub</u></font>&#8221;), and DevvStream
          Holdings Inc., a company existing under the laws of the Province of British Columbia (&#8220;<font style="font-size: 10pt;"><u>Legacy Devvstream</u></font>&#8221;), are party to that certain Business Combination Agreement, dated as of September 12, 2023, as
          amended by Amendment No. 1 to Business Combination Agreement, dated as of May 1, 2024, and as further amended by Amendment No. 2 to Business Combination Agreement, dated as of August 10, 2024 (as amended, the &#8220;<font style="font-size: 10pt;"><u>Business
              Combination Agreement</u></font>&#8221;), pursuant to which, on the date hereof, Legacy Devvstream and the Company combined (as further described in the Business Combination Agreement, the &#8220;<font style="font-size: 10pt;"><u>Business Combination</u></font>&#8221;)
          by way of an arrangement on the terms and subject to the conditions set forth in a plan of arrangement under Section 288 of the Business Corporations Act (British Columbia), pursuant to which, among other things, Amalco Sub and Legacy Devvstream
          amalgamated to form one corporate entity;</font></div>
      <div style="text-align: justify; text-indent: 24pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-family: 'Times New Roman';"> <br>
        </font></div>
      <div style="text-align: justify; font-family: 'Times New Roman',Times,serif; font-size: 10pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">WHEREAS</font><font style="font-family: 'Times New Roman';">, pursuant to the Business Combination Agreement and in connection with the consummation of the Business Combination, the Legacy Devvstream Holders received shares of Common Stock (as defined herein) (the &#8220;<font style="font-size: 10pt;"><u>Business
              Combination Shares</u></font>&#8221;);</font></div>
      <div style="text-align: justify; text-indent: 24pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-family: 'Times New Roman';"> <br>
        </font></div>
      <div style="text-align: justify; font-family: 'Times New Roman',Times,serif; font-size: 10pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">WHEREAS, </font><font style="font-family: 'Times New Roman';">immediately following the consummation of the Business Combination, the Sponsor held an aggregate of 5,015,610 shares of Common Stock (as defined herein) (the &#8220;<font style="font-size: 10pt;"><u>Sponsor Shares</u></font>&#8221;) and 11,200,000
          private placement warrants to purchase shares of Common Stock at an exercise price of $11.50 per share (the &#8220;<font style="font-size: 10pt;"><u>Sponsor Warrants</u></font>&#8221;);</font></div>
      <div style="text-align: justify; text-indent: 24pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-family: 'Times New Roman';"> <br>
        </font></div>
      <div style="text-align: justify; font-family: 'Times New Roman',Times,serif; font-size: 10pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">WHEREAS</font><font style="font-family: 'Times New Roman';">, the Company and the Sponsor are parties to that certain Registration and Stockholder Rights Agreement, dated as of November 1, 2021 (the &#8220;<font style="font-size: 10pt;"><u>Prior Agreement</u></font>&#8221;);</font></div>
      <div style="text-align: justify; text-indent: 24pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-family: 'Times New Roman';"> <br>
        </font></div>
      <div style="text-align: justify; font-family: 'Times New Roman',Times,serif; font-size: 10pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">WHEREAS</font><font style="font-family: 'Times New Roman';">, pursuant to Section 6.8 of the Prior Agreement, the provisions, covenants and conditions set forth in the Prior Agreement may be amended or modified upon the written consent of the Company and the holders of at least a majority in
          interest of the registrable securities under the Prior Agreement at the time in question and the Sponsor is the holder of at least a majority in interest of such registrable securities as of the date hereof; and<br>
          <br>
        </font></div>
      <div style="text-align: justify; font-family: 'Times New Roman',Times,serif; font-size: 10pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">WHEREAS</font><font style="font-family: 'Times New Roman';">, in connection with the consummation of the Business Combination, the parties to the Prior Agreement desire to amend and restate the Prior Agreement in its entirety as set forth herein, and the parties hereto desire to enter into this
          Agreement pursuant to which the Company shall grant the Holders certain registration rights with respect to the Registrable Securities (as defined below) on the terms and conditions set forth in this Agreement.</font></div>
      <div style="text-align: justify; text-indent: 24pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-family: 'Times New Roman';"> <br>
        </font></div>
      <div style="text-align: justify; font-family: 'Times New Roman',Times,serif; font-size: 10pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">NOW, THEREFORE</font><font style="font-family: 'Times New Roman';">, in consideration of the premises and the mutual premises and covenants contained in this Agreement, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged,</font></div>
      <div style="text-align: justify; text-indent: 24pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-family: 'Times New Roman';"> <br>
        </font></div>
      <div style="text-align: justify; font-family: 'Times New Roman',Times,serif; font-size: 10pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">IT IS AGREED </font><font style="font-family: 'Times New Roman';">as follows:</font></div>
      <div style="font-family: 'Times New Roman';"><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <!--PROfilePageNumberReset%Num%2%%%-->
      <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">1.</font><font style="font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; <font style="font-size: 10pt; font-weight: bold;">DEFINITIONS</font></font></div>
      <div style="text-align: justify;"><font style="font-family: 'Times New Roman';"><font style="font-size: 10pt; font-weight: bold;"> <br>
          </font></font></div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 27pt;">As used in this Agreement, the following terms shall have the following meanings:</div>
      <div style="text-align: justify; text-indent: 24pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 27pt;">&#8220;<font style="font-size: 10pt;"><u>Affiliate</u></font>&#8221; of any specified Person shall mean any other Person directly or indirectly controlling or
        controlled by, or under common control with, such specified Person. The term &#8220;control&#8221; (including the terms &#8220;controlling,&#8221; &#8220;controlled by&#8221; and &#8220;under common control with&#8221;) means the possession, directly or indirectly, of the power to direct or
        cause the direction of the management and policies of a Person, whether through the ownership of voting securities, by contract or otherwise.<br>
        <br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 27pt;">&#8220;<font style="font-size: 10pt;"><u>Agreement</u></font>&#8221; shall have the meaning set forth in the Preamble hereof.</div>
      <div style="text-align: justify; text-indent: 24pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 27pt;">&#8220;<font style="font-size: 10pt;"><u>Amalco Sub</u></font>&#8221; shall have the meaning set forth in the Preamble hereof.</div>
      <div style="text-align: justify; text-indent: 24pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 27pt;">&#8220;<font style="font-size: 10pt;"><u>Blackout Period</u></font>&#8221; shall have the meaning set forth in <font style="font-size: 10pt;"><u>Section
            2(e)(ii)</u></font>.</div>
      <div style="text-align: justify; text-indent: 24pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 27pt;">&#8220;<font style="font-size: 10pt;"><u>Block Trade</u></font>&#8221; shall mean an offering and/or sale of Registrable Securities by any Holder on a block
        trade or underwritten basis (whether firm commitment or otherwise) without substantial marketing efforts prior to pricing, including, without limitation, a same day trade, overnight trade or similar transaction and without a lock-up agreement of
        more than forty-five (45) days to which the Company is a party (including, for the avoidance of doubt, any lock-up or clear market covenant contained in the underwriting agreement for such transaction).</div>
      <div style="text-align: justify; text-indent: 24pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 27pt;">&#8220;<font style="font-size: 10pt;"><u>Board</u></font>&#8221; shall mean the Board of Directors of the Company.</div>
      <div style="text-align: justify; text-indent: 24pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 27pt;">&#8220;<font style="font-size: 10pt;"><u>Business Combination</u></font>&#8221; shall have the meaning set forth in the Recitals hereof.</div>
      <div style="text-align: justify; text-indent: 24pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 27pt;">&#8220;<font style="font-size: 10pt;"><u>Business Combination Agreement</u></font>&#8221; shall have the meaning set forth in the Recitals hereof.</div>
      <div style="text-align: justify; text-indent: 24pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 27pt;">&#8220;<font style="font-size: 10pt;"><u>Business Combination Shares</u></font>&#8221; shall have the meaning set forth in the Recitals hereof.</div>
      <div style="text-align: justify; text-indent: 24pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 27pt;">&#8220;<font style="font-size: 10pt;"><u>Business Day</u></font>&#8221; shall mean any day except Saturday, Sunday or any days on which banks are generally not
        open for business in New York, New York and the Provinces of Ontario and Alberta, Canada.</div>
      <div style="text-align: justify; text-indent: 24pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 27pt;">&#8220;<font style="font-size: 10pt;"><u>Commission</u></font>&#8221; shall mean the Securities and Exchange Commission.</div>
      <div style="text-align: justify; text-indent: 24pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman',Times,serif; font-size: 10pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">&#8220;<u>Common Stock</u>&#8221; shall mean the&#160;Company&#8217;s common shares, par value
          $0.0001 per share.</font></div>
      <div style="text-align: justify; text-indent: 24pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"> <br>
        </font></div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 27pt;">&#8220;<font style="font-size: 10pt;"><u>Company</u></font>&#8221; shall have the meaning set forth in the Preamble hereof.</div>
      <div style="text-align: justify; text-indent: 24pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 27pt;">&#8220;<font style="font-size: 10pt;"><u>Demanding Holder</u></font>&#8221; shall have the meaning set forth in <font style="font-size: 10pt;"><u>Section
            2(a)(iv)</u></font>.</div>
      <div style="text-align: justify; text-indent: 24pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 27pt;">&#8220;<font style="font-size: 10pt;"><u>Exchange Act</u></font>&#8221; shall mean the Securities Exchange Act of 1934, as amended (or any corresponding
        provision of succeeding law) and the rules and regulations thereunder.</div>
      <div style="text-align: justify; text-indent: 24pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 27pt;">&#8220;<font style="font-size: 10pt;"><u>FINRA</u></font>&#8221; shall mean the Financial Industry Regulatory Authority.</div>
      <div style="text-align: justify; text-indent: 24pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 27pt;">&#8220;<font style="font-size: 10pt;"><u>Holder</u></font>&#8221; shall have the meaning set forth in the Preamble hereof.</div>
      <div style="text-align: justify; text-indent: 24pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 27pt;">&#8220;<font style="font-size: 10pt;"><u>In-Kind Distribution</u></font>&#8221; shall have the meaning set forth in <font style="font-size: 10pt;"><u>Section
            6(e)</u></font>.</div>
      <div style="text-align: justify; text-indent: 24pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 27pt;">&#8220;<font style="font-size: 10pt;"><u>Legacy Devvstream</u></font>&#8221; shall have the meaning set forth in the Recitals hereof.</div>
      <div style="text-align: justify; text-indent: 24pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 27pt;">&#8220;<font style="font-size: 10pt;"><u>Legacy Devvstream Holders</u></font>&#8221; shall have the meaning set forth in the Preamble hereof.</div>
      <div style="text-align: justify; text-indent: 24pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 27pt;">&#8220;<font style="font-size: 10pt;"><u>Legal Dispute</u></font>&#8221; shall have the meaning set forth in <font style="font-size: 10pt;"><u>Section 6(j)</u></font>.<br>
        <br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 27pt;">&#8220;<font style="font-size: 10pt;"><u>Liabilities</u></font>&#8221; shall have the meaning set forth in <font style="font-size: 10pt;"><u>Section 4(a)(i)</u></font>.</div>
      <div style="text-align: justify; text-indent: 24pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 27pt;">&#8220;<font style="font-size: 10pt;"><u>Maximum Threshold</u></font>&#8221; shall have the meaning set forth in <font style="font-size: 10pt;"><u>Section
            2(a)(v)</u></font>.</div>
      <div style="text-align: justify; text-indent: 24pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 27pt;">&#8220;<font style="font-size: 10pt;"><u>Minimum Takedown Threshold</u></font>&#8221; shall have the meaning set forth in <font style="font-size: 10pt;"><u>Section
            2(a)(iv)</u></font>.</div>
      <div style="text-align: justify; text-indent: 24pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 27pt;">&#8220;<font style="font-size: 10pt;"><u>Misstatement</u></font>&#8221; means an untrue statement of a material fact or an omission to state a material fact
        required to be stated in a Registration Statement or Prospectus or necessary to make the statements in a Registration Statement or Prospectus (in the case of a Prospectus, in the light of the circumstances under which they were made) not
        misleading.</div>
      <div style="text-align: justify; text-indent: 24pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 27pt;">&#8220;<font style="font-size: 10pt;"><u>New Registration Statement</u></font>&#8221; shall have the meaning set forth in <font style="font-size: 10pt;"><u>Section
            2(a)(i)</u></font>.</div>
      <div style="text-align: justify; text-indent: 24pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 27pt;">&#8220;<font style="font-size: 10pt;"><u>Non-Holder Securities</u></font>&#8221; shall have the meaning set forth in <font style="font-size: 10pt;"><u>Section
            2(a)(v)</u></font>.</div>
      <div style="font-family: 'Times New Roman';"><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">2</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 27pt;">&#8220;<font style="font-size: 10pt;"><u>Other Coordinated Offering</u></font>&#8221; shall have the meaning set forth in <font style="font-size: 10pt;"><u>Section
            2(c)(i)</u></font>.</div>
      <div style="text-align: justify; text-indent: 24pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 27pt;">&#8220;<font style="font-size: 10pt;"><u>Person</u></font>&#8221; shall mean any individual, partnership, joint venture, corporation, trust, limited liability
        company, unincorporated organization or other entity or any governmental entity.</div>
      <div style="text-align: justify; text-indent: 24pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 27pt;">&#8220;<font style="font-size: 10pt;"><u>Piggyback Registration</u></font>&#8221; shall have the meaning set forth in <font style="font-size: 10pt;"><u>Section
            2(b)(i)</u></font>.</div>
      <div style="text-align: justify; text-indent: 24pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 27pt;">&#8220;<font style="font-size: 10pt;"><u>Prior Agreement</u></font>&#8221; shall have the meaning set forth in the Recitals hereof.</div>
      <div style="text-align: justify; text-indent: 24pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 27pt;">&#8220;<font style="font-size: 10pt;"><u>Prospectus</u></font>&#8221; means the prospectus or prospectuses included in any Registration Statement (including
        without limitation, any prospectus subject to completion and a prospectus that includes any information previously omitted from a prospectus filed as part of an effective registration statement in reliance upon Rule 430A promulgated under the
        Securities Act and any term sheet filed pursuant to Rule 434 under the Securities Act), as amended or supplemented by any prospectus supplement with respect to the terms of the offering of any portion of Registrable Securities covered by such
        Registration Statement and by all other amendments and supplements to the prospectus, including post-effective amendments and all material incorporated by reference or deemed to be incorporated by reference in such prospectus or prospectuses.</div>
      <div style="text-align: justify; text-indent: 24pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 27pt;">&#8220;<font style="font-size: 10pt;"><u>Registrable Securities</u></font>&#8221; shall mean (a) the Sponsor Shares, (b) the Sponsor Warrants (including any
        shares of Common Stock issued or issuable upon the exercise of the Sponsor Warrants), (c) any outstanding shares of Common Stock or Warrants held by a Holder immediately following the consummation of the Business Combination (including the Common
        Stock constituting a portion of the Business Combination Shares), (d) any shares of Common Stock that may be acquired by Holders upon the exercise of a Warrant or other right to acquire Common Stock held by a Holder as of the date of this
        Agreement, (e) any shares of Common Stock or Warrants otherwise acquired or owned by a Holder following the date hereof to the extent that such securities are &#8220;restricted securities&#8221; (as defined in Rule 144) or are otherwise held by an &#8220;affiliate&#8221;
        (as defined in Rule 144) of the Company, and (f) any other equity security of the Company or any of its subsidiaries issued or issuable with respect to any securities referenced in clauses (a) through (e) above by way of a stock dividend or stock
        split or in connection with a recapitalization, merger, consolidation, spin-off, reorganization or similar transaction; provided, however, that such Registrable Securities shall cease to be Registrable Securities with respect to any Holder upon the
        earliest to occur of (x) when such Registrable Securities shall have been sold, transferred, disposed of or exchanged by such Holder in a transaction effected in accordance with, or exempt from, the registration requirements of the Securities Act,
        and (y) the date on which such securities shall have ceased to be outstanding.</div>
      <div style="text-align: justify; text-indent: 24pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 27pt;">&#8220;<font style="font-size: 10pt;"><u>Registration</u></font>&#8221; shall mean a registration, including any related Underwritten Shelf Takedown, effected
        by preparing and filing a Registration Statement, Prospectus or similar document in compliance with the requirements of the Securities Act, and the applicable rules and regulations promulgated thereunder, and such registration statement becoming
        effective.</div>
      <div style="text-align: justify; text-indent: 24pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 27pt;">&#8220;<font style="font-size: 10pt;"><u>Registration Statement</u></font>&#8221; means any registration statement of the Company filed with the Commission
        under the Securities Act which covers any Registrable Securities pursuant to the provisions of this Agreement, including the Prospectus, amendments and supplements to such Registration Statement, including post-effective amendments, all exhibits
        and all materials incorporated by reference or deemed to be incorporated by reference in such Registration Statement.</div>
      <div style="text-align: justify; text-indent: 24pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 27pt;">&#8220;<font style="font-size: 10pt;"><u>Sale Expenses</u></font>&#8221; shall mean (a) the fees and disbursements of counsel and independent public accountants
        for the Company incurred in connection with the Company&#8217;s performance of or compliance with this Agreement, including the expenses of any special audits or &#8220;comfort&#8221; letters required by or incident to such performance and compliance, and any
        premiums and other costs of policies of insurance obtained by the Company against Liabilities arising out of the sale of any securities, (b) all registration, filing and stock exchange fees, all fees and expenses of complying with securities or
        &#8220;blue sky&#8221; laws (including any legal investment memoranda related thereto), all fees and expenses of custodians, transfer agents and registrars, all printing and producing expenses, messenger and delivery expenses, (c) expenses relating to any
        analyst or Holder presentations or any &#8220;road shows&#8221; undertaken in connection with the marketing or selling of Registrable Securities, (d) fees and expenses in connection with any review by FINRA of the underwriting arrangements or other terms of
        the offering, and all fees and expenses of any &#8220;qualified independent underwriter,&#8221; (e) costs of any selling agreements and other documents in connection with the offering, sale or delivery of Registrable Securities, (f) the reasonable fees and
        disbursements of one legal counsel for all Holders participating in any Underwritten Offering, (g) any reasonable fees and disbursements of underwriters customarily paid by issuers or sellers of securities and (h) all of the Company&#8217;s internal
        expenses (including all salaries and expenses of its officers and employees performing legal or accounting duties); provided, however, that &#8220;<font style="font-size: 10pt;"><u>Sale Expenses</u></font>&#8221; shall not include any out-of-pocket expenses of
        any Holder (other than as set forth in clauses (b) and (f) above), transfer taxes, underwriting or brokerage commissions or discounts associated with effecting any sales of Registrable Securities that may be offered, which expenses shall be borne
        by such Holder.</div>
      <div style="font-family: 'Times New Roman';"><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">3</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 27pt;">&#8220;<font style="font-size: 10pt;"><u>SEC Guidance</u></font>&#8221; shall have the meaning set forth in <font style="font-size: 10pt;"><u>Section 2(a)(i)</u></font>.</div>
      <div style="text-align: justify; text-indent: 24pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 27pt;">&#8220;<font style="font-size: 10pt;"><u>Securities Act</u></font>&#8221; Securities Act of 1933, as amended.</div>
      <div style="text-align: justify; text-indent: 24pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 27pt;">&#8220;<font style="font-size: 10pt;"><u>Shelf Registration Statement</u></font>&#8221; shall have the meaning set forth in <font style="font-size: 10pt;"><u>Section
            2(a)(i)</u></font>.</div>
      <div style="text-align: justify; text-indent: 24pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 27pt;">&#8220;<font style="font-size: 10pt;"><u>Shelf Takedown Limit</u></font>&#8221; shall have the meaning set forth in <font style="font-size: 10pt;"><u>Section
            2(a)(iv)</u></font>.</div>
      <div style="text-align: justify; text-indent: 24pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 27pt;">&#8220;<font style="font-size: 10pt;"><u>Sponsor</u></font>&#8221; shall have the meaning set forth in the Preamble hereof.</div>
      <div style="text-align: justify; text-indent: 24pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 27pt;">&#8220;<font style="font-size: 10pt;"><u>Sponsor Shares</u></font>&#8221; shall have the meaning set forth in the Recitals hereof.</div>
      <div style="text-align: justify; text-indent: 24pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 27pt;">&#8220;<font style="font-size: 10pt;"><u>Sponsor Warrants</u></font>&#8221; shall have the meaning set forth in the Recitals hereof.</div>
      <div style="text-align: justify; text-indent: 24pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 27pt;">&#8220;<font style="font-size: 10pt;"><u>Subsequent Shelf Registration</u></font>&#8221; shall have the meaning set forth in <font style="font-size: 10pt;"><u>Section
            2(a)(ii)</u></font>.</div>
      <div style="text-align: justify; text-indent: 24pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 27pt;">&#8220;<font style="font-size: 10pt;"><u>Suspension Period</u></font>&#8221; shall have the meaning set forth in <font style="font-size: 10pt;"><u>Section
            2(e)(i)</u></font>.</div>
      <div style="text-align: justify; text-indent: 24pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 27pt;">&#8220;<font style="font-size: 10pt;"><u>Underwritten Offering</u></font>&#8221; shall mean a sale of securities of the Company to an underwriter or
        underwriters for reoffering to the public.</div>
      <div style="text-align: justify; text-indent: 24pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 27pt;">&#8220;<font style="font-size: 10pt;"><u>Underwritten Shelf Takedown</u></font>&#8221; shall have the meaning set forth in <font style="font-size: 10pt;"><u>Section
            2(a)(iv)</u></font>.</div>
      <div style="text-align: justify; text-indent: 24pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 27pt;">&#8220;<font style="font-size: 10pt;"><u>Warrants</u></font>&#8221; shall mean warrants of the Company that entitle the holder to Common Stock (including, for
        the avoidance of doubt, the Sponsor Warrants).</div>
      <div style="text-align: justify; text-indent: 24pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 27pt;">&#8220;<font style="font-size: 10pt;"><u>Withdrawal Notice</u></font>&#8221; shall have the meaning set forth in <font style="font-size: 10pt;"><u>Section
            2(a)(vi)</u></font>.</div>
      <div style="text-align: justify; text-indent: 24pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">2.</font><font style="font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-weight: bold;">REGISTERED
            OFFERINGS</font></font></div>
      <div style="text-align: justify;"><font style="font-family: 'Times New Roman';"><font style="font-size: 10pt; font-weight: bold;"> <br>
          </font></font></div>
      <div style="text-align: justify; margin-left: 24pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)</font><font style="font-family: 'Times New Roman';">&#160;&#160;&#160;&#160; <font style="font-size: 10pt;"><font style="font-size: 10pt; font-style: italic;">Registration Rights.</font></font></font></div>
      <div>
        <div style="font-family: 'Times New Roman';"><br>
        </div>
        <div style="text-align: justify; text-indent: 54pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(i)</font><font style="font-family: 'Times New Roman';">&#160; <font style="font-size: 10pt;"><font style="font-size: 10pt; font-style: italic;">Shelf Registration</font>. Subject to <font style="font-size: 10pt;"><u>Section 3(c)</u></font>, the Company agrees to file within sixty (60) days after the date of this Agreement, a shelf Registration Statement on Form S-1, or
              such other form under the Securities Act then available to the Company, providing for the<font style="font-size: 10pt;">&#160;</font>resale of all Registrable Securities (determined as of two (2) business days prior to such filing) pursuant to
              Rule 415, from time to time (a &#8220;<font style="font-size: 10pt;"><u>Shelf Registration Statement</u></font>&#8221;). The Company shall use commercially reasonable efforts to cause such Shelf Registration Statement to be declared effective by the
              Commission as soon as practicable after the filing thereof. The Shelf Registration Statement shall provide for the resale from time to time, and pursuant to any method or combination of methods legally available (including, without
              limitation, an Underwritten Offering, a direct sale to purchasers or a sale through brokers or agents) to the Holders of any and all Registrable Securities. Following the filing of the Shelf Registration Statement, the Company shall use its
              commercially reasonable efforts to convert the Shelf Registration Statement on Form S-1 (and any Subsequent Shelf Registration) to a Registration Statement on Form S-3 as soon as practicable after the Company is eligible to use Form S-3. <font style="font-size: 10pt; color: rgb(0, 0, 0);">Notwithstanding the registration obligations set forth in this <u>Section 2(a)(i)</u>, in the event the Commission informs the Company that all of the Registrable Securities cannot, as a result
                of the application of Rule 415, be registered for resale as a secondary offering on a single registration statement, the Company agrees to promptly (A) inform each of the Holders and use its commercially reasonable efforts to file
                amendments to the Shelf Registration Statement as required by the Commission and/or (B) withdraw the Shelf Registration Statement and file a new registration statement (a &#8220;<u>New Registration Statement</u>&#8221;), in either case covering the
                maximum number of Registrable Securities permitted to be registered by the Commission, on Form S-1 or Form S-3 or such other form available to register for resale the Registrable Securities as a secondary offering; provided, however, that
                prior to filing such amendment or New Registration Statement, the Company shall be obligated to use its commercially reasonable efforts to advocate with the Commission for the registration of all of the Registrable Securities in accordance
                with any publicly-available written or oral guidance, comments, requirements or requests of the Commission staff (the &#8220;<u>SEC Guidance</u>&#8221;), including, without limitation, relevant Compliance and Disclosure Interpretations. Notwithstanding
                any other provision of this Agreement, if any SEC Guidance sets forth a limitation of the number of Registrable Securities permitted to be registered on a particular Registration Statement as a secondary offering (and notwithstanding that
                the Company used diligent efforts to advocate with the Commission for the registration of all or a greater number of Registrable Securities), unless otherwise directed in writing by a Holder as to its Registrable Securities, the number of
                Registrable Securities to be registered on such Registration Statement will be reduced pro rata, based on the number of Registrable Securities held by each Holder, subject to a determination by the Commission that certain Holders must be
                reduced first based on the number of Registrable Securities held by such Holders. In the event the Company amends the Shelf Registration Statement or files a New Registration Statement, as the case may be, under clauses (A) or (B) above,
                the Company will use its commercially reasonable efforts to file with the Commission, as promptly as allowed by Commission or SEC Guidance provided to the Company or to registrants of securities in general, one or more registration
                statements on Form S-1 or Form S-3 or such other form available to register for resale those Registrable Securities that were not registered for resale on the Shelf Registration Statement, as amended, or the New Registration Statement.</font></font></font></div>
      </div>
      <div style="font-family: 'Times New Roman';"><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">4</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 54pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(ii)</font><font style="font-family: 'Times New Roman';">&#160; <font style="font-size: 10pt;"><font style="font-size: 10pt; font-style: italic;">Subsequent Shelf Registration</font>. If any Shelf Registration Statement ceases to be effective under the Securities Act for any reason at any time while Registrable Securities are still outstanding, the Company shall, subject to <font style="font-size: 10pt;"><u>Section 2(e)</u></font>, use its commercially reasonable efforts to as promptly as is reasonably practicable cause such Shelf Registration Statement to again become effective under the Securities Act (including
            obtaining the prompt withdrawal of any order suspending the effectiveness of such Shelf Registration Statement), and shall use its commercially reasonable efforts to as promptly as is reasonably practicable amend such Shelf Registration
            Statement in a manner reasonably expected to result in the withdrawal of any order suspending the effectiveness of such Shelf Registration Statement or file an additional registration statement as a Shelf Registration Statement (a &#8220;<font style="font-size: 10pt;"><u>Subsequent Shelf Registration</u></font>&#8221;) registering the resale of all Registrable Securities (determined as of two business days prior to such filing), and pursuant to any method or combination of methods
            legally available to, and requested by, any Holder named therein. If a Subsequent Shelf Registration is filed, the Company shall use its commercially reasonable efforts to (i) cause such Subsequent Shelf Registration to become effective under
            the Securities Act as promptly as is reasonably practicable after the filing thereof (it being agreed that the Subsequent Shelf Registration shall be an automatic shelf registration statement (as defined in Rule 405 promulgated under the
            Securities Act) if the Company is a well-known seasoned issuer (as defined in Rule 405 promulgated under the Securities Act) at the most recent applicable eligibility determination date) and (ii) keep such Subsequent Shelf Registration
            continuously effective, available for use and in compliance with the provisions of the Securities Act until such time as there are no longer any Registrable Securities. Any such Subsequent Shelf Registration shall be on Form S-3 to the extent
            that the Company is eligible to use such form. Otherwise, such Subsequent Shelf Registration shall be on another appropriate form.</font></font></div>
      <div style="text-align: justify; text-indent: 48pt;"><font style="font-family: 'Times New Roman';"><font style="font-size: 10pt;"> <br>
          </font></font></div>
      <div style="text-align: justify; text-indent: 54pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(iii)</font><font style="font-family: 'Times New Roman';"> <font style="font-size: 10pt;"><font style="font-size: 10pt; font-style: italic;">Additional Registrable Securities</font>. In the event that any Holder holds Registrable Securities that are not registered for resale on a delayed or continuous basis, the Company, upon request of a Holder that holds at least five
            percent (5.0%) of the Registrable Securities, shall promptly use its commercially reasonable efforts to cause the resale of such Registrable Securities to be covered by either, at the Company&#8217;s option, the Shelf Registration Statement
            (including by means of a post-effective amendment) or a Subsequent Shelf Registration and cause the same to become effective as soon as practicable after such filing and such Shelf Registration Statement or Subsequent Shelf Registration shall
            be subject to the terms hereof; <font style="font-size: 10pt;"><u>provided</u></font>, <font style="font-size: 10pt;"><u>however</u></font>, that the Company shall only be required to cause such Registrable Securities to be so covered twice
            per calendar year.</font></font></div>
      <div style="text-align: justify; text-indent: 48pt;"><font style="font-family: 'Times New Roman';"><font style="font-size: 10pt;"> <br>
          </font></font></div>
      <div style="text-align: justify; text-indent: 54pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(iv)</font><font style="font-family: 'Times New Roman';">&#160; <font style="font-size: 10pt;"><font style="font-size: 10pt; font-style: italic;">Requests for Underwritten Shelf Takedowns</font>. At any time and from time to time when an effective Shelf Registration Statement is on file with the Commission, any one or more Holders (any of the Holders being, in such case, a &#8220;<font style="font-size: 10pt;"><u>Demanding Holder</u></font>&#8221;) may request to sell all or any portion of its Registrable Securities in an Underwritten Offering that is registered pursuant to the Shelf Registration Statement (each, an &#8220;<font style="font-size: 10pt;"><u>Underwritten Shelf Takedown</u></font>&#8221;); <font style="font-size: 10pt;"><u>provided</u></font> in each case that the Company shall only be obligated to effect an Underwritten Offering if such offering shall
            include Registrable Securities proposed to be sold by the Demanding Holder(s) with a total offering price reasonably expected to exceed, in the aggregate, $10.0 million (the &#8220;<font style="font-size: 10pt;"><u>Minimum Takedown Threshold</u></font>&#8221;).
            All requests for Underwritten Shelf Takedowns shall be made by giving written notice to the Company, which shall specify the approximate number of Registrable Securities proposed to be sold in the Underwritten Shelf Takedown. Promptly (but in
            any event within five (5) days) after receipt of a request for Underwritten Shelf Takedown, the Company shall give written notice of the Underwritten Shelf Takedown to all other Holders. The Company shall have the right to select the
            underwriters for such offering (which shall consist of one or more reputable nationally recognized investment banks), subject to the initial Demanding Holder&#8217;s prior approval (which shall not be unreasonably withheld, conditioned or delayed).
            The Holders may collectively demand no more than two (2) Underwritten Shelf Takedowns pursuant to this <font style="font-size: 10pt;"><u>Section 2(a)(iv)</u></font> in any 12-month period (the &#8220;<font style="font-size: 10pt;"><u>Shelf Takedown
                Limit</u></font>&#8221;). Notwithstanding anything to the contrary in this Agreement, the Company may effect any Underwritten Shelf Takedown pursuant to any then effective Registration Statement, including a Form S-3, that is then available for
            such offering.</font></font></div>
      <div style="font-family: 'Times New Roman';"><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">5</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 54pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(v)</font><font style="font-family: 'Times New Roman';">&#160; <font style="font-size: 10pt;"><font style="font-size: 10pt; font-style: italic;">Reduction of Underwritten Shelf Takedown</font>. If, in connection with an Underwritten Offering that is effectuated for the account of stockholders of the Company, including pursuant to <font style="font-size: 10pt;"><u>Section
                2(a)(iv)</u></font>, in which Registrable Securities are included, the managing underwriters of such Underwritten Offering advise the Company in writing that, in their opinion and in consultation with the Company, the number of Registrable
            Securities requested to be included in such Underwritten Offering exceeds the number that can be sold in such Underwritten Offering and/or that the number of Registrable Securities proposed to be included in any such Underwritten Offering would
            adversely affect the price per share of the Company&#8217;s equity securities to be sold in such Underwritten Offering (such maximum number of securities or Registrable Securities, as applicable, the &#8220;<font style="font-size: 10pt;"><u>Maximum
                Threshold</u></font>&#8221;), then the number of Registrable Securities to be included in such Underwritten Offering shall be allocated among the Holders and holders of Non-Holder Securities as follows: (A) first, the securities comprised of
            Registrable Securities, pro rata, based on the amount of such Registrable Securities initially requested to be included by the Holders (pursuant to either <font style="font-size: 10pt;"><u>Section 2(a)(iv) or 2(b)(i))</u></font> or as such
            Holders may otherwise agree, that can be sold without exceeding the Maximum Threshold; (B) second, to the extent that the Maximum Threshold has not been reached under the foregoing clause (A), the equity securities of a holder of the Company&#8217;s
            securities other than Registrable Securities (&#8220;<font style="font-size: 10pt;"><u>Non-Holder Securities</u></font>&#8221;) that either (1) the Company is obligated to include pursuant to written contractual rights entered into prior to or on the date
            hereof or (2) such other contractual rights governing the applicable Non-Holder Securities, pro rata, based on the amount of such equity securities initially requested to be included by the holders of Non-Holder Securities or as such holders of
            Non-Holder Securities may otherwise agree, that can be sold without exceeding the Maximum Threshold; (C) third, to the extent that the Maximum Threshold has not been reached under the foregoing <font style="font-size: 10pt;"><u>clauses (A) and
                (B)</u></font>, Non-Holder Securities that the Company is obligated to include pursuant to written contractual rights entered into after the date hereof that do not comply with <font style="font-size: 10pt;"><u>clause (B)(2)</u></font>
            above, that can be sold<font style="font-size: 10pt;">&#160;</font>without exceeding the Maximum Threshold; and (D) fourth, to the extent that the Maximum Threshold has not been reached under the foregoing <font style="font-size: 10pt;"><u>clauses
                (A)</u></font>, <font style="font-size: 10pt;"><u>(B)</u></font> and <font style="font-size: 10pt;"><u>(C)</u></font>, the shares of Common Stock or other securities that the Company desires to sell that can be sold without exceeding the
            Maximum Threshold.&#160; Notwithstanding this <font style="font-size: 10pt;"><u>Section 2(a)(v)</u></font>, the Sponsor shall be entitled to initiate one Underwritten Shelf Takedown pursuant to which it shall be entitled to sell all Registrable
            Securities it requests to be included in such offering, prior to the application of the reduction principles set forth in clauses (A) through (D) above; provided, however, that the number of Registrable Securities so requested by the Sponsor
            shall not exceed the Maximum Threshold.</font></font></div>
      <div style="text-align: justify; text-indent: 48pt;"><font style="font-family: 'Times New Roman';"><font style="font-size: 10pt;"> <br>
          </font></font></div>
      <div style="text-align: justify; text-indent: 54pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(vi)</font><font style="font-family: 'Times New Roman';"> <font style="font-size: 10pt;"><font style="font-size: 10pt; font-style: italic;">Withdrawal</font>. Prior to the filing of the applicable &#8220;red herring&#8221; prospectus or prospectus supplement used for marketing such Underwritten Shelf Takedown, a majority-in-interest of the Demanding Holders initiating an
            Underwritten Shelf Takedown shall have the right to withdraw from such Underwritten Shelf Takedown for any or no reason whatsoever upon written notification (a &#8220;<font style="font-size: 10pt;"><u>Withdrawal Notice</u></font>&#8221;) to the Company and
            the underwriter or underwriters (if any) of their intention to withdraw from such Underwritten Shelf Takedown; <font style="font-size: 10pt;"><u>provided</u></font> that any Holder may elect to have the Company continue an Underwritten Shelf
            Takedown if the Minimum Takedown Threshold would still be satisfied by the Registrable Securities proposed to be sold in the Underwritten Shelf Takedown by the Holders. If withdrawn, a demand for an Underwritten Shelf Takedown shall constitute
            a demand for an Underwritten Shelf Takedown for purposes of <font style="font-size: 10pt;"><u>Section 2(a)(iv)</u></font>, unless the Holder reimburses the Company for all Sale Expenses with respect to such Underwritten Shelf Takedown; <font style="font-size: 10pt;"><u>provided</u></font> that, if a Holder elects to continue an Underwritten Shelf Takedown pursuant to the proviso in the immediately preceding sentence, such Underwritten Shelf Takedown shall instead count as an
            Underwritten Shelf Takedown demanded by the Holders for purposes of <font style="font-size: 10pt;"><u>Section 2(a)(iv)</u></font>. Following the receipt of any Withdrawal Notice, the Company shall promptly forward such Withdrawal Notice to any
            other Holders that had elected to participate in such Underwritten Shelf Takedown. Notwithstanding anything to the contrary in this Agreement, the Company shall be responsible for the Sale Expenses incurred in connection with a Underwritten
            Shelf Takedown prior to its withdrawal under this <font style="font-size: 10pt;"><u>Section 2(a)(vi)</u></font>, other than if a Demanding Holder elects to pay such Sale Expenses pursuant to the second sentence of this <font style="font-size: 10pt;"><u>Section 2(a)(vi)</u></font>.</font></font></div>
      <div style="font-family: 'Times New Roman';"><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">6</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 27pt;">(b)&#160;&#160;&#160; <font style="font-size: 10pt; font-style: italic;">Piggyback Rights.</font></div>
      <div style="text-align: justify; margin-left: 23.75pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-style: italic;"> <br>
        </font></div>
      <div style="text-align: justify; text-indent: 54pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(i)</font><font style="font-family: 'Times New Roman';">&#160; <font style="font-size: 10pt;"><font style="font-size: 10pt; font-style: italic;">Right to Piggyback</font>. If the Company or any Holder proposes to conduct a registered offering of, or if the Company proposes to file a Registration Statement under the Securities Act with respect to the Registration of, equity
            securities, or securities or other obligations exercisable or exchangeable for, or convertible into equity securities, for its own account or for the account of stockholders of the Company (or by the Company and by the stockholders of the
            Company including, without limitation, an Underwritten Shelf Takedown pursuant to <font style="font-size: 10pt;"><u>Section 2(a)(iv)</u></font>), other than a Registration Statement (or any registered offering with respect thereto) (i) filed
            in connection with any employee stock option or other benefit plan, (ii) pursuant to a Registration Statement on Form S-4 (or similar form that relates to a transaction subject to Rule 145 under the Securities Act or any successor rule
            thereto), (iii) for an offering of debt that is convertible into equity securities of the Company, (iv) for a dividend reinvestment plan or (v) for a rights offering, then the Company shall give written notice of such proposed offering to all
            of the Holders of Registrable Securities as soon as practicable but not less than ten (10) days before the anticipated filing date of such Registration Statement or, in the case of an Underwritten Offering pursuant to a Shelf Registration
            Statement, the applicable &#8220;red herring&#8221; prospectus or prospectus supplement used for marketing such offering, which notice shall (A) describe the amount and type of securities to be included in such offering, the intended method(s) of
            distribution, and the name of the proposed managing underwriter or underwriters, if any, in such<font style="font-size: 10pt;">&#160;</font>offering, and (B) offer to all of the Holders of Registrable Securities the opportunity to include in such
            registered offering such number of Registrable Securities as such Holders may request in writing within five (5) days after receipt of such written notice (such Registration, a &#8220;<font style="font-size: 10pt;"><u>Piggyback</u></font>&#160;<font style="font-size: 10pt;"><u>Registration</u></font>&#8221;). Subject to <font style="font-size: 10pt;"><u>Section 2(b)(ii)</u></font>, the Company shall cause all such Registrable Securities to be included in such Piggyback Registration and, if
            applicable, shall use its commercially reasonable efforts to cause the managing underwriter or underwriters of such Piggyback Registration to permit the Registrable Securities requested by the Holders pursuant to this <font style="font-size: 10pt;"><u>Section</u></font>&#160;<font style="font-size: 10pt;"><u>2(b)(i)</u></font> to be included therein on the same terms and conditions as any similar securities of the Company included in such Registration and to permit the sale or other
            disposition of such Registrable Securities in accordance with the intended method(s) of distribution thereof. The inclusion of any Holder&#8217;s Registrable Securities in a Piggyback Registration shall be subject to such Holder&#8217;s agreement to enter
            into an underwriting agreement in customary form with the underwriter(s) selected for such Underwritten Offering by the Company.</font></font></div>
      <div style="text-align: justify; text-indent: 48.25pt;"><font style="font-family: 'Times New Roman';"><font style="font-size: 10pt;"> <br>
          </font></font></div>
      <div style="text-align: justify; text-indent: 54pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(ii)</font><font style="font-family: 'Times New Roman';">&#160; <font style="font-size: 10pt;"><font style="font-size: 10pt; font-style: italic;">Reduction of Offering</font>. If the managing underwriter or underwriters in an Underwritten Offering that is to be a Piggyback Registration advises the Company and the Holders of Registrable Securities participating in the Piggyback
            Registration in writing that the dollar amount or number of shares of Common Stock or other equity securities that the Company desires to sell, taken together with (i) the Non-Holder Securities as to which Registration or a registered offering
            has been demanded pursuant to separate written contractual arrangements (including any other applicable contractual piggy-back registration rights) and (ii) the Registrable Securities as to which registration has been requested pursuant to <font style="font-size: 10pt;"><u>Section 2(b)</u></font>&#160; exceeds the Maximum Threshold, then:</font></font></div>
      <div style="text-align: justify; text-indent: 48pt;"><font style="font-family: 'Times New Roman';"><font style="font-size: 10pt;"> <br>
          </font></font></div>
      <div style="text-align: justify; text-indent: 24pt; margin-left: 48pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(A)</font><font style="font-family: 'Times New Roman';">&#160;&#160;&#160; &#160;&#160; <font style="font-size: 10pt;">If the Registration
            or registered offering is initiated by the Company primarily for its own account, the number of shares of Common Stock to be included in such Underwritten Offering shall be allocated as follows: (A) first, the shares of Common Stock or other
            securities to be sold by the Company; (B) second, to the extent that the Maximum Threshold has not been reached under the foregoing clause (A), the Registrable Securities of Holders exercising their rights to register their Registrable
            Securities hereunder pro rata, based on the number of shares of such Common Stock initially requested to be included by the Holders that can be sold without exceeding the Maximum Threshold; and (C) third, to the extent that the Maximum
            Threshold has not been reached under the foregoing clauses (A) and (B), Non-Holder Securities that the Company is obligated to include pursuant to separate written contractual rights that can be sold without exceeding the Maximum Threshold;</font></font></div>
      <div style="text-align: justify; text-indent: 24pt; margin-left: 48pt;"><font style="font-family: 'Times New Roman';"><font style="font-size: 10pt;"> <br>
          </font></font></div>
      <div style="text-align: justify; text-indent: 24pt; margin-left: 48pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(B)</font><font style="font-family: 'Times New Roman';">&#160;&#160;&#160;&#160; <font style="font-size: 10pt;">If the Registration or
            registered offering is initiated for the account of stockholders of the Company other than the Holders of Registrable Securities, the number of shares of Common Stock to be included in such Underwritten Offering shall be allocated as follows:
            (A) first, the Non-Holder Securities that the Company is obligated to include pursuant to written contractual rights that provide that such securities must be included on a <font style="font-size: 10pt; font-style: italic;">pari passu </font>basis
            to the Registrable Securities, and any Registrable Securities requested to be included, pro rata, based on the amount of such securities initially requested to be included or as such holders of Non-Holder Securities and Registrable Securities
            may otherwise agree, that can be sold without exceeding the Maximum Threshold; (B) second, to the extent that the Maximum Threshold has not been reached under the foregoing clause (A), Non-Holder Securities that the Company is obligated to
            include pursuant to written contractual rights entered into after the date hereof that do not comply with clause (A) above, that can be sold without exceeding the Maximum Threshold; and (C) third, to the extent that the Maximum Threshold has
            not been reached under the foregoing clauses (A) and (B), the shares of Common Stock or other securities that the Company desires to sell that can be sold without exceeding the Maximum Threshold; and</font></font></div>
      <div style="font-family: 'Times New Roman';"><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">7</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 18pt; margin-left: 54pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(C)</font><font style="font-family: 'Times New Roman';">&#160;&#160; &#160; &#160; <font style="font-size: 10pt;">If the Registration
            or registered offering is pursuant to a request by Holder(s) of Registrable Securities pursuant to <font style="font-size: 10pt;"><u>Section 2(a)(iv)</u></font>, then the Company shall include in any such Registration or registered offering
            securities pursuant to <font style="font-size: 10pt;"><u>Section 2(a)(v)</u></font>.</font></font></div>
      <div style="text-align: justify; text-indent: 24pt; margin-left: 48pt;"><font style="font-family: 'Times New Roman';"><font style="font-size: 10pt;"> <br>
          </font></font></div>
      <div style="text-align: justify; text-indent: 54pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(iii)</font><font style="font-family: 'Times New Roman';"> <font style="font-size: 10pt;"><font style="font-size: 10pt; font-style: italic;">Withdrawal</font>. Any Holder of Registrable Securities (other than a Demanding Holder, whose right to withdrawal from an Underwritten Shelf Takedown, and related obligations, shall be governed by <font style="font-size: 10pt;"><u>Section
                2(a)(vi)</u></font>) shall have the right to withdraw from a Piggyback Registration for any or no reason whatsoever upon written notification to the Company and the underwriter or underwriters (if any) of his, her or its intention to
            withdraw from such Piggyback Registration prior to the effectiveness of the Registration Statement filed with the Commission with respect to such Piggyback Registration or, in the case of a Piggyback Registration pursuant to a Shelf
            Registration Statement, the filing of the applicable &#8220;red herring&#8221; prospectus or prospectus supplement with respect to such Piggyback Registration used for marketing such transaction. The Company (whether on its own determination or as the
            result of a request for withdrawal by persons pursuant to separate written contractual obligations) may withdraw a Registration Statement filed with the Commission in connection with a Piggyback Registration (which, in no circumstance, shall
            include the Shelf Registration Statement) at any time prior to the effectiveness of such Registration Statement. Notwithstanding anything to the contrary in this Agreement (other than <font style="font-size: 10pt;"><u>Section 2(a)(vi)</u></font>),
            the Company shall be responsible for the Sale Expenses incurred in connection with the Piggyback Registration prior to its withdrawal under this <font style="font-size: 10pt;"><u>Section</u></font>&#160;<font style="font-size: 10pt;"><u>2(b)(iii)</u></font>.</font></font></div>
      <div style="text-align: justify; text-indent: 48pt;"><font style="font-family: 'Times New Roman';"><font style="font-size: 10pt;"> <br>
          </font></font></div>
      <div style="text-align: justify; text-indent: 54pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(iv)</font><font style="font-family: 'Times New Roman';"> <font style="font-size: 10pt;"><font style="font-size: 10pt; font-style: italic;">Unlimited Piggyback Registration Rights</font>. For purposes of clarity, subject to <font style="font-size: 10pt;"><u>Section 2(a)(vi)</u></font>, any Piggyback Registration effected pursuant to <font style="font-size: 10pt;"><u>Section
                2(b)</u></font> shall not be counted as a demand for an Underwritten Shelf Takedown under <font style="font-size: 10pt;"><u>Section 2(a)(iv)</u></font>.</font></font></div>
      <div style="text-align: justify; text-indent: 48pt;"><font style="font-family: 'Times New Roman';"><font style="font-size: 10pt;"> <br>
          </font></font></div>
      <div style="text-indent: 27pt;">
        <div>
          <div style="text-align: justify;"><font style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(c) &#160;&#160; </font></font><font style="font-family: 'Times New Roman';"><font style="font-size: 10pt;"><font style="font-size: 10pt; font-style: italic;">Block Trades; Other Coordinated Offerings.</font></font></font></div>
        </div>
      </div>
      <div style="text-align: justify; margin-left: 24pt;"><font style="font-family: 'Times New Roman';"><font style="font-size: 10pt;"><font style="font-size: 10pt; font-style: italic;"> <br>
            </font></font></font></div>
      <div style="text-align: justify; text-indent: 54pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(i)</font><font style="font-family: 'Times New Roman';">&#160;&#160; <font style="font-size: 10pt;"><font style="font-size: 10pt; font-style: italic;">Block Trades</font>. Notwithstanding the foregoing, at any time and from time to time when an effective Shelf Registration Statement is on file with the Commission, if a Demanding Holder wishes to engage in (A) a Block Trade or (B)
            an &#8220;at the market&#8221; or similar registered offering through a broker, sales agent or distribution agent, whether as agent or principal<font style="font-size: 10pt;">&#160;</font>(an &#8220;<font style="font-size: 10pt;"><u>Other Coordinated Offering</u></font>&#8221;),
            in each case with a total offering price reasonably expected to exceed, in the aggregate, either (x) $10.0 million or (y) all remaining Registrable Securities held by the Demanding Holder, then notwithstanding the time periods provided for in <font style="font-size: 10pt;"><u>Section 2(a)(iv)</u></font>, such Demanding Holder shall notify the Company of the Block Trade or Other Coordinated Offering at least five (5) business days prior to the day such offering is to commence and the
            Company shall as expeditiously as possible use its commercially reasonable efforts to facilitate such Block Trade or Other Coordinated Offering; <font style="font-size: 10pt;"><u>provided</u></font> that the Demanding Holders representing a
            majority of the Registrable Securities wishing to engage in the Block Trade or Other Coordinated Offering shall use commercially reasonable efforts to work with the Company and any underwriters or placement agents or sales agents prior to
            making such request in order to facilitate preparation of the registration statement, prospectus and other offering documentation related to the Block Trade or Other Coordinated Offering; <font style="font-size: 10pt;"><u>provided further</u></font>
            that in the case of such underwritten Block Trade or Other Coordinated Offering, only such Holder shall have a right to notice of and to participate in such offering.</font></font></div>
      <div style="text-align: justify; text-indent: 48pt;"><font style="font-family: 'Times New Roman';"><font style="font-size: 10pt;"> <br>
          </font></font></div>
      <div style="text-align: justify; text-indent: 54pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(ii)</font><font style="font-family: 'Times New Roman';">&#160; <font style="font-size: 10pt;"><font style="font-size: 10pt; font-style: italic;">Withdrawal</font>. Prior to the filing of the applicable &#8220;red herring&#8221; prospectus or prospectus supplement used in connection with a Block Trade or Other Coordinated Offering, a majority-in-interest of the Demanding Holders
            initiating such Block Trade or Other Coordinated Offering shall have the right to submit a Withdrawal Notice to the Company and the underwriter or underwriters or placement agents or sales agents (if any) of their intention to withdraw from
            such Block Trade or Other Coordinated Offering. If withdrawn, a demand for a Block Trade or Other Coordinated Offering shall constitute a demand for an Underwritten Shelf Takedown, unless the Holder reimburses the Company for all Sale Expenses
            with respect to such Block Trade or Other Coordinated Offering.</font></font></div>
      <div style="text-align: justify; text-indent: 48pt;"><font style="font-family: 'Times New Roman';"><font style="font-size: 10pt;"> <br>
          </font></font></div>
      <div style="text-align: justify; text-indent: 54pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(iii)</font><font style="font-family: 'Times New Roman';"> <font style="font-size: 10pt;"><font style="font-size: 10pt; font-style: italic;">Cap on Block Trades and Other Coordinated Offerings</font>. Any Registration effected pursuant to this <font style="font-size: 10pt;"><u>Section 2(c)</u></font> shall be deemed an Underwritten Shelf Takedown and counted towards the
            Shelf Takedown Limit. Notwithstanding anything to the contrary in this Agreement, <font style="font-size: 10pt;"><u>Section 2(b)</u></font> shall not apply to a Block Trade or Other Coordinated Offering initiated by a Demanding Holder pursuant
            to this Agreement.&#160; Provided, however, a Block Trade or Other Coordinated Offering shall not be deemed an Underwritten Shelf Takedown and shall not count towards the Shelf Takedown Limit if the Company is not required to take any of the actions
            described in <font style="font-size: 10pt;"><u>subsections (v), (vi)</u></font> and <font style="font-size: 10pt;"><u>(xi)</u></font> of <font style="font-size: 10pt;"><u>Section 3(a)</u></font> in connection with such Block Trade or Other
            Coordinated Offering.</font></font></div>
      <div style="font-family: 'Times New Roman';"><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">8</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(d)</font><font style="font-family: 'Times New Roman';">&#160;<font style="font-size: 10pt;"> <font style="font-size: 10pt; font-style: italic;">Continued Effectiveness</font>. The Company shall use commercially reasonable efforts to keep any Registration Statement continuously effective for the period beginning on the date on which such Registration Statement is declared
            effective and ending on the date that all of Registrable Securities registered under the Registration Statement cease to be Registrable Securities. During the period that such Registration Statement is effective, the Company shall use
            commercially reasonable efforts to supplement or make amendments to the Registration Statement, if required by the Securities Act or if reasonably requested by Holder (whether or not required by the form on which the securities are being
            registered), including to reflect any specific plan of distribution or method of sale, and shall use its commercially reasonable efforts to have such supplements and amendments declared effective, if required, as soon as practicable after
            filing.</font></font></div>
      <div style="text-align: justify; text-indent: 24pt;"><font style="font-family: 'Times New Roman';"><font style="font-size: 10pt;"> <br>
          </font></font></div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 27pt;">(e)&#160;&#160; <font style="font-size: 10pt; font-style: italic;">Suspension Period</font>; <font style="font-size: 10pt; font-style: italic;">Blackout
          Period</font>.</div>
      <div style="text-align: justify; margin-left: 24pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: justify; text-indent: 54pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(i)</font><font style="font-family: 'Times New Roman';">&#160;&#160; <font style="font-size: 10pt;"><font style="font-size: 10pt; font-style: italic;">Misstatement</font>. Upon receipt of written notice from the Company that a Registration Statement or Prospectus contains a Misstatement, each of the Holders shall forthwith<font style="font-size: 10pt;">&#160;</font>discontinue
            disposition of Registrable Securities until it has received copies of a supplemented or amended Prospectus correcting the Misstatement (it being understood that the Company hereby covenants to prepare and file such supplement or amendment as
            soon as practicable after the time of such notice), or until it is advised in writing by the Company that the use of the Prospectus may be resumed (any such period, a &#8220;<font style="font-size: 10pt;"><u>Suspension Period</u></font>&#8221;).</font></font></div>
      <div style="text-align: justify; text-indent: 48pt;"><font style="font-family: 'Times New Roman';"><font style="font-size: 10pt;"> <br>
          </font></font></div>
      <div style="text-align: justify; text-indent: 54pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(ii)</font><font style="font-family: 'Times New Roman';">&#160; <font style="font-size: 10pt;"><font style="font-size: 10pt; font-style: italic;">Other Suspension</font>. Notwithstanding any provision of this Agreement to the contrary, if the Board determines in good faith that any use of a Registration Statement or Prospectus hereunder involving Registrable Securities would
            (i) reasonably be expected to, in the good faith judgment of the majority of the Board, after consultation with counsel to the Company, materially impede, delay or interfere with, or require premature disclosure of, any material financing,
            offering, acquisition, disposition, merger, corporate reorganization, segment reclassification or discontinuance of operations that is required to be reflected in pro forma or restated financial statements that amends historical financial
            statements of the Company, or other significant transaction or any negotiations, discussions or pending proposals with respect thereto, involving the Company or any of its subsidiaries; (ii) require the inclusion in such Registration Statement
            of financial statements that are unavailable to the Company for reasons beyond the Company&#8217;s control; or (iii) require, after consultation with counsel to the Company, the disclosure of material non-public information, the disclosure of which
            would (x) not be required to be made if a Registration Statement were not being used and (y) reasonably be expected to materially and adversely affect the Company, then the Company shall be entitled to suspend, for not more than sixty (60)
            consecutive days (any such period, a &#8220;<font style="font-size: 10pt;"><u>Blackout Period</u></font>&#8221;), but in no event more than two (2) times in any consecutive twelve (12) month period (which periods may be successive), commencing on the date
            of this Agreement, the use of any Registration Statement or Prospectus and shall not be required to amend or supplement the Registration Statement, any related Prospectus or any document incorporated therein by reference. The Company promptly
            will give written notice of any such Blackout Period to the Holders.</font></font></div>
      <div style="text-align: justify; text-indent: 48pt;"><font style="font-family: 'Times New Roman';"><font style="font-size: 10pt;"> <br>
          </font></font></div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 27pt;">(f)&#160;&#160; <font style="font-size: 10pt; font-style: italic;">Sale Expenses</font>. All Sale Expenses of any Holder incurred in connection with <font style="font-size: 10pt;"><u>Section 2</u></font> and <font style="font-size: 10pt;"><u>Section 3</u></font> shall be borne by the Company. It is acknowledged by the Holders that the Holders shall bear all incremental selling expenses relating to
        the sale of Registrable Securities, such as underwriters&#8217; or agents&#8217; commissions and discounts, brokerage fees, underwriter marketing costs and, other than as set forth in the definition of &#8220;Sale Expenses,&#8221; all reasonable fees and expenses of any
        legal counsel representing the Holders.</div>
      <div style="text-align: justify; text-indent: 24pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: justify; text-indent: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(g)</font><font style="font-family: 'Times New Roman';">&#160; <font style="font-size: 10pt;"><font style="font-size: 10pt; font-style: italic;">Market Stand-Off</font>. In connection with any Underwritten Offering of equity securities of the Company (other than a Block Trade or Other Coordinated Offering), each Holder that holds greater than five percent (5%) of the
            outstanding Common Stock that is given an opportunity to participate in the Underwritten Offering pursuant to the terms of this Agreement and participates in such Underwritten Offering and each Holder that is an executive officer or director of
            the Company agrees that it shall not transfer any shares of Common Stock or other equity securities of the Company (other than those included in such offering pursuant to this Agreement), without the prior written consent of the Company, during
            the 90-day period beginning on the date of pricing of such offering or such shorter period during which the Company agrees not to conduct an underwritten primary offering of Common Stock, except in the event the underwriters managing the
            offering otherwise agree by written consent. Each Holder that holds<font style="font-size: 10pt;">&#160;</font>greater than five percent (5%) of the outstanding Common Stock and participates in such Underwritten Offering or is an executive officer
            or director of the Company agrees to execute a customary lock-up agreement in favor of the underwriters to such effect (in each case on substantially the same terms and conditions as all such Holders).</font></font></div>
      <div style="font-family: 'Times New Roman';"><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">9</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">3.</font><font style="font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; <font style="font-size: 10pt; font-weight: bold;">PROCEDURES</font></font></div>
      <div style="text-align: justify;"><font style="font-family: 'Times New Roman';"><font style="font-size: 10pt; font-weight: bold;"> <br>
          </font></font></div>
      <div style="text-align: justify; text-indent: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)</font><font style="font-family: 'Times New Roman';">&#160;&#160; <font style="font-size: 10pt;">In connection with the filing of any
            Registration Statement or sale of Registrable Securities as provided in this Agreement, the Company shall use commercially reasonable efforts to, as expeditiously as reasonably practicable:</font></font></div>
      <div style="text-align: justify; text-indent: 24pt;"><font style="font-family: 'Times New Roman';"><font style="font-size: 10pt;"> <br>
          </font></font></div>
      <div style="text-align: justify; text-indent: 54pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(i)</font><font style="font-family: 'Times New Roman';">&#160;&#160; <font style="font-size: 10pt;">notify promptly the Holders and, if
            requested by a Holder, confirm such advice in writing promptly at the address determined in accordance with <font style="font-size: 10pt;"><u>Section 6(d)</u></font>, (A) of the issuance by the Commission or any state securities authority of
            any stop order suspending the effectiveness of a Registration Statement or the initiation of any proceedings for that purpose, (B) if, between the effective date of a Registration Statement and the closing of any sale of Registrable Securities
            covered thereby, the representations and warranties of the Company contained in any underwriting agreement, securities sales agreement or other similar agreement, if any, relating to the offering cease to be true and correct in all material
            respects, (C) of the happening of any event or the discovery of any facts during the period a Registration Statement is effective as a result of which such Registration Statement or any document incorporated by reference therein contains any
            Misstatement or alleged Misstatement (which information shall be accompanied by an instruction to suspend the use of the Registration Statement and the prospectus until the requisite changes have been made), (D) of the receipt by the Company of
            any notification with respect to the suspension of the qualification of Registrable Securities for sale in any jurisdiction or the initiation or threatening of any proceeding for such purpose and (E) of the filing of a post-effective amendment
            to such Registration Statement;</font></font></div>
      <div style="text-align: justify; text-indent: 48pt;"><font style="font-family: 'Times New Roman';"><font style="font-size: 10pt;"> <br>
          </font></font></div>
      <div style="text-align: justify; text-indent: 54pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(ii)</font><font style="font-family: 'Times New Roman';">&#160; <font style="font-size: 10pt;">furnish each Holder&#8217;s legal counsel, if
            any, copies of any comment letters relating to such Holder received from the Commission or any other request by the Commission or any state securities authority for amendments or supplements to a Registration Statement and prospectus or for
            additional information relating to such Holder;</font></font></div>
      <div style="text-align: justify; text-indent: 48pt;"><font style="font-family: 'Times New Roman';"><font style="font-size: 10pt;"> <br>
          </font></font></div>
      <div style="text-align: justify; text-indent: 54pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(iii)</font><font style="font-family: 'Times New Roman';"> <font style="font-size: 10pt;">use commercially reasonable efforts to
            obtain the withdrawal of any order suspending the effectiveness of a Registration Statement as promptly as practicable;</font></font></div>
      <div style="text-align: justify; text-indent: 48pt;"><font style="font-family: 'Times New Roman';"><font style="font-size: 10pt;"> <br>
          </font></font></div>
      <div style="text-align: justify; text-indent: 54pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(iv)</font><font style="font-family: 'Times New Roman';"> <font style="font-size: 10pt;">upon the occurrence of any event or the
            discovery of any facts, as contemplated by <font style="font-size: 10pt;"><u>Section 3(a)(i)(C)</u></font>, as promptly as practicable after the occurrence of such an event, use its commercially reasonable efforts to prepare a supplement or
            post-effective amendment to the Registration Statement or the related prospectus or any document incorporated therein by reference or file any other required document so that, as thereafter delivered to the purchasers of Registrable Securities,
            such prospectus will not contain at the time of such delivery any Misstatement or alleged Misstatement. At such time as such public disclosure is otherwise made or the Company determines that such disclosure is not necessary, in each case to
            correct any Misstatement, the Company agrees promptly to notify the Holders of such determination and to furnish any Holder such number of copies of the prospectus as amended or supplemented, as such Holder may reasonably request;</font></font></div>
      <div style="text-align: justify; text-indent: 48pt;"><font style="font-family: 'Times New Roman';"><font style="font-size: 10pt;"> <br>
          </font></font></div>
      <div style="text-align: justify; text-indent: 54pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(v)</font><font style="font-family: 'Times New Roman';">&#160; <font style="font-size: 10pt;">enter into agreements in customary form
            (including underwriting agreements) and take all other reasonable and customary appropriate actions in order to expedite or facilitate the disposition of such Registrable Securities regardless of whether an underwriting agreement is entered
            into and regardless of whether the registration is an underwritten registration, including:</font></font></div>
      <div style="text-align: justify; text-indent: 48pt;"><font style="font-family: 'Times New Roman';"><font style="font-size: 10pt;"> <br>
          </font></font></div>
      <div style="text-align: justify; text-indent: 18pt; margin-left: 54pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(A)</font><font style="font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt;">for an Underwritten
            Offering, making such representations and warranties to the underwriters, if any, in form, substance and scope as are customarily made by issuers to underwriters in similar Underwritten Offerings as may be reasonably requested by them;</font></font></div>
      <div style="text-align: justify; text-indent: 24pt; margin-left: 48pt;"><font style="font-family: 'Times New Roman';"><font style="font-size: 10pt;"> <br>
          </font></font></div>
      <div style="text-align: justify; text-indent: 18pt; margin-left: 54pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(B)</font><font style="font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt;">for an Underwritten
            Offering, obtaining opinions of counsel to the Company and updates thereof (which counsel and opinions (in form, scope and substance) shall be reasonably satisfactory to any managing underwriter(s) and their counsel) addressed to the
            underwriters, if any, covering the matters customarily covered in opinions requested in Underwritten Offerings and such other matters as may be reasonably requested by the underwriter(s);</font></font></div>
      <div style="text-align: justify; text-indent: 24pt; margin-left: 48pt;"><font style="font-family: 'Times New Roman';"><font style="font-size: 10pt;"> <br>
          </font></font></div>
      <div style="text-align: justify; text-indent: 18pt; margin-left: 54pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(C)</font><font style="font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt;">for an Underwritten
            Offering, obtaining &#8220;comfort&#8221; letters and updates thereof from the Company&#8217;s independent registered public accounting firm (and, if necessary, any other independent certified public accountants of any subsidiary of the Company or of any
            business acquired by the Company for which financial statements are, or are required to be, included in the Registration Statement) addressed to the underwriter(s), such letters to be in customary form and covering matters of the type
            customarily covered in &#8220;comfort&#8221; letters to underwriters in connection with similar Underwritten Offerings;</font></font></div>
      <div style="text-align: justify; text-indent: 24pt; margin-left: 48pt;"><font style="font-family: 'Times New Roman';"><font style="font-size: 10pt;"> <br>
          </font></font></div>
      <div style="text-align: justify; text-indent: 18pt; margin-left: 54pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(D)</font><font style="font-family: 'Times New Roman';">&#160;&#160;&#160;&#160; <font style="font-size: 10pt;">entering into a
            securities sales agreement with the Holder(s) and an agent of Holder(s) providing for, among other things, the appointment of such agent for the Holder(s) for the purpose of soliciting purchases of Registrable Securities, which agreement shall
            be in form, substance and scope customary for similar offerings;</font></font></div>
      <div style="font-family: 'Times New Roman';"><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">10</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 18pt; margin-left: 54pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(E)</font><font style="font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt;">if an underwriting
            agreement is entered into, using commercially reasonable efforts to cause the same to set forth indemnification provisions and procedures substantially similar to the indemnification provisions and procedures set forth in <font style="font-size: 10pt;"><u>Section 4</u></font> with respect to the underwriters or, at the request of any underwriters, in the form customarily provided to underwriters in similar types of transactions; and</font></font></div>
      <div style="text-align: justify; text-indent: 24pt; margin-left: 48pt;"><font style="font-family: 'Times New Roman';"><font style="font-size: 10pt;"> <br>
          </font></font></div>
      <div style="text-align: justify; text-indent: 18pt; margin-left: 54pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(F)</font><font style="font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160; &#160; <font style="font-size: 10pt;">delivering such
            documents and certificates as may be reasonably requested and as are customarily delivered in similar offerings to the managing underwriters, if any;</font></font></div>
      <div style="text-align: justify; text-indent: 24pt; margin-left: 48pt;"><font style="font-family: 'Times New Roman';"><font style="font-size: 10pt;"> <br>
          </font></font></div>
      <div style="text-align: justify; text-indent: 54pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(vi)</font><font style="font-family: 'Times New Roman';"> <font style="font-size: 10pt;">make available for inspection by any
            underwriter participating in any disposition pursuant to a Registration Statement, the Holders&#8217; legal counsel and any accountant retained by a Holder, all financial and other records, pertinent corporate documents and properties<font style="font-size: 10pt;">&#160;</font>or assets of the Company reasonably requested by any such Persons (excluding all trade secrets and other proprietary or privileged information) to the extent required for the offering, and cause the respective
            officers, directors, employees, and any other agents of the Company to supply all information reasonably requested by any such representative, underwriter, counsel or accountant in connection with a Registration Statement, and make such
            representatives of the Company available for discussion of such documents as shall be reasonably requested by the Company; provided, however, that the Holders&#8217; legal counsel, if any, and the representatives of any underwriters will use
            commercially reasonable efforts, to the extent reasonably practicable, to coordinate the foregoing inspection and information gathering and to not unreasonably disrupt the Company&#8217;s business operations;</font></font></div>
      <div style="text-align: justify; text-indent: 48pt;"><font style="font-family: 'Times New Roman';"><font style="font-size: 10pt;"> <br>
          </font></font></div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 54pt;">(vii) a reasonable time prior to filing any Registration Statement, any prospectus forming a part thereof, any amendment to such Registration
        Statement, or amendment or supplement to such prospectus, provide copies of such document to the underwriter(s) of an Underwritten Offering of Registrable Securities; within five (5) Business Days after the filing of any Registration Statement,
        provide copies of such Registration Statement to any Holder&#8217;s legal counsel upon request; consider in good faith making any changes requested and make such changes in any of the foregoing documents as are legally required prior to the filing
        thereof, or in the case of changes received from any Holder&#8217;s legal counsel by filing an amendment or supplement thereto, as the underwriter or underwriters, or in the case of changes received from a Holder&#8217;s legal counsel relating to such Holder
        or the plan of distribution of Registrable Securities, as such Holder&#8217;s legal counsel reasonably requests prior to the effectiveness of the applicable Registration Statement; not file any such document in a form to which any underwriter shall not
        have previously been advised and furnished a copy of; not include in any amendment or supplement to such documents any information about any Holders or any change to the plan of distribution of Registrable Securities that would limit the method of
        distribution of Registrable Securities unless such Holder&#8217;s legal counsel has been advised in advance and has approved such information or change (it being understood that any Holder that determines not to approve the inclusion of such change or
        information that has been specifically requested by the Commission will not have its Registrable Securities included in such Registration Statement and the Company shall not be in breach of this Agreement as a result of such exclusion); and
        reasonably during normal business hours make the representatives of the Company available for discussion of such document as shall be reasonably requested by the Holders&#8217; legal counsel, if any, on behalf of a Holder, Holder&#8217;s legal counsel or any
        underwriter;</div>
      <div style="text-align: justify; text-indent: 48pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 54pt;">(viii) otherwise use commercially reasonable efforts to comply with all applicable rules and regulations of the Commission and make available to its
        securityholders, as soon as reasonably practicable, an earnings statement covering at least twelve (12) months beginning with the first day of the Company&#8217;s first full calendar quarter after the effective date of the Registration Statement, which
        shall satisfy the provisions of Section 11(a) of the Securities Act and Rule 158 thereunder;</div>
      <div style="text-align: justify; text-indent: 48pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: justify; text-indent: 54pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(ix)</font><font style="font-family: 'Times New Roman';"> <font style="font-size: 10pt;">cooperate and assist in any filings required
            to be made with FINRA and in the performance of any due diligence investigation by any underwriter and its counsel (including any &#8220;qualified independent underwriter&#8221; that is required to be retained in accordance with the rules and regulations
            of FINRA);</font></font></div>
      <div style="text-align: justify; text-indent: 48pt;"><font style="font-family: 'Times New Roman';"><font style="font-size: 10pt;"> <br>
          </font></font></div>
      <div style="text-align: justify; text-indent: 54pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(x)</font><font style="font-family: 'Times New Roman';">&#160; <font style="font-size: 10pt;">if Registrable Securities are to be sold in
            an Underwritten Offering, include in the registration statement to be used all such information as may be reasonably requested by the underwriters for the marketing and sale of such Registrable Securities; and</font></font></div>
      <div style="font-family: 'Times New Roman';"><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">11</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 54pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(xi)</font><font style="font-family: 'Times New Roman';"> <font style="font-size: 10pt;">in connection with an Underwritten Offering,
            use its reasonable efforts to cause the appropriate officers of the Company to (A) prepare and make presentations at any &#8220;road shows&#8221; and before analysts and (B) cooperate as reasonably requested by the underwriters in the offering, marketing
            or selling of Registrable Securities.</font></font></div>
      <div style="text-align: justify; text-indent: 48pt;"><font style="font-family: 'Times New Roman';"><font style="font-size: 10pt;"> <br>
          </font></font></div>
      <div style="text-align: justify; text-indent: 24pt; font-family: 'Times New Roman'; font-size: 10pt;">(b) &#160;&#160; Each Holder agrees that, upon receipt of any notice from the Company of the happening of any event or the discovery of any facts of the type
        described in <font style="font-size: 10pt;"><u>Section 3(a)(i)</u></font>, each Holder will forthwith discontinue disposition of Registrable Securities pursuant to a Registration Statement relating to such Registrable Securities until such
        Holder&#8217;s receipt of the copies of the supplemented or amended prospectus contemplated by <font style="font-size: 10pt;"><u>Section 3(a)(i)</u></font>, and, if so directed by the Company, each Holder will deliver to the Company (at the Company&#8217;s
        expense) all copies in such Holder&#8217;s possession, other than permanent file copies then in such Holder&#8217;s possession, of the prospectus covering such Registrable Securities at the time of receipt of such notice.</div>
      <div style="text-align: justify; text-indent: 24pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: justify; text-indent: 24pt; font-family: 'Times New Roman'; font-size: 10pt;">(c) &#160;&#160; The Company may (as a condition to any Holder&#8217;s participation in an Underwritten Offering or Holder&#8217;s inclusion in a Registration Statement)
        require each Holder to furnish to the Company such information regarding the Holder and the proposed distribution by the Holder as the Company may from time to time reasonably request in writing.</div>
      <div style="text-align: justify; text-indent: 24pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">4.</font><font style="font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; <font style="font-size: 10pt; font-weight: bold;">INDEMNIFICATION</font></font></div>
      <div style="text-align: justify;"><font style="font-family: 'Times New Roman';"><font style="font-size: 10pt; font-weight: bold;"> <br>
          </font></font></div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 27pt;">(a)&#160;&#160; <font style="font-size: 10pt; font-style: italic;">Indemnification by The Company</font>. The Company agrees to indemnify and hold harmless
        each Holder, and the respective officers, directors, partners, employees, representatives and agents of each Holder, and each Person, if any, who controls (within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act) a
        Holder, as follows:</div>
      <div style="text-align: justify; text-indent: 24pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: justify; text-indent: 54pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(i)</font><font style="font-family: 'Times New Roman';">&#160;&#160; <font style="font-size: 10pt;">against any and all loss, liability, claim,
            damage, judgment, actions, other liabilities and expenses whatsoever (the &#8220;<font style="font-size: 10pt;"><u>Liabilities</u></font>&#8221;), as incurred, arising out of any Misstatement contained in any Registration Statement (or any amendment or
            supplement thereto) pursuant to which Registrable Securities were registered under the Securities Act at the time such Registration Statement became effective, including all documents incorporated therein by reference;</font></font></div>
      <div style="text-align: justify; text-indent: 48pt;"><font style="font-family: 'Times New Roman';"><font style="font-size: 10pt;"> <br>
          </font></font></div>
      <div style="text-align: justify; text-indent: 54pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(ii)</font><font style="font-family: 'Times New Roman';">&#160; <font style="font-size: 10pt;">against any and all Liabilities, as
            incurred, to the extent of the aggregate amount paid in settlement of any litigation, or any investigation or proceeding by any governmental agency or body, commenced or threatened, or of any claim whatsoever based upon any such untrue
            statement or omission, or any such alleged untrue statement or omission; provided that any such settlement is effected with the written consent of the Company; and</font></font></div>
      <div style="text-align: justify; text-indent: 48pt;"><font style="font-family: 'Times New Roman';"><font style="font-size: 10pt;"> <br>
          </font></font></div>
      <div style="text-align: justify; text-indent: 54pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(iii)</font><font style="font-family: 'Times New Roman';"> <font style="font-size: 10pt;">against any and all expense whatsoever, as
            incurred (including the fees and disbursements of counsel chosen by any indemnified party), reasonably incurred in investigating, preparing or defending against any litigation, or any investigation or proceeding by any governmental agency or
            body, commenced or threatened, or any claim whatsoever based upon any such untrue statement or omission, or any such alleged untrue statement or omission, to the extent that any such expense is not paid under <font style="font-size: 10pt;"><u>Section
                4(a)(i)</u></font> or <font style="font-size: 10pt;"><u>Section 4(a)(ii)</u></font>; provided, however, that<font style="font-size: 10pt;">&#160;</font>the indemnity obligations in this <font style="font-size: 10pt;"><u>Section 4(a)</u></font>
            shall not apply to any Liabilities (A) to the extent arising out of any untrue statement or omission or alleged untrue statement or omission made in reliance upon and in conformity with written information furnished to the Company by any Holder
            with the understanding that such information will be used in a Registration Statement (or any amendment thereto) or any prospectus (or any amendment or supplement thereto) or (B) to the extent they arise from the use of any Registration
            Statement during any Suspension Period or Blackout Period.</font></font></div>
      <div style="text-align: justify; text-indent: 48pt;"><font style="font-family: 'Times New Roman';"><font style="font-size: 10pt;"> <br>
          </font></font></div>
      <div style="text-align: justify; text-indent: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)</font><font style="font-family: 'Times New Roman';">&#160;<font style="font-size: 10pt;"> <font style="font-size: 10pt; font-style: italic;">Indemnification by the Holders</font>. The Holders agree, severally and not jointly, to indemnify and hold harmless the Company, and each of its respective officers, directors, partners, employees, representatives and agents and any
            person controlling the Company, against any and all Liabilities described in the indemnity contained in <font style="font-size: 10pt;"><u>Section 4(a)</u></font>, as incurred, but only with respect to Misstatements or alleged Misstatements
            made in the Registration Statement (or any amendment thereto) or any prospectus included therein (or any amendment or supplement thereto) in reliance upon and in conformity with written information with respect to such Holder furnished to the
            Company by such Holder with the understanding that such information will be used in the Registration Statement (or any amendment thereto) or such prospectus (or any amendment or supplement thereto); provided, however, that Holder shall not be
            liable for any claims hereunder in excess of the amount of net proceeds received by such Holder from the sale of Registrable Securities pursuant to such Registration Statement.</font></font></div>
      <div style="font-family: 'Times New Roman';"><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">12</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(c)</font><font style="font-family: 'Times New Roman';">&#160;&#160;&#160; <font style="font-size: 10pt;"><font style="font-size: 10pt; font-style: italic;">Notices of Claims, etc. </font>Each indemnified party shall give notice as promptly as reasonably practicable to each indemnifying party of any action or proceeding commenced against it in respect of which indemnity may be sought
            hereunder, but failure so to notify an indemnifying party shall not relieve such indemnifying party from any Liability hereunder to the extent it is not materially prejudiced as a result thereof and in any event shall not relieve it from any
            Liability which it may have otherwise than on account of this indemnity agreement. An indemnifying party may participate at its own expense in the defense of such action; provided, however, that counsel to the indemnifying party shall not
            (except with the consent of the indemnified party) also be counsel to the indemnified party. In no event shall the indemnifying party or parties be liable for the fees and expenses of more than one counsel (in addition to any local counsel)
            separate from their own counsel for all indemnified parties in connection with any one action or separate but similar or related actions in the same jurisdiction arising out of the same general allegations or circumstances. No indemnifying
            party shall, without the prior written consent of the indemnified parties, settle or compromise or consent to the entry of any judgment with respect to any litigation, or any investigation or proceeding by any governmental agency or body,
            commenced or threatened, or any claim whatsoever in respect of which indemnification or contribution could be sought under this <font style="font-size: 10pt;"><u>Section 4</u></font> (whether or not the indemnified parties are actual or
            potential parties thereto), unless such settlement, compromise or consent (i) includes an unconditional release of each indemnified party from all Liability arising out of such litigation, investigation, proceeding or claim and (ii) does not
            include a statement as to or an admission of fault, culpability or a failure to act by or on behalf of any indemnified party.</font></font></div>
      <div style="text-align: justify; text-indent: 24pt;"><font style="font-family: 'Times New Roman';"><font style="font-size: 10pt;"> <br>
          </font></font></div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 27pt;">(d)&#160;&#160;&#160; <font style="font-size: 10pt; font-style: italic;">Contribution</font>. If the indemnification provided for in this <font style="font-size: 10pt;"><u>Section 4</u></font> is for any reason unavailable to or insufficient to hold harmless an indemnified party in respect of any Liabilities referred to therein, then each indemnifying party shall contribute to the aggregate amount of such
        Liabilities incurred by such indemnified party, as incurred, in such proportion as is appropriate to<font style="font-size: 10pt;">&#160;</font>reflect the relative fault of the Company, on the one hand, and the Holders, on the other hand, in connection
        with the statements or omissions which resulted in such Liabilities, as well as any other relevant equitable considerations. The relative fault of the Company, on the one hand, and the Holders, on the other hand, shall be determined by reference
        to, among other things, whether any Misstatement or alleged Misstatements relates to information supplied by the Company or a Holder and the parties&#8217; relative intent, knowledge, access to information and opportunity to correct or prevent such
        statement or omission. The Company and each Holder agree that it would not be just and equitable if contribution pursuant to this <font style="font-size: 10pt;"><u>Section 4</u></font> were determined by pro rata allocation or by any other method
        of allocation which does not take account of the equitable considerations referred to above in this <font style="font-size: 10pt;"><u>Section 4</u></font>. The aggregate amount of Liabilities incurred by an indemnified party and referred to above
        in this <font style="font-size: 10pt;"><u>Section 4</u></font> shall be deemed to include any legal or other expenses reasonably incurred by such indemnified party in investigating, preparing or defending against any litigation, or any
        investigation or proceeding by any governmental agency or body, commenced or threatened, or any claim whatsoever based upon any such untrue or alleged untrue statement or omission or alleged omission. No Person guilty of fraudulent
        misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any Person who was not guilty of such fraudulent misrepresentation. For purposes of this <font style="font-size: 10pt;"><u>Section
            4</u></font>, each Person, if any, who controls a Holder within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act, shall have the same rights to contribution as the Holder, and each director of the Company, and
        each Person, if any, who controls the Company within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act shall have the same rights to contribution as the Company.</div>
      <div style="text-align: justify; text-indent: 24pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">5.</font><font style="font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160; &#160;&#160; &#160;&#160; <font style="font-size: 10pt;"><font style="font-size: 10pt; font-weight: bold;">TERMINATION</font>. The rights of the Holders under this Agreement shall terminate in accordance with the terms of this Agreement and in any event, with respect to each Holder, the date on which such Holder or any of its
            permitted assignees no longer hold any Registrable Securities. Notwithstanding the foregoing, the obligations of the parties under <font style="font-size: 10pt;"><u>Section 4</u></font> of this Agreement shall remain in full force and effect
            following such time.</font></font></div>
      <div style="text-align: justify;"><font style="font-family: 'Times New Roman';"><font style="font-size: 10pt;"> <br>
          </font></font></div>
      <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">6.</font><font style="font-family: 'Times New Roman';">&#160;&#160;&#160; &#160;&#160; &#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-weight: bold;">MISCELLANEOUS</font></font></div>
      <div style="text-align: justify;"><font style="font-family: 'Times New Roman';"><font style="font-size: 10pt; font-weight: bold;"> <br>
          </font></font></div>
      <div style="text-align: justify; text-indent: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)</font><font style="font-family: 'Times New Roman';">&#160;&#160; <font style="font-size: 10pt;"><font style="font-size: 10pt; font-style: italic;">Covenants Relating To Rule 144</font>. With a view to making available to the Holders the benefits of Rule 144 and any other rule or regulation of the SEC that may at any time permit a Holder to sell securities of the Company to the
            public without registration or pursuant to a registration statement, if the Shares of the Company are registered under the Exchange Act, the Company agrees to: (A) file with the SEC all reports and other documents required of the Company under
            Section 13(a) or 15(d) of the Exchange Act (at any time after it has become subject to such reporting requirements); and (B) furnish to any Holder, so long as the Holder owns any Registrable Securities, upon request, (i) a written statement by
            the Company that it has complied with the reporting requirements of the Exchange Act (at any time after it has become subject to such reporting requirements), or that it qualifies as a registrant whose securities may be resold pursuant to a
            registration statement (at any time after it so qualifies) and (ii) such other information as may be reasonably requested by any Holder in order to avail itself of any rule or regulation of the SEC which permits the selling of any such
            securities without registration or pursuant to such form.</font></font></div>
      <div style="font-family: 'Times New Roman';"><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">13</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 27pt;">(b)&#160;&#160; <font style="font-size: 10pt; font-style: italic;">No Inconsistent Agreements</font>. The Company has not entered into, and the Company will
        not after the date of this Agreement enter into, any agreement which is inconsistent with the rights granted to the Holders pursuant to this Agreement or otherwise conflicts with the provisions of this Agreement, and the Company hereby represents
        and warrants that, as of the date hereof, no registration or similar rights have been granted to any other person other than pursuant to this Agreement.</div>
      <div style="text-align: justify; text-indent: 24pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: justify; text-indent: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(c)</font><font style="font-family: 'Times New Roman';">&#160;&#160; <font style="font-size: 10pt;"><font style="font-size: 10pt; font-style: italic;">Amendment; Modification; Waiver</font>. This Agreement may be amended, modified or supplemented at any time only by written agreement of the Company and the Holders owning a majority in voting power of the then-outstanding
            Registrable Securities;<font style="font-size: 10pt;">&#160;</font>provided, however, that notwithstanding the foregoing, any amendment hereto or waiver hereof that adversely affects one Holder, solely in its capacity as a holder of the shares of
            the Company, in a manner that is materially different from the other Holders (in such capacity) shall require the consent of the Holder so affected. The conditions to the respective obligations of each of the parties to this Agreement to
            consummate the transactions contemplated hereby are for the sole benefit of such party and may be waived by such party in whole or in part to the extent permitted by applicable law; provided, however, that any such waiver shall only be
            effective if made in writing and executed by the party against whom the waiver is to be effective. No failure or delay by any party to this Agreement in exercising any right, power or privilege hereunder or under applicable law shall operate as
            a waiver of such rights and, except as otherwise expressly provided herein, no single or partial exercise thereof shall preclude any other or further exercise thereof or the exercise of any other right, power or privilege. The rights and
            remedies herein provided shall be cumulative and not exclusive of any rights or remedies provided by law.</font></font></div>
      <div style="text-align: justify; text-indent: 24pt;"><font style="font-family: 'Times New Roman';"><font style="font-size: 10pt;"> <br>
          </font></font></div>
      <div style="text-align: justify; text-indent: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(d)</font><font style="font-family: 'Times New Roman';">&#160;&#160; <font style="font-size: 10pt;"><font style="font-size: 10pt; font-style: italic;">Notices</font>. All notices and other communications hereunder shall be in writing and shall be deemed to have been duly given (a) when delivered in person or, by e-mail (return receipt requested), (b) on the next Business Day when
            sent by overnight courier or (c) on the second succeeding Business Day when sent by registered or certified mail (postage prepaid, return receipt requested) to the respective parties to this Agreement at the following addresses (or at such
            other address for a party to this Agreement as shall be specified by like notice):</font></font></div>
      <div style="text-align: justify; text-indent: 24pt;"><font style="font-family: 'Times New Roman';"><font style="font-size: 10pt;"> <br>
          </font></font></div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 0pt; margin-left: 27pt;">If to a Holder, to the most current address given by such Holder to the Company by means of a notice given in accordance with the
        provisions of this <font style="font-size: 10pt;"><u>Section 6(d)</u></font>.</div>
      <div style="text-align: justify; margin-left: 24pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 0pt; margin-left: 27pt;">If to the Company to:</div>
      <div style="text-align: justify; margin-left: 24pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: left; margin-left: 48pt; font-family: 'Times New Roman'; font-size: 10pt;">DevvStream Corp.</div>
      <div style="text-align: left; margin-left: 48pt; font-family: 'Times New Roman'; font-size: 10pt;">c/o DevvStream Holdings Inc.</div>
      <div style="text-align: left; margin-left: 48pt; font-family: 'Times New Roman'; font-size: 10pt;">2133-1177 West Hastings Street</div>
      <div style="text-align: left; margin-left: 48pt; font-family: 'Times New Roman'; font-size: 10pt;">Vancouver, BC V6E 2K3</div>
      <div style="text-align: left; margin-left: 48pt; font-family: 'Times New Roman'; font-size: 10pt;">Attention: Sunny Trinh</div>
      <div style="text-align: left; margin-left: 48pt; font-family: 'Times New Roman'; font-size: 10pt;">E-mail: sunny@devvstream.com</div>
      <div style="text-align: left; margin-left: 48pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 27pt;">with a copy (which shall not constitute notice) to:</div>
      <div style="text-align: justify; margin-left: 24pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: justify; margin-left: 48.25pt; font-family: 'Times New Roman'; font-size: 10pt;">Morrison &amp; Foerster LLP</div>
      <div style="text-align: justify; margin-left: 48.25pt; font-family: 'Times New Roman'; font-size: 10pt;">12531 High Bluff Drive</div>
      <div style="text-align: justify; margin-left: 48.25pt; font-family: 'Times New Roman'; font-size: 10pt;">San Diego, CA 92130</div>
      <div style="text-align: justify; margin-left: 48.25pt; font-family: 'Times New Roman'; font-size: 10pt;">Attention: Shai Kalansky; Omar Pringle; Justin Salon</div>
      <div style="text-align: justify; margin-left: 48.25pt; font-family: 'Times New Roman'; font-size: 10pt;">Email: skalansky@mofo.com; opringle@mofo.com; justinsalon@mofo.com</div>
      <div style="text-align: justify; margin-left: 48.25pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: justify; margin-left: 48.25pt; font-family: 'Times New Roman'; font-size: 10pt;">and</div>
      <div style="text-align: justify; margin-left: 48.25pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: justify; margin-left: 48.25pt; font-family: 'Times New Roman'; font-size: 10pt;">Kirkland &amp; Ellis LLP</div>
      <div style="text-align: justify; margin-left: 48.25pt; font-family: 'Times New Roman'; font-size: 10pt;">601 Lexington Avenue</div>
      <div style="text-align: justify; margin-left: 48.25pt; font-family: 'Times New Roman'; font-size: 10pt;">New York, NY 10022</div>
      <div style="text-align: justify; margin-left: 48.25pt; font-family: 'Times New Roman'; font-size: 10pt;">Attn: Lauren M. Colasacco, P.C.; Peter Seligson, P.C.</div>
      <div style="text-align: justify; margin-left: 48.25pt; font-family: 'Times New Roman'; font-size: 10pt;">Email: lauren.colasacco@kirkland.com; peter.seligson@kirkland.com</div>
      <div style="text-align: justify; margin-left: 48.25pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">All such notices, requests, demands, waivers and communications shall be deemed received upon (i) actual receipt thereof by the addressee, or (ii) actual delivery
        thereof to the appropriate address.</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">14</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(e)</font><font style="font-family: 'Times New Roman';">&#160;&#160;<font style="font-size: 10pt;"> <font style="font-size: 10pt; font-style: italic;">Binding Agreement; Assignment</font>. This Agreement and all of the provisions hereof shall be binding upon and shall inure to the benefit of the parties to this Agreement and their respective successors and permitted assigns. Other
            than with respect to registration rights provided hereunder which may be assigned by a Holder to its Affiliates, no party to this Agreement may assign its rights under this Agreement without the prior written consent of the other parties, and
            any attempted or purported assignment or delegation in violation of this <font style="font-size: 10pt;"><u>Section 6(e)</u></font> shall be null and void. Provided, however, that <font style="font-size: 10pt;"><u>i</u></font>f Sponsor seeks
            to effectuate an in-kind distribution of all or part of its Registrable Securities to its direct or indirect equityholders (an &#8220;<font style="font-size: 10pt;"><u>In-Kind Distribution</u></font>&#8221;), the Company will use reasonable best efforts to
            work with Sponsor to facilitate such In-Kind Distribution in the manner reasonably requested. Prior to any In-Kind Distribution, each distributee shall deliver to the Company a written acknowledgment and agreement in form and substance
            reasonably satisfactory to the Company that the distributee will be bound by, and will be a party to, this Agreement; provided, however, that a failure by a distributee to deliver such acknowledgment and agreement shall not render such
            distribution to such distributee void, but such distributee shall not be entitled to the benefits of this Agreement until such time as such acknowledgment and agreement is delivered. Upon any In-Kind Distribution, (i) in the event of a
            distribution of all of Sponsor&#8217;s Registrable Securities, the distributees holding Registrable Securities equal to a majority-in-interest of the Registrable Securities then held by Sponsor at the time of such distribution shall thereafter be
            entitled to exercise and enforce the rights specifically granted to Sponsor hereunder and (ii) each distributee shall be considered a &#8220;Holder&#8221; hereunder.</font></font></div>
      <div style="text-align: justify; text-indent: 24pt;"><font style="font-family: 'Times New Roman';"><font style="font-size: 10pt;"> <br>
          </font></font></div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 27pt;">(f)&#160;&#160; <font style="font-size: 10pt; font-style: italic;">Specific Performance</font>. The parties to this Agreement acknowledge that the rights of
        each party hereto to consummate the transactions contemplated hereby are unique and recognize and affirm that in the event of a breach of this Agreement by any party hereto, money damages may be inadequate and the non-breaching party may have no
        adequate remedy at law. Accordingly, the parties to this Agreement agree that such non-breaching party shall have the right, in addition to any other rights and remedies existing in their favor at law or in equity, to enforce its rights and the
        other parties&#8217; obligations hereunder not only by an action or actions for damages but also by an action or actions for specific performance, injunctive and/or other equitable relief (without posting of bond or other security), including any order,
        injunction or decree sought by such non-breaching party to cause the other parties hereto to perform their respective agreements and covenants contained in this Agreement. Each party to this Agreement further agrees that the only permitted
        objection that it may raise in response to any action for equitable relief is that it contests the existence of a breach or threatened breach of this Agreement, and that no party to this Agreement shall allege, and each party to this Agreement
        hereby waives the defense, that there is an adequate remedy at law.</div>
      <div style="text-align: justify; text-indent: 24pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: justify; text-indent: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(g)</font><font style="font-family: 'Times New Roman';">&#160; <font style="font-size: 10pt;"><font style="font-size: 10pt; font-style: italic;">Counterparts</font>. This Agreement may be executed in counterparts, each of which shall be deemed to be an original, but all of which taken together shall constitute one and the same agreement. Delivery of an executed counterpart of
            a signature page to this Agreement by e-mail shall be as effective as delivery of a manually executed counterpart of the Agreement.</font></font></div>
      <div style="text-align: justify; text-indent: 24pt;"><font style="font-family: 'Times New Roman';"><font style="font-size: 10pt;"> <br>
          </font></font></div>
      <div style="text-align: justify; text-indent: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(h)</font><font style="font-family: 'Times New Roman';">&#160;&#160; <font style="font-size: 10pt;"><font style="font-size: 10pt; font-style: italic;">Headings</font>. The article and section headings contained in this Agreement are exclusively for the purpose of reference, are not part of the agreement of the parties to this Agreement and shall not in any way affect the meaning or
            interpretation of this Agreement.</font></font></div>
      <div style="text-align: justify; text-indent: 24pt;"><font style="font-family: 'Times New Roman';"><font style="font-size: 10pt;"> <br>
          </font></font></div>
      <div style="text-align: justify; text-indent: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(i)</font><font style="font-family: 'Times New Roman';">&#160;&#160;<font style="font-size: 10pt;"> <font style="font-size: 10pt; font-style: italic;">Governing Law</font>. This Agreement shall be governed by and construed in accordance with the laws of the State of Delaware (regardless of the laws that might otherwise govern under applicable principles of conflicts of laws
            thereof) as to all matters, including matters of validity, construction, effect, performance and remedies.</font></font></div>
      <div style="font-family: 'Times New Roman';"><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">15</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(j)</font><font style="font-family: 'Times New Roman';">&#160;&#160; <font style="font-size: 10pt;"><font style="font-size: 10pt; font-style: italic;">Consent to Jurisdiction, etc.; WAIVER OF JURY TRIAL</font>. Each party to this Agreement irrevocably agrees that any action, suit or proceeding between or among the parties to this Agreement arising in connection with any
            disagreement, dispute, controversy or claim arising out of or relating to this Agreement or any related document (each, a &#8220;<font style="font-size: 10pt;"><u>Legal Dispute</u></font>&#8221;) shall be brought exclusively in the courts of the State of
            Delaware; <font style="font-size: 10pt;"><u>provided</u></font> that if subject matter<font style="font-size: 10pt;">&#160;</font>jurisdiction over the Legal Dispute is vested exclusively in the United States federal courts, such Legal Dispute
            shall be heard in the United States District Court for the District of Delaware. Each party to this Agreement hereby irrevocably and unconditionally submits to the jurisdiction of such courts (and of the appropriate appellate courts therefrom)
            in any such suit, action or proceeding and irrevocably waives, to the fullest extent permitted by law, any objection that it may now or hereafter have to the laying of the venue of any such suit, action or proceeding in any such court or that
            any such suit, action or proceeding that is brought in any such court has been brought in an inconvenient forum. During the period a Legal Dispute that is filed in accordance with this <font style="font-size: 10pt;"><u>Section 6(j)</u></font>
            is pending before a court, all actions, suits or proceedings with respect to such Legal Dispute or any other Legal Dispute, including any counterclaim, cross-claim or interpleader, shall be subject to the exclusive jurisdiction of such court.
            Each party to this Agreement may bring such Legal Dispute only if he, she or it hereby waives, and shall not assert as a defense in any Legal Dispute, that (a) such party is not personally subject to the jurisdiction of the above-named courts
            for any reason, (b) such action, suit or proceeding may not be brought or is not maintainable in such court, (c) such party&#8217;s property is exempt or immune from execution, (d) such action, suit or proceeding is brought in an inconvenient forum,
            or (e) the venue of such action, suit or proceeding is improper. A final judgment in any action, suit or proceeding described in this <font style="font-size: 10pt;"><u>Section 6(j)</u></font> following the expiration of any period permitted
            for appeal and subject to any stay during appeal shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by applicable laws. EACH OF THE PARTIES TO THIS AGREEMENT MAY BRING A LEGAL
            DISPUTE ONLY IF HE, SHE OR IT IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT TO TRIAL BY JURY ON ANY CLAIMS OR COUNTERCLAIMS ASSERTED IN ANY LEGAL DISPUTE RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY AND FOR ANY
            COUNTERCLAIM RELATING THERETO. IF THE SUBJECT MATTER OF ANY SUCH LEGAL DISPUTE IS ONE IN WHICH THE WAIVER OF JURY TRIAL IS PROHIBITED, NO PARTY NOR ANY PERSON ASSERTING RIGHTS AS A THIRD-PARTY BENEFICIARY SHALL ASSERT IN SUCH LEGAL DISPUTE A
            NONCOMPULSORY COUNTERCLAIM ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY. FURTHERMORE, NO PARTY TO THIS AGREEMENT SHALL SEEK TO CONSOLIDATE ANY SUCH LEGAL DISPUTE WITH A SEPARATE ACTION OR OTHER LEGAL
            PROCEEDING IN WHICH A JURY TRIAL CANNOT BE WAIVED.</font></font></div>
      <div style="text-align: justify; text-indent: 27pt;"><font style="font-family: 'Times New Roman';"><font style="font-size: 10pt;"> <br>
          </font></font></div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 27pt;">(k)&#160;&#160; <font style="font-size: 10pt; font-style: italic;">Severability</font>. If any term or other provision of this Agreement is invalid, illegal
        or incapable of being enforced by any rule of law or public policy, all other terms, conditions and provisions of this Agreement shall nevertheless remain in full force and effect so long as the economic or legal substance of the transactions
        contemplated hereby are not affected in any manner materially adverse to any party to this Agreement. Upon such determination that any term or other provision is invalid, illegal or incapable of being enforced, the parties to this Agreement shall
        negotiate in good faith to modify this Agreement so as to effect the original intent of the parties hereto as closely as possible in a mutually acceptable manner in order that the transactions contemplated hereby be consummated as originally
        contemplated to the fullest extent possible.</div>
      <div style="text-align: justify; text-indent: 24pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 27pt;">(l)&#160;&#160; <font style="font-size: 10pt; font-style: italic;">Brokered Sales</font>.&#160; At any time and from time to time in connection with a sale or
        transfer of Registrable Securities exempt from registration under the Securities Act or through any broker-dealer transactions described in the plan of distribution set forth within any prospectus and pursuant to the Registration Statement of which
        such prospectus forms a part, the Company shall, subject to the receipt of customary documentation required from the applicable Holders in connection therewith and compliance with applicable laws, (i) promptly instruct its transfer agent to remove
        any restrictive legends applicable to the Registrable Securities being sold or transferred and (ii) cause its legal counsel to deliver the necessary legal opinions, if any, to the transfer agent in connection with the instruction under subclause
        clause (i). In addition, the Company shall cooperate reasonably with, and take such customary actions as may reasonably be requested by such Holders in connection with the aforementioned sales or transfers.</div>
      <div style="text-align: justify; text-indent: 24pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">[SIGNATURE PAGE FOLLOWS]</div>
      <div style="font-family: 'Times New Roman';"><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">16</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 24pt; font-family: 'Times New Roman'; font-size: 10pt;">IN WITNESS WHEREOF, the parties have caused this Agreement to be executed as of the date first above written.</div>
      <div style="text-align: justify; text-indent: 24pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z48f5ca54dcaa496c80992228497ed01d">

          <tr>
            <td nowrap="nowrap" style="width: 50%; vertical-align: bottom; font-family: 'Times New Roman';">&#160;</td>
            <td colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman';">
              <div style="text-align: justify; color: rgb(0, 0, 0); font-size: 10pt;">DEVVSTREAM CORP.</div>
            </td>
          </tr>
          <tr>
            <td nowrap="nowrap" style="width: 50%; vertical-align: bottom; font-family: 'Times New Roman';">&#160;</td>
            <td style="width: 5%; vertical-align: bottom; font-family: 'Times New Roman';">&#160;</td>
            <td style="width: 45%; vertical-align: bottom; font-family: 'Times New Roman';">&#160;</td>
          </tr>
          <tr>
            <td nowrap="nowrap" style="width: 50%; vertical-align: bottom; font-family: 'Times New Roman';">&#160;</td>
            <td style="width: 5%; vertical-align: bottom; font-family: 'Times New Roman';">
              <div style="text-align: left; text-indent: -10pt; margin-left: 10pt; color: rgb(0, 0, 0); font-size: 10pt;">By:</div>
            </td>
            <td style="width: 45%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman';">
              <div style="text-align: left; color: rgb(0, 0, 0); font-size: 10pt;">/s/ Sunny Trinh</div>
            </td>
          </tr>
          <tr>
            <td nowrap="nowrap" style="width: 50%; vertical-align: bottom; font-family: 'Times New Roman';">&#160;</td>
            <td style="width: 5%; vertical-align: bottom; font-family: 'Times New Roman';">
              <div style="text-align: left; text-indent: -10pt; margin-left: 10pt; color: rgb(0, 0, 0); font-size: 10pt;">Name:</div>
            </td>
            <td style="width: 45%; vertical-align: bottom; font-family: 'Times New Roman';">
              <div style="text-align: left; color: rgb(0, 0, 0); font-size: 10pt;">Sunny Trinh</div>
            </td>
          </tr>
          <tr>
            <td nowrap="nowrap" style="width: 50%; vertical-align: bottom; font-family: 'Times New Roman';">&#160;</td>
            <td style="width: 5%; vertical-align: bottom; font-family: 'Times New Roman';">
              <div style="text-align: left; text-indent: -10pt; margin-left: 10pt; color: rgb(0, 0, 0); font-size: 10pt;">Title:</div>
            </td>
            <td style="width: 45%; vertical-align: bottom; font-family: 'Times New Roman';">
              <div style="text-align: left; color: rgb(0, 0, 0); font-size: 10pt;">Chief Executive Officer</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman';"><br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z93644a1571bf48d497843421f03b6bca">

          <tr>
            <td nowrap="nowrap" style="width: 50%; vertical-align: bottom; font-family: 'Times New Roman';">&#160;</td>
            <td colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman';">
              <div style="text-align: justify; color: rgb(0, 0, 0); font-size: 10pt;">FOCUS IMPACT SPONSOR, LLC</div>
            </td>
          </tr>
          <tr>
            <td nowrap="nowrap" style="width: 50%; vertical-align: bottom; font-family: 'Times New Roman';">&#160;</td>
            <td style="width: 5%; vertical-align: bottom; font-family: 'Times New Roman';">&#160;</td>
            <td style="width: 45%; vertical-align: bottom; font-family: 'Times New Roman';">&#160;</td>
          </tr>
          <tr>
            <td nowrap="nowrap" style="width: 50%; vertical-align: bottom; font-family: 'Times New Roman';">&#160;</td>
            <td style="width: 5%; vertical-align: bottom; font-family: 'Times New Roman';">
              <div style="text-align: left; text-indent: -10pt; margin-left: 10pt; color: rgb(0, 0, 0); font-size: 10pt;">By:</div>
            </td>
            <td style="width: 45%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman';">
              <div style="text-align: left; color: rgb(0, 0, 0); font-size: 10pt;">/s/ Carl Stanton</div>
            </td>
          </tr>
          <tr>
            <td nowrap="nowrap" style="width: 50%; vertical-align: bottom; font-family: 'Times New Roman';">&#160;</td>
            <td style="width: 5%; vertical-align: bottom; font-family: 'Times New Roman';">
              <div style="text-align: left; text-indent: -10pt; margin-left: 10pt; color: rgb(0, 0, 0); font-size: 10pt;">Name:</div>
            </td>
            <td style="width: 45%; vertical-align: bottom; font-family: 'Times New Roman';">
              <div style="text-align: left; color: rgb(0, 0, 0); font-size: 10pt;">Carl Stanton</div>
            </td>
          </tr>
          <tr>
            <td nowrap="nowrap" style="width: 50%; vertical-align: bottom; font-family: 'Times New Roman';">&#160;</td>
            <td style="width: 5%; vertical-align: bottom; font-family: 'Times New Roman';">
              <div style="text-align: left; text-indent: -10pt; margin-left: 10pt; color: rgb(0, 0, 0); font-size: 10pt;">Title:</div>
            </td>
            <td style="width: 45%; vertical-align: bottom; font-family: 'Times New Roman';">
              <div style="text-align: left; color: rgb(0, 0, 0); font-size: 10pt;">Authorized Signatory</div>
            </td>
          </tr>
          <tr>
            <td nowrap="nowrap" rowspan="1" style="width: 50%; vertical-align: bottom; font-family: 'Times New Roman';">&#160;</td>
            <td rowspan="1" style="width: 5%; vertical-align: bottom; font-family: 'Times New Roman';">&#160;</td>
            <td rowspan="1" style="width: 45%; vertical-align: bottom; font-family: 'Times New Roman';">&#160;</td>
          </tr>
          <tr>
            <td nowrap="nowrap" style="width: 50%; vertical-align: bottom; font-family: 'Times New Roman';">&#160;</td>
            <td colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman';">
              <div style="text-align: justify; color: rgb(0, 0, 0); font-size: 10pt; font-weight: bold;"><u>Legacy Devvstream Holders</u></div>
            </td>
          </tr>
          <tr>
            <td nowrap="nowrap" rowspan="1" style="width: 50%; vertical-align: bottom; font-family: 'Times New Roman';">&#160;</td>
            <td rowspan="1" colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman';">&#160;</td>
          </tr>
          <tr>
            <td nowrap="nowrap" style="width: 50%; vertical-align: bottom; font-family: 'Times New Roman';">&#160;</td>
            <td colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman';">
              <div style="text-align: justify; color: rgb(0, 0, 0); font-size: 10pt;">DEVVIO, INC.</div>
            </td>
          </tr>
          <tr>
            <td nowrap="nowrap" style="width: 50%; vertical-align: bottom; font-family: 'Times New Roman';">&#160;</td>
            <td style="width: 5%; vertical-align: bottom; font-family: 'Times New Roman';">&#160;</td>
            <td style="width: 45%; vertical-align: bottom; font-family: 'Times New Roman';">&#160;</td>
          </tr>
          <tr>
            <td nowrap="nowrap" style="width: 50%; vertical-align: bottom; font-family: 'Times New Roman';">&#160;</td>
            <td style="width: 5%; vertical-align: bottom; font-family: 'Times New Roman';">
              <div style="text-align: left; text-indent: -10pt; margin-left: 10pt; color: rgb(0, 0, 0); font-size: 10pt;">By:</div>
            </td>
            <td style="width: 45%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman';">
              <div style="text-align: left; color: rgb(0, 0, 0); font-size: 10pt;">&#160;/s/ Tom Anderson</div>
            </td>
          </tr>
          <tr>
            <td nowrap="nowrap" style="width: 50%; vertical-align: bottom; font-family: 'Times New Roman';">&#160;</td>
            <td style="width: 5%; vertical-align: bottom; font-family: 'Times New Roman';">
              <div style="text-align: left; text-indent: -10pt; margin-left: 10pt; color: rgb(0, 0, 0); font-size: 10pt;">Name:</div>
            </td>
            <td style="width: 45%; vertical-align: bottom; font-family: 'Times New Roman';">
              <div style="text-align: left; color: rgb(0, 0, 0); font-size: 10pt;">Tom Anderson</div>
            </td>
          </tr>
          <tr>
            <td nowrap="nowrap" style="width: 50%; vertical-align: bottom; font-family: 'Times New Roman';">&#160;</td>
            <td style="width: 5%; vertical-align: bottom; font-family: 'Times New Roman';">
              <div style="text-align: left; text-indent: -10pt; margin-left: 10pt; color: rgb(0, 0, 0); font-size: 10pt;">Title:</div>
            </td>
            <td style="width: 45%; vertical-align: bottom; font-family: 'Times New Roman';">
              <div style="text-align: left; color: rgb(0, 0, 0); font-size: 10pt;">Chief Executive Officer</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman';"><br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z3b04442995c243dfbf25082f447b7b42">

          <tr>
            <td nowrap="nowrap" style="width: 50%; vertical-align: bottom; font-family: 'Times New Roman';">&#160;</td>
            <td colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman';">
              <div style="text-align: justify; color: rgb(0, 0, 0); font-size: 10pt;">Sunny Trinh</div>
            </td>
          </tr>
          <tr>
            <td nowrap="nowrap" style="width: 50%; vertical-align: bottom; font-family: 'Times New Roman';">&#160;</td>
            <td style="width: 5%; vertical-align: bottom; font-family: 'Times New Roman';">&#160;</td>
            <td style="width: 45%; vertical-align: bottom; font-family: 'Times New Roman';">&#160;</td>
          </tr>
          <tr>
            <td nowrap="nowrap" style="width: 50%; vertical-align: bottom; font-family: 'Times New Roman';">&#160;</td>
            <td style="width: 5%; vertical-align: bottom; font-family: 'Times New Roman';">
              <div style="text-align: left; text-indent: -10pt; margin-left: 10pt; color: rgb(0, 0, 0); font-size: 10pt;">By:</div>
            </td>
            <td style="width: 45%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman';">
              <div style="text-align: left; color: rgb(0, 0, 0); font-size: 10pt;">/s/ Sunny Trinh</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman';"><br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z0808d0ceaa6a48ce90e3b39b7450ef4e">

          <tr>
            <td nowrap="nowrap" style="width: 50%; vertical-align: bottom; font-family: 'Times New Roman';">&#160;</td>
            <td colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman';">
              <div style="text-align: justify; color: rgb(0, 0, 0); font-size: 10pt;">Thomas Anderson</div>
            </td>
          </tr>
          <tr>
            <td nowrap="nowrap" style="width: 50%; vertical-align: bottom; font-family: 'Times New Roman';">&#160;</td>
            <td style="width: 5%; vertical-align: bottom; font-family: 'Times New Roman';">&#160;</td>
            <td style="width: 45%; vertical-align: bottom; font-family: 'Times New Roman';">&#160;</td>
          </tr>
          <tr>
            <td nowrap="nowrap" style="width: 50%; vertical-align: bottom; font-family: 'Times New Roman';">&#160;</td>
            <td style="width: 5%; vertical-align: bottom; font-family: 'Times New Roman';">
              <div style="text-align: left; text-indent: -10pt; margin-left: 10pt; color: rgb(0, 0, 0); font-size: 10pt;">By:</div>
            </td>
            <td style="width: 45%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman';">
              <div style="text-align: left; color: rgb(0, 0, 0); font-size: 10pt;">&#160;/s/ Thomas Anderson</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman';"><br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zdab654ed77324ed2a80195068fe305a5">

          <tr>
            <td nowrap="nowrap" style="width: 50%; vertical-align: bottom; font-family: 'Times New Roman';">&#160;</td>
            <td colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman';">
              <div style="text-align: justify; color: rgb(0, 0, 0); font-size: 10pt;">Ray Quintana</div>
            </td>
          </tr>
          <tr>
            <td nowrap="nowrap" style="width: 50%; vertical-align: bottom; font-family: 'Times New Roman';">&#160;</td>
            <td style="width: 5%; vertical-align: bottom; font-family: 'Times New Roman';">&#160;</td>
            <td style="width: 45%; vertical-align: bottom; font-family: 'Times New Roman';">&#160;</td>
          </tr>
          <tr>
            <td nowrap="nowrap" style="width: 50%; vertical-align: bottom; font-family: 'Times New Roman';">&#160;</td>
            <td style="width: 5%; vertical-align: bottom; font-family: 'Times New Roman';">
              <div style="text-align: left; text-indent: -10pt; margin-left: 10pt; color: rgb(0, 0, 0); font-size: 10pt;">By:</div>
            </td>
            <td style="width: 45%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman';">
              <div style="text-align: left; color: rgb(0, 0, 0); font-size: 10pt;">&#160;/s/ Ray Quintana</div>
            </td>
          </tr>

      </table>
      <br>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">[Signature Page to Amended and Restated Registration Rights Agreement]</div>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="za1c147b6f03d470193a1cfb10c1a271b">

          <tr>
            <td nowrap="nowrap" style="width: 50%; vertical-align: bottom; font-family: 'Times New Roman';">&#160;</td>
            <td colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman';">
              <div style="text-align: justify; color: rgb(0, 0, 0); font-size: 10pt;">Jamila Aziza Piracci</div>
            </td>
          </tr>
          <tr>
            <td nowrap="nowrap" style="width: 50%; vertical-align: bottom; font-family: 'Times New Roman';">&#160;</td>
            <td style="width: 5%; vertical-align: bottom; font-family: 'Times New Roman';">&#160;</td>
            <td style="width: 45%; vertical-align: bottom; font-family: 'Times New Roman';">&#160;</td>
          </tr>
          <tr>
            <td nowrap="nowrap" style="width: 50%; vertical-align: bottom; font-family: 'Times New Roman';">&#160;</td>
            <td style="width: 5%; vertical-align: bottom; font-family: 'Times New Roman';">
              <div style="text-align: left; text-indent: -10pt; margin-left: 10pt; color: rgb(0, 0, 0); font-size: 10pt;">By:</div>
            </td>
            <td style="width: 45%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman';">
              <div style="text-align: left; color: rgb(0, 0, 0); font-size: 10pt;">&#160;/s/ Jamila Aziza Piracci</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman';"><br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z8df18358ef394fa99e82cee0ecb9c101">

          <tr>
            <td nowrap="nowrap" style="width: 50%; vertical-align: bottom; font-family: 'Times New Roman';">&#160;</td>
            <td colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman';">
              <div style="text-align: justify; color: rgb(0, 0, 0); font-size: 10pt;">Stephen Kukucha</div>
            </td>
          </tr>
          <tr>
            <td nowrap="nowrap" style="width: 50%; vertical-align: bottom; font-family: 'Times New Roman';">&#160;</td>
            <td style="width: 5%; vertical-align: bottom; font-family: 'Times New Roman';">&#160;</td>
            <td style="width: 45%; vertical-align: bottom; font-family: 'Times New Roman';">&#160;</td>
          </tr>
          <tr>
            <td nowrap="nowrap" style="width: 50%; vertical-align: bottom; font-family: 'Times New Roman';">&#160;</td>
            <td style="width: 5%; vertical-align: bottom; font-family: 'Times New Roman';">
              <div style="text-align: left; text-indent: -10pt; margin-left: 10pt; color: rgb(0, 0, 0); font-size: 10pt;">By:</div>
            </td>
            <td style="width: 45%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman';">
              <div style="text-align: left; color: rgb(0, 0, 0); font-size: 10pt;">&#160;/s/ Stephen Kukucha</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman';"><br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z5bdaebff5f0f4c49bb1bded41cc56f44">

          <tr>
            <td nowrap="nowrap" style="width: 50%; vertical-align: bottom; font-family: 'Times New Roman';">&#160;</td>
            <td colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman';">
              <div style="text-align: justify; color: rgb(0, 0, 0); font-size: 10pt;">Michael Buehler</div>
            </td>
          </tr>
          <tr>
            <td nowrap="nowrap" style="width: 50%; vertical-align: bottom; font-family: 'Times New Roman';">&#160;</td>
            <td style="width: 5%; vertical-align: bottom; font-family: 'Times New Roman';">&#160;</td>
            <td style="width: 45%; vertical-align: bottom; font-family: 'Times New Roman';">&#160;</td>
          </tr>
          <tr>
            <td nowrap="nowrap" style="width: 50%; vertical-align: bottom; font-family: 'Times New Roman';">&#160;</td>
            <td style="width: 5%; vertical-align: bottom; font-family: 'Times New Roman';">
              <div style="text-align: left; text-indent: -10pt; margin-left: 10pt; color: rgb(0, 0, 0); font-size: 10pt;">By:</div>
            </td>
            <td style="width: 45%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman';">
              <div style="text-align: left; color: rgb(0, 0, 0); font-size: 10pt;">&#160;/s/ Michael Buehler</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman';"><br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z211dd4fee3964c1ba0ec4266c39f8130">

          <tr>
            <td nowrap="nowrap" style="width: 50%; vertical-align: bottom; font-family: 'Times New Roman';">&#160;</td>
            <td colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman';">
              <div style="text-align: justify; color: rgb(0, 0, 0); font-size: 10pt;">David Goertz</div>
            </td>
          </tr>
          <tr>
            <td nowrap="nowrap" style="width: 50%; vertical-align: bottom; font-family: 'Times New Roman';">&#160;</td>
            <td style="width: 5%; vertical-align: bottom; font-family: 'Times New Roman';">&#160;</td>
            <td style="width: 45%; vertical-align: bottom; font-family: 'Times New Roman';">&#160;</td>
          </tr>
          <tr>
            <td nowrap="nowrap" style="width: 50%; vertical-align: bottom; font-family: 'Times New Roman';">&#160;</td>
            <td style="width: 5%; vertical-align: bottom; font-family: 'Times New Roman';">
              <div style="text-align: left; text-indent: -10pt; margin-left: 10pt; color: rgb(0, 0, 0); font-size: 10pt;">By:</div>
            </td>
            <td style="width: 45%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman';">
              <div style="text-align: left; color: rgb(0, 0, 0); font-size: 10pt;">&#160;/s/ David Goertz</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman';"><br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z074fca653ef9437f91e53173f068c2b8">

          <tr>
            <td nowrap="nowrap" style="width: 50%; vertical-align: bottom; font-family: 'Times New Roman';">&#160;</td>
            <td colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman';">
              <div style="text-align: justify; color: rgb(0, 0, 0); font-size: 10pt;">Christopher Merkel</div>
            </td>
          </tr>
          <tr>
            <td nowrap="nowrap" style="width: 50%; vertical-align: bottom; font-family: 'Times New Roman';">&#160;</td>
            <td style="width: 5%; vertical-align: bottom; font-family: 'Times New Roman';">&#160;</td>
            <td style="width: 45%; vertical-align: bottom; font-family: 'Times New Roman';">&#160;</td>
          </tr>
          <tr>
            <td nowrap="nowrap" style="width: 50%; vertical-align: bottom; font-family: 'Times New Roman';">&#160;</td>
            <td style="width: 5%; vertical-align: bottom; font-family: 'Times New Roman';">
              <div style="text-align: left; text-indent: -10pt; margin-left: 10pt; color: rgb(0, 0, 0); font-size: 10pt;">By:</div>
            </td>
            <td style="width: 45%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman';">
              <div style="text-align: left; color: rgb(0, 0, 0); font-size: 10pt;">&#160;/s/ Christopher Merkel</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman';"><br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zbae467ed7d6442fa89d36629600d50c8">

          <tr>
            <td nowrap="nowrap" style="width: 50%; vertical-align: bottom; font-family: 'Times New Roman';">&#160;</td>
            <td colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman';">
              <div style="text-align: justify; color: rgb(0, 0, 0); font-size: 10pt;">Bryan Went</div>
            </td>
          </tr>
          <tr>
            <td nowrap="nowrap" style="width: 50%; vertical-align: bottom; font-family: 'Times New Roman';">&#160;</td>
            <td style="width: 5%; vertical-align: bottom; font-family: 'Times New Roman';">&#160;</td>
            <td style="width: 45%; vertical-align: bottom; font-family: 'Times New Roman';">&#160;</td>
          </tr>
          <tr>
            <td nowrap="nowrap" style="width: 50%; vertical-align: bottom; font-family: 'Times New Roman';">&#160;</td>
            <td style="width: 5%; vertical-align: bottom; font-family: 'Times New Roman';">
              <div style="text-align: left; text-indent: -10pt; margin-left: 10pt; color: rgb(0, 0, 0); font-size: 10pt;">By:</div>
            </td>
            <td style="width: 45%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman';">
              <div style="text-align: left; color: rgb(0, 0, 0); font-size: 10pt;">&#160;/s/ Bryan Went</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman';"><br>
      </div>
      <div style="font-family: 'Times New Roman';"><br>
      </div>
      <div style="font-family: 'Times New Roman'; text-align: center; font-style: italic;">[Signature Page to Amended and Restated Registration Rights Agreement]</div>
      <div style="font-family: 'Times New Roman';">
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    </div>
  </div>
  <font style="font-family: 'Times New Roman';"> </font>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.17
<SEQUENCE>6
<FILENAME>ef20038430_ex10-17.htm
<DESCRIPTION>EXHIBIT 10.17
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 24.9.1.5252
         Copyright 1995 - 2024 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <!--PROfilePageNumberReset%Num%1%%%-->

  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div>
      <div style="text-align: right; font-weight: bold;"> Exhibit 10.17<br>
      </div>
      <div style="text-align: justify; margin-left: 144pt; font-weight: bold;"> <br>
      </div>
      <div style="text-align: center; font-weight: bold;">EXECUTIVE EMPLOYMENT AGREEMENT</div>
      <div>&#160;</div>
      <div style="text-align: justify; font-weight: bold;">BETWEEN:</div>
      <div>&#160;</div>
      <div style="text-align: center; font-weight: bold;">DEVVSTREAM CORP.</div>
      <div>&#160;</div>
      <div style="text-align: right; font-weight: bold;">(the &#8220;Company&#8221;)</div>
      <div>&#160;</div>
      <div style="text-align: justify; font-weight: bold;">AND:</div>
      <div>&#160;</div>
      <div style="text-align: center; font-weight: bold;">SUNNY TRINH</div>
      <div>&#160;</div>
      <div style="text-align: right; font-weight: bold;">(the &#8220;Executive&#8221;)</div>
      <div>&#160;</div>
      <div style="text-align: justify; font-weight: bold;">RECITALS</div>
      <div>&#160;</div>
      <div style="text-align: justify;">A.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;On September 12, 2023, Focus Impact
            Acquisition Corp., a Delaware corporation (&#8220;<font style="font-weight: bold;">FIAC</font>&#8221;) entered into a Business Combination Agreement (as may be amended, supplemented or otherwise modified from time
            to time, the &#8220;<font style="font-weight: bold;">Business Combination Agreement</font>&#8221; and the transactions contemplated thereby, collectively, the &#8220;<font style="font-weight: bold;">Business Combination</font>&#8221;), by and among FIAC, Focus Impact Amalco Sub Ltd., and DevvStream Holdings Inc. (&#8220;<font style="font-weight: bold;">Devvstream</font>&#8221;). Pursuant to the
            Business Combination Agreement, among other things, FIAC will acquire DevvStream for consideration of shares in FIAC following its continuance to the Province of Alberta;</div>
      <div>&#160;</div>
      <div style="text-align: justify;">B.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; The Company and the Executive are
            currently party to that certain Executive Employment Agreement dated October 1, 2021 (the &#8220;<font style="font-weight: bold;">Prior Agreement</font>&#8221;);</div>
      <div>&#160;</div>
      <div style="text-align: justify;">C.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company and the Executive wish to
            continue their employment relationship for their mutual benefit;</div>
      <div>&#160;</div>
      <div style="text-align: justify;">D.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; The Company and the Executive wish to
            enter into an Agreement respecting the terms and conditions of the Executive&#8217;s continued employment, including the agreement of the Executive to be bound by the restrictive covenants set out in Article 8 hereof; and</div>
      <div>&#160;</div>
      <div style="text-align: justify;">E.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; This Agreement is effective upon on
            the consummation of the Business Combination (such date, the &#8220;<font style="font-weight: bold;">Commencement Date</font>&#8221;) and if the Business Combination is not consummated by November 6, 2024, then
            this Agreement shall have no force or effect and shall be void ab initio;</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">NOW THEREFORE, in consideration of the mutual covenants and promises set forth herein and for other good and valuable consideration, the
        receipt and sufficiency of which is hereby acknowledged by the Company and the Executive, the parties hereby covenant and agree as follows:</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">1</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt; color: rgb(1, 0, 0);">ARTICLE 1 &#8211; </font><font style="font-size: 10pt;">INTERPRETATION</font></div>
      <div>&#160;</div>
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;" id="z614022255ee24cf59431e49295360154" class="DSPFListTable">

            <tr style="vertical-align: top;">
              <td style="text-align: right; vertical-align: top; width: 63pt;">
                <div style="text-align: justify;"><font style="font-weight: bold; color: rgb(1, 0, 0);">Section 1.1</font></div>
              </td>
              <td style="text-align: left; vertical-align: top; width: auto;">
                <div style="text-align: justify;"><font style="font-weight: bold;">Definitions.</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">In this Agreement:</div>
      <div>&#160;</div>
      <div style="text-align: justify;"><font style="color: rgb(1, 0, 0);">(1)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;<font style="font-weight: bold;">Affiliate</font>&#8221; of a person means any person that directly or indirectly controls, is controlled by, or is under common control with, that person;</div>
      <div>&#160;</div>
      <div style="text-align: justify;"><font style="color: rgb(1, 0, 0);">(2)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;<font style="font-weight: bold;">Agreement</font>&#8221; means this agreement, including any schedules hereto, as amended, supplemented, or modified in writing from time to time;</div>
      <div>&#160;</div>
      <div style="text-align: justify;"><font style="color: rgb(1, 0, 0);">(3)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;<font style="font-weight: bold;">Business</font>&#8221; means the business of investing in a diversified portfolio of projects and/or companies that generate or are actively involved, directly or indirectly, with
            voluntary and/or compliance carbon credits;</div>
      <div>&#160;</div>
      <div style="text-align: justify;"><font style="color: rgb(1, 0, 0);">(4)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;">&#8220;Cause&#8221; </font>means the Executive has engaged in any of the following: (i) dishonest statements or acts with respect to the Company or any current or prospective
            customers, suppliers, vendors or other third parties with which such entity does business that adversely affects the Company, (ii) indictment, commission of, or plea of guilty or no contest to, (A) a felony or (B) any misdemeanor involving
            moral turpitude, deceit, dishonesty or fraud, (iii) the Executive&#8217;s gross negligence, willful misconduct or insubordination with respect to the Company, (iv) a material breach of any covenant or condition under this Agreement; (v) any act
            constituting dishonesty, fraud, immoral or disreputable conduct; (vi) any conduct which constitutes a felony under applicable law; (vii) a material violation of any Company policy (including the Company&#8217;s anti-discrimination and anti-harassment
            policies and other policies related to discrimination, harassment, performance of illegal or unethical activities, or ethical misconduct) or any act of misconduct; (viii) refusal to follow or implement a clear and reasonable directive of the
            Company; (ix) gross negligence or incompetence in the performance of the Executive&#8217;s duties or failure to perform such duties in a manner satisfactory to the Company; or (x) breach of fiduciary duty to the Company. Except for a failure, breach,
            or refusal which, by its nature, cannot reasonably be expected to be cured (in the discretion of the Board), the Executive shall have ten (10) days from the delivery of written notice from the Company within which to cure any acts constituting
            Cause, if curable, under prongs (vii)-(ix);</div>
      <div>&#160;</div>
      <div style="text-align: justify;"><font style="color: rgb(1, 0, 0);">(5)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;<font style="font-weight: bold;">Confidential Information</font>&#8221; means information disclosed or accessible to the Executive or acquired by the Executive as a result of the Executive&#8217;s employment with the
            Company and which is not in the public domain or otherwise required to be publicly disclosed by applicable law and includes, but is not limited to, information relating to the Company&#8217;s or any of its Affiliates&#8217; current, future or proposed
            products/services or development of new or improved products/services, marketing strategies, sales or business plans, the names and information about the Company&#8217;s past, present and prospective customers and clients, the Company&#8217;s employees
            (including, without limitation, compensation information and performance reviews), employee handbooks and documents related to the Company&#8217;s internal processes and procedures, source code, inventions, discoveries, business methods, trade
            secrets, compositions, technical data, records, reports, presentation materials, interpretations, forecasts, test results, formulae, projects, research data, personnel data, compensation arrangements, budgets, financial statements, office
            plans, contracts and commercial documents, suppliers, manufacturers and any information received by the Company from third parties pursuant to an obligation of confidentiality. Notwithstanding the foregoing, &#8220;Confidential Information&#8221; does not
            include information that the Executive can prove by written evidence is information that is or becomes generally known to the public through lawful means and through no fault of the Executive;</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">2</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify;"><font style="color: rgb(1, 0, 0);">(6)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;<font style="font-weight: bold;">Corporate Transaction</font>&#8221; has the same meaning as such term is defined in the Equity Plan;</div>
      <div>&#160;</div>
      <div style="text-align: justify;"><font style="color: rgb(1, 0, 0);">(7)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;<font style="font-weight: bold;">Date of Termination</font>&#8221; means the Executive&#8217;s last active day of employment with the Company;</div>
      <div>&#160;</div>
      <div style="text-align: justify;"><font style="color: rgb(1, 0, 0);">(8)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;<font style="font-weight: bold;">Equity Plan</font>&#8221; means the DevvStream Corp 2024 Equity Incentive Plan, as may be amended, restated or modified from time to time.</div>
      <div>&#160;</div>
      <div style="text-align: justify;"><font style="color: rgb(1, 0, 0);">(9)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;<font style="font-weight: bold;">Good Reason</font>&#8221; means the occurrence of any of the following events without the Executive&#8217;s consent: (i) a material reduction in the Executive&#8217;s Base Salary,; or (ii) a
            material reduction in the Executive&#8217;s duties, authority, responsibilities, and title relative to the Executive&#8217;s duties, authority, responsibilities, and title in effect immediately prior to such reduction, <font style="font-weight: bold; font-style: italic;">provided</font>, <font style="font-weight: bold; font-style: italic;">however</font>, that the acquisition of the Company and
            subsequent conversion of the Company to a division or unit of an acquiring company will not by itself result in a diminution of the Executive&#8217;s position. Any such resignation by the Executive shall only be deemed for Good Reason pursuant to
            this definition if: (1) the Executive gives the Company written notice of his intent to resign for Good Reason within thirty (30) days following the first occurrence of the condition(s) that the Executive believes constitute(s) Good Reason,
            which notice shall describe such condition(s); (2) the Company fails to remedy such condition(s) within thirty (30) days following receipt of the written notice (the &#8220;<font style="font-weight: bold;">Cure
              Period</font>&#8221;); (3) the Company has not, prior to receiving such notice from the Executive, already informed the Executive that his employment with the Company is being terminated; and (4) the Executive voluntarily resigns his employment
            within thirty (30) days following the end of the Cure Period.</div>
      <div>&#160;</div>
      <div style="text-align: justify;"><font style="color: rgb(1, 0, 0);">(10)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;<font style="font-weight: bold;">Territory</font>&#8221; means the United States and Canada; and</div>
      <div>&#160;</div>
      <div style="text-align: justify;"><font style="color: rgb(1, 0, 0);">(11)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;<font style="font-weight: bold;">Total Disability</font>&#8221; means, as determined by a legally qualified medical practitioner selected by the Company in good faith and taking into account any accommodation
            required by the Company in accordance with applicable State and Federal laws, the Executive is unable to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment which can be expected to
            result in death or which has lasted or can be expected to last for a continuous period of twelve (12) months.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">3</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt; color: rgb(1, 0, 0);">ARTICLE 2 &#8211; </font><font style="font-size: 10pt;">TERM</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">The Executive&#8217;s employment is on an at-will basis under this Agreement, which shall commence as of the Commencement Date and the initial
        term of which shall continue until the third (3<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">rd</sup>) anniversary of the Commencement Date (the &#8220;<font style="font-weight: bold;">Initial Term</font>&#8221;), and thereafter shall automatically renew for
        additional terms of one (1) year (referred to as the &#8220;<font style="font-weight: bold;">Renewal Terms</font>&#8221;) unless either party delivers to the other party a written notice of nonrenewal at least ninety
        (90) days before the end of the Initial Term or any Renewal Term (a &#8220;<font style="font-weight: bold;">Non-Renewal</font>&#8221;). The Initial Term and any Renewal Term maybe be terminated earlier pursuant to
        Article 6 below. The period of time between the Commencement Date and the Date of Termination of the Executive&#8217;s employment hereunder shall be referred to herein as the &#8220;<font style="font-weight: bold;"><u>Employment
            Term</u></font>.&#8221;</div>
      <div>&#160;</div>
      <div style="text-align: center; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt; color: rgb(1, 0, 0);">ARTICLE 3 &#8211; </font><font style="font-size: 10pt;">EMPLOYMENT
          AND POSITION</font></div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z82263aa34bf743b595621f8bc4006a99" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 3.1</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Position.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">Subject to the terms and conditions set out in this Agreement, the Company hereby agrees to employ the Executive, and the Executive hereby
        agrees to serve the Company, in the position of Chief Executive Officer of the Company.</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z930341bb6f524296a85878a490be6ff9" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 3.2</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Place of Employment.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">The Executive shall provide the Executive&#8217;s duties and services to the Company remotely, but the Executive may be asked to work from the
        Company&#8217;s offices from time to time. The Company reserves the right in its sole discretion to change the Executives&#8217; remote status. If the Company requires the Executive to move to perform the Executive&#8217;s duties and services pursuant to this
        Agreement, the Company shall reimburse the Executive reasonable and documented relocation costs incurred by the Executive, subject to a reasonable cap determined by the Company and preapproval and receipt of appropriate documentation substantiating
        that such costs have in fact been incurred in accordance with the Company&#8217;s expense reimbursement policy.</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z3934d7a859ad47a78a58d78a6fbcec4d" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 3.3</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Travel.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">The Executive acknowledges that the duties of the Executive&#8217;s position may require some travel within and outside United States.</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z082732ead40a48308ecfabc87bf9ea28" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 3.4</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Executive&#8217;s Covenant.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">The Executive represents and warrants to the Company that the Executive is free to be employed by the Company as contemplated herein and
        that the Executive is not subject to any obligation or restriction (statutory, contractual, or at common law) which would prevent or interfere with the performance of all of the Executive&#8217;s obligations hereunder.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">4</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt; color: rgb(1, 0, 0);">ARTICLE 4 &#8211; </font><font style="font-size: 10pt;">DUTIES</font></div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zacf0fffad1f3449ca967d08964f0361e" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 4.1</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Full-Time Employment.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">The Executive&#8217;s position with the Company constitutes full-time employment. Throughout the duration of the Executive&#8217;s employment, the
        Executive shall devote the Executive&#8217;s full working time and attention to the business and affairs of the Company, acting in the best interests of the Company at all times. The Executive shall not accept nor hold any position as an officer,
        director, employee, consultant, or any like position; provided, that Executive may engage in charitable, civic, fraternal and community affairs and educational, professional and/or trade industry association activities; <u>provided</u>, further, that, such activities do not (i) violate the terms of this Agreement, (ii) interfere, either individually or in the aggregate, with the performance of Executive&#8217;s duties under this
        Agreement or (iii) create a potential business or fiduciary conflict.</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z4b0212fc7bc44d7aabc0e909e58c8486" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 4.2</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Duties; Reporting.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">The Executive shall report to and be subject to the direction of the Board of Directors of the Company (the <font style="font-weight: bold;">&#8220;Board&#8221;</font>) or such other person as the Board or Company may subsequently designate, at any time, in the Board&#8217;s sole discretion. The Executive shall have duties and responsibilities consistent
        with the Executive&#8217;s position as may be assigned to the Executive from time to time. The Executive shall perform all duties in accordance with the instructions of the CEO or such other person as the Company may designate, and all of the Company&#8217;s
        policies and codes of conduct, rules and regulations in effect from time to time, which the Company may amend without advance notice to the Executive. The Executive shall also comply with all applicable laws in the performance of the Executive&#8217;s
        duties.</div>
      <div>&#160;</div>
      <div style="text-align: center; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt; color: rgb(1, 0, 0);">ARTICLE 5 &#8211; </font><font style="font-size: 10pt;">COMPENSATION
          AND BENEFITS</font></div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z9c4691ecb8984f1b9aa42968938624a4" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 5.1</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Base Salary.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">During the Employment Term, the Executive&#8217;s base salary will be $250,000 annually (&#8220;<font style="font-weight: bold;">Base Salary</font>&#8221;), less applicable deductions and withholdings as required by applicable law, paid in accordance with the Company&#8217;s standard payroll practices and prorated in any year where the Executive is not actively
        employed with the Company for the full calendar year. The Executive&#8217;s base salary will be reviewed by the Board (or a designated committee thereof) on an annual basis, based on personal and corporate achievements and the overall financial
        performance of the Company.</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zbf51d96f7a9943048e15c9651d3d568e" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 5.2</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Benefits.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">During the Employment Term, the Executive shall be eligible to participate in the Company&#8217;s employee benefit programs for which similarly
        situated executives are generally eligible that may be in effect from time to time, subject to the terms and conditions of such plan and applicable policies, as may be amended from time to time without advance notice. The Company reserves the right
        to change its benefit plan or carrier in its sole and absolute discretion.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">5</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="z98e2cd40e4f34e5a9cd4b16095752071" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 5.3</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Vacation.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">During the Employment Term, the Executive shall be entitled to accrue 15 days of vacation per calendar year, up to a maximum accrual of 23
        days (the &#8220;<font style="font-weight: bold;">Vacation Cap</font>&#8221;), such vacation to extend for such periods and to be taken at such intervals as shall be appropriate and consistent with the proper
        performance of the Executive&#8217;s duties and as agreed upon between the Executive and the Company. Vacation will accrue up to the Vacation Cap (at which point the Executive shall not accrue, at any time, any additional vacation until the Executive&#8217;s
        vacation accrual falls below the Vacation Cap) and any accrued but unused vacation will be paid out at termination.</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z4be84ac4c5be46c4b22e0de421065e73" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 5.4</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Reimbursement of Expenses.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">During the Employment Term, the Executive will be eligible for reimbursement of reasonable and necessary business and travel expenses
        actually incurred by the Executive directly in connection with the business affairs of the Company and the performance of the Executive&#8217;s duties hereunder, upon presentation of proper receipts or other proof of expenditure acceptable to the
        Company, in accordance with the Company&#8217;s expense reimbursement policy. The Executive shall comply with such reasonable limitations and reporting requirements with respect to such expenses as the Company may establish from time to time.</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z5ff84ddf283144d1a3d7434fa23d2878" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 5.5</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">No Other Benefits.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">The Executive is not entitled to any other payment, benefit, perquisite, allowance or entitlement other than as specifically set out in
        this Agreement, or as mandated by applicable laws, or as otherwise approved in writing and signed by the Company and the Executive.</div>
      <div>&#160;</div>
      <div style="text-align: center; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt; color: rgb(1, 0, 0);">ARTICLE 6 &#8211; </font><font style="font-size: 10pt;">TERMINATION
          OF EMPLOYMENT</font></div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z25b4dc31341245b88fba736062e34c49" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 6.1</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Termination.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">The Company and the Executive acknowledge that the Executive&#8217;s employment relationship with the Company is at-will. Either the Executive
        or the Company may terminate the employment relationship at any time, with or without cause. In addition to a Non-Renewal, as described in Article 2 hereof, the Executive&#8217;s employment may be terminated at any time as follows:</div>
      <div>&#160;</div>
      <div style="text-align: justify;"><font style="color: rgb(1, 0, 0);">(1)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;">Death</font>. This Agreement and the Executive&#8217;s employment shall automatically terminate upon the death of the Executive.</div>
      <div>&#160;</div>
      <div style="text-align: justify;"><font style="color: rgb(1, 0, 0);">(2)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;">Total&#160; Disability</font>.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company may terminate this Agreement and the Executive&#8217;s employment at
            any time as a result of Total Disability in accordance with Section 6.4.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">6</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify;"><font style="color: rgb(1, 0, 0);">(3)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;">Cause</font>. The Company may terminate this Agreement and the Executive&#8217;s employment at any time for Cause in accordance with Section 6.3.</div>
      <div>&#160;</div>
      <div style="text-align: justify;"><font style="color: rgb(1, 0, 0);">(4)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;">Without Cause</font>. The Company may terminate this Agreement and the Executive&#8217;s employment at any time without Cause, for any reason or no reason whatsoever, by providing
            written notice to the Executive specifying the effective Date of Termination (which may be immediate). In such event, the Company shall provide, and the Executive shall be entitled to receive the notice, payments, benefits and/or entitlements
            set out in Section 6.5 below. For the avoidance of doubt, a termination of the Executive&#8217;s employment at the conclusion of the Initial Term or a Renewal Term, as applicable, due to the Company&#8217;s Non-Renewal shall be treated as a termination by
            the Company without Cause so long as grounds for Cause do not exist.</div>
      <div>&#160;</div>
      <div style="text-align: justify;"><font style="color: rgb(1, 0, 0);">(5)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;">Resignation Without Good Reason</font>. The Executive may terminate this Agreement and the Executive&#8217;s employment at any time by providing three (3) months&#8217; advance written
            notice to the Company. The Company may elect to waive all or part of such notice period and shall have no obligation to provide any pay-in-lieu of notice. For the avoidance of doubt, a termination of the Executive&#8217;s employment at the conclusion
            of the Initial Term or Renewal Term, as applicable, due to Executive&#8217;s Non-Renewal shall be treated as a termination by Executive without Good Reason.</div>
      <div>&#160;</div>
      <div style="text-align: justify;"><font style="color: rgb(1, 0, 0);">(6)</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;">Resignation for Good Reason</font>. The Executive may terminate this Agreement and the Executive&#8217;s employment for Good Reason, provided the Executive follows the notice
            procedures in Section 1.1(8) of this Agreement. In such event, the Company shall provide, and the Executive shall be entitled to receive the notice, payments, benefits and/or entitlements set out in Section 6.5 below.</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zc8cc33b45b23434e895ef7835bb805db" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 6.2</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Termination by Reason of Death or Resignation by the Executive Without Good Reason.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">If this Agreement and the Executive&#8217;s employment is terminated pursuant to Sections 6.1(1) or 6.1(5) above, then the Company shall pay to
        the Executive (or, in the case of the Executive&#8217;s death, to the Executive&#8217;s estate) (i) an amount equal to the base salary and vacation pay up to the Date of Termination within thirty (30) days following the termination date (or such earlier date
        as required by applicable law), and (ii) any other vested employee benefits that the Executive is entitled up to the Date of Termination under any applicable employee benefit plan or arrangement of the Company in which the Executive is a
        participant during the Executive&#8217;s employment with the Company, in accordance with the terms of such plan or arrangement (collectively, the &#8220;<font style="font-weight: bold;">Accrued Obligations</font>&#8221;),
        and the Executive shall have no entitlement to any further notice of termination, payment in lieu of notice of termination, severance or termination pay, benefits or any damages whatsoever. Participation in all equity or profit participation plans
        (if any) terminates immediately upon the Date of Termination and the Executive shall not be entitled to any bonus or incentive awards, pro rata or otherwise, except as required by applicable law.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">7</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="z94d48495409243489d23974d3b0786b9" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 6.3</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Termination by the Company for Cause.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">If this Agreement and the Executive&#8217;s employment is terminated for Cause pursuant to Section 6.1(3) above, then the Company shall pay to
        the Executive the Accrued Obligations, and the Executive shall have no entitlement to any further notice of termination, payment in lieu of notice of termination, severance or termination pay, benefits or any damages whatsoever, except as may be
        required by applicable law. Participation in all equity or profit participation plans (if any) terminates immediately upon the Date of Termination and the Executive shall not be entitled to any additional bonus or incentive award, pro rata or
        otherwise, except as required by applicable law.</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z9d925fbe1d46460ca757743012cd365f" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 6.4</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Termination by Reason of Total Disability.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">If this Agreement and the Executive&#8217;s employment is terminated pursuant to Section 6.1(2) above, then the Company shall pay to the
        Executive the Accrued Obligations, and the Executive shall have no entitlement to any further notice of termination, payment in lieu of notice of termination, severance or termination pay, benefits or any damages whatsoever, except as may be
        required by applicable law. Participation in all equity or profit participation plans (if any) terminates immediately upon the Date of Termination and the Executive shall not be entitled to any additional bonus or incentive award, pro rata or
        otherwise, except as required by applicable law.</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z85a24390551e416cb221d46a1229f984" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 6.5</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Termination by the Company Without Cause or Resignation by the Executive for Good Reason</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">If this Agreement and the Executive&#8217;s employment is terminated by the Company without Cause or by the Executive for Good Reason pursuant
        to Sections 6.1(4) or 6.1(6) above, then the Company shall pay to the Executive the Accrued Obligations. Participation in all equity, equity- based and profit participation plans and arrangements (if any), including the vesting of any award
        outstanding thereunder will terminate immediately upon the applicable Date of Termination and the Executive shall not be entitled to any additional bonus or incentive award, pro rata or otherwise. Further, subject to the terms of Section 6.7 and
        Executive complying with the terms in Section 6.8, the Executive shall be entitled to an amount equal to the Executive&#8217;s then-current Base Salary for twelve (12) months, less all applicable withholdings and deduction (the &#8220;<font style="font-weight: bold;">Severance Benefits</font>&#8221;), to be paid in equal installments over a period of twelve (12) months following the Date of Termination in accordance with the Company&#8217;s regular payroll practices, with
        the first installment being paid beginning on the Company&#8217;s second regularly scheduled payroll date following the Release Effective Date (as defined in Section 6.7), with the first installment including any amount of the Severance Benefits that
        would otherwise have been due prior to the Release Effective Date; and</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">The Severance Benefits provided to the Executive pursuant to this Section 6.5 are in lieu of, and not in addition to, any benefits to
        which the Executive may otherwise be entitled under any Company severance plan, policy or program.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">8</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="z9976c66007754436ada12ed4783f02e0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 6.6</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Termination by the Company Without Cause or Resignation by the Executive for Good Reason following a Corporate Transaction.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">If the Executive&#8217;s employment hereunder is terminated by the Company without Cause (other than on account of the Executive&#8217;s death or
        Total Disability) or the Executive resigns for Good Reason, in each case within twelve (12) months following the consummation of a Corporate Transaction, the Executive shall be eligible to receive (i) the Accrued Obligations and (ii) subject to the
        Executive&#8217;s compliance with Section 6.8, including execution of the Release, the Executive shall be entitled to receive the following benefits (the &#8220;<font style="font-weight: bold;">Change in Control
          Benefits</font>&#8221;):</div>
      <div>&#160;</div>
      <div style="text-align: justify;"><font style="color: rgb(1, 0, 0);">(1)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the Severance
            Benefits, in accordance with the terms and conditions described in Section 6.5 above; and</div>
      <div>&#160;</div>
      <div style="text-align: justify;"><font style="color: rgb(1, 0, 0);">(2)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; all of the
            Executive&#8217;s outstanding Company equity awards that were granted prior to the Corporate Transaction will vest (collectively, the &#8220;<font style="font-weight: bold;">Accelerated Equity Awards</font>&#8221;) and,
            if applicable, become exercisable upon the applicable Date of Termination as follows: In the case of any Accelerated Equity Award (or any portion thereof) that, as of immediately prior to the Executive&#8217;s termination of employment, was scheduled
            to vest based solely on continued service with the Company (the &#8220;<font style="font-weight: bold;">Time Vesting Shares</font>&#8221;), 100% of such Time Vesting Shares will vest. In the case of any Accelerated
            Equity Award (or any portion thereof) that, as of immediately prior to the Executive&#8217;s termination of employment, was subject to performance-based vesting (the &#8220;<font style="font-weight: bold;">Performance
              Vesting Shares</font>&#8221;), the number of Performance Vesting Shares that will vest will equal the greater of the number of shares determined based on achievement of (i) the &#8220;target&#8221; level of performance and (ii) the Company&#8217;s actual
            performance, measured as of the Date of Termination, as determined by the Committee (as defined in the Equity Plan).</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zb34c05b464aa4a2cae592afb3671d6fe" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 6.7</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">All Inclusive.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">The Executive acknowledges and agrees that provision of the entitlements set out in this Article 6 shall constitute full and final
        satisfaction of any claim which the Executive might have arising from or relating to the termination of the Executive&#8217;s employment, whether such claim arises under legislation, contract, common law or otherwise, except for such claim that cannot be
        released by operation of legislation.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">9</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="zb61fb4ea75244b03aa9a7e1b5c2b598b" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 6.8</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Release; Forfeiture.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">The Executive shall receive the Severance Benefits pursuant to Section 6.5 or the Change in Control Benefits pursuant to Section 6.6 of
        this Agreement if, and only if: (i) by the sixtieth (60th) day following the Date of Termination from the Company, the Executive has signed and delivered to the Company a separation agreement containing a general release of claims in favor of the
        Company and its affiliates and representatives, in the form reasonably presented by the Company (the &#8220;<font style="font-weight: bold;">Release</font>&#8221;), which cannot be revoked in whole or part by such date
        (the date that the Release can no longer be revoked is referred to as the &#8220;<font style="font-weight: bold;">Release Effective Date</font>&#8221;); (ii) if the Executive holds any other positions with the Company
        or any affiliate, including a position on the Board, the Executive resigns such position(s) to be effective no later than the Date of Termination (or such other date as requested by the Company); (iii) the Executive returns all Company property;
        (iv) the Executive complies with the Executive&#8217;s post-termination obligations under this Agreement; and (v) the Executive complies with the terms of the Release. If the Executive materially breaches any of the Executive&#8217;s post-termination
        obligations under this Agreement (including under Sections 6.9, Article 7 or Article 8) or the Company discovers, on or prior to the twelve (12)-month anniversary of Executive&#8217;s Date of Termination, that incurable Cause grounds existed as of the
        Executive&#8217;s Date of Termination, the Executive&#8217;s right (if any) to receive the Severance Benefits or the Change in Control Benefits (as applicable) shall immediately cease and be forfeited, such that the Company shall have no further obligation to
        make any of the foregoing payments, all Accelerated Equity Awards (or any shares of common stock received upon vesting or exercise thereunder) shall be immediately forfeited for no reason, and Executive will immediately repay to the Company any
        Severance Benefits or the Change in Control Benefits (as applicable) previously paid to Executive.</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z8162a0cc5a4f4a33ae7e0df844d0233c" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 6.9</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Return of Property.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">All equipment, keys, pass cards, credit cards, software, material, data, written correspondence, memoranda, communication, reports, or
        other documents or property pertaining to the business of the Company or containing Confidential Information, used or produced by the Executive in connection with the Executive&#8217;s employment, or in the Executive&#8217;s possession or under the Executive&#8217;s
        control, shall at all times remain the exclusive property of the Company. The Executive shall return all property of the Company in the Executive&#8217;s possession or under the Executive&#8217;s control in good condition (wear and tear excepted), and all
        documents or property containing Confidential Information (without retaining any copy, electronic or otherwise), forthwith upon any request by the Company or upon any termination of the Executive&#8217;s employment for any reason.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">10</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt; color: rgb(1, 0, 0);">ARTICLE 7 &#8211; </font><font style="font-size: 10pt;">ASSIGNMENT
          OF INVENTIONS</font></div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z579a9ee5fa144beab2cd4604af48af88" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 7.1</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Definitions.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">The term (1) &#8220;<font style="font-weight: bold;">Intellectual Property Rights</font>&#8221; means all
        trade secrets, Copyrights, trademarks, mask work rights, patents and other intellectual property rights recognized by the laws of any jurisdiction, together with all national, foreign and state registrations, applications for registration and all
        renewals and extensions thereof (including, without limitation, any provisionals, continuations, continuations-in-part, divisionals, reissues, substitutions and reexaminations), all goodwill associated therewith and all benefits, privileges, causes
        of action and remedies relating to any of the foregoing, whether before or hereafter accrued (including, without limitation, the exclusive rights to apply for and maintain all such registrations, renewals and extensions; to sue for all past,
        present and future infringements or other violations of any rights relating thereto; and to settle and retain proceeds from any such actions); (2) &#8220;<font style="font-weight: bold;">Copyright</font>&#8221; means
        the exclusive legal right to reproduce, perform, display, distribute, and make derivative works of a work of authorship recognized by the laws of any jurisdiction; (3) &#8220;<font style="font-weight: bold;">Inventions</font>&#8221;
        means all ideas, methods, inventions, discoveries, improvements, work products, developments, software, know-how, processes, techniques, works of authorship and other work product, whether or not patentable or registrable under copyright or similar
        statutes; (4) &#8220;<font style="font-weight: bold;">Moral Rights</font>&#8221; means any rights to claim authorship of an Invention or to object to or prevent the modification of any Invention, or to withdraw from
        circulation or control the publication or distribution of any Invention, and any similar right existing under judicial or statutory law of any country in the world or under any treaty, regardless of whether or not such right is denominated or
        generally referred to as a &#8220;moral right&#8221;; (5) &#8220;<font style="font-weight: bold;">Company Inventions</font>&#8221; means all Inventions (and all Intellectual Property Rights with respect thereto) made, conceived,
        reduced to practice, fixed in a tangible medium, or learned by the Executive, either alone or with others, during the period of the Executive&#8217;s employment by the Company other than Excluded Inventions and Nonassignable Inventions; and (6) &#8220;<font style="font-weight: bold;">Excluded Inventions</font>&#8221; means Inventions listed on <font style="font-weight: bold;">Exhibit A</font>: (i) that are owned by the
        Executive or in which the Executive has an interest and were made or acquired by the Executive prior to the Executive&#8217;s date of first employment by the Company and (ii) that the Executive considers to be the Executive&#8217;s property or the property of
        third parties and that the Executive wishes to have excluded from the scope of this Agreement.</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z570d7ddd806b4a5ea9010a3cecfa6705" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 7.2</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Excluded Inventions.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">Inventions, if any, patented or unpatented, which the Executive made prior to the commencement of the Executive&#8217;s employment with the
        Company are excluded from the scope of this Agreement. The Executive has set forth on <font style="font-weight: bold;">Exhibit A </font>a complete list describing all Excluded Inventions. If no such list
        is attached, the Executive represents that it is because the Executive has no Excluded Inventions. If disclosure of any such Excluded Invention would cause the Executive to violate any prior confidentiality agreement, the Executive understands that
        the Executive is not to list such Excluded Inventions in <font style="font-weight: bold;">Exhibit A </font>but is only to disclose a cursory name for each such Excluded Invention, a listing of the party
        or parties to which it belongs and the fact that full disclosure as to such Excluded Inventions has not been made for that reason. The Executive agrees that if the Executive uses any Excluded Inventions in the scope of the Executive&#8217;s employment,
        or if the Executive includes any Excluded Inventions in any product or service of the Company, or if the Executive&#8217;s rights in any Excluded Inventions may block or interfere with, or may otherwise be required for, the exercise by the Company of any
        rights assigned to the Company under this Agreement, the Executive will immediately notify the Company in writing. The Executive hereby grants to the Company a non-exclusive, perpetual, transferable, fully-paid and royalty-free, irrevocable,
        worldwide license, with rights to sublicense through multiple levels of sublicensees, to reproduce, make derivative works of, distribute, publicly perform, and publicly display in any form or medium, whether now known or later developed, make, have
        made, use, sell, import, offer for sale, and exercise any and all present or future rights in, such Excluded Inventions that the Executive incorporates into a Company product, process or machine during the course of the Executive&#8217;s employment.
        Notwithstanding the foregoing, the Executive agrees that the Executive will not incorporate, or permit to be incorporated, Excluded Inventions in any Company Inventions, except as authorized in writing by the Board. To the extent that any third
        parties have rights in any such Excluded Inventions, the Executive hereby warrants that such third parties have given the Executive the right to grant the license stated above.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">11</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="z703f845408fb436d90cd9babf8034068" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 7.3</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Assignment of Company Inventions.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">Subject to Article 8 and except for Excluded Inventions set forth in <font style="font-weight: bold;">Exhibit A</font>, the Executive hereby assigns, and agrees to automatically assign in the future (when any such Inventions are first reduced to practice or fixed in a tangible medium, as applicable), to the Company all of the Executive&#8217;s
        right, title, and interest in and to all Company Inventions, including all benefits, privileges, causes of action and remedies relating to such Company Inventions, free and clear of all liens and encumbrances. The Executive further agrees that such
        assignment includes an assignment of Moral Rights. To the extent such Moral Rights cannot be assigned to the Company and to the extent the following is allowed by the laws in any jurisdiction where Moral Rights exist, the Executive waives the
        enforcement of such Moral Rights, and all claims of any kind with respect to Moral Rights against the Company or related to the Company&#8217;s customers. The Executive further agrees that neither the Executive&#8217;s successors-in-interest nor legal heirs
        retain any Moral Rights in any Company Inventions.</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z7ece9b50309f4fed90c40386f2be9b08" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 7.4</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Unassigned or Nonassignable Inventions.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">The Company recognizes that this Agreement does not require the assignment of any Invention that either: (a) the Executive developed
        entirely on the Executive&#8217;s own time without using Company equipment, supplies, facilities, trade secrets, or Confidential Information or third party information, which is not related to the Company&#8217;s actual or anticipated business, research, or
        development and which does not result from or are connected with work performed by the Executive for the Company; or (b) which qualifies fully for protection from assignment to the Company under any specifically applicable state law, regulation,
        rule or public policy (&#8220;<font style="font-weight: bold;">Nonassignable Inventions</font>&#8221;). The Executive has received and understands the state specific statutory notices set forth on <font style="font-weight: bold;">Exhibit B</font>.</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z065f49ce8dd94a5b835814b4e14ec134" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 7.5</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Ownership of Work Product.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">The Executive acknowledges that all original works of authorship made by the Executive (solely or jointly with others) within the scope of
        the Executive&#8217;s employment protectable by copyright are &#8220;works made for hire&#8221; pursuant to the United States Copyright Act. To the extent that any such work of authorship cannot be a &#8220;work made for hire,&#8221; pursuant to United States Copyright Act (17
        U.S.C., Section 101), the Executive hereby irrevocably and unconditionally assigns to the Company all right, title, and interest worldwide in and to such work of authorship. The Executive understands and agrees that the Executive has no right to
        publish on, submit for publishing, or use for any publication any work product protected by this Section, except as necessary to perform services for the Company.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">12</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="z08d9ea3dcfd445a19eaffcd1403a6bff" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 7.6</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Enforcement of Intellectual Property Rights and Assistance.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">The Executive will assist the Company in every reasonable way to obtain, and from time to time enforce, Intellectual Property Rights and
        Moral Rights relating to Company Inventions. To that end, the Executive will execute, verify, and deliver such documents and perform such other acts (including appearances as a witness) as the Company may reasonably request for use in applying for,
        obtaining, perfecting, evidencing, sustaining, enforcing, and assigning such Intellectual Property Rights. The Executive&#8217;s obligation to assist the Company with respect to Intellectual Property Rights relating to Company Inventions will continue
        beyond the termination of the Executive&#8217;s employment, but the Company will compensate the Executive at a reasonable rate after the Executive&#8217;s termination for the time actually spent by the Executive at the Company&#8217;s request on such assistance. In
        the event the Company is unable for any reason, after reasonable effort, to secure the Executive&#8217;s signature on any document needed in connection with the actions specified in this Section, the Executive hereby irrevocably designates and appoints
        the Company and its duly authorized officers and agents as the Executive&#8217;s agent and attorney in fact, which appointment is coupled with an interest, to act for and on the Executive&#8217;s behalf to execute, verify, and file any such documents and to do
        all other lawfully permitted acts to further the purposes of this Section with the same legal force and effect as if executed by the Executive. The Executive hereby waives and quitclaims to the Company any and all claims, of any nature whatsoever,
        which the Executive now or may hereafter have for infringement of any Intellectual Property Rights assigned under this Agreement to the Company.</div>
      <div>&#160;</div>
      <div style="text-align: center; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt; color: rgb(1, 0, 0);">ARTICLE 8 &#8211; </font><font style="font-size: 10pt;">CONFIDENTIALITY
          &amp; RESTRICTIVE COVENANTS</font></div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z0e9309f913104264bafd0e251d5133b0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 8.1</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Protection of Confidential Information.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">While employed by the Company and following the termination of this Agreement and the Executive&#8217;s employment for any reason, the Executive
        shall not, directly or indirectly, in any way use or disclose to any person any Confidential Information except as provided for herein and shall only use or disclose any Confidential Information in the proper performance of the Executive&#8217;s duties.
        The Executive agrees and acknowledges that the Confidential Information of the Company is the exclusive property of the Company to be used exclusively by the Executive to perform the Executive&#8217;s duties and fulfil the Executive&#8217;s obligations to the
        Company and not for any other reason or purpose. Therefore, the Executive agrees to hold all such Confidential Information in trust for the Company, and the Executive further confirms and acknowledges the Executive&#8217;s fiduciary duty to use the
        Executive&#8217;s best efforts to protect the Confidential Information, not to misuse such information, and to protect such Confidential Information from any misuse, misappropriation, harm or interference by others in any manner whatsoever. The Executive
        agrees to protect the Confidential Information regardless of whether the information was disclosed in verbal, written, electronic, digital, visual or other form, and the Executive hereby agrees to give notice promptly to the Company of any
        unauthorized use or disclosure of Confidential Information of which the Executive becomes aware. The Executive further agrees to reasonably assist the Company in remedying any such unauthorized use or disclosure of Confidential Information. In the
        event that the Executive is required to disclose to third parties any Confidential Information or any memoranda, opinions, judgments or recommendations developed from the Confidential Information, by law, valid court order or subpoena, the
        Executive will, prior to disclosing such Confidential Information, provide the Company with prompt written notice of such request(s) or requirement(s) so that the Company may seek appropriate legal protection or waive compliance with the provisions
        of this Agreement. The Executive will not oppose action by, and will reasonably cooperate with, the Company to obtain legal protection or other reliable assurance that confidential treatment will be accorded the Confidential Information.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">13</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="zbc629296123b4a929f73782b066c8b0e" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 8.2</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Protected Rights.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">Nothing in this Agreement shall limit the Executive&#8217;s right to discuss the Executive&#8217;s employment or report possible violations of law or
        regulation with the Equal Employment Opportunity Commission, United States Department of Labor, the National Labor Relations Board, the Securities and Exchange Commission, or other federal government agency or similar state or local agency or to
        discuss the terms and conditions of the Executive&#8217;s employment to others to the extent expressly permitted by Section 7 of the National Labor Relations Act or to the extent that such disclosure is protected under the applicable provisions of law or
        regulation, including but not limited to &#8220;whistleblower&#8221; statutes or other similar provisions that protect such disclosure. Further, nothing in this Agreement in any way restricts or impedes the Executive from: (i) disclosing the underlying facts
        and circumstances regarding any claims of sexual assault or sexual harassment, or (ii) filing or initiating or assisting others to file or initiate unfair labor practice charges with the National Labor Relations Board.</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zb9eb992efca44e9ca83d337e5e38def4" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 8.3</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Notice Under the Defend Trade Secrets Act of 2016.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">In accordance with the Defense of Trade Secrets Act, the Executive will not be held criminally or civilly liable under any federal or
        state trade secret law for the disclosure of a trade secret that: (i) is made (a) in confidence to a federal, state, or local government official, either directly or indirectly, or to an attorney, and (b) solely for the purpose of reporting or
        investigating a suspected violation of law; or (ii) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal. Nothing in this Agreement is intended to conflict with the Defend Trade Secrets
        Act or create liability for disclosures of trade secrets that are expressly allowed by the Defend Trade Secrets Act. If the Executive files a lawsuit for retaliation by the Company for reporting a suspected violation of law, the Executive may
        disclose the Company&#8217;s trade secrets to the Executive&#8217;s attorney and use the trade secret information in the court proceeding if the Executive: (y) files any document containing trade secrets under seal; and (z) does not disclose trade secrets,
        except pursuant to court order. The Executive may also disclose trade secrets in a document filed in a lawsuit or other proceeding, but only if the filing is made under seal and protected from public disclosure.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">14</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="z06d63ee0e8e54034aac080fa030133df" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 8.4</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Corporate Opportunities.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">Any business opportunities related in any way to the business and affairs of the Company or any of its Affiliates which become known to
        the Executive during the Executive&#8217;s employment hereunder shall be fully disclosed and made available to the Company and shall not be appropriated by the Executive under any circumstance without the prior written consent of the Company.</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z76864ae583924491b1d4c4ba3faa6e68" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 8.5</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Non-Competition.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">The Executive covenants that the Executive will not (without prior written consent of the Company) at any time during the Executive&#8217;s
        employment with the Company nor during the twelve (12) months following the Date of Termination (the &#8220;<font style="font-weight: bold;">Restricted Period</font>&#8221;), directly or indirectly, anywhere within the
        Territory, either individually or in partnership, jointly or in conjunction with any other person, firm, association, syndicate, company or corporation, whether as agent, shareholder, employee, consultant, or in any manner whatsoever, engage in,
        carry on or otherwise be concerned with, any business that is in competition with that of the Business.</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z743bd718de5e4a2bbd555c3002da6e30" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 8.6</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Non-Solicitation.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">The Executive covenants that the Executive will not (without prior written consent of the Company) at any time during the Restricted
        Period, directly or indirectly, either individually or in partnership, jointly or in conjunction with any other person, firm, association, syndicate, company or corporation, whether as agent, shareholder, employee, consultant, or in any manner
        whatsoever:</div>
      <div>&#160;</div>
      <div style="text-align: justify;"><font style="color: rgb(1, 0, 0);">(1)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; solicit or
            entice away, or attempt to solicit or entice away from the Company, employ, or otherwise engage (as an employee, independent contractor, or otherwise) any person whom the Executive had contact with or received Confidential Information about
            during the Executive&#8217;s employment with the Company (in connection with such employment), and who is employed by the Company or engaged as a contractor or consultant by the Company as of the date of solicitation or who was so employed or engaged
            within the twelve (12) month period preceding such date; or</div>
      <div>&#160;</div>
      <div style="text-align: justify;"><font style="color: rgb(1, 0, 0);">(2)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; for any purpose
            competitive with the Business, canvass, solicit or approach for orders, or cause to be canvassed or solicited or approached for orders, any person or entity whom the Executive had contact with or received Confidential Information about during
            the Executive&#8217;s employment with the Company (in connection with such employment), and who is or which is a customer, client, supplier or licensee of the Company as of the date of solicitation or within the twelve (12) month period preceding
            such date; or</div>
      <div>&#160;</div>
      <div style="text-align: justify;"><font style="color: rgb(1, 0, 0);">(3)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; induce or
            attempt to induce any customer, client, supplier or licensee of the Company whom the Executive had contact with or received Confidential Information about during the Executive&#8217;s employment with the Company (in connection with such employment),
            to cease doing business with the Company; or</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">15</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify;"><font style="color: rgb(1, 0, 0);">(4)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; at any time
            following the date the Executive ceases to be an employee of the Company, disparage or denigrate the Company or its Affiliates or their respective businesses, officers or employees. Nothing contained in this Section 8.6(4) shall in any way
            restrict the Executive from exercising protected rights to the extent that such rights cannot be waived by agreement or from complying with any applicable law or regulation or a valid order of a court of competent jurisdiction or an authorized
            government agency, including discussing or disclosing information about unlawful acts in the workplace, such as harassment or discrimination or any other conduct that the Executive has reason to believe is unlawful, provided that such
            compliance does not exceed that required by the law, regulation, or order.</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zd8104bdedc43451fae504f9b326870af" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 8.7</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Passive Investments; etc.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">Nothing in this Agreement shall:</div>
      <div>&#160;</div>
      <div style="text-align: justify;"><font style="color: rgb(1, 0, 0);">(1)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; prohibit or
            restrict the Executive from holding or becoming beneficially interested in up to two percent (2%) of any class of securities in any corporation provided that such class of securities are listed on a recognized stock exchange in Canada or the
            United States; or</div>
      <div>&#160;</div>
      <div style="text-align: justify;"><font style="color: rgb(1, 0, 0);">(2)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; prevent the
            employment or involvement of the Executive in any part of the business of a competitor of the Company that is unrelated to and not competitive with any business of the Company in which the Executive was engaged or learned Confidential
            Information at any time during the period of twelve (12) months preceding the cessation of the Executive&#8217;s employment with the Company.</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="ze9309d27639e4eb9b68110be4faeca7c" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 8.8</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Other Agreements.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">For greater certainty, the covenants contained in this Article 8 shall be in addition to, and complement, and not in replacement of nor
        shall they in any way derogate from any fiduciary duty the Executive owes to the Company or any other restrictive covenants (including any non- competition, confidentiality, non-disparagement or non-solicitation covenants) that the Executive is
        bound, or may become bound, in respect of the Company.</div>
      <div>&#160;</div>
      <div style="text-align: center; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt; color: rgb(1, 0, 0);">ARTICLE 9 &#8211; </font><font style="font-size: 10pt;">REMEDIES</font></div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z5edf5d8a8f4f44f3b6546426ecf5c9fa" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 9.1</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Remedy.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">The Executive acknowledges and agrees that the Executive is employed in a fiduciary capacity, with obligations of trust and loyalty owed
        by the Executive to the Company. Accordingly, the Executive agrees that the restrictions in Article 8 are reasonable in the circumstances of the Executive&#8217;s employment and that the business and affairs of the Company cannot be properly protected
        from the adverse consequences of the actions of the Executive other than by the restrictions set forth in this Agreement.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">16</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="zc4e347786177410a8a107b85d399ea22" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 9.2</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Injunctions, etc.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">The Executive acknowledges and agrees that, in the event of a breach of the covenants, provisions and restrictions in Article 8 by the
        Executive, the Company&#8217;s remedy in the form of monetary damages will be inadequate. Therefore, the Company is hereby authorized and entitled, in addition to all other rights and remedies available to it at law or in equity, to interim and permanent
        injunctive relief and an accounting of all profits and benefits arising out of such breach without the necessity of posting a bond or other security, and the Executive consents to the entry of such relief.</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zbdb381431eae4c0aa2b476da71bff89a" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 9.3</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Loss of Entitlements.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">In addition to all other rights and remedies available to the Company, the Executive acknowledges and agrees that the Executive will
        immediately lose and not be entitled to the payments and benefits set out in Section 6.5 or Section 6.6 (if applicable) if the Executive breaches any of the covenants in Article 8.</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z1a179156b5c84a5b8f363d2b7d8ed33c" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 9.4</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Survival.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">Each and every provision of Article 1, Article 7, Article 8 and Article 9 shall survive the termination of this Agreement and the
        Executive&#8217;s employment for any reason.</div>
      <div>&#160;</div>
      <div style="text-align: center; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt; color: rgb(1, 0, 0);">ARTICLE 10 &#8211; </font><font style="font-size: 10pt;">GENERAL
          CONTRACT TERMS</font></div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z1927d71599f24e4182ab346aaf5dfe24" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 10.1</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Currency.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">All amounts payable pursuant to this Agreement are expressed in and shall be paid in United States of America currency unless otherwise
        indicated.</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z0754717c2edb4c9682b46ae9abd0e7fa" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 10.2</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Withholding.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">The Company may withhold from any payments or benefits payable under this Agreement all US Federal, state, city or other taxes as shall be
        required pursuant to any applicable law or governmental regulation or ruling.</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z66e0b97bbae240ce8c6a340b195a2f73" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 10.3</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Rights and Remedies.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">All rights and remedies of the parties are separate and cumulative, and none of them, whether exercised or not, shall be deemed to be to
        the exclusion of any other rights or remedies or shall be deemed to limit or prejudice any other legal or equitable rights or remedies which either of the parties may have.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">17</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="z9e3b293a271d4a3681c69ca901b06600" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 10.4</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Waiver.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">Any purported waiver of any default, breach or non-compliance under this Agreement is not effective unless in writing and signed by the
        party to be bound by the waiver. No waiver shall be inferred from or implied by any failure to act or delay in acting by a party in respect of any default, breach or non-observance or by anything done or omitted to be done by the other party. The
        waiver by a party of any default, breach or non-compliance under this Agreement shall not operate as a waiver of that party&#8217;s rights under this Agreement in respect of any continuing or subsequent default, breach or non-observance (whether of the
        same or any other nature).</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z9f8d0a54bf5e477ab94c35d06d1aabc3" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 10.5</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Severability.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">Whenever possible, each provision of this Agreement will be interpreted in such manner as to be effective and valid under applicable law,
        but if any provision of this Agreement is held to be invalid, illegal or unenforceable in any respect under any applicable law or rule in any jurisdiction, such invalidity, illegality or unenforceability will not affect any other provision or any
        other jurisdiction, but this Agreement will be reformed, construed and enforced in such jurisdiction as if such invalid, illegal or unenforceable provisions had never been contained herein. The Company and the Executive agree that a court of
        competent jurisdiction is expressly authorized to modify any such unenforceable provision of this Agreement in lieu of severing such unenforceable provision from this Agreement in its entirety, whether by rewriting the offending provision, deleting
        any or all of the offending provision, adding additional language to this Agreement, or by making such other modifications as it deems warranted to carry out the intent and agreement of the parties as embodied herein to the maximum extent permitted
        by law. The Company and the Executive further expressly agree that this Agreement as so modified by the court shall be binding upon and enforceable against each of them. In any event, should one or more of the provisions of this Agreement be held
        to be invalid, illegal, or unenforceable in any respect, such invalidity, illegality, or unenforceability shall not affect any other provisions hereof, and if such provision or provisions are not modified as provided above, this Agreement shall be
        construed as if such invalid, illegal, or unenforceable provisions had not been set forth herein.</div>
      <div>&#160;</div>
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;" id="z4fcebd87bc9c49efaf21ff1b709a11b9" class="DSPFListTable">

            <tr style="vertical-align: top;">
              <td style="text-align: right; vertical-align: top; width: 63pt;">
                <div style="text-align: justify; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt; color: rgb(1, 0, 0);">Section 10.6</font></div>
              </td>
              <td style="text-align: left; vertical-align: top; width: auto;">
                <div style="text-align: justify; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt;">Section 409A Compliance.</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">The intent of the Company and the Executive is that payments, benefits and rights to which the Executive could be entitled to under this
        Agreement comply with, or be exempt from, Section 409A of the Internal Revenue Code of 1986, as amended (the &#8220;<font style="font-weight: bold;">Code</font>&#8221;) and the Treasury Regulations and guidance
        promulgated thereunder (collectively &#8220;<font style="font-weight: bold;">Code Section 409A</font>&#8221;) (to the extent that the requirements of Code Section 409A are applicable thereto), and, accordingly, to the
        maximum extent permitted, shall be interpreted to be in compliance therewith or exempt therefrom. If any provision of this Agreement contravenes Code Section 409A, or would cause the Executive to incur any additional tax, interest or penalty under
        Code Section 409A, the Company and the Executive agree in good faith to reform this Agreement to comply with Code Section 409A, or to take such other actions as they deem necessary or appropriate to maintain, to the maximum extent practicable,
        without violating the provisions of Code Section 409A, the original intent and economic benefit to Company and the Executive of the applicable provision; provided that Company shall have no obligation to make any changes that could create any
        additional economic cost or loss of benefit to Company. In no event whatsoever shall the Company be liable for any additional tax, interest or penalty that may be imposed on the Executive by Code Section 409A or damages for failing to comply with
        Code Section 409A. Any provision required for compliance with Code Section 409A that is omitted from this Agreement shall be incorporated herein by reference and shall apply retroactively, if necessary, and be deemed a part of this Agreement to the
        same extent as though expressly set forth herein.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">18</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">Notwithstanding anything herein to the contrary, if required to comply with Code Section 409A (but only to the extent so required), a
        termination of employment shall be deemed to have occurred at the time such termination constitutes a &#8220;separation from service&#8221; within the meaning of Code Section 409A for purposes of any provision of this Agreement providing for the payment of any
        amounts or benefits in connection with a termination of employment and, for purposes of any such provision of this Agreement, references to a &#8220;termination,&#8221; &#8220;termination of employment&#8221; or like terms shall mean a &#8220;separation from service.&#8221;</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">Notwithstanding anything herein to the contrary, if, on the date of a &#8220;separation from service&#8221; (as defined in Code Section 409A), the
        Executive is a &#8220;specified employee&#8221; (as defined in Code Section 409A), no payments of any amounts hereunder that are subject to Code Section 409A shall be made until the earliest date on which payment is permissible under 409A(a)(2)(B)(i) (the six
        (6)-month delay rule for specified employees).</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">For purposes of Code Section 409A, the Executive&#8217;s right to receive any installment payments pursuant to this Agreement shall be treated
        as a right to receive a series of separate and distinct payments.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">If any payment due under this Agreement is both deferred compensation subject to Code Section 409A and is conditioned upon the execution
        of a release of claims and involves a consideration time period that begins in one calendar year and ends in the next calendar year, will be paid as soon as practicable in the second calendar year even if the Executive signed the general release
        and such general release becomes irrevocable in the first calendar year.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">To the extent that reimbursements or other in-kind benefits under this Agreement constitute nonqualified deferred compensation for
        purposes of Code Section 409A, (1) all such expenses or other reimbursements hereunder shall be made on or prior to the last day of the taxable year following the taxable year in which such expenses were incurred by the Executive, (2) any right to
        such reimbursement or in-kind benefits shall not be subject to liquidation or exchange for another benefit, and (3) no such reimbursement, expenses eligible for reimbursement, or in-kind benefits provided in any taxable year shall in any way affect
        the expenses eligible for reimbursement, or in-kind benefits to be provided, in any other taxable year.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">19</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="z40c5e66e83e142e286e64765f9f72ea5" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 10.7</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Parachute Payments.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">In the event that the severance and other benefits provided for in this Agreement or otherwise payable or provided to the Executive (i)
        constitute &#8220;parachute payments&#8221; within the meaning of Section 280G of the Code and (ii) but for this Section 10.7, would be subject to the excise tax imposed by Section 4999 of the Code (the &#8220;<font style="font-weight: bold;">Excise Tax</font>&#8221;), then the Executive&#8217;s severance benefits hereunder shall be either (a) delivered in full, or (b) delivered as to such lesser extent which would result in no portion of such severance benefits being subject
        to the Excise Tax, whichever of the foregoing amounts, taking into account the applicable federal, state and local income taxes and the Excise Tax, results in the receipt by executive on an after-tax basis, of the greatest amount of severance
        benefits, notwithstanding that all or some portion of such severance benefits may be taxable under Section 4999 of the Code. Unless the Company and the Executive otherwise agree in writing, any determination required under this Section 10.7 shall
        be made in writing in good faith by the Company&#8217;s independent tax accountants immediately prior to the Corporate Transaction.</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zf9b3fbc38c42437483ca3260ac6ab81b" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 10.8</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Notices.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">Any notice required or permitted to be given under this Agreement shall be in writing and shall be properly given if personally delivered,
        delivered by electronic transmission or mailed by prepaid registered mail addressed as follows:</div>
      <div>&#160;</div>
      <div style="margin-right: 36pt; margin-left: 36pt;">to the Company at:</div>
      <div>&#160;</div>
      <div style="margin-right: 36pt; margin-left: 36pt;">DevvStream, Corp.</div>
      <div style="margin-right: 36pt; margin-left: 36pt;">2133-1177 West Hastings Street</div>
      <div style="margin-right: 36pt; margin-left: 36pt;">Vancouver, BC V6E 2K3</div>
      <div style="margin-right: 36pt; margin-left: 36pt;">Attention: Sunny Trinh</div>
      <div style="margin-right: 36pt; margin-left: 36pt;">Email: sunny@devvstream.com</div>
      <div>&#160;</div>
      <div style="margin-right: 36pt; margin-left: 36pt;">With a copy to:</div>
      <div>&#160;</div>
      <div style="margin-right: 36pt; margin-left: 36pt;">McMillan LLP</div>
      <div style="margin-right: 36pt; margin-left: 36pt;">1055 W Georgia Street, Suite #1500</div>
      <div style="margin-right: 36pt; margin-left: 36pt;">Vancouver, BC V6E 4N7</div>
      <div style="margin-right: 36pt; margin-left: 36pt;">Attention: Mark Neighbor</div>
      <div style="margin-right: 36pt; margin-left: 36pt;">Email: Mark.Neighbor@mcmillan.ca</div>
      <div>&#160;</div>
      <div style="margin-right: 36pt; margin-left: 36pt;">to the Executive at:</div>
      <div>&#160;</div>
      <div style="margin-right: 36pt; margin-left: 36pt;">Sunny Trinh</div>
      <div style="margin-right: 36pt; margin-left: 36pt;">[]</div>
      <div>&#160;</div>
      <div style="text-align: justify;">or to such other address as the parties may from time to time specify by notice given in accordance herewith. Any notice so given shall be conclusively
        deemed to have been given or made on the day of delivery, if personally delivered, or if delivered by electronic transmission or mailed as aforesaid, upon the date the electronic transmission is sent or on the postal return receipt as the date upon
        which the envelope containing such notice was actually received by the addressee.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">20</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="z8c97d251c045426181759d3cfbd6491a" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 10.9</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Successors and Assigns.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">This Agreement shall inure to the benefit of, and be binding on, the parties and their respective heirs, administrators, executors,
        successors (whether direct or indirect, by purchase, amalgamation, arrangement, merger, consolidation or otherwise) and permitted assigns. The Company shall have the right to assign this Agreement, or the benefit thereof, to any of its Affiliates
        or to any successor (whether direct or indirect, by purchase, amalgamation, arrangement, merger, consolidation or otherwise). The Executive, by the Executive&#8217;s signature hereto, expressly consents to such assignment and, provided that such
        successor agrees to assume and be bound by the terms and conditions of this Agreement, all references to the &#8220;Company&#8221; hereunder shall include such successor. The parties agree that the services to be provided by the Executive are personal in
        nature, and therefore the Executive shall not subcontract, assign or transfer, whether absolutely, by way of security or otherwise, all or any part of the Executive&#8217;s rights or obligations under this Agreement.</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z9222c3c8f27848a3809a5a2a55fa4fef" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 10.10</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Amendment.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">No amendment of this Agreement will be effective unless made in writing and signed by both the Executive and an authorized officer of the
        Company, other than the Executive, and approved by the Board.</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zdd8f390ea5ef4cb5a46a46889371ee0b" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 10.11</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Entire Agreement.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">This Agreement constitutes the entire agreement between the parties pertaining to the subject matter of this Agreement and supersedes all
        prior agreements, understandings, negotiations and discussions, whether oral or written with respect to the Executive&#8217;s employment with the Company (including, without limitation, the Prior Agreement, which shall become null and void and terminate
        automatically upon the Commencement Date). For the avoidance of doubt, following the execution of this Agreement, any existing employment agreements or contracts governing the Executive&#8217;s current employment with the Company (including, but not
        limited to, the Prior Agreement) is null and void and is of no further effect. Each party agrees there are no conditions, warranties, representations or other agreements between the parties in connection with the subject matter of this Agreement
        (whether oral or written, express or implied) except as specifically set out in this Agreement and the Executive agrees that the Executive has not relied on any representation of the Company or its Affiliates to enter into this Agreement.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">21</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="z679865fe9ae144ebb3d90a366b7330b7" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 10.12</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Governing Law.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">This Agreement has been executed and delivered in the State of Delaware and its validity, interpretation, performance, and enforcement
        shall be governed by the laws of the state of Delaware and the federal laws of the United States of America as applicable therein.</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z07d8aa2dce4c46e1a1ca1a1de6e5c1a7" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 10.13</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Headings.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">The division of this Agreement into Sections and the insertion of headings are for convenience or reference only and shall not affect the
        construction or interpretation of this Agreement.</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z1315ac4fae4f44688faa8bb4ea5eeb43" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 10.14</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Independent Legal Advice.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">The parties acknowledge that, prior to executing this Agreement, they have each had the opportunity to obtain independent legal advice and
        that they fully understand the nature of this Agreement and that they are entering into this Agreement voluntarily. Specifically, the Executive represents and warrants to the Company that the Executive (a) has read and understood each and every
        provision of this Agreement, (b) has had the opportunity to obtain advice from legal counsel of Executive&#8217;s choice in order to interpret any and all provisions of this Agreement, and (c) has in fact been individually represented by legal counsel in
        negotiating the terms of this agreement, including the choice of law provision set forth in Section 10.12 hereof. To the extent a court of competent jurisdiction determines that the laws of the State of California govern this Agreement, the
        restrictions set forth in Sections 8.5 and 8.6 shall not apply during the portion of the Restricted Period following the Date of Termination.</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z6261a29cb6224eb894b0a14da69bc594" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 10.15</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Counterparts.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">This Agreement may be executed in any number of counterparts, and delivered by facsimile or other means of electronic transmission, each
        of which shall be deemed to be one and the same instrument and an original document.</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zac6b832a7bfc41998b0f2d51c65c9271" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 10.16</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Ambiguities.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">As each party and its legal counsel have participated in the review and revision of this Agreement, any rule of construction to the effect
        that ambiguities are to be resolved against the drafting party shall not apply in interpreting this Agreement.</div>
      <div>&#160;</div>
      <div style="text-align: center; font-style: italic; font-weight: bold;">[Signature Page Follows]</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">22</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify;">The parties have executed this Agreement.</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" id="z6d72e4d906714cc48272e20f8a103cbf" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

          <tr>
            <td style="width: 3%; vertical-align: top;" rowspan="1" colspan="3">
              <div style="text-align: justify; font-weight: bold;">DEVVSTREAM CORP.</div>
            </td>
            <td style="width: 50%; vertical-align: top;" colspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: top;" rowspan="1" colspan="3">&#160;</td>
            <td style="width: 50%; vertical-align: top;" colspan="1" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: top; padding-bottom: 2px;">
              <div>By:</div>
            </td>
            <td style="width: 5%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1" colspan="2">
              <div>/s/ Chris Merkel</div>
            </td>
            <td style="width: 50%; vertical-align: top; padding-bottom: 2px;" colspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: top;">&#160;</td>
            <td style="width: 5%; vertical-align: top;">
              <div>Name:</div>
            </td>
            <td style="width: 42%; vertical-align: top;">
              <div>Chris Merkel</div>
            </td>
            <td style="width: 50%; vertical-align: top;" colspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: top;">&#160;</td>
            <td style="width: 5%; vertical-align: top;">
              <div>Title:</div>
            </td>
            <td style="width: 42%; vertical-align: top;">
              <div>Chief Operating Officer</div>
            </td>
            <td style="width: 50%; vertical-align: top;" colspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: top;" rowspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: top;" rowspan="1">&#160;</td>
            <td style="width: 42%; vertical-align: top;" rowspan="1">&#160;</td>
            <td style="width: 50%; vertical-align: top;" colspan="1" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: top;" rowspan="1" colspan="3">
              <div style="text-align: justify; font-weight: bold;">SUNNY TRINH</div>
            </td>
            <td style="width: 50%; vertical-align: top;" colspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: top;" rowspan="1" colspan="3">&#160;</td>
            <td style="width: 50%; vertical-align: top;" colspan="1" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: top; padding-bottom: 2px;">
              <div>By:</div>
            </td>
            <td style="width: 5%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1" colspan="2">
              <div>/s/ Sunny Trinh</div>
            </td>
            <td style="width: 50%; vertical-align: top; padding-bottom: 2px;" colspan="1">&#160;</td>
          </tr>

      </table>
      <div> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; font-weight: bold;"><u>Exhibit A</u></div>
      <div>&#160;</div>
      <div style="text-align: center; font-weight: bold;">Excluded Inventions</div>
      <div>&#160;</div>
      <div style="text-align: justify; font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Excluded Inventions</u></font><font style="font-size: 10pt;">: List all
          such materials on this <u>Exhibit A</u> and indicate Executive&#8217;s agreement with the following by initialing where indicated: Executive represents and warrants that Executive has
          listed on this <u>Exhibit A</u> all Excluded Inventions.</font></div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" id="zcdfd545caa2b447f8951002e46e6c1cc" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

          <tr>
            <td style="width: 80%; vertical-align: top; padding-bottom: 2px;">
              <div style="text-align: right;">Executive&#8217;s Initial</div>
            </td>
            <td style="width: 20%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify;">/s/ ST</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div style="text-align: justify; font-size: 12pt;"><font style="font-size: 10pt;"><u>List of Prior Inventions </u></font><font style="font-size: 10pt; font-weight: bold;"><u>(write NONE if there are none)</u></font></div>
      <div>&#160;</div>
      <div style="text-align: justify;">NONE</div>
      <div>&#160;</div>
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
      <div> <br>
      </div>
      <div>
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
      <div> <br>
      </div>
      <div>
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"> </div>
      <div> <br>
      </div>
      <div>
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
      <div> <br>
      </div>
      <div>
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
      <div> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; font-weight: bold;"><u>Exhibit B</u></div>
      <div>&#160;</div>
      <div style="text-align: center; font-weight: bold;">Statutory Notices</div>
      <div>&#160;</div>
      <div style="text-align: justify;">Section 2870 of the California Labor Code is as follows:</div>
      <div>&#160;</div>
      <div style="text-align: justify;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Any provision in an employment
            agreement which provides that an employee shall assign, or offer to assign, any of his or her rights in an invention to his or her employer shall not apply to an invention that the employee developed entirely on his or her own time without
            using the employer&#8217;s equipment, supplies, facilities, or trade secret information except for those inventions that either:</div>
      <div>&#160;</div>
      <div style="text-align: justify; margin-left: 36pt;">(1)&#160;&#160;&#160;&#160;&#160; &#160;&#160; Relate at the
            time of conception or reduction to practice of the invention to the employer&#8217;s business, or actual or demonstrably anticipated research or development of the employer; or</div>
      <div>&#160;</div>
      <div style="text-align: justify; margin-left: 36pt;">(2)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Result from any
            work performed by the employee for the employer.</div>
      <div>&#160;</div>
      <div style="text-align: justify;">(b)&#160;&#160;&#160;&#160;&#160; &#160; &#160; To the extent a provision in an
            employment agreement purports to require an employee to assign an invention otherwise excluded from being required to be assigned under subdivision (a), the provision is against the public policy of this state and is unenforceable.</div>
      <div>&#160;</div>
      <div><br>
      </div>
      <div>
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    </div>
  </div>


</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.18
<SEQUENCE>7
<FILENAME>ef20038430_ex10-18.htm
<DESCRIPTION>EXHIBIT 10.18
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 24.9.1.5252
         Copyright 1995 - 2024 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <!--PROfilePageNumberReset%Num%1%%%-->






  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div style="text-align: right;"><font style="font-weight: bold;">Exhibit 10.18</font><br>
      </div>
    <div><font style="font-weight: bold;"> <br>
      </font></div>
    <div>
      <div style="text-align: center; font-weight: bold;">EXECUTIVE EMPLOYMENT AGREEMENT</div>
      <div>&#160;</div>
      <div style="text-align: justify; font-weight: bold;">BETWEEN:</div>
      <div>&#160;</div>
      <div style="text-align: center; font-weight: bold;">DEVVSTREAM CORP.</div>
      <div>&#160;</div>
      <div style="text-align: right; font-weight: bold;">(the &#8220;Company&#8221;)</div>
      <div>&#160;</div>
      <div style="text-align: justify; font-weight: bold;">AND:</div>
      <div>&#160;</div>
      <div style="text-align: center; font-weight: bold;">CHRIS MERKEL</div>
      <div>&#160;</div>
      <div style="text-align: right; font-weight: bold;">(the &#8220;Executive&#8221;)</div>
      <div>&#160;</div>
      <div style="text-align: justify; font-weight: bold;">RECITALS</div>
      <div>&#160;</div>
      <div style="text-align: justify;">A.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;On September 12, 2023, Focus Impact
            Acquisition Corp., a Delaware corporation (&#8220;<font style="font-weight: bold;">FIAC</font>&#8221;) entered into a Business Combination Agreement (as may be amended, supplemented or otherwise modified from time
            to time, the &#8220;<font style="font-weight: bold;">Business Combination Agreement</font>&#8221; and the transactions contemplated thereby, collectively, the &#8220;<font style="font-weight: bold;">Business Combination</font>&#8221;), by and among FIAC, Focus Impact Amalco Sub Ltd., and DevvStream Holdings Inc. (&#8220;<font style="font-weight: bold;">Devvstream</font>&#8221;). Pursuant to the
            Business Combination Agreement, among other things, FIAC will acquire DevvStream for consideration of shares in FIAC following its continuance to the Province of Alberta;</div>
      <div>&#160;</div>
      <div style="text-align: justify;">B.&#160;&#160;&#160;&#160;&#160;&#160; The Company and the Executive are
            currently party to that certain Executive Employment Agreement dated December 20, 2021 (the &#8220;<font style="font-weight: bold;">Prior Agreement</font>&#8221;);</div>
      <div>&#160;</div>
      <div style="text-align: justify;">C.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company and the Executive wish to
            continue their employment relationship for their mutual benefit;</div>
      <div>&#160;</div>
      <div style="text-align: justify;">D.&#160;&#160;&#160;&#160;&#160;&#160;&#160; The Company and the Executive wish to
            enter into an Agreement respecting the terms and conditions of the Executive&#8217;s continued employment, including the agreement of the Executive to be bound by the restrictive covenants set out in Article 8 hereof; and</div>
      <div>&#160;</div>
      <div style="text-align: justify;">E.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;This Agreement is effective upon on
            the consummation of the Business Combination (such date, the &#8220;<font style="font-weight: bold;">Commencement Date</font>&#8221;) and if the Business Combination is not consummated by November 6, 2024, then
            this Agreement shall have no force or effect and shall be void ab initio;</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">NOW THEREFORE, in consideration of the mutual covenants and promises set forth herein and for other good and valuable consideration, the
        receipt and sufficiency of which is hereby acknowledged by the Company and the Executive, the parties hereby covenant and agree as follows:</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">1</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt; color: rgb(1, 0, 0);">ARTICLE 1 &#8211; </font><font style="font-size: 10pt;">INTERPRETATION</font></div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z323fabf12d8446eea634ac72f5cf5bfe" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 1.1</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Definitions.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">In this Agreement:</div>
      <div>&#160;</div>
      <div style="text-align: justify;"><font style="color: rgb(1, 0, 0);">(1)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;<font style="font-weight: bold;">Affiliate</font>&#8221; of a person means any person that directly or indirectly controls, is controlled by, or is under common control with, that person;</div>
      <div>&#160;</div>
      <div style="text-align: justify;"><font style="color: rgb(1, 0, 0);">(2)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;<font style="font-weight: bold;">Agreement</font>&#8221; means this agreement, including any schedules hereto, as amended, supplemented, or modified in writing from time to time;</div>
      <div>&#160;</div>
      <div style="text-align: justify;"><font style="color: rgb(1, 0, 0);">(3)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;<font style="font-weight: bold;">Business</font>&#8221; means the business of investing in a diversified portfolio of projects and/or companies that generate or are actively involved, directly or indirectly, with
            voluntary and/or compliance carbon credits;</div>
      <div>&#160;</div>
      <div style="text-align: justify;"><font style="color: rgb(1, 0, 0);">(4)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;">&#8220;Cause&#8221; </font>means the Executive has engaged in any of the following: (i) dishonest statements or acts with respect to the Company or any current or prospective
            customers, suppliers, vendors or other third parties with which such entity does business that adversely affects the Company, (ii) indictment, commission of, or plea of guilty or no contest to, (A) a felony or (B) any misdemeanor involving
            moral turpitude, deceit, dishonesty or fraud, (iii) the Executive&#8217;s gross negligence, willful misconduct or insubordination with respect to the Company, (iv) a material breach of any covenant or condition under this Agreement; (v) any act
            constituting dishonesty, fraud, immoral or disreputable conduct; (vi) any conduct which constitutes a felony under applicable law; (vii) a material violation of any Company policy (including the Company&#8217;s anti-discrimination and anti-harassment
            policies and other policies related to discrimination, harassment, performance of illegal or unethical activities, or ethical misconduct) or any act of misconduct; (viii) refusal to follow or implement a clear and reasonable directive of the
            Company; (ix) gross negligence or incompetence in the performance of the Executive&#8217;s duties or failure to perform such duties in a manner satisfactory to the Company; or (x) breach of fiduciary duty to the Company. Except for a failure, breach,
            or refusal which, by its nature, cannot reasonably be expected to be cured (in the discretion of the Board), the Executive shall have ten (10) days from the delivery of written notice from the Company within which to cure any acts constituting
            Cause, if curable, under prongs (vii)-(ix);</div>
      <div>&#160;</div>
      <div style="text-align: justify;"><font style="color: rgb(1, 0, 0);">(5)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;<font style="font-weight: bold;">Confidential Information</font>&#8221; means information disclosed or accessible to the Executive or acquired by the Executive as a result of the Executive&#8217;s employment with the
            Company and which is not in the public domain or otherwise required to be publicly disclosed by applicable law and includes, but is not limited to, information relating to the Company&#8217;s or any of its Affiliates&#8217; current, future or proposed
            products/services or development of new or improved products/services, marketing strategies, sales or business plans, the names and information about the Company&#8217;s past, present and prospective customers and clients, the Company&#8217;s employees
            (including, without limitation, compensation information and performance reviews), employee handbooks and documents related to the Company&#8217;s internal processes and procedures, source code, inventions, discoveries, business methods, trade
            secrets, compositions, technical data, records, reports, presentation materials, interpretations, forecasts, test results, formulae, projects, research data, personnel data, compensation arrangements, budgets, financial statements, office
            plans, contracts and commercial documents, suppliers, manufacturers and any information received by the Company from third parties pursuant to an obligation of confidentiality. Notwithstanding the foregoing, &#8220;Confidential Information&#8221; does not
            include information that the Executive can prove by written evidence is information that is or becomes generally known to the public through lawful means and through no fault of the Executive;</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">2</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify;"><font style="color: rgb(1, 0, 0);">(6)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;<font style="font-weight: bold;">Corporate Transaction</font>&#8221; has the same meaning as such term is defined in the Equity Plan;</div>
      <div>&#160;</div>
      <div style="text-align: justify;"><font style="color: rgb(1, 0, 0);">(7)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;<font style="font-weight: bold;">Date of Termination</font>&#8221; means the Executive&#8217;s last active day of employment with the Company;</div>
      <div>&#160;</div>
      <div style="text-align: justify;"><font style="color: rgb(1, 0, 0);">(8)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;<font style="font-weight: bold;">Equity Plan</font>&#8221; means the DevvStream Corp 2024 Equity Incentive Plan, as may be amended, restated or modified from time to time.</div>
      <div>&#160;</div>
      <div style="text-align: justify;"><font style="color: rgb(1, 0, 0);">(9)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;<font style="font-weight: bold;">Good Reason</font>&#8221; means the occurrence of any of the following events without the Executive&#8217;s consent: (i) a material reduction in the Executive&#8217;s Base Salary,; or (ii) a
            material reduction in the Executive&#8217;s duties, authority, responsibilities, and title relative to the Executive&#8217;s duties, authority, responsibilities, and title in effect immediately prior to such reduction, <font style="font-weight: bold; font-style: italic;">provided</font>, <font style="font-weight: bold; font-style: italic;">however</font>, that the acquisition of the Company and
            subsequent conversion of the Company to a division or unit of an acquiring company will not by itself result in a diminution of the Executive&#8217;s position. Any such resignation by the Executive shall only be deemed for Good Reason pursuant to
            this definition if: (1) the Executive gives the Company written notice of his intent to resign for Good Reason within thirty (30) days following the first occurrence of the condition(s) that the Executive believes constitute(s) Good Reason,
            which notice shall describe such condition(s); (2) the Company fails to remedy such condition(s) within thirty (30) days following receipt of the written notice (the &#8220;<font style="font-weight: bold;">Cure
              Period</font>&#8221;); (3) the Company has not, prior to receiving such notice from the Executive, already informed the Executive that his employment with the Company is being terminated; and (4) the Executive voluntarily resigns his employment
            within thirty (30) days following the end of the Cure Period.</div>
      <div>&#160;</div>
      <div style="text-align: justify;"><font style="color: rgb(1, 0, 0);">(10)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;<font style="font-weight: bold;">Territory</font>&#8221; means the United States and Canada; and</div>
      <div>&#160;</div>
      <div style="text-align: justify;"><font style="color: rgb(1, 0, 0);">(11)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;<font style="font-weight: bold;">Total Disability</font>&#8221; means, as determined by a legally qualified medical practitioner selected by the Company in good faith and taking into account any accommodation
            required by the Company in accordance with applicable State and Federal laws, the Executive is unable to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment which can be expected to
            result in death or which has lasted or can be expected to last for a continuous period of twelve (12) months.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">3</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt; color: rgb(1, 0, 0);">ARTICLE 2 &#8211; </font><font style="font-size: 10pt;">TERM</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">The Executive&#8217;s employment is on an at-will basis under this Agreement, which shall commence as of the Commencement Date and the initial
        term of which shall continue until the third (3<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">rd</sup>) anniversary of the Commencement Date (the &#8220;<font style="font-weight: bold;">Initial Term</font>&#8221;), and thereafter shall automatically
        renew for additional terms of one (1) year (referred to as the &#8220;<font style="font-weight: bold;">Renewal Terms</font>&#8221;) unless either party delivers to the other party a written notice of nonrenewal at
        least ninety (90) days before the end of the Initial Term or any Renewal Term (a &#8220;<font style="font-weight: bold;">Non-Renewal</font>&#8221;). The Initial Term and any Renewal Term maybe be terminated earlier
        pursuant to Article 6 below. The period of time between the Commencement Date and the Date of Termination of the Executive&#8217;s employment hereunder shall be referred to herein as the &#8220;<font style="font-weight: bold;"><u>Employment Term</u></font>.&#8221;</div>
      <div>&#160;</div>
      <div style="text-align: center; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt; color: rgb(1, 0, 0);">ARTICLE 3 &#8211; </font><font style="font-size: 10pt;">EMPLOYMENT AND POSITION</font></div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zb725fecaabaa459d80fdd6a155c217ba" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 3.1</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Position.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">Subject to the terms and conditions set out in this Agreement, the Company hereby agrees to employ the Executive, and the Executive hereby
        agrees to serve the Company, in the position of Chief Operating Officer of the Company.</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z2f19716c1eb44bdabdd211d01f2668ac" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 3.2</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Place of Employment.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">The Executive shall provide the Executive&#8217;s duties and services to the Company remotely, but the Executive may be asked to work from the
        Company&#8217;s offices from time to time. The Company reserves the right in its sole discretion to change the Executives&#8217; remote status. If the Company requires the Executive to move to perform the Executive&#8217;s duties and services pursuant to this
        Agreement, the Company shall reimburse the Executive reasonable and documented relocation costs incurred by the Executive, subject to a reasonable cap determined by the Company and preapproval and receipt of appropriate documentation substantiating
        that such costs have in fact been incurred in accordance with the Company&#8217;s expense reimbursement policy.</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z76a0fc2d7abf4701834421ef0ef7c84b" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 3.3</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Travel.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">The Executive acknowledges that the duties of the Executive&#8217;s position may require some travel within and outside United States.</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zd8a5c7e0440044c08e11d6c65a037645" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 3.4</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Executive&#8217;s Covenant.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">The Executive represents and warrants to the Company that the Executive is free to be employed by the Company as contemplated herein and
        that the Executive is not subject to any obligation or restriction (statutory, contractual, or at common law) which would prevent or interfere with the performance of all of the Executive&#8217;s obligations hereunder.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">4</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt; color: rgb(1, 0, 0);">ARTICLE 4 &#8211; </font><font style="font-size: 10pt;">DUTIES</font></div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zb7bcc1a5e01444b79847e2bc0f84341d" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 4.1</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Full-Time Employment.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">The Executive&#8217;s position with the Company constitutes full-time employment. Throughout the duration of the Executive&#8217;s employment, the
        Executive shall devote the Executive&#8217;s full working time and attention to the business and affairs of the Company, acting in the best interests of the Company at all times. The Executive shall not accept nor hold any position as an officer,
        director, employee, consultant, or any like position; provided, that Executive may engage in charitable, civic, fraternal and community affairs and educational, professional and/or trade industry association activities; <u>provided</u>, further, that, such activities do not (i) violate the terms of this Agreement, (ii) interfere, either individually or in the aggregate, with the performance of Executive&#8217;s duties
        under this Agreement or (iii) create a potential business or fiduciary conflict.</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zafc0d6f39b27491690d69a6d00b8764e" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 4.2</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Duties; Reporting.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">The Executive shall report to and be subject to the direction of the Company&#8217;s Chief Executive Officer (&#8220;CEO&#8221;), or such other person as
        the Board of Directors of the Company (the <font style="font-weight: bold;">&#8220;Board&#8221;</font>) or Company may subsequently designate, at any time, in the Board&#8217;s sole discretion. The Executive shall have
        duties and responsibilities consistent with the Executive&#8217;s position as may be assigned to the Executive from time to time. The Executive shall perform all duties in accordance with the instructions of the CEO or such other person as the Company
        may designate, and all of the Company&#8217;s policies and codes of conduct, rules and regulations in effect from time to time, which the Company may amend without advance notice to the Executive. The Executive shall also comply with all applicable laws
        in the performance of the Executive&#8217;s duties.</div>
      <div>&#160;</div>
      <div style="text-align: center; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt; color: rgb(1, 0, 0);">ARTICLE 5 &#8211; </font><font style="font-size: 10pt;">COMPENSATION AND BENEFITS</font></div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z91474c684828486a8b3cd8421c6f457a" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 5.1</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Base Salary.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">During the Employment Term, the Executive&#8217;s base salary will be $180,000 annually (&#8220;<font style="font-weight: bold;">Base Salary</font>&#8221;), less applicable deductions and withholdings as required by applicable law, paid in accordance with the Company&#8217;s standard payroll practices and prorated in any year where the Executive is not actively
        employed with the Company for the full calendar year. The Executive&#8217;s base salary will be reviewed by the Board (or a designated committee thereof) on an annual basis, based on personal and corporate achievements and the overall financial
        performance of the Company.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">5</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="zdfa301f2684e4102a9afc39608971800" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 5.2</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Benefits.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">During the Employment Term, the Executive shall be eligible to participate in the Company&#8217;s employee benefit programs for which similarly
        situated executives are generally eligible that may be in effect from time to time, subject to the terms and conditions of such plan and applicable policies, as may be amended from time to time without advance notice. The Company reserves the right
        to change its benefit plan or carrier in its sole and absolute discretion.</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z06f46ae83a8b4c268af6d578e8927642" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 5.3</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Vacation.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">During the Employment Term, the Executive shall be entitled to accrue 15 days of vacation per calendar year, up to a maximum accrual of 23
        days (the &#8220;<font style="font-weight: bold;">Vacation Cap</font>&#8221;), such vacation to extend for such periods and to be taken at such intervals as shall be appropriate and consistent with the proper
        performance of the Executive&#8217;s duties and as agreed upon between the Executive and the Company. Vacation will accrue up to the Vacation Cap (at which point the Executive shall not accrue, at any time, any additional vacation until the Executive&#8217;s
        vacation accrual falls below the Vacation Cap) and any accrued but unused vacation will be paid out at termination.</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z2bb4a76eba824e4eb968384ce6ef8beb" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 5.4</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Reimbursement of Expenses.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">During the Employment Term, the Executive will be eligible for reimbursement of reasonable and necessary business and travel expenses
        actually incurred by the Executive directly in connection with the business affairs of the Company and the performance of the Executive&#8217;s duties hereunder, upon presentation of proper receipts or other proof of expenditure acceptable to the
        Company, in accordance with the Company&#8217;s expense reimbursement policy. The Executive shall comply with such reasonable limitations and reporting requirements with respect to such expenses as the Company may establish from time to time.</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z5b855376c3914ee6b47e59e9fe339f81" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 5.5</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">No Other Benefits.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">The Executive is not entitled to any other payment, benefit, perquisite, allowance or entitlement other than as specifically set out in
        this Agreement, or as mandated by applicable laws, or as otherwise approved in writing and signed by the Company and the Executive.</div>
      <div>&#160;</div>
      <div style="text-align: center; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt; color: rgb(1, 0, 0);">ARTICLE 6 &#8211; </font><font style="font-size: 10pt;">TERMINATION OF EMPLOYMENT</font></div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="ze5c2fd69f473410b8934b35d8f154d23" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 6.1</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Termination.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">The Company and the Executive acknowledge that the Executive&#8217;s employment relationship with the Company is at-will. Either the Executive
        or the Company may terminate the employment relationship at any time, with or without cause. In addition to a Non-Renewal, as described in Article 2 hereof, the Executive&#8217;s employment may be terminated at any time as follows:</div>
      <div>&#160;</div>
      <div style="text-align: justify;"><font style="color: rgb(1, 0, 0);">(1)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;">Death</font>. This Agreement and the Executive&#8217;s employment shall automatically terminate upon the death of the Executive.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">6</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify;"><font style="color: rgb(1, 0, 0);">(2)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;">Total&#160; Disability</font>.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company may terminate this Agreement and the Executive&#8217;s employment at
            any time as a result of Total Disability in accordance with Section 6.4.</div>
      <div>&#160;</div>
      <div style="text-align: justify;"><font style="color: rgb(1, 0, 0);">(3)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;">Cause</font>. The Company may terminate this Agreement and the Executive&#8217;s employment at any time for Cause in accordance with Section 6.3.</div>
      <div>&#160;</div>
      <div style="text-align: justify;"><font style="color: rgb(1, 0, 0);">(4)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;">Without Cause</font>. The Company may terminate this Agreement and the Executive&#8217;s employment at any time without Cause, for any reason or no reason whatsoever, by providing
            written notice to the Executive specifying the effective Date of Termination (which may be immediate). In such event, the Company shall provide, and the Executive shall be entitled to receive the notice, payments, benefits and/or entitlements
            set out in Section 6.5 below. For the avoidance of doubt, a termination of the Executive&#8217;s employment at the conclusion of the Initial Term or a Renewal Term, as applicable, due to the Company&#8217;s Non-Renewal shall be treated as a termination by
            the Company without Cause so long as grounds for Cause do not exist.</div>
      <div>&#160;</div>
      <div style="text-align: justify;"><font style="color: rgb(1, 0, 0);">(5)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;">Resignation Without Good Reason</font>. The Executive may terminate this Agreement and the Executive&#8217;s employment at any time by providing three (3) months&#8217; advance written
            notice to the Company. The Company may elect to waive all or part of such notice period and shall have no obligation to provide any pay-in-lieu of notice. For the avoidance of doubt, a termination of the Executive&#8217;s employment at the conclusion
            of the Initial Term or Renewal Term, as applicable, due to Executive&#8217;s Non-Renewal shall be treated as a termination by Executive without Good Reason.</div>
      <div>&#160;</div>
      <div style="text-align: justify;"><font style="color: rgb(1, 0, 0);">(6)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;">Resignation for Good Reason</font>. The Executive may terminate this Agreement and the Executive&#8217;s employment for Good Reason, provided the Executive follows the notice
            procedures in Section 1.1(8) of this Agreement. In such event, the Company shall provide, and the Executive shall be entitled to receive the notice, payments, benefits and/or entitlements set out in Section 6.5 below.</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zfa778e32ee86480ba4509b5e29071106" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 6.2</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Termination by Reason of Death or Resignation by the Executive Without Good Reason.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">If this Agreement and the Executive&#8217;s employment is terminated pursuant to Sections 6.1(1) or 6.1(5) above, then the Company shall pay to
        the Executive (or, in the case of the Executive&#8217;s death, to the Executive&#8217;s estate) (i) an amount equal to the base salary and vacation pay up to the Date of Termination within thirty (30) days following the termination date (or such earlier date
        as required by applicable law), and (ii) any other vested employee benefits that the Executive is entitled up to the Date of Termination under any applicable employee benefit plan or arrangement of the Company in which the Executive is a
        participant during the Executive&#8217;s employment with the Company, in accordance with the terms of such plan or arrangement (collectively, the &#8220;<font style="font-weight: bold;">Accrued Obligations</font>&#8221;),
        and the Executive shall have no entitlement to any further notice of termination, payment in lieu of notice of termination, severance or termination pay, benefits or any damages whatsoever. Participation in all equity or profit participation plans
        (if any) terminates immediately upon the Date of Termination and the Executive shall not be entitled to any bonus or incentive awards, pro rata or otherwise, except as required by applicable law.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">7</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="z153727dad841458cbc90753ef1bd94b5" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 6.3</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Termination by the Company for Cause.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">If this Agreement and the Executive&#8217;s employment is terminated for Cause pursuant to Section 6.1(3) above, then the Company shall pay to
        the Executive the Accrued Obligations, and the Executive shall have no entitlement to any further notice of termination, payment in lieu of notice of termination, severance or termination pay, benefits or any damages whatsoever, except as may be
        required by applicable law. Participation in all equity or profit participation plans (if any) terminates immediately upon the Date of Termination and the Executive shall not be entitled to any additional bonus or incentive award, pro rata or
        otherwise, except as required by applicable law.</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zfbe2a70598fe4dc09370982fb72ef943" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 6.4</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Termination by Reason of Total Disability.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">If this Agreement and the Executive&#8217;s employment is terminated pursuant to Section 6.1(2) above, then the Company shall pay to the
        Executive the Accrued Obligations, and the Executive shall have no entitlement to any further notice of termination, payment in lieu of notice of termination, severance or termination pay, benefits or any damages whatsoever, except as may be
        required by applicable law. Participation in all equity or profit participation plans (if any) terminates immediately upon the Date of Termination and the Executive shall not be entitled to any additional bonus or incentive award, pro rata or
        otherwise, except as required by applicable law.</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z8c6b014caff0499c817e7af9ca19d53c" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 6.5</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Termination by the Company Without Cause or Resignation by the Executive for Good Reason</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">If this Agreement and the Executive&#8217;s employment is terminated by the Company without Cause or by the Executive for Good Reason pursuant
        to Sections 6.1(4) or 6.1(6) above, then the Company shall pay to the Executive the Accrued Obligations. Participation in all equity, equity- based and profit participation plans and arrangements (if any), including the vesting of any award
        outstanding thereunder will terminate immediately upon the applicable Date of Termination and the Executive shall not be entitled to any additional bonus or incentive award, pro rata or otherwise. Further, subject to the terms of Section 6.7 and
        Executive complying with the terms in Section 6.8, the Executive shall be entitled to an amount equal to the Executive&#8217;s then-current Base Salary for twelve (12) months, less all applicable withholdings and deduction (the &#8220;<font style="font-weight: bold;">Severance Benefits</font>&#8221;), to be paid in equal installments over a period of twelve (12) months following the Date of Termination in accordance with the Company&#8217;s regular payroll practices, with
        the first installment being paid beginning on the Company&#8217;s second regularly scheduled payroll date following the Release Effective Date (as defined in Section 6.7), with the first installment including any amount of the Severance Benefits that
        would otherwise have been due prior to the Release Effective Date; and</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">8</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">The Severance Benefits provided to the Executive pursuant to this Section 6.5 are in lieu of, and not in addition to, any benefits to
        which the Executive may otherwise be entitled under any Company severance plan, policy or program.</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z7fcb05362cc347ecb7bfec14dde1b739" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 6.6</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Termination by the Company Without Cause or Resignation by the Executive for Good Reason following a Corporate Transaction.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">If the Executive&#8217;s employment hereunder is terminated by the Company without Cause (other than on account of the Executive&#8217;s death or
        Total Disability) or the Executive resigns for Good Reason, in each case within twelve (12) months following the consummation of a Corporate Transaction, the Executive shall be eligible to receive (i) the Accrued Obligations and (ii) subject to the
        Executive&#8217;s compliance with Section 6.8, including execution of the Release, the Executive shall be entitled to receive the following benefits (the &#8220;<font style="font-weight: bold;">Change in Control
          Benefits</font>&#8221;):</div>
      <div>&#160;</div>
      <div style="text-align: justify;"><font style="color: rgb(1, 0, 0);">(1)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the Severance
            Benefits, in accordance with the terms and conditions described in Section 6.5 above; and</div>
      <div>&#160;</div>
      <div style="text-align: justify;"><font style="color: rgb(1, 0, 0);">(2)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; all of the
            Executive&#8217;s outstanding Company equity awards that were granted prior to the Corporate Transaction will vest (collectively, the &#8220;<font style="font-weight: bold;">Accelerated Equity Awards</font>&#8221;) and,
            if applicable, become exercisable upon the applicable Date of Termination as follows: In the case of any Accelerated Equity Award (or any portion thereof) that, as of immediately prior to the Executive&#8217;s termination of employment, was scheduled
            to vest based solely on continued service with the Company (the &#8220;<font style="font-weight: bold;">Time Vesting Shares</font>&#8221;), 100% of such Time Vesting Shares will vest. In the case of any Accelerated
            Equity Award (or any portion thereof) that, as of immediately prior to the Executive&#8217;s termination of employment, was subject to performance-based vesting (the &#8220;<font style="font-weight: bold;">Performance
              Vesting Shares</font>&#8221;), the number of Performance Vesting Shares that will vest will equal the greater of the number of shares determined based on achievement of (i) the &#8220;target&#8221; level of performance and (ii) the Company&#8217;s actual
            performance, measured as of the Date of Termination, as determined by the Committee (as defined in the Equity Plan).</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z59363ab9c54d43c6b09901a0333ed16e" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 6.7</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">All Inclusive.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">The Executive acknowledges and agrees that provision of the entitlements set out in this Article 6 shall constitute full and final
        satisfaction of any claim which the Executive might have arising from or relating to the termination of the Executive&#8217;s employment, whether such claim arises under legislation, contract, common law or otherwise, except for such claim that cannot be
        released by operation of legislation.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">9</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="z5c7a06f9a58c4a24836e55a2978257bb" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 6.8</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Release; Forfeiture.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">The Executive shall receive the Severance Benefits pursuant to Section 6.5 or the Change in Control Benefits pursuant to Section 6.6 of
        this Agreement if, and only if: (i) by the sixtieth (60th) day following the Date of Termination from the Company, the Executive has signed and delivered to the Company a separation agreement containing a general release of claims in favor of the
        Company and its affiliates and representatives, in the form reasonably presented by the Company (the &#8220;<font style="font-weight: bold;">Release</font>&#8221;), which cannot be revoked in whole or part by such date
        (the date that the Release can no longer be revoked is referred to as the &#8220;<font style="font-weight: bold;">Release Effective Date</font>&#8221;); (ii) if the Executive holds any other positions with the Company
        or any affiliate, including a position on the Board, the Executive resigns such position(s) to be effective no later than the Date of Termination (or such other date as requested by the Company); (iii) the Executive returns all Company property;
        (iv) the Executive complies with the Executive&#8217;s post-termination obligations under this Agreement; and (v) the Executive complies with the terms of the Release. If the Executive materially breaches any of the Executive&#8217;s post-termination
        obligations under this Agreement (including under Sections 6.9, Article 7 or Article 8) or the Company discovers, on or prior to the twelve (12)-month anniversary of Executive&#8217;s Date of Termination, that incurable Cause grounds existed as of the
        Executive&#8217;s Date of Termination, the Executive&#8217;s right (if any) to receive the Severance Benefits or the Change in Control Benefits (as applicable) shall immediately cease and be forfeited, such that the Company shall have no further obligation to
        make any of the foregoing payments, all Accelerated Equity Awards (or any shares of common stock received upon vesting or exercise thereunder) shall be immediately forfeited for no reason, and Executive will immediately repay to the Company any
        Severance Benefits or the Change in Control Benefits (as applicable) previously paid to Executive.</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zc215af314e494bd9aadf4bde51b6566b" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 6.9</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Return of Property.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">All equipment, keys, pass cards, credit cards, software, material, data, written correspondence, memoranda, communication, reports, or
        other documents or property pertaining to the business of the Company or containing Confidential Information, used or produced by the Executive in connection with the Executive&#8217;s employment, or in the Executive&#8217;s possession or under the Executive&#8217;s
        control, shall at all times remain the exclusive property of the Company. The Executive shall return all property of the Company in the Executive&#8217;s possession or under the Executive&#8217;s control in good condition (wear and tear excepted), and all
        documents or property containing Confidential Information (without retaining any copy, electronic or otherwise), forthwith upon any request by the Company or upon any termination of the Executive&#8217;s employment for any reason.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">10</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt; color: rgb(1, 0, 0);">ARTICLE 7 &#8211; </font><font style="font-size: 10pt;">ASSIGNMENT OF INVENTIONS</font></div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z8d387e37753e4698ae48beb5eb470e74" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 7.1</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Definitions.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">The term (1) &#8220;<font style="font-weight: bold;">Intellectual Property Rights</font>&#8221; means all
        trade secrets, Copyrights, trademarks, mask work rights, patents and other intellectual property rights recognized by the laws of any jurisdiction, together with all national, foreign and state registrations, applications for registration and all
        renewals and extensions thereof (including, without limitation, any provisionals, continuations, continuations-in-part, divisionals, reissues, substitutions and reexaminations), all goodwill associated therewith and all benefits, privileges, causes
        of action and remedies relating to any of the foregoing, whether before or hereafter accrued (including, without limitation, the exclusive rights to apply for and maintain all such registrations, renewals and extensions; to sue for all past,
        present and future infringements or other violations of any rights relating thereto; and to settle and retain proceeds from any such actions); (2) &#8220;<font style="font-weight: bold;">Copyright</font>&#8221; means
        the exclusive legal right to reproduce, perform, display, distribute, and make derivative works of a work of authorship recognized by the laws of any jurisdiction; (3) &#8220;<font style="font-weight: bold;">Inventions</font>&#8221;
        means all ideas, methods, inventions, discoveries, improvements, work products, developments, software, know-how, processes, techniques, works of authorship and other work product, whether or not patentable or registrable under copyright or similar
        statutes; (4) &#8220;<font style="font-weight: bold;">Moral Rights</font>&#8221; means any rights to claim authorship of an Invention or to object to or prevent the modification of any Invention, or to withdraw from
        circulation or control the publication or distribution of any Invention, and any similar right existing under judicial or statutory law of any country in the world or under any treaty, regardless of whether or not such right is denominated or
        generally referred to as a &#8220;moral right&#8221;; (5) &#8220;<font style="font-weight: bold;">Company Inventions</font>&#8221; means all Inventions (and all Intellectual Property Rights with respect thereto) made, conceived,
        reduced to practice, fixed in a tangible medium, or learned by the Executive, either alone or with others, during the period of the Executive&#8217;s employment by the Company other than Excluded Inventions and Nonassignable Inventions; and (6) &#8220;<font style="font-weight: bold;">Excluded Inventions</font>&#8221; means Inventions listed on <font style="font-weight: bold;">Exhibit A</font>: (i) that are owned by the
        Executive or in which the Executive has an interest and were made or acquired by the Executive prior to the Executive&#8217;s date of first employment by the Company and (ii) that the Executive considers to be the Executive&#8217;s property or the property of
        third parties and that the Executive wishes to have excluded from the scope of this Agreement.</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z39299a2eca5a4b6f9ce110addc8aceb2" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 7.2</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Excluded Inventions.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">Inventions, if any, patented or unpatented, which the Executive made prior to the commencement of the Executive&#8217;s employment with the
        Company are excluded from the scope of this Agreement. The Executive has set forth on <font style="font-weight: bold;">Exhibit A </font>a complete list describing all Excluded Inventions. If no such list
        is attached, the Executive represents that it is because the Executive has no Excluded Inventions. If disclosure of any such Excluded Invention would cause the Executive to violate any prior confidentiality agreement, the Executive understands that
        the Executive is not to list such Excluded Inventions in <font style="font-weight: bold;">Exhibit A </font>but is only to disclose a cursory name for each such Excluded Invention, a listing of the party
        or parties to which it belongs and the fact that full disclosure as to such Excluded Inventions has not been made for that reason. The Executive agrees that if the Executive uses any Excluded Inventions in the scope of the Executive&#8217;s employment,
        or if the Executive includes any Excluded Inventions in any product or service of the Company, or if the Executive&#8217;s rights in any Excluded Inventions may block or interfere with, or may otherwise be required for, the exercise by the Company of any
        rights assigned to the Company under this Agreement, the Executive will immediately notify the Company in writing. The Executive hereby grants to the Company a non-exclusive, perpetual, transferable, fully-paid and royalty-free, irrevocable,
        worldwide license, with rights to sublicense through multiple levels of sublicensees, to reproduce, make derivative works of, distribute, publicly perform, and publicly display in any form or medium, whether now known or later developed, make, have
        made, use, sell, import, offer for sale, and exercise any and all present or future rights in, such Excluded Inventions that the Executive incorporates into a Company product, process or machine during the course of the Executive&#8217;s employment.
        Notwithstanding the foregoing, the Executive agrees that the Executive will not incorporate, or permit to be incorporated, Excluded Inventions in any Company Inventions, except as authorized in writing by the Board. To the extent that any third
        parties have rights in any such Excluded Inventions, the Executive hereby warrants that such third parties have given the Executive the right to grant the license stated above.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">11</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="z537ad50d72524f2ca098a6b12f48657c" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 7.3</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Assignment of Company Inventions.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">Subject to Article 8 and except for Excluded Inventions set forth in <font style="font-weight: bold;">Exhibit A</font>, the Executive hereby assigns, and agrees to automatically assign in the future (when any such Inventions are first reduced to practice or fixed in a tangible medium, as applicable), to the Company all of the Executive&#8217;s
        right, title, and interest in and to all Company Inventions, including all benefits, privileges, causes of action and remedies relating to such Company Inventions, free and clear of all liens and encumbrances. The Executive further agrees that such
        assignment includes an assignment of Moral Rights. To the extent such Moral Rights cannot be assigned to the Company and to the extent the following is allowed by the laws in any jurisdiction where Moral Rights exist, the Executive waives the
        enforcement of such Moral Rights, and all claims of any kind with respect to Moral Rights against the Company or related to the Company&#8217;s customers. The Executive further agrees that neither the Executive&#8217;s successors-in-interest nor legal heirs
        retain any Moral Rights in any Company Inventions.</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z8c7d7a88a5d145deb5b75a8f5f0bf641" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 7.4</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Unassigned or Nonassignable Inventions.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">The Company recognizes that this Agreement does not require the assignment of any Invention that either: (a) the Executive developed
        entirely on the Executive&#8217;s own time without using Company equipment, supplies, facilities, trade secrets, or Confidential Information or third party information, which is not related to the Company&#8217;s actual or anticipated business, research, or
        development and which does not result from or are connected with work performed by the Executive for the Company; or (b) which qualifies fully for protection from assignment to the Company under any specifically applicable state law, regulation,
        rule or public policy (&#8220;<font style="font-weight: bold;">Nonassignable Inventions</font>&#8221;). The Executive has received and understands the state specific statutory notices set forth on <font style="font-weight: bold;">Exhibit B</font>.</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z9ff55d54e5fd45a3b08fc273890a2fba" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 7.5</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Ownership of Work Product.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">The Executive acknowledges that all original works of authorship made by the Executive (solely or jointly with others) within the scope of
        the Executive&#8217;s employment protectable by copyright are &#8220;works made for hire&#8221; pursuant to the United States Copyright Act. To the extent that any such work of authorship cannot be a &#8220;work made for hire,&#8221; pursuant to United States Copyright Act (17
        U.S.C., Section 101), the Executive hereby irrevocably and unconditionally assigns to the Company all right, title, and interest worldwide in and to such work of authorship. The Executive understands and agrees that the Executive has no right to
        publish on, submit for publishing, or use for any publication any work product protected by this Section, except as necessary to perform services for the Company.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">12</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="z0cef8af92efa4c4a83265df00e6ed9f0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 7.6</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Enforcement of Intellectual Property Rights and Assistance.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">The Executive will assist the Company in every reasonable way to obtain, and from time to time enforce, Intellectual Property Rights and
        Moral Rights relating to Company Inventions. To that end, the Executive will execute, verify, and deliver such documents and perform such other acts (including appearances as a witness) as the Company may reasonably request for use in applying for,
        obtaining, perfecting, evidencing, sustaining, enforcing, and assigning such Intellectual Property Rights. The Executive&#8217;s obligation to assist the Company with respect to Intellectual Property Rights relating to Company Inventions will continue
        beyond the termination of the Executive&#8217;s employment, but the Company will compensate the Executive at a reasonable rate after the Executive&#8217;s termination for the time actually spent by the Executive at the Company&#8217;s request on such assistance. In
        the event the Company is unable for any reason, after reasonable effort, to secure the Executive&#8217;s signature on any document needed in connection with the actions specified in this Section, the Executive hereby irrevocably designates and appoints
        the Company and its duly authorized officers and agents as the Executive&#8217;s agent and attorney in fact, which appointment is coupled with an interest, to act for and on the Executive&#8217;s behalf to execute, verify, and file any such documents and to do
        all other lawfully permitted acts to further the purposes of this Section with the same legal force and effect as if executed by the Executive. The Executive hereby waives and quitclaims to the Company any and all claims, of any nature whatsoever,
        which the Executive now or may hereafter have for infringement of any Intellectual Property Rights assigned under this Agreement to the Company.</div>
      <div>&#160;</div>
      <div style="text-align: center; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt; color: rgb(1, 0, 0);">ARTICLE 8 &#8211; </font><font style="font-size: 10pt;">CONFIDENTIALITY &amp; RESTRICTIVE COVENANTS</font></div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z9691d57c12a84220ad40aaa1b9a094eb" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 8.1</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Protection of Confidential Information.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">While employed by the Company and following the termination of this Agreement and the Executive&#8217;s employment for any reason, the Executive
        shall not, directly or indirectly, in any way use or disclose to any person any Confidential Information except as provided for herein and shall only use or disclose any Confidential Information in the proper performance of the Executive&#8217;s duties.
        The Executive agrees and acknowledges that the Confidential Information of the Company is the exclusive property of the Company to be used exclusively by the Executive to perform the Executive&#8217;s duties and fulfil the Executive&#8217;s obligations to the
        Company and not for any other reason or purpose. Therefore, the Executive agrees to hold all such Confidential Information in trust for the Company, and the Executive further confirms and acknowledges the Executive&#8217;s fiduciary duty to use the
        Executive&#8217;s best efforts to protect the Confidential Information, not to misuse such information, and to protect such Confidential Information from any misuse, misappropriation, harm or interference by others in any manner whatsoever. The Executive
        agrees to protect the Confidential Information regardless of whether the information was disclosed in verbal, written, electronic, digital, visual or other form, and the Executive hereby agrees to give notice promptly to the Company of any
        unauthorized use or disclosure of Confidential Information of which the Executive becomes aware. The Executive further agrees to reasonably assist the Company in remedying any such unauthorized use or disclosure of Confidential Information. In the
        event that the Executive is required to disclose to third parties any Confidential Information or any memoranda, opinions, judgments or recommendations developed from the Confidential Information, by law, valid court order or subpoena, the
        Executive will, prior to disclosing such Confidential Information, provide the Company with prompt written notice of such request(s) or requirement(s) so that the Company may seek appropriate legal protection or waive compliance with the provisions
        of this Agreement. The Executive will not oppose action by, and will reasonably cooperate with, the Company to obtain legal protection or other reliable assurance that confidential treatment will be accorded the Confidential Information.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">13</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="z5a42274e949c46329e01b300c04a2109" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 8.2</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Protected Rights.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">Nothing in this Agreement shall limit the Executive&#8217;s right to discuss the Executive&#8217;s employment or report possible violations of law or
        regulation with the Equal Employment Opportunity Commission, United States Department of Labor, the National Labor Relations Board, the Securities and Exchange Commission, or other federal government agency or similar state or local agency or to
        discuss the terms and conditions of the Executive&#8217;s employment to others to the extent expressly permitted by Section 7 of the National Labor Relations Act or to the extent that such disclosure is protected under the applicable provisions of law or
        regulation, including but not limited to &#8220;whistleblower&#8221; statutes or other similar provisions that protect such disclosure. Further, nothing in this Agreement in any way restricts or impedes the Executive from: (i) disclosing the underlying facts
        and circumstances regarding any claims of sexual assault or sexual harassment, or (ii) filing or initiating or assisting others to file or initiate unfair labor practice charges with the National Labor Relations Board.</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z43bd106460d9436fa9e7a6d8f4c2a911" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 8.3</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Notice Under the Defend Trade Secrets Act of 2016.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">In accordance with the Defense of Trade Secrets Act, the Executive will not be held criminally or civilly liable under any federal or
        state trade secret law for the disclosure of a trade secret that: (i) is made (a) in confidence to a federal, state, or local government official, either directly or indirectly, or to an attorney, and (b) solely for the purpose of reporting or
        investigating a suspected violation of law; or (ii) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal. Nothing in this Agreement is intended to conflict with the Defend Trade Secrets
        Act or create liability for disclosures of trade secrets that are expressly allowed by the Defend Trade Secrets Act. If the Executive files a lawsuit for retaliation by the Company for reporting a suspected violation of law, the Executive may
        disclose the Company&#8217;s trade secrets to the Executive&#8217;s attorney and use the trade secret information in the court proceeding if the Executive: (y) files any document containing trade secrets under seal; and (z) does not disclose trade secrets,
        except pursuant to court order. The Executive may also disclose trade secrets in a document filed in a lawsuit or other proceeding, but only if the filing is made under seal and protected from public disclosure.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">14</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="z45cb904114ed491f968206d2635a03bd" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 8.4</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Corporate Opportunities.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">Any business opportunities related in any way to the business and affairs of the Company or any of its Affiliates which become known to
        the Executive during the Executive&#8217;s employment hereunder shall be fully disclosed and made available to the Company and shall not be appropriated by the Executive under any circumstance without the prior written consent of the Company.</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zcf446cb894684d6fa842e001b50ead7a" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 8.5</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Non-Competition.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">The Executive covenants that the Executive will not (without prior written consent of the Company) at any time during the Executive&#8217;s
        employment with the Company nor during the twelve (12) months following the Date of Termination (the &#8220;<font style="font-weight: bold;">Restricted Period</font>&#8221;), directly or indirectly, anywhere within the
        Territory, either individually or in partnership, jointly or in conjunction with any other person, firm, association, syndicate, company or corporation, whether as agent, shareholder, employee, consultant, or in any manner whatsoever, engage in,
        carry on or otherwise be concerned with, any business that is in competition with that of the Business.</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zd042d29e6dc54f0396375b67a117bfc0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 8.6</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Non-Solicitation.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">The Executive covenants that the Executive will not (without prior written consent of the Company) at any time during the Restricted
        Period, directly or indirectly, either individually or in partnership, jointly or in conjunction with any other person, firm, association, syndicate, company or corporation, whether as agent, shareholder, employee, consultant, or in any manner
        whatsoever:</div>
      <div>&#160;</div>
      <div style="text-align: justify;"><font style="color: rgb(1, 0, 0);">(1)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;solicit or
            entice away, or attempt to solicit or entice away from the Company, employ, or otherwise engage (as an employee, independent contractor, or otherwise) any person whom the Executive had contact with or received Confidential Information about
            during the Executive&#8217;s employment with the Company (in connection with such employment), and who is employed by the Company or engaged as a contractor or consultant by the Company as of the date of solicitation or who was so employed or engaged
            within the twelve (12) month period preceding such date; or</div>
      <div>&#160;</div>
      <div style="text-align: justify;"><font style="color: rgb(1, 0, 0);">(2)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;for any purpose
            competitive with the Business, canvass, solicit or approach for orders, or cause to be canvassed or solicited or approached for orders, any person or entity whom the Executive had contact with or received Confidential Information about during
            the Executive&#8217;s employment with the Company (in connection with such employment), and who is or which is a customer, client, supplier or licensee of the Company as of the date of solicitation or within the twelve (12) month period preceding
            such date; or</div>
      <div>&#160;</div>
      <div style="text-align: justify;"><font style="color: rgb(1, 0, 0);">(3)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;induce or
            attempt to induce any customer, client, supplier or licensee of the Company whom the Executive had contact with or received Confidential Information about during the Executive&#8217;s employment with the Company (in connection with such employment),
            to cease doing business with the Company; or</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">15</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify;"><font style="color: rgb(1, 0, 0);">(4)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;at any time
            following the date the Executive ceases to be an employee of the Company, disparage or denigrate the Company or its Affiliates or their respective businesses, officers or employees. Nothing contained in this Section 8.6(4) shall in any way
            restrict the Executive from exercising protected rights to the extent that such rights cannot be waived by agreement or from complying with any applicable law or regulation or a valid order of a court of competent jurisdiction or an authorized
            government agency, including discussing or disclosing information about unlawful acts in the workplace, such as harassment or discrimination or any other conduct that the Executive has reason to believe is unlawful, provided that such
            compliance does not exceed that required by the law, regulation, or order.</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z6bf12bf18c0345ae82564a103a4752f8" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 8.7</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Passive Investments; etc.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">Nothing in this Agreement shall:</div>
      <div>&#160;</div>
      <div style="text-align: justify;"><font style="color: rgb(1, 0, 0);">(1)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; prohibit or
            restrict the Executive from holding or becoming beneficially interested in up to two percent (2%) of any class of securities in any corporation provided that such class of securities are listed on a recognized stock exchange in Canada or the
            United States; or</div>
      <div>&#160;</div>
      <div style="text-align: justify;"><font style="color: rgb(1, 0, 0);">(2)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; prevent the
            employment or involvement of the Executive in any part of the business of a competitor of the Company that is unrelated to and not competitive with any business of the Company in which the Executive was engaged or learned Confidential
            Information at any time during the period of twelve (12) months preceding the cessation of the Executive&#8217;s employment with the Company.</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zb95a417a0f7e41eb91b02f5438fc9a8c" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 8.8</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Other Agreements.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">For greater certainty, the covenants contained in this Article 8 shall be in addition to, and complement, and not in replacement of nor
        shall they in any way derogate from any fiduciary duty the Executive owes to the Company or any other restrictive covenants (including any non- competition, confidentiality, non-disparagement or non-solicitation covenants) that the Executive is
        bound, or may become bound, in respect of the Company.</div>
      <div>&#160;</div>
      <div style="text-align: center; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt; color: rgb(1, 0, 0);">ARTICLE 9 &#8211; </font><font style="font-size: 10pt;">REMEDIES</font></div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z0f9fb31e25e64d2c94b505b7c7f0ba38" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 9.1</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Remedy.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">The Executive acknowledges and agrees that the Executive is employed in a fiduciary capacity, with obligations of trust and loyalty owed
        by the Executive to the Company. Accordingly, the Executive agrees that the restrictions in Article 8 are reasonable in the circumstances of the Executive&#8217;s employment and that the business and affairs of the Company cannot be properly protected
        from the adverse consequences of the actions of the Executive other than by the restrictions set forth in this Agreement.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">16</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="z7a6c35ed996c413bac2b4375f0185dd1" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 9.2</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Injunctions, etc.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">The Executive acknowledges and agrees that, in the event of a breach of the covenants, provisions and restrictions in Article 8 by the
        Executive, the Company&#8217;s remedy in the form of monetary damages will be inadequate. Therefore, the Company is hereby authorized and entitled, in addition to all other rights and remedies available to it at law or in equity, to interim and permanent
        injunctive relief and an accounting of all profits and benefits arising out of such breach without the necessity of posting a bond or other security, and the Executive consents to the entry of such relief.</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z16d782f7c3a94008b746869293b61f25" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 9.3</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Loss of Entitlements.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">In addition to all other rights and remedies available to the Company, the Executive acknowledges and agrees that the Executive will
        immediately lose and not be entitled to the payments and benefits set out in Section 6.5 or Section 6.6 (if applicable) if the Executive breaches any of the covenants in Article 8.</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="ze193aaa2bba54be3b008c03a1ff23005" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 9.4</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Survival.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">Each and every provision of Article 1, Article 7, Article 8 and Article 9 shall survive the termination of this Agreement and the
        Executive&#8217;s employment for any reason.</div>
      <div>&#160;</div>
      <div style="text-align: center; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt; color: rgb(1, 0, 0);">ARTICLE 10 &#8211; </font><font style="font-size: 10pt;">GENERAL CONTRACT TERMS</font></div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zed6ffbb5c0ca4071937ec803d2005e55" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 10.1</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Currency.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">All amounts payable pursuant to this Agreement are expressed in and shall be paid in United States of America currency unless otherwise
        indicated.</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z708ec7d849044526a41fb1a94b7a7fcf" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 10.2</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Withholding.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">The Company may withhold from any payments or benefits payable under this Agreement all US Federal, state, city or other taxes as shall be
        required pursuant to any applicable law or governmental regulation or ruling.</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z3fc76f8d594143b08a54acadd2daf073" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 10.3</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Rights and Remedies.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">All rights and remedies of the parties are separate and cumulative, and none of them, whether exercised or not, shall be deemed to be to
        the exclusion of any other rights or remedies or shall be deemed to limit or prejudice any other legal or equitable rights or remedies which either of the parties may have.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">17</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="z8018d58669e84584aeb6d50b79ed97ac" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 10.4</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Waiver.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">Any purported waiver of any default, breach or non-compliance under this Agreement is not effective unless in writing and signed by the
        party to be bound by the waiver. No waiver shall be inferred from or implied by any failure to act or delay in acting by a party in respect of any default, breach or non-observance or by anything done or omitted to be done by the other party. The
        waiver by a party of any default, breach or non-compliance under this Agreement shall not operate as a waiver of that party&#8217;s rights under this Agreement in respect of any continuing or subsequent default, breach or non-observance (whether of the
        same or any other nature).</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zabf31a47c3ac4d54ac9e43c39fdce8a7" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 10.5</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Severability.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">Whenever possible, each provision of this Agreement will be interpreted in such manner as to be effective and valid under applicable law,
        but if any provision of this Agreement is held to be invalid, illegal or unenforceable in any respect under any applicable law or rule in any jurisdiction, such invalidity, illegality or unenforceability will not affect any other provision or any
        other jurisdiction, but this Agreement will be reformed, construed and enforced in such jurisdiction as if such invalid, illegal or unenforceable provisions had never been contained herein. The Company and the Executive agree that a court of
        competent jurisdiction is expressly authorized to modify any such unenforceable provision of this Agreement in lieu of severing such unenforceable provision from this Agreement in its entirety, whether by rewriting the offending provision, deleting
        any or all of the offending provision, adding additional language to this Agreement, or by making such other modifications as it deems warranted to carry out the intent and agreement of the parties as embodied herein to the maximum extent permitted
        by law. The Company and the Executive further expressly agree that this Agreement as so modified by the court shall be binding upon and enforceable against each of them. In any event, should one or more of the provisions of this Agreement be held
        to be invalid, illegal, or unenforceable in any respect, such invalidity, illegality, or unenforceability shall not affect any other provisions hereof, and if such provision or provisions are not modified as provided above, this Agreement shall be
        construed as if such invalid, illegal, or unenforceable provisions had not been set forth herein.</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z2009d019f73c49a5bf74d22158f0942b" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 10.6</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Section 409A Compliance.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">The intent of the Company and the Executive is that payments, benefits and rights to which the Executive could be entitled to under this
        Agreement comply with, or be exempt from, Section 409A of the Internal Revenue Code of 1986, as amended (the &#8220;<font style="font-weight: bold;">Code</font>&#8221;) and the Treasury Regulations and guidance
        promulgated thereunder (collectively &#8220;<font style="font-weight: bold;">Code Section 409A</font>&#8221;) (to the extent that the requirements of Code Section 409A are applicable thereto), and, accordingly, to the
        maximum extent permitted, shall be interpreted to be in compliance therewith or exempt therefrom. If any provision of this Agreement contravenes Code Section 409A, or would cause the Executive to incur any additional tax, interest or penalty under
        Code Section 409A, the Company and the Executive agree in good faith to reform this Agreement to comply with Code Section 409A, or to take such other actions as they deem necessary or appropriate to maintain, to the maximum extent practicable,
        without violating the provisions of Code Section 409A, the original intent and economic benefit to Company and the Executive of the applicable provision; provided that Company shall have no obligation to make any changes that could create any
        additional economic cost or loss of benefit to Company. In no event whatsoever shall the Company be liable for any additional tax, interest or penalty that may be imposed on the Executive by Code Section 409A or damages for failing to comply with
        Code Section 409A. Any provision required for compliance with Code Section 409A that is omitted from this Agreement shall be incorporated herein by reference and shall apply retroactively, if necessary, and be deemed a part of this Agreement to the
        same extent as though expressly set forth herein.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">18</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">Notwithstanding anything herein to the contrary, if required to comply with Code Section 409A (but only to the extent so required), a
        termination of employment shall be deemed to have occurred at the time such termination constitutes a &#8220;separation from service&#8221; within the meaning of Code Section 409A for purposes of any provision of this Agreement providing for the payment of any
        amounts or benefits in connection with a termination of employment and, for purposes of any such provision of this Agreement, references to a &#8220;termination,&#8221; &#8220;termination of employment&#8221; or like terms shall mean a &#8220;separation from service.&#8221;</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">Notwithstanding anything herein to the contrary, if, on the date of a &#8220;separation from service&#8221; (as defined in Code Section 409A), the
        Executive is a &#8220;specified employee&#8221; (as defined in Code Section 409A), no payments of any amounts hereunder that are subject to Code Section 409A shall be made until the earliest date on which payment is permissible under 409A(a)(2)(B)(i) (the six
        (6)-month delay rule for specified employees).</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">For purposes of Code Section 409A, the Executive&#8217;s right to receive any installment payments pursuant to this Agreement shall be treated
        as a right to receive a series of separate and distinct payments.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">If any payment due under this Agreement is both deferred compensation subject to Code Section 409A and is conditioned upon the execution
        of a release of claims and involves a consideration time period that begins in one calendar year and ends in the next calendar year, will be paid as soon as practicable in the second calendar year even if the Executive signed the general release
        and such general release becomes irrevocable in the first calendar year.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">To the extent that reimbursements or other in-kind benefits under this Agreement constitute nonqualified deferred compensation for
        purposes of Code Section 409A, (1) all such expenses or other reimbursements hereunder shall be made on or prior to the last day of the taxable year following the taxable year in which such expenses were incurred by the Executive, (2) any right to
        such reimbursement or in-kind benefits shall not be subject to liquidation or exchange for another benefit, and (3) no such reimbursement, expenses eligible for reimbursement, or in-kind benefits provided in any taxable year shall in any way affect
        the expenses eligible for reimbursement, or in-kind benefits to be provided, in any other taxable year.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">19</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="z94beb25c09d240ef9cf5797aca70d2e2" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 10.7</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Parachute Payments.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">In the event that the severance and other benefits provided for in this Agreement or otherwise payable or provided to the Executive (i)
        constitute &#8220;parachute payments&#8221; within the meaning of Section 280G of the Code and (ii) but for this Section 10.7, would be subject to the excise tax imposed by Section 4999 of the Code (the &#8220;<font style="font-weight: bold;">Excise Tax</font>&#8221;), then the Executive&#8217;s severance benefits hereunder shall be either (a) delivered in full, or (b) delivered as to such lesser extent which would result in no portion of such severance benefits being subject
        to the Excise Tax, whichever of the foregoing amounts, taking into account the applicable federal, state and local income taxes and the Excise Tax, results in the receipt by executive on an after-tax basis, of the greatest amount of severance
        benefits, notwithstanding that all or some portion of such severance benefits may be taxable under Section 4999 of the Code. Unless the Company and the Executive otherwise agree in writing, any determination required under this Section 10.7 shall
        be made in writing in good faith by the Company&#8217;s independent tax accountants immediately prior to the Corporate Transaction.</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zb712542da35b487aa3439a31617b8048" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 10.8</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Notices.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">Any notice required or permitted to be given under this Agreement shall be in writing and shall be properly given if personally delivered,
        delivered by electronic transmission or mailed by prepaid registered mail addressed as follows:</div>
      <div>&#160;</div>
      <div style="margin-right: 36pt; margin-left: 36pt;">to the Company at:</div>
      <div>&#160;</div>
      <div style="margin-right: 36pt; margin-left: 36pt;">DevvStream, Corp.</div>
      <div style="margin-right: 36pt; margin-left: 36pt;">2133-1177 West Hastings Street</div>
      <div style="margin-right: 36pt; margin-left: 36pt;">Vancouver, BC V6E 2K3</div>
      <div style="margin-right: 36pt; margin-left: 36pt;">Attention: Sunny Trinh</div>
      <div style="margin-right: 36pt; margin-left: 36pt;">Email: sunny@devvstream.com</div>
      <div>&#160;</div>
      <div style="margin-right: 36pt; margin-left: 36pt;">With a copy to:</div>
      <div>&#160;</div>
      <div style="margin-right: 36pt; margin-left: 36pt;">McMillan LLP</div>
      <div style="margin-right: 36pt; margin-left: 36pt;">1055 W Georgia Street, Suite #1500</div>
      <div style="margin-right: 36pt; margin-left: 36pt;">Vancouver, BC V6E 4N7</div>
      <div style="margin-right: 36pt; margin-left: 36pt;">Attention: Mark Neighbor</div>
      <div style="margin-right: 36pt; margin-left: 36pt;">Email: Mark.Neighbor@mcmillan.ca</div>
      <div>&#160;</div>
      <div style="margin-right: 36pt; margin-left: 36pt;">to the Executive at:</div>
      <div>&#160;</div>
      <div style="margin-right: 36pt; margin-left: 36pt;">Janice L. Miller</div>
      <div style="margin-right: 36pt; margin-left: 36pt;">[]</div>
      <div>&#160;</div>
      <div style="text-align: justify;">or to such other address as the parties may from time to time specify by notice given in accordance herewith. Any notice so given shall be conclusively
        deemed to have been given or made on the day of delivery, if personally delivered, or if delivered by electronic transmission or mailed as aforesaid, upon the date the electronic transmission is sent or on the postal return receipt as the date upon
        which the envelope containing such notice was actually received by the addressee.</div>
      <div style="text-align: justify;"> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">20</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="zd5b637acffc14023b47e336ed9651bff" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 10.9</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Successors and Assigns.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">This Agreement shall inure to the benefit of, and be binding on, the parties and their respective heirs, administrators, executors,
        successors (whether direct or indirect, by purchase, amalgamation, arrangement, merger, consolidation or otherwise) and permitted assigns. The Company shall have the right to assign this Agreement, or the benefit thereof, to any of its Affiliates
        or to any successor (whether direct or indirect, by purchase, amalgamation, arrangement, merger, consolidation or otherwise). The Executive, by the Executive&#8217;s signature hereto, expressly consents to such assignment and, provided that such
        successor agrees to assume and be bound by the terms and conditions of this Agreement, all references to the &#8220;Company&#8221; hereunder shall include such successor. The parties agree that the services to be provided by the Executive are personal in
        nature, and therefore the Executive shall not subcontract, assign or transfer, whether absolutely, by way of security or otherwise, all or any part of the Executive&#8217;s rights or obligations under this Agreement.</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zfda1ead152634965ac6a09f43a742581" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 10.10</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Amendment.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">No amendment of this Agreement will be effective unless made in writing and signed by both the Executive and an authorized officer of the
        Company, other than the Executive, and approved by the Board.</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z75c53a1d56a548059e07b39cc3c46fb1" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 10.11</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Entire Agreement.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">This Agreement constitutes the entire agreement between the parties pertaining to the subject matter of this Agreement and supersedes all
        prior agreements, understandings, negotiations and discussions, whether oral or written with respect to the Executive&#8217;s employment with the Company (including, without limitation, the Prior Agreement, which shall become null and void and terminate
        automatically upon the Commencement Date). For the avoidance of doubt, following the execution of this Agreement, any existing employment agreements or contracts governing the Executive&#8217;s current employment with the Company (including, but not
        limited to, the Prior Agreement) is null and void and is of no further effect. Each party agrees there are no conditions, warranties, representations or other agreements between the parties in connection with the subject matter of this Agreement
        (whether oral or written, express or implied) except as specifically set out in this Agreement and the Executive agrees that the Executive has not relied on any representation of the Company or its Affiliates to enter into this Agreement.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">21</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="z4b1334330f4e42fb9d4896a91ef5d3fe" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 10.12</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Governing Law.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">This Agreement has been executed and delivered in the State of Delaware and its validity, interpretation, performance, and enforcement
        shall be governed by the laws of the state of Delaware and the federal laws of the United States of America as applicable therein.</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z996a8ccc2de24df69751c0a404c49bc2" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 10.13</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Headings.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">The division of this Agreement into Sections and the insertion of headings are for convenience or reference only and shall not affect the
        construction or interpretation of this Agreement.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: -36pt; margin-left: 36pt; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt; color: rgb(1, 0, 0);">Section
          10.14</font><font style="font-size: 10pt;">Independent Legal Advice.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">The parties acknowledge that, prior to executing this Agreement, they have each had the opportunity to obtain independent legal advice and
        that they fully understand the nature of this Agreement and that they are entering into this Agreement voluntarily. Specifically, the Executive represents and warrants to the Company that the Executive (a) has read and understood each and every
        provision of this Agreement, (b) has had the opportunity to obtain advice from legal counsel of Executive&#8217;s choice in order to interpret any and all provisions of this Agreement, and (c) has in fact been individually represented by legal counsel in
        negotiating the terms of this agreement, including the choice of law provision set forth in Section 10.12 hereof. To the extent a court of competent jurisdiction determines that the laws of the State of California govern this Agreement, the
        restrictions set forth in Sections 8.5 and 8.6 shall not apply during the portion of the Restricted Period following the Date of Termination.</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zabb08f1790af452eac153b790512082d" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 10.15</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Counterparts.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">This Agreement may be executed in any number of counterparts, and delivered by facsimile or other means of electronic transmission, each
        of which shall be deemed to be one and the same instrument and an original document.</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="ze614204b781646668436381552e881ad" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 63pt; vertical-align: top; color: rgb(1, 0, 0); font-weight: bold;">Section 10.16</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Ambiguities.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">As each party and its legal counsel have participated in the review and revision of this Agreement, any rule of construction to the effect
        that ambiguities are to be resolved against the drafting party shall not apply in interpreting this Agreement.</div>
      <div>&#160;</div>
      <div style="text-align: center; font-style: italic; font-weight: bold;">[Signature Page Follows]</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">22</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify;">The parties have executed this Agreement.</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" id="z89e2cff5916745d48699c6cb102e5966" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

          <tr>
            <td style="vertical-align: top;" colspan="3">
              <div style="text-align: justify; font-weight: bold;">DEVVSTREAM CORP.</div>
            </td>
            <td style="width: 50%; vertical-align: top;" colspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align: top;" colspan="3" rowspan="1">&#160;</td>
            <td style="width: 50%; vertical-align: top;" colspan="1" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: top; padding-bottom: 2px;">
              <div>By:</div>
            </td>
            <td style="width: 5%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1" colspan="2">
              <div>/s/ Sunny Trinh</div>
            </td>
            <td style="width: 50%; vertical-align: top; padding-bottom: 2px;" colspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: top;">&#160;</td>
            <td style="width: 5%; vertical-align: top;">
              <div>Name:</div>
            </td>
            <td style="width: 42%; vertical-align: top;">
              <div>Sunny Trinh</div>
            </td>
            <td style="width: 50%; vertical-align: top;" colspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: top;">&#160;</td>
            <td style="width: 5%; vertical-align: top;">
              <div>Title:</div>
            </td>
            <td style="width: 42%; vertical-align: top;">
              <div>CEO</div>
            </td>
            <td style="width: 50%; vertical-align: top;" colspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: top;" rowspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: top;" rowspan="1">&#160;</td>
            <td style="width: 42%; vertical-align: top;" rowspan="1">&#160;</td>
            <td style="width: 50%; vertical-align: top;" colspan="1" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align: top;" colspan="3">
              <div style="text-align: justify; font-weight: bold;">CHRIS MERKEL</div>
            </td>
            <td style="width: 50%; vertical-align: top;" colspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align: top;" colspan="3" rowspan="1">&#160;</td>
            <td style="width: 50%; vertical-align: top;" colspan="1" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: top; padding-bottom: 2px;">
              <div>By:</div>
            </td>
            <td style="width: 5%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1" colspan="2">
              <div>/s/ Chris Merkel</div>
            </td>
            <td style="width: 50%; vertical-align: top; padding-bottom: 2px;" colspan="1">&#160;</td>
          </tr>

      </table>
      <div> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; font-weight: bold;"><u>Exhibit A</u></div>
      <div>&#160;</div>
      <div style="text-align: center; font-weight: bold;">Excluded Inventions</div>
      <div>&#160;</div>
      <div style="text-align: justify; font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Excluded Inventions</u></font><font style="font-size: 10pt;">: List all such materials on this <u>Exhibit A</u> and indicate Executive&#8217;s agreement with the following by initialing where indicated: Executive represents and
          warrants that Executive has listed on this <u>Exhibit A</u> all Excluded Inventions.</font></div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" id="z3cc349672cb641e582c97d433fe44ae0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

          <tr>
            <td style="width: 80%; vertical-align: top; padding-bottom: 2px;">
              <div style="text-align: right;">Executive&#8217;s Initial</div>
            </td>
            <td style="width: 20%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">/s/ CM</td>
          </tr>

      </table>
      <div><br>
      </div>
      <div style="text-align: justify; font-size: 12pt;"><font style="font-size: 10pt;"><u>List of Prior Inventions </u></font><font style="font-size: 10pt; font-weight: bold;"><u>(write NONE if there are none)</u></font></div>
      <div>&#160;</div>
      <div style="text-align: justify;">NONE</div>
      <div>&#160;</div>
      <div style="text-align: justify;">
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
      <div>&#160;</div>
      <div>
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
        <div> <br>
        </div>
      </div>
      <div>
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
        <div> <br>
        </div>
        <div>
          <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
      </div>
      <div> <br>
      </div>
      <div>
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
      <div> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; font-weight: bold;"><u>Exhibit B</u></div>
      <div>&#160;</div>
      <div style="text-align: center; font-weight: bold;">Statutory Notices</div>
      <div>&#160;</div>
      <div style="text-align: justify;">Section 2870 of the California Labor Code is as follows:</div>
      <div>&#160;</div>
      <div style="text-align: justify;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Any provision in an employment
            agreement which provides that an employee shall assign, or offer to assign, any of his or her rights in an invention to his or her employer shall not apply to an invention that the employee developed entirely on his or her own time without
            using the employer&#8217;s equipment, supplies, facilities, or trade secret information except for those inventions that either:</div>
      <div>&#160;</div>
      <div style="text-align: justify; margin-left: 36pt;">(1)&#160;&#160;&#160;&#160;&#160;&#160;&#160; Relate at the time
            of conception or reduction to practice of the invention to the employer&#8217;s business, or actual or demonstrably anticipated research or development of the employer; or</div>
      <div>&#160;</div>
      <div style="text-align: justify; margin-left: 36pt;">(2)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Result from any
            work performed by the employee for the employer.</div>
      <div>&#160;</div>
      <div style="text-align: justify;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;To the extent a provision in an
            employment agreement purports to require an employee to assign an invention otherwise excluded from being required to be assigned under subdivision (a), the provision is against the public policy of this state and is unenforceable.</div>
      <div>&#160;</div>
      <div><br>
      </div>
      <div>
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    </div>
  </div>


</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.19
<SEQUENCE>8
<FILENAME>ef20038430_ex10-19.htm
<DESCRIPTION>EXHIBIT 10.19
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 24.9.1.5252
         Copyright 1995 - 2024 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <!--PROfilePageNumberReset%Num%1%%%--><font style="font-size: 10pt;"> </font>
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div>
      <div style="text-align: right;"> <font style="font-weight: bold; font-size: 10pt;">Exhibit 10.19</font></div>
      <div> <font style="font-size: 10pt;"><br>
        </font></div>
      <div>
        <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">CONFIDENTIAL</div>
      </div>
      <div> <font style="font-size: 10pt;"><br>
        </font></div>
      <table cellspacing="0" cellpadding="0" border="0" id="z2c9a8513d7414d5293b481f408ced238" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 30%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td style="width: 40%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">EXECUTIVE EMPLOYMENT AGREEMENT</div>
            </td>
            <td style="width: 30%; vertical-align: top; font-size: 10pt;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top; font-size: 10pt;" rowspan="1">&#160;</td>
            <td style="width: 40%; vertical-align: top; font-size: 10pt; text-align: center;" rowspan="1">&#160;</td>
            <td style="width: 30%; vertical-align: top; font-size: 10pt;" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: justify; font-family: 'Times New Roman'; font-weight: bold;">BETWEEN:</div>
            </td>
            <td style="width: 40%; vertical-align: top; font-size: 10pt; text-align: center;">&#160;</td>
            <td style="width: 30%; vertical-align: top; font-size: 10pt;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top; font-size: 10pt;" rowspan="1">&#160;</td>
            <td style="width: 40%; vertical-align: top; font-size: 10pt; text-align: center;" rowspan="1">&#160;</td>
            <td style="width: 30%; vertical-align: top; font-size: 10pt;" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td style="width: 40%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">DEVVSTREAM CORP.</div>
            </td>
            <td style="width: 30%; vertical-align: top; font-size: 10pt;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top; font-size: 10pt;" rowspan="1">&#160;</td>
            <td style="width: 40%; vertical-align: top; font-size: 10pt; text-align: center;" rowspan="1">&#160;</td>
            <td style="width: 30%; vertical-align: top; font-size: 10pt;" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td style="width: 40%; vertical-align: top; font-size: 10pt; text-align: center;">&#160;</td>
            <td style="width: 30%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: right; font-family: 'Times New Roman'; font-weight: bold;">(the &#8220;Company&#8221;)</div>
            </td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top; font-size: 10pt;" rowspan="1">&#160;</td>
            <td style="width: 40%; vertical-align: top; font-size: 10pt; text-align: center;" rowspan="1">&#160;</td>
            <td style="width: 30%; vertical-align: top; font-size: 10pt;" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: justify; font-family: 'Times New Roman'; font-weight: bold;">AND:</div>
            </td>
            <td style="width: 40%; vertical-align: top; font-size: 10pt; text-align: center;">&#160;</td>
            <td style="width: 30%; vertical-align: top; font-size: 10pt;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top; font-size: 10pt;" rowspan="1">&#160;</td>
            <td style="width: 40%; vertical-align: top; font-size: 10pt; text-align: center;" rowspan="1">&#160;</td>
            <td style="width: 30%; vertical-align: top; font-size: 10pt;" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td style="width: 40%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">BRYAN WENT</div>
            </td>
            <td style="width: 30%; vertical-align: top; font-size: 10pt;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top; font-size: 10pt;" rowspan="1">&#160;</td>
            <td style="width: 40%; vertical-align: top; font-size: 10pt; text-align: center;" rowspan="1">&#160;</td>
            <td style="width: 30%; vertical-align: top; font-size: 10pt;" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td style="width: 40%; vertical-align: top; font-size: 10pt; text-align: center;">&#160;</td>
            <td style="width: 30%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: right; font-family: 'Times New Roman'; font-weight: bold;">(the &#8220;Executive&#8221;)</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">RECITALS</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman';">1.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; &#160; &#160; <font style="font-family: 'Times New Roman';">On September 12, 2023, Focus Impact Acquisition Corp., a
            Delaware corporation (&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">FIAC</font>&#8221;) entered into a Business Combination Agreement (as may be amended, supplemented or otherwise modified from time to time, the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Business Combination Agreement</font>&#8221; and the transactions contemplated thereby, collectively, the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Business
              Combination</font>&#8221;), by and among FIAC, Focus Impact Amalco Sub Ltd., and DevvStream Holdings Inc. (&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Devvstream</font>&#8221;). Pursuant to the Business Combination Agreement, among
            other things, FIAC will acquire DevvStream for consideration of shares in FIAC following its continuance to the Province of Alberta;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman';">2.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">The Company and the Executive are currently party to that
            certain Executive Employment Agreement dated February 21, 2022 (the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Prior Agreement</font>&#8221;);</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman';">3.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <font style="font-family: 'Times New Roman';">The Company and the Executive wish to continue their
            employment relationship for their mutual benefit;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman';">4.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; <font style="font-family: 'Times New Roman';">The Company and the Executive wish to enter into an
            Agreement respecting the terms and conditions of the Executive&#8217;s continued employment, including the agreement of the Executive to be bound by the restrictive covenants set out in Article 8 hereof; and</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman';">5.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">This Agreement is effective upon on the consummation of
            the Business Combination (such date, the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Commencement Date</font>&#8221;) and if the Business Combination is not consummated by November 6, 2024, then this Agreement shall have no
            force or effect and shall be void ab initio;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">NOW THEREFORE, in consideration of the mutual covenants and promises set forth herein and for other good and valuable consideration, the receipt and
        sufficiency of which is hereby acknowledged by the Company and the Executive, the parties hereby covenant and agree as follows:</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">1</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div style="width: 100%;" class="BRPFPageHeader">
          <div style="text-align: right;"><font style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none;">CONFIDENTIAL</font><br>
          </div>
        </div>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">ARTICLE 1 &#8211; </font><font style="font-size: 10pt;">INTERPRETATION</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">Section 1.1 </font><font style="font-size: 10pt;">Definitions.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">In this Agreement:</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(1)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Affiliate</font>&#8221; of a person means any person that directly or indirectly controls, is controlled by, or is under common control with, that person;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(2)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Agreement</font>&#8221; means this agreement, including any schedules hereto, as amended, supplemented, or modified in writing from time to time;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(3)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Business</font>&#8221; means the business of investing in a diversified portfolio of projects and/or companies that generate or are actively involved, directly or indirectly, with voluntary and/or compliance carbon
            credits;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(4)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">&#8220;Cause&#8221; </font>means the Executive has engaged in any of the following: (i) dishonest statements or acts with respect to the Company or any current or prospective customers, suppliers, vendors or other third
            parties with which such entity does business that adversely affects the Company, (ii) indictment, commission of, or plea of guilty or no contest to, (A) a felony or (B) any misdemeanor involving moral turpitude, deceit, dishonesty or fraud,
            (iii) the Executive&#8217;s gross negligence, willful misconduct or insubordination with respect to the Company, (iv) a material breach of any covenant or condition under this Agreement; (v) any act constituting dishonesty, fraud, immoral or
            disreputable conduct; (vi) any conduct which constitutes a felony under applicable law; (vii) a material violation of any Company policy (including the Company&#8217;s anti-discrimination and anti-harassment policies and other policies related to
            discrimination, harassment, performance of illegal or unethical activities, or ethical misconduct) or any act of misconduct; (viii) refusal to follow or implement a clear and reasonable directive of the Company; (ix) gross negligence or
            incompetence in the performance of the Executive&#8217;s duties or failure to perform such duties in a manner satisfactory to the Company; or (x) breach of fiduciary duty to the Company. Except for a failure, breach, or refusal which, by its nature,
            cannot reasonably be expected to be cured (in the discretion of the Board), the Executive shall have ten (10) days from the delivery of written notice from the Company within which to cure any acts constituting Cause, if curable, under prongs
            (vii)-(ix);</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(5)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Confidential Information</font>&#8221; means information disclosed or accessible to the Executive or acquired by the Executive as a result of the Executive&#8217;s employment with the Company and which is not in the public
            domain or otherwise required to be publicly disclosed by applicable law and includes, but is not limited to, information relating to the Company&#8217;s or any of its Affiliates&#8217; current, future or proposed products/services or development of new or
            improved products/services, marketing strategies, sales or business plans, the names and information about the Company&#8217;s past, present and prospective customers and clients, the Company&#8217;s employees (including, without limitation, compensation
            information and performance reviews), employee handbooks and documents related to the Company&#8217;s internal processes and procedures, source code, inventions, discoveries, business methods, trade secrets, compositions, technical data, records,
            reports, presentation materials, interpretations, forecasts, test results, formulae, projects, research data, personnel data, compensation arrangements, budgets, financial statements, office plans, contracts and commercial documents, suppliers,
            manufacturers and any information received by the Company from third parties pursuant to an obligation of confidentiality. Notwithstanding the foregoing, &#8220;Confidential Information&#8221; does not include information that the Executive can prove by
            written evidence is information that is or becomes generally known to the public through lawful means and through no fault of the Executive;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">2</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div style="width: 100%;" class="BRPFPageHeader">
          <div style="text-align: right;"><font style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none;">CONFIDENTIAL</font><br>
          </div>
        </div>
      </div>
      <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(6)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Corporate Transaction</font>&#8221; has the same meaning as such term is defined in the Equity Plan;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(7)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Date of Termination</font>&#8221; means the Executive&#8217;s last active day of employment with the Company;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(8)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Equity Plan</font>&#8221; means the DevvStream Corp 2024 Equity Incentive Plan, as may be amended, restated or modified from time to time.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(9)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; &#160;&#160; <font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Good Reason</font>&#8221; means the occurrence of any of the following events without the Executive&#8217;s consent: (i) a material reduction in the Executive&#8217;s Base Salary,; or (ii) a material reduction in the Executive&#8217;s
            duties, authority, responsibilities, and title relative to the Executive&#8217;s duties, authority, responsibilities, and title in effect immediately prior to such reduction, <font style="font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">provided</font>, <font style="font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">however</font>, that the acquisition of the Company and subsequent conversion of the Company to a division or unit of
            an acquiring company will not by itself result in a diminution of the Executive&#8217;s position. Any such resignation by the Executive shall only be deemed for Good Reason pursuant to this definition if: (1) the Executive gives the Company written
            notice of his intent to resign for Good Reason within thirty (30) days following the first occurrence of the condition(s) that the Executive believes constitute(s) Good Reason, which notice shall describe such condition(s); (2) the Company
            fails to remedy such condition(s) within thirty (30) days following receipt of the written notice (the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Cure Period</font>&#8221;); (3) the Company has not, prior to receiving such
            notice from the Executive, already informed the Executive that his employment with the Company is being terminated; and (4) the Executive voluntarily resigns his employment within thirty (30) days following the end of the Cure Period.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(10)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Territory</font>&#8221; means the United States and Canada; and</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(11)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Total Disability</font>&#8221; means, as determined by a legally qualified medical practitioner selected by the Company in good faith and taking into account any accommodation required by the Company in accordance with
            applicable State and Federal laws, the Executive is unable to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment which can be expected to result in death or which has lasted or can
            be expected to last for a continuous period of twelve (12) months.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">3</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div style="width: 100%;" class="BRPFPageHeader">
          <div style="text-align: right;"><font style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none;">CONFIDENTIAL</font><br>
          </div>
        </div>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">ARTICLE 2 &#8211; </font><font style="font-size: 10pt;">TERM</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The Executive&#8217;s employment is on an at-will basis under this Agreement, which shall commence as of the Commencement Date and the initial term of
        which shall continue until the third (3<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">rd</sup>) anniversary of the Commencement Date (the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Initial Term</font>&#8221;), and thereafter shall automatically renew for additional terms
        of one (1) year (referred to as the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Renewal Terms</font>&#8221;) unless either party delivers to the other party a written notice of nonrenewal at least ninety (90) days before the end of
        the Initial Term or any Renewal Term (a &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Non-Renewal</font>&#8221;). The Initial Term and any Renewal Term maybe be terminated earlier pursuant to Article 6 below. The period of time
        between the Commencement Date and the Date of Termination of the Executive&#8217;s employment hereunder shall be referred to herein as the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Employment Term</u></font>.&#8221;</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">ARTICLE 3 &#8211; </font><font style="font-size: 10pt;">EMPLOYMENT AND
          POSITION</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">Section 3.1 </font><font style="font-size: 10pt;">Position.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Subject to the terms and conditions set out in this Agreement, the Company hereby agrees to employ the Executive, and the Executive hereby agrees to
        serve the Company, in the position of Chief Revenue Officer of the Company.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">Section 3.2 </font><font style="font-size: 10pt;">Place of
          Employment.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The Executive shall provide the Executive&#8217;s duties and services to the Company remotely, but the Executive may be asked to work from the Company&#8217;s
        offices from time to time. The Company reserves the right in its sole discretion to change the Executives&#8217; remote status. If the Company requires the Executive to move to perform the Executive&#8217;s duties and services pursuant to this Agreement, the
        Company shall reimburse the Executive reasonable and documented relocation costs incurred by the Executive, subject to a reasonable cap determined by the Company and preapproval and receipt of appropriate documentation substantiating that such
        costs have in fact been incurred in accordance with the Company&#8217;s expense reimbursement policy.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">Section 3.3 </font><font style="font-size: 10pt;">Travel.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The Executive acknowledges that the duties of the Executive&#8217;s position may require some travel within and outside United States.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">Section 3.4 </font><font style="font-size: 10pt;">Executive&#8217;s
          Covenant.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The Executive represents and warrants to the Company that the Executive is free to be employed by the Company as contemplated herein and that the
        Executive is not subject to any obligation or restriction (statutory, contractual, or at common law) which would prevent or interfere with the performance of all of the Executive&#8217;s obligations hereunder.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">4</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div style="width: 100%;" class="BRPFPageHeader">
          <div style="text-align: right;"><font style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none;">CONFIDENTIAL</font><br>
          </div>
        </div>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">ARTICLE 4 &#8211; </font><font style="font-size: 10pt;">DUTIES</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">Section 4.1 </font><font style="font-size: 10pt;">Full-Time
          Employment.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The Executive&#8217;s position with the Company constitutes full-time employment. Throughout the duration of the Executive&#8217;s employment, the Executive
        shall devote the Executive&#8217;s full working time and attention to the business and affairs of the Company, acting in the best interests of the Company at all times. The Executive shall not accept nor hold any position as an officer, director,
        employee, consultant, or any like position; provided, that Executive may engage in charitable, civic, fraternal and community affairs and educational, professional and/or trade industry association activities; <font style="font-family: 'Times New Roman';"><u>provided</u></font>, further, that, such activities do not (i) violate the terms of this Agreement, (ii) interfere, either individually or in the aggregate, with the performance of Executive&#8217;s duties under this Agreement or (iii)
        create a potential business or fiduciary conflict.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">Section 4.2 </font><font style="font-size: 10pt;">Duties;
          Reporting.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The Executive shall report to and be subject to the direction of the Company&#8217;s Chief Executive Officer (&#8220;CEO&#8221;), or such other person as the Board of
        Directors of the Company (the <font style="font-family: 'Times New Roman'; font-weight: bold;">&#8220;Board&#8221;</font>) or Company may subsequently designate, at any time, in the Board&#8217;s sole discretion. The Executive shall have duties and responsibilities
        consistent with the Executive&#8217;s position as may be assigned to the Executive from time to time. The Executive shall perform all duties in accordance with the instructions of the CEO or such other person as the Company may designate, and all of the
        Company&#8217;s policies and codes of conduct, rules and regulations in effect from time to time, which the Company may amend without advance notice to the Executive. The Executive shall also comply with all applicable laws in the performance of the
        Executive&#8217;s duties.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">ARTICLE 5 &#8211; </font><font style="font-size: 10pt;">COMPENSATION
          AND BENEFITS</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">Section 5.1 </font><font style="font-size: 10pt;">Base Salary.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">During the Employment Term, the Executive&#8217;s base salary will be $180,000 annually (&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Base

          Salary</font>&#8221;), less applicable deductions and withholdings as required by applicable law, paid in accordance with the Company&#8217;s standard payroll practices and prorated in any year where the Executive is not actively employed with the Company
        for the full calendar year. The Executive&#8217;s base salary will be reviewed by the Board (or a designated committee thereof) on an annual basis, based on personal and corporate achievements and the overall financial performance of the Company.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">Section 5.2 </font><font style="font-size: 10pt;">Benefits.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">During the Employment Term, the Executive shall be eligible to participate in the Company&#8217;s employee benefit programs for which similarly situated
        executives are generally eligible that may be in effect from time to time, subject to the terms and conditions of such plan and applicable policies, as may be amended from time to time without advance notice. The Company reserves the right to
        change its benefit plan or carrier in its sole and absolute discretion.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">5</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div style="width: 100%;" class="BRPFPageHeader">
          <div style="text-align: right;"><font style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none;">CONFIDENTIAL</font><br>
          </div>
        </div>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">Section 5.3 </font><font style="font-size: 10pt;">Vacation.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">During the Employment Term, the Executive shall be entitled to accrue 15 days of vacation per calendar year, up to a maximum accrual of 23 days (the
        &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Vacation Cap</font>&#8221;), such vacation to extend for such periods and to be taken at such intervals as shall be appropriate and consistent with the proper performance of the
        Executive&#8217;s duties and as agreed upon between the Executive and the Company. Vacation will accrue up to the Vacation Cap (at which point the Executive shall not accrue, at any time, any additional vacation until the Executive&#8217;s vacation accrual
        falls below the Vacation Cap) and any accrued but unused vacation will be paid out at termination.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">Section 5.4 </font><font style="font-size: 10pt;">Reimbursement
          of Expenses.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">During the Employment Term, the Executive will be eligible for reimbursement of reasonable and necessary business and travel expenses actually
        incurred by the Executive directly in connection with the business affairs of the Company and the performance of the Executive&#8217;s duties hereunder, upon presentation of proper receipts or other proof of expenditure acceptable to the Company, in
        accordance with the Company&#8217;s expense reimbursement policy. The Executive shall comply with such reasonable limitations and reporting requirements with respect to such expenses as the Company may establish from time to time.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">Section 5.5 </font><font style="font-size: 10pt;">No Other
          Benefits.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The Executive is not entitled to any other payment, benefit, perquisite, allowance or entitlement other than as specifically set out in this
        Agreement, or as mandated by applicable laws, or as otherwise approved in writing and signed by the Company and the Executive.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">ARTICLE 6 &#8211; </font><font style="font-size: 10pt;">TERMINATION OF
          EMPLOYMENT</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">Section 6.1 </font><font style="font-size: 10pt;">Termination.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The Company and the Executive acknowledge that the Executive&#8217;s employment relationship with the Company is at-will. Either the Executive or the
        Company may terminate the employment relationship at any time, with or without cause. In addition to a Non-Renewal, as described in Article 2 hereof, the Executive&#8217;s employment may be terminated at any time as follows:</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(1)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">Death</font>. This Agreement and the Executive&#8217;s employment shall automatically terminate upon the death of the Executive.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">6</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div style="width: 100%;" class="BRPFPageHeader">
          <div style="text-align: right;"><font style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none;">CONFIDENTIAL</font><br>
          </div>
        </div>
      </div>
      <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(2)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">Total&#160; Disability</font><font style="font-family: 'Times New Roman';">.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company may terminate this Agreement and the Executive&#8217;s employment at any time as a result of Total Disability in
            accordance with Section 6.4.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(3)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">Cause</font>. The Company may terminate this Agreement and the Executive&#8217;s employment at any time for Cause in accordance with Section 6.3.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(4)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">Without Cause</font>. The Company may terminate this Agreement and the Executive&#8217;s employment at any time without Cause, for any reason or no reason whatsoever, by providing written notice to the Executive
            specifying the effective Date of Termination (which may be immediate). In such event, the Company shall provide, and the Executive shall be entitled to receive the notice, payments, benefits and/or entitlements set out in Section 6.5 below. For
            the avoidance of doubt, a termination of the Executive&#8217;s employment at the conclusion of the Initial Term or a Renewal Term, as applicable, due to the Company&#8217;s Non-Renewal shall be treated as a termination by the Company without Cause so long
            as grounds for Cause do not exist.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(5)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">Resignation Without Good Reason</font>. The Executive may terminate this Agreement and the Executive&#8217;s employment at any time by providing three (3) months&#8217; advance written notice to the Company. The Company
            may elect to waive all or part of such notice period and shall have no obligation to provide any pay-in-lieu of notice. For the avoidance of doubt, a termination of the Executive&#8217;s employment at the conclusion of the Initial Term or Renewal
            Term, as applicable, due to Executive&#8217;s Non-Renewal shall be treated as a termination by Executive without Good Reason.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(6)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;">Resignation for Good Reason</font>. The Executive may terminate this Agreement and the Executive&#8217;s employment for Good Reason, provided the Executive follows the notice procedures in Section 1.1(8) of this
            Agreement. In such event, the Company shall provide, and the Executive shall be entitled to receive the notice, payments, benefits and/or entitlements set out in Section 6.5 below.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">Section 6.2 </font><font style="font-size: 10pt;">Termination
          by Reason of Death or Resignation by the Executive Without Good Reason.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">If this Agreement and the Executive&#8217;s employment is terminated pursuant to Sections 6.1(1) or 6.1(5) above, then the Company shall pay to the
        Executive (or, in the case of the Executive&#8217;s death, to the Executive&#8217;s estate) (i) an amount equal to the base salary and vacation pay up to the Date of Termination within thirty (30) days following the termination date (or such earlier date as
        required by applicable law), and (ii) any other vested employee benefits that the Executive is entitled up to the Date of Termination under any applicable employee benefit plan or arrangement of the Company in which the Executive is a participant
        during the Executive&#8217;s employment with the Company, in accordance with the terms of such plan or arrangement (collectively, the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Accrued Obligations</font>&#8221;), and the Executive shall
        have no entitlement to any further notice of termination, payment in lieu of notice of termination, severance or termination pay, benefits or any damages whatsoever. Participation in all equity or profit participation plans (if any) terminates
        immediately upon the Date of Termination and the Executive shall not be entitled to any bonus or incentive awards, pro rata or otherwise, except as required by applicable law.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">7</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div style="width: 100%;" class="BRPFPageHeader">
          <div style="text-align: right;"><font style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none;">CONFIDENTIAL</font><br>
          </div>
        </div>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">Section 6.3 </font><font style="font-size: 10pt;">Termination
          by the Company for Cause.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">If this Agreement and the Executive&#8217;s employment is terminated for Cause pursuant to Section 6.1(3) above, then the Company shall pay to the
        Executive the Accrued Obligations, and the Executive shall have no entitlement to any further notice of termination, payment in lieu of notice of termination, severance or termination pay, benefits or any damages whatsoever, except as may be
        required by applicable law. Participation in all equity or profit participation plans (if any) terminates immediately upon the Date of Termination and the Executive shall not be entitled to any additional bonus or incentive award, pro rata or
        otherwise, except as required by applicable law.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">Section 6.4 </font><font style="font-size: 10pt;">Termination
          by Reason of Total Disability.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">If this Agreement and the Executive&#8217;s employment is terminated pursuant to Section 6.1(2) above, then the Company shall pay to the Executive the
        Accrued Obligations, and the Executive shall have no entitlement to any further notice of termination, payment in lieu of notice of termination, severance or termination pay, benefits or any damages whatsoever, except as may be required by
        applicable law. Participation in all equity or profit participation plans (if any) terminates immediately upon the Date of Termination and the Executive shall not be entitled to any additional bonus or incentive award, pro rata or otherwise, except
        as required by applicable law.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">Section 6.5 </font><font style="font-size: 10pt;">Termination
          by the Company Without Cause or Resignation by the Executive for Good Reason</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">If this Agreement and the Executive&#8217;s employment is terminated by the Company without Cause or by the Executive for Good Reason pursuant to Sections
        6.1(4) or 6.1(6) above, then the Company shall pay to the Executive the Accrued Obligations. Participation in all equity, equity- based and profit participation plans and arrangements (if any), including the vesting of any award outstanding
        thereunder will terminate immediately upon the applicable Date of Termination and the Executive shall not be entitled to any additional bonus or incentive award, pro rata or otherwise. Further, subject to the terms of Section 6.7 and Executive
        complying with the terms in Section 6.8, the Executive shall be entitled to an amount equal to the Executive&#8217;s then-current Base Salary for twelve (12) months, less all applicable withholdings and deduction (the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Severance Benefits</font>&#8221;), to be paid in equal installments over a period of twelve (12) months following the Date of Termination in accordance with the Company&#8217;s regular payroll practices, with the first
        installment being paid beginning on the Company&#8217;s second regularly scheduled payroll date following the Release Effective Date (as defined in Section 6.7), with the first installment including any amount of the Severance Benefits that would
        otherwise have been due prior to the Release Effective Date; and</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">8</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div style="width: 100%;" class="BRPFPageHeader">
          <div style="text-align: right;"><font style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none;">CONFIDENTIAL</font><br>
          </div>
        </div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The Severance Benefits provided to the Executive pursuant to this Section 6.5 are in lieu of, and not in addition to, any benefits to which the
        Executive may otherwise be entitled under any Company severance plan, policy or program.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">Section 6.6 </font><font style="font-size: 10pt;">Termination
          by the Company Without Cause or Resignation by the Executive for Good Reason following a Corporate Transaction.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">If the Executive&#8217;s employment hereunder is terminated by the Company without Cause (other than on account of the Executive&#8217;s death or Total
        Disability) or the Executive resigns for Good Reason, in each case within twelve (12) months following the consummation of a Corporate Transaction, the Executive shall be eligible to receive (i) the Accrued Obligations and (ii) subject to the
        Executive&#8217;s compliance with Section 6.8, including execution of the Release, the Executive shall be entitled to receive the following benefits (the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Change in Control Benefits</font>&#8221;):</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(1)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">the Severance Benefits, in
            accordance with the terms and conditions described in Section 6.5 above; and</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(2)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">all of the Executive&#8217;s outstanding
            Company equity awards that were granted prior to the Corporate Transaction will vest (collectively, the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Accelerated Equity Awards</font>&#8221;) and, if applicable, become exercisable
            upon the applicable Date of Termination as follows: In the case of any Accelerated Equity Award (or any portion thereof) that, as of immediately prior to the Executive&#8217;s termination of employment, was scheduled to vest based solely on continued
            service with the Company (the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Time Vesting Shares</font>&#8221;), 100% of such Time Vesting Shares will vest. In the case of any Accelerated Equity Award (or any portion thereof) that,
            as of immediately prior to the Executive&#8217;s termination of employment, was subject to performance-based vesting (the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Performance Vesting Shares</font>&#8221;), the number of Performance
            Vesting Shares that will vest will equal the greater of the number of shares determined based on achievement of (i) the &#8220;target&#8221; level of performance and (ii) the Company&#8217;s actual performance, measured as of the Date of Termination, as
            determined by the Committee (as defined in the Equity Plan).</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">Section 6.7 </font><font style="font-size: 10pt;">All
          Inclusive.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The Executive acknowledges and agrees that provision of the entitlements set out in this Article 6 shall constitute full and final satisfaction of
        any claim which the Executive might have arising from or relating to the termination of the Executive&#8217;s employment, whether such claim arises under legislation, contract, common law or otherwise, except for such claim that cannot be released by
        operation of legislation.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">9</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div style="width: 100%;" class="BRPFPageHeader">
          <div style="text-align: right;"><font style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none;">CONFIDENTIAL</font><br>
          </div>
        </div>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
        <div style="font-size: 10pt;">
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">Section 6.8 </font><font style="font-size: 10pt;">Release;
              Forfeiture.</font></div>
        </div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The Executive shall receive the Severance Benefits pursuant to Section 6.5 or the Change in Control Benefits pursuant to Section 6.6 of this
        Agreement if, and only if: (i) by the sixtieth (60th) day following the Date of Termination from the Company, the Executive has signed and delivered to the Company a separation agreement containing a general release of claims in favor of the
        Company and its affiliates and representatives, in the form reasonably presented by the Company (the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Release</font>&#8221;), which cannot be revoked in whole or part by such date (the date
        that the Release can no longer be revoked is referred to as the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Release Effective Date</font>&#8221;); (ii) if the Executive holds any other positions with the Company or any affiliate,
        including a position on the Board, the Executive resigns such position(s) to be effective no later than the Date of Termination (or such other date as requested by the Company); (iii) the Executive returns all Company property; (iv) the Executive
        complies with the Executive&#8217;s post-termination obligations under this Agreement; and (v) the Executive complies with the terms of the Release. If the Executive materially breaches any of the Executive&#8217;s post-termination obligations under this
        Agreement (including under Sections 6.9, Article 7 or Article 8) or the Company discovers, on or prior to the twelve (12)-month anniversary of Executive&#8217;s Date of Termination, that incurable Cause grounds existed as of the Executive&#8217;s Date of
        Termination, the Executive&#8217;s right (if any) to receive the Severance Benefits or the Change in Control Benefits (as applicable) shall immediately cease and be forfeited, such that the Company shall have no further obligation to make any of the
        foregoing payments, all Accelerated Equity Awards (or any shares of common stock received upon vesting or exercise thereunder) shall be immediately forfeited for no reason, and Executive will immediately repay to the Company any Severance Benefits
        or the Change in Control Benefits (as applicable) previously paid to Executive.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">Section 6.9 </font><font style="font-size: 10pt;">Return of
          Property.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">All equipment, keys, pass cards, credit cards, software, material, data, written correspondence, memoranda, communication, reports, or other
        documents or property pertaining to the business of the Company or containing Confidential Information, used or produced by the Executive in connection with the Executive&#8217;s employment, or in the Executive&#8217;s possession or under the Executive&#8217;s
        control, shall at all times remain the exclusive property of the Company. The Executive shall return all property of the Company in the Executive&#8217;s possession or under the Executive&#8217;s control in good condition (wear and tear excepted), and all
        documents or property containing Confidential Information (without retaining any copy, electronic or otherwise), forthwith upon any request by the Company or upon any termination of the Executive&#8217;s employment for any reason.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">10</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div style="width: 100%;" class="BRPFPageHeader">
          <div style="text-align: right;"><font style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none;">CONFIDENTIAL</font><br>
          </div>
        </div>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">ARTICLE 7 &#8211; </font><font style="font-size: 10pt;">ASSIGNMENT
            OF INVENTIONS</font></div>
        <div style="font-size: 10pt;">&#160;</div>
        <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">Section 7.1 </font><font style="font-size: 10pt;">Definitions.</font></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The term (1) &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Intellectual Property Rights</font>&#8221; means all trade secrets,
        Copyrights, trademarks, mask work rights, patents and other intellectual property rights recognized by the laws of any jurisdiction, together with all national, foreign and state registrations, applications for registration and all renewals and
        extensions thereof (including, without limitation, any provisionals, continuations, continuations-in-part, divisionals, reissues, substitutions and reexaminations), all goodwill associated therewith and all benefits, privileges, causes of action
        and remedies relating to any of the foregoing, whether before or hereafter accrued (including, without limitation, the exclusive rights to apply for and maintain all such registrations, renewals and extensions; to sue for all past, present and
        future infringements or other violations of any rights relating thereto; and to settle and retain proceeds from any such actions); (2) &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Copyright</font>&#8221; means the exclusive legal
        right to reproduce, perform, display, distribute, and make derivative works of a work of authorship recognized by the laws of any jurisdiction; (3) &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Inventions</font>&#8221; means all
        ideas, methods, inventions, discoveries, improvements, work products, developments, software, know-how, processes, techniques, works of authorship and other work product, whether or not patentable or registrable under copyright or similar statutes;
        (4) &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Moral Rights</font>&#8221; means any rights to claim authorship of an Invention or to object to or prevent the modification of any Invention, or to withdraw from circulation or control
        the publication or distribution of any Invention, and any similar right existing under judicial or statutory law of any country in the world or under any treaty, regardless of whether or not such right is denominated or generally referred to as a
        &#8220;moral right&#8221;; (5) &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Company Inventions</font>&#8221; means all Inventions (and all Intellectual Property Rights with respect thereto) made, conceived, reduced to practice, fixed in a
        tangible medium, or learned by the Executive, either alone or with others, during the period of the Executive&#8217;s employment by the Company other than Excluded Inventions and Nonassignable Inventions; and (6) &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Excluded Inventions</font>&#8221; means Inventions listed on <font style="font-family: 'Times New Roman'; font-weight: bold;">Exhibit A</font>: (i) that are owned by the Executive or in which the Executive has an interest
        and were made or acquired by the Executive prior to the Executive&#8217;s date of first employment by the Company and (ii) that the Executive considers to be the Executive&#8217;s property or the property of third parties and that the Executive wishes to have
        excluded from the scope of this Agreement.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">Section 7.2 </font><font style="font-size: 10pt;">Excluded
          Inventions.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Inventions, if any, patented or unpatented, which the Executive made prior to the commencement of the Executive&#8217;s employment with the Company are
        excluded from the scope of this Agreement. The Executive has set forth on <font style="font-family: 'Times New Roman'; font-weight: bold;">Exhibit A </font>a complete list describing all Excluded Inventions. If no such list is attached, the
        Executive represents that it is because the Executive has no Excluded Inventions. If disclosure of any such Excluded Invention would cause the Executive to violate any prior confidentiality agreement, the Executive understands that the Executive is
        not to list such Excluded Inventions in <font style="font-family: 'Times New Roman'; font-weight: bold;">Exhibit A </font>but is only to disclose a cursory name for each such Excluded Invention, a listing of the party or parties to which it
        belongs and the fact that full disclosure as to such Excluded Inventions has not been made for that reason. The Executive agrees that if the Executive uses any Excluded Inventions in the scope of the Executive&#8217;s employment, or if the Executive
        includes any Excluded Inventions in any product or service of the Company, or if the Executive&#8217;s rights in any Excluded Inventions may block or interfere with, or may otherwise be required for, the exercise by the Company of any rights assigned to
        the Company under this Agreement, the Executive will immediately notify the Company in writing. The Executive hereby grants to the Company a non-exclusive, perpetual, transferable, fully-paid and royalty-free, irrevocable, worldwide license, with
        rights to sublicense through multiple levels of sublicensees, to reproduce, make derivative works of, distribute, publicly perform, and publicly display in any form or medium, whether now known or later developed, make, have made, use, sell,
        import, offer for sale, and exercise any and all present or future rights in, such Excluded Inventions that the Executive incorporates into a Company product, process or machine during the course of the Executive&#8217;s employment. Notwithstanding the
        foregoing, the Executive agrees that the Executive will not incorporate, or permit to be incorporated, Excluded Inventions in any Company Inventions, except as authorized in writing by the Board. To the extent that any third parties have rights in
        any such Excluded Inventions, the Executive hereby warrants that such third parties have given the Executive the right to grant the license stated above.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">11</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div style="width: 100%;" class="BRPFPageHeader">
          <div style="text-align: right;"><font style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none;">CONFIDENTIAL</font><br>
          </div>
        </div>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">Section 7.3 </font><font style="font-size: 10pt;">Assignment of
          Company Inventions.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Subject to Article 8 and except for Excluded Inventions set forth in <font style="font-family: 'Times New Roman'; font-weight: bold;">Exhibit A</font>,
        the Executive hereby assigns, and agrees to automatically assign in the future (when any such Inventions are first reduced to practice or fixed in a tangible medium, as applicable), to the Company all of the Executive&#8217;s right, title, and interest
        in and to all Company Inventions, including all benefits, privileges, causes of action and remedies relating to such Company Inventions, free and clear of all liens and encumbrances. The Executive further agrees that such assignment includes an
        assignment of Moral Rights. To the extent such Moral Rights cannot be assigned to the Company and to the extent the following is allowed by the laws in any jurisdiction where Moral Rights exist, the Executive waives the enforcement of such Moral
        Rights, and all claims of any kind with respect to Moral Rights against the Company or related to the Company&#8217;s customers. The Executive further agrees that neither the Executive&#8217;s successors-in-interest nor legal heirs retain any Moral Rights in
        any Company Inventions.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">Section 7.4 </font><font style="font-size: 10pt;">Unassigned or
          Nonassignable Inventions.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The Company recognizes that this Agreement does not require the assignment of any Invention that either: (a) the Executive developed entirely on the
        Executive&#8217;s own time without using Company equipment, supplies, facilities, trade secrets, or Confidential Information or third party information, which is not related to the Company&#8217;s actual or anticipated business, research, or development and
        which does not result from or are connected with work performed by the Executive for the Company; or (b) which qualifies fully for protection from assignment to the Company under any specifically applicable state law, regulation, rule or public
        policy (&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Nonassignable Inventions</font>&#8221;). The Executive has received and understands the state specific statutory notices set forth on <font style="font-family: 'Times New Roman'; font-weight: bold;">Exhibit B</font><font style="font-family: 'Times New Roman';">.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">Section 7.5 </font><font style="font-size: 10pt;">Ownership of
          Work Product.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The Executive acknowledges that all original works of authorship made by the Executive (solely or jointly with others) within the scope of the
        Executive&#8217;s employment protectable by copyright are &#8220;works made for hire&#8221; pursuant to the United States Copyright Act. To the extent that any such work of authorship cannot be a &#8220;work made for hire,&#8221; pursuant to United States Copyright Act (17
        U.S.C., Section 101), the Executive hereby irrevocably and unconditionally assigns to the Company all right, title, and interest worldwide in and to such work of authorship. The Executive understands and agrees that the Executive has no right to
        publish on, submit for publishing, or use for any publication any work product protected by this Section, except as necessary to perform services for the Company.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">12</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div style="width: 100%;" class="BRPFPageHeader">
          <div style="text-align: right;"><font style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none;">CONFIDENTIAL</font><br>
          </div>
        </div>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">Section 7.6 </font><font style="font-size: 10pt;">Enforcement
          of Intellectual Property Rights and Assistance.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The Executive will assist the Company in every reasonable way to obtain, and from time to time enforce, Intellectual Property Rights and Moral
        Rights relating to Company Inventions. To that end, the Executive will execute, verify, and deliver such documents and perform such other acts (including appearances as a witness) as the Company may reasonably request for use in applying for,
        obtaining, perfecting, evidencing, sustaining, enforcing, and assigning such Intellectual Property Rights. The Executive&#8217;s obligation to assist the Company with respect to Intellectual Property Rights relating to Company Inventions will continue
        beyond the termination of the Executive&#8217;s employment, but the Company will compensate the Executive at a reasonable rate after the Executive&#8217;s termination for the time actually spent by the Executive at the Company&#8217;s request on such assistance. In
        the event the Company is unable for any reason, after reasonable effort, to secure the Executive&#8217;s signature on any document needed in connection with the actions specified in this Section, the Executive hereby irrevocably designates and appoints
        the Company and its duly authorized officers and agents as the Executive&#8217;s agent and attorney in fact, which appointment is coupled with an interest, to act for and on the Executive&#8217;s behalf to execute, verify, and file any such documents and to do
        all other lawfully permitted acts to further the purposes of this Section with the same legal force and effect as if executed by the Executive. The Executive hereby waives and quitclaims to the Company any and all claims, of any nature whatsoever,
        which the Executive now or may hereafter have for infringement of any Intellectual Property Rights assigned under this Agreement to the Company.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">ARTICLE 8 &#8211; </font><font style="font-size: 10pt;">CONFIDENTIALITY


          &amp; RESTRICTIVE COVENANTS</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">Section 8.1 </font><font style="font-size: 10pt;">Protection of
          Confidential Information.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">While employed by the Company and following the termination of this Agreement and the Executive&#8217;s employment for any reason, the Executive shall
        not, directly or indirectly, in any way use or disclose to any person any Confidential Information except as provided for herein and shall only use or disclose any Confidential Information in the proper performance of the Executive&#8217;s duties. The
        Executive agrees and acknowledges that the Confidential Information of the Company is the exclusive property of the Company to be used exclusively by the Executive to perform the Executive&#8217;s duties and fulfil the Executive&#8217;s obligations to the
        Company and not for any other reason or purpose. Therefore, the Executive agrees to hold all such Confidential Information in trust for the Company, and the Executive further confirms and acknowledges the Executive&#8217;s fiduciary duty to use the
        Executive&#8217;s best efforts to protect the Confidential Information, not to misuse such information, and to protect such Confidential Information from any misuse, misappropriation, harm or interference by others in any manner whatsoever. The Executive
        agrees to protect the Confidential Information regardless of whether the information was disclosed in verbal, written, electronic, digital, visual or other form, and the Executive hereby agrees to give notice promptly to the Company of any
        unauthorized use or disclosure of Confidential Information of which the Executive becomes aware. The Executive further agrees to reasonably assist the Company in remedying any such unauthorized use or disclosure of Confidential Information. In the
        event that the Executive is required to disclose to third parties any Confidential Information or any memoranda, opinions, judgments or recommendations developed from the Confidential Information, by law, valid court order or subpoena, the
        Executive will, prior to disclosing such Confidential Information, provide the Company with prompt written notice of such request(s) or requirement(s) so that the Company may seek appropriate legal protection or waive compliance with the provisions
        of this Agreement. The Executive will not oppose action by, and will reasonably cooperate with, the Company to obtain legal protection or other reliable assurance that confidential treatment will be accorded the Confidential Information.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">13</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div style="width: 100%;" class="BRPFPageHeader">
          <div style="text-align: right;"><font style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none;">CONFIDENTIAL</font><br>
          </div>
        </div>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">Section 8.2 </font><font style="font-size: 10pt;">Protected
          Rights.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Nothing in this Agreement shall limit the Executive&#8217;s right to discuss the Executive&#8217;s employment or report possible violations of law or regulation
        with the Equal Employment Opportunity Commission, United States Department of Labor, the National Labor Relations Board, the Securities and Exchange Commission, or other federal government agency or similar state or local agency or to discuss the
        terms and conditions of the Executive&#8217;s employment to others to the extent expressly permitted by Section 7 of the National Labor Relations Act or to the extent that such disclosure is protected under the applicable provisions of law or regulation,
        including but not limited to &#8220;whistleblower&#8221; statutes or other similar provisions that protect such disclosure. Further, nothing in this Agreement in any way restricts or impedes the Executive from: (i) disclosing the underlying facts and
        circumstances regarding any claims of sexual assault or sexual harassment, or (ii) filing or initiating or assisting others to file or initiate unfair labor practice charges with the National Labor Relations Board.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">Section 8.3 </font><font style="font-size: 10pt;">Notice Under
          the Defend Trade Secrets Act of 2016.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="font-size: 10pt;">In accordance with the Defense of Trade Secrets Act, the Executive will not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that: (i) is made (a) in
        confidence to a federal, state, or local government official, either directly or indirectly, or to an attorney, and (b) solely for the purpose of reporting or investigating a suspected violation of law; or (ii) is made in a complaint or other
        document filed in a lawsuit or other proceeding, if such filing is made under seal. Nothing in this Agreement is intended to conflict with the Defend Trade Secrets Act or create liability for disclosures of trade secrets that are expressly allowed
        by the Defend Trade Secrets Act. If the Executive files a lawsuit for retaliation by the Company for reporting a suspected violation of law, the Executive may disclose the Company&#8217;s trade secrets to the Executive&#8217;s attorney and use the trade secret
        information in the court proceeding if the Executive: (y) files any document containing trade secrets under seal; and (z) does not disclose trade secrets, except pursuant to court order. The Executive may also disclose trade secrets in a document
        filed in a lawsuit or other proceeding, but only if the filing is made under seal and protected from public disclosure. <br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);"> <br>
        </font></div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">14</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        <div style="width: 100%;" class="BRPFPageHeader">
          <div style="text-align: right;"><font style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none;">CONFIDENTIAL</font><br>
          </div>
        </div>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">Section 8.4 </font><font style="font-size: 10pt;">Corporate
          Opportunities.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Any business opportunities related in any way to the business and affairs of the Company or any of its Affiliates which become known to the
        Executive during the Executive&#8217;s employment hereunder shall be fully disclosed and made available to the Company and shall not be appropriated by the Executive under any circumstance without the prior written consent of the Company.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">Section 8.5 </font><font style="font-size: 10pt;">Non-Competition.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The Executive covenants that the Executive will not (without prior written consent of the Company) at any time during the Executive&#8217;s employment
        with the Company nor during the twelve (12) months following the Date of Termination (the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Restricted Period</font>&#8221;), directly or indirectly, anywhere within the Territory, either
        individually or in partnership, jointly or in conjunction with any other person, firm, association, syndicate, company or corporation, whether as agent, shareholder, employee, consultant, or in any manner whatsoever, engage in, carry on or
        otherwise be concerned with, any business that is in competition with that of the Business.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">Section 8.6 </font><font style="font-size: 10pt;">Non-Solicitation.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The Executive covenants that the Executive will not (without prior written consent of the Company) at any time during the Restricted Period,
        directly or indirectly, either individually or in partnership, jointly or in conjunction with any other person, firm, association, syndicate, company or corporation, whether as agent, shareholder, employee, consultant, or in any manner whatsoever:</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(1)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">solicit or entice away, or attempt
            to solicit or entice away from the Company, employ, or otherwise engage (as an employee, independent contractor, or otherwise) any person whom the Executive had contact with or received Confidential Information about during the Executive&#8217;s
            employment with the Company (in connection with such employment), and who is employed by the Company or engaged as a contractor or consultant by the Company as of the date of solicitation or who was so employed or engaged within the twelve (12)
            month period preceding such date; or</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(2)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">for any purpose competitive with
            the Business, canvass, solicit or approach for orders, or cause to be canvassed or solicited or approached for orders, any person or entity whom the Executive had contact with or received Confidential Information about during the Executive&#8217;s
            employment with the Company (in connection with such employment), and who is or which is a customer, client, supplier or licensee of the Company as of the date of solicitation or within the twelve (12) month period preceding such date; or</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(3)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">induce or attempt to induce any
            customer, client, supplier or licensee of the Company whom the Executive had contact with or received Confidential Information about during the Executive&#8217;s employment with the Company (in connection with such employment), to cease doing
            business with the Company; or</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">15</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div style="width: 100%;" class="BRPFPageHeader">
          <div style="text-align: right;"><font style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none;">CONFIDENTIAL</font><br>
          </div>
        </div>
      </div>
      <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(4)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">at any time following the date the
            Executive ceases to be an employee of the Company, disparage or denigrate the Company or its Affiliates or their respective businesses, officers or employees. Nothing contained in this Section 8.6(4) shall in any way restrict the Executive from
            exercising protected rights to the extent that such rights cannot be waived by agreement or from complying with any applicable law or regulation or a valid order of a court of competent jurisdiction or an authorized government agency, including
            discussing or disclosing information about unlawful acts in the workplace, such as harassment or discrimination or any other conduct that the Executive has reason to believe is unlawful, provided that such compliance does not exceed that
            required by the law, regulation, or order.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">Section 8.7 </font><font style="font-size: 10pt;">Passive
          Investments; etc.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Nothing in this Agreement shall:</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(1)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">prohibit or restrict the Executive
            from holding or becoming beneficially interested in up to two percent (2%) of any class of securities in any corporation provided that such class of securities are listed on a recognized stock exchange in Canada or the United States; or</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(2)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">prevent the employment or
            involvement of the Executive in any part of the business of a competitor of the Company that is unrelated to and not competitive with any business of the Company in which the Executive was engaged or learned Confidential Information at any time
            during the period of twelve (12) months preceding the cessation of the Executive&#8217;s employment with the Company.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">Section 8.8 </font><font style="font-size: 10pt;">Other
          Agreements.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">For greater certainty, the covenants contained in this Article 8 shall be in addition to, and complement, and not in replacement of nor shall they
        in any way derogate from any fiduciary duty the Executive owes to the Company or any other restrictive covenants (including any non- competition, confidentiality, non-disparagement or non-solicitation covenants) that the Executive is bound, or may
        become bound, in respect of the Company.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">ARTICLE 9 &#8211; </font><font style="font-size: 10pt;">REMEDIES</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">Section 9.1 </font><font style="font-size: 10pt;">Remedy.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The Executive acknowledges and agrees that the Executive is employed in a fiduciary capacity, with obligations of trust and loyalty owed by the
        Executive to the Company. Accordingly, the Executive agrees that the restrictions in Article 8 are reasonable in the circumstances of the Executive&#8217;s employment and that the business and affairs of the Company cannot be properly protected from the
        adverse consequences of the actions of the Executive other than by the restrictions set forth in this Agreement.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">16</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div style="width: 100%;" class="BRPFPageHeader">
          <div style="text-align: right;"><font style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none;">CONFIDENTIAL</font><br>
          </div>
        </div>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">Section 9.2 </font><font style="font-size: 10pt;">Injunctions,
          etc.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The Executive acknowledges and agrees that, in the event of a breach of the covenants, provisions and restrictions in Article 8 by the Executive,
        the Company&#8217;s remedy in the form of monetary damages will be inadequate. Therefore, the Company is hereby authorized and entitled, in addition to all other rights and remedies available to it at law or in equity, to interim and permanent injunctive
        relief and an accounting of all profits and benefits arising out of such breach without the necessity of posting a bond or other security, and the Executive consents to the entry of such relief.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">Section 9.3 </font><font style="font-size: 10pt;">Loss of
          Entitlements.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">In addition to all other rights and remedies available to the Company, the Executive acknowledges and agrees that the Executive will immediately
        lose and not be entitled to the payments and benefits set out in Section 6.5 or Section 6.6 (if applicable) if the Executive breaches any of the covenants in Article 8.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">Section 9.4 </font><font style="font-size: 10pt;">Survival.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Each and every provision of Article 1, Article 7, Article 8 and Article 9 shall survive the termination of this Agreement and the Executive&#8217;s
        employment for any reason.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">ARTICLE 10 &#8211; </font><font style="font-size: 10pt;">GENERAL
          CONTRACT TERMS</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">Section 10.1 </font><font style="font-size: 10pt;">Currency.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">All amounts payable pursuant to this Agreement are expressed in and shall be paid in United States of America currency unless otherwise indicated.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">Section 10.2 </font><font style="font-size: 10pt;">Withholding.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The Company may withhold from any payments or benefits payable under this Agreement all US Federal, state, city or other taxes as shall be required
        pursuant to any applicable law or governmental regulation or ruling.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">Section 10.3 </font><font style="font-size: 10pt;">Rights and
          Remedies.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">All rights and remedies of the parties are separate and cumulative, and none of them, whether exercised or not, shall be deemed to be to the
        exclusion of any other rights or remedies or shall be deemed to limit or prejudice any other legal or equitable rights or remedies which either of the parties may have.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">17</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div style="width: 100%;" class="BRPFPageHeader">
          <div style="text-align: right;"><font style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none;">CONFIDENTIAL</font><br>
          </div>
        </div>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
        <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">Section 10.4 </font><font style="font-size: 10pt;">Waiver.</font></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Any purported waiver of any default, breach or non-compliance under this Agreement is not effective unless in writing and signed by the party to be
        bound by the waiver. No waiver shall be inferred from or implied by any failure to act or delay in acting by a party in respect of any default, breach or non-observance or by anything done or omitted to be done by the other party. The waiver by a
        party of any default, breach or non-compliance under this Agreement shall not operate as a waiver of that party&#8217;s rights under this Agreement in respect of any continuing or subsequent default, breach or non-observance (whether of the same or any
        other nature).</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">Section 10.5 </font><font style="font-size: 10pt;">Severability.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Whenever possible, each provision of this Agreement will be interpreted in such manner as to be effective and valid under applicable law, but if any
        provision of this Agreement is held to be invalid, illegal or unenforceable in any respect under any applicable law or rule in any jurisdiction, such invalidity, illegality or unenforceability will not affect any other provision or any other
        jurisdiction, but this Agreement will be reformed, construed and enforced in such jurisdiction as if such invalid, illegal or unenforceable provisions had never been contained herein. The Company and the Executive agree that a court of competent
        jurisdiction is expressly authorized to modify any such unenforceable provision of this Agreement in lieu of severing such unenforceable provision from this Agreement in its entirety, whether by rewriting the offending provision, deleting any or
        all of the offending provision, adding additional language to this Agreement, or by making such other modifications as it deems warranted to carry out the intent and agreement of the parties as embodied herein to the maximum extent permitted by
        law. The Company and the Executive further expressly agree that this Agreement as so modified by the court shall be binding upon and enforceable against each of them. In any event, should one or more of the provisions of this Agreement be held to
        be invalid, illegal, or unenforceable in any respect, such invalidity, illegality, or unenforceability shall not affect any other provisions hereof, and if such provision or provisions are not modified as provided above, this Agreement shall be
        construed as if such invalid, illegal, or unenforceable provisions had not been set forth herein.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">Section 10.6 </font><font style="font-size: 10pt;">Section 409A
          Compliance.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The intent of the Company and the Executive is that payments, benefits and rights to which the Executive could be entitled to under this Agreement
        comply with, or be exempt from, Section 409A of the Internal Revenue Code of 1986, as amended (the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Code</font>&#8221;) and the Treasury Regulations and guidance promulgated thereunder
        (collectively &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Code Section 409A</font>&#8221;) (to the extent that the requirements of Code Section 409A are applicable thereto), and, accordingly, to the maximum extent permitted, shall
        be interpreted to be in compliance therewith or exempt therefrom. If any provision of this Agreement contravenes Code Section 409A, or would cause the Executive to incur any additional tax, interest or penalty under Code Section 409A, the Company
        and the Executive agree in good faith to reform this Agreement to comply with Code Section 409A, or to take such other actions as they deem necessary or appropriate to maintain, to the maximum extent practicable, without violating the provisions of
        Code Section 409A, the original intent and economic benefit to Company and the Executive of the applicable provision; provided that Company shall have no obligation to make any changes that could create any additional economic cost or loss of
        benefit to Company. In no event whatsoever shall the Company be liable for any additional tax, interest or penalty that may be imposed on the Executive by Code Section 409A or damages for failing to comply with Code Section 409A. Any provision
        required for compliance with Code Section 409A that is omitted from this Agreement shall be incorporated herein by reference and shall apply retroactively, if necessary, and be deemed a part of this Agreement to the same extent as though expressly
        set forth herein.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">18</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div style="width: 100%;" class="BRPFPageHeader">
          <div style="text-align: right;"><font style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none;">CONFIDENTIAL</font><br>
          </div>
        </div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Notwithstanding anything herein to the contrary, if required to comply with Code Section 409A (but only to the extent so required), a termination of
        employment shall be deemed to have occurred at the time such termination constitutes a &#8220;separation from service&#8221; within the meaning of Code Section 409A for purposes of any provision of this Agreement providing for the payment of any amounts or
        benefits in connection with a termination of employment and, for purposes of any such provision of this Agreement, references to a &#8220;termination,&#8221; &#8220;termination of employment&#8221; or like terms shall mean a &#8220;separation from service.&#8221;</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Notwithstanding anything herein to the contrary, if, on the date of a &#8220;separation from service&#8221; (as defined in Code Section 409A), the Executive is
        a &#8220;specified employee&#8221; (as defined in Code Section 409A), no payments of any amounts hereunder that are subject to Code Section 409A shall be made until the earliest date on which payment is permissible under 409A(a)(2)(B)(i) (the six (6)-month
        delay rule for specified employees).</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">For purposes of Code Section 409A, the Executive&#8217;s right to receive any installment payments pursuant to this Agreement shall be treated as a right
        to receive a series of separate and distinct payments.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">If any payment due under this Agreement is both deferred compensation subject to Code Section 409A and is conditioned upon the execution of a
        release of claims and involves a consideration time period that begins in one calendar year and ends in the next calendar year, will be paid as soon as practicable in the second calendar year even if the Executive signed the general release and
        such general release becomes irrevocable in the first calendar year.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">To the extent that reimbursements or other in-kind benefits under this Agreement constitute nonqualified deferred compensation for purposes of Code
        Section 409A, (1) all such expenses or other reimbursements hereunder shall be made on or prior to the last day of the taxable year following the taxable year in which such expenses were incurred by the Executive, (2) any right to such
        reimbursement or in-kind benefits shall not be subject to liquidation or exchange for another benefit, and (3) no such reimbursement, expenses eligible for reimbursement, or in-kind benefits provided in any taxable year shall in any way affect the
        expenses eligible for reimbursement, or in-kind benefits to be provided, in any other taxable year.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">19</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div style="width: 100%;" class="BRPFPageHeader">
          <div style="text-align: right;"><font style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none;">CONFIDENTIAL</font><br>
          </div>
        </div>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
        <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">Section 10.7 </font><font style="font-size: 10pt;">Parachute
            Payments.</font></div>
        <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt;"> <br>
          </font></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">In the event that the severance and other benefits provided for in this Agreement or otherwise payable or provided to the Executive (i) constitute
        &#8220;parachute payments&#8221; within the meaning of Section 280G of the Code and (ii) but for this Section 10.7, would be subject to the excise tax imposed by Section 4999 of the Code (the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Excise

          Tax</font>&#8221;), then the Executive&#8217;s severance benefits hereunder shall be either (a) delivered in full, or (b) delivered as to such lesser extent which would result in no portion of such severance benefits being subject to the Excise Tax,
        whichever of the foregoing amounts, taking into account the applicable federal, state and local income taxes and the Excise Tax, results in the receipt by executive on an after-tax basis, of the greatest amount of severance benefits,
        notwithstanding that all or some portion of such severance benefits may be taxable under Section 4999 of the Code. Unless the Company and the Executive otherwise agree in writing, any determination required under this Section 10.7 shall be made in
        writing in good faith by the Company&#8217;s independent tax accountants immediately prior to the Corporate Transaction.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">Section 10.8 </font><font style="font-size: 10pt;">Notices.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Any notice required or permitted to be given under this Agreement shall be in writing and shall be properly given if personally delivered, delivered
        by electronic transmission or mailed by prepaid registered mail addressed as follows:</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; margin-right: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">to the Company at:</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; margin-right: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">DevvStream, Corp.</div>
      <div style="text-align: left; margin-right: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">2133-1177 West Hastings Street</div>
      <div style="text-align: left; margin-right: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Vancouver, BC V6E 2K3</div>
      <div style="text-align: left; margin-right: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Attention: Sunny Trinh</div>
      <div style="text-align: left; margin-right: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Email: sunny@devvstream.com</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; margin-right: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">With a copy to:</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; margin-right: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">McMillan LLP</div>
      <div style="text-align: left; margin-right: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">1055 W Georgia Street, Suite #1500</div>
      <div style="text-align: left; margin-right: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Vancouver, BC V6E 4N7</div>
      <div style="text-align: left; margin-right: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Attention: Mark Neighbor</div>
      <div style="text-align: left; margin-right: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Email: Mark.Neighbor@mcmillan.ca</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; margin-right: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">to the Executive at:</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; margin-right: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Bryan Went</div>
      <div style="text-align: left; margin-right: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#9744;</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">or to such other address as the parties may from time to time specify by notice given in accordance herewith. Any notice so given shall be conclusively deemed to have
        been given or made on the day of delivery, if personally delivered, or if delivered by electronic transmission or mailed as aforesaid, upon the date the electronic transmission is sent or on the postal return receipt as the date upon which the
        envelope containing such notice was actually received by the addressee.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">20</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div style="width: 100%;" class="BRPFPageHeader">
          <div style="text-align: right;"><font style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none;">CONFIDENTIAL</font><br>
          </div>
        </div>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">Section 10.9 </font><font style="font-size: 10pt;">Successors
          and Assigns.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">This Agreement shall inure to the benefit of, and be binding on, the parties and their respective heirs, administrators, executors, successors
        (whether direct or indirect, by purchase, amalgamation, arrangement, merger, consolidation or otherwise) and permitted assigns. The Company shall have the right to assign this Agreement, or the benefit thereof, to any of its Affiliates or to any
        successor (whether direct or indirect, by purchase, amalgamation, arrangement, merger, consolidation or otherwise). The Executive, by the Executive&#8217;s signature hereto, expressly consents to such assignment and, provided that such successor agrees
        to assume and be bound by the terms and conditions of this Agreement, all references to the &#8220;Company&#8221; hereunder shall include such successor. The parties agree that the services to be provided by the Executive are personal in nature, and therefore
        the Executive shall not subcontract, assign or transfer, whether absolutely, by way of security or otherwise, all or any part of the Executive&#8217;s rights or obligations under this Agreement.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">Section 10.10 </font><font style="font-size: 10pt;">Amendment.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">No amendment of this Agreement will be effective unless made in writing and signed by both the Executive and an authorized officer of the Company,
        other than the Executive, and approved by the Board.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">Section 10.11 </font><font style="font-size: 10pt;">Entire
          Agreement.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">This Agreement constitutes the entire agreement between the parties pertaining to the subject matter of this Agreement and supersedes all prior
        agreements, understandings, negotiations and discussions, whether oral or written with respect to the Executive&#8217;s employment with the Company (including, without limitation, the Prior Agreement, which shall become null and void and terminate
        automatically upon the Commencement Date). For the avoidance of doubt, following the execution of this Agreement, any existing employment agreements or contracts governing the Executive&#8217;s current employment with the Company (including, but not
        limited to, the Prior Agreement) is null and void and is of no further effect. Each party agrees there are no conditions, warranties, representations or other agreements between the parties in connection with the subject matter of this Agreement
        (whether oral or written, express or implied) except as specifically set out in this Agreement and the Executive agrees that the Executive has not relied on any representation of the Company or its Affiliates to enter into this Agreement.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">21</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div style="width: 100%;" class="BRPFPageHeader">
          <div style="text-align: right;"><font style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none;">CONFIDENTIAL</font><br>
          </div>
        </div>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">Section 10.12 </font><font style="font-size: 10pt;">Governing
          Law.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">This Agreement has been executed and delivered in the State of Delaware and its validity, interpretation, performance, and enforcement shall be
        governed by the laws of the state of Delaware and the federal laws of the United States of America as applicable therein.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">Section 10.13 </font><font style="font-size: 10pt;">Headings.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The division of this Agreement into Sections and the insertion of headings are for convenience or reference only and shall not affect the
        construction or interpretation of this Agreement.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">Section 10.14 </font><font style="font-size: 10pt;">Independent
          Legal Advice.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The parties acknowledge that, prior to executing this Agreement, they have each had the opportunity to obtain independent legal advice and that they
        fully understand the nature of this Agreement and that they are entering into this Agreement voluntarily. Specifically, the Executive represents and warrants to the Company that the Executive (a) has read and understood each and every provision of
        this Agreement, (b) has had the opportunity to obtain advice from legal counsel of Executive&#8217;s choice in order to interpret any and all provisions of this Agreement, and (c) has in fact been individually represented by legal counsel in negotiating
        the terms of this agreement, including the choice of law provision set forth in Section 10.12 hereof. To the extent a court of competent jurisdiction determines that the laws of the State of California govern this Agreement, the restrictions set
        forth in Sections 8.5 and 8.6 shall not apply during the portion of the Restricted Period following the Date of Termination.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">Section 10.15 </font><font style="font-size: 10pt;">Counterparts.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">This Agreement may be executed in any number of counterparts, and delivered by facsimile or other means of electronic transmission, each of which
        shall be deemed to be one and the same instrument and an original document.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">Section 10.16 </font><font style="font-size: 10pt;">Ambiguities.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">As each party and its legal counsel have participated in the review and revision of this Agreement, any rule of construction to the effect that
        ambiguities are to be resolved against the drafting party shall not apply in interpreting this Agreement.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">[Signature Page Follows]</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">22</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div style="width: 100%;" class="BRPFPageHeader">
          <div style="text-align: right;"><font style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none;">CONFIDENTIAL</font><br>
          </div>
        </div>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">The parties have executed this Agreement.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" id="zf3a9d50c40ec4062a66f327938deba39" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="vertical-align: top; font-size: 10pt;" colspan="3">
              <div style="text-align: justify; font-family: 'Times New Roman'; font-weight: bold;">DEVVSTREAM CORP.</div>
            </td>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align: top; font-size: 10pt;" colspan="3">&#160;</td>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">By:</div>
            </td>
            <td style="vertical-align: top; border-bottom: 2px solid black; font-size: 10pt;" colspan="2">
              <div style="text-align: left; font-family: 'Times New Roman';">/s/ Sunny Trinh</div>
            </td>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Name:</div>
            </td>
            <td style="width: 42%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Sunny Trinh</div>
            </td>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Title:</div>
            </td>
            <td style="width: 42%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">CEO</div>
            </td>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td style="width: 42%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align: top; font-size: 10pt;" colspan="3">
              <div style="text-align: justify; font-family: 'Times New Roman'; font-weight: bold;">BRYAN WENT</div>
            </td>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align: top; font-size: 10pt;" colspan="3" rowspan="1">&#160;</td>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">By:</div>
            </td>
            <td style="vertical-align: top; border-bottom: 2px solid black; font-size: 10pt;" colspan="2">
              <div style="text-align: left; font-family: 'Times New Roman';">/s/ Bryan Went</div>
            </td>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
          </tr>

      </table>
      <div> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><u>Exhibit A</u></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Excluded Inventions</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Excluded Inventions</u></font><font style="font-size: 10pt;">: List all such
          materials on this <font style="font-family: 'Times New Roman';"><u>Exhibit A</u></font> and indicate Executive&#8217;s agreement with the following by initialing where indicated: Executive represents and warrants that Executive has listed on this <font style="font-family: 'Times New Roman';"><u>Exhibit A</u></font> all Excluded Inventions.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" id="z5ecdb38548034015b64c01f61d76cd44" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 70%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: right; font-family: 'Times New Roman';">Executive&#8217;s Initial</div>
            </td>
            <td style="width: 30%; vertical-align: top; border-bottom: 2px solid black; font-size: 10pt;">
              <div style="text-align: justify; font-family: 'Times New Roman';">/s/ BW</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>List of Prior Inventions </u></font><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>(write NONE if there are none)</u></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">NONE</div>
      <div style="text-align: justify; font-size: 10pt;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;" id="zf43494e31cb54346936d1d0b10ca0048">

            <tr>
              <td style="width: 100%; border-bottom: 2px solid rgb(0, 0, 0);">
                <div>&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 100%; border-bottom: 2px solid rgb(0, 0, 0);">
                <div>&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 100%; border-bottom: 2px solid rgb(0, 0, 0);">
                <div>&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 100%; border-bottom: 2px solid rgb(0, 0, 0);">
                <div>&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 100%; border-bottom: 2px solid rgb(0, 0, 0);">
                <div>&#160;</div>
              </td>
            </tr>

        </table>
      </div>
      <div style="text-align: justify; font-size: 10pt;"><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><u>Exhibit B</u></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Statutory Notices</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Section 2870 of the California Labor Code is as follows:</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman';">1.</font><font style="font-size: 10pt;"> &#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">Any provision in an employment agreement which provides
            that an employee shall assign, or offer to assign, any of his or her rights in an invention to his or her employer shall not apply to an invention that the employee developed entirely on his or her own time without using the employer&#8217;s
            equipment, supplies, facilities, or trade secret information except for those inventions that either:</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">1.</font><font style="font-size: 10pt;"> &#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">Relate at the time of conception or
            reduction to practice of the invention to the employer&#8217;s business, or actual or demonstrably anticipated research or development of the employer; or</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">2.</font><font style="font-size: 10pt;"> &#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">Result from any work performed by the
            employee for the employer.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman';">2.</font><font style="font-size: 10pt;"> &#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">To the extent a provision in an employment agreement
            purports to require an employee to assign an invention otherwise excluded from being required to be assigned under subdivision (a), the provision is against the public policy of this state and is unenforceable.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="font-size: 10pt;">
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    </div>
  </div>
  <font style="font-size: 10pt;"> </font>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.20
<SEQUENCE>9
<FILENAME>ef20038430_ex10-20.htm
<DESCRIPTION>EXHIBIT 10.20
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 24.9.1.5252
         Copyright 1995 - 2024 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <font style="font-size: 10pt;">
  </font>
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div style="text-align: right;"><font style="font-weight: bold; font-size: 10pt;">Exhibit 10.20</font><font style="font-size: 10pt;"><br>
      </font></div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">STRATEGIC CONSULTING AGREEMENT</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">This Strategic Consulting Agreement (this &#8220;Agreement&#8221;) is made as of November 13, 2024 (the &#8220;Effective Date&#8221;), by and between Focus Impact
        Partners, LLC, a Delaware limited liability company (the &#8220;Consultant&#8221;), and DevvStream Corp., a Vancouver, BC company (together with its direct and indirect subsidiaries, the &#8220;Company&#8221;).</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">WHEREAS, the Consultant, by and through its officers, employees, directors, agents, representatives, and affiliates, has expertise in the
        areas of corporate management, finance, investment, acquisitions, and other matters relating to the business of the Company; and</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">WHEREAS, the Company desires to avail itself, for the term of this Agreement, of the consulting services offered by, and the expertise of,
        the Consultant, in exchange for the fees described herein.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">NOW, THEREFORE, in consideration of the foregoing recitals and the covenants and conditions herein set forth, the parties hereto agree as
        follows:</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z6968fe6817c6469580ae09e10537fd8d" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">ENGAGEMENT</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">The Company hereby retains and engages the Consultant, on a non-exclusive basis, to render or cause to be rendered the consulting services described in <font style="font-family: 'Times New Roman';"><u>Section </u></font><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>2</u></font> (such services giving rise to those fees and expenses as set forth in <font style="font-family: 'Times New Roman';"><u>Section </u></font><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>3</u></font> of this Agreement) from time to time to the Company by and through the
        Consultant or its affiliated or otherwise associated entities, or their respective officers, members, partners, consultants, employees, representatives, agents and advisors (collectively, the &#8220;Consultant Affiliates&#8221;) as the Consultant, in its sole
        discretion, may designate from time to time.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z959ffafcca7a4074bc2e0c7ff4d1010c" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">CONSULTING SERVICES</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">The Consultant hereby agrees to provide the Company with strategic consulting services as requested by the Company in connection with the Company&#8217;s acquisitions, divestitures and investments, capital raising, strategy, financial
            and business affairs, relationships with lenders, equity holders and other third-party associates or affiliates, and the expansion of its business (the &#8220;Consulting Services&#8221;); <font style="font-family: 'Times New Roman';"><u>provided</u></font>,
            that such Consulting Services will not involve Brokerage Services or Investment Advisory Services. The scope of the Consulting Services may be adjusted from time to time by mutual agreement of the parties hereto in writing.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">The Consultant may, in its discretion, and on written notice to the Company, subcontract, delegate or assign all or part of its service obligations hereunder to any Consultant Affiliate or other Person or Persons which, in the
            reasonable view of the Consultant, are competent and qualified to provide such services.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <font style="font-family: 'Times New Roman';">Notwithstanding anything to the contrary contained herein, the Company and the Consultant each acknowledge that the Consultant, in performing the services pursuant to this Agreement, is providing such services solely in a
            third-party consultant capacity to the Company.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <!--PROfilePageNumberReset%Num%2%%%-->
      <table cellspacing="0" cellpadding="0" id="z5c427c7b2f2f4ff09ef17d0e61ed548d" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">3.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">FEES</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">In consideration for the Consulting Services to be provided by the Consultant, the Company agrees to pay or cause to be paid to the Consultant an annual fee
        of $500,000 (the &#8220;Annual Consulting Fee)&#8221;. The Annual Consulting Fee shall accrue and be paid in arrears in quarterly installments of $125,000 and shall be due within 30 days of the end of each calendar quarter, starting with an initial payment on
        the Effective Date for the period beginning December 31, 2023 (pro-rated based on the number of days from December 31, 2023 through and including the Effective Date). Notwithstanding and in addition to the foregoing, the Company agrees to pay or
        cause to be paid to the Consultant an additional consulting fee in connection with any acquisition, merger, consolidation, business combination, sale, divestiture, financing, refinancing, restructuring or other similar transaction for which the
        Consultant provides Consulting Services, the amount and terms of which shall be mutually agreed between the Consultant and the Company consistent with the market practice for such Consulting Services (any such fees collectively referred to herein
        as &#8220;Additional Consulting Fees&#8221;).&#160; Notwithstanding the foregoing, any fees due under this agreement shall accrue and not be payable until (a) the Company has successfully raised $5.0 million in outside debt and/or equity capital, cumulatively since
        the period beginning December 31, 2023 or (b) the company has 2 or more consecutive quarters of positive cash flow from operations.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">In addition, the Company agrees to issue shares to Focus Impact Sponsor, LLC in the amount of 557,290 shares.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zac2b982dc7a74821b7efbfbbbb3ef280" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">4.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">REIMBURSEMENT OF EXPENSES</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">In addition to the <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">fees</font> payable under this Agreement, the Company hereby
        agrees to pay or cause to be paid directly, or to reimburse or cause to be reimbursed to the Consultant or the Consultant Affiliates (at the election and direction of the Consultant or Consultant Affiliates, as applicable), for the Consultant&#8217;s and
        the Consultant Affiliates&#8217; reasonable and documented out-of-pocket expenses incurred by the Consultant or the Consultant Affiliates and their respective personnel in connection with the Consulting Services. All reimbursements for out-of-pocket
        expenses contemplated under this <font style="font-family: 'Times New Roman';"><u>Section </u></font><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>4</u></font> shall be made by wire transfer of
        immediately available funds to an account designated by the Consultant or the Consulting Affiliates, as the case may be, promptly upon, and in any event within thirty (30) days following, receipt of reasonable documentation from the Consultant or
        the Consultant Affiliates in connection therewith.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z96c77d3145784eb9b5c43df0ac13579a" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">5.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">TERM</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">This Agreement shall commence on the Effective Date and shall continue in full force and effect for a term of three (3) years unless earlier terminated as
        provided herein (the &#8220;Term&#8221;); <font style="font-family: 'Times New Roman';"><u>provided</u></font> that this Agreement shall be automatically extended for successive one (1)-year periods at the end of each year unless either the
        Consultant or the Company provides a prior written notice of its desire not to automatically extend the then-current Term to the other party at least 120 days prior to the end of each year during the Term.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">2</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="zc13a8c637fa94884a16dda2fb6691756" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">6.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">TERMINATION</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">The Consultant, on the one hand, or the Company, on the other hand, may terminate this Agreement upon 120 days&#8217; prior written notice to the other party. In
        the event the Company terminates this Agreement without &#8220;Cause,&#8221; the Company shall pay or cause to be paid the Consultant any and all fees that would be due and payable through the expiration of the then-current Term if this Agreement had not been
        so terminated. For the purpose of this <font style="font-family: 'Times New Roman';"><u>Section </u></font><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>6</u></font>, &#8220;Cause&#8221; shall mean (a) the
        Consultant&#8217;s material failure to perform the Consulting Services as and when requested by the Company, provided that the Company has notified the Consultant in writing of such condition within thirty (30) days of the first occurrence of such
        condition, and the Consultant is provided with a period of no less than thirty (30) days following such notice to cure such condition, or (b) the Consultant&#8217;s entry into an agreement for similar services with another producer of sustainable
        aviation fuel. In the event this Agreement is terminated for any other reason, the Company shall pay or cause to be paid the Consultant any and all fees that are due and payable through the date of such termination. The provisions of <font style="font-family: 'Times New Roman';"><u>Sections </u></font><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>7</u></font> through <font style="font-family: 'Times New Roman';"><u>23</u></font>
        (inclusive) shall survive any termination of this Agreement.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zb82882fe02a740b48016d8b92c57c0e0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">7.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">LIMITATION OF LIABILITY; RELEASE</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160; <font style="font-family: 'Times New Roman';">The Consultant makes no representations or warranties, express or implied, in respect of the services to be provided by the Consultant or any Consultant Affiliate hereunder.&#160; In no event shall the Consultant or any Consultant
            Affiliate be liable to the Company for any act, alleged act, omission or alleged omission that does not constitute intentional fraud, gross negligence or willful misconduct of the Consultant as determined by a final, non-appealable
            determination of a court of competent jurisdiction.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160; <font style="font-family: 'Times New Roman';">Neither the Consultant nor any of its Consultant Affiliates shall have any liability to the Company on account of (a) any advice which either the Consultant any Consultant Affiliate renders to the Company, provided such Consultant
            or Consultant Affiliate reasonably believed in good faith that such advice was useful or beneficial to the Company at the time it was rendered,(b) the Consultant&#8217;s inability to obtain financing or achieve other results desired by the Company,
            (c) a failure by either the Consultant or any Consultant Affiliate to render services to the Company at any particular time or from time to time, or (d) the failure of any transaction or financing, including for which fees were paid hereunder,
            to meet the financial, operating, or other expectations of the Company.&#160; In addition, neither the Consultant nor any of its Consultant Affiliates shall have any liability to the Company for any indirect, special, incidental or consequential
            damages, including lost profits or savings, whether or not such damages are foreseeable, or for any third-party claims (whether based in contract, tort or otherwise), relating to, in connection with or arising out of this Agreement, including
            the services to be provided by the Consultant or any of its Consultant Affiliates hereunder, or for any act or omission that does not constitute intentional fraud, gross negligence or willful misconduct as determined by a final, non-appealable
            determination of a court of competent jurisdiction or in excess of the fees actually received by the Consultant hereunder.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">3</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <font style="font-family: 'Times New Roman';">The Company hereby irrevocably and unconditionally releases and forever discharges the Consultant and the Consultant Affiliates and their respective partners (both general and limited), members (both managing and otherwise),
            officers, directors, employees, attorneys, agents and representatives from any and all liabilities, claims and causes of action in connection with the services contemplated by this Agreement or the engagement of the Consultant pursuant to, and
            the performance by the Consultant of the services contemplated by, this Agreement that the Company may have, or may claim to have, on or after the date hereof, except with respect to any act or omission that constitutes intentional fraud, gross
            negligence or willful misconduct as determined by a final, non-appealable determination of a court of competent jurisdiction.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zd2c24123395345e89baeef47828b1216" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">8.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">INDEMNIFICATION</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">The Company hereby agrees to defend, indemnify and hold harmless, to the fullest extent permitted by applicable law, the Consultant, the Consultant
        Affiliates and each of their respective general partners, managing members, owners, members, partners, officers, directors, employees, attorneys, representatives and agents (each such Person being an &#8220;Indemnified Party&#8221;), from and against any and
        all actions, suits, investigations, losses, liabilities, damages, claims or expenses (including the fees and expenses of counsel) including in connection with seeking indemnification, whether joint or several (collectively, the &#8220;Liabilities&#8221;),
        related to, arising out of or in connection with the services contemplated by this Agreement or the engagement of the Consultant pursuant to, and the performance by the Consultant and any Consultant Affiliates of the services contemplated by this
        Agreement, whether or not pending or threatened, whether or not an Indemnified Party is a party, whether or not resulting in any liability and whether or not such action, claim, suit, investigation or proceeding is initiated or brought by the
        Company.&#160; The Company will reimburse any Indemnified Party for all reasonable costs and expenses (including reasonable attorneys&#8217; fees and expenses and any other litigation-related expenses) as they are incurred in connection with investigating,
        preparing, pursuing, defending or assisting in the defense of any action, claim, suit, investigation or proceeding from which the Indemnified Party would be entitled to indemnification under the terms of the previous sentence, or any action or
        proceeding arising therefrom, whether or not such Indemnified Party is a party thereto.&#160; The Company hereby agrees that it will not, without the prior written consent of the Indemnified Party, settle, compromise, or consent to the entry of any
        judgment in any pending or threatened claim, action or proceeding relating to the matters contemplated hereby (if any Indemnified Party is a party thereto or has been threatened to be made a party thereto) unless such settlement, compromise or
        consent includes an unconditional release of the Indemnified Party from all liability, without future obligation or prohibition on the part of the Indemnified Party, arising or that may arise out of such claim, action or proceeding, and does not
        contain an admission of guilt or liability on the part of the Indemnified Party.&#160; The Company will not be liable under the foregoing indemnification provision with respect to any particular loss, claim, damage, liability, cost or expense of an
        Indemnified Party that is determined by a court, in a final judgment from which no further appeal may be taken, to have resulted solely from the gross negligence or willful misconduct of such Indemnified Party. The rights and obligations of an
        Indemnified Party to indemnification hereunder will be in addition to any other rights and remedies any such other Person may have under any other agreement or instrument to which each Indemnified Party is or becomes a party or is or otherwise
        becomes a beneficiary or under any law or regulation.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">4</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="zf78ca31ec2fd4f298324bbb8d17859f8" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">9.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">CONFIDENTIALITY</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">No advice rendered by the Consultant or any Consultant Affiliate, whether formal or informal, may be disclosed, in whole or in part, or summarized, excerpted
        from or otherwise referred to without the Consultant&#8217;s prior written consent.&#160; Unless otherwise required by applicable law or regulatory authority, all information provided hereunder (including the terms of this Agreement) by one party hereto (the
        &#8220;Disclosing Party&#8221;) to another party hereto (the &#8220;Receiving Party&#8221;) shall be confidential and shall not be disclosed to third parties without the prior written approval of the Disclosing Party, except where such information is at the time of the
        disclosure or thereafter becomes available (a) to the general public (other than as a result of its disclosure by the Receiving Party); or (b) to the Receiving Party on a non-confidential basis from a Person not bound by confidentiality
        obligations. The Receiving Party shall be responsible for any breach of the obligation set forth in this <font style="font-family: 'Times New Roman';"><u>Section </u></font><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>9</u></font> by its affiliates, representatives and agents.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zd12bc63bc66b4a669cc066e7f7ce8e1b" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">10.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">INDEPENDENT CONTRACTOR</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">The Consultant, the Consultant Affiliates and their respective personnel shall, for purposes of this Agreement, be independent contractors with respect to
        the Company.&#160; The Consultant is not and, in providing the Consulting Services hereunder, will not hold itself out as an employee, agent or partner of the Company.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z0ddd9add39c54e469f65bf2752bca088" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">11.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">GOVERNING LAW</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">This Agreement shall be governed by, and construed in accordance with, the laws of the State of New York applicable to contracts made and to be performed
        therein, without giving effect to any choice of law or conflict of law rules or provisions (whether of the State of New York or any other jurisdiction) that would cause the application of the laws of any jurisdiction other than the State of New
        York.&#160; Subject to <font style="font-family: 'Times New Roman';"><u>Section </u></font><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>12</u></font>, any Dispute (as defined below) relating hereto shall be
        heard in the state or federal courts of or located in New York, New York, in the borough of Manhattan (a &#8220;Competent Court&#8221;), and the parties agree to jurisdiction and venue therein.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z3fc3685a9df445afa63ffd94d7638d4e" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">12.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">ARBITRATION</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">A</font><font style="font-size: 10pt;">ny dispute, controversy, or claim
          (each a &#8220;Dispute&#8221;)<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">&#160;</font>arising out of, resulting from, relating to, or in connection with this Agreement, including any Dispute regarding the validity or termination
          of this Agreement, or the performance or breach of any of the provisions of this Agreement, shall be resolved exclusively by arbitration, before a single arbitrator, in accordance with the rules and regulations of the American Arbitration
          Association or its legal successor in effect at the time of the arbitration.&#160; The arbitration award in any such arbitration may be confirmed by any Competent Court.&#160; Any such arbitration shall take place in Manhattan, New York.&#160; In the event of
          any such arbitration, the prevailing party shall be awarded its costs and reasonable attorney&#8217;s fees as part of the award, and the costs of the arbitration shall be borne by the parties on such equitable basis as the arbitrators shall determine.&#160;
          Except as may be required by applicable law, statute, rule, regulation, order, or decree, each party agrees to maintain confidentiality with respect to all aspects of this Agreement and any arbitration, including their existence, conduct, and
          results, except that nothing herein shall prevent a party from disclosing information regarding such arbitration for purposes of proceedings to enforce this clause,&#160; to enforce the award granted in such arbitration, or for purposes of seeking
          provisional remedies from a Competent Court.&#160; The parties further agree to obtain the agreement of the arbitral tribunal to preserve the confidentiality of the arbitration.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">5</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="z5ddc3db01fee4a96b454b02384119fa5" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">13.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">WAIVER OF JURY TRIAL</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">EACH PARTY TO THIS AGREEMENT HEREBY WAIVES, TO THE FULLEST EXTENT PERMITTED BY LAW, ANY RIGHT TO TRIAL BY JURY OF ANY CLAIM, DEMAND, ACTION, OR CAUSE OF
        ACTION (A) ARISING OUT OF, RESULTING FROM, RELATING TO, OR IN CONNECTION WITH THIS AGREEMENT OR (B) IN ANY WAY CONNECTED WITH OR RELATED OR INCIDENTAL TO THE DEALINGS OF THE PARTIES HERETO IN RESPECT OF THIS AGREEMENT OR ANY OF THE TRANSACTIONS
        RELATED HERETO, IN EACH CASE, WHETHER NOW EXISTING OR HEREAFTER ARISING, AND WHETHER IN CONTRACT, TORT, EQUITY OR OTHERWISE.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zd70fdf94a51d4b24922b208cdfda1c5d" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">14.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">NOTICES</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Except as otherwise specifically provided herein, notice given hereunder shall be deemed sufficient if delivered personally or sent by registered or
        certified mail to the address of the party for whom such notice is intended at the principal executive offices of such party or at such other address as such party may hereinafter specify by written notice to the other party or by e-mail or similar
        electronic delivery.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zc5a46850636f472d9c6464e6c39cbdbf" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">15.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">ASSIGNMENT</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">No party hereto may assign any obligations hereunder to any other party without the prior written consent of the other parties (which consent shall not be
        unreasonably withheld); <font style="font-family: 'Times New Roman';"><u>provided</u></font> that the Consultant may, without the consent of the Company, assign its rights under this Agreement to any of its Consultant Affiliates.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="ze198330448f6410a9037fcaf00e8c817" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">16.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">SUBSEQUENT SUBSIDIARIES</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">If at any time after the date upon which this Agreement is executed, the Company acquires or creates one or more subsidiary corporations or other entities (a
        &#8220;<font style="font-family: 'Times New Roman';"><u>Subsequent Subsidiary</u></font>&#8221;), the Company shall cause, or in the case of Subsequent Subsidiaries that are not direct or indirect subsidiaries of the Company, shall cause to the
        extent it is able, such Subsequent Subsidiary to be subject to this Agreement and all references herein to the Company shall be interpreted to include all Subsequent Subsidiaries.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zb20caafb46764eab96ea700b20f4e2d0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">17.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">NO WAIVER</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">No failure by any party to insist upon the strict performance of any covenant, duty, agreement, or condition of this Agreement or to exercise any right or
        remedy consequent upon a breach thereof shall constitute a waiver by such party to the performance of any such covenant, duty, agreement, or condition or of any such breach. No waiver by any party of any breach of any provision of this Agreement
        shall be deemed a continuing waiver or a waiver of any preceding or succeeding breach of such provision or of any other provision herein contained.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z09bbb85e19824fce83d39f50600e6e45" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">18.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">ENTIRE AGREEMENT</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">The terms and conditions hereof constitute the entire agreement between the parties hereto with respect to the subject matter of this Agreement and supersede
        all previous communications, either oral or written, representations, or warranties of any and every kind whatsoever, except as expressly set forth herein.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">6</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="zb9e6978af5da42ae845aa20f120f07df" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">19.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">THIRD PARTY BENEFICIARIES</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Except as is otherwise provided herein, the terms and provisions of this Agreement are intended solely for the benefit of each party hereto and their
        respective successors and permitted assigns and not any other Person.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z7d2a12947bf040bca80dcced921fefe5" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">20.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">SEVERABILITY</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">In the event that any provision of this Agreement shall be held to be void or unenforceable in whole or in part, the remaining provisions of this Agreement
        and the remaining portion of any provision held void or unenforceable in part shall continue in full force and effect.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z673b9c2321714be3a70ad9e54ffd536d" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">21.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">CONSTRUCTION</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">The definitions in this Agreement shall apply equally to both the singular and plural forms of the terms defined. Whenever the context may require, any
        pronoun shall include the corresponding masculine, feminine and neuter forms. The words &#8220;include&#8221;, &#8220;includes&#8221; and &#8220;including&#8221; shall be deemed to be followed by the phrase &#8220;without limitation&#8221;. The word &#8220;will&#8221; shall be construed to have the same
        meaning and effect as the word &#8220;shall&#8221;; and the words &#8220;asset&#8221; and &#8220;property&#8221; shall be construed as having the same meaning and effect and to refer to any and all tangible and intangible assets and properties, including cash, securities, accounts
        and contract rights. All references to &#8220;$&#8221; shall mean the lawful currency of the United States.&#160; All references herein to Articles, Sections, Exhibits and Schedules shall be deemed references to Articles and Sections of, and Exhibits and Schedules
        to, this Agreement unless the context shall otherwise require. Except as otherwise expressly provided herein, (a) any reference to this Agreement or other documents herein shall mean such document as amended, restated, supplemented or otherwise
        modified from time to time and (b) all terms of an accounting or financial nature shall be construed in accordance with GAAP, as in effect from time to time.&#160; This Agreement was jointly prepared by the Company and the Consultant.&#160; The language used
        in this Agreement shall be deemed to be the language chosen by the parties hereto to express their mutual intent and no rule of strict construction shall be applied against any party hereto.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z9246df42ce3d4051ae70a5463e6cb80a" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">22.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">COUNTERPARTS</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">This Agreement may be executed in counterparts (and by different parties hereto on different counterparts), each of which shall constitute an original but
        all of which when taken together shall constitute one and the same agreement binding on all the parties hereto.&#160; Delivery of an executed signature page to this Agreement by customary means of electronic transmission (e.g., &#8220;pdf&#8221;) shall be as
        effective as delivery of a manually signed counterpart of this Agreement.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z0901a666b77d426098ae92b38c8b6e67" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">23.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">DEFINITIONS</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">In addition to the terms defined elsewhere in this Agreement, unless the context otherwise requires, the following terms shall have the following meanings
        for purposes of this Agreement:</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">7</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;Brokerage Services&#8221; means buying or selling securities for the Company or its Subsidiaries, including offers, purchases or placements of
        securities.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;Investment Advisory Services&#8221; means investment advice with respect to the value of securities or as to the advisability of investing in,
        purchasing, or selling securities.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;Person&#8221; means an individual, a corporation, limited liability company, association, partnership, joint venture, organization, business,
        trust, or any other entity or organization, including a government or any subdivision or agency thereof.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">[signature pages follow]</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">8</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the Effective Date first above written.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" id="zc8746a4d4bb941b081b533135f526567" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td style="width: 5%; vertical-align: top;" rowspan="1" colspan="2">
              <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 12pt;"><u><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">THE CONSULTANT</font></u><font style="font-size: 10pt;">:</font></div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;" rowspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: top;" rowspan="1" colspan="2">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;" rowspan="1" colspan="2">
              <div style="text-align: justify; font-family: 'Times New Roman'; font-weight: bold;">FOCUS IMPACT PARTNERS, LLC</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;" rowspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;" rowspan="1" colspan="2">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt; padding-bottom: 2px;">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; padding-bottom: 2px;">
              <div style="text-align: left; font-family: 'Times New Roman';">By</div>
            </td>
            <td style="width: 45%; vertical-align: top; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman';">/s/ Wray Thorn</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Name:</div>
            </td>
            <td style="width: 45%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Wray Thorn</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Title:</div>
            </td>
            <td style="width: 45%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Authorized Signatory</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;"><br>
      </div>
      <table cellspacing="0" cellpadding="0" id="zbfb08c555a614f63a07efdcf1d7457d0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td style="width: 5%; vertical-align: top;" rowspan="1" colspan="2">
              <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 12pt;"><u><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">THE COMPANY</font></u><font style="font-size: 10pt;">:</font></div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;" rowspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: top;" rowspan="1" colspan="2">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;" rowspan="1" colspan="2">
              <div style="text-align: justify; font-family: 'Times New Roman'; font-weight: bold;">DEVVSTREAM CORP.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;" rowspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;" rowspan="1" colspan="2">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">By:</div>
            </td>
            <td style="width: 45%; vertical-align: top; border-bottom: 2px solid black; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">/s/ Sunny Trinh</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Name:</div>
            </td>
            <td style="width: 45%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Sunny Trinh</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Title:</div>
            </td>
            <td style="width: 45%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Chief Executive Officer</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">[<font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Signature Page to Strategic Consulting Agreement</font>]</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
    </div>
    <div>
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
  </div>
  <font style="font-size: 10pt;">
  </font>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.21
<SEQUENCE>10
<FILENAME>ef20038430_ex10-21.htm
<DESCRIPTION>EXHIBIT 10.21
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 24.9.1.5252
         Copyright 1995 - 2024 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr align="center" noshade="noshade" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div>
      <div style="text-align: right; font-weight: bold;">Exhibit 10.21</div>
      <div>&#160;</div>
      <div style="text-align: justify; font-weight: bold;">THE SECURITIES REPRESENTED HEREBY, AND EXCEPT AS OTHERWISE EXPRESSLY PROVIDED HEREIN, AND THE SECURITIES ISSUABLE UPON CONVERSION THEREOF HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES
        ACT OF 1933, AS AMENDED (THE &#8220;U.S. SECURITIES ACT&#8221;), OR THE SECURITIES LAWS OF ANY STATE OF THE UNITED STATES.&#160; THE HOLDER HEREOF, BY PURCHASING SUCH SECURITIES, AGREES FOR THE BENEFIT OF THE COMPANY THAT SUCH SECURITIES MAY BE OFFERED, SOLD OR
        OTHERWISE TRANSFERRED ONLY: (A) SUBJECT TO THE COMPANY&#8217;S CONSENT, TO THE COMPANY; (B) OUTSIDE THE UNITED STATES IN ACCORDANCE WITH RULE 904 OF REGULATION S UNDER THE U.S. SECURITIES ACT; (C) IN ACCORDANCE WITH THE EXEMPTION FROM REGISTRATION UNDER
        THE U.S. SECURITIES ACT PROVIDED BY RULE 144 THEREUNDER, IF AVAILABLE, AND IN COMPLIANCE WITH ANY APPLICABLE STATE SECURITIES LAWS; OR (D) IN A TRANSACTION THAT DOES NOT REQUIRE REGISTRATION UNDER THE U.S. SECURITIES ACT AND ANY APPLICABLE STATE
        SECURITIES LAWS; AND, IN THE CASE OF CLAUSE (C) OR (D), THE SELLER FURNISHES TO THE COMPANY AN OPINION OF COUNSEL OF RECOGNIZED STANDING IN FORM AND SUBSTANCE SATISFACTORY TO THE COMPANY TO SUCH EFFECT.</div>
      <div>&#160;</div>
      <div style="text-align: center; font-weight: bold;">DEVVSTREAM CORP.</div>
      <div>&#160;</div>
      <div style="text-align: center; font-weight: bold;">5.30% SECURED CONVERTIBLE NOTE</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zb22d013826774331927fe81d05f802a5">

          <tr>
            <td style="width: 75%; vertical-align: top;">
              <div style="text-align: justify; font-weight: bold;">NOTE CERTIFICATE NO. [&#9679;]</div>
            </td>
            <td style="width: 25%; vertical-align: top;">
              <div style="text-align: justify; font-weight: bold;">Principal Amount: $[&#9679;]</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div style="text-align: justify;"><font style="font-weight: bold;">DEVVSTREAM CORP. </font>(the &#8220;<font style="font-weight: bold;">Company</font>&#8221;), a corporation incorporated under the laws of the Province of Alberta, for value received, hereby
        acknowledges itself indebted and promises to pay to <font style="font-weight: bold;">[&#9679;]</font> of <font style="font-weight: bold;">[&#9679;]</font> or its registered assigns (hereinafter referred to as the &#8220;<font style="font-weight: bold;">holder</font>&#8221;
        or the &#8220;<font style="font-weight: bold;">Noteholder</font>&#8221;) the Principal Amount (as defined herein) in the manner hereinafter provided at such place as the Noteholder may designate by notice in writing to the Company, on such date as the
        Principal Amount may become due and payable hereunder, and to pay interest on the Principal Amount outstanding from time to time owing hereunder to the date of payment as hereinafter provided, both before and after maturity or demand, default and
        judgement.</div>
      <div>&#160;</div>
      <div style="text-align: justify;">Subject to the terms set forth herein, on <font style="color: rgb(0, 0, 0);">the Maturity Date (as defined herein), the outstanding Principal Amount of the Note and any accrued and unpaid interest will become due
          and payable. Alternatively, should the holder exercise its option to convert, then on the Conversion Date (as defined herein), the </font>outstanding Principal Amount of the Note and any accrued and unpaid interest as of the Conversion Date will
        be converted into Shares (as defined herein) at the Conversion Price (as defined herein). This Note is issued subject to the terms and conditions appended hereto as <font style="font-weight: bold;">Schedule &#8220;A&#8221;</font>. Unless otherwise indicated,
        all monetary amounts herein are in United States dollars.</div>
      <div>&#160;</div>
      <div style="text-align: center; font-style: italic;">[Signature Page Follows]</div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;">IN WITNESS WHEREOF</font><font style="font-size: 10pt;">, the Company has caused this Note to be executed by a duly authorized officer.</font></div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="z2826504cb76d4340a6aa7f595ff90962">

          <tr>
            <td rowspan="1" style="width: 50%; vertical-align: top;">
              <div style="text-align: justify; font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;">DATED</font><font style="font-size: 10pt;"> for reference this <font style="font-weight: bold;">[&#9679;]</font></font></div>
            </td>
            <td rowspan="1" colspan="2" style="vertical-align: top;">&#160;</td>
            <td rowspan="1" colspan="1" style="vertical-align: top; width: 5%;">&#160;</td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
            <td rowspan="1" colspan="2" style="vertical-align: top;">&#160;</td>
            <td rowspan="1" colspan="1" style="vertical-align: top; width: 5%;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td colspan="2" style="vertical-align: top;">
              <div style="text-align: justify; font-weight: bold;">DEVVSTREAM CORP.</div>
            </td>
            <td colspan="1" style="vertical-align: top; width: 5%;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;" rowspan="1">&#160;</td>
            <td colspan="2" style="vertical-align: top;" rowspan="1">&#160;</td>
            <td colspan="1" style="vertical-align: top; width: 5%;" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
            <td style="width: 5%; vertical-align: top; padding-bottom: 2px;">
              <div style="text-align: justify;">Per:</div>
            </td>
            <td style="width: 40%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td colspan="1" style="width: 5%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 5%; vertical-align: top;">&#160;</td>
            <td style="width: 40%; vertical-align: top;">
              <div style="text-align: justify;">Authorized Signatory</div>
            </td>
            <td colspan="1" style="width: 5%; vertical-align: top;">&#160;</td>
          </tr>

      </table>
      <div><br>
      </div>
      <div style="text-align: center; font-style: italic;">(See terms and conditions attached hereto)</div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div>
        <div style="text-align: center; font-weight: bold;">SCHEDULE &#8220;A&#8221;</div>
        <div>&#160;</div>
        <div style="text-align: center; font-weight: bold;">TERMS AND CONDITIONS FOR 5.30% SECURED CONVERTIBLE NOTE</div>
        <div>&#160;</div>
        <div style="text-align: center; font-weight: bold;">ARTICLE 1</div>
        <div style="text-align: center; font-weight: bold;">DEFINITIONS AND INTERPRETATION</div>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="z47337e33df354375aed4892185e9af10" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 72pt; vertical-align: top;">1.1</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-weight: bold;">Definitions</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 72pt;">In this Note, unless there is something in the subject matter or context inconsistent therewith, the following words and terms shall have the meanings set out below:</div>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="z9d716a6b072340b7b6b69a056767c7ad" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt; vertical-align: top;">(a)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>&#8220;<font style="font-weight: bold;">Applicable Securities Laws</font>&#8221; means the securities laws, regulations, policies, notices, rulings and orders in the Provinces of British Columbia, Alberta and Ontario, as well as the federal and
                  state securities laws of the United States;</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="ze4d27e552039496a8dfe75f487f7c8da" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt; vertical-align: top;">(b)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>&#8220;<font style="font-weight: bold;">Business Day</font>&#8221; means a day, other than a Saturday, Sunday or a day on which major commercial banks are CLOSED in the Provinces of British Columbia or Alberta or in New York City;</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="z995eec941ad34f50a509ff43e3ae2a96" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt; vertical-align: top;">(c)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>&#8220;<font style="font-weight: bold;">Capital Reorganization</font>&#8221; has the meaning ascribed thereto in Section 5.4(a)(i)</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="z0dbcb907c59d4b81af4c92645d760740" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt; vertical-align: top;">(d)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>&#8220;<font style="font-weight: bold;">Company</font>&#8221; means DevvStream Corp.;</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="z1b7cb253601f45488747f99cf7e1ee70" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt; vertical-align: top;">(e)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>&#8220;<font style="font-weight: bold;">Conversion Date</font>&#8221; has the meaning ascribed thereto in Section 5.2(c);</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="z9b396ca487e048a19aeaf20b950170fa" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt; vertical-align: top;">(f)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>&#8220;<font style="font-weight: bold;">Conversion Price</font>&#8221; means the price that is a 25% discount to the 20-day VWAP of the Shares on the Exchange calculated on the date of the Conversion Date; provided, that, to the extent that the
                  number of Shares issuable on conversion is greater than the number of Shares equal to the Principal Amount and all accrued interest on this Note divided by the De-SPAC Floor Price (the &#8220;<font style="font-weight: bold;">Maximum Shares</font>&#8221;),



                  then the amount of Initial Conversion Shares shall be the Maximum Shares;</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="z6d15606c270543fd90c2565e2420904c" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt; vertical-align: top;">(g)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>"<font style="font-weight: bold;">Current Market Price</font>&#8221; has the meaning ascribed thereto in Section 5.4(b);</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="z9b756a1914db4eefbb83f43cc55f6ea1" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt; vertical-align: top;">(h)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>&#8220;<font style="font-weight: bold;">De-SPAC Floor Price</font>&#8221; means $0.867;</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="z806f205c47bd4d89b54832f78cc11ce1" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt; vertical-align: top;">(i)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>&#8220;<font style="font-weight: bold;">Exchange</font>&#8221; means the Nasdaq Global Market;</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="z9e102067652840c6af6089ce0271de4d" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt; vertical-align: top;">(j)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>&#8220;<font style="font-weight: bold;">Events of Default</font>&#8221; has the meaning ascribed thereto in Section 6.1;</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="z95e18365e2494c53a0236ccf6e9ee7c9" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt; vertical-align: top;">(k)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>&#8220;<font style="font-weight: bold;">Issue Date</font>&#8221; means <font style="font-weight: bold;">[&#9679;]</font>;</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="z34c4ff9b4a71422aa60b18e265252592" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt; vertical-align: top;">(l)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>&#8220;<font style="font-weight: bold;">Maturity Date</font>&#8221; means two years from the Issue Date;</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="z1849b27b6ea743f9a14eecc1c5008686" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt; vertical-align: top;">(m)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>&#8220;<font style="font-weight: bold;">Note</font>&#8221; means this 5.3% secured convertible note;</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="zbcd81e3f961c473da44b44a8351e3cad" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt; vertical-align: top;">(n)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>&#8220;<font style="font-weight: bold;">Official Body</font>&#8221; means any government or political subdivision or any agency, authority, bureau, central bank, monetary authority, commission, department or instrumentality thereof, or any court,
                  tribunal or arbitrator, whether foreign or domestic;</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="z37912fc87d144885b8a0d7519cc063e3" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt; vertical-align: top;">(o)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>&#8220;<font style="font-weight: bold;">Person</font>&#8221; means an individual, partnership, corporation, limited or unlimited liability company, trust, unincorporated association, joint venture or government or any agent, instrument or
                  political subdivision thereof, and any stock exchange;</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="z8ccdf82cebb94270b6cc76918b6e31a9" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt; vertical-align: top;">(p)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>&#8220;<font style="font-weight: bold;">Principal Amount</font>&#8221; means the principal amount outstanding under this Note, as set forth on the face page to this Note;</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <table cellspacing="0" cellpadding="0" id="z753f6c958fc649bdb561b233ece82f59" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt; vertical-align: top;">(q)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>&#8220;<font style="font-weight: bold;">Reclassification of Shares&#8221;</font> has the meaning ascribed thereto in Section 5.4(c);</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="zb8be0b6c051b4487adf1cf540827af08" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt; vertical-align: top;">(r)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>&#8220;<font style="font-weight: bold;">Regulation D</font>&#8221; means Regulation D under the U.S. Securities Act;</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="z6803a43868514737ab522edb3c1fd6ef" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt; vertical-align: top;">(s)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>&#8220;<font style="font-weight: bold;">Regulation S</font>&#8221; means Regulation S under the U.S. Securities Act;</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="z9d1cf2cfa5414c6da4717544640473da" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt; vertical-align: top;">(t)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>&#8220;<font style="font-weight: bold;">Rights Offering</font>&#8221; has the meaning ascribed thereto in Section 5.4(a)(ii);</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="zf184db890a974747b486ec0ffaf7a29f" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt; vertical-align: top;">(u)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>&#8220;<font style="font-weight: bold;">Shares</font>&#8221; means fully-paid and non-assessable common shares in the capital of the Company as constituted on the date hereof and which the Noteholder can elect to receive upon a conversion of this
                  Note as set out in Article 5;</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="zca26ce53a3a04a46aad5017b6b7dca0c" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt; vertical-align: top;">(v)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>&#8220;<font style="font-weight: bold;">Special Distribution</font>&#8221; has the meaning ascribed thereto in Section 5.4(a)(iii);</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="za46ac0dbf3974899af51a8522a04fa29" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt; vertical-align: top;">(w)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>&#8220;<font style="font-weight: bold;">Time of Expiry</font>&#8221; has the meaning ascribed thereto in Section 5.4(a)(i);</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="z7bfd0827d33841108852625d27b3d3de" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt; vertical-align: top;">(x)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>&#8220;<font style="font-weight: bold;">United States</font>&#8221;, or &#8220;<font style="font-weight: bold;">U.S.</font>&#8221; means, as the context requires, the United States of America, its territories and possessions, any state of the United States,
                  and/or the District of Columbia;</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="z14fadfa8f4cf4983936bd2af7b5510c8" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt; vertical-align: top;">(y)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>&#8220;<font style="font-weight: bold;">U.S. Person</font>&#8221; has the meaning ascribed to it in Rule 902(k) of Regulation S (the definition of which includes, but is not limited to, (i) any natural person resident in the United States, (ii)
                  any partnership or corporation organized or incorporated under the laws of the United States, (iii) any partnership or corporation organized outside of the United States by a U.S. Person principally for the purpose of investing in
                  securities not registered under the U.S. Securities Act, unless it is organized, or incorporated, and owned, by U.S. Accredited Investors who are not natural persons, estates or trusts, and (iv) any estate or trust of which any executor
                  or administrator or trustee is a U.S. Person); and</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="z0de3d58be79b45589c404ca3f7d654f7" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt; vertical-align: top;">(z)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>&#8220;<font style="font-weight: bold;">VWAP</font>&#8221; on any date means the volume weighted average trading price of the Shares on the Exchange for the prior number of trading days as indicated herein.</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="zf9295df1ab9c448f870bdacf66f3293d" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 72pt; vertical-align: top;">1.2</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-weight: bold;">Interpretation</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 72pt;">For the purposes of this Note, except as otherwise expressly provided herein:</div>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="z6b9b8d8edf51454593f55a159b50ae8a" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt; vertical-align: top;">(a)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>the words &#8220;<font style="font-weight: bold;">herein</font>&#8221;, &#8220;<font style="font-weight: bold;">hereof</font>&#8221;, and &#8220;<font style="font-weight: bold;">hereunder</font>&#8221; and other words of similar import refer to this Note as a whole and
                  not to any particular Article, clause, subclause or other subdivision or Schedule;</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="zbf6674876bcd4d028b34f50a9cea1a9a" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt; vertical-align: top;">(b)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>a reference to an Article or Section means an Article or Section of this Note, as applicable;</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="z46e4d023b57d4bc782ff2a86177b3a90" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt; vertical-align: top;">(c)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>the headings are for convenience only, do not form a part of this Note and are not intended to interpret, define or limit the scope, extent or intent of this Note or any of its provisions;</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="z2d8d64f6009c4a6290f7f6b6569ca591" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt; vertical-align: top;">(d)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>the word &#8220;including&#8221;, when following a general statement, term or matter, is not to be construed as limiting such general statement, term or matter to the specific items or matters set forth or to similar items or matters (whether or
                  not qualified by non&#8209;limiting language such as &#8220;without limitation&#8221; or &#8220;but not limited to&#8221; or words of similar import) but rather as permitting the general statement or term to refer to all other items or matters that could reasonably
                  fall within its possible scope;</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="z39b53c83eacb40d6b698d8e9be945e8f" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt; vertical-align: top;">(e)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>unless otherwise indicated, all monetary amounts herein are in United States dollars; and</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="z2eb34d2a16b344359f3c66e9fe9935c7" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt; vertical-align: top;">(f)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>words importing the masculine gender include the feminine or neuter, words in the singular include the plural, words importing a corporate entity include individuals, and vice versa.</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="text-align: center; font-weight: bold;">ARTICLE 2</div>
        <div style="text-align: center; font-weight: bold;">NOTE</div>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="z8a3e8d743de949048493193593428466" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 72pt; vertical-align: top;">2.1</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-weight: bold;">Principal Amount and Repayment</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 72pt;">The Company agrees that it is indebted to the Noteholder in the amount of the Principal Amount of the Note, together with accrued interest thereon, in accordance with the terms and conditions of
          this Note. The Company will repay to the Noteholder the Principal Amount, together with interest thereon, on or before the Maturity Date, subject to conversion, as applicable, pursuant to the terms set forth herein.</div>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="z9276353fb1d14c959ee2235d42e45022" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 72pt; vertical-align: top;">2.2</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-weight: bold;">Interest on Note</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt;">The Principal Amount of the Note outstanding from time to time will bear simple, non-cumulative interest from the Issue Date at a rate of 5.30% per annum, calculated at the Maturity Date or the
          Conversion Date, if applicable, on the basis of 365 days per year and payable only (a) in cash at the Maturity Date; (b) in Shares on the Conversion Date in accordance with Article 5, or (c) in connection with an Event of Default in accordance
          with Article 7. If the Company fails to make any payment of Principal Amount or interest required to be made hereunder, on the day on which the same is due and payable, the Company will pay interest on the amount or amounts so required to have
          been paid at the rate of interest as aforesaid calculated and payable from the date of such failure until the date of payment.</div>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="z7b94fbeed6b94ffc9d2c14d597bcf308" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 72pt; vertical-align: top;">2.3</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-weight: bold;">Outstanding Balance</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 72pt;">The actual outstanding balance of the Note from time to time shall be the aggregate outstanding Principal Amount of the Note, together with accrued interest thereon and all other amounts payable
          by the Company to the Noteholder pursuant to this Note.</div>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="zc1b679a778034a0a87235ed9f84583ec" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 72pt; vertical-align: top;">2.4</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-weight: bold;">Security</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 72pt;">This Note constitutes a direct senior obligation of the Company. As continuing security for the due and timely payment by the Company of all amounts owing under this Note, the Company will grant
          the Noteholder a first ranking security interest in all of the carbon credits and similar environmental assets held by the Company, presently existing or hereafter created or acquired, and the Company will, within 14 days of the date of this
          Note, deliver to the Noteholder a security agreement in registerable form evidencing the Noteholder&#8217;s security interest. The Company will not grant any other debt instruments or security interests which rank equal or senior to this Note without
          the written consent of the Noteholder.</div>
        <div>&#160;</div>
        <div style="text-align: center; font-weight: bold;">ARTICLE 3</div>
        <div style="text-align: center; font-weight: bold;">PREPAYMENT</div>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="z16332a44554a4e299952a6b189dc8d68" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 72pt; vertical-align: top;">3.1</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-weight: bold;">Right of Prepayment</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 72pt;">The Issuer has the right and privilege of prepaying the whole or any portion of the Principal Amount of this Note, together with any accrued and unpaid interest thereon, at any time prior to the
          Maturity Date without notice, bonus or penalty. All such prepayments shall be applied first in satisfaction of any accrued but unpaid interest and thereafter to the outstanding Principal Amount.</div>
        <div>&#160;</div>
        <div style="text-align: center; font-weight: bold;">ARTICLE 4</div>
        <div style="text-align: center; font-weight: bold;">&#160;COVENANTS</div>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="z63214aaa303744bba2cb77df4e4d936c" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 72pt; vertical-align: top;">4.1</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-weight: bold;">Covenants of the Company</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 72pt;">The Company covenants and agrees with the Noteholder that for such time as this Note remains outstanding, unless otherwise consented to in writing by the Noteholder:</div>
        <div>&#160;</div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <table cellspacing="0" cellpadding="0" id="zcd70954ee57c4824a22692de84c6b551" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt; vertical-align: top;">(a)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div><font style="font-weight: bold;">Observe Obligations.</font> The Company will duly pay or cause to be paid to the Noteholder the Principal Amount and interest of this Note and any other amounts owed to the Noteholder in the manner set
                  forth herein;</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="zde8a704925ef4a36a5b43b32aba0045e" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt; vertical-align: top;">(b)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div><font style="font-weight: bold;">Reservation of Shares.</font> The Company shall at all times have reserved for issuance out of its authorized capital a sufficient number of Shares to satisfy its obligations to issue and deliver Shares
                  upon the due conversion of the Note;</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="z73db0e8e5fde412f9264422e3b6a162a" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt; vertical-align: top;">(c)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div><font style="font-weight: bold;">Approvals and Filings.</font> The Company shall, in connection with the execution and delivery of this Note and the possible conversion of the Note into Shares, obtain any and all requisite approvals of
                  the shareholders of the Company and statutory and regulatory approvals required to effect and complete the same and shall file all notices, reports and other documents required to be filed by or on behalf of the Company pursuant to
                  Applicable Securities Laws in respect thereof, including the rules and regulations of the Exchange;</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="z5e91d334661445129457f103a7142ce3" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt; vertical-align: top;">(d)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div><font style="font-weight: bold;">Listing.</font> The Company shall at all times while this Note is outstanding, use its commercially reasonable efforts to maintain the listing of the Shares on the Exchange;</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="z4c8a25942d004c1a8be24883317dcc00" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt; vertical-align: top;">(e)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div><font style="font-weight: bold;">Securities Laws.</font> All Shares issued to the Noteholder upon conversion of the Note or any part thereof shall be made pursuant to an exemption from prospectus and registration requirements available
                  to the Noteholder or the Company in respect of the transactions contemplated herein under Applicable Securities Laws; and</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="z8ff0050883144a54ba8b19e7c3a820c9" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt; vertical-align: top;">(f)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div><font style="font-weight: bold;">No Additional Debt.</font> The Company shall not incur any debt, other than indebtedness incurred in the ordinary course of business, without the written consent of the Noteholder, provided that the
                  Noteholder shall not unreasonably withhold consent to further debt by the Company if such additional indebtedness is determined by the board of directors of the Company to be in the best interests of the Company.</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <div style="text-align: center; font-weight: bold;">ARTICLE 5</div>
        <div style="text-align: center; font-weight: bold;">CONVERSION OF PRINCIPAL AMOUNT</div>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="z646e4f71690d4ccb86bbfa5bb723bb55" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 72pt; vertical-align: top;">5.1</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-weight: bold;">Conversion</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 72pt;">The Principal Amount and all accrued interest on this Note will be convertible Shares at the option of the Noteholder at any time prior to repayment by the Company as set out in Section 5.2
          below, at the Conversion Price.</div>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="z18ff2ba8c3ea403581cfd5b65f2f65b5" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 72pt; vertical-align: top;">5.2</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-weight: bold;">Manner of Conversion</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="zf512fa043b1b45568aefb13d710fd1b7" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt; vertical-align: top;">(a)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>The Noteholder may convert this Note, in whole but not in part, into Shares at the Conversion Price by delivering to the Company at the address provided for herein, a notice in writing of the Noteholder&#8217;s election to convert the Note.
                  Thereupon, the Noteholder shall be entitled to be entered in the books of the Company as at the Conversion Date as the holder of the number of Shares into which this Note is convertible in accordance with the provisions of this Note.</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="z336af9b2bb004eca9f6b78c0d5037caf" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt; vertical-align: top;">(b)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>This Note shall be deemed to be surrendered for conversion on the date (the &#8220;<font style="font-weight: bold;">Conversion Date</font>&#8221;) on which notice is delivered pursuant to Section 5.2(b). If this Note is surrendered for conversion
                  on a day on which the register of Shares is closed, the person or persons entitled to receive the Shares shall become the holder or holders of record of such Shares as at the date on which such register is next re-opened.</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="z05710f845a5744089fc64ca420b0f812" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt; vertical-align: top;">(c)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>The Noteholder or, subject to payment of all applicable stamp or security transfer taxes or other governmental charges by such Noteholder, the Noteholder's nominee(s) or assignee(s), shall be entitled to be entered in the books of the
                  Company as of the Conversion Date as the holder of the number of Shares into which the Note is convertible.</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <table cellspacing="0" cellpadding="0" id="z7c0b0aea8f1b4b6b9567966d1972fe2c" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 72pt; vertical-align: top;">5.3</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-weight: bold;">No Requirement to Issue Fractional Securities</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 72pt;">The Company shall not be required to issue fractional Shares upon the conversion of the Note pursuant to this Article 5 and the number of Shares to be issued pursuant to this Article 5 shall be
          rounded down to the nearest whole number without compensation therefor.</div>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="z2a983c6f715d4bfdb15f4a6bc5dfbc9f" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 72pt; vertical-align: top;">5.4</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-weight: bold;">Adjustment of Conversion Price</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="zb0b1ada6e7d8472fafd832aa10f3961e" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt; vertical-align: top;">(a)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>Where applicable, the Conversion Price in effect at any time will be subject to adjustment from time to time as follows:</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="z737215753b0e4c31b306bf687ed732cb" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 36pt; vertical-align: top;">(i)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>If and whenever at any time up to and including the Conversion Date (referred to in this &#167;5.4 as the &#8220;<font style="font-weight: bold;">Time of Expiry</font>&#8221;), the Company will:</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="za3f40af25a3b4bc8a26d0ecbefd2c176" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 72pt;"><br>
              </td>
              <td style="width: 36pt; vertical-align: top;">(A)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>subdivide, redivide or change its Shares into a greater number of shares;</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="ze4cbfa7c0bd74bf4a969b5887ebf0bc8" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 72pt;"><br>
              </td>
              <td style="width: 36pt; vertical-align: top;">(B)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>consolidate, reduce or combine its Shares into a lesser number of shares; or</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="z5301208de9504250b7e939cad616a152" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 72pt;"><br>
              </td>
              <td style="width: 36pt; vertical-align: top;">(C)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>issue Shares to all or substantially all of the holders of its Shares by way of a stock dividend or other distribution on such Shares payable in Shares (other than dividends paid in the ordinary course);</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <div style="text-align: justify; margin-left: 72pt;">(any such event being hereinafter referred to as a &#8220;<font style="font-weight: bold;">Capital Reorganization</font>&#8221;), the Conversion Price will be adjusted by multiplying the Conversion Price in
          effect on the effective date of such event referred to in &#167;5.4(b)(i) or &#167;5.4(b)(ii) or on the record date of such stock dividend referred to in &#167;5.6(a)(iii), as the case may be, by a fraction, the numerator of which will be the number of Shares
          outstanding before giving effect to such Capital Reorganization and the denominator of which will be the number of Shares outstanding after giving effect to such Capital Reorganization.&#160; Such adjustment will be made successively whenever any
          Capital Reorganization will occur and any such issue of Shares by way of a stock dividend or other such distribution will be deemed to have been made on the record date thereof for the purpose of calculating the number of outstanding Shares;</div>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="zef8ff88d102b473490d66e787f414797" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 36pt; vertical-align: top;">(ii)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>If and whenever at any time prior to the Time of Expiry, the Company will fix a record date for the issuance of rights, options or warrants to all or substantially all the holders of Shares entitling them, for a period expiring not
                  more than 45 days after such record date, to subscribe for or purchase Shares at a price per share (or having a conversion or exchange price per share) of less than 95% of the Current Market Price per Share on such record date (any such
                  event being hereinafter referred to as a &#8220;<font style="font-weight: bold;">Rights Offering</font>&#8221;), the Conversion Price will be adjusted immediately after such record date so that it will equal the price determined by multiplying the
                  Conversion Price in effect on such record date by a fraction, of which the numerator will be the total number of Shares outstanding on such record date plus a number equal to the number determined by dividing the aggregate purchase price
                  of the additional Shares offered for subscription or purchase by such Current Market Price per Share, and of which the denominator will be the total number of Shares outstanding on such record date plus the number of the additional Shares
                  offered for subscription or purchase.&#160; Any Shares owned by or held for the account of the Company will be deemed not to be outstanding for the purpose of any such computation.&#160; Such adjustment will be made successively whenever such a
                  record date is fixed.&#160; To the extent that such Rights Offering is not made or any such rights, options or warrants are not exercised prior to the expiration thereof, the Conversion Price will then be readjusted to the Conversion Price
                  which would then be in effect if such record date had not been fixed or if such expired rights, options or warrants had not been issued;</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="z21b459c16a5c4da8a8bf11362fedd89f" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 36pt; vertical-align: top;">(iii)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>If and whenever at any time prior to the Time of Expiry, the Company will fix a record date for the distribution to all or substantially all the holders of its Shares of:</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <table cellspacing="0" cellpadding="0" id="z8f4fcac1bfcd4c7eadfb252f9a2962ed" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 72pt;"><br>
              </td>
              <td style="width: 36pt; vertical-align: top;">(A)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>shares of any class whether of the Company or any other corporation (excluding dividends paid in the ordinary course);</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="z38c80bcb016f49bab26be8a14376fca1" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 72pt;"><br>
              </td>
              <td style="width: 36pt; vertical-align: top;">(B)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>rights, options or warrants;</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="z1fe47c09a7184984bec4b9fcf363ce10" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 72pt;"><br>
              </td>
              <td style="width: 36pt; vertical-align: top;">(C)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>evidences of indebtedness; or</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="z00b1d93b95214934a25e83b12cb8a9c3" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 72pt;"><br>
              </td>
              <td style="width: 36pt; vertical-align: top;">(D)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>other assets or property (excluding dividends paid in the ordinary course);</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <div style="text-align: justify; margin-left: 72pt;">and if such distribution does not constitute a Capital Reorganization or a Rights Offering or does not consist of rights, options or warrants entitling the holders, for a period expiring not more
          than 45 days after such record date, to subscribe for or purchase Shares at a price per share or having a conversion or exchange price per share of at least 95% of the Current Market Price per Share on such record date (any such non-excluded
          event being hereinafter referred to as a &#8220;<font style="font-weight: bold;">Special Distribution</font>&#8221;), the Conversion Price will be adjusted immediately after such record date so that it will equal the price determined by multiplying the
          Conversion Price in effect on such record date by a fraction, of which the numerator will be the total number of Shares outstanding on such record date multiplied by the Current Market Price per Share determined on such record date, less the
          excess of the fair market value (as determined by the board of directors of the Company, which determination will be conclusive) of such Special Distribution over the fair market value (as determined by the board of directors of the Company,
          which determination will be conclusive) of the consideration therefor, if any, received by the Company and of which the denominator will be the total number of Shares outstanding on such record date multiplied by such Current Market Price per
          Share.&#160; Any Shares owned by or held for the account of the Company will be deemed not to be outstanding for the purposes of any such computation.&#160; Such adjustment will be made successively whenever such a record date is fixed.&#160; The extent that
          such Special Distribution is not so made or to the extent any such rights, options or warrants are not exercised prior to the expiration thereof, the Conversion Price will then be readjusted to the Conversion Price which would then be in effect
          if such record date had not been fixed or if such expired rights, options or warrants had not been issued;</div>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="z9c5a08dcd7c9479291771bf36073c53a" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt; vertical-align: top;">(b)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>For the purpose of any computation under &#167;5.4(a)(ii) or &#167;5.4(a)(iii), the &#8220;<font style="font-weight: bold;">Current Market Price</font>&#8221; per Share at any date will be the closing market price per share of such Shares on the day
                  immediately preceding such date on the Exchange;</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="z510826ac7e0a4b3aa8cfad014f0a278e" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt; vertical-align: top;">(c)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>If and whenever at any time prior to the Time of Expiry, there is a reclassification or change of Shares into other shares or there is a consolidation, merger, reorganization or amalgamation of the Company with or into another
                  corporation or entity that results in any reclassification of Shares or a change of Shares into other shares or there is a transfer of the undertaking or assets of the Company as an entirety or substantially as an entirety to another
                  person (any such event being hereinafter referred to as a &#8220;<font style="font-weight: bold;">Reclassification of Shares</font>&#8221;), the Noteholder will be entitled to receive and will accept, upon the exercise of the Noteholder&#8217;s right of
                  conversion at any time after the effective date thereof, in lieu of the number of Shares of the Company to which the Noteholder was theretofore entitled on conversion, the kind and amount of shares or other securities or money or other
                  property that the Noteholder would have been entitled to receive as a result of such Reclassification of Shares, if, on the effective date thereof, the Noteholder had been the registered holder of the number of such Shares to which the
                  Noteholder was theretofore entitled upon conversion, subject to adjustment thereafter in accordance with provisions the same, as nearly as may be possible, as those contained in this &#167;5.4; provided, however, that the De-SPAC Transaction
                  shall not constitute a Reclassification of Shares under this &#167;5.4(c);</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="ze35faa09f1584678ac6d535b9dbf1fac" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt; vertical-align: top;">(d)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>In any case in which this &#167;5.4 will require that an adjustment become effective immediately after a record date or agreement date for an event referred to herein, the Company may defer, until the occurrence of such event, issuing or
                  transferring to the Noteholder who converts on a Conversion Date after such record date or agreement date and before the occurrence of such event the additional Shares issuable upon conversion by reason of the adjustment of the Conversion
                  Price required by such event before giving effect to such adjustment; provided, however, that the Company will deliver to the Noteholder an appropriate instrument evidencing the Noteholder&#8217;s right to receive such additional Shares upon
                  the occurrence of the event requiring such adjustment and the right to receive any distributions made on such additional Shares on and after the Conversion Date or such later date as the Noteholder would, but for the provisions of this
                  &#167;5.4(d), have become the holder of record of such additional Shares pursuant to this &#167;5.4;</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <table cellspacing="0" cellpadding="0" id="z4b97a06b47804787a972cdc6670c609f" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt; vertical-align: top;">(e)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>In case the Company after the date hereof will take any action affecting its Shares, other than any action described in this &#167;5.4, which in the opinion of the Company, acting reasonably, would materially affect the conversion rights of
                  the Noteholder, the Conversion Price will be adjusted in such manner, at such time and by such action by the directors of the Company, as they may determine, acting reasonably, to be equitable to the Noteholder and the Company in the
                  circumstances, but subject in all cases to any necessary regulatory approval;</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="z07e9d4c0fed34f9990d86027b643c4bb" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt; vertical-align: top;">(f)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>The adjustments provided for in this &#167;5.4 are cumulative and will apply to successive subdivisions, redivisions, reductions, combinations, consolidations, distributions, issues or other events resulting in any adjustment under the
                  provisions of this Section, provided that, notwithstanding any other provision of this Section, no adjustment will be made which would result in any increase in the Conversion Price (except upon a consolidation, reduction or combination
                  of outstanding Shares) and no adjustment of the Conversion Price will be required unless such adjustment would require a decrease of at least 1% in the Conversion Price then in effect; provided, however, that any adjustments which by
                  reason of this subsection 5.4(f) are not required to be made will be carried forward and taken into account in any subsequent adjustment;</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="za1dbcfd645634c9aa1fd3f60831a16b4" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt; vertical-align: top;">(g)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>In the event of any dispute arising with respect to the adjustments provided in this &#167;5.4, such question will be conclusively determined by a firm of chartered accountants appointed by the Company (who may be auditors of the Company)
                  and acceptable to the Noteholder.&#160; Such accountants will have access to all necessary records of the Company and such determination will be binding upon the Company and the Noteholder; and</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="z5cb59d328c214459bd3fa0aeac8daa44" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt; vertical-align: top;">(h)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>Notwithstanding any other provision herein contained, no adjustment to the Conversion Price will be made in respect of any event described in this &#167;5.4 (other than the events referred to in paragraphs (i) and (ii) of subsection (a)),
                  if the Noteholder is entitled, without converting the Note, to participate in such event on the same terms mutatis mutandis as if the Noteholder had converted the Note into Shares prior to or on the effective date or record date of such
                  event.</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="z9bb7d7761cd94d20a5037cba95b2fc80" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 72pt; vertical-align: top;">5.5</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-weight: bold;">Resale Restrictions</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 72pt;">The Noteholder acknowledges and agrees that:</div>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="z278ce2e07eae46b0ae2cb5b3c0feccf8" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt; vertical-align: top;">(a)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>All Shares issued to the Noteholder upon conversion of the Note will be subject to resale restrictions imposed under Applicable Securities Laws, and the rules of regulatory bodies having jurisdiction over the Company;</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="z4d46ad69b0dc470cbbfba723b9b89250" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt; vertical-align: top;">(b)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>The Note and the underlying Shares have not been and will not be registered under the U.S. Securities Act or under any U.S. state securities laws, and conversion of the Note will be effected in reliance on an exclusion or an exemption
                  from the registration requirements of the U.S. Securities Act and any applicable U.S. state securities laws;</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="za97e6b2646ce4e4997ab50d233718067" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt; vertical-align: top;">(c)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>If the Note was originally issued in reliance on the exemption from registration provided by Rule 506(b) of Regulation D, the Note is, and any Shares issued upon conversion thereof will be, &#8220;restricted securities&#8221; within the meaning of
                  Rule 144 under the U.S. Securities Act;</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="zc7a76908a9574b1297a8f061d5745a8f" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt; vertical-align: top;">(d)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>Until such time as the same is no longer required under the U.S. Securities Act or applicable U.S. state securities laws, the certificates or other instruments representing any Shares issued as restricted securities upon conversion of
                  the Note pursuant to the exemption from registration provided by Rule 506(b) of Regulation D, and all certificates or other instruments issued in exchange therefor or in substitution thereof, will bear a legend in substantially the
                  following form:</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="text-align: justify; margin-right: 72pt; margin-left: 72pt; font-weight: bold;">&#8220;<font style="color: rgb(0, 0, 0);">THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED
            (THE &#8220;U.S. SECURITIES ACT&#8221;), OR THE SECURITIES LAWS OF ANY STATE OF THE UNITED STATES.&#160; THE HOLDER HEREOF, BY PURCHASING SUCH SECURITIES, AGREES FOR THE BENEFIT OF THE COMPANY THAT SUCH SECURITIES MAY BE OFFERED, SOLD OR OTHERWISE TRANSFERRED
            ONLY: (A) SUBJECT TO THE COMPANY&#8217;S CONSENT, TO THE COMPANY; (B) OUTSIDE THE UNITED STATES IN ACCORDANCE WITH RULE 904 OF REGULATION S UNDER THE U.S. SECURITIES ACT; (C) IN ACCORDANCE WITH THE EXEMPTION FROM REGISTRATION UNDER THE U.S.
            SECURITIES ACT PROVIDED BY RULE 144 THEREUNDER, IF AVAILABLE, AND IN COMPLIANCE WITH ANY APPLICABLE STATE SECURITIES LAWS; OR (D) IN A TRANSACTION THAT DOES NOT REQUIRE REGISTRATION UNDER THE U.S. SECURITIES ACT AND ANY APPLICABLE STATE
            SECURITIES LAWS; AND, IN THE CASE OF CLAUSE (C) OR (D), THE SELLER FURNISHES TO THE COMPANY AN OPINION OF COUNSEL OF RECOGNIZED STANDING IN FORM AND SUBSTANCE SATISFACTORY TO THE COMPANY TO SUCH EFFECT</font>.&#160; <font style="color: rgb(0, 0, 0);">THE PRESENCE OF THIS LEGEND MAY IMPAIR THE ABILITY OF THE HOLDER HEREOF TO EFFECT &#8220;GOOD DELIVERY&#8221; OF THE SECURITIES REPRESENTED HEREBY ON A CANADIAN STOCK EXCHANGE</font>.&#8221;</div>
        <div>&#160;</div>
        <div style="text-align: justify; margin-left: 36pt;">provided, that if the Shares are being sold outside the United States in compliance with the requirements of Rule 904 of Regulation S and the Company qualifies as a &#8220;foreign issuer&#8221; (as defined
          in Rule 902 of Regulation S) at the time of issuance of such Shares, the legend set forth above in this Section 5.5(f) may be removed by providing a declaration to the registrar and transfer agent of the Company, in such form as the Issuer may
          prescribe from time to time; and provided, further, that, if the Shares are being sold otherwise than in accordance with Rule 904 of Regulation S and other than to the Company, the legend may be removed by delivery to the registrar and transfer
          agent and the Company of an opinion of counsel of recognized standing in form and substance reasonably satisfactory to the Company that such legend is no longer required under applicable requirements of the U.S. Securities Act;</div>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="zb5e999d843d24261970bba349d3a6826" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt; vertical-align: top;">(e)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>The Company is not obligated to remain a &#8220;foreign issuer.&#8221;</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <div style="text-align: center; font-weight: bold;">ARTICLE 6</div>
        <div style="text-align: center; font-weight: bold;">EVENTS OF DEFAULT</div>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="z1d256ff1bfee48218342789372ef2bf1" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 72pt; vertical-align: top;">6.1</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-weight: bold;">General</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 72pt;">The occurrence of any one or more of the following events (&#8220;<font style="font-weight: bold;">Events of Default</font>&#8221;) will constitute a default hereunder (whether any such event is voluntary or
          involuntary or is effected by operation of law or pursuant to or in compliance with any judgment, decree or order of any court of any order, rule or regulation of any administrative or governmental body):</div>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="zcaaf351c8d654064ac9e609495491816" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt; vertical-align: top;">(a)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div><font style="font-weight: bold;">Non-Compliance:</font> the Company fails to observe or perform one or more material covenants, agreements, conditions or obligations in favour of the Noteholder, including a failure to pay any or all of
                  the Principal Amount, interest and other monies due under the Note when due, and such failure continues unremedied for a period of 30 days;</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="z48a209047b31474c93a980ff923a8fcb" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt; vertical-align: top;">(b)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div><font style="font-weight: bold;">Ceasing to Carry on Business:</font> the Company ceases or threatens to cease to carry on business or causes any material subsidiary to cease or threaten to cease to carry on business;</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <table cellspacing="0" cellpadding="0" id="z9af67195d8ba4f9cbe4a55c74e44939a" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt; vertical-align: top;">(c)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div><font style="font-weight: bold;">Bankruptcy or Insolvency:</font> the Company or any of its material subsidiaries becomes insolvent or makes a voluntary assignment or proposal in bankruptcy or otherwise acknowledges its insolvency, or
                  a bankruptcy petition is filed or presented against the Company or any of its material subsidiaries, or the Company or any of its material subsidiaries commits or threatens to commit an act of bankruptcy;</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="zafa0a4dd4d85412da2ea878750a300be" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt; vertical-align: top;">(d)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div><font style="font-weight: bold;">Receivership:</font> a receiver or receiver manager of the Company or any of its material subsidiaries is appointed under any statute or pursuant to any document issued by the Company or any of its
                  material subsidiaries;</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="z7b37ce5a58124a13898317844d63145a" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt; vertical-align: top;">(e)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div><font style="font-weight: bold;">Compromise or Arrangement:</font> any proceedings with respect to the Company or any of its material subsidiaries are commenced under the compromise or arrangement provisions of the corporations statute
                  pursuant to which the Company or such subsidiaries are governed, or the Company or any of its material subsidiaries enter into an arrangement or compromise with any or all of their respective creditors pursuant to such provisions or
                  otherwise;</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="z7b6aa72539064864ab1e076d580d6141" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt; vertical-align: top;">(f)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div><font style="font-weight: bold;">Companies' Creditors Arrangement Act:</font> any proceedings with respect to the Company are commenced in any jurisdiction under the <font style="font-style: italic;">Companies' Creditors Arrangement
                    Act</font> (Canada) or any similar legislation; and</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="z3c6eeb4720434b318a1cdbfcd992a61d" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt; vertical-align: top;">(g)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div><font style="font-weight: bold;">Liquidation:</font> an order is made, a resolution is passed, or a petition is filed, for the liquidation, dissolution or winding-up of the Company or any of its material subsidiaries.</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <div style="text-align: center; font-weight: bold;">ARTICLE 7</div>
        <div style="text-align: center; font-weight: bold;">RIGHTS, REMEDIES AND POWERS</div>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="zf23f03c436254ae8ba12369ef3189d95" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 72pt; vertical-align: top;">7.1</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-weight: bold;">Upon Default</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 72pt;">Upon the occurrence of an Event of Default and at any time thereafter, so long as such Event of Default is continuing, the Noteholder may exercise any or all of the rights, remedies and powers of
          the Noteholder under any applicable legislation or otherwise existing, whether under this Note or any other agreement or at law or in equity, and in addition will have the right and power (but will not be obligated) to declare any or all of the
          Note to be immediately due and payable.</div>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="zb84b3cfef4964ecb91ded4db797c042f" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 72pt; vertical-align: top;">7.2</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-weight: bold;">Waiver</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 72pt;">Without limiting Section 8.2 hereof, the Noteholder in its absolute discretion may, at any time and from time to time by written notice, waive any breach by the Company of any of its covenants or
          agreements herein. No failure or delay on the part of the Noteholder to exercise any right, remedy or power given herein or by any other existing or future agreement or now or hereafter existing by statute, at law or in equity will operate as a
          waiver thereof, nor will any single or partial exercise of any such right, remedy or power preclude any other exercise thereof or the exercise of any other such right, remedy or power, nor will any waiver by the Noteholder be deemed to be a
          waiver of any subsequent, similar or other event.</div>
        <div>&#160;</div>
        <div style="text-align: center; font-weight: bold;">ARTICLE 8</div>
        <div style="text-align: center; font-weight: bold;">OTHER AGREEMENTS</div>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="z0b5df9e9d15d49f6bd6fad99c72706c0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 72pt; vertical-align: top;">8.1</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-weight: bold;">Tax Characterization and Withholding Taxes</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 72pt;">Unless otherwise required by applicable law, the Noteholder and the Company agree to treat the Note as debt of the Company for U.S. federal and applicable state income tax purposes. If the
          Company is obliged to withhold any payment hereunder on account of present or future taxes, duties, assessments or other governmental charges required by law, the Company shall make such withholding or deduction and pay the balance owing to the
          Noteholder, such withheld or deducted amounts shall be treated for all purposes has having been paid to the Noteholder to whom such amounts would otherwise have been paid.&#160; For greater certainty, the Company may reduce the number of Shares (based
          on the Conversion Price as set out in Article 5 hereof) issuable to the Noteholder pursuant to Article 5 to satisfy its withholding obligations.</div>
        <div>&#160;</div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <table cellspacing="0" cellpadding="0" id="z27bfb19b52f04a69a5f40c897b50cd0c" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 72pt; vertical-align: top;">8.2</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-weight: bold;">Amendment and Waiver</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 72pt;">Neither this Note nor any provision hereof may be amended, waived, discharged or terminated except by a document in writing executed by the party against whom enforcement of the amendment,
          waiver, discharge or termination is sought.</div>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="zc09c8ba9f46649d6abe29569fa875efa" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 72pt; vertical-align: top;">8.3</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-weight: bold;">Notices and Other Instruments</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 72pt;">Any notice, demand or other communication required or permitted to be given to any party hereunder shall be in writing and shall be:</div>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="z6f2ff6edaf10459f9006a96c34c4bf0c" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt; vertical-align: top;">(a)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>personally delivered to such party; or</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="za111cea492224660bcbc80ec815c3749" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt; vertical-align: top;">(b)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>except during a period of strike, lock-out or other postal disruption, sent by double registered mail, postage prepaid to the address of such party set forth below; or</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="zd2d1d11186ae4f8c8549a34481ec210a" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt; vertical-align: top;">(c)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>sent by facsimile transmission or other means of electronic communication to the address of such party set forth below;</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <div style="text-align: justify;">and shall be deemed to have been received by such party on the earliest of the date of delivery under subsection 8.3(a), the actual date of receipt when mailed under subsection 8.3(b) and the Business Day following
          the date of communication under subsection 8.3(c).</div>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="zb4075c44ba344ef5a1658d535288cecc" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 36pt; vertical-align: top;">(i)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>if to the Company, at:</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <div style="margin-left: 72pt;">DevvStream Corp.</div>
        <div style="margin-left: 72pt; font-size: 10pt; font-family: 'Times New Roman';">
          <div style="text-align: left; color: rgb(74, 74, 74);">2108 N St., Suite 4254</div>
        </div>
        <font style="font-size: 10pt; font-family: 'Times New Roman';"> </font>
        <div style="margin-left: 72pt; font-size: 10pt; font-family: 'Times New Roman';">
          <div style="text-align: left; color: rgb(74, 74, 74);">Sacramento, CA 95816</div>
        </div>
        <font style="font-size: 10pt;"> </font>
        <div style="font-size: 10pt;">&#160;</div>
        <div style="margin-left: 72pt;">Attention:&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;David Goertz, CFO</div>
        <div style="margin-left: 72pt;">E-mail:&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; info@devvstream.com</div>
        <div>&#160;</div>
        <div style="margin-left: 72pt;">With a copy to (which will not constitute notice) to:</div>
        <div>&#160;</div>
        <div style="margin-left: 108pt;">Kirkland &amp; Ellis LLP</div>
        <div style="margin-left: 108pt;">601 Lexington Avenue, New York, NY 10022</div>
        <div style="margin-left: 108pt;">Attention: Peter Seligson</div>
        <div style="margin-left: 108pt;">Email: peter.seligson@kirkland.com</div>
        <div>&#160;</div>
        <div style="margin-left: 108pt;">McMillan LLP</div>
        <div style="margin-left: 108pt;">Royal Centre, 1055 W. Georgia Street, Suite 1500</div>
        <div style="margin-left: 108pt;">PO Box 11117</div>
        <div style="margin-left: 108pt;">Vancouver, BC V6E 4N7</div>
        <div style="margin-left: 108pt;">Attention: Mark Neighbor</div>
        <div style="margin-left: 108pt;">Email: mark.neighbor@mcmillan.ca</div>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="z981a84efab5740b4abf955a69aab059e" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 36pt; vertical-align: top;">(ii)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>if to the Noteholder, at the address set forth on the face page to this Note.</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <div style="text-align: justify;">Any party may give written notice to the other parties of a change of address to some other address, in which event any communication shall thereafter be given to such party as hereinbefore provided, at the last
          such changed address of which the party communication has received written notice.</div>
        <div>&#160;</div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <table cellspacing="0" cellpadding="0" id="z5edca503e6bf485daba949a46f3a669d" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 72pt; vertical-align: top;">8.4</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-weight: bold;">Maximum Rate</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 72pt;">Notwithstanding any other provisions of this Note or any other agreement, the maximum amount (including interest, fees, bonus and any other consideration) payable to the Noteholder in connection
          with the Note and each part thereof shall not exceed the maximum allowable return permitted under the laws of British Columbia and the laws of Canada applicable therein, and the provisions of this Note and all other existing and future agreements
          are hereby modified to the extent necessary to effect the foregoing.</div>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="z22abd59517ff4c2cad32447cb0a8d9da" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 72pt; vertical-align: top;">8.5</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-weight: bold;">Successors and Assigns</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 72pt;">This Note shall be binding upon the Company and its successors and shall enure to the benefit of the Noteholder and its successors. This Note is not assignable without the consent of the Company,
          at its sole discretion.&#160; The Company shall maintain at its office a copy of each and any assignment of this Note delivered to it by the Noteholder and consented to by the Company and a register for the recordation of the name and address of the
          Noteholder&#8217;s successors and permitted assigns and remaining principal amount of, and interest accrued on, this Note (the &#8220;<u>Register</u>&#8221;). The entries in the Register shall be conclusive absent manifest error, and the Company and the Noteholder
          may treat each person whose name is recorded in the Register pursuant to the terms hereof as a Noteholder for all purposes of this Note, notwithstanding notice to the contrary. The Register shall be available for inspection by the Company and the
          Noteholder, at any reasonable time and from time to time upon reasonable notice. This Note is intended to be in registered form under Section 5f.103-1(c) of the U.S. Treasury Regulations, and the parties hereto shall report consistently therewith
          for all tax purposes. The Noteholder shall deliver to the Company a properly completed and duly executed IRS Form W-9 or applicable Form W-8, along with such other documentation that is reasonably requested by the Company that is reasonably
          necessary for the Company to determine whether any payment under this Note is subject to deduction or withholding for taxes under applicable law.</div>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="zca936dcf62604bc69fa9a8a3dfb1c0d1" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 72pt; vertical-align: top;">8.6</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-weight: bold;">Headings, etc.</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 72pt;">The division of this Note into sections and subsections and the insertion of headings are for convenience of reference only and shall not affect the construction or interpretation hereof.</div>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="z5c3596fc5c5b4d22a033dc36bb62d13c" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 72pt; vertical-align: top;">8.7</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-weight: bold;">Severability</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 72pt;">The provisions of this Note are intended to be severable. If any provision of this Note shall be deemed by any court of competent jurisdiction or held to be invalid or void or unenforceable in
          whole or in part in any jurisdiction, such provision shall, as to such jurisdiction, be ineffective to the extent of such invalidity or unenforceability without in any manner affecting the validity or enforceability thereof in any other
          jurisdiction or the remaining provisions hereof in any jurisdiction.</div>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="z54b9f659236146e1a14b2845701b26c0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 72pt; vertical-align: top;">8.8</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-weight: bold;">Noteholder's Rights and Remedies</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 72pt;">In addition to the foregoing without limitation: (i) the Noteholder's rights and remedies hereunder shall be cumulative and not exclusive of any rights or remedies which it would otherwise have;
          (ii) no delay or omission by the Noteholder in exercising or enforcing any of the Noteholder's rights and remedies hereunder shall operate as, or constitute, a waiver thereof; (iii) no waiver by the Noteholder of any Event of Default shall
          operate as a waiver of any other default hereunder; (iv) no single or partial exercise of any of the Noteholder's rights or remedies hereunder, and no express or implied agreement or transaction of whatever nature entered into between the
          Noteholder and any Person, at any time, shall preclude the other or further exercise of the Noteholder's rights and remedies hereunder; (v) no waiver by the Noteholder of any of the Noteholder's rights and remedies hereunder on any one occasion
          shall be deemed a waiver on any subsequent occasion, nor shall it be deemed a continuing waiver; and (vi) the Noteholder's rights and remedies hereunder may be exercised at such time or times and in such order of preference as the Noteholder may
          determine.</div>
        <div>&#160;</div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <table cellspacing="0" cellpadding="0" id="z3db66badc6284d6e80e73703f095a0cd" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 72pt; vertical-align: top;">8.9</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-weight: bold;">Modification</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 72pt;">From time to time the Company may modify the terms and conditions hereof for any purpose not inconsistent with the terms hereof, including the correction or rectification of any ambiguities,
          defective provisions, errors or omissions herein.</div>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="zcf32fb465c794881b6a940b186f7fc22" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 72pt; vertical-align: top;">8.10</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-weight: bold;">Governing Law</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 72pt;">This Note shall be governed by and construed in accordance with the laws of the Province of British Columbia and of Canada applicable therein and shall be treated in all respects as a British
          Columbia contract.</div>
        <div>&#160;</div>
      </div>
      <br>
      <hr align="center" noshade="noshade" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-14.1
<SEQUENCE>11
<FILENAME>ef20038430_ex14-1.htm
<DESCRIPTION>EXHIBIT 14.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 24.9.1.5252
         Copyright 1995 - 2024 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <font style="font-size: 10pt;">
  </font>
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div>
      <div style="font-size: 10pt; font-weight: bold; text-align: right;"><font style="font-size: 10pt;">Exhibit 14.1</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; margin-left: 42pt; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Message from the CEO</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; margin-right: 61.85pt; margin-left: 42pt; font-family: 'Times New Roman'; font-size: 10pt;">To all DevvStream employees:</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; margin-right: 61.85pt; margin-left: 42pt; font-family: 'Times New Roman'; font-size: 10pt;">Climate Change poses one of the greatest risks to survival of the human species. It is imperative that we act
        quickly to remove greenhouse gas emissions from our atmosphere. In meeting this moment, our commitment to behave ethically and fairly will provide the basis for dealing with our various constituents: our colleagues, our customers, our investors,
        our communities, and our world.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; margin-right: 61.85pt; margin-left: 42pt; font-family: 'Times New Roman'; font-size: 10pt;">The Code of Business Conduct (the &#8220;Code&#8221;), which has been approved by our Board of Directors, is the foundation of
        our compliance program and reflects our core values. It complements and is supplemented by our policies and procedures, which together with the Code, should guide your conduct in all settings.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; margin-right: 61.85pt; margin-left: 42pt; font-family: 'Times New Roman'; font-size: 10pt;">The distinguishing factor for any company is its people. At DevvStream, we live daily through our shared values and
        our commitment to the highest standards of ethical conduct. We foster an environment that motivates our employees to love where they work and what they do every day.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; margin-right: 61.85pt; margin-left: 42pt; font-family: 'Times New Roman'; font-size: 10pt;">Compliance with the law is a basic starting point and we will not tolerate violations. The Code is designed to help
        you navigate the primary laws that may apply to our business and provide some general guidance. Our leadership team is always available to assist you in understanding your legal obligations. But mere compliance with the law is not enough. We also
        insist on high standards of corporate ethics and integrity. The Code will also provide you with guidance in this area.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; margin-right: 61.85pt; margin-left: 42pt; font-family: 'Times New Roman'; font-size: 10pt;">We understand that these issues can be complex. The Code is just one part of our compliance program. It is designed
        to supplement, not be a substitute for, other policy statements, employee handbooks, and compliance documents which may be published from time to time by DevvStream.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; margin-right: 61.85pt; margin-left: 42pt; font-family: 'Times New Roman'; font-size: 10pt;">If you are every unsure of how to handle a situation, reach out to your manager or the Chief Operating Officer. Our
        Code has the full support of DevvStream&#8217;s leadership team and must be adhered to by all employees, officers, and directors worldwide.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; margin-right: 61.85pt; margin-left: 42pt; font-family: 'Times New Roman'; font-size: 10pt;">Thank you for always acting with integrity and helping us uphold our values and our reputation.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; margin-right: 61.85pt; margin-left: 42pt; font-family: 'Times New Roman'; font-size: 10pt;">Sunny Trinh</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; margin-right: 61.85pt; margin-left: 42pt; font-family: 'Times New Roman'; font-size: 10pt;">Chief Executive Officer</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div style="width: 100%;" class="BRPFPageHeader">
          <div style="text-align: right;"><img src="image04.jpg"><br>
          </div>
        </div>
      </div>
      <!--PROfilePageNumberReset%Num%2%%%-->
      <div style="text-align: left; color: rgb(118, 146, 60); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">INTRODUCTION</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">DevvStream is committed to achieving the highest standards of professionalism and ethical conduct in its operations and activities and expects its employees
        to conduct their business according to the highest ethical standards of conduct and to comply with all applicable laws. All employees are expected to review and comply with DevvStream&#8217;s Code of Conduct.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">At DevvStream, we conduct business ethically, honestly, with integrity, and in full compliance with all laws that apply to us wherever we do business.&#160; This
        Code of Business Conduct and Ethics sets forth the key ethical principles and rules that should govern our behavior.&#160; This Code is not intended to cover every law that applies to DevvStream, or to address every ethical issue that might arise in the
        course of your work for DevvStream.&#160; It is not a replacement for good judgment.&#160; This Code provides guidance and directs you to the right resources.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">If you are ever unsure whether an act is ethical, ask yourself the following questions:</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="za64cf77dc1b64b1bb65d1b438126bcbb" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 37.55pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: rgb(118, 146, 60); font-family: 'Times New Roman'; font-size: 10pt;">&#9726;</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">Is the action legal?</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z5f8f2bf41b4f49debfbc3df53a3cefe6" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 37.55pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: rgb(118, 146, 60); font-family: 'Times New Roman'; font-size: 10pt;">&#9726;</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">Does the action comply with the Code and all applicable DevvStream policies and procedures?</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zbfad0871ad4e4f1f8266f35690954157" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 37.55pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: rgb(118, 146, 60); font-family: 'Times New Roman'; font-size: 10pt;">&#9726;</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">Would the action withstand public scrutiny if disclosed?</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z1f0caf14da314e4f8b3ef6038d014fd0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 37.55pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: rgb(118, 146, 60); font-family: 'Times New Roman'; font-size: 10pt;">&#9726;</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">Will the action reinforce DevvStream&#8217;s reputation as an ethical company?</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">If you cannot answer these questions with an unqualified <font style="font-family: 'Times New Roman'; font-style: italic;">yes</font>, you should
        seek guidance by discussing the situation with your manager or with our Chief Operating Officer before proceeding with the action.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; color: rgb(118, 146, 60); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">This Code Applies to All of Us</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">This Code governs how all full-time and part-time employees, Executive Officers, and members of the Board of Directors of DevvStream or any DevvStream
        majority-owned subsidiaries and joint ventures (collectively &#8220;Employees&#8221;) should conduct business. More specific rules and day-to-day procedures are outlined in DevvStream&#8217;s policies and procedures, which can be found on the Company's internal
        SharePoint site under <u><font style="font-family: 'Times New Roman';">Operations/Company Policies</font></u>.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">DevvStream also expects its suppliers, contractors, consultants, and other business partners to follow these principles when providing goods and services to
        DevvStream or acting on our behalf.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; color: rgb(118, 146, 60); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Additional Responsibilities for Managers</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">All Employees who have supervisory authority over others have special responsibilities under the Code of Business Conduct and Ethics to lead by example, to
        escalate issues, and to maintain an ethical work environment at DevvStream. They must ensure that the Employees they supervise understand and follow the Code, and that they complete all required compliance training. Managers must encourage
        Employees to ask questions, make suggestions, and report wrongdoing. And managers have a responsibility to appropriately escalate any allegations of wrongdoing or violations of the Code, DevvStream policies, or the law that are brought to their
        attention to their manger, or the Chief Operating Officer.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="width: 100%;" class="BRPFPageFooter"></div>
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">2</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div style="width: 100%;" class="BRPFPageHeader">
          <div style="text-align: right;"><img src="image04.jpg"><br>
          </div>
        </div>
      </div>
      <div style="text-align: left; color: rgb(118, 146, 60); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Reporting Concerns and Violations</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">At DevvStream we have an open-door policy for reporting any and all concerns or potential issues.&#160; There are many ways that you may raise issues or concerns,
        including to your manager or any member of the Leadership Team or by sending an email to ethics@devvstream.com.&#160; You may raise issues or concerns anonymously.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">If you are or become aware of any actual or potential violation of this Code, DevvStream&#8217;s policies, or the law, it is your responsibility to report the
        violation immediately.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">DevvStream will not tolerate retaliation against any Employee who makes a good faith report about a violation or possible violation of
        applicable law, the Code, or any other DevvStream policy.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; color: rgb(118, 146, 60); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">We Live Our Values and Are Good Citizens of Our Communities</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">DevvStream operates in an ethical manner, and expects Employees to conduct themselves in a way that promotes accountability, integrity, and trust &#8211; for each
        other, as well as for our business partners, regulators, and customers.&#160; Below are some of DevvStream&#8217;s guiding principles that we expect everyone to follow as we interact with people both inside and outside of the Company.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; margin-left: 42pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic; color: rgb(118, 146, 60);">We Act
          with Integrity.</font><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(118, 146, 60);">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(192, 0, 0);">&#160;</font><font style="font-size: 10pt;">Employees should always be mindful that their actions, whether intentional or inadvertent, could impact DevvStream&#8217;s reputation.&#160; Even more importantly, DevvStream and its Employees have an obligation to each other, our
          customers, and third parties to act ethically.&#160; Employees are responsible for being honest and truthful when interacting with others.&#160; Even when challenging situations arise, we expect employees to rise to the occasion and make ethical decisions.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; margin-left: 42pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic; color: rgb(118, 146, 60);">We Do Not
          Tolerate Discrimination or Harassment</font><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(118, 146, 60);">.</font><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(192, 0, 0);">&#160;
        </font><font style="font-size: 10pt;">We are committed to providing equal opportunity in all aspects of employment.&#160; Providing people with equal opportunities to develop their full potential encourages higher quality and more productive work,
          reduces employee turnover, and increases employee morale and engagement. We make all employment-related decisions and actions without regard to personal characteristics such as race, sex, religion, national origin, sexual orientation, disability,
          or any other characteristic protected under applicable law and we will not tolerate discrimination in our selection, training and promotion processes.&#160; We will not tolerate harassment -- whether by words, actions or behavior -- or unlawful
          behaviors of any kind, including, for example, derogatory comments based on race or ethnicity, offensive jokes, or display of materials that offend a particular characteristic protected by applicable law, or unwelcome touching or sexual
          advances.&#160; <font style="font-family: 'Times New Roman'; font-weight: bold;">For additional information, see DevvStream&#8217;s Equal Employment Opportunity Policy and Anti-Harassment Policy on the Company's internal SharePoint site under
            Operations/Company Policies.</font></font></div>
      <div style="text-align: justify; margin-left: 42pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt;"><font style="font-family: 'Times New Roman'; font-weight: bold;"> <br>
          </font></font></div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="width: 100%;" class="BRPFPageFooter"></div>
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">3</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div style="width: 100%;" class="BRPFPageHeader">
          <div style="text-align: right;"><img src="image04.jpg"><br>
          </div>
        </div>
      </div>
      <div style="text-align: justify; margin-left: 42pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic; color: rgb(118, 146, 60);">We Create
          a Workplace that is Safe and Secure. </font><font style="font-size: 10pt;">Nothing is more important than the safety and health of our employees and contractors, our customers, and the communities in which we operate. At DevvStream, it is every
          Employee&#8217;s responsibility to create a safe and healthy environment. Employees are required to perform their work in accordance with applicable safety standards and practices. We do not tolerate violence in the workplace, which may include
          physical harm, direct or implied threats to physically harm others, or violent outbursts. Employees are entitled to a safe, secure, clean, and healthy working environment that complies with all relevant laws, rules, regulations, and policies, as
          well as DevvStream&#8217;s own standards and guidelines.&#160; All business activities must be conducted with all necessary permits, approvals, and controls. DevvStream Employees are responsible for understanding and complying with DevvStream&#8217;s Equal
          Employment Opportunity Policy and Anti-Harassment Policy. You must report any unsafe conditions or behavior immediately to our Chief Operating Officer .</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; margin-left: 42pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic; color: rgb(118, 146, 60);">We Respect
          Human Rights. </font><font style="font-size: 10pt;">At DevvStream, we conduct our business in a manner that respects human rights.&#160; We support fundamental human rights for all people.&#160; We do not use slave, child, forced, bonded, indentured, or
          involuntary prison labor.&#160; We do not engage in human trafficking or exploitation, or import goods tainted by slavery or human trafficking. We will not do business with any third party engaging in the use of forced or involuntary labor, human
          trafficking, or child labor. We prohibit physical punishment or abuse. We respect the right of employees to associate or not to associate with any group, as permitted by and in accordance with applicable laws and regulations. DevvStream, and any
          supplier, vendor, intermediary, or service provider working with DevvStream, must comply with all labor laws in the jurisdictions where it operates.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; margin-left: 42pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic; color: rgb(118, 146, 60);">We Are
          Good Stewards of the Environment:</font><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic; color: rgb(192, 0, 0);">&#160;</font><font style="font-size: 10pt;">We are committed to
          environmental stewardship and protecting environmental resources for future generations. We recognize that Climate Change poses one of the greatest risks to survival of the human species and that we are obligated to act.&#160; To that end, you must
          follow all environmental rules and regulations established by local, regional, or national authorities, as well as DevvStream&#8217;s own policies and reporting obligations.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; margin-left: 41.95pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic; color: rgb(118, 146, 60);">We
          Treat People With Mutual Respect: </font><font style="font-size: 10pt;">We treat people with dignity and respect, and we set high standards for professional and ethical conduct that govern how we interact with customers, suppliers, colleagues,
          and members of the public. This includes extending courtesy and respect to individuals; respecting DevvStream property and that of others; acting fairly and honestly at all times; working together to achieve better results and taking steps to
          understand the laws and customs of the different countries in which we operate.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="width: 100%;" class="BRPFPageFooter"></div>
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">4</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div style="width: 100%;" class="BRPFPageHeader">
          <div style="text-align: right;"><img src="image04.jpg"><br>
          </div>
        </div>
      </div>
      <div style="text-align: justify; text-indent: -6pt; margin-left: 6pt; color: rgb(118, 146, 60); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">We Conduct Business Ethically</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; margin-left: 45pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic; color: rgb(118, 146, 60);">We Comply
          With All Applicable Laws and Regulations. </font><font style="font-size: 10pt;">Obeying the law is the foundation of our Code of Business Conduct and Ethics. DevvStream works with governments and corporations in different countries and
          jurisdictions, and Employees are required to comply with the applicable laws in all locations to which they travel and where DevvStream does business. Although Employees may not know the details of all laws, rules and regulations, it is important
          to know enough to determine when to seek advice.&#160; Employees are reminded that the law takes precedence in cases where the law imposes a more stringent standard than traditional or industry practices.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; margin-left: 45pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic; color: rgb(118, 146, 60);">We Do Not
          Pay Bribes &#8211; To Anyone, at Any Time, for Any Reason. </font><font style="font-size: 10pt;">DevvStream is committed to complying with applicable anti-corruption laws, including the U.S. Foreign Corrupt Practices Act (FCPA), the U.K. Bribery Act,
          and the anti-corruption laws of all other countries where we do business. It is never appropriate to offer, give, request, or accept bribes, kickbacks, or any other type of improper preferential benefit to or from anyone whether they are a
          government official, political candidate, party official, customer, supplier, business partner or third- party intermediary. In addition to cash, be aware that gifts, business entertainment (such as meals, travel, or other hospitality), offers of
          employment or internships (even if unpaid), political contributions or charitable donations may also constitute a bribe, kickback, or other type of unlawful benefit. DevvStream is committed to doing business only with business partners that share
          our ethical values and commitment to anti-corruption compliance. <font style="font-family: 'Times New Roman'; font-weight: bold;">For more information, see the DevvStream Anti-Corruption Policy on the Company's internal SharePoint site
            under Operations/Company Policies.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; margin-left: 45pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic; color: rgb(118, 146, 60);">We Comply
          With All Import-Export &amp; Global Trade Laws.&#160; </font><font style="font-size: 10pt;">DevvStream&#8217;s ability to conduct business around the world is a privilege that must be carefully safeguarded.<font style="font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">&#160;</font>We must comply with all laws, rules, and regulations that govern these activities. These laws include trade laws and export controls and anti-boycott regulations that apply whether an
          employee is based in, or a citizen of, the United States or another country. The United States and many other countries also impose and enforce sanctions against certain individuals and companies worldwide, and the scope of these sanctions can
          vary widely. DevvStream does not do business with sanctioned individuals or companies. Employees are required to help ensure that DevvStream complies with all applicable trade laws in the jurisdictions where we do business and ensure that
          information provided to customs or other relevant authorities, as may be required from time to time, is current, accurate and complete.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; margin-left: 41.95pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic; color: rgb(118, 146, 60);">We
          Comply with Anti-Money Laundering Laws. </font><font style="font-size: 10pt;">We comply with all applicable anti-money laundering and counter-terrorism financing laws and regulations. We will not attempt to conceal or &#8220;launder&#8221; illegally
          received funds or make the source of the funds appear legitimate. Employees must follow all company payment procedures. In addition, employees should be alert for and immediately report any irregular payments, unusual payment methods, refund
          requests or other suspicious transactions. <font style="font-family: 'Times New Roman'; font-weight: bold;">For more information, see the Anti-Money Laundering &amp; Countering the Financing of Terrorism Policy on the Company's
            internal SharePoint site under Operations/Company Policies.</font></font></div>
      <div style="text-align: justify; margin-left: 41.95pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt;"><font style="font-family: 'Times New Roman'; font-weight: bold;"> <br>
          </font></font></div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="width: 100%;" class="BRPFPageFooter"></div>
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">5</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div style="width: 100%;" class="BRPFPageHeader">
          <div style="text-align: right;"><img src="image04.jpg"><br>
          </div>
        </div>
      </div>
      <div style="text-align: justify; margin-right: 31.15pt; margin-left: 42pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic; color: rgb(118, 146, 60);">We Do Not Trade on Inside Information. </font><font style="font-size: 10pt;">From time to time in the course of your work on behalf of DevvStream, you may have or receive material information about DevvStream or other
          companies that has not been disclosed publicly (inside information). Information is likely to be considered material if a reasonable investor would consider the information important in deciding whether to buy, sell or hold a stock or other
          security. If you have inside information about DevvStream or any other company, you must refrain from trading in DevvStream&#8217;s or that company&#8217;s stock, advising anyone else to do so, or communicating the information to anyone (i.e., &#8220;tipping&#8221;)
          until the information is disseminated to and absorbed by the public or is no longer material. </font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; color: rgb(118, 146, 60); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">We Operate With Transparency</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; margin-left: 36pt; color: rgb(118, 146, 60); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">We avoid conflicts of interest</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">DevvStream respects the right of our employees, Executive Officers, and members of our Board of Directors to manage their personal
        affairs. Nevertheless, our personal interests must never interfere (or appear to interfere) with the interests of DevvStream. A conflict of interest situation can arise when someone takes actions or has interests that may make it difficult to
        perform his or her company work objectively and effectively.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Employees must avoid apparent or actual conflicts of interest and must disclose potential conflicts of interest to their supervisor, or to
        the Chief Operating Officer. Executive Officers and members of the Board of Directors should report apparent or actual conflicts of interest to the Chief Operating Officer<font style="font-family: 'Times New Roman';">.&#160; </font>Examples
        of situations in which potential conflicts of interest could arise include, but are not limited to:</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; margin-left: 85.5pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic; color: rgb(118, 146, 60);">Personal
          Relationships. </font><font style="font-size: 10pt;">Employees should not participate in any business decision that could benefit an individual with whom they have a close personal relationship at a cost or detriment of any kind to DevvStream.
          Conflicts of interest can arise when an Employee or a member of his or her family receives improper personal benefits as a result of his or her position at DevvStream.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: -0.05pt; margin-left: 85.5pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic; color: rgb(118, 146, 60);">Gifts &amp; Business Entertainment. </font><font style="font-size: 10pt;">Providing and receiving modest gifts or entertainment can be beneficial to long-term business relationships, provided they are reasonable and
          appropriate for the situation, not offered to improperly influence a business decision, and are permissible under laws and policies that apply to the recipient. Gifts and entertainment should always be in good taste, should not be lavish, and
          should be considered courtesies, not regular practices. Gifts in cash, or cash equivalents, such as gift cards, are always prohibited. Giving or offering gifts and hospitality to government officials presents enhanced risk. <font style="font-family: 'Times New Roman'; font-weight: bold;">For further guidance see DevvStream&#8217;s Anti-Corruption Policy on the Company's internal SharePoint site under Operations/Company Policies.</font></font></div>
      <div style="text-align: justify; text-indent: -0.05pt; margin-left: 85.5pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt;"><font style="font-family: 'Times New Roman'; font-weight: bold;"> <br>
          </font></font></div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="width: 100%;" class="BRPFPageFooter"></div>
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">6</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div style="width: 100%;" class="BRPFPageHeader">
          <div style="text-align: right;"><img src="image04.jpg"><br>
          </div>
        </div>
      </div>
      <div style="text-align: justify; margin-left: 85.5pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic; color: rgb(118, 146, 60);">Outside
          Employment. </font><font style="font-size: 10pt;">Full-time employees must have prior written approval from their manager before providing services to another for-profit business, unless otherwise allowed under the terms of their employment or
          local law. You may never provide services to a competitor while you are employed by DevvStream.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; margin-left: 85.5pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic; color: rgb(118, 146, 60);">Political
          Activities. </font><font style="font-size: 10pt;">You should keep your political activities separate from your work for DevvStream. Accordingly, it is inappropriate to use company resources (including time, property, or equipment) for such
          activities. You should notify your manager before accepting a public office.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; margin-left: 85.5pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic; color: rgb(118, 146, 60);">Corporate
          Opportunities.</font><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic; color: rgb(192, 0, 0);">&#160;</font><font style="font-size: 10pt;">You are prohibited from (a) taking for yourself
          opportunities that are discovered through the use of DevvStream property, information, or position; (b) using DevvStream property, information, or position for personal gain; and (c) competing with DevvStream.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; margin-left: 45pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic; color: rgb(118, 146, 60);">Fraud and
          Misappropriation of Company Resources.</font><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic; color: rgb(192, 0, 0);">&#160;</font><font style="font-size: 10pt;">You should follow all
          internal approval processes and accounting and financial reporting principles to properly record all transactions.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; margin-left: 45pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic; color: rgb(118, 146, 60);">We Keep
          Accurate Books, Records &amp; Accounts and Make Accurate Disclosures. </font><font style="font-size: 10pt;">Accurate information is essential to DevvStream&#8217;s ability to meet legal and regulatory obligations and to compete effectively. The
          records and books of account of DevvStream must meet the highest standards and accurately reflect the true nature of the transactions they record.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; margin-left: 45pt; font-family: 'Times New Roman'; font-size: 10pt;">No undisclosed or unrecorded account or fund may be established for any purpose.&#160; No disbursement of corporate funds or other corporate
        property may be made without adequate supporting documentation or for any purpose other than as described in the documents.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; margin-left: 45.35pt; font-family: 'Times New Roman'; font-size: 10pt;">Do not knowingly create, use, or accept any falsified or forged documents in connection with DevvStream business activities or request
        or accept the delivery of any DevvStream proceeds into personal bank accounts. You cannot facilitate or participate in any third-party attempts to defraud DevvStream and must take appropriate steps to protect against any misuse of company
        resources. You must report all suspected attempts of external fraud.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; margin-left: 45pt; font-family: 'Times New Roman'; font-size: 10pt;">You must follow DevvStream&#8217;s system of internal controls and disclosure controls and ensure that corporate records and all securities
        filings are timely, legitimate, and accurate. Creating false or misleading records of any kind is prohibited.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="width: 100%;" class="BRPFPageFooter"></div>
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">7</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div style="width: 100%;" class="BRPFPageHeader">
          <div style="text-align: right;"><img src="image04.jpg"><br>
          </div>
        </div>
      </div>
      <div style="text-align: justify; margin-left: 5.75pt; color: rgb(118, 146, 60); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">We Act With Integrity In Our Business Relationships</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; margin-left: 41.95pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic; color: rgb(118, 146, 60);">Competition,
          Antitrust and Fair Dealing Laws: </font><font style="font-size: 10pt;">We comply with all antitrust and competition laws wherever we do business.&#160; These laws are designed to ensure a fair and level playing field.&#160; We should always deal fairly
          with our customers, suppliers, and competitors, as well as Employees. We should not take unfair advantage of anyone through manipulation, concealment, abuse of confidential or privileged information, misrepresentation of material factors or other
          unfair dealing practices. Fair dealing laws and antitrust laws protect industry competition by generally prohibiting formal or informal agreements that would restrain trade, for example, agreements between competitors seeking to manipulate or fix
          prices, divide markets, or unfairly impact competitors.&#160; If you ever learn of or are involved in discussions where these topics arise, you should immediately contact the Chief Operating Officer<font style="font-family: 'Times New Roman';">.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; margin-left: 41.75pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic; color: rgb(118, 146, 60);">Gathering
          Competitive Information: </font><font style="font-size: 10pt;">Obtaining and using information about competitors can be a legitimate part of the competitive process if gathered properly. However, information should be gathered only from publicly
          available sources. If you believe someone is improperly giving you confidential information, politely decline to continue the conversation and report the incident to your manager or the Chief Operating Officer.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; margin-left: 41.75pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic; color: rgb(118, 146, 60);">Interacting
          with Government Officials: </font><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(118, 146, 60);">&#160;</font><font style="font-size: 10pt;">For information regarding interactions with government officials
          worldwide, see DevvStream&#8217;s Anti-Corruption Policy on the Company's internal SharePoint site under Operations/Company Policies.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; margin-left: 6pt; color: rgb(118, 146, 60); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">We manage corporate assets and proprietary information responsibly</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; margin-left: 41.95pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic; color: rgb(118, 146, 60);">Protecting
          Assets and Confidential Information:</font><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic; color: rgb(192, 0, 0);">&#160;</font><font style="font-size: 10pt;">You must protect and exercise
          good judgment when using DevvStream&#8217;s assets. Personal use of company assets (such as technology resources) should be minimal and not interfere with job performance. You may not use DevvStream&#8217;s email or intranet assets to send or access
          offensive or inappropriate content. Also, Employees should be careful to protect DevvStream&#8217;s intellectual property from improper disclosure to or use by a third party. DevvStream may be entrusted with property and/or valuable information
          belonging to our business partners. You must use the same care to protect any property or valuable information entrusted to DevvStream by others. We should maintain the confidentiality of our own information and information entrusted to us by
          others, except when disclosure is authorized or legally mandated. Confidential information includes all non-public information that might be of use to competitors, or harmful to the company or its customers, if disclosed. This includes, but is
          not limited to, marketing plans, sales data, financial performance data, personal data of employees or customers, strategies, intellectual property, and any legally privileged materials. To protect this confidential information, you must follow
          all relevant laws and respect the privacy of information when collecting, keeping, and transferring confidential or otherwise private information. You are prohibited from using DevvStream confidential information for personal gain or to compete
          with DevvStream.<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 255);">&#160;</font>Any waste, misuse, destruction, or theft of DevvStream&#8217;s assets or any improper or illegal activity must be brought to the attention of
          management. Individuals ceasing employment or business relationship with the DevvStream must return all confidential information, objects, documents, or data such as computer hardware and software, databases, cellular telephones, credit cards,
          books, manuals, etc. and shall comply with the DevvStream&#8217;s guidelines and policies in that respect.</font></div>
      <div style="text-align: justify; margin-left: 41.95pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt;"> <br>
        </font></div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="width: 100%;" class="BRPFPageFooter"></div>
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">8</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div style="width: 100%;" class="BRPFPageHeader">
          <div style="text-align: right;"><img src="image04.jpg"><br>
          </div>
        </div>
      </div>
      <div style="text-align: justify; margin-left: 41.95pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic; color: rgb(118, 146, 60);">Safeguarding
          Intellectual Property: </font><font style="font-size: 10pt;">Intellectual property is one of DevvStream&#8217;s most valuable assets and thus protection of our IP is a core responsibility for every employee. Each of us is responsible for safeguarding
          our trademarks, patents, copyrights, trade secrets, and proprietary know-how, methods, and processes. It is critical that you never disclose to unauthorized individuals &#8211; whether inside or outside of DevvStream &#8211; any information that may
          compromise DevvStream&#8217;s proprietary technology or trade secrets. It is equally important that we respect the valid intellectual property rights of third parties. Unauthorized use of third-party intellectual property may expose DevvStream and
          individual Employees to civil damages and criminal penalties.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; margin-left: 41.95pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic; color: rgb(118, 146, 60);">Personal
          Data: </font><font style="font-size: 10pt;">DevvStream is committed to protecting the personal data of our Employees, customers, and others who entrust it to us. If you create, discover, use, access, receive or otherwise handle personal data you
          should follow applicable privacy laws and DevvStream&#8217;s data privacy policies and procedures.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; margin-left: 41.95pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic; color: rgb(118, 146, 60);">Data
          Security: </font><font style="font-size: 10pt;">Keeping DevvStream&#8217;s data safe strengthens our business by building trust between our Employees, customers, and business partners. Specifically, you must protect all passwords, user IDs, access
          cards, and encryption or authentication keys. You must safeguard all confidential and non-public information, including, but not limited to, trade secrets, contracts, manufacturing, customer, employee, and pricing data.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; margin-left: 42pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic; color: rgb(118, 146, 60);">Speaking
          on DevvStream&#8217;s Behalf and Careful Communications: </font><font style="font-size: 10pt;">Unless specifically authorized, you should refrain from speaking publicly on DevvStream&#8217;s behalf or publicly disclosing proprietary or confidential
          information about DevvStream. Only Employees who have been given permission to speak publicly on DevvStream&#8217;s behalf are permitted to do so. Those individuals permitted to speak on DevvStream&#8217;s behalf must always be truthful, accurate, and
          respectful in their communications.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Nothing in this policy is intended to preclude or dissuade employees from
          engaging in legally protected activities or activities protected by state or federal law, </font><font style="font-size: 10pt;">including the National Labor Relations Act (e.g., discussing wages, benefits, or terms and conditions of employment,
          raising complaints about working conditions for mutual aid or protection, or legally required activities), <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">giving truthful testimony, or truthfully responding to a
            valid subpoena, or communicating or filing a charge with government or regulatory entities (such as the Equal Employment Opportunity Commission, National Labor Relations Board, Department of Labor, or Securities and Exchange Commission).</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; color: rgb(118, 146, 60); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Reports, Investigations, and Potential Violations</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; margin-left: 42pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic; color: rgb(118, 146, 60);">Consequences
          for Violating the Code:</font><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic; color: rgb(192, 0, 0);">&#160;</font><font style="font-size: 10pt;">Violation of any law or this Code is a
          serious matter. Any Employee who compromises or violates any applicable law or the Code may be subject to disciplinary action, up to, and including, termination; loss of employment-related benefits; and, if applicable, criminal or civil
          proceedings.</font></div>
      <div style="text-align: justify; margin-left: 42pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt;"> <br>
        </font></div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="width: 100%;" class="BRPFPageFooter"></div>
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">9</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div style="width: 100%;" class="BRPFPageHeader">
          <div style="text-align: right;"><img src="image04.jpg"><br>
          </div>
        </div>
      </div>
      <div style="text-align: justify; margin-left: 41.95pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic; color: rgb(118, 146, 60);">Cooperating
          in Investigations:</font><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic; color: rgb(192, 0, 0);">&#160;</font><font style="font-size: 10pt;">You may be asked to cooperate or provide
          information in an investigation into violations of this Code, the law, or other DevvStream policies. Your full cooperation and assistance are required and the failure to do so will be considered a violation of the Code and DevvStream policy.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; margin-left: 42pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic; color: rgb(118, 146, 60);">Non-retaliation:</font><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic; color: rgb(192, 0, 0);">&#160;</font><font style="font-size: 10pt;">We will not tolerate retaliation against any Employee who makes a good faith
          report about a violation or possible violation of applicable law or the Code, or who participates in any investigation conducted internally or by a government enforcement agency. Any employee who believes he or she has been retaliated against
          should promptly report it to one of the resources listed below.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; margin-left: 41.95pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic; color: rgb(118, 146, 60);">To Ask
          a Question, Raise a Concern, or Report a Violation: </font><font style="font-size: 10pt;">Any Employee who would like guidance on how to comply with the Code or applicable law, or who becomes aware of a violation of the Code or of any applicable
          law, is encouraged to report his or her concerns or questions through any of the following channels:</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z6c63585a88cd44ffae9859217f9f11bd" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 77.95pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(192, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#9726;</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">His or her manager</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" id="z1f647711c8f243dc918434616ccc71d3" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 77.95pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(192, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#9726;</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">The Chief Operating Officer, who can be reached at: <u><font style="font-family: 'Times New Roman';">chris@devvstream.com</font></u> or <u><font style="font-family: 'Times New Roman';">ethics@devvstream.com</font></u></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; margin-left: 42pt; font-family: 'Times New Roman'; font-size: 10pt;">Except where prohibited by local law:</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z6342911847c94d6badd8677b5c6fbf7b" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 78pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 35.95pt; vertical-align: top; color: rgb(192, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#9726;</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">Employees may make reports anonymously and DevvStream will take steps to maintain the confidentiality of reports; and</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" id="z936ceb1baa0547f7aee83251120e843d" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 78pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 35.95pt; vertical-align: top; color: rgb(192, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#9726;</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">Third parties may report potential business misconduct by contacting the DevvStream employee with whom the person has a working relationship, or by submitting their report to the Chief
                Operating Officer.</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; margin-left: 41.95pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic; color: rgb(118, 146, 60);">Investigating
          and Resolving Reported Violations:</font><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic; color: rgb(192, 0, 0);">&#160;</font><font style="font-size: 10pt;">The Audit Committee has
          established procedures for the receipt, investigation, and resolution of whistleblower reports.&#160; Please send any reports to Chief Operating Officer, who can be reached at: <u><font style="font-family: 'Times New Roman';">chris@devvstream.com</font></u>,
          or <u><font style="font-family: 'Times New Roman';">ethics@devvstream.com</font></u>. All reports of possible violations of the Code or applicable laws will be evaluated promptly and investigated, where appropriate.</font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; color: rgb(118, 146, 60); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Certification of Compliance with this Code</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; margin-left: 5.75pt; font-family: 'Times New Roman'; font-size: 10pt;">Each Employee must certify annually that he or she has read and understands this Code, that he or she recognizes that this Code applies
        to him or her, and that he or she has complied with all of the rules and requirements of this Code that apply to him or her.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; color: rgb(118, 146, 60); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Review and Monitoring of this Code</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">The B</font><font style="font-size: 10pt;">oard of Directors, directly or through the Nominating
          and Corporate Governance Committee, will monitor compliance to this Code. <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">&#160;</font>The Nominating and Corporate Governance Committee shall review this Code of Cond<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">uct periodically, as it deems appropriate, and propose recommended changes to the Board of Directors.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">This Code was approved by the </font><font style="font-size: 10pt;">Board
          of Directors on September 16, 2024. The Board of Directors last reviewed and amended the Code on September 16, 2024.</font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="font-size: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">10</font></div>
      </div>
      <div style="font-size: 10pt;">
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    </div>
  </div>

  <div style="width: 100%;" class="BRPFPageFooter"></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>12
<FILENAME>ef20038430_ex21-1.htm
<DESCRIPTION>EXHIBIT 21.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 24.9.1.5252
         Copyright 1995 - 2024 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <font style="font-size: 10pt;"> </font>
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div>
      <div style="text-align: right; font-size: 9pt;"><font style="font-weight: bold; font-size: 10pt;">Exhibit 21.1</font><font style="font-size: 10pt;"><br>
        </font></div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">&#160;</div>
      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Subsidiaries

          of DevvStream Corp.</font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" id="z1c2c1f377d6e474a9fd70907def33a38" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 50%; vertical-align: middle; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Name of Subsidiary</div>
            </td>
            <td style="width: 50%; vertical-align: middle; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Jurisdiction of Organization</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: middle; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">DevvStream Holdings Inc.</div>
            </td>
            <td style="width: 50%; vertical-align: middle; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">British Columbia, Canada</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">
        <table cellspacing="0" cellpadding="0" border="0" id="z837a359ab82a433c9684536a480466ec" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td style="width: 50.00%;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">DevvStream Inc.</div>
              </td>
              <td style="width: 50.00%;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Delaware, U.S.</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50.00%;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">DevvESG Streaming Finco Ltd.</div>
              </td>
              <td style="width: 50.00%;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">British Columbia, Canada</div>
              </td>
            </tr>

        </table>
        <div><br>
        </div>
        <br>
      </div>
      <div style="text-align: left; font-size: 10pt;">
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    </div>
  </div>
  <font style="font-size: 10pt;"> </font>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>13
<FILENAME>ef20038430_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 24.9.1.5252
         Copyright 1995 - 2024 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <font style="font-size: 10pt;">
  </font>
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div>
      <div>
        <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <font style="font-weight: bold; font-size: 10pt;">Exhibit 99.1<br>
          </font></div>
        <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <font style="font-size: 10pt;"><br>
          </font></div>
        <div style="text-align: left; color: rgb(4, 101, 180); font-family: 'Times New Roman'; font-size: 10pt;">DevvStream Holdings Inc. Announces Completion of Business Combination with Focus Impact Acquisition Corp.; Secures Up to US$43M of
          Additional Capital to Execute Growth Plans</div>
        <div style="font-size: 10pt;">&#160;</div>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Completion of the business combination makes DevvStream the first publicly traded carbon credit generation company on a major U.S. stock
        exchange</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">The combined entity will be renamed DevvStream Corp. and its shares are expected to commence trading on the Nasdaq at the market open on
        November 7, 2024 under the ticker &#8220;DEVS&#8221;</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">VANCOUVER, BC, November 6, 2024</font><font style="font-size: 10pt;"> &#8211;
          DevvStream Holdings Inc. (&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">DevvStream</font>&#8221; or the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Company</font>&#8221;) (CBOE: DESG) (OTCQB:
          DSTRF) (FSE: CQ0), a leading carbon credit project co-development and generation firm specializing in technology-based solutions, today announced that it has completed its previously announced business combination (the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Business Combination</font>&#8221;) with Focus Impact Acquisition Corp. (&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Focus Impact&#8221; </font>or<font style="font-family: 'Times New Roman'; font-weight: bold;"> &#8220;FIAC</font>&#8221;) and will be the first publicly traded carbon credit generation company listed on a major U.S. stock exchange.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">In connection with the completion of the business combination, FIAC has been renamed DevvStream Corp. In addition, among other things, FIAC&#8217;s Class A common
        stock and Class B common stock issued and outstanding prior to completion of the business combination were converted into 0.9692 common shares of DevvStream Corp., and FIAC&#8217;s warrants issued and outstanding prior to completion of the business
        combination were converted into warrants of DevvStream Corp. to purchase 0.9692 common shares of DevvStream Corp. DevvStream Corp&#8217;s common shares are expected to commence trading on the Nasdaq under the new ticker symbol &#8220;DEVS&#8221; at the opening of
        trading on November 7, 2024.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Additionally, DevvStream</font><font style="font-size: 10pt;"> has announced
          that it has secured access to up to $43 million in additional financing, a move aimed at accelerating its mission to democratize access to carbon markets. This funding will support DevvStream&#8217;s efforts to help organizations meet their climate and
          decarbonization targets while enhancing their financial stability.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;At DevvStream, we are deeply committed to executing our global growth strategy through advancing transparency and reliability in global carbon markets,&#8221; said
        Sunny Trinh, CEO and co-Founder of DevvStream. &#8220;This exciting transaction positions us extremely well to execute our accelerated growth plans as we work with partners and customers to drive further alignment between sustainability and profitability
        through expanded carbon market access. We look forward to our continued partnership with the FIAC team and delivering long-term value to all stakeholders.&#8221;</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;We are tremendously excited to have completed our business combination with DevvStream as they continue strong progress toward their goal of making carbon
        markets accessible to organizations both large and small around the globe,&#8221; said Carl Stanton, CEO of Focus Impact. &#8220;We are extremely confident in the ability of DevvStream&#8217;s management team to deliver shareholder value by harnessing the full
        potential of the company&#8217;s systematic approach to the design, validation, and verification of technology-based carbon credits. We are excited to have contributed to the company&#8217;s rapid growth and are eager to continue partnering with Sunny and his
        team for many successful years ahead.&#8221;</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Company Overview</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Through DevvStream&#8217;s Carbon Management and Carbon Investment platforms, the Company is focused on the co-development and generation of technology-based carbon
        offset credits, in partnership with governments and corporations worldwide, across voluntary and compliance markets. These programs leverage a systematic approach to the process of generating high quality technology-based carbon credits by
        partnering with project owners to either directly invest as a co-developer, or execute project design, documentation, and certification efforts in exchange for a substantial portion of multi-year carbon credit streams.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Typical projects incur ongoing management and administrative costs during the contract term and generate recurring streams of carbon credits. Through a curated,
        technology-focused approach to the implementation of green technology projects, DevvStream aims to democratize access to carbon markets while helping governments and corporations worldwide meet their sustainability goals.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Since the announcement of the business combination with FIAC in September 2023, DevvStream has accelerated its global commercial progress and market strategy
        with several announcements and partnerships:</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z564c5dd7e0b94270b355dfec29d849d8" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Acquired 50% Equity Stake in Carbon Sequestration Hub Facility: </font><font style="font-size: 10pt;">Closed a transaction with Monroe Sequestration Partners LLC (&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">MSP</font>&#8221;), a subsidiary of Crestmont Investments LLC, whereby DevvStream
                  acquired a 50% equity stake in MSP and its carbon sequestration operations. Funded by Crestmont, MSP is working within the geographic area and geologic formations capable of carbon storage for a legacy oil and gas field&#8212;covering 425
                  square-miles across 3 parishes in northern Louisiana&#8212;to develop one of the largest carbon sequestration reservoirs in the United States, with an estimated total storage capacity of 260 MMT of CO2, and capable of capturing a significant
                  portion of the 30 million metric tons of CO2 emitted from local sources annually.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; margin-left: 36pt;">Revenues from the project are expected to be generated within a two-year timeframe via carbon sequestration federal tax credits&#8212;typically
        referred to as &#8220;45Q&#8221; credits, named for Section 45Q in the Internal Revenue Code&#8212;which currently sell for $85 per tonne of CO2 stored. Project revenues are also anticipated to be derived from the sale of voluntary carbon offset credits, as well as
        storage fees from accepted CO2 to be sequestered in the converted reservoir. Other potential revenues are projected to originate from timberland sequestration, stream bed remediation, and wetlands restoration.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z7a586014f16d4d508533896a6769a627" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Signed a Definitive Agreement to Purchase 1.2 Million Carbon Credits for Conservation of
                  200,000 Hectares of Amazon Territory from the Ipixuna REDD+ Project: </font><font style="font-size: 10pt;">The Project is located in the Ipixuna Indigenous Territory of Brazil and is designed to enhance environmental conservation
                  efforts, reduce GHG emissions caused by deforestation, and promote decent living conditions in the local villages inhabited by the indigenous Parintintin tribe. The Parintintin people own, manage, and document all Project activities
                  Certified under the Cercarbono Certified Carbon Standard Program and listed on the EcoRegistry at <font style="font-family: 'Times New Roman';">https://www.ecoregistry.io/projects/125</font>, the Project is expected to reduce
                  emissions by 13,227,635 tCO2e during its 30-year life, an average of 440,921 tCO2e per year.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="zff6cd8af071940e68d9f95e188b4608a" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Establishment of Electric Vehicle Charging Carbon Offset Program (&#8220;EVCCOP&#8221;):</font><font style="font-size: 10pt;"> DevvStream&#8217;s EVCCOP enables electric vehicle (&#8220;EV&#8221;) charging partners to leverage charging station networks for the generation of high volumes of carbon credits to help fund network expansion efforts. By
                  participating in DevvStream&#8217;s EVCCOP, partners receive a majority of the net revenues generated by the sale of carbon credits on an annual basis, reflecting the emission reductions (measured in tonnes of CO2e) generated by their chargers,
                  with DevvStream in turn retaining a portion of the carbon credits generated in exchange for services related to the development and monetization of carbon credits from EV charging stations. In the past year, DevvStream has enrolled <font style="font-family: 'Times New Roman';">OK2Charge</font>, <font style="font-family: 'Times New Roman';">E-Fill Electric LLC</font>, <font style="font-family: 'Times New Roman';">Green Energy Technology</font>,
                  and <font style="font-family: 'Times New Roman';">Go-Station</font> in the EVCCOP.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z0d776a6e2cab4c42a1d3984905e6c120" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Expansion of Buildings and Facilities Carbon Offset Program (&#8220;BFCOP&#8221;): </font><font style="font-size: 10pt;">The BFCOP is a first-of-its-kind project which aims to designed to help building owners in the US and Canada generate carbon credit revenue via energy efficiencies and the use of renewable power. Residential,
                  commercial, and institutional buildings, both new and retrofit, are eligible for the program.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Advisors</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Cohen &amp; Company Capital Markets, a division of J.V.B. Financial Group, LLC (&#8220;CCM&#8221;), served as exclusive financial advisor, lead capital markets advisor to
        Focus Impact. Morrison &amp; Foerster LLP and McMillan LLP served as legal counsel to DevvStream. Kirkland &amp; Ellis LLP and Stikeman Elliott LLP served as legal counsel to Focus Impact.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">About DevvStream</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Founded in 2021, DevvStream is a leading authority in the use of technology in carbon project development. The Company's mission is to create alignment between
        sustainability and profitability, helping organizations achieve their climate initiatives while directly improving their financial health. With a pipeline of over 140 technology-based projects worldwide, DevvStream makes it simple for corporations
        and governments to address their net-zero goals while generating premium carbon credits in the process. DevvStream takes a programmatic approach to evaluating project opportunities, and co-develops projects spanning energy-efficient buildings,
        facilities and homes, industrial facilities, LED systems, EV charging stations, and technologies to seal oil wells. The Company's end-to-end proprietary solution removes the risk and complexity from every step, allowing organizations to move from
        project ideation to credit monetization with ease. The result is a multi-year stream of carbon credit revenue that transforms sustainability into a financial investment. In addition, for organizations that need help to offset their most
        difficult-to-reduce emissions, we also provide premium carbon credits for purchase.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">About Focus Impact Acquisition Corp.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Focus Impact Acquisition Corp. is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase,
        reorganization or similar business combination with one or more businesses.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Forward-Looking Statements</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Certain statements in this news release may be considered forward-looking statements. Forward-looking statements are statements that are not historical facts
        and generally relate to future events or Focus Impact&#8217;s or DevvStream&#8217;s future financial or other performance metrics. In some cases, you can identify forward-looking statements by terminology such as &#8220;may&#8221;, &#8220;should&#8221;, &#8220;expect&#8221;, &#8220;intend&#8221;, &#8220;will&#8221;,
        &#8220;estimate&#8221;, &#8220;anticipate&#8221;, &#8220;believe&#8221;, &#8220;predict&#8221;, &#8220;potential&#8221; or &#8220;continue&#8221;, or the negatives of these terms or variations of them or similar terminology. These forward-looking statements, including, without limitation, Focus Impact&#8217;s, DevvStream&#8217;s
        and the combined company&#8217;s expectations with respect to future performance and anticipated financial impacts of the transaction, are subject to risks and uncertainties, which could cause actual results to differ materially from those expressed or
        implied by such forward-looking statements. These forward-looking statements are based upon estimates and assumptions that, while considered reasonable by Focus Impact and its management, and DevvStream and its management, as the case may be, are
        inherently uncertain and subject to material change. New risks and uncertainties may emerge from time to time, and it is not possible to predict all risks and uncertainties. Factors that may cause actual results to differ materially from current
        expectations include, but are not limited to: (1) factors associated with companies, such as DevvStream, that are engaged in&#160; carbon credit project co-development and generation, including anticipated trends, growth rates, and challengese in those
        businesses and in the markets in which they operate;(2) the outcome of any legal proceedings that may be instituted against Focus Impact, DevvStream, the combined company or others;&#160; (3) the risk that the transaction disrupts current plans and
        operations of the combined company as a result of the announcement and consummation of the transaction; (4) the ability to recognize the anticipated benefits of the transaction, which may be affected by, among other things, competition, the ability
        of the combined company to grow and manage growth profitably, maintain relationships with customers and retain its management and key employees; (5) costs related to the transaction; (6) changes in applicable laws or regulations; (7) the
        possibility that the combined company may be adversely affected by other economic, business, and/or competitive factors; (8) Focus Impact&#8217;s estimates of expenses and profitability and underlying assumptions with respect to purchase price and other
        adjustments; (9) various factors beyond management&#8217;s control, including general economic conditions and other risks, uncertainties and factors set forth in the section entitled &#8220;Risk Factors&#8221; and &#8220;Cautionary Note Regarding Forward-Looking
        Statements&#8221; in the Registration Statement on Form S-4 that includes a proxy statement and prospectus of Focus Impact (as amended, the &#8220;proxy statement/prospectus&#8221;), first filed with the SEC on December 4, 2023, as amended from time to time, and
        other filings with the SEC; and (10) certain other risks identified and discussed in DevvStream&#8217;s Annual Information Form for the year ended July 31, 2023, and DevvStream&#8217;s other public filings with Canadian securities regulatory authorities,
        available on DevvStream&#8217;s profile on SEDAR at <font style="font-family: 'Times New Roman';">www.sedarplus.ca</font>.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">These forward-looking statements are expressed in good faith, and Focus Impact, DevvStream and the combined company believe there is a reasonable basis for
        them. However, there can be no assurance that the events, results or trends identified in these forward-looking statements will occur or be achieved. Forward-looking statements speak only as of the date they are made, and none of Focus Impact,
        DevvStream or the combined company is under any obligation, and expressly disclaim any obligation, to update, alter or otherwise revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as
        required by law. Readers should carefully review the statements set forth in the reports, which Focus Impact has filed or the combined company will file from time to time with the SEC and DevvStream&#8217;s public filings with Canadian securities
        regulatory authorities. This news release is not intended to be all-inclusive or to contain all the information that a person may desire in considering an investment in Focus Impact or DevvStream and is not intended to form the basis of an
        investment decision in Focus Impact or DevvStream. All subsequent written and oral forward-looking statements concerning Focus Impact and DevvStream, the transaction or other matters and attributable to Focus Impact and DevvStream or any person
        acting on their behalf are expressly qualified in their entirety by the cautionary statements above.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">On Behalf of the Board of Directors,</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Sunny Trinh, CEO</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">DevvStream Media &amp; Investor Contacts</div>
      <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><u>DevvStream@icrinc.com</u></div>
      <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><u>info@fcir.ca</u></div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Phone: (332) 242-4316</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="font-size: 10pt;">&#160;
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    </div>
  </div>
  <font style="font-size: 10pt;">
  </font>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>14
<FILENAME>ef20038430_ex99-2.htm
<DESCRIPTION>EXHIBIT 99.2
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 24.9.1.5252
         Copyright 1995 - 2024 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <font style="font-size: 10pt;"> </font>
  <div style="text-align: right;">
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"><font style="font-weight: bold; font-size: 10pt;">Exhibit 99.2</font><font style="font-size: 10pt;"><br>
    </font> </div>
  <font style="font-size: 10pt;"> </font>
  <div><font style="font-size: 10pt;"><br>
    </font> </div>
  <font style="font-size: 10pt;"> </font>
  <div>
    <div>
      <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">DEVVSTREAM HOLDINGS INC. PRO FORMA COMBINED INCOME STATEMENT</div>
    </div>
    <div>
      <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">UNAUDITED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS</div>
      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">
        <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">For the Period From January 1, 2024 to July 31, 2024 (Expressed in USD)</div>
      </div>
    </div>
    <div><font style="font-size: 10pt;"><br>
      </font> </div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;" id="zfe6895018fb74b54b12db2cc99eb21b5" class="cfttable">

        <tr>
          <td valign="bottom" colspan="1" rowspan="3" style="vertical-align: top; width: 43%; font-size: 10pt;">&#160; <br>
          </td>
          <td valign="bottom" rowspan="3" style="vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftguttercell"><br>
          </td>
          <td valign="bottom" rowspan="3" style="vertical-align: top;" colspan="2"><font style="font-size: 10pt;">&#160; </font>
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Devstream</div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Holdings Inc.</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" rowspan="3" style="vertical-align: top;" colspan="2">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Focus Impact</div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Acquisition</div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Corp.</div>
          </td>
          <td valign="bottom" style="vertical-align: top; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" style="vertical-align: top; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" style="vertical-align: top; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" style="vertical-align: top; width: 9%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: top; width: 9%; font-size: 10pt;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: top; font-size: 10pt;" colspan="2">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" nowrap="nowrap" rowspan="2" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftfncell"><br>
          </td>
          <td valign="bottom" rowspan="2" style="vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftguttercell"><br>
          </td>
          <td valign="bottom" nowrap="nowrap" rowspan="2" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftfncell"><br>
          </td>
          <td valign="bottom" rowspan="2" style="vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" rowspan="2" style="vertical-align: top;" colspan="2">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Pro-forma</div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Adjustments</div>
          </td>
          <td valign="bottom" style="vertical-align: top; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" colspan="1" rowspan="2" style="vertical-align: top; width: 9%;"><font style="font-size: 10pt;">&#160; </font>
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Notes</div>
          </td>
          <td valign="bottom" rowspan="2" style="vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftguttercell"><br>
          </td>
          <td valign="bottom" rowspan="2" style="vertical-align: top;" colspan="2">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Pro-forma</div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Results</div>
          </td>
          <td valign="bottom" nowrap="nowrap" rowspan="2" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftfncell"><br>
          </td>
        </tr>
        <tr>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); width: 43%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); width: 1%; font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); width: 1%; font-size: 10pt;" colspan="1" class="cftcurrcell">$</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); width: 9%; font-size: 10pt;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); width: 1%; font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); width: 1%;" colspan="1" class="cftguttercell"><font style="font-size: 10pt;">$ <br>
            </font> </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="2">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); width: 1%; font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); width: 1%; font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); width: 1%; font-size: 10pt;" colspan="1" class="cftcurrcell">$</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); width: 9%; font-size: 10pt;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); width: 1%; font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-align: center;">&#160;A</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); width: 1%; font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="2">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; background-color: rgb(204, 238, 255); width: 1%; font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 43%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; font-size: 10pt;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; font-size: 10pt;" colspan="2">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; font-size: 10pt;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 9%; font-size: 10pt;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: top; font-size: 10pt;" colspan="2">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; background-color: rgb(204, 238, 255); width: 43%;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Operating expenses</div>
          </td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%; font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%; font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: rgb(204, 238, 255); width: 9%; font-size: 10pt;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%; font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%; font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="2">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%; font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%; font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%; font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: rgb(204, 238, 255); width: 9%; font-size: 10pt;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%; font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); width: 9%; font-size: 10pt;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%; font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: top; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="2">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%; font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 43%;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">Advertising and promotion</div>
          </td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">116,957</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 9%; font-size: 10pt;" colspan="1">&#160;</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">116,957</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 43%; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">Depreciation</div>
          </td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">910</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="text-align: center; vertical-align: bottom; width: 9%; background-color: rgb(204, 238, 255); font-weight: bold; font-size: 10pt;" colspan="1">&#160;</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">910</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 43%;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">General and administrative</div>
          </td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">266,439</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">608,177</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(368,177</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>
          <td valign="bottom" style="text-align: center; vertical-align: bottom; width: 9%; font-weight: bold; font-size: 10pt;" colspan="1">&#160;B</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">506,439</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 43%; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">Professional fees</div>
          </td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,690,869</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2,084,716</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(3,282,339</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>
          <td valign="bottom" style="text-align: center; vertical-align: bottom; width: 9%; background-color: rgb(204, 238, 255); font-weight: bold; font-size: 10pt;" colspan="1">&#160;C</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">493,246</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 43%;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">Salaries and wages</div>
          </td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">158,902</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="text-align: center; vertical-align: bottom; width: 9%; font-weight: bold; font-size: 10pt;" colspan="1">&#160;</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">158,902</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 43%; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">Share-based compensation</div>
          </td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">633,029</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="text-align: center; vertical-align: bottom; width: 9%; background-color: rgb(204, 238, 255); font-weight: bold; font-size: 10pt;" colspan="1">&#160;</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">633,029</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 43%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">Travel expenses</div>
          </td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="text-align: center; vertical-align: bottom; width: 9%; font-weight: bold; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" colspan="1">&#160;</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 43%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(2,867,106</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(2,692,893</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">3,650,516</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="text-align: center; vertical-align: bottom; width: 9%; background-color: rgb(204, 238, 255); font-weight: bold; font-size: 10pt;" colspan="1">&#160;</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(1,909,483</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 43%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; font-size: 10pt;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; font-size: 10pt;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; font-size: 10pt;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="text-align: center; vertical-align: bottom; width: 9%; font-weight: bold; font-size: 10pt;" colspan="1">&#160;</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; font-size: 10pt;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 43%; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Other income</div>
          </td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="text-align: center; vertical-align: bottom; width: 9%; background-color: rgb(204, 238, 255); font-weight: bold; font-size: 10pt;" colspan="1">&#160;</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 43%;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">Foreign exchange gain/loss</div>
          </td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(30,086</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="text-align: center; vertical-align: bottom; width: 9%; font-weight: bold; font-size: 10pt;" colspan="1">&#160;</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(30,086</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 43%; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">Interest expense</div>
          </td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(11,227</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="text-align: center; vertical-align: bottom; width: 9%; background-color: rgb(204, 238, 255); font-weight: bold; font-size: 10pt;" colspan="1">&#160;</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(11,227</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 43%;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">Interest income</div>
          </td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">471,525</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(471,525</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>
          <td valign="bottom" style="text-align: center; vertical-align: bottom; width: 9%; font-weight: bold; font-size: 10pt;" colspan="1">&#160;D</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 43%; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">Accretion expense</div>
          </td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(23,010</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="color: rgb(0, 128, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="text-align: center; vertical-align: bottom; width: 9%; background-color: rgb(204, 238, 255); font-weight: bold; font-size: 10pt;" colspan="1">&#160;</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(23,010</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 43%;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">Change in fair value of warrant liability</div>
          </td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(454,000</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; font-size: 10pt;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="text-align: center; vertical-align: bottom; width: 9%; font-weight: bold; font-size: 10pt;" colspan="1">&#160;</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(454,000</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 43%; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">Unrealized gain (loss)</div>
          </td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(50,561</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="color: rgb(0, 128, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="text-align: center; vertical-align: bottom; width: 9%; background-color: rgb(204, 238, 255); font-weight: bold; font-size: 10pt;" colspan="1">&#160;</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(50,561</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 43%;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">Tax expense</div>
          </td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(176,530</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">176,530</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="text-align: center; vertical-align: bottom; width: 9%; font-weight: bold; font-size: 10pt;" colspan="1">&#160;D</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 43%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="text-align: center; vertical-align: bottom; width: 9%; background-color: rgb(204, 238, 255); font-weight: bold; font-size: 10pt;" colspan="1">&#160;</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 43%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Net loss</div>
          </td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(2,981,990</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftfncell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(2,851,898</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftfncell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">3,355,521</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="text-align: center; vertical-align: bottom; width: 9%; font-weight: bold; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" colspan="1">&#160;</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(2,478,367</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 43%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="text-align: center; vertical-align: bottom; width: 9%; background-color: rgb(204, 238, 255); font-weight: bold; font-size: 10pt;" colspan="1">&#160;</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 43%;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Foreign currency translation</div>
          </td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(1,190,077</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; font-size: 10pt;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="text-align: center; vertical-align: bottom; width: 9%; font-weight: bold; font-size: 10pt;" colspan="1">&#160;</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(1,190,077</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 43%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="text-align: center; vertical-align: bottom; width: 9%; background-color: rgb(204, 238, 255); font-weight: bold; font-size: 10pt;" colspan="1">&#160;</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 43%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Comprehensive loss</div>
          </td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(4,172,067</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftfncell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">)</div>
          </td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(2,851,898</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftfncell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">)</div>
          </td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">3,355,521</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="text-align: center; vertical-align: bottom; width: 9%; font-weight: bold; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" colspan="1">&#160;</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(3,668,444</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 43%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="text-align: center; vertical-align: bottom; width: 9%; background-color: rgb(204, 238, 255); font-weight: bold; font-size: 10pt;" colspan="1">&#160;</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 43%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Weighted average number of shares outstanding</div>
          </td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">34,175,629</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">7,467,578</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="text-align: center; vertical-align: bottom; width: 9%; font-weight: bold; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" colspan="1">&#160;E</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: right; font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">27,413,444</div>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 43%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="text-align: center; vertical-align: bottom; width: 9%; background-color: rgb(204, 238, 255); font-weight: bold; font-size: 10pt;" colspan="1">&#160;</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 43%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Loss per share</div>
          </td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">- 0.09</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">- 0.38</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="text-align: center; vertical-align: bottom; width: 9%; font-weight: bold; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" colspan="1">&#160;</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">- 0.09</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; font-size: 10pt;" colspan="1" class="cftfncell">&#160;</td>
        </tr>

    </table>
    <div><font style="font-size: 10pt;"><br>
      </font> </div>
    <div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Notes:</font><font style="font-size: 10pt;"> <br>
        </font> </div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">A: These fiancials are based on management's best estimates as of the date hereof and are pro forma for the combination of Devvstream and FIAC. These financials and
        related adjustments have not been audited nor reviewed by the company's external advisers and the company makes no representations as to their accuracy or applicability. The combined results are for the period from January 1, 2024 and ending June
        30, 2024.<br>
      </div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">B: Adjustment reflects the elimnation of general and administrative expenses of FIAC not to be incurred following the transaction and the addition of general and
        administrative expenses related to the listing, franchise taxes and other miscellaneous items, which are exepcted to continue to be incurred post transaction closing.</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt;"><br>
        </font> </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt;">C: Adjustment reflects the elimination of professional fees in conjunction with the transaction and FIAC espenses not expected to reoccur
          post-transaction plus the addition of legal, audit and investor relations fees expected to be incurred on an ongoing basis following the transaction. <br>
        </font> </div>
      <font style="font-size: 10pt;"><br>
      </font>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt;">D: Adjsutment reflects the elimination of interest income on the cash balances in Trust and the corresponding elimination of income taxes
          on such interst income. <br>
        </font> </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <font style="font-size: 10pt;"><br>
        </font> </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">E: Weighted average number of shares outstanding reflects pro forma number of shares estimated to be outstanding following the transaction as of the final transaction
        exchange ratio. The pro forma number of shares issued and outstanding does not include issuances that occured after closing of the Business Combination, such as share issuances with respect to the Strategic Consulting Agreement, the New Convertible
        Notes, New PubCo Warrants, the Converted Warrants, the Converted Options, the Converted RSUs or any other security pursuant to which New PubCo Common Shares may be issuable (each term used in the foregoing as defined in the Current Report on Form
        8-K with which this exhibit has been furnished).</div>
      <div style="font-size: 10pt;">&#160;</div>
    </div>
    <font style="font-size: 10pt;"><br>
    </font> </div>
  <font style="font-size: 10pt;"> </font>
  <div>
    <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
  <font style="font-size: 10pt;"> </font>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>15
<FILENAME>fiac-20241106.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 24.9.1.5252 Broadridge-->
<xs:schema targetNamespace="http://auldbrasspartners.com/20241106" elementFormDefault="qualified" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:fiac="http://auldbrasspartners.com/20241106" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:us-types="http://fasb.org/us-types/2024" xmlns:srt-types="http://fasb.org/srt-types/2024">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="fiac-20241106_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="fiac-20241106_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:roleType roleURI="http://auldbrasspartners.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000100 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/country/2024" schemaLocation="https://xbrl.sec.gov/country/2024/country-2024.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/currency/2024" schemaLocation="https://xbrl.sec.gov/currency/2024/currency-2024.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/exch/2024" schemaLocation="https://xbrl.sec.gov/exch/2024/exch-2024.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/naics/2024" schemaLocation="https://xbrl.sec.gov/naics/2024/naics-2024.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/sic/2024" schemaLocation="https://xbrl.sec.gov/sic/2024/sic-2024.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/stpr/2024" schemaLocation="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd" />
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2004/ref" schemaLocation="http://www.xbrl.org/2004/ref-2004-08-10.xsd" />
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xs:import namespace="http://fasb.org/us-types/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xs:import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd" />
  <xs:import namespace="http://fasb.org/srt-types/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd" />
  <xs:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/cyd/2024" schemaLocation="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd" />
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>16
<FILENAME>fiac-20241106_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 24.9.1.5252 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:label xlink:type="resource" xlink:label="dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CoverAbstract" xml:lang="en-US" id="dei_CoverAbstract">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CoverAbstract" xlink:to="dei_CoverAbstract" xlink:title="label: CoverAbstract to dei_CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentType" xml:lang="en-US" id="dei_DocumentType">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentType" xlink:to="dei_DocumentType" xlink:title="label: DocumentType to dei_DocumentType" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:label xlink:type="resource" xlink:label="dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_WrittenCommunications" xml:lang="en-US" id="dei_WrittenCommunications">Written Communications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WrittenCommunications" xlink:to="dei_WrittenCommunications" xlink:title="label: WrittenCommunications to dei_WrittenCommunications" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:label xlink:type="resource" xlink:label="dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SolicitingMaterial" xml:lang="en-US" id="dei_SolicitingMaterial">Soliciting Material</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SolicitingMaterial" xlink:to="dei_SolicitingMaterial" xlink:title="label: SolicitingMaterial to dei_SolicitingMaterial" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementTenderOffer" xml:lang="en-US" id="dei_PreCommencementTenderOffer">Pre-commencement Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer" xlink:title="label: PreCommencementTenderOffer to dei_PreCommencementTenderOffer" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementIssuerTenderOffer" xml:lang="en-US" id="dei_PreCommencementIssuerTenderOffer">Pre-commencement Issuer Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer" xlink:title="label: PreCommencementIssuerTenderOffer to dei_PreCommencementIssuerTenderOffer" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:label xlink:type="resource" xlink:label="dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_AmendmentFlag" xml:lang="en-US" id="dei_AmendmentFlag">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmendmentFlag" xlink:to="dei_AmendmentFlag" xlink:title="label: AmendmentFlag to dei_AmendmentFlag" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalYearFocus" xml:lang="en-US" id="dei_DocumentFiscalYearFocus">Document Fiscal Year Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus" xlink:title="label: DocumentFiscalYearFocus to dei_DocumentFiscalYearFocus" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalPeriodFocus" xml:lang="en-US" id="dei_DocumentFiscalPeriodFocus">Document Fiscal Period Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus" xlink:title="label: DocumentFiscalPeriodFocus to dei_DocumentFiscalPeriodFocus" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentPeriodEndDate" xml:lang="en-US" id="dei_DocumentPeriodEndDate">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate" xlink:title="label: DocumentPeriodEndDate to dei_DocumentPeriodEndDate" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:label xlink:type="resource" xlink:label="dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityRegistrantName" xml:lang="en-US" id="dei_EntityRegistrantName">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityRegistrantName" xlink:to="dei_EntityRegistrantName" xlink:title="label: EntityRegistrantName to dei_EntityRegistrantName" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityCentralIndexKey" xml:lang="en-US" id="dei_EntityCentralIndexKey">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey" xlink:title="label: EntityCentralIndexKey to dei_EntityCentralIndexKey" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityFileNumber" xml:lang="en-US" id="dei_EntityFileNumber">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityFileNumber" xlink:to="dei_EntityFileNumber" xlink:title="label: EntityFileNumber to dei_EntityFileNumber" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityTaxIdentificationNumber" xml:lang="en-US" id="dei_EntityTaxIdentificationNumber">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber" xlink:title="label: EntityTaxIdentificationNumber to dei_EntityTaxIdentificationNumber" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityIncorporationStateCountryCode" xml:lang="en-US" id="dei_EntityIncorporationStateCountryCode">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:title="label: EntityIncorporationStateCountryCode to dei_EntityIncorporationStateCountryCode" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="CurrentFiscalYearEndDate" xlink:title="CurrentFiscalYearEndDate" />
    <link:label xlink:type="resource" xlink:label="dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CurrentFiscalYearEndDate" xml:lang="en-US" id="dei_CurrentFiscalYearEndDate">Current Fiscal Year End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate" xlink:title="label: CurrentFiscalYearEndDate to dei_CurrentFiscalYearEndDate" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:label xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityEmergingGrowthCompany" xml:lang="en-US" id="dei_EntityEmergingGrowthCompany">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany" xlink:title="label: EntityEmergingGrowthCompany to dei_EntityEmergingGrowthCompany" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="EntityExTransitionPeriod" xlink:title="EntityExTransitionPeriod" />
    <link:label xlink:type="resource" xlink:label="dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityExTransitionPeriod" xml:lang="en-US" id="dei_EntityExTransitionPeriod">Entity Ex Transition Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod" xlink:title="label: EntityExTransitionPeriod to dei_EntityExTransitionPeriod" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine1" xml:lang="en-US" id="dei_EntityAddressAddressLine1">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1" xlink:title="label: EntityAddressAddressLine1 to dei_EntityAddressAddressLine1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine2" xml:lang="en-US" id="dei_EntityAddressAddressLine2">Entity Address, Address Line Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2" xlink:title="label: EntityAddressAddressLine2 to dei_EntityAddressAddressLine2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine3" xml:lang="en-US" id="dei_EntityAddressAddressLine3">Entity Address, Address Line Three</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3" xlink:title="label: EntityAddressAddressLine3 to dei_EntityAddressAddressLine3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCityOrTown" xml:lang="en-US" id="dei_EntityAddressCityOrTown">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown" xlink:title="label: EntityAddressCityOrTown to dei_EntityAddressCityOrTown" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressStateOrProvince" xml:lang="en-US" id="dei_EntityAddressStateOrProvince">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince" xlink:title="label: EntityAddressStateOrProvince to dei_EntityAddressStateOrProvince" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCountry" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCountry" xml:lang="en-US" id="dei_EntityAddressCountry">Entity Address, Country</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCountry" xlink:to="dei_EntityAddressCountry" xlink:title="label: EntityAddressCountry to dei_EntityAddressCountry" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressPostalZipCode" xml:lang="en-US" id="dei_EntityAddressPostalZipCode">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode" xlink:title="label: EntityAddressPostalZipCode to dei_EntityAddressPostalZipCode" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:label xlink:type="resource" xlink:label="dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CityAreaCode" xml:lang="en-US" id="dei_CityAreaCode">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CityAreaCode" xlink:to="dei_CityAreaCode" xlink:title="label: CityAreaCode to dei_CityAreaCode" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:label xlink:type="resource" xlink:label="dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_LocalPhoneNumber" xml:lang="en-US" id="dei_LocalPhoneNumber">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber" xlink:title="label: LocalPhoneNumber to dei_LocalPhoneNumber" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:label xlink:type="resource" xlink:label="dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_Security12bTitle" xml:lang="en-US" id="dei_Security12bTitle">Title of 12(b) Security</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Security12bTitle" xlink:to="dei_Security12bTitle" xlink:title="label: Security12bTitle to dei_Security12bTitle" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:label xlink:type="resource" xlink:label="dei_NoTradingSymbolFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_NoTradingSymbolFlag" xml:lang="en-US" id="dei_NoTradingSymbolFlag">No Trading Symbol Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag" xlink:title="label: NoTradingSymbolFlag to dei_NoTradingSymbolFlag" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:label xlink:type="resource" xlink:label="dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_TradingSymbol" xml:lang="en-US" id="dei_TradingSymbol">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TradingSymbol" xlink:to="dei_TradingSymbol" xlink:title="label: TradingSymbol to dei_TradingSymbol" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:label xlink:type="resource" xlink:label="dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SecurityExchangeName" xml:lang="en-US" id="dei_SecurityExchangeName">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SecurityExchangeName" xlink:to="dei_SecurityExchangeName" xlink:title="label: SecurityExchangeName to dei_SecurityExchangeName" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>17
<FILENAME>fiac-20241106_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 24.9.1.5252 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:roleRef roleURI="http://auldbrasspartners.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="fiac-20241106.xsd#DocumentAndEntityInformation" />
  <link:presentationLink xlink:type="extended" xlink:role="http://auldbrasspartners.com/role/DocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentType" xlink:title="presentation: CoverAbstract to DocumentType" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="AmendmentFlag" xlink:title="presentation: CoverAbstract to AmendmentFlag" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentPeriodEndDate" xlink:title="presentation: CoverAbstract to DocumentPeriodEndDate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="CurrentFiscalYearEndDate" xlink:title="CurrentFiscalYearEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="CurrentFiscalYearEndDate" xlink:title="presentation: CoverAbstract to CurrentFiscalYearEndDate" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalYearFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalYearFocus" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalPeriodFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalPeriodFocus" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityFileNumber" xlink:title="presentation: CoverAbstract to EntityFileNumber" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityRegistrantName" xlink:title="presentation: CoverAbstract to EntityRegistrantName" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityCentralIndexKey" xlink:title="presentation: CoverAbstract to EntityCentralIndexKey" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityIncorporationStateCountryCode" xlink:title="presentation: CoverAbstract to EntityIncorporationStateCountryCode" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityTaxIdentificationNumber" xlink:title="presentation: CoverAbstract to EntityTaxIdentificationNumber" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine1" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine1" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine2" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine2" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine3" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine3" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCityOrTown" xlink:title="presentation: CoverAbstract to EntityAddressCityOrTown" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressStateOrProvince" xlink:title="presentation: CoverAbstract to EntityAddressStateOrProvince" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCountry" xlink:title="presentation: CoverAbstract to EntityAddressCountry" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressPostalZipCode" xlink:title="presentation: CoverAbstract to EntityAddressPostalZipCode" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="CityAreaCode" xlink:title="presentation: CoverAbstract to CityAreaCode" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="LocalPhoneNumber" xlink:title="presentation: CoverAbstract to LocalPhoneNumber" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="Security12bTitle" xlink:title="presentation: CoverAbstract to Security12bTitle" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="TradingSymbol" xlink:title="presentation: CoverAbstract to TradingSymbol" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="NoTradingSymbolFlag" xlink:title="presentation: CoverAbstract to NoTradingSymbolFlag" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SecurityExchangeName" xlink:title="presentation: CoverAbstract to SecurityExchangeName" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityEmergingGrowthCompany" xlink:title="presentation: CoverAbstract to EntityEmergingGrowthCompany" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="EntityExTransitionPeriod" xlink:title="EntityExTransitionPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityExTransitionPeriod" xlink:title="presentation: CoverAbstract to EntityExTransitionPeriod" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="WrittenCommunications" xlink:title="presentation: CoverAbstract to WrittenCommunications" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SolicitingMaterial" xlink:title="presentation: CoverAbstract to SolicitingMaterial" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="PreCommencementTenderOffer" xlink:title="presentation: CoverAbstract to PreCommencementTenderOffer" order="28.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="PreCommencementIssuerTenderOffer" xlink:title="presentation: CoverAbstract to PreCommencementIssuerTenderOffer" order="29.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>image01.jpg
<TEXT>
begin 644 image01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  Y *D# 2(  A$! Q$!_\0
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MUO>QR17*O_POOXF99UEB20*PP84:6X,,/EV^^W\G[!9_OG10!_G*_&A)I/\
M@]KTJY47,T$7QW_9^MY+F2-MD4TG[!GP_P#(MFD#2(OR6MPEHC.K2V]J[I%&
M(WCCO?\ !SY97DO_  <'?\$V[R*"[N+2U^#?[%K75PD#/;6 N/VW?C]!;I--
M%$$A6XF1_)-S(7EF9TC<J$C3_1<HH _@%_X/E(KBZG_X)A0VT#7#6UI^VS>2
MK;B2:>&W3_ADYI[B>&.,F"TBCA+_ &EG*';/O$8AW/TW_!WO;7%Y_P $[O\
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MX(\>)?\ @G1X-^'WQH\!_M[?"?QS\1?"?P)\?Q>!OAEJ'@/P#IWC/XOMX_\
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M+C]M[XV:/=:C8^+-)^ GC/PAX!O]'GTV'5](^(7Q1LQ\,O!'B6P35@]I=_\
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M4>('O[3P'\+[W4;ER^IF[\&V$/Q.1-*3['IXD\7?:[]-5O;72GT3\+?^"O\
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MGZ[XFO/!WQ5\(6[)I6I^"M$\1I;Z]KGA1M1L++PT=<\0^'/H;_@WC\(>+/\
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LS5_'BW^K\0?]A'P?_P"H3:T ?YUU%?Z*.J?\@.+_ +!VC_\ JP[*LZ@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>image02.jpg
<TEXT>
begin 644 image02.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #Z /H# 2(  A$! Q$!_\0
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MQ.US5KQ[GXJ?&#1O!.K6_@5?&TFE^%/"NF:=%X@N_AW\-OAQ)\0?B!;^)?\
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MS\/V>KZ[H>EW6LW%I'IUOJ.LZ58S7*7.HVD4WT__ ,.G?^"IO_2-/]O_ /\
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MN?$7P_\ "7PGK7P9^(_B5_B9X5T+PK\"_$&F^)_A9X:^&+_$"'Q+J_P8\/\
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MB!X2^"7A*.\\?OH_B?X@?\(E_P 4Y<>-_%OVCX@>!]0\6@' ?M+?'3_AG?\
MX/:?#GC_ /X1;_A,/^$@_: _9.^!?]D_VW_PC_V3_AJ#]A_X-_LT?\)3]O\
M[(UOS_\ A!_^%M_\)K_8GV.'_A)O^$?_ .$<_M?P_P#VK_;VF_K]_P 'JW_*
M++X!_P#9_P#\+/\ UG7]JJC_ (*[_P#!+C]NS]J#_@OI_P $P?VUO@9\#/\
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MC^U9XJ_;>_;S_8Y_X(C? ?Q!X?TVYL?C!\&KGXGZIXL&HZ=X5C_:?_:2?2_
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M_%/C?XR:%'%>^'?$WA/_ %&OV>O@IX6_9K^ 7P/_ &=/ M_X@U;P3\ ?@_\
M#3X*>#M4\676G7WBK4O"OPK\%Z+X%\/:AXEOM'TK0M(O/$%YI&A6EQK-UI>A
MZ-IUQJ,ES-8Z5IUL\5I" ?XLW_!0K_@F+^V3_P $OOBGIGPM_:Y^&'_")?\
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M&WB*Z\"?!_\ 9QFU#Q=XY_:>UCP[X.UGPY>_V>^)?^"*GPL_:@_X)'_LE?\
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M>%_T_P#@1_P2Y_X)H_$7]O/2_P#@M;\ /'/B#XU?%;QEX?\ ']GX>^('A/\
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M?&+X.Z#81?\ ) /]?J?Q!^'NF0?\8_\ ^E>*O"MK_P * _M;2?V?_P"(*O\
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M^&M/\0^.O">NZO9^'[/5]=US5+71K>[CTZWU'6=5OH;9+G4;R68 _C"\6?\
M!#?Q5X]\5>)?'7CK_@N=_P $(?&GC;QIX@UGQ9XQ\8^+/^"FFH^(_%7BSQ5X
MCU&YUCQ#XE\2^(=8^$EYJ^N^(-=U>\N]4UG6=4N[K4=4U&ZN;Z^N9[F>65N?
M_P"'!?\ UFH_X( _^+&__P 3=?Z??_#IW_@EE_TC3_8 _P#$-_V=?_G<T?\
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MM.T?QYH^G:G:W6F>%?B!X5^(7P]\$@'[O?\ !H)_P53^#?CC]F#0_P#@EO\
M$;Q'X?\ !/[0?P5\0?%'Q+^S]H5S83Z-!\;/@UXO\0:Q\7_%=MHVOZAXCU2V
M\5?&#X>>-O$_Q*U;Q+X3L-(\(3GX-#PGXC\,:-XOC\$_&+Q+X:_M=K^"/PG_
M ,&1_BKP%XJ\->.O O\ P5J\0>"_&W@OQ!HWBSP=XQ\)_L?ZCX<\5>$_%7AS
M4;;6/#WB7PUXAT?]L&SU?0O$&A:O9VFJ:-K.EW=KJ.EZC:VU]8W,%S!%*O\
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MX@^%=LFN?$3X;6-O=_$.=/@U%XY\.PI\./AW\ _".EZS_%%_P4L_Y.*^'/\
MV8!_P2=_]=9?L;UX!^RK^TO\4_V-_P!H[X+_ +4?P4U;^R/B;\#OB!H'C_PU
MY]_XCL-'UW^R+H?VSX*\7?\ ")Z]X7\0:G\/_B!X?EU7P-\1?#FG^(-(_P"$
MK\">(O$7AFZO([+5[G(!_N\45X!^RK^TO\+/VR/V<?@O^U'\%-6_M?X9?''X
M?Z!X_P##7GW_ (=O]8T+^U[4?VSX*\7?\(GKWBCP_IGQ ^'_ (@BU7P-\1?#
MFG^(-7_X13QWX=\1>&;J\DO=(N<>/_MO?MO>%?V.O"O@?1]'\#^(/C[^U'\?
M?$&H_#W]D?\ 9'^'NHZ=8_$S]HCXF6.G+J>IP0:GJ:RZ1\./@_\ #C2)8O&/
MQ^^/WC&*/X>_!'X>QS>(?$,VHZYJ/A'PCXK /'_^"KG_  5<_9Q_X)*_LXW7
MQK^-=U_PE7Q \5?VOH7P!^ .A:M:Z=X[^./CO3K6VFGT_3YYK;4?^$5^'_A7
M^T=*U#XI?%*_TK4='\!Z/J.F6MKIGBKX@>*OA[\/?&W^*-7^DW^UY_P:J?M<
M?\%(_C+>_M5_ML_\%7O#\_QV\:>']!M=8\"^ /V1];\1_!KX)Z=:P2WT7P4^
M!%WXA_:9\)ZLWP?\!:OJFM6OA;5=7\)^'/%7C>>ZU3XD?$+3Y_B3XT\8ZIJ/
MP!\?O^#.'X-_LM?!KXA?M!_M!_\ !8?P_P#"OX-_"OP_-XE\=>.O$O[%DZ:=
MI&G)/!8VEM;6EC^UA>:OKOB#7=7O-/\ #WA/PGX>T_5O%7C+Q5JVC>%/"FC:
MSXDUG2]+NP#^&.O8/@#\ ?C+^U+\9?A[^SY^SY\/?$'Q4^,?Q4\00^&? O@7
MPU# ^HZOJ+P3WUY<W-Y?3V>D:%X?T+2+/4/$/BSQ9XAU#2?"O@WPKI.L^*_%
M>LZ-X;T;5-4M.?\ ^$*_X3'XI_\ "NO@79?$#XK_ /"5?$#_ (0KX.Z?_P (
M!_9WQ3^)7]N>(_["^'UG_P *M\'^(_B5]@^('C'[5I$'_" >%O%WC[[+XCU'
M_A'=$\1^*MEKJ=__ *K7_!N+_P $.-1_X)2?!KQ=\7_V@Y?#^L_MH?M'^'_#
M%KXZTG2[/PKK>G?L[_#W29[O6K/X*>%OB#8V=YJ^N^(-=U>\T_7?COJOA[Q*
M_P ,_$?BKPCX T#PII_B+3OA7I?Q3^((!^O_ /P3J_9=^(7[(/[(_P )_A!\
M9OCG\8/VC_CM'X?TKQ-\>OB[\9/CG\3/C]J/B/XRZWHFD#Q[;> ?%7Q1^QZM
MH7P?T+5[-]"^%_A/3O#7A&"V\*Z=9:_XGT:^^)/B+QUXJ\2?;]%% '\X/_!7
MG_@Y-_9Q_P""4/Q3UK]G#4_V=OV@/C;^T;;_  _\"?$7P[I7]E6OP?\ @3K>
MC^,O$=UI\\'_  NOQ=!J_B#5_P"R/#^D:[J'_"1?"WX/_%7P)/XQLO\ A5VH
M>+M$\9Z+\1;7X>_Q!_MB_P#!U/\ \%</VN_ EG\.M-^(WP__ &2/#[?:/^$E
MU#]CK0?&_P +O'?C#&L>&-=T;[9\4O%GQ&^)'Q-\&?\ "/WOAJ2"W_X5+XN^
M'/\ PD6C^)/$_AWQY_PE_A_4+;3+'_1[_P""KG_!*/\ 9Q_X*U?LXW7P4^-=
MK_PBOQ \*_VOKOP!^/VA:1:ZCX[^!WCO4;6VAGU#3X)KG3O^$J^'_BK^SM*T
M_P"*7PMO]5T[1_'FCZ=IEU:ZGX5^('A7X>_$+P3_ ),O_!3#_@E9^UQ_P2A^
M,NB?"#]J3PYX?GMO&GA]?$WPR^+OPVO];\1_!KXIZ=:P::/%%MX)\5:]X<\)
MZNWB#P%J^J6NA>.?"?B3PUX<\5:#/=:'K[Z-/X)\:> O%7BH ^ /%GBSQ5X]
M\5>)?'7CKQ+X@\:>-O&GB#6?%GC'QCXLUG4?$?BKQ9XJ\1ZC<ZQXA\2^)?$.
ML7-YJ^N^(-=U>\N]4UG6=4N[K4=4U&ZN;Z^N9[F>65OO_P#X)6?\%,/C+_P2
MA_:X\.?M2?"#0_#_ (TMI_#]_P##;XN_#+Q*D%KIWQ3^#7B/6_#FO>*O!-MX
MH&FZIJ_@+Q VK^$_#7B3PGXYT*UNI]!\5>'-&?7]#\:>"9_%7@+Q5^<%?7_[
M"W["W[1W_!1?]H[P9^R_^R_X,_X2KX@>*O,U/6=9U.2ZT[P)\,? FG75C;>)
M?BE\4O$UM8ZC_P (K\/_  K_ &C8IJ&H)8ZCK&LZQJ.A>"_!>A>*OB!XJ\)^
M$]= /]MGX _'[X-_M2_!KX>_M!_L^?$+P_\ %3X-_%3P_#XE\"^.O#4T[Z=J
M^G///8W=M<VE]!9ZOH7B#0M7L]0\/>+/"?B'3])\5>#?%6DZSX4\5Z-HWB31
MM4TNTZ#XI?"WP)\:/ FN_#;XDZ%_PD'A+Q!_9D]S;0:GK/A_6-*UCP_K&G^)
M?"?B[PCXL\-:AH_BWP)\0/ GBW1]#\;?#KXB^"=<\/\ COX=>._#_AWQSX&\
M1>'_ !;X?T;6;'P#]A;]A;]G'_@G1^SCX,_9?_9?\&?\(K\/_"OF:GK.LZG)
M:ZCX[^)WCO4;6QMO$WQ2^*7B:VL=._X2KX@>*O[.L4U#4$L=.T?1M'T[0O!?
M@O0O"OP_\*^$_">A?7] 'X _M3_\%%_CM^Q/^RQ^VO\ "C]J#4?^%;_M:>!_
M@!^V-XP_X)U_M >';3P=\6_^&W?!WP:^'5EK7@CXQ1?"KP/X(?\ X0S]H#X&
M?\+"^&.I?MF?#[Q9\#O!7P)L?[$^)O[1OPLM;C]DOPC\5(O@3_D"U_NL_MA_
ML>? +]NOX!>._P!G3]HOP'X?\:>"?&GA_P 4:;I>J:EX7\%^(_%7PN\5>(_!
M?B?P+8_%OX2WWCKPQXOTCP3\8/!.D>+]<N/ ?CRWT.ZU'PWJ-U)-#'/;3WEI
M<_YX?_!4K_@T2^,O['7P:^,O[4O[*G[1GA_]H+X-_![P_P#%/XM^.OAE\3M
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MH /^'L7_  2R_P"DEG[ '_B9'[.O_P \:C_A[%_P2R_Z26?L ?\ B9'[.O\
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M_9U_^=S1_P .G?\ @EE_TC3_ & /_$-_V=?_ )W- !_P]B_X)9?])+/V /\
MQ,C]G7_YXU'_  ]B_P""67_22S]@#_Q,C]G7_P">-1_PZ=_X)9?](T_V /\
MQ#?]G7_YW-'_  Z=_P""67_2-/\ 8 _\0W_9U_\ G<T '_#V+_@EE_TDL_8
M_P#$R/V=?_GC5\0?\%-?^"FW_!-SQ[_P3;_X*#>!? O_  4&_8@\:>-O&G[$
M'[5_A/P=X.\)_M7_  &\1^*O%GBKQ'\!O'VC^'O#7AKP]H_CV\U?7?$&NZO>
M6FEZ-HVEVEUJ.J:C=6UC8VT]S/%$WV__ ,.G?^"67_2-/]@#_P 0W_9U_P#G
M<U\0?\%-?^"97_!-SP%_P3;_ ."@WCKP+_P3X_8@\%^-O!?[$'[5_BSP=XQ\
M)_LH? ;PYXJ\)^*O#GP&\?:QX>\2^&O$.C^ ;/5]"\0:%J]G::IHVLZ7=VNH
MZ7J-K;7UC<P7,$4J@'^7)_P4L_Y.*^'/_9@'_!)W_P!=9?L;U\ 5]_\ _!2S
M_DXKX<_]F ?\$G?_ %UE^QO7U_\ \$D_^""?[9/_  5R^T^/_A;??#_X4?LR
M^%?B!-\/?B+^T!X_\06.H_V3XBT/_A6^M>+O!_@KX4^';VZ^('C'X@6'P_\
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M /L>E^'_  =XO^*=EXC^)5O_ ,+-\->'_@+X^TG_ $^Z_P H7_@YG_X(O?\
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M(_!+>.KB74=3\5>*_B3\1+3P_P##Z/XCW'P_\-?Q144 ?Z??_$:M_P $LO\
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MT[ T_C'QY\+M3\?ZC\+O$DGARV_E"_X**_\ !SU\&O&GP:^+'P\OOV,O@_\
MM<?L.?&GQ!JOPDT?QM\&_P#@K-/\"?C+\7?A[=3ZO=RQ^/OV8_#WP=^'G[>'
MP#\/Z]8>%M4\)?%#3?'7@?0OAGXB@NKWP9:>//BM\(_B9X.\1?$S^.+]D;_@
MJ9\=O^":O[1WB_XQ?\$W-=^('P2^&7C7_A K/Q9\"_CKXS\'?M&Z/\2?#O@V
MZTC6[GPY\6]7T;X2? [P_P"(OM_B"/Q;:^'_ !KX ^'WPJ^*?P^\">.O$O@_
MP9X_TV]UKQ+XI\1@']/MY_P<-_\ !:O_ ()@?MV>(_\ @G?^VKX/^ '_  4P
M^)OA?X@>"M,U*V^#7AC7OA_\4_'>L?'#X.^ /$OPG^%OP1\6?#3X6^"?#]S]
MF\0>-O"MV^GZ_P#LE>,?'?B?Q'J?BWP1I6NRV5_X-UGP[^_W[3G_  5Y_8V_
M;(_X)V_\%./@5INM?$#]F[]KK1OV /VP/^$F_8C_ &Q? E]^SK^UCH7]H_LN
M_&[QCHWV/X9^++J6R^(']I_#+PO)\6[C_A4OB7XA?\(I\-M=\,>(/'G_  B<
MNMVU@/X _P#@IS_P7V_;)_X*M^!/!?PZ_:%^%_[('A#P_P""?^$C_L_4/A;^
MS[8W/CL_\))K'@'7;K^POBE\:_$?QG^)OPL_TWX=:+!J?_"C_%WPN_X3?1[G
M4/#OQ+_X3;P^NE:9I7Y0_$?]H7X^_&/PK\,? OQ=^.'Q@^*G@GX)^'V\)_!G
MP=\1_B7XT\<>%?A'X5?3O#^COX:^&/A[Q/K6J:1X"\/MI'A/PKI;:-X5M-*T
MYM.\->'[$VQMM&TZ*V /I_\ X*6?\G%?#G_LP#_@D[_ZZR_8WK]OO^#>'_@X
M?^%G_!)?X6?&?]FC]I?X,?$#QW\$O'?Q OOCIX*\:_ NQ\.ZQ\4]$^*>L>'/
M /@#Q'X6\4^'/'_C[P)X2UCX?ZQX2\":#JVB:WI.O:/XC\(>(]'U>PO](\=Z
M9X[L[SX:?B#_ ,%+/^3BOAS_ -F ?\$G?_767[&]? % '^GW_P 1JW_!++_H
M@?[?_P#X:S]G7_Z*JC_B-6_X)9?]$#_;_P#_  UG[.O_ -%57^8)10!_I]_\
M1JW_  2R_P"B!_M__P#AK/V=?_HJJ\?^/W_!VQ_P1-_:E^#7Q"_9\_:#_9!_
M;?\ BI\&_BIX?F\->.O OB7X3?L^/IVKZ<\\%]:7-M=V/[6-GJ^A>(-"U>ST
M_P 0^$_%GA[4=)\5>#?%6DZ-XK\*:SHWB31M+U2T_P V2B@#H/%EMX6L_%7B
M6T\"ZSX@\1^";7Q!K-MX.\0^+/#.G>"_%6N^%8-1N8O#VL^)?!VC^+/'ND>$
M_$&J:0MI?:SX:TOQUXTT[0M1GN=+L?%GB.VM8M8O/Z/O^#?K_@N?\ O^"2&H
M^.O"_P =OV-/#_Q/TCXC^(-7U*7]J3X2Z)X+B_:X\ ^%=6\*Z.FL?"6.Z\8_
MV/;?$SX/Z_XV^'7PPU[3? ;?$WX4Z=X%UN7QYX]NI/B/J]_X>\-Z1_-#10!_
MN\_LT?M5?LX_MD?"S2?C7^RY\:/A_P#''X9:O]@@_P"$E\ :_:ZO_86L7_AS
M0?%G_"(^-=&S%X@^'_Q TSP_XH\/:AXC^'7CG2O#OCOPI_:]G:^)O#ND7LGV
M8>_U_B#?\$T?^'CO_#4_A/\ X=<?\- ?\--?\2+_ )(%_:G_ ")W_"Q? ?\
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M_P"$O^$MT*>]_P D7_@JY_P5<_:._P""M7[1UU\:_C7=?\(K\/\ PK_:^A?
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M^U+_ ,*[^&7P5^(%CX \2_ OX.-X=O/VCO$/]O>!-4UO1O&NJZOXLMM;\/\
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M]I_O^"C?_O&Z_P @6O\ 5;_X(*?%O4?B'\??^#C+]D?1Y/$'PVU?P%_P5?\
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M_P# [1/@]_P5=\%_M5ZC\</C+_P4)^"'[1O_  5&_P""97P_^.?PG_:@\0^
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M_9]\0>*/"O\ P3^\2V'[&-U_PE.F?M/:BW?_ +#'B'QI#JOC;X(_ '0O#_\
MP5W\+>%O@_\ M*>)/A3^SU^U!^UM\ H_"OQP^'OB;_@I=_P7]^&GQ4_;K3Q]
M\0_@Y\6[GXG_ !@^,7@G3?A!^R7XT^('PKL/!WPS^*^G?MO6)_:0U6/X4OX;
M\3?#[Y@_95\+?"+7OV5/C\OQZ\%_$#0/"6I?L@?\$^M-^%UM\'/VA_C9^SIX
M[_X*??&S2O\ @C'_ ,$N?$NG_P#!+K5?%GP?\5Z=X2\5?\)5X2T[6_AQX'^
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M%G_"T_V-_AE_PUK\0/\ A=O_  L#_@I9%_PP;_POGP[_ ,,S_P##3'_"1_\
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MPSNH/ [^)_'=K\$]1\=>#OAY. ?UN_L"_MB_M8^.O^#>G]M3]L/_ (+3V?\
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MH?A3X4Z%\.P#]'_ 'BWXN_%'_@CGXU^%G@#]M+X@>)?V:_A_^P!XC^+7B/\
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M'OA[\<=974/'=OX[_P"">G[)WB'_ ((Q_P#!*RV\;_\ !0[]GOQ-X$T+4?\
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M_P %#OVJ/^"A?[$7A7Q5\=O@/^QOX?\ ^"D'PIN?$'@[1K'X#_!2]\??"/\
M:?\ @WIUUIUII.J>+-0%IHO[25M^U;X?\3>-KLM=6WPV^&'P/\5?!'P^VE76
MK>&OC'X6G\=?$GX8?SQ> /\ @]Y_99U'X6>-=7^*7[#_ .T!X.^-MA_PD?\
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M$.GWL'[*T%[K/A3Q7HWCK]J/QUJFE_&'_+DKZ _9.^.G_#+_ .U/^S3^TO\
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ME^)7QD^(5QXT\3Z5X8\!Z;\0[:.[U^$ ^(+S_@J%\$_V8?\ A([G]@;X$_\
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M)I?Q$\>^'U^(GBSXX^(;764T?Q=X@U+43JO@[0+F[MO#NC^'-+_CB_X)P_\
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MM+Q9X_\ 'WB9=.\.>%="UGQMX^\4V>D:7K>NP?Z3?_!%'_@W-_9Q_P""5?\
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4 !1110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>image03.jpg
<TEXT>
begin 644 image03.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" && %L# 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
,B@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>image04.jpg
<TEXT>
begin 644 image04.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1"  O #$# 2(  A$! Q$!_\0
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M^MFG4"*Z3D2CC/\ O>WOVI?">IR7MK);W>1=VQV/GJ1V-52JSA/V577L^_\
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/)*7M:KO+\$ 4445U ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>image05.jpg
<TEXT>
begin 644 image05.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" !% .X# 2(  A$! Q$!_\0
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MQ9;7UKX,FU>P\37<YMX-R.A0K)SP3Q[U7L6FDWN+GTNCT_'M17DWBHZAX?\
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M#I=E?Q1VOE3Q2L 5?)YR3@C!IMOX0U&V^&FHZ+\C7MTSR+&#\D>XYV GL*]
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MMXO,GECCC_ONX H2]MWMS.DT;0@9WA@5_.G[66X<B//+7P7>Z=\2XM5L]O\
M8Q620QY_U<C#G ]#79>,+&;4O"^I65J 9YX&1 3@9-7K74;6[)%K<0S$=?+<
M-C\JB;6=/6;RC>6PDSMV>:,Y],4G.3:;Z HI+0Y3Q'X=OM0\#Z9I<,:-<0/
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M(FD9F7S0,Y+'.[DD'- '0:AXNTJQ\::5X6D=WU?4H9+B.- "(XT!.Y^<@'#
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MH'W<>G>:W_/"7\U_QH Y#2_B%8ZA)ILATK5K;2M4E\FPU.>.,07+'.S #F1
MX!*ET4'CN0"^^\?Z=:7]W&UAJ,FFV=RMG=ZJD<9M;>8X&ULN)#@LH9E0JI/)
M&&QAQ74OQ(U_3+VS@D7P=H]W]KBN<@'4KJ/*H8^?]2AR=W\; 8X&3RM].(O@
MM\0=+G!;46U/4K0QDKN>>>=FA7&<DN)(R/K0!Z/K'CNUT^^U2"WTC5]2@TD*
M=1NK*.(Q6I*[RI#R*[L$(8B-7(##OQ6KK_BC2=#\(W'B2^N5_LF&W%SYJ<[U
M;&P+GJ6)4 =R17*>,M7OM?>Z\$>'$D.H20+'JU^2"FG02+SW^:9USL7MG<<
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M\^UC_P!\/_\ %4?\+'U;_GVL?^^'_P#BJ**7LH=@YF!^(^K?\^UC_P!\/_\
M%4'XCZK_ ,^MC_WP_P#\5111[*'8.9G<>"-:N-<TU[FZ2)'#E<1@@?J371T4
*5Q5$E)I&T=C_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45777794352656">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Nov. 06, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Nov.  06,  2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-40977<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">DEVVSTREAM CORP.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001854480<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">A0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">86-2433757<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">2108 N St., Suite 4254<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Sacramento<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">95816<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">647<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">689-6041<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common shares<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">DEVS<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>25
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    (  **;5D'04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    "  "BFU9F%]UM^X    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9+/
M2L0P$(=?17)O)TEE#Z';B^))07!!\1:2V=U@\X=DI-VWMZV[740?P&-F?OGF
M&YC6)&5BQN<<$V9R6&Y&WX>B3-JR(U%2 ,4<T>M23XDP-?<Q>TW3,Q\@:?.A
M#PB2\PUX)&TU:9B!55J)K&NM42:CIIC/>&M6?/K,_0*S!K!'CX$*B%H Z^:)
MZ33V+5P!,XPP^_)=0+L2E^J?V*4#[)P<BUM3PS#40[/DIAT$O#T]OBSK5BX4
MTL'@]*LX1:>$6W:9_-K<W>\>6">YO*V$J$2SDU*)C>+\?7;]X7<5]M&ZO?O'
MQA?!KH5?=]%] 5!+ P04    "  "BFU9F5R<(Q &  "<)P  $P   'AL+W1H
M96UE+W1H96UE,2YX;6SM6EMSVC@4?N^OT'AG]FT+QC:!MK03<VEVV[29A.U.
M'X416(UL>621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X
M8-DOV]:[MR_>X%<R)!%!,!FGK_# "J5,7K5::0##.'W)$Q+#W(*+"$MX%,O6
M7.!;&B\CUNJTV]U6A&ELH1A'9&!]7BQH0-!445IO7R"TY1\S^!7+5(UEHP$3
M5T$FN8BT\OELQ?S:WCYES^DZ'3*!;C ;6"!_SF^GY$Y:B.%4PL3 :F<_5FO'
MT=)(@(+)?90%NDGVH],5"#(-.SJ=6,YV?/;$[9^,RMIT-&T:X./Q>#BVR]*+
M<!P$X%&[GL*=]&R_I$$)M*-IT&38]MJND::JC5-/T_=]W^N;:)P*C5M/TVMW
MW=..B<:MT'@-OO%/A\.NB<:KT'3K:28G_:YKI.D6:$)&X^MZ$A6UY4#3( !8
M<';6S-(#EEXI^G64&MD=N]U!7/!8[CF)$?[&Q036:=(9EC1&<IV0!0X -\31
M3%!\KT&VBN#"DM)<D-;/*;50&@B:R('U1X(AQ=RO_?67N\FD,WJ=?3K.:Y1_
M::L!I^V[F\^3_'/HY)^GD]=-0LYPO"P)\?LC6V&')VX[$W(Z'&="?,_V]I&E
M)3+/[_D*ZTX\9Q]6EK!=S\_DGHQR([O=]EA]]D]';B/7J<"S(M>41B1%G\@M
MNN01.+5)#3(3/PB=AIAJ4!P"I DQEJ&&^+3&K!'@$WVWO@C(WXV(]ZMOFCU7
MH5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU+,76>)7 \:V<
M/!T3$LV4"P9!AI<D)A*I.7Y-2!/^*Z7:_IS30/"4+R3Z2I&/:;,CIW0FS>@S
M&L%&KQMUAVC2/'K^!?F<-0H<D1L= F<;LT8AA&F[\!ZO)(Z:K<(1*T(^8ADV
M&G*U%H&V<:F$8%H2QM%X3M*T$?Q9K#63/F#([,V1=<[6D0X1DEXW0CYBSHN0
M$;\>ACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=*Y \FIS_I,C0'
MHYI9";V$5FJ?JH<T/J@>,@H%\;D>/N5Z> HWEL:\4*Z">P'_T=HWPJOX@L Y
M?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=RS<C'5*^3*=@Y
MG\#L_6@^GO'M^MDDA*^:62TC%I!+@;-!)+C\B\KP*L0)Z&1;)0G+5--E-XH2
MGD(;;NE3]4J5U^6ON2BX/%ODZ:^A=#XLS_D\7^>TS0LS0[=R2^JVE+ZU)CA*
M]+',<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^ VVZG=PZ.)Z8D;D*
MTU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCRHB'NH8:8S\-#
MAWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+: '@Z]1 O)256 Q6\8#*Y"B
M?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYEL<%5'<]56_*P
MOFH]M!5.S_Y9K<B?#!%.%@L22&.4%Z9*HO,94[[G*TG$53B_13.V$I<8O./F
MQW%.4[@2=K8/ C*YNSFI>F4Q9Z;RWRT,"2Q;B%D2XDU=[=7GFYRN>B)V^I=W
MP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41 71% B.5' 86%S+D4.Z2
MD 83 <V4R43P H)DIAR F/H+O?(,N2D5SJT^.7]%+(.&3E[2)1(4BK ,!2$7
M<N/O[Y-J=XS7^BR!;814,F35%\I#B<$],W)#V%0E\Z[:)@N%V^)4S;L:OB9@
M2\-Z;ITM)__;7M0]M!<]1O.CF> >LX=SFWJXPD6L_UC6'ODRWSEPVSK> U[F
M$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X Q\U*M:I60K$3]+
M!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F 6/,,H68XWX=%FAHSU8NL.8T*;T'5
M0.4_V]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\!4$L#!!0    (
M  **;5D7PE%>?@0  *\1   8    >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL
MC9AM<^(V$,>_BL:=Z;0S(;:%>4@*S!!"KLQ=$B[0W+2=OA"V ,W9%I7D0+Y]
M5P9L+C5KWH"?]/?/NZO_6NYMI?JNUYP;LDOB5/>=M3&;6]?5X9HG3%_+#4_A
MS%*JA!G852M7;Q1G43XHB5WJ>6TW82)U!KW\V%0->C(SL4CY5!&=)0E3[W<\
MEMN^XSO' R]BM3;V@#OH;=B*S[CY8S-5L.<6*I%(>*J%3(GBR[XS]&_O:-L.
MR*]X%7RK3[:)?92%E-_MSB3J.YXEXC$/C95@\/?&1SR.K1)P_'L0=8I[VH&G
MVT?UA_SAX6$63/.1C+^)R*S[3M<A$5^R+#8O<OL[/SQ0R^J%,M;Y+]GNKPT"
MAX29-C(Y# :"1*3[?[8[!.)D &V>&4 / VC.O;]13GG/#!OTE-P29:\&-;N1
M/VH^&N!$:K,R,PK."AAG!O<RS"#(AK T(N/4"/-.)ND^VQ"UGFO@)O92-SP(
MWNT%Z1G!)_EV3;SV%:$>#7X<[@); 4@+0)KK-<_HC>0;5^3OX4(;!2G\IXIH
MKQ!4*]BZOM4;%O*^ X6KN7KCSN#GG_RV]QO"URSXFIAZ&<#Y^X97P>'#NXW/
M"$100 2HRA (HISB(6:K*@I\_)+%FB,<K8*C=5DPIEP):0LJ(E"6E7'!E?(R
MRNNHKI#:!5L;51QE2N41$CID,?F3,X7RX6J-AD\;31_AZA1<'53I,.D>1,S)
M4Y8LN*JBP34\SV\$WDVG@_!T"Y[N)3PO?"7LE(.(/;&D,D*XSOWX]74V?QD/
M'\GH^65ZC:#=%&@WEZ"-((T*4CA)([XCG_E[%1RNY$'$NJT@Z'H(EN^5)NI=
M C9)0ZDV4N76>45F!DJ+2$5&,@-B )=192!KU(<HY(G3^Y= SMF.3"((H5B*
M,"=%RJY&LMMNT*#9[+2PPO-+J_=1ISX2#J,(?%I?'3?(%[B./*?5L<,EJ>]U
MR1.DXAKRD0G(1T!;F)WXI?'[N'5_I!W9/<CV7&ZK^R8N-V.A8M8\)497=@0?
MM_2/=$4Q3I5\$VE8'4Q<<S3$T,HFX>/>_A%M*K6!Z?R7V)R?(;CB3:OKMS&V
MLDGX-5TB)X/WV_,HN$ [0.="V15\W-*_2-NEIFN98FVA1J3=O6FTO0!K4W[9
M%WS<T.?"0(N22^+37Q:_DAD/,P71JL3"E48R2<!V])I! 6!L96/P<3^?*Q:)
M=$5F[\E"QI5(N !TJQGVMEJV HJ;]3$L9+P+URQ=\;/MLT;H:3B['W[%F$KG
MIQ<Y_SCA:F6C] D4S!HJ/-FPM#*!-8)&9=CK(CUYN;_(\<<[ AF$I5[>CO8O
MCY58N%K=:RPMO9WB9OP-4FAX:D.49.FA3^I*)%RH%JDT=(J;[TS&(H0 0?X>
MP<J58)5U7J-2RU.Z.,4]=ZIX(X3P<.@E^P40K$%@J?:\7%9[58U>+5GIX12W
MX/^13;3.@*P6$)<]"^B>++_MIXQ'9J>9)C%?@I!WW8$'5_NO _L=(S?YBGPA
M#:SO\\TU9\!F+X#S2RG-<<<N\HMO-(/_ %!+ P04    "  "BFU9GZ ;\+$"
M  #B#   #0   'AL+W-T>6QE<RYX;6S=5VUKVS 0_BM"/V!N8FKBD1BV0&&P
MC4+S85^56'8$>O%DN7/ZZZ>S;"=I=67=A['-H<G=/;J[1W<GF:Y;=Y+\X<BY
M([V2NMW0HW/-^R1I#T>N6/O.-%Q[I#)6,>=56R=M8SDK6W!2,EG>W&2)8D+3
M8JT[=:=<2PZFTVY#;VA2K"NCSY:4!H-?RA0GCTQNZ)9)L;=B6,N4D*=@7H+A
M8*2QQ'DJ?$,78&F? KP(&K <XRBAC05C$C*$[_VX_!DP::U7A90SP24-AF+=
M,.>XU7=>&18/QA<0&>7=J?$,:\M.B^4M/3L,/S[)WMB2VSG-@DZF8BUY!72L
MJ(_PZTR3 .B<45XH!:N-9@.'R6,4?-@#E_(!6OBMNHK=5R3TXE,);2"PU4GT
MA$8QA D*Q+^,%F)?A+W]K;"D$8_&?>S\;O2@?^^,X_>65Z(?]+Z:\V/1%WAT
MUC3R]$&*6BL>]O[+"8LUF_S(T5CQY+/!I!R\@5M*'KEUXG!I^6%9L^.]FZ:I
MKW#.RW^0\Y^M<\TUMTQ>DO:C_S=7^2V,D_'T7!S1JP,Z6PE<A!OZ%>Y7>>9
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M)$WS/(X %F>0IA@"IQ%', ;  4/2='@//GL?)=-[*CG_5U/\!%!+ P04
M"  "BFU9EXJ[',     3 @  "P   %]R96QS+RYR96QSG9*Y;L,P#$!_Q=">
M, ?0(8@S9?$6!/D!5J(/V!(%BD6=OZ_:I7&0"QEY/3P2W!YI0.TXI+:+J1C]
M$%)I6M6X 4BV)8]ISI%"KM0L'C6'TD!$VV-#L%HL/D N&6:WO606IW.D5XA<
MUYVE/=LO3T%O@*\Z3'%":4A+,P[PS=)_,O?S##5%Y4HCE5L:>-/E_G;@2=&A
M(E@6FD7)TZ(=I7\=Q_:0T^FO8R*T>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X
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M%_\;SO$1PNZ_/[&\UDX:?^:+X3]>?P%02P$"% ,4    "  "BFU9!T%-8H$
M  "Q    $               @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4
M Q0    (  **;5F87W6W[@   "L"   1              "  :\   !D;V-0
M<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    (  **;5F97)PC$ 8  )PG   3
M          "  <P!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @
M HIM61?"45Y^!   KQ$  !@              ("!#0@  'AL+W=O<FMS:&5E
M=',O<VAE970Q+GAM;%!+ 0(4 Q0    (  **;5F?H!OPL0(  .(,   -
M          "  <$,  !X;"]S='EL97,N>&UL4$L! A0#%     @  HIM69>*
MNQS     $P(   L              ( !G0\  %]R96QS+RYR96QS4$L! A0#
M%     @  HIM61PX9>H_ 0  / (   \              ( !AA   'AL+W=O
M<FMB;V]K+GAM;%!+ 0(4 Q0    (  **;5DD'INBK0   /@!   :
M      "  ?(1  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0
M   (  **;5EED'F2&0$  ,\#   3              "  =<2  !;0V]N=&5N
B=%]4>7!E<UTN>&UL4$L%!@     )  D /@(  "$4      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="ef20038430_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000100 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://auldbrasspartners.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="ef20038430_8k.htm">ef20038430_8k.htm</File>
    <File>fiac-20241106.xsd</File>
    <File>fiac-20241106_lab.xml</File>
    <File>fiac-20241106_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="24">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>31
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ef20038430_8k.htm": {
   "nsprefix": "fiac",
   "nsuri": "http://auldbrasspartners.com/20241106",
   "dts": {
    "inline": {
     "local": [
      "ef20038430_8k.htm"
     ]
    },
    "schema": {
     "local": [
      "fiac-20241106.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2004/ref-2004-08-10.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/currency/2024/currency-2024.xsd",
      "https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/exch/2024/exch-2024.xsd",
      "https://xbrl.sec.gov/naics/2024/naics-2024.xsd",
      "https://xbrl.sec.gov/sic/2024/sic-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "fiac-20241106_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "fiac-20241106_pre.xml"
     ]
    }
   },
   "keyStandard": 24,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2024": 3
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 31,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 24
   },
   "report": {
    "R1": {
     "role": "http://auldbrasspartners.com/role/DocumentAndEntityInformation",
     "longName": "000100 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c20241106to20241106",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20038430_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c20241106to20241106",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20038430_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://auldbrasspartners.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://auldbrasspartners.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://auldbrasspartners.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://auldbrasspartners.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://auldbrasspartners.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://auldbrasspartners.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://auldbrasspartners.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://auldbrasspartners.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://auldbrasspartners.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://auldbrasspartners.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://auldbrasspartners.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://auldbrasspartners.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://auldbrasspartners.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://auldbrasspartners.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://auldbrasspartners.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://auldbrasspartners.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://auldbrasspartners.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://auldbrasspartners.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://auldbrasspartners.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://auldbrasspartners.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://auldbrasspartners.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://auldbrasspartners.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://auldbrasspartners.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://auldbrasspartners.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://auldbrasspartners.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://auldbrasspartners.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://auldbrasspartners.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://auldbrasspartners.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://auldbrasspartners.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://auldbrasspartners.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>32
<FILENAME>0001140361-24-046512-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001140361-24-046512-xbrl.zip
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M QO0.^3EV!"I@NX:*3!W8L^\"=,X\C(WC>*-\SY*Y5WBNDX4WWU/] WP6T!
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M/!U7/<G;\'K[X:2&R)T/C>QQ*3S6OST)!+TBZ! %^*DM_>F4B$IQ>J54SK&
ML$_\-:'XEUD?J@5$3<LH\% NHW(AL*!%,V<P^D>!V3">D-H$Y_L[H+<" "R1
MOC4,12U*XT43&S:&"'/5ON&J<YE>2AD6@&SVK];3O2,VB9\UG.OI5CL"ZK#6
MGN82*!-^T/I+DRZ%K AE'D:,U+P)(B7P'[5NODAOT6B^=TL=LZ?6N[!8=4&@
MJRUT. I+I)D?4ZYBY^HX\4X@Q@?5@-H8Q;W%*.Y%E7S-GE7"JBMU2H."%560
MG%8A<)\YLVF6:"HDFIOO-G-]%X5Q)*OLU1Q6K1):L:\Z2G^+5#H#.O4[: ^
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M"FE2D(C8(: _Z#%/4@8*DCHB&E*]9JP894'[S25,-??O\6@5Q9.&#HK_?O^
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M82E8=HI2W/P0C*F,B)C6@<T*%@NL&R57OJKIB,UP^67/C[[ZGF0#35MB&"7
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MB4*YECAV!LG0QDD3BY9P%Y<1B 5/+6C0ZXU9S$I7K*2U!L"[0:_?+RP2V\8
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M,) X:@"H)E2/1::<_/B(W:S7P8;;1*:B[/2Q>G JQ:<,1FRK9RVGQ+%!EIR
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MA3M>+(0/B'Y.#MK]7.R#7(G)\\V1_CPMS/:BJ2,YP#LQFEC5>HK;TDFNZ$:
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M40UR,8L$FF'L 6!H9.G"FCUXS,ANVBJ5BRQRQ8U7[%*D*A;N@:O3J301@BY
M"J PO1?<ASX%78>,C6+GS\T6I<*%AG7O[D#ES!@Y\>H>:<(;NUB(B]X+]CVY
M@L]DZ Q_GD @&[A-3H*IITQ^7 [U:><8YL#)(O:F4CVC5+ 0NR%EX X>KO0D
MQA&%=4*IZ(P) JP&84[5@PBMER@]#Y&R?U/E ;1'4L8I[J=72E4.EIHG&V?&
M10";Q#KC/W<"!D6JD%=%68511*L>5D(46O%6]BC :_F;FH;0#NIA%^L"FS$@
M:8AJ+0&A*@.>R@D6[\YYITL8:D95A.QO%6VM-2/@:[5)"XKF-^&*!O=_SVQT
MTGFFF]84$RE!@$=G<+4ZN6&80#:(66B[=_@P+Z8HNAJH9,Y3.D2OZCV7.C[8
MV2"7.%T<HL>TFL'OXXE,]8DH+TB%%N(2_HGM*^$Q*UHTCCL_ZI"^W&R@YWX#
M-R]D( (]B6#!%W6(1;E<.C31$L5 \(_6H;8P;8F3/KC15S;CAR<*&RG0!+H3
MVBQ$;SC_2V1J3?_X1C?Q.!\(%66W>[R>W +^!&[^,C;UG#C4&V@5@8JU.Q?5
MUT@$%-"?)=1VK8_B^82_,\DRKZ_^=6-PAJKAOJ :[KK3)XP%Z5- X3(D&JP&
M3$=B<3BOT8C#.#/5** 3\.A-Z-)6%T0-CMD$UA"-6U;YA;6ETIW:+[F6BG(M
M>ZOF- 4!J "ZLY"W0+_:C<?.R!1&D#RT7&I.Y_R+(]'<9%,D]HCQ-QPQH2_F
MQLV$YKI-9ER/JA=N=3T)S&NH&4*=&S$K$J+P>452!F)H#GIYG _NI!,!0X7
M:],Y<]]]J.7XU9QK$I]&1T"=@RQ6P#.P45)TW2\W]Z3=BIUAHG;'+@=0M;6W
M+MFK*31O:*$$,]WT)-D]]PD/4=U]9E!IY-RX/OG8OP6&7+MAPR3"80*'Z-"5
ML2=U2@TC-F8,KEUOM JBO$!\W'<.9'V'%\>)JC*+79_JKU)Q]\0\^5B=O"PA
M^$;-L==V/C8K)C2-'B")YI2U9$] TPH0B0;F>F)>R#YYW36MGP9M/^9J"O)
M9\U-YH$.D.8A 34)8*B+2C5\,@'I5 [J "G>MGZL!DDO=2SI+DG9B@0VD0Y&
M$0A:-O<!1>5P 924&\D>+.BU,C2F1U!WKN":PI7(,&LL.JY27X-LQ^@>- $M
MVRIZURK![O$9AO$L-741*W<AT>!1A;D9Y7 C#Y>+V Z@F@!:BT6ZGMN,_X:
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MM8(+=-0H9,*=3R)\+Y1UQ+'S3*"<\/-;6(9LQJHH=4,:0GB]\?)EU$3!@Z9
M_LQ;SZ=>%@.-YLR1;S1%3OQV;^ &W9-?2P/6F'4A8@/T1NTPSC/86F]4[$!)
M!3I469N]RQ'<'"(G&C6-:"TLJ%0I*PY4.YNLCE1G8N@\2Y*6J'0R4'OU6@SW
MN6=<JF@Z=8M2=6 OL=0-Q%*MGPVN3<'TEAMJD#MLH))1!]9Q6MT<W\'JU/'F
MP?%GL/1ILQK0WY1 V()5 .LO%G36R0/HWTH#@.3%=@X&OY,S3&'Q7FEAB[:*
M,PZ>9ZN7!K"8*TQG1PNL3P/^1%>6$;B!^0L2/O"[V]N35ZZ/1MS-F''YV+?K
MD%Q5AJF#OLO.]#LG-=O (,C,?(,L]/76P&3+J(PR5J7.M!<5FRH-@&Z@B=O.
M'P,Q)%7)!\EMCUH7KP+^8V0X83DEK"M&A;*R#/]TS$XZ HW\]D:VH-#:X/R4
M8G$%X?/ZGDY5R=V5G3F1^111)I")4B\2)AE1\EV!&#D4E\J4/9F^AG?!+ JA
MX"R,YB@!:H9PPF#',DO4%E4J&2.$#U_> F&CK%CC*A$_&Z;+%KAC!U]2E;_7
M[ZZO,@!"'\(@"EFZ7I\NN($2.8CGI6[TGD$Q24Z-_Y)6@%+V\Q?#IY2[C!=M
M$\I*Q4^WSB66>O>Q A*<#2SKEOUKI0XDMT^ANK.BL0$JZ%BCZD3PPP>,:35C
M\*YVD(Q<1Y]J")N]=ION2 "[*0P<\^L2]8: *^"A\$ \8H+A1?PHHW1QP,2'
MF253@Y"']*>Z$=@CFTR-=@/BF!OATT%_P%'K6!)Y:B=\2:=\!9\3?MYGC7,S
MY&TT%+PN/(K-QW9>=.]F=6_[H'3O!UDI_P&AK8=ZJIEHH>)L("AX[OR#JK6J
M'EAV$)HX-\AL1&W.ZK(/-JMF=RU;^Q+^>4HIW8L WJ  /J/\R.$(X$L$'<$L
M&J3(HM 7S8D+HB@OPK98V.8Z/K*GK#B5IW3<)^S/A.X9L-%%6<$KW;])GUN3
MZ30,@A'J7^I;K=ZJC9G$@G*[\FG:(GR(PFRS<@A* 4283M'"Y/6"!GC(7I=H
MQ2A?WN<(>$<S[VI7+GJY$QJ+'.F4]YR?[U/'8.3]=JHF\451;591'5:4[C6#
M#ER0-2:8 [CC4DK*VIP?G2O9!F]^]4<8XQ-ZP4RB-V>O4W TP&A]JSTY^_47
MS9CNLUT$M_#%;OTF?>@.N0P:871$C6.P&EL7*P11DJ,ZGXU@"$2Q:JIS 68P
M1.[<^3(.(ZKFNW0C+!P(9MCG *6&5-U#($4R#C9DB% J)T#R)2-.P] %@84Q
M%;CT%NH/H:!65[;)SB.@-XT1(C"Q-*SD!RZ,7<:]7_?1>?77/[7.6C^.?8 !
MOIFQZ9@%SJ_)5_Y M^;\ F_"=:Z]B!^:5W,^\^W\,^%WY\H?%\'W-G%CYZW&
M].B#01*'P2'6\WS*-HK5$.W>.A/XA3P%@8^LAF?IQI?8X2<,_<Z!U0Y-59^Z
M7#&G]U(=M4%=#Q0"%"]>W=F&*S-7JO$H4BLV&VHDLK.@+(B"PNVHU4;":W![
M3!>TIF QL(IU+F:^6T6IV;ITLVL'6\L])JI5@8&'A]E4DDYG*%DVX>:B9XHR
MW2\%_P*^-_'?#,C57.BBFL8<L$'L= %O&FPNOV"V:%XNM<OKR<>>F'QLC1RH
MY17KVL\9F@A7^; @J9[I=#G2:^M^V2&"R@3/QV_2=GP:PRE]X67^B5KJ/^>:
M=<=&IV^5"V>7_E+^\-N\(UBIY-BL#"X":#-2!(5X8*NXCJ5*7U_<ASUW'PXK
MT="'M!_9\ESG]6&E(M'_3E&R*#YZ-0<8:.X-8&@,..*-%_-].?]F;O1B]:>6
M<9U*XRXSV85>M=OU 1.-#&X\\Q'63_\GB;QX1-V_VFC#6 QAE_HPCR"-!4AE
M2>*CMX0>KF9+P)W>NP\JK0WY5U$;T/<'(#]KW#4(W)&KVA8B-H#!K%R],D*R
MA5X6#>.CHW[&QM7#*&E[).Y-&65SBX!""XM)SXJEIQ\-CM-8M/V)ZP]#YR89
M."[_\<Z=" Q"M7^J$0^8,7L)]?)VH9U>4C@;0Y[>F/6K4,N4"RX[7H"\39%I
M-M, 56HW@V2G,HX%>K]HT],E$)%*[MH('.H-+<0>C"CTG,3Q&LVR:6B?A1U"
MSI'ZJ77LB)8QIT3;DF&6I1JA[39<R_G*C4;'T(R$]VN=-4TI1TU)MD^Z0FO2
M ;IPE^'4TR[ :@1+1^8G([N?IEUOFDTE_-^M@G"[-;$[!='TK;X0-=7*"RH;
MO6JJSUNRRW V)J,*LU\2?^ZTFS_%R?3G>/;3*?RM0V+&1".LWT)C$)JH$/5.
MFHA%#538RHPTHA$$(9ZDBMACW8DD=@,1SB2@J2M#A#Z)$!_30 5SY+@1N0U^
M2[$+"FQ9E7*R3*S9:G5@\K@L$[O2L.BOO7N%(:.&:NG(**Z6&:7WM#L,1[J
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MEJWF8\]DS%:]M5%>>A8N>8,5&'W;PUX.B6(RSP=W[J@.R"UR389%LERT&M?
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M5+WO!8Q_\S0^=5Z[]][(>1ORY?]O6S#LN;2W_H#2"FAOX]-1%[VPC^Z$54^
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M6D$_@?6%U8EHG6;PQ(!.J3Z;P61:5M,(_@*_PG7'2< #7VPE/1P/GQ#[&V%
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MVX^LH 3EC1L )6+V=!C/Y][+E,*\<R+6Z&):P6.5-]@2_E<['T^V>*@)V3
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MW\-HXKP6=UR@0 ]Q?#?]8;Q/UD.K!>1B=/W\94#YER/AHEA#X+J!;B[9Q\*
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MU>06PHY-W4I[RC$2]GJ-EHJHCCJ1.NRD766R,+;<SIE_VIFUU#H*SAD([1.
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M>]/"DR9"M]Q/D.> T/\PIY",/HG+LHRNW'6IVCL#NI-1K)H4['!^Y0=?)81
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MY.+JY%UPRI^C$>I!79Q\.+K"H3>G!4_">5]=')U='AWC@"[AT?#DCY_@._#
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M1S&&\<#(N$N)!A)J1C$+K&+FWH5:8?Y!IK522DG4D<6K)11?2E-VV)$"AV,
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ML0*; _DH!_(L&B</="2_SEG;G+,G><ZNL,+W3W70CJ^Q[NN$4_9@G9\/A^D
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M5I)T:Y9+(]SP=YUB]*1JXENZS?OI&7@&#"?F,;V#K[=U.6YTMN7%,(^\J.U
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MS'/A1)C-X;$)/&4Q/64A[ND)F3?-NZQ8F)@!/EH?ZQ5(,O#?3_R@F),2I*V
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M_._O<VDP/[_A'?[ D;X#5R(;B&LXR$8-N+,;I)CI1&Y11F1-0IUHYK,R^+T
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MQOO-W7@:S"\Y&,I..#<IE+7P*._<IBQ4VC:O.)+X"+F0 E<2HY+Y,#(8MHU
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ME*#M)= +.2O;?*H$7"?3SW0K(9I<? $E^ EA97P?!Y#&$#07@(@F@ZH$4#4
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M\.+J4N%.%,!+,K2KH_M[5V+L18=V"MMJU'6%_'E[?E%_3-;I-MI-:]D #6'
MD-'OKK1 '>_G*11:M)R*<#07PW0NPY&,EJ-H.$ZGX621QDNQV#?=4 IM\7P,
MKV1S&9WPDH$K/\&5NB!0*1B)L"((D;T9*/2C3I)T_0+;D,, 15"&)%S) FLY
M4+4MV&Z12Q.T3*!B93)DM2S*/9@S/0_>?^,B9L V+"[0_S%5[^VR?4]F%->R
MP_W38BU@+><G@UP&-LJ YZ_<].>@W31Q0!\QGIH6M?A++XQFWM#;_C9S$O(1
M^LBFBYU"]ZA?TL(Q'=H#H2_/S0>TO"<?T-G)+R=O3T^>D.QGF"[3:#*2XZF<
MA<DX7H;1=#B-YO$\'49BLG<.Z/PNGY'LYXR(#5ZP!/4SRQ[AR&[J8C>;1;!K
M*])B@0<7!0R'@!UV%@+X-ZJ']XH;.:*\<T(1?30QKK@(CJFL!2["ZN:V)GY&
M4*K^>TXG)FQG:'G_-&3>JV6[B\GD->F^"R32QH.8/F=U8T-*=A%,>E4D<#HK
M[C*.E KNP#298,<@=IK*J]7T%L)K,?7 )N'[8+<7[)[M@]T/56)S,8LG4YDL
ME[,X'$W@_>,HG,RGZ7"TF";)OBQ2*;'GHQ X-<@<;%7ZHB-;=U=G RWS.?Y
M<0*\ALAJG/H>Q, MRN86<-O4"HM;.VLS%H\IQN&U1?/ M-RCYK\I>O*R)M]
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MCXJML#F>0%_K&58D&6Q""^JA&WAF>O8#?HLTV$[2V/*"NC$HWW> *1.F*29
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M6X&\@)U+4\U'$&Y_T34R;7#;]/-N1WX[JP]S#E_0-?TQY4!YZXW[=T;2D,K
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M]L2 < N7%WASF>H)Z-<KC6;%>T+ME:T\P-Y6E(_V#E<5Y4S1P>QK!J>&-TO
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M*+$U $>*FCR-16]QQPQN#D#GJL<-4,2- $=+>T1BW-B8EX;7P?0O:9$18(]
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MV#F@43?.E@F4HY0W6?M=*N=SBC+PGG!O.FJ9]V-L/A)7*3Q>NR 6UA;2WAC
M28TLH3<%,KW4;6_7,601,4<"41BF9/G8DT#ECI,S*>)F:^U8:5Z5;?IX-DZG
M35IO7E^\2OIF< A6G,KPK"&;A4R?.)VKVGFEI;Y*X>[<4&^8W(S"DLCV1)O!
ML[I-J:NQSI6GR96;43)06)1!\R.)3F*9[0D&6*H)65S\$FTM3]:4'-)=N^Q>
M-2I>'F5JR?[_]]&"(3!L%KWC*JO_NPW:KBEH>[@-VFZ#MO<[:-MU3=G!-,;(
MNG4=MQ&-=995<Q6#-OWIP?X#^GW.K5WH=Q9.^C%-?GKP/Y,C]3QYO!\_VM?P
MOR>'ZLF3R='AT^='SQ(]5D?/'WS!9N;%[=L3R,&OYA5<8WZ2I0W*%UK[P)?<
M8&7K<*7QD\0,]PK#4^ (FSN#_NM9'GP4S%;^TX.C!ZU[K4L:6B?#VY/??OMX
M<7YR_$OTYOWYA[VV>+)0ULGPF\F\/L9I7>TMK;RT;@L?M/;*FF=TX+GWXG7D
MN4>K/W95^6 AOD$X'KQZO7AQ^\7O':IL+G.@PS$3$9PS&F=PN"Q=I,.UO]8/
MU0_#Y:[W6;YO+Q"W$>\_3<S.P*O\ D&3<3\Z_-,&OA6B^R-$%]AM:".EZ,W)
M^ZWTW%9Z;G'7VRSM?38'[JN]^/K\OX_/HM_!Q=D<,;[]7$9E<<T_']R5F*SR
MB*T%>5\LR*&Z]S]5[%W0@'SMP%F_L1W\-XG:_14B7]\BQ-M.932O3CY?IN.T
MCHY__*&YL_S!6@=]\IEJU)+H%,$XE'&]=XFCK\T2#2Y6SZOCLJV2+WH1_9Q6
MM:5D][?&3"$20V454R"D572;>'>?'-& I =!@FV3^PH#E%<F):AXE_(>8Q8E
MK6%4^-OU);.T\[V2%ZL 0##K'T+7,^2+2];]DC"A/0NSMIS<E\4_'^LX&1\]
M>_SHV?[1H_V#Q^,GC^+]@\F3@^3IDSAY]&A3XY_R]*>W. 17/<8Y1W#S.=X5
MY%,6U"\^TH\&W^;6!LS:K7>Q6WY?Z>5N85@,[X(;#(Y[I*=)*9!6+292E>04
M0+2J:O[2TV 'ZX!T=/;^[$1:I]@BIESO^D^_3\>CE,W"H+_D(0.B?GLE^:7:
MKVW1A1E*3CT].GKT_)$^.HC'C^'')\^/GB0'R?[X8#]6^_N/GH5[M*T;VKJO
M3U\$NK>K&X+L95<CB&'?M]*#&[O'A]P.=CO831NLIS':1]+7*J.MF_Q7<)-?
M;XR;C/AF)!Q:1$)5?@^M -?%XNF^+1MV<.R?%4@4]YI(JV]!ZFU>Y:O-PH.]
MU7SRB$>W_-^W]%.#!ND,#>ZMXC<]-IFPIPHU)S==R&U[3-/>G/AVB/.IF$RX
M&L%\)F1/Z%C#GZG%&W/E\!!28Q@39Z2[2)Y0=C"4Q!'E?\V@^.V8$LUTBXGP
M4\"7X#KOWL6UM#HT+ U-91D0Y+'&APM?'\GQYXPDK1HL'T0"@ D8EEG*9 #,
M.)10-T,LQ$ASJGND@4H%/C=?*2KMWD&"$MR"Y(6USK^-D=XE2OWSQ?R6HGVN
M,VI?XK6"9GPO3CC7U(7K6.K$X7ZE%Z4VFB:0R#Z9B,8H+[KB]6;B3OPIT3."
M%(,!@?AEAU'&.)0J$29?&N%TO$#N_M@H>?,7_W ].N[6(D"M=JAZBKH2%N4G
M4W9L"XE;F]GH"]./VZS#WK==A/LRXU\Q^^TBK%7.F7 QJ'MHR?5YTH,D.&<<
MSV"@_%WS'6U"K20"W$G)[U@_UG(#VWNG:L:)J0/>4=(PVQMY%2#[Y\TX2^-H
M#EY)O+"E!:YO4HIL;U+6CA[$'0K1EX;&ED9*>LU[DE3P0<@ M=;^EYKO?39M
MH("0TZC-YLV?L0MA<=#^.[J?O9]NV BR*'__VX\_C(MD03]<UK,,?OC_ 5!+
M P04    "  "BFU90R]AC_TI  "5ZP  %@   &5F,C P,S@T,S!?97@Q,"TR
M,"YH=&WM?>ESVTB2[_>-V/\!JYG>E2(H->_#[NX(6J+=W) E/Y)N;\>+]Z$
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M+QL*:<L"@X\A&B+*?D?I.Q3AVZ0,HXAHZ+P(XE[S^)@D/KP)2:I D#!^R$"
M''@+RW*GTY6&,_%F>6MM7+XPH>!OV.2#:J"/XG9I2 6J-2+<$Z*5>\$#:\SC
M6LI0G*0;%JF;L$%][0"C*1O<6/^;/4;W$-,@C=G8&_9& 9OTQ^,^ZPQ]GW4#
M=SB<=$:#X8N8WBTKAD]&3,\OIJOYY<4SE-:U&'+BTB!NUB!T6Q4I86X@-BYN
M052O!6U5SB'"U_Q=:8^- J8N($Z<><4%(M0#6VSI%V?5-R-@!]U.1XNA;MZ2
MDKW4A!#%._U55:.XB&? 1\B 3,+])BDB7SF#\&=E@K!BL%&C#,M).'4I&5;#
MO8'&RO3,+6)DB85M3IRWRA=4I-LDXSIJ_/O148=V7%UI3M24B&G8<% [I56]
M";9H>P7 #H!!Z#0$Q;5(:<YDL,A.7R83]H0;(/O.T,N608=63(JQG>-J%6%)
MY85A(NF0^N3ET*E3.Q5:E8P5IH""$D\L!0&VL 7+ ::::C5%T^B %^B6<&XI
MYP T%"<.P4$8S3Z56G39[$4/:5H>1LOV)S1,"2S7%+VFTG:@ES!A6>GNRDR\
M)#GAY'9/$[_PA"LR V[&0M+G+</<=2AU^H)'R!=*[*"T8>"+!?M)78"I$^\1
MIH+60V]_C%[;M_-]BIV3JT)U#D8CO-4T=1E%X<$]7[MELX??LZ.R$B/&<^_^
M=>U\%C.CA^1*1N7F2$Y!5L#2N.:.S=8UL[2G^%'-,.ZX.QYW ][NLE&_[?;'
M;0!X8W?2]08CK\U?7"][T,7H2>"[\_G[^8K@'?I=SN?3-_/S^>KWU\YB=CZ;
M+F??.>A[DHD93L.EOQA$_9FC<"XEEA%+!:#)TA3NH00V &$I)=6G3KC91B#(
M*<Q4.A>40,[N&OWD2/'2&"VM8ZI54,(<P:Z46H+G?:FU\JHS3;N<BDU$M=P_
M)>\H'!S>P*_0]H5?DDV8B9R*5/^@KY$8\Q,B84Y1 1C6DJ,=#@,^1,A%D+("
MR 4:-1 PYE>P$ 5:22G[(2@ OH49PH7"D-(6GF@^$IQ=T))1T$S4HJQ5MMUR
M%I7%/OZI1[0P8-"_0D2SFY#Q/XHTS/R01.&S#0Q_F%2&O[[W+HQIT9[?6&$M
M82IL=JV(=;]F4M";DBF5A9P8[Q.TAQH!+6N?,A=$0%-S+W9N1Y'LG-4R*/3N
MM@.7:GMOAY/5>)_0M07\Y%KD2E\E@+Y!-2&'I,H;4KV'C0 P$_<+M.KRF <A
MU<*JD$!J'Y32$^;TF$K8;NV!X8B=-4D3%\&T"4ZCW>^ML9\:$V,#RK);4X?*
M5#CTCG#72I4+;FV>@WU<T22CVURV,FZR2&-\I%=0D!R2 !JMI3H)E<07M%#=
M0AZ!&-**K,-G34B>B6(T$7>$YF^ M@+W:]Y=30)+0$7EN53;9-I<2\5%8>,Z
MP@\]R)X60Z4B+I9 , %+\2/L*B4>5*V@EH-RCX8 1 F1A3%:E108!AIRG-?2
M GVVP?H#-AFC)*/8Q(!J\,#,,LS!AUM U:8Q)2D)%MH%\GG2FC D+^,<N3Y1
M3O6OE(X1L7"3.8>J+1'"*ERT,N\I3]*\E+U^U++KZ;2:X@3P32FE0F((0%/%
M&3V^:JK(5P"$O;-G%IM- XQ(PS%]0QG]6!*9X!95VK$*&HF:#)Z,126'_G4C
M"0V.>N)I-]^I_Z?WXO_Y7A'?=Y,*N*K7I G3E%\G'D$?M'P5L;84RAV-WET9
MPX6,'C1\2G!=PXS6ZM<TV36_& <FRXPXA[A4'.!T((4CNE>6Y#O214GD/52F
M3:4F6.*B O9T21.K=IQ5O80!&TAC?ENN6U*I:2+0BFTQ5&*9-%$IUJC&%EH=
MB2]*N+(CK$U+G5),&C',D@E4>@-$H2 [^]O.)# )E*UR\)^2<=*:CI7LFN1:
ML+=+K6J?:L9T=!LA8"&9AU^((!3_+ZX*3169C3&BXM)+@A9)DJW,0U"ZNTQ<
M;A2;1EIF.\5EF0(/)CN_ P7V'N9.O^MU^YUNKS<9]/H#/IZXC/.@/QIWQVZG
MVWEQ9^\Q=XZ?A+ES?G$V>W\Q?SL_?<XN[9*D,F'=/@]X3"8_GV]B> /Q7ZQ7
M EPGW:"CK*6SU(H(ON<BK"E'=KA!A[78ZSJJVHG83;TT:?F[H5Q%HE%LD^"D
M9<FF1)DII*4%ERZRE=S$NZINW4-^5846R2HATPZI>Z2SR7H/+A>B4SEPYY*,
MZ _%\KBWIK*M%'[8&%:NTZXSRZ='^56R=DU6A'FF"J:JJA0M5"PS['!)<FH%
M5(K0)#71VH?E#,5ZW3=BN@5\C(XL!;9!X():^EG\),?HR=P_I8?^D81"UF:(
M;&"R=I<K.S?=UQ0RA"!-E?($6E655.A-CXT%[B#^:69WF'BR+X$#ZJ.U*8S*
M7;$7P)SYTFB%D9[P>(P&^\I=L!YK"Q'=P$R$D=3N%Q8O.>UE<XD,#ZC9+,0Z
ME2M.K-;*8J4B*VGB<2X65";S>65=/9>\I[FDI!W94#((V<R+*@J9_!*\5!]F
M(*SY=A"\EV1Y9=%;N\+.W%!<0,7E-%1)E-,L+%JX@L5HC]6:57>JHGNW9-;1
MV1X-B]>B6GQE[0)@0S!=9$*C]4B?!+]6=LL,\T_EO!$DQ%\S;?"[]R01C]()
MMPW4U7$]5 $Q$KD\%8:@<T*X2;BE_0,*3Y@46&X' :<G@*[I9RD5P>J4X@"4
M=8 ];+:B[5OQXMD\:5I5%9&(X!AMR[)Z54N'38DAV'%:9!(T_*/6@186U,S1
MD(>H-D4 +L:L'M1QO1@F(N;,4."/PK\2\1MB3S9N?36UQJIK$:Y:0%L5UBXQ
M'SG\PS#8L:'J5,378.2/*W*D=5^$Z4_4GB\_<:1"L&7Q&:2*X&^&,N7\=DDA
ML4UIWY75::5,[R2^E+>6DGEKYC(H<K*+ZWI/DG)T;@)]%?M)%8G:,;U:-J5B
MW:#2QJC.JI16(EQH]Q2U9+*8,&&6AD]>"LKAUV[*P+DJPH@DF&'0=^GI3F8J
M4[BEY]3L6U,,N[JW=6Q.HZII>2@0J&C.(P!*RYX*9,H64!'+WU"@/I]B9]9U
M3%(=R: M]4VS<RQV%B<PZ2DQ#:&)JJIQ.?O,XY;2LJ4H1-^7*(RD4Z;N[N1M
MYD8BM(D.]9!U *UB8U\>?)W+F@)E-)4NKQ:6L**\S%M3CBENM*%DZ8%2_3)E
M@Y!KP33!;/R$\#45)]' >Z3OD>WBP>32@WW.#2/!-K*2?\(,WMRK'8$I/6&Z
M!!H&7H U6HC2BR^9#P]D^>Z_6+Z_WE04C,8>ZW6XUPW\?M"=C'O=ONNZ8[\S
M&@\FP?C%5+3;2#%Y$J:BT\N+M_.SV<5J/L6(N&=G*KI(5$B&+H1_KP@O@\Q)
M4XZ$L!"?6TKBHL<#T($,-+M9@Z"5:CT*!P+(6;&!O0X]\X5E.]V"2#8T%)57
M[-KL=K4<&[ W1(,T8GB%D#X*F&HW_(]"18&4;5R6!,*:M; RUTE*T 9!IQRU
MP4PJNU)(L8I5QM*3RJ7MW5M*/1%24Z+OPY*^+ TJ9X*HV&#)[B2 @)UD:+6B
M'EZ0J[G^K,[)!"H%% L12F^2^$7"1SVALO9DZNNJNKN5)R FD 67B "MU0$8
MEP9V6$ 5FZAA5@H'$JT8LL@^$<I/A1HB/"<:7NC\?DJN$!J2MC(6 ,X\YU#5
M:D8<CHA$H$.=^FG>(7=)A9# "56"0-+TNSFAHD1@.J1"ZB\*F!&I47SAJ^R[
M8<6945N84N#-Z@OUC")PQ_)55.! [FB4Z=K\:BM'I7,AOK,\FHD=DX].6/L$
MA[WFW$>-FO<[7=<;]N#_0[?/AL.)Y[6'0SX*1AX?\X[[@@WVG+_3?A+@ /U(
M'V87" _P ,+58GJZNEP\.XQ0CC.O>G;N4:J&>)$HP2/3]!I$8$LHMCY'\Q<=
M?2ICW/ XE(H)HIP:V6A(MC/$A*5<H!!3'MD:3BE5S@I)TZ83<I.)X]K(XD/I
M=-JM)$,A5+'Q6&1SV5U[3 ;4]GU_ A=[$V_0Y_WA)!@.W* [&@!?8NWQBW*R
MCP$]C1/ WEW^-EM<X!$JY]-/SY#O--<+N4J X+%UV"&%MJ2%<+9@R'SJD\\.
MN85@5X#>M5=BF<M<1'S[[TGZV8;YF/8I^8TZ5#56=F[I#N3E*F&BV+N"O?+H
M+5FI1=KDO'4BZX=(+0+A'+PQ5Y?2(N*9-!2K1$@=[+NSVZ6\3CMXYLBQ4K)E
M/B>T((=IIU\KNF [Y6A5@X.K+S>CQUXH;KLLW#_DD+\?J-CIEG*N<92@=6PQ
M8OB0@I<"857F47)S9+PG4F%2"\X,>,U9ZBO76Y;+\R "[I,.07;I3/JLH\0C
M;PO<K":L97V2;;B)2"F%9]ZS&"8MI]QO^[1:$1MUBFV7#\U53@"R[=*1D]#G
MTB3B7=<<:PGE#W6"YSWD3R_P>L/Q@$W\H-\?L( ->T'@3_K^:-@;^WW^(G_V
MR)^G<8;7=/%FCD=P/Z\@JN[#!C-;+&EZMU!F/"-8L*F6D$8H\#)1<)/\:S9-
M18@2L\Q"^*!B%0_ 1Q6]J>?EX)R6%4@B_/2EE)-=H3L[<DQ*_#GE5\!K%3Z_
MAOGT0^%'LD));3HTG9>LR\/K,!Z*0U%&#YF5DM<J$%0;LHTH>+(5!GW(U/U(
M'#:9NF&>JGKI'+VI,"5(*0PRD3]B6>4Z0*'7"P @W'7*Q:4!RW3#4]C>L3,U
M;[%'/I6GB:DL$Y!!> 92I*JGR<P3 4GJ)C2[\[;N9%UV\)!W7:%2A -9OTHS
M+QFI$!^)XS=OG8KX4HU/F]J0R<#L,\Q%Q#SR;6J1:"2GE3:6Z_(7=D5/I[&+
M+1V/PD!7A46U+1O':'R<5#LK>*@A4$@;E46@4%9RPU,K1CB+ANI$-J]UL4UE
M2E2R'&_ [E,Q='JY, _*,J)F-:F<-^T?E\2QB3$3)E6FSTS;;=ZF\QAR8CJX
M'%O64L2MI'*S?.ZEJ.K2)I)5['1PZ8:%(HZA8K"LQPY@Y"-]:]AP.N:J-(,E
M WJ(<014BM\33!)]\;4H?IG8J2W+!(O1-JY07J@F Y<&O5D.B6RQOK%0VX9H
MPYIJJ[AJVC"!'T0>'HMBCC1<X.2B'A,MZ-*O<BDY5YBT+T!D?47+/#G[=3)@
MTR:!9FP402-# :2E><?^7%F+48=0*( ILVFIC]63]63W8!NGH5O$(IV7C+'I
M-9=;HKPL&CC02V;;@_KW!R_^_:]780:^[_5\M]T!;M]GDZ';'_3==K<W[G<Z
MDX -7E28/2K,TSC>ZM-T_MML@65O_OOCXG=GM9A/SY^1+B->,YN>_NI\F"Y6
M,,!+9_7K?.E,WRUFXJ2%7V>+V9O?'2+$LB5NF#EO/YZ?SY8K9_8_*[SI U:
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M)Z64&BM\'*>;@G!! ]-5=&#[I5:UB:U.E[E9 _ZWJUV&,B<8^\]T\$[LA5L
M\?Q/=3Z62*K+=,RSCNU5Y7UDZ+!\+\OLVRC2F&@CXG($]<A\\L4ZN&2WN77X
M,0W/%-,T%*"C8M(D#CU%P\?UMGH#UA^.!^UA;QCT1UU_X@W[PSX?>KV)Y_IN
M\,+:]K"VIW%8Q72YG+^[0*'^[+C;15*.%:2\%GEZ.AI)]QV3;F_3.Z=.F8?0
MRG H,@K4/7:LH2%@$5N%QO!%:Q[Y#WQ 1?U4>GM$E3'H\FF24F@\E(D73>=N
M:7KMJ8/TJ"R+=R;C7J_=[X^#8;_39I-V;Q1X+&BW^=@;=T8O+&L/RWH:A?N7
M']\L ?2C'H(?YV=S4!6>(3J;!ZID'CDV*B53J *_2G*M5LH6Z ;CSJT]+<[%
M3450AD?YCAG%92?RU-"L<+/0IT0E+TFW26IJK<K2=Y@N2[R-U4*W[Q\@ 6\3
MI>@PSD*^V&)?)C# 'H,\3XBLS-(71UQ,)E$V-1K:];R1 8OB">)I^3FS;ZZR
M0NN=$L99$$U4D0B)[*+>'<'#QM')F)O,A)4T^0@H[3O@5#(^4Q;]2L$_#;@1
MX:9;D&\JB9DR3:F1';1XW#+;W;;'6.#VAR, CLR=##D;M=MP.>CSKO]29GL?
M.WX:=;8O+H69[?G%" . M$JBJLQ@F<:*-0L$$Q9Q4RF&OI6\\L(7[R6@*E.(
ML5]06DW)E6_.DJ@[#,616<#*4R^4A2((B9649')_W5IU/46?F(H(R$5I+7,.
MFZHNR9P;AAHE#LU2:"6?:1B(/#3BCJ-)2X^)SN!!\M9;#4'EK>4@!I.C72.-
M&7[5\,#447/HR92OHI/EU&?5-O>XJD- $07BF^F!((GI@GY4GVPA?Y'\6>:Z
M<_]QPZ$GF)DY0-#;[0<>'_?\WB0 A1W@[I#W7WPY^]CKTZCKA6F:BYFQO3\[
M+KO2F8,R[%FPD$P6!;1YEBPS@B<5&C^]R_,;4<+#>/BEQE\-T"!.+<&7*".R
M(TXC*]!2R7W[J!H94$&U7_#@RR*6<<<8BA'*0BXB653:!\II6W1CZ=@"7> &
M2_.@<<_Y'%*A(I9G"5[0,1XL4R<<1+=6'MM#!<"^A!506,'P):S@+R#]"1].
M1F,6#'S6[S(^[@\8 YC?@?^W1_Z+K7B?*'H:=0-6O\X79]+E_F9V,7L[/WVF
MIA?C& MMWUC-'9:79->^>%M9/TVZHU19'AG,*TK$Y/I8W)+96N<?VJ!?)R+J
M<%C9!5W-4MAOQ561(WA;*I+SJ#AUY'=9ISOIC]R@W6^['ANW?>BW/^EV A[P
M%YRZ9RUVGT;>\'+VVVPAS]AZ=OR@<C"A.LEDMX9J%%-TZ$B[WW42^J($E(R*
MI0W46#V$XN<Y1AY38/<>QF(A5!FB;3T'*%$5IR[UESJULSL4_GW'@]L?E8T,
M1SUWXG5[W<ZHTW=YCXW:S)_P03\(_$%O^!)JLX^-/(WLW]/+B^5J\?'TF:5?
M&567\C.EAJOJD%39!N8PW&*N!$7*(/-(5'E@V ]4F)"$?52@PHF&.NVT$&A$
M)H&>.)_6 "VNI=^(*F;^*0H\RI2)5KE:)W"(&-0$V0WE3!#/IJ+8"MG)-BSS
MB@A>T7("OD%F(WA"S(M<EDV2I5MN0*O)E(](-B@].ZW*955#F5HJ_02O+!\G
M; Q^@K.*XVY-G:?M.D6'D&Q$N;OI\ C2Q&5KIHOFUBBJO<JD8JOZBC05;&.9
M!_" 8W7^A,I*$KDM=O/4I&S_M6;8)1H!_^)Y R5@:@#<Z;)&3;V#%Z[IA";=
MO\9NB=QO<C'IPQ6DWREG\145T\$+F/6BOF*G-,C%?H3EDZ(\EJVQ4*Q7I+*:
MMSSE+2O+)Y6'+F,*3IQIV=L%_9'C_7O# =(RNQN+5<HSE76VQ<<8SP41.=V9
M3LK:Y4J;(G>+L)OJF-V6,_N3ZJ:*42Z]-?<I?ZVZX,J=50V)A]21O9A$B!>:
MFS04P7S"ZL'JL3S5V6Q7T8-:,:\3IRE\SYB):LJ*.FQ/CZ#! :E=O7[B46G,
MK)Q21-,@CON2-U"YD VI-90YB1/@HQ,4>!BU*0IE-Y3(W"2^".^K'?]&],*"
M4[0F554QIH\.E(9[?5";$S.JA-NP)QIR$]]-IQ]:I-OI!,):#TS:4/GP>7B*
MZL,3?;&P=>UDO88#;^P<I BV5,&N.)X4:*5U[9($54:7VTUXZR3C<3753JJ-
MY#H2AZ**U+)-@4=RR6-2I%I(27'D[A#^*TDWKYS11REUO%SRWU91'Q4#3KK]
MH1_TNQ[O^?WVH,,X@,!!?]CC0\\=M]D+!MR# 9]&!O[IY<>+U6R!AJ;G9UJJ
M<!29P:H"=D1N>4%!'0P+;QPR42P/6"5Q[;RZSV&CFM_L1X]:^AP2$294=P&C
M7S.\HFK3;F%KDE%D'KM9HW,%ZTO#"K@2Y5MJ3242 &K@8?EG0EGQ/7;4T<CE
M(2CV>"9#G"6OUR1!.Y;@[VA\;Q!:6$L0)@1(#@^CA")Q805/TY&AJ@#Y(3^Y
M.M'8<^L']4*1S)+10D+0 ?:9CL(6QSW!% N$CCW$*O:&^O_BT^W;DW:'#8=#
M=S3R^]UA>S)F?-)U>V-O[ [Y\"4*<A^3?!HY?F>SM_.+.>5</3L>.2^7@*_I
MM;"W,RXJJM: 4ZL)0M? <R9,;$)O)(V)VK?.VRW_+/4HBR_L+_CWZL4G^S ^
MV=&+3_8O'V+Z%3M02L<W:?*9IRAU505)I94+,>L6MRJ("L0058_0)@#MW=)'
MOXLR+G8LJFU"2!#$9'1*D+>F T9QAV'9%*&'V@51S%L>-/CAF]-S3J<6$6B9
M^M=AAB6WFRD;FCO5\?(-P2S7+"J$_F;(3B<JF6PY>(L^9"50QR91\0_[D"9!
M<W70>7TRGQ:9A8>S3% 64[3W=>@76,6=V2'N+76NK'4BC6<EPJA*1.8LOG6X
M;<F3XM G5*04C7X%0N*?JF!2 >3$<P<M<T\*@]7'15DA];0WRH];!:1D;4AE
MGQ%!E2X.184F8H56[U;%>GZSN9)BX2OFY?^6,7PF)>O_>Y">[I1T?T5^/BTI
M.=XG)1MEX)=EY]VEY'XI6)&A7RT62Y+W>Y"1<RK,<#%;+K$\P6*&=1T:#'&$
M)K4R6XT*T8Z;F=8SSS"])PA3M+2YL/55..%C:9!BPJPLX/&H/V1]O^^ZDW['
M;8\[[J#7Z_0&P: ['* R^2!JHUPG>-@FVV9PC_JT1Z.L5/7[>K5R@#UHU.5V
MD_8..N)@1ZL'3IK<P!S$/Q]T#G PXG-WOT[X4$4@B[]8![+$E]PD\BDV;(:5
M.;"JR12#E"4[^L*K#GYYM8-SB4V]7X=]\*FU9^7;3O..QK_U !]B4/O)]@B+
MN;+RWEZ>?EPZ\_<?IJ<K"DZ\F"V6+>?\_/19KJE[D/]?L\@<*4LTH$(Y_VV&
MON-5=UUV0I1\T=+VYO9."ZEI)/V[#T6*/VLD&"4:^KMEW(,,[L?L1^=3RFZ=
MU3I)X^]BQWR;7?+0A+M@&_[J$1;&@W?\9;:_@F@K/";Z24[W5)SH]D\,CB$E
M/$GOQL\>Q&'PDVO:^ NY)0%H'=Y@,&##3C\8]EA[Q /?"SK^J#\881;YOTP#
M>0B?UHOR\2#*!R# B]]?-(\7S>.Q-(^SV6^_+5>+V?0]K+[%AY-GN9*^>WWC
MB2"(-[?? C[LU!K<B'F?'V%8J#\LBS@&2)F&\?J[V )/8T$\607B9;K_=VD0
MI^N0!\Y,%TR]I(*IZ7>A1#R\I_(!T*GTSH4Y],;##:.=GQ]D .,2#X;@5Z%G
M']*IO4(2F.[QCC[,6)W').S.EY4^E_K0Z'.DCOQ\(#JB%;^O]2DVC4WZ@W%W
MJ"@_>2D5+Q'7A.A%)VS,2_Y(Z]-^#43<3'/][__VTX]NXM_2AW6^B>##_P=0
M2P,$%     @  HIM67&2IV5D20  ?,(! !8   !E9C(P,#,X-#,P7V5X,3 M
M,C$N:'1M[7WK5^-(LN?W/6?_!VW=G3MPCHO1^]'5T^>ZP-7%+@4LAN[;NV<_
MI*04:,J6/)(-Q?SU&Q&9*:5DF8)JJ#;>KGD MI3/R,AX_N+'F^5\]M-__2^&
M\>,-9RG]!K\O\^6,__3CW\1/^>%_>_O6.,D37M0\-9;E#\;[JF1IE:?7W/B0
M%ZQ(<C8SIN5LM<S+HAX9QT5R8(B7Z=]1F:SFO%@:2<79$AI9U7EQK3=S?G&6
MY3-NV.Y!=& =>+9G:^\?EHO[*K^^61I6%'G&6\,V;5=__>U;,96_R;G\&)?I
MO1%?)^6LK/[^YM\R^O?&J)?W,_[W-UE9+-]F;)[/[G\P_GJ9SWEMG/([XZ*<
ML^*O[PSZOL[_Q7\P+'.Q?&<L^9?E6S;+KXL?C!G/X!-J^0?CWTSZ]^Z-Z#_-
M;]6BW50&O?#W-[!P2UZ],8JROF$I="]_:89SPW%N/QCNXLM:PT;,DL_75;DJ
MTK?]K_11B4[>&7-67>?%6QSD#P9;+<OFHTIT(CZ+RRKET%91%EP.OC-\\8<:
MH-X1-2.7Z$X./"YG*;0R^7*3QSELDGE@6S_^K=_:3__^;Y9OOEO_8JB;?ZSJ
M99[=#W=T^7%B3">'5Q?'E\>3J7$Q.;^83">GEY,CX^/D8O+^MY$Q/CTR)O]Y
M.#F_-,93XPS>N/CU>#J!S_#9Z<EO2'*_'!_)5XY/Q2N]EH^GTZOQ^Y.)<75^
M=FH<GIW^,KF8'L.OV-[D[(/Q<?S+Q#@]NS3>3R:G,)"?CZ>7\,V1<75Z-+F@
MYJY.CW%@T\OQ);38-M[2]_CPTH"VK,AQ1CC:\:?)*0YL#U__]W\+;=M\=W4P
M/=!'!N_0-]:[_9%Q=M$?^,GXURFV.3[]3?2,?ZR-YD#L"'WQ\>P$1RSF-3+>
MPP)=71Q^'$^/3W\VIE>''[7F890_7TR@FP^RY_>3T\F'XTO5R>'9IW/L^?+C
M^++_KO%I_!L\#X]^P(4:&5/H&&;0+D>[69<7X],I/(8+>G9Z\ML/QMYX'QI\
M_S\FL&279WIGN!I6\&Z*NX2T,.I]_\[8>[]OG%U=3F'3!S;F^!36]/#LXFA\
M>C@Q?CV^_&A<7,'.1Z:+TX*MO3H97^+>3_7-7=\6Z.AP?Z@Y?'[RGY-/Y]3*
MAXNS3Y)@+D2[U&J[#!N:;^D6MHA&:+FNH$=J +@O;/LOX^,3)%Q!U<>GM HG
MQ^U@<'O&Y_#1(=&WH)$> ;U#PMH[$I,1FP$#$.0/&WMT!L\A[5],_M?5\<5D
M8#8;)X&C&AI"._VUL< K(QP)[>EX2A1]>#*^@M]PP<501_(@G)Q YQ^N+DZ/
MIQ^AA2XI0%/&V?GQ*0X3&SF[ HHY$;M\>/;SZ?'_%F1Q>H2T#UT"F7^B(0/I
MX>>PB%.8Y?0#3.7LXK=^\_ G$?T$2/SP\N!W<D+%V8<8X='DEU]@Q2?C3]#Y
MQ?E+=N4=..9?Q*[ Z@A6>'F,&P<D,'ELQTL6PRV?\-FL7K $A("_OS'?T-\+
MEJ;J;W$[T:_?>F/?Y>GR!O\P_Z)N.[P_9VQ1PS/JM\?<[$:>_OW-OV+;3DW+
M"6T_"%S'L2([R'AHI::7A:;-O#<_M:2K22XPX^HG_6_\)%6SDH,,/!CC+:^6
M><)F:C#+<O'N3>_5;[PN<8.,0]RN#W#6+G''#HS_\^__%OE!].[_=G=(=O.W
M9?K58=LO/.SS*@?)<@&BY7@.\@]\\=^?-FCXH!K8%O@8J;!+K3_&[:-/DU#>
M_/0CCKY#J5\YIM #/O;3WO*&JPO^JXT<EO,%*^[EJ^WESX!BJT59,12^#5@R
M^1>*V060O8&=S-A=;909_7Y>E;?P&,>_Q[,8-I"-8 ,JXY;-5MRH>,+S6YZ.
MC!M>\?B^74"01(OR;L9!XJZ-?%GS60;]I3S&OEB1&HNJG.<U?+DLC06[QQ]?
MG9:VI30Q'-4WO%3A@&#LUWD-+ S'4]>P3;6QA[, )26#C^'[C%<5:3'P@/&4
MY;^!'[SJKGZ[-&7UI,9.RR4?:G!?;E"7\(T]&&O*L[R D8OI[,/"T[/ _@J8
MF#[)!>YOBDL 8U@E-\9BQF"WY7S;KN'=>V@6EPFHQ8CO01N L\RQZ;LJ7Z**
M!NN$+TG:&QE 8=1DBF^(%MM%6!LW=A#SI)QS(P7*(A)A]W0%X(")/$?TL228
M'.\?7B^QG\&5*%?+>@DOX-@RH#9C"5<!C1)_EG?X>=.T&CT-%L@*>B M%,8]
MM%XCV)WE#0P8SH(8K/A^SI8K6(Y[W.24PX+#D[ ;;#5;XE/M_/^Q@I.!/?S>
M>[AE+=-5_ ^>+-5,8#CSVJCY$L\KC%5,@[:E0W/R#JNNXSUS9.!_]Z$Q;.&3
MFLP1+LH 88VH(WV=US<A:RA)+%-Q#[PAJ5:2#:R*!<O3=C/O\ME,HP.=16LD
M<0#,"%X 6@3N,P-:JV_*U2REKB3!\B^\2H#!T%DO%\3P8&62LL!KB$9>*-(Y
MI ]K?.3AJ<H3^*PS9@VS[0\#UZ)=@)BKP7-ZNS2F-PQ:&#SQ<)Q[+<(XD\&9
M'1B7-WDMQ@L_\[K&D=9#Q(3#AS&D.=EN#+98\"*5+0DN^55N-DUN>+J:->QO
M++F97-D#XZJ8\1J6!'JM[FC_H+\$KZB1=KL D<S+@B]9!8M+ZZ[.J0%K@ESI
MJLAQH:9+>!7FC$)<53^KT$O?_P#T!5\F>-%,B3NNH/]SAN8NZ+.\J__O-_29
MS#BK?B >T]AD0%I2 JO\!+Y>EG/Y(4C&,[C'_O[F_<7Y!^S_?<79YS'\GRYB
MZ9TLX*&W,3[UEIC7#["L=^R^WM!45U)#F]5&(Y48'QFI#!,-54,2MOS,?&<H
MFY;]1)N6ODH@6757\QLL1U(GL'$U!P0U7648(FU0_D!=/IU,I\:OPC0BB?K!
MIM[\--*O3>,&3E'"5F0^;<XE'"XX_L#2DA42-5R_#+CC[!XM=#=E!:VEP$0R
M..'5@>ITY[2L[@TE5"T;E"S/=),X\%/7<4WF,Q9D7N1E661&OOTT5:N"XPJ;
M\/<WUIN>_N*9SZR__$Y:.P+5[.AQY$7B.@FS' 5Y(JHG"\V#1*5.VJ#^IZ\E
M;*#XW6[6=7@M%84^OD7KP185T8'VN;'QGN;WK+3Q]/F\XA5ZGE5Y]$H\B]W@
M8:/8@P2^O0NLT\'S+/8WM/CX57E,X\^[0H:\VAH)"B6/KTRLU_336GXJK;[Y
MZ1SDL6^VMKD;)R[O76UT1EW.0!WIJ7]/W>-O6Y9MX#>/F\"3&MFX_-]"".-6
MPA/Z15G=_SXN]:U3?5D3Z8.JU=Z4;])!ETN&*J740??_5+:V0MG:L J/=2!-
M#S].CM!?N68E6&][<'^_K=O+R<6G*3GO#L].CX[1-RG\UD]Q:#W[J,;0U2'Z
M;I^CL:/)A^-3.3/A[H5)GU],+LD3^Y29/$YQ)"W-#1PGX(Z39H[G.H''>.J&
MD6V%'H]89IG-&3B:GG\XR>OE);;]3*KF(^-Q^FQ-S;)_\PPZY5"-V\!,K0-K
M@#4/M2*B;0:OS^&KH=]DER(&=Q]-?X)S#MTAP[=(_S;6:*#'^K^)]!OYG#Y$
M'Q&Z[P*A&1\7K15D9*R$;1!-@V2KK,LYAZ^+:^7A4%;+.5P+O$(C/%P5V"[Y
MNHH:'3[%4C1PER]OA.DE(T,=-G,'W%)<,=)Z?H.6QAMVRX4#A;,"'A-6]7*U
M-&(.+Z[):<]T:J(TL'SFQV9@.ZX9![$?^Q$S/3_P@R1@Z6L_-8Z_^=3LL?WO
M>VI^>JP[;KQ8@$Q"NSCE"?I'<EC8$W97=]US1"S"C5:WSZ%O=82NQ]6,R0#(
M!<C?"7PWDBXU_'XU(S)#0J3[NU8$KORQY#-XCXW6-\9A.5O-XYR-E(N67CPK
MEJS*RQ&:Y>^ OI13+^/0()MUW5'MOQH-YOTA*P]%QZB^1MP-4W@Q%O*$T\/=
MU ZXY]FF$[F1S\(TXX&7N6&0!4F8LIT^/?&VGI[W&,V+//R(W0^>%V:D#'W'
MR**!Y%@!GTS1J4(?3T$R9>1<I>?0?W=WDR<WP/#_0<Q^/D>O'U!WS(K/-?F"
M#D_.IB"T/>8 8</J"&&40$%;_EM9?38.\^7]=A-\%'F<)Y%KL=1Q,\]DGAEE
MF>MPAW&;1?Y.$WRRK01_R!:HQ1H7O*RN07KX%[']'NG?2-8LY0O@U$F5Q^0!
M$IY5H$2X;,B'[1VX<#GNY?M;38QF&B=Q9 :)%Z5N'%HL<Y/(]ETO#7PS<%^]
MQ/\@,:9;2XQ#86&2\1[QV]OILN)L#NRP6AQL-[.SXB");<_Q32MS/3<, S?(
MHBC) FYQ'NPV??'MI:]. ,OOXG(V\/3MIL$H=B(_82!1<M,-F14QSC+;C"//
MM (SVVT),WL%-$@A3QNUL@4%1(&(N413 L,092/-ZX2"N&38DVV^13'SEU_'
MYTH%DD%7,G)L\B4!&?4:*(;-$M3I,!"CZ$02#D1VO=/B"'$ (]4?+(BP3XCX
MK2']K !)%4T;F1H)!FP1T4+C2=L/S.F:,NBD&(W-K[W+_[D"V41VOA;)1M%K
MJ#C*Z+5NQ*6*38'-H0C2^)Y:.>)OI^?C0^/#K 016D:=/27>]1/[DL]7<SG$
M?@CS?_TOXC_K"T,!?=@1:^+PCM'6!?/1EE].7!AV8F'6Z?:XW4S'3RW/-_W$
M#DS/=;(T,A/;\SUNN[89F6ZRTTSG^GLSG3=?9S>KJL(C^XE5G_ERD.4\5;J/
MM_[>"SP?KCO+36.7\RR.0P?TS"3QO,SGS-II$KS9UGMO@.\.7GW_W3P(_6"[
M*2PT?1"DO,0-XM1-PR@&"=^QLR!,$LM*^&Y36+ZM%*9DG8T2U2FK4_9/X^=9
M&<.E*SCB=A-:Q"W3-OW ]^S0-1.?9;X91@DW[<!*N;O;+I9_;"VAW7*,YP<!
M[DBDSOR."]4_6(\:V"X2]+@5.B3!16[B.<RT'3])X":-. ^2:*=)\/.VDN Q
M9L$,&3$$MWMR_/1VTZ#C)FZ61;'+ LNU;<9\,[9";ON(K>)%]D[3X&Q;:;"3
M?C=\Z=Z5QCUG52WS&X$GMH2[W21GA6X4VT$,"D, >FS$+% E0+Q+/-,,_7"W
MO57S;24Y-.AL$._R&J/@_B(B WBJ<A%SW/&BW'9RBY,TM#C0F6^!5N&DS'5C
MUV6AX\&GR8['TA3;2FYGF+*&!KKW9;HA'*"X-ZY+&%%!V=B@V6*X# T/@[W0
M]DAF/8P(P#S;:UXD]R.5%K>$7V.@5K8:45!D)0,#1EKR:/LD1@_D-3:'.=L+
M5BU5GWE1+RM")8,56-X+.;/,1JK;I%Q5R]'Z8AC&$@3350'=XI-5G,,0EF4U
M,NYN.$4X8/HXK"FEBY= 53"S[3Y(3A!9=I:$06JY;AAZ<<C,-/"L*$E,W^'.
M3A^D<EL/TCFOZK6H G6"*(/Z-D]7;#8RD*P+>/HF7XQT,)"1,<OG%-P%I+@J
MU!^SG,4YT7RB8!W@)-1+C,7LP(? GI=PE$53_RAS&"]J<9@,#0UVC[ ZJ=!*
M>[+@BZ$#-'S<FP.H$NSK99E\-KBT4&SW$0J3),U".^%Q'+EV8,:@[@5^9(4@
M##D6VVV-;[&U1ZCG_7K(;R@?9.LX(PI%IPE99CH$A_0,9@BQ@@DAPO,FG_T#
MB!8CLC<FLOR>])C.Z#9VTW2Q.3FF/_,M3X0QC-_#& +/R?PD\L(L\4$[2F//
MMV+;<7C"0SOS=ILQ_'-;&<,%IU7/,T0A(5E3N<^[T"5/]O-M>WQ+',8<+R?3
MLT!7"@.69E:2>:X9V@'+S'"GR;':7G)4N0/&T> =I3^@H;H)9,TVK'^<;+EO
MQ@]-A[E.Z(>>!2I[P&+/MGD:.XF5I3[/=IK\ZE= ?M.OD=_T-9-?E *SLY.,
M>:[E)G[*W, */-?U79,,2#M-?LNM)3_\JS;.LHR#&'[]#''T^9;?PID5NFD<
M1B:+ A?^$[NASQ,SRU@6,#O:;3:XVE8Z' I.E PP6\UF]V\)XP^M$T59O(7]
MX74M]KR<SQ$84\9N"H4PD4DB3;2H@ )#)+"R@!$O5_VX4F'_H Y$ E0/KC-A
MA<%G$L!/HK0:JT59$ 1L$PU)'>;UD.%%X!>VJ:XPU#&N+LS!V^X3DS#;3[CG
M,(>9+G-]QE*,R([].$@39NYVB.3MUIZ8!2=3_Q$L.!K%GRD-:NOY-Q)@8J9Q
MY@#_#J.(99[%0A!E@3@S8. [38UWVTJ-EP0!G!F3+XN\ZKN>OBD=;[NI,(BS
M%/7VU'%"U[+,$"C0M[W4#F(G=="(ML-4^&5;J;"33M\E0O(M/KH=4*Z&9)&1
MROE7*!@5_^<JKQ!B8"V;GQ#>YR!5)VQ$F,E+7H&N5E:HK1'T<DE2C  M$#X7
M+<.ET]:@*Q3:^)N$/A=W0$(Y&BKW>KO/CP6\.LU8F+E)YD:A$SE^G-H@@L>>
M9YG);MO"[K?V_*!18=#WN9F% _<F8?8"0:@CT][[O(]DV#%;4+Y2VF#EX/="
MRLZ+9+9*\?S$*TH;*\IEXSA=EB,#+@(Z&X0##=+.@@8'YZ[.$==&"?S=TV*@
M%CI\9.YUAZW LVGK-\B,<N&S?40QA_5>Y6@?U\=JB9,8;$P@$FO;T7K)9O<$
M0$N>LQ6T6U,+.:@@]5(@]PS-7,,?P276:C4\:%)J(()RVIUF\*/^"@G/<7E7
M$)3_O6AKG"30 TWKF,975C5L?$DP$CB,[J["$O):\LY*N,5KT>Y>?BL6EDL>
M*;]N"8F^)#CG8;<W>LG3.=!?+2)&FB8X%]F*VEKOO\-.MYI]FBEW4B^,>1#%
MKN>%4>*:;L*<+$A]S\V"G6:?_]I6]HEIK3V^B08"($VR,;0N[UN\H[DA7L=@
M#Q@CN:\K1EYOD4K[<()LPP2J''YK,U%5&RF[KU%<:>#^)9[_("3OUA!V%MF1
MEV86BX&DW3 + S-.69+Y?N;8D?/JXPH?1K:SMP?9[AASDQ>@G4E\E=< ;O>A
M>R_6RAPG0T?XEX0O1'V0IA@&_P)SK&NX5)O*/>*8O!0(G1]'<9B&/,T\R_5<
M+W(RSV.6%\6>R7BXVVZ0[PY"A]0@, @?76J*=K^O.S[E[3+KOXTBS%-:()&L
M=Y&0>$4AKF(^0-HUR,DS!G+8'(2PI2A)T(F 0E)G*'#-^"9T.I3"L-*,%%IS
MQ%RHE&%ZA+2XJN%GO8K%KR@WB6'THH55'9KM5CMCN$@"-PS\.$G=U+3#6$![
M10EG%HMV^_1]=Q [II?)0")K/!Y(,-+@UT35#GS7Y=^,*B1)L,CMIC/7YTA>
M3NP%J1LG06AGF<U"WPJ"V&'1;L,I?7?L.*I2QDGL%1"%F0"JO>5%3L17%EC3
M+"V)W<&7<V"+R.XZ!"9BGZ5FBM L5(J+K--2%!K)4E](HF2D$&BD2;D@Z6+9
M9#>(W_2V990V:NK+6L@:9/G;;C*VTS#UW<PW39#&F6]'9A9D?NQ[?I0P+]IM
MW(#OCCJGA!4E*PCC&&Q((TC<(21/BZ[,C&M>$/8LF47FE & 0,M(;@*R>:2,
M:J+B%;F_1>6\6I PMD-5);_:E((UJM'QF.4)4#*?U^WWG<!L>KH14/H/[JET
MG6%C#8X7@92@%X&#5)0%KH$9O6O&/ ,E>(4Z,PV>-0(>HE"C>YT>)-VE4<4;
M^S_:&KN&1NV9#>+5/EDH*T;#ANX6L#;Y4M3IA$596SU: EP_BA>0DAEB) GI
M:6U)"*(JH:*+%6=U6<!)NA]:G P;P5GFA> E95U3TB#QH>WF)PYH.4X2.IPE
ML6NFB+^-NE 4\\CU>+C;L3??'65PM;GRXS<7?-Q^TZC-0:9/;6;Y\--UO"AS
M$M_G4<:CR/&2W3:-?G<40<$M!8M4O'#.Z@0!UXDKHG-!>GDD6CI:X84,5? 5
M75&R$5ER )HA)51_:S%#/T'S9--=6W^;&\!T,:].O=8FZ4DGPBW:5#%0B_T!
M)M _,X->/C-H@\GP,:5@[.=H[/2)I6N>DN+('!ZF@>ND<%-&IANZD6,!.XL<
MUPY=_]6C.SQD%K>WJ>#+(*;G!9?5S5^'F?Q2#XF]KCB7TJ?P\>+#L9"*^T&P
M>1\/=+A,?%NO&W%8KX6DCQ+K.O"IR#LN,&\9OP3&P5!?IX<WELDN,WWE&AT;
MZVZW$Z.ZYQ5NS,!$AL;='^OZ&(6A4Y:H7ZOG/M)+?+<AP3VSU0B=$_6*%5\I
M*[]V13U7%H8=^([G9+&56FX2>1'GMNUXJ6MSUS/M5X],]# CV3;_FL3^%2@Q
M6\TZ2.H4K..A ]_)W1882A@8BJ2./^E0QG"IHW*]P-. T?S):DZA0K>\/70#
M^$L&L"AF5#)&3E206Z R7A2K^4@'C!9@S]WC:0C?H+YP/1!I8$)9YZ1*CWO,
MZIP, H[O":\Z]HHP42*,C]U+M.C9O;'']I&5):R^&1S%.V,OIB>Z3OW>2(:X
M89,K0*$W>XGHIRP*:2H7_+4P".M/@_KKMJ5/O]-L<& <=Y,E,I;/:MRY.?O,
MI8/H?BX;7Z>!JMT[&1292IO3'"1'HW%KC=JT"ZW<# G^;$ZQ..F*ZPO;K>9.
M%(1,O8N=W5Y*5:/-UF5G)%AT3)]^S'EAB*P2L5&*LIJ6D7$CKZ_Q(9V\M%UO
MZ%2ADY,Y"M<.D3I@'/FL\[5<PY=B[T$<N1G,+/7QERR)4CNQW-2+@CC)G->?
M8OPP>W>VA[V?:7SP/9OAV=MR#J\)ARQ9(HR]SLMC,8<.KU_G[QT4>'8-LN4U
MZUT*SR$N-D#ZPI:J#KP\DYU#?M_A'NN28%<:4Y+D"YW.Q(K](&)!$)J.RTP6
M!B!Z\33*0M<+'?[J$ZD>/IWN]IQ.&>0Z6/=Y&X^D\B*VV8M4V VN-E W:EY@
M!& 90U.L=9LW5']@C"GO<9D7*_+VR,DW$83JPL4C/&NO^=[9P>S(V:PY;,(#
MM0;/LW977U=PNKKZ6N< ,B/+*Q0:6/&Y,[KFT*, ,VMR.1-6Q5B8@P*+A6JH
M'#6\N,VKLA"P<@B@Q<FF/4M[4P$=#!J&IV88,YR+L&E8"V0N9!3#UIF$[F*)
M$"&$#;$_O9'RQ%BN$ WE*-M:)=UD4+%(*9^!L%L-L"/6SI\T\[F,<5?QVD+F
M0 <VQV"U(E$VU[8-=&59P;MZ?24'%&3T@M$.">\TL5-4_S4<,?)2K;552\$-
MMTU6/:''B!0[,4C2(=<G@3MH;LE)A*UY]QH0\W@2$_X=IC_G.1H[OYB<CW_[
M-#F]?*&KP_(=QV:NZWDN<[D=19%G,S^VPBA-PM3?:<'.V28#( $F"!7H]5G]
M2)FNFF2>BN9"ZDR5W^8S?BUT%)J9XBPB?%#&KY#?I;UAAH6Y]C+H2G-H;I02
M'?:Y*DC[6K>S,<&-2*(4T>V"4>HKU]7ME=-?%/P=P5X5*^);"UZPV1*OP-E,
MJ&:+9MNTHD6D]<.PQ%4$_+:&B[3.6!.%IH\=XP#Z8Y=W@[H_)&-_2.[]7NS-
M?8[&Q+ .SWZ9G(Y/+Z<O%1KMV);+&'-,)W#=.&9V$@=!FKG<32/'WVGQV-TF
M'G=8WL*YD24C-)'G]3 Z)>0DS4Q(913.CL:[T/$(,#+ "R9!K(?5FA13\3G+
MT??0'NDF-ZX-L)#"C H;)"&'M.?[7G]/RB[XTW>\5:B221J8D>=R[@6)&]HN
MLVT_LE,>NHF/V<NOG4UM5P;'US'/XYI7M]PX:_3?6N7NK^L[Z4HHN)252_D,
MPD9-M_GC_(3$25KK\UH <:-'M9KR0\Y4V/0"LRGX<GT!C(Y+<+M#^X#^66"Z
MD>WQS&6.S[S8=6+066)FFJZWVX 8WSVSXA&P@G@J>OBJ@^="",$H<\./)2T\
MNDHPQ1[/54JW(M5$)?OO:JF"V"72/Z:R*[PM!M<GE2! C7ZM."I&!)-<?4_O
MMP8K^BHG1Q\>(64>$:\-'0L"WE*FJS[\%O^CT)^?XJ=QTMCD(?>RE+N6G6$I
M=]>VN1/[S/+MW<Y#^N[Y(5\]+>,%9F2PF1 3/^0SS"39?%I&0[[7)94;1@2"
M7'HH)!W?KU\2%-*HXK:'Z1>OF%(>@1&<E27+12JY\GV0;[/.EZ2]RM%W(V/4
M/W*N8D/BYNE+]<*&N@2%>EE6XJ]*@'?0GTWCNC.59QF:GD5@#GKRE[SUX5)[
MQ%6R'#,/A9T1%'.8"&C?<*756CIC6B;2SMCS&^/+9+I%XW8!GT"367_LFO]F
M:.KCQIVO UN<((8'654QET%9'K*1T61<"//(:B:A>JH&S*19O,FK*(W@\<A*
M'<?U?<MU/<N.7"_(+-.ANF3)CE<7^>X)/%_E,R?"V?#8>_CN!L]/RSKROOZ)
M,?W+FC P>85H@"#=-MDC'$\I'38*X@!^PJ3,.5,^CX< )K:;L-TD9+87N78*
MTF5BL3#FMAN&CF,%:9*8NYU@^=TS2;X.1MEEK@V!H]E5DA?)=T.*$ ES&RY!
M97;&7$W)I5NK+046Z0Y\Q&C]PN<+NH$I.@'N+F+QJX:/"P"@G#"DZ+H1=P^[
M9?FL'SV@_JV/67I.U=G5[A(Y>NBDJ(7]6#A?85@S#85%>DXWWT_;GV@39IEI
M>B8<.KA;F.?&< BMB >)PT+;W/%"J]\]T>81I0:-<2I"I!$5EL?+!ZX9D>(,
M!"?0B>#AD13'EC>BP!7%@!<$_87/512&([P:%= !IHUAE3:!/A:OZAR?'36>
MF$>Y>$<MZ K97WL^'O5/.W?MZ%=%FR9)O>(335=P8K-5U;JS>[$,N8S38^V"
M=:=<PVL8F VS:J('XI)5*4Y"Q%V4ZX*TD%OE,L4B=D&YRWLQ&5MC2G^,#\E[
MCL8.STY_F5Q,C\].C;,/QOG%\>GA\?GXQ!A_.KMZ,;>YCT ,66#YD9FZ21*'
M?AQGS(OCP';BV/->.X]ZR*7D;9=+2=WO6T/Y7W4B#5I^24COQR62Z-P&O CQ
M1"_H*F4@&6E<+I8]04>%_PQYOAN'=9^+=<'D6P!E6U^TF,_*NY'J60LT/T>,
MN9>*=+1 .+!!($@<SES3\4(KR5(O]KW,SGPOWO%SMT5I)I^$>X%P@?^X$_@4
M $#/LC-FNDYL(;*E'S*>Q9:3!I:9I5:\V^G;W]V[=MGE/W-VK]B6'L>#GFR*
M E+ &7E!*ME(-U)N8C'(M:0EE QK99>'B9> "A"&KY4',QF/F6,\D#0?ZA[U
M-=[9A#U2E0ZJ:5IJ<Q&/'@R)EY>4F[+ R*,>.VXT34HMGS6629)R6H$X+LO/
MZT;5H041:4PB^$IIDN*U-6<)K:Q*CM$,0/JMLB%ILD47ZEB>MQOXTW%\ED6Q
M'<>FZ?*$19D?!V%BII[I! G;;6B0[^X_;$/*&QI/,=I847B-&A]:*.11U,TS
M6M4<PO5^++)A[QQT\0WWVUPP==AKQ39@#+J51Q-T8.%DWIIV0C:/?>CT4P6?
MM5PT%6^M'T@X>[.RQDAP.F0"EIMB# F\NL,D5(4@S;RJ%CHIY[S# "I#\\O
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MVF]Q6%+T6#;@:4E++DP2;9$94& V.'W(AMPW:915MY%<X.,^I-)WC--*V7G
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M\@6,:TS $]@B.I/KI29US\L")<=TQ353OG">8;P\?#YJHUO5*##2,"]6!"F
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ME2OB]2</)GMCP607NQN?G/BU-$T5 %IX :1CGMQ#LR[;4&\M-"Y:LB^_\0U
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ML&TA&+S$3G6^K&;280GM/ >S69>M[985EW559 #5RP 2:MI?B9+8CIMX%OE
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MDYFT,&\9!FE.";Q1>FX'ZQT7!X23^:PL+ES!J33I8)X.!-#WTL[/0%9R=IA
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MU+(T75ZE; 4G0*.FSZOFM,,$BKPY;^.&4PS<^L/<L\8<QC%"QW ZSH5"D].
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M]?']4>?=:Q2Y"O96$-VM$D@3BJV?JN8HW$;S@KPPY@9)C8T!-642H+[!J/[
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M516@IUD_"V'$HN(\)SM_FK /)8@PR7.22L3%+HU%W[ED-K(A0?OGE)"4ZH9
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MLOV^5?L?L)Y]Q'4E198?\2,SM8[B9+*;3+)Q9O8S1$(2QA3! 4DKRJ^_IQL
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MOIZ (,@O1M">*T((8DXO,0VZ42$2N)<T5C$W"YWT&FMBRWO,R2\O?,J!./C
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M8*NSCW9=1KNV88DB6C1:-%KT4I;36KM0%K%61JRMF5>$]=$L3AI2Q:H]&K,
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M)Y47])*2SUFAP>4CA;C6I%W!;1A#9X3K_KTP5[MIK&]/TX6D1\";Z@I1;V<
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MF<1+0\KVI5LA4J&MR-?/EJ1X=,&<L]*WDJRS]-WR#A,C0U*SQ!S)>([Y4>]
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MQ0'Y3RBV$?E#_M.&#_\#4$L! A0#%     @  HIM64/2F$58D@  VTH$ !$
M             ( !     &5F,C P,S@T,S!?.&LN:'1M4$L! A0#%     @
M HIM632T&OCR8P  L;4" !8              ( !AY(  &5F,C P,S@T,S!?
M97@Q,"TQ,RYH=&U02P$"% ,4    "  "BFU9FMI!5/9>  #W%P( %@
M        @ &M]@  968R,# S.#0S,%]E>#$P+3$W+FAT;5!+ 0(4 Q0    (
M  **;5D"-._[6EX  $82 @ 6              "  ==5 0!E9C(P,#,X-#,P
M7V5X,3 M,3@N:'1M4$L! A0#%     @  HIM634RJY%$6P  3E " !8
M         ( !9;0! &5F,C P,S@T,S!?97@Q,"TQ.2YH=&U02P$"% ,4
M"  "BFU90R]AC_TI  "5ZP  %@              @ '=#P( 968R,# S.#0S
M,%]E>#$P+3(P+FAT;5!+ 0(4 Q0    (  **;5EQDJ=E9$D  'S" 0 6
M          "  0XZ @!E9C(P,#,X-#,P7V5X,3 M,C$N:'1M4$L! A0#%
M  @  HIM65R%#D^L,@  U08! !4              ( !IH," &5F,C P,S@T
M,S!?97@Q-"TQ+FAT;5!+ 0(4 Q0    (  **;5DT;[3E5 ,  !$0   5
M          "  86V @!E9C(P,#,X-#,P7V5X,C$M,2YH=&U02P$"% ,4
M"  "BFU9I59H,R86   &KP  %               @ $,N@( 968R,# S.#0S
M,%]E>#,M,2YH=&U02P$"% ,4    "  "BFU9RZ.]H(D]  #RD0$ %
M        @ %DT ( 968R,# S.#0S,%]E>#,M,BYH=&U02P$"% ,4    "  "
MBFU9^Z>]!4H+   _3   %               @ $?#@, 968R,# S.#0S,%]E
M>#0M,RYH=&U02P$"% ,4    "  "BFU9NB@L=Y ;   1:@  %0
M    @ &;&0, 968R,# S.#0S,%]E>#DY+3$N:'1M4$L! A0#%     @  HIM
M67SMCX_R$   JM<! !4              ( !7C4# &5F,C P,S@T,S!?97@Y
M.2TR+FAT;5!+ 0(4 Q0    (  **;5D#X.(,5@,  ,H/   1
M  "  8-& P!F:6%C+3(P,C0Q,3 V+GAS9%!+ 0(4 Q0    (  **;5E 7;.D
M\ @  -];   5              "  0A* P!F:6%C+3(P,C0Q,3 V7VQA8BYX
M;6Q02P$"% ,4    "  "BFU92XK642<&  #_0@  %0              @ $K
M4P, 9FEA8RTR,#(T,3$P-E]P<F4N>&UL4$L%!@     1 !$ ;@0  (59 P
!  $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>ef20038430_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="fiac-20241106.xsd" xlink:type="simple"/>
    <context id="c20241106to20241106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001854480</identifier>
        </entity>
        <period>
            <startDate>2024-11-06</startDate>
            <endDate>2024-11-06</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="c20241106to20241106"
      id="Fact_6aef2da6017649ca8eaf9ef1cbb46fa5">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate
      contextRef="c20241106to20241106"
      id="Fact_01468f25e490424da8667e9f9557717c">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:EntityCentralIndexKey
      contextRef="c20241106to20241106"
      id="Fact_3bcebf742a8848dd80751ab414941c8a">0001854480</dei:EntityCentralIndexKey>
    <dei:DocumentType
      contextRef="c20241106to20241106"
      id="Fact_9dc2d34fc96a46a4b6df842da5fb07e7">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="c20241106to20241106"
      id="Fact_61baca87c3ba484e99fce19ab406f016">2024-11-06</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="c20241106to20241106"
      id="Fact_79488c88d7ec43f89c11163737988078">DEVVSTREAM CORP.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="c20241106to20241106"
      id="Fact_d9b828f9166c455ab41606de79c398df">A0</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="c20241106to20241106"
      id="Fact_06077e7ca8674217baa379bf6e6676af">001-40977</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="c20241106to20241106"
      id="Fact_0280d14b08724b04b8c86ba6bc7258d2">86-2433757</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="c20241106to20241106"
      id="Fact_f55bbaa99b6a41938500ced7c8730859">2108 N St., Suite 4254</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="c20241106to20241106"
      id="Fact_944d8a61959545d39e5896d2c36bddfa">Sacramento</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="c20241106to20241106"
      id="Fact_70adaa552b73496e948b78e8d93e9e4b">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="c20241106to20241106"
      id="Fact_83b6a4ede69b49399c64f4676fb99fb5">95816</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="c20241106to20241106"
      id="Fact_0f666df4c42e4a55b6fe7cd95a898cf1">647</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="c20241106to20241106"
      id="Fact_fe616e4f45604ea3b5e2612032acbfdb">689-6041</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="c20241106to20241106"
      id="Fact_9db15126f62e45abb375a183157c2075">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="c20241106to20241106"
      id="Fact_d1702915bad04d20b1a72cc949abdd81">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="c20241106to20241106"
      id="Fact_9818771142f948a0a5de7dd552aa305b">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="c20241106to20241106"
      id="Fact_38a2b1734d5845bf9dfc63ed3d1a6c51">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="c20241106to20241106"
      id="Fact_09eb785f23054fb080d0e8e0bbe96205">Common shares</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="c20241106to20241106"
      id="Fact_7426a65284b843448961634b4fd52d7a">DEVS</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="c20241106to20241106"
      id="Fact_f171f6715996479f95c531fceaa43512">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="c20241106to20241106"
      id="Fact_7dc736359f6248ddaeb02acbac86ce2e">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod
      contextRef="c20241106to20241106"
      id="Fact_40362fdaad5d496ba5cc5d4958a35da4">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
